cell_line_id,drug_id,response
NB4,24753719,3.7028003977883137
SNU-878,1716436,2.8972114014071364
JHOC-5,49766530,-2.297129087448997
JHH-2,54618771,-0.1274840314711515
BT 159,6918638,2.114216253864974
SNU-738,151289,-0.5354491033571672
OCI-Ly3,4259181,-0.1616612088591607
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
CL-11,124202324,1.843948943741181
HCC1419,49766530,1.3909719340179874
CHP-212,49766530,0.7165809127280346
SK-MEL-30,124202324,3.0453520252747492
Caki-1,148198,-2.50080081476661
SW1783,374536,1.729044945983793
NCI-H1339,9911830,3.231454639260267
HCC1171,2729026,3.0352560520523237
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685
SNG-M,654092,0.6619410782765897
SNU-1214,654092,-0.8857733624045308
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787
Ci-1,6450551,3.768274811847363
SNU-119,54618771,1.6343524810724477
U-BLC1,135659046,3.900294549540867
Hs 766T,11404337,0.6729236116595668
FTC-133,1716436,3.3698315146098015
DAN-G,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9455128127631007
MDA-MB-361,44137675,1.9369823567119144
KNS-62,2708,5.476682649345074
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552
U-937,11404337,-0.2465746995884755
Kasumi-2,24753719,3.2877720740856815
SK-ES-1,2729026,2.1867888828313125
BICR 6,4259181,1.0672551037347004
Karpas-422,136227924,2.027369566350396
JHH-4,135984461,4.02642317281815
BT 164,54618771,1.1636109320756167
DB,selumetinib-BRD-A02303741 (4-1 mol-mol),5.46389451195271
CFPAC-1,654092,1.0465040814172588
SR,9929138,6.2909687425027405
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
CHP-212,1716436,3.7133704430251377
Jurkat,9868037,1.5278313323124582
NCI-H520,135659046,3.9949277821053704
647V,100016,6.109475002217934
SK-MEL-1,124202324,3.0885647549901707
TE-1,9911463,4.060857496316997
CAL-78,9911463,4.373353120464338
SNU-213,100016,6.954868306659309
TE-4,1716436,3.7258776330910672
BT 172,6450551,2.5931679062768063
SNU-449,16013152,4.866412327860677
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
FTC-238,10385095,1.0815791008824205
NCI-H841,6918638,0.9604631046268464
KYSE-150,selumetinib-BRD-A02303741 (4-1 mol-mol),6.4716321316706615
MKN1,9868037,3.4608837590202746
RD,151289,1.7088771869586346
Hs 766T,374536,4.375830267271585
KMBC-2,71729975,0.876835648832875
HD-MY-Z,2708,3.182258749778764
253J,44137675,2.286546537898652
JHUEM-2,9903786,1.0264930895087971
Mono-Mac-6,9911830,2.162103940200585
HT-1197,selumetinib-BRD-A02303741 (4-1 mol-mol),3.93591752601404
COLO 792,46926350,-3.904644275362758
CAMA-1,10385095,1.2422213124573045
BT 224,9911463,3.280505090907216
Sq-1,9911830,3.1818230032109587
SK-CO-1,24772860,-2.764468608226056
NCI-H1581,1716436,3.0504144562003823
NCI-H929,151289,1.2109794778223528
EN,44137675,4.18132918009496
ACC-MESO-1,10385095,1.944189744357827
NCI-H1355,16013152,4.90739501068702
HCC2935,11485656,3.30580870934939
NCI-H441,2729026,3.0015839199726626
LMSU,6450551,2.7750286997333515
CGTH-W-1,327653,4.251940578984738
COV362,9903786,6.486394788749974
HOS,24753719,4.020757044996551
DMS 79,49766530,-1.9641825285331105
U-937,sirolimus-bortezomib (250-1 mol-mol),0.5850227728036819
Mono-Mac-6,9911463,2.1674354406749914
NCI-H650,327653,3.3544160833227337
786-O,374536,2.061350463775134
KNS-81,49766530,2.7158517560502293
LN-229,44137675,5.667926871541482
T84,374536,1.231955264187491
SK-ES-1,11167602,2.2216524822610886
M-07e,136227924,2.437184343955499
SW1710,10385095,1.3769987294121624
SW982,11404337,-0.6290614073029407
SK-MES-1,2708,5.649304428959478
NCI-H1703,73707371,6.5885481962841475
BT 330,54618771,1.126600316617638
NCI-H226,11167602,2.8727400053308054
OAW28,24753719,4.434201172795376
BHY,2729026,2.0722348583541828
Caki-1,135984461,1.2044683879292255
SEM,44137675,3.2773016295912445
PaTu 8988t,54618771,0.599962301527202
EFO-21,16013152,4.636668076939603
RPMI-6666,9903786,1.3063050389166864
NCI-H522,54618305,4.230012053256092
IM95,tanespimycin-bortezomib (250-1 mol-mol),-3.0654337981747273
L-428,6918638,-0.3138373301557662
HCC-56,54618771,1.0985960691001735
HEC-265,100016,5.251492285111922
SNU-685,JQ-1-UNC0638 (2-1 mol-mol),2.3507130145280613
BT 224,374536,3.804565107250823
C2BBe1,327653,3.1461118239439183
MV4-11,54618305,3.9427264192697304
CAL-148,374536,0.4158058599652137
OCI-M1,49766530,0.2650302716544968
G-361,9911830,2.7036070449516956
P3HR-1,3815108,2.9512459624798475
Karpas-299,327653,2.737482841251175
NCI-H1651,71729975,1.6343816445459696
LS1034,11404337,-0.6299919233148044
Kuramochi,374536,-0.2139382777479462
L-540,9911830,2.3452957340804845
RPMI-6666,54618305,4.308512579148535
HEC-108,2708,6.110657664739327
COLO 800,2729026,3.0608891355077423
HCC1937,136227924,3.58866664774513
HCC78,148198,-2.104540151198766
MOLM-6,654092,0.1956499513490257
ECC12,9911463,4.410460667736256
G-401,24753719,3.1602445998928186
KYSE-520,374536,4.45526699852495
WM983B,6450551,3.5533890395991428
HCT 15,54618771,1.4400117592771968
RCH-ACV,9911463,3.0164495694829903
MKN1,54618771,0.4952124443033494
BFTC-909,2708,5.254338200716292
TE-8,327653,2.91040693421224
P3HR-1,374536,2.4503308700310904
BL-70,44493528,3.7970898660168584
NU-DHL-1,148198,-4.718908672184396
SK-MEL-5,3815108,3.389102935160336
SNU-C1,tanespimycin-bortezomib (250-1 mol-mol),-0.731545490498155
AML-193,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6927849137400492
KMS-18,sirolimus-bortezomib (250-1 mol-mol),0.6867934925830966
NCI-H1944,10385095,1.274017817809668
U-BLC1,71729975,2.20107347292816
COR-L105,2729026,3.0417945234466863
EJM,24753719,3.944145631978448
TF-1,10385095,0.9707611134468052
JHH-6,10385095,3.92462202352124
SNU-46,11485656,2.352857034894664
PaTu 8988s,100016,6.475282567189534
DAN-G,tanespimycin-bortezomib (250-1 mol-mol),-0.938511355699207
Mino,9911463,2.4278795242831253
NCI-H1869,24753719,5.307545419394006
AsPC-1,136227924,3.2025742465891938
TE-6,9903786,2.448917190367821
COLO 699,2708,6.003722790200246
WM983B,2729026,2.1809700397444236
SK-N-MC,327653,2.919056740223589
WM88,10302451,3.9540346970245337
EoL-1,46926350,-6.477823582380018
BT 187,10385095,1.3711588262291492
NH-6,24772860,-1.61053354282491
HDLM-2,9929138,7.073059321939057
TE-6,10385095,3.1103566350783476
MHH-CALL-4,2729026,2.223040922218365
Panc 03.27,44137675,3.8404407681111414
Calu-3,2729026,1.038033647832599
MOLP-8,753704,3.0200894206550877
SKM-1,6450551,0.4724418001355981
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066
BT 328,100016,6.778172011931934
SK-MEL-5,1716436,0.9417842907205056
TM-31,10302451,3.782179608043209
A-549,4259181,-1.4635956785215285
GDM-1,9929138,5.504057309727688
NCI-H647,9911463,4.264902637756033
SNU-245,54618305,4.280035674003469
SW1710,9911830,2.762967184848754
Rh30,4259181,-0.0513529873152824
HOP-62,9911463,3.8769302944036266
ECC10,9868037,1.7411053203163678
EoL-1,753704,2.475731119120275
Mono-Mac-1,54618305,4.078084902520956
BT 248,2729026,1.163283415080523
CMK,753704,4.452910464777183
NCI-H650,9911463,4.297971078148598
DMS 273,4259181,0.4383145170351891
Hs 839.T,49766530,-2.6127392720366296
KP-N-SI9s,100016,6.171993249574907
OVK18,10385095,0.3993250675244317
KMRC-2,49766530,0.0425057620545657
CAL-78,148198,-3.3120211354405953
KE-37,156414,0.759529623484987
KMS-34,327653,1.2067417719719684
OV-90,11485656,2.959062717330634
KE-97,11404337,-2.252102327608571
U266B1,1716436,2.8780287039679013
Daudi,24772860,-3.9771177154169304
COLO 684,6450551,2.775675383133718
CAL-62,44137675,4.158311698716794
NCI-H1581,148198,-2.796222248008704
NH-6,6450551,1.0845110763020014
PE/CA-PJ41 (clone D2),1716436,3.6798676111614457
NCI-H661,3815108,3.885074716587427
LN-229,9911830,2.743513873470427
JMSU-1,24772860,-3.0251420704404848
MDA-MB-435S,9911463,3.9126633903128143
SK-CO-1,49766530,2.416603727276247
SCaBER,327653,3.3904080006606394
BT 286,374536,3.426675663898697
K-562,6918638,0.0740833242167517
Hs 888.T,10385095,1.428283638903242
YD-38,44137675,2.339878994758295
JK-1,1716436,2.364387913594
Hs 688(A).T,11485656,3.741191414447006
Capan-1,327653,3.1248384671803353
NCI-H211,10302451,3.113222756869034
G-401,327653,2.827166761380022
U-87MG ATCC,tanespimycin-bortezomib (250-1 mol-mol),0.7593284831518214
NCI-H1341,46926350,-6.117833817798342
G-401,49766530,-2.7444300270308113
HMCB,148198,-4.3449695976370055
BT 248,156414,1.4948422332158926
SUP-HD1,327653,2.769714391892401
Tm87-16,49766530,0.8637146059158625
K-562,10302451,0.1323934402367818
HeLa,2729026,2.7909248989081346
KALS-1,2708,4.964455322707892
KE-97,9868037,2.0832362410238736
KYSE-30,135659046,3.903698290168812
YH-13,44137675,2.4918035822396973
Capan-1,49766530,2.9089609583789535
ACHN,2729026,3.113905064018773
BT 147,9903786,1.444914560684451
Hs 895.T,135984461,4.899016961012941
HEC-265,11485656,2.4370263560731926
U266B1,151289,0.75093926537015
PSN1,4259181,0.8608268947596887
SNU-685,11485656,2.7967045381666877
NCI-H2110,1716436,3.4022042263381675
CMK,54618771,0.9710170961013548
IGR-37,46926350,-3.713079769128535
NCI-H2291,10302451,3.44442862522121
TE-9,9903786,2.6320007696302894
OV7,44493528,4.3650629685356055
NCI-H1563,156414,1.562418155700701
COR-L105,156414,4.037454349539868
LS123,54618771,1.1296400370948565
KMS-21-BM,374536,-3.263973560371936
SU-DHL-8,selumetinib-BRD-A02303741 (4-1 mol-mol),5.245597075026839
HCC95,sirolimus-bortezomib (250-1 mol-mol),1.734022258386224
GI-1,2729026,3.0501619618303986
SHP-77,4259181,-2.0611623813860103
TUHR4TKB,10385095,1.8119484720686647
Lu-65,10385095,0.4710137676717799
TM-31,54618771,1.840176176931743
RS4;11,136227924,1.742872720779967
NCI-H2126,sirolimus-bortezomib (250-1 mol-mol),2.4996087284391493
T-47D,1716436,3.2356481192687507
KNS-42,327653,5.121244030514587
NCI-H358,11167602,2.5925137081670293
Ku812,2708,3.4695310575636262
RT-112,54618771,0.4568083672151968
JMSU-1,9911830,0.8629404413226613
BICR 6,156414,1.5223204989206929
SW1353,9911463,4.226440696401509
SNU-1272,9911463,4.2598402664697685
MES-SA,11485656,1.9187947649537451
HCC1428,10385095,1.0242844092900787
BT 147,10302451,3.751322201692566
HMC-1-8,10302451,3.7891789370584967
HCC38,6918638,0.6464158254242791
SK-UT-1,11404337,0.3155392200884543
OVK18,374536,2.82447185414735
253J-BV,44137675,3.873286387408149
Mino,9911830,1.0503076614334173
SNU-601,2708,4.262229732722477
SK-N-MC,11485656,1.4655490415518024
LCLC-103H,654092,0.5307026796707454
NCI-H1869,2708,5.656178474810682
CA46,1716436,3.005257864158129
BICR 16,44137675,4.155589962246474
CGTH-W-1,100016,5.226111530095554
BT 232,9911463,3.3781399253099256
NU-DUL-1,136227924,1.961051427269065
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
HCC-56,10302451,3.7677535656973538
HEC-265,9911463,4.29184324369936
MM1.S,135984461,3.1063926235928703
TF-1,6918638,-0.802877327266543
NU-DUL-1,148198,-2.450510583541313
KYSE-140,24753719,4.654807821882373
HuH-1,4259181,-0.1704791553622929
AsPC-1,10302451,4.160835682979353
SW1088,1716436,1.604548500044702
LXF 289,2708,6.094251503540483
HSC-3,3815108,3.409091117249246
MOLP-8,9903786,1.299688823902182
NCI-H2228,9911463,3.8620959723614474
NCI-H2405,2708,4.380289355594943
COV644,10302451,3.712338518023003
MFE-296,sirolimus-bortezomib (250-1 mol-mol),-4.372432753750482
TCC-Pan2,44137675,3.247460964649526
A101D,49766530,0.6153321218578233
SW1710,4259181,0.6388275128085489
NCI-H460,374536,2.933441634270558
SK-LU-1,JQ-1-UNC0638 (2-1 mol-mol),2.0319660183745434
MFE-296,6450551,2.347983889751037
NCI-H929,124202324,1.4595728205494207
BT 320,9911463,3.706038906545982
NCI-H1355,9903786,1.6922210610733373
SNU-1272,124202324,3.3198251305185975
TE-9,tanespimycin-bortezomib (250-1 mol-mol),-0.7055515782179059
TTC-709,9911463,3.2608867997672935
SNU-475,11485656,2.631087250262813
RPMI-7951,44137675,2.7666009410901284
OCI-AML-2,654092,-1.596825626136991
NCI-H650,100016,5.632760623979546
BT-20,44137675,1.5709438408524368
LNCaP clone FGC,2729026,3.004810986448101
KG-1-C,54618771,0.7082793216949752
HT-1080,148198,-4.2926124844234765
HCC44,327653,3.1372767049709296
CCF-STTG1,6918638,2.2635117256438835
HT-55,9911463,3.2790943482968986
SK-N-AS,11167602,1.8912366678699168
HDLM-2,4259181,-0.5875112476137577
ECC12,10302451,3.676093433206526
KPL-1,1716436,3.0436551779675134
BT 330,6450551,1.8703937125350776
LS513,3815108,3.88906805795628
OCUM-1,4259181,1.1079950036965132
ZR-75-30,1716436,2.715118045417219
SK-N-FI,54618305,4.445177677039758
SiMa,11485656,1.7152313811667237
GSU,2729026,2.813938061074571
MDA-MB-453,4259181,0.7923345004369465
COV362,136227924,2.2847413829349947
NCI-H1755,4259181,1.0124007009100535
G-402,10302451,2.796814888628964
SNU-1079,49766530,-2.354055789977545
A4/Fukuda,54618771,0.259551202975953
HOP-62,11485656,2.83083000651899
NU-DHL-1,156414,1.5243299906287209
Peer,9911830,1.0689341420266956
NH-6,44493528,5.783725141488281
GSS,10302451,2.0776350865742623
SNU-61,10385095,2.7560205308704044
Hs 940.T,136227924,0.9830608526546036
SF539,54618771,0.9520052550930058
KE-97,44137675,2.8401864970569703
COLO 829,11485656,3.3013884087788794
U-BLC1,10385095,1.1292120884131938
SUP-HD1,4259181,0.3829881633856215
HT,135984461,4.608558257937864
SW948,1716436,3.337695569228523
8505C,54618305,4.737027632312438
SNU-61,10302451,2.848073588995495
SW1990,46926350,-4.013688074453093
MOLP-8,24772860,-3.493237790177901
NCI-H1650,327653,2.4203242647198153
T-47D,327653,3.493418775441787
CHP-212,6450551,0.5161014031000566
LP-1,6918638,-1.2002393899697523
SK-LU-1,54618771,0.3237862890103595
BT 416,10302451,2.165106846355265
L-540,JQ-1-UNC0638 (2-1 mol-mol),0.6861596172973606
TE 617.T,11404337,-2.8418150062947487
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
HuH-1,9911830,3.3566600016915755
Capan-2,327653,3.5536187124726104
NCI-H2106,tanespimycin-bortezomib (250-1 mol-mol),0.3731532829488707
NCI-H1703,24753719,4.328584237137895
LP-1,4259181,0.3929382473497618
SW982,9903786,2.8939777098979333
SK-MEL-1,100016,6.470813601542051
MEC-1,9911830,1.5566898660599335
COV644,46926350,-4.374766029543544
LC-1/sq-SF,9911463,4.2961748372048465
BCP-1,151289,0.6455205839579172
HEC-1-A,49766530,-0.9816829149963144
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
VM-CUB-1,49766530,4.3854090079907015
TYK-nu,54618771,0.511557548457066
JVM-2,JQ-1-UNC0638 (2-1 mol-mol),2.283419421674946
U-118MG,9843750,4.481895856411635
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
IGR-37,156414,1.774854831406992
C2BBe1,374536,1.3393255609997938
NCI-H2110,9911463,4.283441783130732
SF268,156414,1.5872153411250456
KCL-22,148198,-2.536000653707389
KE-37,6450551,0.741855379514727
MHH-CALL-3,sirolimus-bortezomib (250-1 mol-mol),2.0420007480682925
HEC-265,44137675,3.7743452166975344
NCI-H810,46926350,-6.121386804153376
RPMI-6666,44493528,4.272159691282271
KYSE-70,10385095,0.9665013844498838
BT-20,11167602,1.9201106442116993
ZR-75-1,sirolimus-bortezomib (250-1 mol-mol),-0.944196489916664
OE21,135659046,3.360946677017383
COLO 678,2729026,2.9665776066744973
NCI-H69,2729026,1.3965842548795562
NCI-H1693,54618305,4.535108475988098
CCF-STTG1,6450551,2.47123391002199
NCI-H2087,24753719,4.17997265759222
TCC-Pan2,327653,3.0100478974076585
SK-LMS-1,136227924,4.704854352606181
MKN74,11485656,1.8439400608742984
LCLC-103H,148198,-1.3742012361346914
OVSAHO,54618305,4.336452781819542
TE-1,10302451,2.6320165218762392
OCI-AML-3,327653,2.492530436962648
AN3-CA,selumetinib-BRD-A02303741 (4-1 mol-mol),5.034678301732505
HEC-1-A,sirolimus-bortezomib (250-1 mol-mol),1.0212510715684435
PL-21,9911830,2.7327137399498302
LP-1,10385095,1.2298439845363769
HEC-108,24753719,4.945792887212488
OPM-2,4259181,-0.0185783035827133
ME-1 [Human leukemia],4259181,1.0162660070131528
MDA-MB-361,11167602,2.1507003029997023
SNU-489,10385095,2.294114675628452
DV-90,24753719,3.9838843577401057
Caov-3,753704,4.746187720084039
BT 228,6450551,3.116687781420001
Caki-2,135984461,3.6867665044524025
LOU-NH91,49766530,0.361985362717411
HEC-50B,2708,5.75291723392243
CW-2,156414,-1.1793376368039696
HCT 116,654092,0.512849736782994
KMS-21-BM,11404337,-1.2049963736057572
NCI-H28,10302451,3.4627926284269503
SW982,11485656,3.4639453633875985
BT 239,1716436,1.9087781155973864
KO52,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.410719813767284
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
BHY,124202324,2.7657460142645793
HOP-92,1716436,3.125653316338052
Lu-99,6450551,2.5444149612854368
OE33,1716436,3.5856703745637195
MFE-319,151289,2.6257885280081945
BHY,44137675,3.649383349259774
GCT,9903786,3.1531512143319396
G-401,10385095,0.8697787767816428
RMG-I,44137675,3.453599202413801
U-118MG,11485656,3.079828371250999
SNU-8,44137675,3.738684584786805
SIG-M5,6918638,-0.9320116161211188
WM88,11167602,2.5186858712876963
JHOS-2,4259181,1.6951681410963
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
HCC1428,11167602,2.130823244043548
NCI-H28,1716436,2.411397067862895
Hs 611.T,135984461,2.1518456912790507
NCI-H2405,10385095,1.0090200859882867
TALL-1 [Human adult T-ALL],100016,4.020437007073488
KMS-12-BM,1716436,2.2490231702489956
KMH-2,9868037,1.8367202409128176
BICR 16,sirolimus-bortezomib (250-1 mol-mol),-4.146745756723436
NCI-H1838,124202324,2.006038481747971
Toledo,9911463,4.445021234029437
HuT 78,24772860,-3.0726220135578353
SIG-M5,148198,-4.503742564102913
TALL-1 [Human adult T-ALL],151289,0.8246895164010757
MCF-7,124202324,1.669454735314292
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006
SK-MEL-30,2708,6.9015332591705585
NCI-H446,sirolimus-bortezomib (250-1 mol-mol),0.5863083212438859
SF126,10385095,2.260425505483892
SH-4,9911830,2.4844641601514863
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065
MKN7,JQ-1-UNC0638 (2-1 mol-mol),4.085476575120813
HEC-265,10385095,1.3618072308793756
DB,148198,-4.69635746988682
KYSE-140,327653,3.149359454040081
NUGC-4,JQ-1-UNC0638 (2-1 mol-mol),-0.7976422990378336
23132/87,654092,0.6345563825378628
BHT-101,124202324,1.4887403013753373
NCI-H2342,2708,6.2205072222546915
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
SYO-1,54618771,-0.0439888220829119
ONCO-DG-1,654092,-0.3940837499823426
U-CH1,10302451,1.8015507562234312
PSN1,2729026,3.0171139698808886
SNU-449,54618305,4.668068655096509
NCI-H1299,24772860,-1.8114387917097616
SBC-5,9911463,4.310936662946409
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
COLO 201,10302451,3.777843454625055
HOS,327653,3.6084770643772126
NCI-H1568,10302451,3.040030486332468
BICR 16,100016,8.634217681257812
TOV-21G,54618771,2.0367745651121867
SNU-1272,44137675,4.576444163035884
MOLP-2,tanespimycin-bortezomib (250-1 mol-mol),0.214791737845908
Tm87-16,JQ-1-UNC0638 (2-1 mol-mol),2.288026655458866
HT,3815108,1.905288388286694
NCI-H2452,2708,3.4614923437122704
P12-Ichikawa,9911830,2.2372509617860414
Hs 888.Lu,selumetinib-BRD-A02303741 (4-1 mol-mol),5.35420488734368
BT 271,tanespimycin-bortezomib (250-1 mol-mol),-3.34346586365967
YH-13,9903786,3.849279075978848
RT-112,11485656,1.7918654430987004
KG-1-C,6450551,3.6298637626939545
BICR 56,6918638,0.6328735578862519
RL,9911463,3.2834076821465525
HOP-92,10302451,3.9702293485609457
KYSE-30,44137675,4.317699456921293
BT 172,2729026,1.3605745020030853
HT-144,49766530,0.4974871030439343
ST486,49766530,-3.0199322417978065
T98G,selumetinib-BRD-A02303741 (4-1 mol-mol),7.193597379594884
BICR 6,54618771,1.779612133300688
OV-90,9903786,3.9551127291738424
HCC15,2729026,2.745990777117554
RT-4,2729026,2.8165603599873306
NCI-H1650,tanespimycin-bortezomib (250-1 mol-mol),-0.4838646802432306
HCC1171,4259181,1.5327045600391374
639V,2729026,3.002943748192407
COLO 201,11485656,2.5416615004104237
RT-112,11404337,0.3024597530600803
BT 187,71729975,2.077715561965723
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
AML-193,JQ-1-UNC0638 (2-1 mol-mol),-0.0998627120499949
SUP-M2,148198,-0.2011306598462228
SNU-738,2729026,3.052453307675739
GP2d,11404337,0.3964770765746153
NCO2,54618771,-0.1705151191723565
LAMA-84,753704,4.417505469352407
NCI-H1341,tanespimycin-bortezomib (250-1 mol-mol),-2.8449301183923756
JHH-5,6450551,1.653121554376384
Rh41,753704,5.0545847278564
OPM-2,1716436,2.6292767753294437
ESS-1,4259181,0.7076598943715965
NCI-H2122,2729026,3.0970241743243654
COLO 205,100016,5.963233409359241
T3M-10,1716436,2.566186854164152
H-STS,4259181,0.3091139042767585
HCC827,327653,2.637856228623
SW620,4259181,0.0662967794588152
CAL-54,11167602,2.099432821181125
5637,selumetinib-BRD-A02303741 (4-1 mol-mol),3.4952884818656993
EBC-1,tanespimycin-bortezomib (250-1 mol-mol),-3.429772106953884
CAL-85-1,148198,-3.2727903710905744
NCI-H2081,4259181,0.351932807704407
HT-1080,24772860,-1.8942973270209964
RMG-I,11485656,3.2385452078002883
NCI-H889,2708,4.676813892692904
TE-1,2729026,2.344095001458036
Kuramochi,4259181,1.3483674721147798
NCI-H1666,10302451,1.573104539002299
MHH-ES-1,151289,0.1383301212391103
SNU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9967147031928247
TYK-nu,73707371,4.322003472954552
EoL-1,135659046,2.6902533100653785
KYSE-450,100016,6.589468110151047
2004,JQ-1-UNC0638 (2-1 mol-mol),0.6783582362203252
BT 131,136227924,1.4796003986288269
LC-1/sq-SF,10302451,3.3793809491586764
Capan-1,11404337,1.6610188182670238
SCC-25,10385095,1.5155908276599988
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749
Hs 688(A).T,9911463,4.549351986100886
NCI-H196,2729026,3.1386730408201187
RS4;11,124202324,0.7406345587673606
ES-2,151289,4.793001662093722
MFE-296,selumetinib-BRD-A02303741 (4-1 mol-mol),5.212102547639401
SU-DHL-1,4259181,-1.4222017445817885
BICR 56,9911830,3.637430453593334
Hs 766T,44137675,3.518724337826282
Hs 683,6450551,2.938905151489075
GDM-1,10385095,1.3683176527917005
NCI-H2172,9911463,3.8994270098936745
Caki-2,136227924,3.8399348879900854
TCCSUP,654092,0.20661025220839
TCCSUP,24753719,4.825833368668945
EM-2,9911830,-2.087916808060928
KATO III,10302451,2.7485935005281736
KMS-12-BM,100016,3.5545657198194873
KMRC-1,4259181,1.968851453570829
NCI-H2052,11404337,-0.3501167429878626
G-402,2708,4.311909983890291
COR-L105,4259181,2.2372065992854133
LS123,9911830,3.2919668415302565
HCC1419,54618305,4.91442381429649
42-MG-BA,6918638,1.602058040932412
VCaP,6918638,-1.0588034112716072
OVSAHO,148198,-1.8727352509545991
EN,9911463,4.4052301302232415
BV-173,3815108,2.2978311215416003
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911
MFE-319,9911463,4.372172899539541
Becker,46926350,-4.071547217187583
2004,9911463,3.209931377747237
COLO 829,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0004416956743445
J82,sirolimus-bortezomib (250-1 mol-mol),0.3485441031707259
JM-1,6450551,1.340572992486765
Mel JuSo,9911463,4.248107858199516
Kasumi-1,9911463,2.7183571819341776
Kuramochi,3815108,2.700543204380364
MCF-7,9911463,4.323534340426757
KCL-22,54618771,-0.0982742970998633
DB,9911830,1.738432800307682
SW1271,9903786,4.005340236032604
LN-229,148198,-2.165786846201969
SW1116,11167602,2.496759203352098
KMS-12-BM,124202324,0.0272958362457217
Hs 688(A).T,4259181,1.1112083370906582
T24,4259181,1.5292017727719016
SNU-119,151289,0.6680539907323628
KYSE-520,54618305,3.9456365566574543
SNB-75,71729975,2.3564347405535937
MOLT-3,148198,-7.168257541547073
PK-59,24753719,4.213783257625297
Becker,151289,0.655779143245145
SK-N-SH,9911830,1.546281106531784
CAL-51,6450551,1.9748462748620472
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
SBC-5,156414,2.5142262290401516
NCI-H1693,2729026,1.4322511884286544
NCI-H1105,9911463,3.5192324604951533
CAL-29,4259181,0.3499471492641841
KYSE-510,10385095,1.814777248632933
WM1799,10385095,1.0402810693524889
HT-1080,11167602,1.7548131113833343
BT 187,9911463,2.9501767294250607
Hep 3B2.1-7,24753719,3.3025122123493573
SNU-449,JQ-1-UNC0638 (2-1 mol-mol),5.2681139205860354
CAL-51,136227924,2.079284078064279
JHH-2,156414,1.429842756041678
SET-2,44493528,4.2834335976641205
TE 617.T,1716436,2.776815289007698
KMH-2,9903786,1.3660293069385576
VMRC-RCZ,49766530,0.1680653140003736
OV56,6918638,2.271106971688871
G-292 clone A141B1,71729975,2.5981668304382732
LAMA-84,148198,-3.5414595786059886
MHH-ES-1,9911830,2.233704183464704
BT 179,24753719,4.0957950149587825
SNU-478,3815108,3.4889039030037603
LNCaP clone FGC,136227924,2.6855023326383387
G-402,24753719,4.198758939409353
REC-1,44137675,4.048277998263935
SK-N-FI,374536,1.9918987494179623
HCC366,sirolimus-bortezomib (250-1 mol-mol),1.704813233293803
Hs 294T,16013152,4.461496069567743
NCI-H1869,135984461,4.367577543921494
ECC12,44493528,5.669506647714131
MDA-MB-468,11485656,1.4404367152008126
Ku812,49766530,-2.390671573618507
SNU-1076,9903786,2.0917140595670585
NCI-H2452,9903786,2.1501841215173396
CCF-STTG1,24772860,-0.8765795135631896
SW982,tanespimycin-bortezomib (250-1 mol-mol),-1.8662349479314355
GP2d,2708,5.0518809004931295
NCI-H1092,374536,2.5568939719400707
PE/CA-PJ49,24753719,4.080575528970359
HCC1569,9911463,3.793678704328586
MHH-CALL-3,54618305,-2.6032617939923672
TUHR10TKB,JQ-1-UNC0638 (2-1 mol-mol),2.720992990852758
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
BxPC-3,4259181,0.1397018777458316
NCI-H1581,11485656,1.8332307875240343
8505C,6450551,3.9943772969832696
GMS-10,327653,2.705235188100399
LOX-IMVI,9911463,3.8715849180913633
KMRC-1,46926350,-4.153095302049271
D283 Med,4259181,-0.2806940214967063
MES-SA,54639665,-0.0179563616855297
NCI-H522,135659046,3.4944475458884012
JURL-MK1,4259181,-1.935656248556129
CJM [Human melanoma],135659046,3.6050904853036703
Calu-3,44493528,4.337619480836725
A2058,tanespimycin-bortezomib (250-1 mol-mol),-0.4864507990371403
JHH-1,54618771,0.3940537570432531
2004,46926350,-4.168097360334947
U-CH1,10385095,3.2714624879482956
CCF-STTG1,11485656,3.67410233042364
SNU-899,9929138,5.051227774447189
VMRC-RCZ,1716436,3.761221448641117
COV434,148198,-5.709180459817414
HOS,16013152,4.243250374371312
253J,49766530,0.1673174329767313
PC-14,16013152,4.486002154562109
MHH-NB-11,9903786,1.7813974868905205
A-549,2729026,2.9601859660531105
HLF,46926350,-4.234809061018556
COV434,11485656,1.9147698543097105
SNU-213,327653,3.9341238423164127
HCC1500,9903786,4.21203406645071
UM-UC-3,374536,4.233441011924494
SNU-620,11485656,1.82591162033248
VMRC-RCZ,11485656,3.731080366455795
SF539,135659046,3.181821233210504
HCC78,1716436,4.133894585754535
OAW42,6450551,3.6149025185851418
NCI-H2029,10385095,1.1841713860109806
5637,49766530,-2.237904920966697
SNU-16,136227924,1.93853165721534
SNU-201,654092,-0.3059555613335444
SJSA-1,100016,7.674645652371816
HuP-T3,6918638,1.0959798369911515
NCI-H146,44137675,3.928890295501361
YD-8,54618771,-1.0700457769979232
P12-Ichikawa,136227924,2.6176590952299477
DOV13,54618771,0.905613637796649
SW1088,24772860,-0.5789569476796274
RL,46926350,-5.889721115518161
G-401,9903786,2.8038927126182327
DND-41,24753719,3.046875575777515
TF-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.633269445545861
LS1034,24753719,3.5681552526361835
HSC-3,2708,5.023023521923633
OCI-AML-5,71729975,1.116439955291679
EB1,100016,6.112181525197604
COV434,4259181,-1.451446052468279
DK-MG,11485656,3.787510091339842
NCI-H1944,6918638,0.6118472454485641
WM115,11404337,-2.7813606850874595
COV362,374536,-0.9774550906475614
MHH-CALL-3,11404337,0.3136523516674954
SNU-1066,124202324,2.98055420758882
SIG-M5,54618771,-0.4946927468469176
EBC-1,327653,3.757400762445518
SK-MEL-2,10385095,1.309860426299206
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738
TE 441.T,135984461,4.21306533466607
SW1353,4259181,0.2746350901066433
RPMI-6666,JQ-1-UNC0638 (2-1 mol-mol),0.3369729201110709
KNS-62,9868037,4.116699778662341
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577
LAMA-84,2729026,2.218752736974602
NCI-H358,sirolimus-bortezomib (250-1 mol-mol),1.7482633742638032
RPMI-8402,6450551,0.6913906875140242
BICR 31,136227924,2.8140968842668923
DK-MG,6450551,3.121106785966397
SK-LU-1,49766530,-1.2707580776234786
COLO 800,4259181,0.2176234402934261
KP-N-YN,10385095,1.8219052928535877
OE21,11485656,1.707456262972337
HCC1937,2729026,2.7772490319674183
HCC366,tanespimycin-bortezomib (250-1 mol-mol),0.9918173547189246
SNU-308,11404337,1.2327957985917497
MKN74,2729026,2.361059527438538
TE-14,24772860,-2.25752573478565
HOP-92,2729026,2.8598779698618255
Panc 08.13,9868037,4.03637116886627
SW48,54618771,0.2213541125267267
DU145,1716436,2.8760857102240034
KNS-42,151289,0.9861409953571912
NCI-H526,124202324,1.2906799461493217
MOLP-2,136227924,2.531478892468582
HuH-28,10302451,3.3389802568514257
NCI-H2126,753704,4.929954232784327
SNU-387,2729026,2.9898449816256227
RT-112,10302451,3.19729006739259
TE-11,54618771,1.216683446725779
SK-ES-1,49766530,-2.1156842470602037
SU-DHL-10,sirolimus-bortezomib (250-1 mol-mol),0.6200641507940263
JK-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8712031645935759
EM-2,9911463,2.8916487141843974
UACC-62,11404337,0.3177271897074518
HCC1438,9911463,4.347213742956148
SK-N-SH,11404337,-0.9981993214283256
SNU-1105,selumetinib-BRD-A02303741 (4-1 mol-mol),3.585929700975504
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333
GSS,2708,3.514621167476827
M-07e,327653,2.415097194547363
TALL-1 [Human adult T-ALL],135984461,3.024733387854321
SNU-407,44137675,2.170632364650884
HCC1806,9911463,4.318466961943044
HT-1080,54618771,1.2813621768338197
CJM [Human melanoma],11167602,4.1800221593609415
NCI-H841,sirolimus-bortezomib (250-1 mol-mol),0.0818724348323602
HCC1954,11404337,0.9656290265602768
KMRC-3,49766530,-1.4126043666581272
BEN,1716436,4.260780053924218
Mel Ho,9911830,3.0073204468383192
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
LP-1,54618771,-0.0349126371834358
COLO 680N,JQ-1-UNC0638 (2-1 mol-mol),4.193549093819176
Malme-3M,JQ-1-UNC0638 (2-1 mol-mol),-0.4724291654506546
NCI-H226,9903786,4.103639248775795
SNU-C4,156414,0.7755904610848084
MEC-1,10302451,2.9779050160540144
SYO-1,11485656,2.328444383399514
SU-DHL-10,136227924,2.6642941314249327
PaTu 8902,54618771,-1.3103145579416535
HCC1195,11485656,3.140969914915027
J82,1716436,2.998123983735976
NCI-H2085,sirolimus-bortezomib (250-1 mol-mol),0.8300546394702069
RERF-LC-A1,9911463,3.9529854896489782
Kasumi-2,24772860,-3.0702303943568197
NCI-H1755,10302451,1.3931824559347357
HL-60,136227924,2.3594265520512447
SNU-1196,100016,6.169672174830197
F-36P,10385095,0.4233873484016709
NCI-H1373,374536,1.9849015702431545
VMRC-LCD,6450551,1.1609878192179426
TE-1,135984461,4.283297519816261
Granta-519,11485656,1.6660529916447626
HEC-6,2729026,2.8904103057341435
COLO 699,9929138,6.696462829183714
NCI-H2196,148198,-4.10304845693827
Caki-1,136227924,3.8203162456228417
NCI-H520,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5796629690366295
KYSE-520,4259181,-1.1472347902805615
BT 172,100016,6.450201924949107
COV362,6918638,2.636273495865165
HuNS1,11404337,-3.482184142703688
KO52,9911830,0.3090306906252232
ECC12,124202324,3.3270282472343133
Hs 944.T,6450551,2.780845845281257
KE-39,3815108,3.17346514425842
NCI-H1693,10385095,0.8246403113712971
KMS-11,sirolimus-bortezomib (250-1 mol-mol),-4.474522876358157
MOLT-16,1716436,2.855172417108442
CAL-51,54618771,0.0049145289548569
NCI-H2342,9911463,3.680960249446254
CAL-78,10302451,3.609429190813552
NCI-H522,9903786,3.9217135447784783
SNU-878,49766530,0.7388609615880275
Kuramochi,9911463,3.7010026849827087
SNU-878,11404337,-0.7245810711343122
EBC-1,10302451,2.6602549654421765
KMH-2,4259181,-1.7257445215614664
HL-60,374536,1.612679295841142
SW1271,10302451,1.5832525718610488
NCI-H196,54618305,5.68839138137451
LXF 289,124202324,2.1762748500922657
HL-60,151289,0.7661107539034757
JHH-5,9911830,1.7602427151080595
KMS-26,151289,-0.1874033438159184
SBC-5,2708,2.061546130614232
RT-4,148198,-0.8360848986797086
QGP-1,124202324,2.139259753063457
NCI-H1341,9903786,1.643545486774536
BL-70,4259181,-0.5589889707355735
CML-T1,753704,4.085313154725238
NCI-H226,4259181,1.8377769952921412
SU.86.86,tanespimycin-bortezomib (250-1 mol-mol),0.1396013159425142
MDA-MB-361,10385095,1.4298673211779267
LS1034,11485656,1.821657133822141
NB1,3815108,2.410977851925272
SNU-886,11485656,2.594845566887895
SK-ES-1,4259181,-0.7252819561793736
Rh41,44137675,1.475596749950218
OCI-M1,2708,3.214265942769868
Raji,3815108,1.348726927410812
SK-MEL-1,2729026,0.783016701629589
NCI-H1573,156414,1.4271496349272998
OV7,11404337,1.1254553955818216
P12-Ichikawa,11167602,1.8664895449187011
HCC1143,124202324,1.6321362493528402
LOU-NH91,9868037,3.6278868560603574
PSN1,1716436,3.6474282357210543
Hs 729.T,54618305,4.441548296188891
HCC2935,71729975,2.914861372275366
Daudi,11485656,1.7254760898020216
NUGC-3,44137675,3.5909447273085937
NCI-H1385,753704,4.4821868924982
SH-10-TC,9903786,4.254901914328344
BT 320,71729975,3.655690084257896
DV-90,11404337,-2.4511468256703908
G-402,753704,4.3503177327823055
NCI-H520,11404337,-0.911000559838952
EN,24753719,4.333025335337193
HCC4006,6450551,3.4851985978736475
NCI-H1092,10302451,4.171918094429464
SNU-601,24772860,-2.136052228229951
MHH-CALL-4,selumetinib-BRD-A02303741 (4-1 mol-mol),3.337205797443014
HLF,10302451,3.786681722046504
MSTO-211H,151289,1.1545674452198869
CAL-120,3815108,3.6966662788585234
HDLM-2,156414,0.7266431352631084
NCI-H2171,46926350,-4.867098709680934
SNU-216,JQ-1-UNC0638 (2-1 mol-mol),2.1879565366107494
C2BBe1,148198,-4.96016580080056
NCI-H2009,10302451,1.2105403110698565
NCI-H1975,54639665,4.272009655983378
OPM-2,148198,-4.827513159673032
SNU-201,44137675,4.106807719534647
NCI-H1581,2729026,2.528011862532561
DOV13,136227924,2.864785745195549
SF268,73707371,2.210444802736955
OV7,11167602,2.335895680675998
NCI-H1105,374536,2.5999586320464756
TALL-1 [Human adult T-ALL],24772860,-2.598635218823236
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
UACC-257,24753719,4.721002106837754
OC 314,4259181,-0.1098665144334052
HD-MY-Z,1716436,3.437361454800368
NB1,11404337,-0.8321448133483081
HCC366,9911463,4.244130983157471
SNU-1076,49766530,1.189560796158491
AML-193,9911830,1.9616986118151176
T3M-10,9911463,3.745237338298436
TE-1,4259181,0.5927596894747944
SK-OV-3,2729026,2.529477515357917
KMS-26,4259181,-1.695112614082753
TE-10,654092,-0.3593944662674118
DMS 114,2708,5.548429842661869
SNU-C5,135659046,3.5746931112208853
HCC44,tanespimycin-bortezomib (250-1 mol-mol),-2.3281487607595515
MHH-ES-1,374536,-4.581990796437391
KMS-27,9911830,2.432969269856635
SK-MES-1,9929138,3.12327700271694
OUMS-23,2729026,1.913056079489749
SNU-C4,2708,5.157005605102466
Pfeiffer,135984461,1.4360263209874906
JHOM-1,sirolimus-bortezomib (250-1 mol-mol),0.2834615362224199
Panc 05.04,124202324,2.40458137163437
KMS-26,9911830,2.0574042745338725
SUP-B15,9903786,1.6008803071908635
Mino,JQ-1-UNC0638 (2-1 mol-mol),-1.8530853214277625
NCI-H2081,156414,1.7676788858922157
SNU-201,2729026,3.0674801010491484
SNU-761,136227924,3.0890701215325085
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
BT 187,100016,7.76208292164505
SK-N-DZ,9911463,3.9970399765376423
H-STS,6918638,-0.6396360846494638
MDA-MB-157,2729026,3.2437974205657816
SW1783,136227924,2.7676121780420364
LMSU,11404337,0.046862413597458
BT 112,selumetinib-BRD-A02303741 (4-1 mol-mol),5.118428363435484
GSS,49766530,0.909441474448473
Hs 729.T,sirolimus-bortezomib (250-1 mol-mol),0.5283641874253757
NCI-H2405,4259181,-0.9091972697869036
THP-1,9903786,3.0926145703043852
BC-3C,10302451,3.564024501759527
TE-6,11485656,1.5497099103986265
CGTH-W-1,3815108,2.9308557320049395
SNU-46,100016,6.6556000707540095
BxPC-3,1716436,3.6064873492654943
SK-BR-3,71729975,2.4880113649696365
NCI-H1623,11485656,1.644044907667622
WM1799,2729026,2.4933561725518114
JMSU-1,49766530,0.5298615958954185
AML-193,156414,0.8692506520261336
HuH-1,10385095,3.172607785650955
KHM-1B,1716436,3.4645640712789545
BICR 22,9903786,3.2901982519836213
COLO 800,11485656,3.591351165158368
IPC-298,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.8257972567970548
SNU-761,156414,2.0745932616636664
NCI-H2106,136227924,2.8262070038466955
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034
ONS-76,136227924,2.542073211711186
SNU-407,JQ-1-UNC0638 (2-1 mol-mol),0.2681079269065803
8305C,2708,5.743310992017522
Panc 04.03,6918638,0.956445062850862
SW1088,124202324,3.201685088989695
BT 164,148198,-5.587345118223356
HCC1954,JQ-1-UNC0638 (2-1 mol-mol),2.973056884794918
EFO-27,10302451,6.465018307145316
SW1353,11485656,2.8326664945571585
SUP-T1,6450551,1.6020206531099637
L-540,9929138,3.361491533267478
KYSE-410,10385095,1.3109396001615272
SNU-1076,10385095,2.120355301569047
BC-3C,135659046,3.4176936154501845
SK-MEL-3,1716436,2.062931798331765
IGR-37,9868037,4.196529232004268
OCI-Ly3,9929138,5.257531923381126
8305C,9903786,1.7590562865334185
DND-41,374536,1.5925527985353087
TE-15,46926350,-4.66402826584901
IM95,44493528,4.078779126887718
JHUEM-1,10385095,0.0269931721526632
MOLP-2,1716436,3.079514243026933
SNU-C5,9903786,3.1730161972997517
SNG-M,4259181,0.7093917409356426
Caov-3,11404337,1.105594084873841
SNU-869,2708,5.475497070806418
SNU-1076,327653,3.6653466863942903
SK-CO-1,156414,0.1991331726980137
NCI-H1373,11485656,2.0239924132240117
BT 328,4259181,1.754792833603723
BT-16,1716436,2.986184597592387
OAW28,54618771,1.1011370240470315
BT 139,9868037,3.9588523345635376
ECC10,327653,1.2684206514801013
NCI-H1651,10302451,3.925825953548281
Panc 08.13,151289,2.983548445684171
GA-10,54618771,-2.458628793316373
PaTu 8902,6450551,4.419968438595772
NCI-H1373,24753719,4.8613532140843105
NCI-H2110,135984461,4.3368706411004325
MKN74,46926350,-4.361505149738949
WM88,156414,1.6850419616886465
EJM,selumetinib-BRD-A02303741 (4-1 mol-mol),6.6447092258899625
NCI-H446,44493528,4.231535039215924
SJSA-1,9868037,3.601599013312942
Rh18,16013152,3.865342032023596
NCI-H929,156414,0.5091151756924145
U266B1,44137675,4.4630375764339805
Caki-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.878209723786705
TE-1,JQ-1-UNC0638 (2-1 mol-mol),3.92220240897555
MIA PaCa-2,2708,5.768507038607672
LS123,24772860,-0.4026378005756317
MOLT-16,sirolimus-bortezomib (250-1 mol-mol),-5.402934760182518
COLO 668,11404337,-0.9260086161567648
TE-15,135984461,4.740662203651603
TALL-1 [Human adult T-ALL],44493528,3.717855911159704
Panc 08.13,JQ-1-UNC0638 (2-1 mol-mol),-0.2148445048514506
MOLT-3,10302451,0.2519809929726158
HEC-251,4259181,0.5128656675600579
NCI-H460,54618771,1.6853262233131374
P12-Ichikawa,753704,3.33414462578563
JVM-2,44137675,-1.0460287576328036
HCC2935,11167602,3.9237673358003766
SNU-387,6450551,3.0803195060672524
NCI-H1568,9911830,1.3917537385715242
SK-MEL-24,148198,-2.756155300346231
LUDLU-1,54618771,1.3669770958947776
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903
NOMO-1,151289,1.0922355572005962
SNU-216,4259181,-0.1596508841879307
HEC-59,10302451,4.030247099665508
A-673,selumetinib-BRD-A02303741 (4-1 mol-mol),7.378712483637354
RPMI-8226,44137675,3.0603793391753813
LS513,327653,2.653571852634388
Hs 683,6918638,0.9726484186750864
MKN74,10302451,4.165847653983995
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581
NCI-H1395,100016,6.569605836811141
SK-MEL-31,sirolimus-bortezomib (250-1 mol-mol),1.406107901853138
A-172,374536,-2.0364874836745877
Lu-65,24753719,4.200901719906933
Kelly,100016,6.527674974645037
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
Lu-99,selumetinib-BRD-A02303741 (4-1 mol-mol),2.745152461824671
NCI-H1092,24772860,3.2138830329080563
MOLT-3,44493528,4.004612742567489
Peer,6450551,-0.3913128765678144
Capan-1,135984461,4.359340050025923
NU-DUL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.8091563692355274
SK-MEL-3,6450551,3.5683510843643296
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
SNU-761,151289,3.735253365334918
CAL-51,3815108,3.0623029951861396
Mono-Mac-1,44137675,2.169476353998281
NCI-H2405,JQ-1-UNC0638 (2-1 mol-mol),1.4404274746575456
NCI-H1694,24753719,4.146900765581546
BT 147,JQ-1-UNC0638 (2-1 mol-mol),3.379723628350543
EoL-1,2708,0.6953704238210308
BT 440,9911463,3.153626294049379
SNU-308,156414,-0.0512353312380724
OV-90,73707371,6.297745696580706
COLO 699,4259181,0.3245175779144991
L3.3,9903786,3.5860218860878263
WM983B,6918638,0.63474278918499
U-CH1,6918638,0.5704766963302896
KYSE-520,1716436,3.82577255869825
TUHR10TKB,4259181,1.0185659270480565
SW1990,136227924,4.2742525725591864
ECC10,135984461,4.0726729521120975
Capan-2,156414,1.6206965519092191
MIA PaCa-2,11167602,2.3171919978995636
JURL-MK1,tanespimycin-bortezomib (250-1 mol-mol),-1.9568027387357825
SNU-C5,tanespimycin-bortezomib (250-1 mol-mol),0.6015716530365237
SNU-398,11404337,-0.6882395076793462
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
NCI-H2405,753704,6.622394975543244
Kasumi-1,9903786,0.9129411943023928
SNU-61,6450551,3.0035817833604783
TE-8,6450551,2.044105461535501
COLO 320,753704,5.035828560681588
Hep-G2,1716436,2.124902478350978
NCI-H23,46926350,-4.564495795452074
Caov-3,151289,1.3352766997596728
BT 112,6450551,1.6386256333107696
SK-HEP-1,136227924,3.6301481247272287
JHH-5,151289,0.7436676008102384
SW1710,49766530,-2.0180793579471183
U-BLC1,156414,-4.628968432164774
IGR-1,10385095,0.5872322378486591
OVCAR-8,11485656,1.8119689787001292
SF539,100016,5.965471494853995
TF-1,11404337,0.9992321487738164
SR,135984461,3.8485164299114714
KMS-28BM,sirolimus-bortezomib (250-1 mol-mol),0.5815431662005854
Jurkat,11404337,-1.079312367340039
NCI-H1299,654092,0.2998187501521066
ST486,374536,0.5049857055827843
P3HR-1,24753719,4.729434793185607
22Rv1,124202324,1.7880919338601249
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
Hs 888.T,44137675,-0.0040323782258604
SK-HEP-1,49766530,-2.8567737760804324
DMS 273,2729026,2.67706862921606
EB1,44137675,0.8362385356656726
NCI-H1869,11485656,1.8296978789565703
K029AX,100016,6.8355789955685395
BT 232,148198,-4.3155726249188
PE/CA-PJ49,11167602,3.7054194129551736
NCI-H2286,24772860,-1.2149543605323567
SNU-C4,46926350,-3.5612530002899945
Panc 10.05,100016,7.2735240015579645
SUP-T1,100016,6.229647258472745
HCC202,4259181,0.8134665998363166
NCI-H292,11404337,-1.5117614396305947
BT-549,753704,4.958873098850826
M-07e,6918638,-1.343658816703153
KYO-1,6450551,-0.9082635093886884
KMRC-20,2729026,2.964214452435718
HPAC,9911830,2.828349444827891
NCI-H2029,11404337,0.5042736669587571
HCC38,374536,2.47724645978947
HEL,654092,-1.523294365181231
HCC1954,2729026,2.8128097196461597
BT 286,9868037,4.125737289056318
SHP-77,JQ-1-UNC0638 (2-1 mol-mol),2.0019843642936426
SiMa,6450551,0.4112912737954897
Kasumi-1,374536,2.341521655103594
BT 239,156414,-0.3891739105228405
PE/CA-PJ49,9911463,4.148173895384107
NCI-H1341,2729026,1.7055836668508928
MDA-MB-415,71729975,2.715085826742981
SiMa,136227924,1.9858625956320377
DMS 454,151289,0.1833425591989079
BT 422,71729975,1.5274717464244087
A101D,9911463,4.385774367797012
ME-1 [Human leukemia],753704,4.464508075625146
KYSE-510,9868037,3.781080992935668
U266B1,9868037,3.3366436031438034
WM115,10302451,3.6553280898048905
KYSE-180,654092,0.3510982053718326
KE-39,16013152,4.246331494143776
COLO 205,10302451,4.21417840913975
NCI-H1734,sirolimus-bortezomib (250-1 mol-mol),-0.1121283938952372
PSN1,9911830,2.6200300963649035
NCI-H2228,11167602,2.310217161878112
SNU-C5,44137675,2.2852225857564004
KYSE-140,54618771,1.7180424995817132
JURL-MK1,11485656,1.8097714180338824
ES-2,10302451,3.824196852311708
MCAS,11485656,2.57416789640687
LOX-IMVI,54618771,-0.8031507578309087
NCI-H2106,124202324,1.1390748026778492
KP-3,151289,0.8654353651458653
NCI-H460,2708,4.613368759945332
NCI-H23,6918638,-0.9097469315005928
BFTC-909,148198,-2.03933057080943
RCH-ACV,6450551,1.4655211052911383
SF295,9929138,4.960030945136907
NCI-H1694,4259181,-0.9016234434199344
Reh,4259181,0.2688658389354381
UO-31,16013152,2.929009613214971
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
PE/CA-PJ41 (clone D2),9903786,4.971136415817363
EoL-1,1716436,1.6530628681775867
LOX-IMVI,10385095,1.0613031288741694
NCI-H2122,11404337,0.2982247321371532
UO-31,151289,1.79942307866593
GB-1,sirolimus-bortezomib (250-1 mol-mol),0.3465048040128788
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
F-36P,46926350,-4.248535974571272
RT-4,9911830,1.893497559140728
COV644,151289,2.5931411156008184
LCLC-97TM1,16013152,5.423690206414697
BT 231,374536,3.025650998981233
HT-1197,9911463,2.9411019344315217
SNU-46,9911463,4.271059077765821
BT 245,54618771,0.8318467537608688
PC-14,24753719,5.07098831205633
CAL-120,11167602,2.9935141150710085
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
BT 159,136227924,3.541986211057949
KYSE-520,148198,-3.940360591916268
SK-ES-1,6450551,0.7591945093124686
SJSA-1,4259181,0.2079005980889057
OVCAR-5,24753719,4.714899424984898
NCI-H1573,JQ-1-UNC0638 (2-1 mol-mol),2.0919145254818066
EBC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6428978978203825
KNS-62,1716436,4.058040991654304
OCI-Ly10,2708,5.262325977457896
BT 147,148198,-4.643582632338319
GA-10,1716436,1.4768172501247965
NCI-H1915,JQ-1-UNC0638 (2-1 mol-mol),1.1979714521679137
F-36P,11404337,-0.3828282129667895
B-CPAP,2708,4.8825948055163835
IST-Mes1,9911463,4.127098730346426
OAW42,9911463,4.338639640842429
ACHN,10385095,1.2392970016125753
JHOS-2,11485656,3.1858119636686104
AU565,151289,0.4389765151464501
NU-DUL-1,16013152,3.66414268148784
NCI-H2196,753704,4.611974031868
IM95,11485656,1.1906630822338928
SNU-182,3815108,1.9776150274116704
MES-SA,24753719,4.32411267678538
JHUEM-1,4259181,0.4565714749709281
KHM-1B,11404337,0.2779693874185021
NCI-H1755,10385095,1.965568648376492
OCI-AML-3,2729026,2.3595540164480804
5637,9911830,2.7400256251979704
NCI-H1703,4259181,0.0989323208657525
AML-193,374536,1.4242090888169197
HCC2279,9903786,3.291578502930839
BT 216,11485656,3.383904918711706
MDA-MB-453,9903786,4.505035222499518
G-401,6918638,0.0373379560261908
8305C,44493528,4.453346362405301
NCI-H1666,374536,4.508271390784048
BT 164,11485656,1.7708908189678425
DOV13,49766530,-2.036556412816105
HCC4006,54618771,1.138326772964569
HCC1569,9929138,7.033632026458537
BT 239,6918638,2.260003296695808
HT-29,10385095,2.6878759136665824
NCI-H2106,54618771,2.789728608480185
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
NCI-H1975,156414,-4.584489477313673
OCI-AML-3,54618305,-5.913694317144885
253J,tanespimycin-bortezomib (250-1 mol-mol),-0.9234008422745912
YD-10B,100016,5.941622042216757
COV434,24772860,-3.2555324395821654
L-1236,1716436,0.9769758938043136
TE-8,16013152,5.595813656803762
PaTu 8988t,9903786,4.140175125497243
HDLM-2,136227924,3.1256787357030937
CHP-212,135659046,3.126756855928974
MOLT-3,tanespimycin-bortezomib (250-1 mol-mol),0.0214957708571904
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223
ALL-SIL,11167602,0.1759872916057691
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
MDA-MB-435S,9911830,2.892652836059052
KMRC-2,9911463,4.365671191059928
LOU-NH91,124202324,3.0671378719618283
BT 416,135659046,3.716005987498819
NCI-H1694,tanespimycin-bortezomib (250-1 mol-mol),-0.386320713281567
P3HR-1,10385095,0.8570193110669726
TUHR10TKB,10385095,1.4872547202456603
SNU-449,44137675,3.6126407514409378
AsPC-1,9911830,2.936776162598985
ChaGo-K-1,753704,5.290331139863328
42-MG-BA,71729975,3.151142074779871
UACC-62,374536,0.1528341374746243
SNU-685,49766530,-2.1503606591822364
SNU-626,11485656,3.731914296666243
Daoy,44137675,3.319506337180179
FTC-133,44137675,6.176024086140045
MDA-MB-231,11404337,0.2282829933143647
YD-15,9903786,1.471025688701345
TCCSUP,4259181,1.0116551093848198
SNU-1066,2729026,2.978685483327677
COR-L105,753704,5.105702577689745
BT 271,148198,-6.332121949886553
NCI-H1693,6918638,0.9296427342900364
Hs 729.T,9911830,2.3189735483487888
Karpas-422,24753719,4.137089222307065
YAPC,10385095,1.3302689043535871
NCI-H1385,24753719,1.900238363016148
PE/CA-PJ15,148198,-2.65559177778782
697,49766530,-5.010660235197008
U-937,54618771,0.4735715356031699
CAL-51,1716436,3.275997904874087
5637,9903786,1.5217427141278097
JHH-2,44137675,3.230114372637719
CHP-212,11404337,-1.6031269960117245
NB1,sirolimus-bortezomib (250-1 mol-mol),-0.0795560213748125
KE-37,10302451,3.144943536566891
SK-HEP-1,4259181,0.3926762831937545
HEC-59,9911830,2.883882492883047
TC-71,1716436,2.8333127798173012
SaOS-2,2708,4.307882235107384
AsPC-1,11404337,0.3809720735493328
KP-N-SI9s,sirolimus-bortezomib (250-1 mol-mol),0.5710762504018412
DMS 454,136227924,3.2899111891910424
Kasumi-1,6918638,-1.672437064714565
ES-2,4259181,-0.5646450757791253
A2780,24772860,-3.463956246093966
MPP 89,374536,2.9908527808488103
KMRC-3,24753719,5.2495549155565655
HCC1395,9911830,2.556253460545972
HCC-56,11404337,1.7100052482003292
JHH-6,49766530,1.0695229920160838
Lu-65,54618305,4.948052353708299
SK-MES-1,JQ-1-UNC0638 (2-1 mol-mol),0.4518091140046482
BT-20,6450551,2.863822185029378
Calu-1,136227924,3.5665542391568774
KP-4,10302451,4.244768589994227
HuH-1,9911463,4.24697261954459
NCI-H1975,10385095,1.0404282110785523
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
NCI-H889,374536,3.459914098523289
OPM-2,151289,0.8971834485048114
NCI-H1339,148198,-2.9438729710882963
JJN-3,100016,3.8434142095984303
BT-12,11485656,2.106070398144325
P3HR-1,24753719,4.729434793185607
SF295,11404337,1.1305596027792637
LUDLU-1,11404337,0.8726842724577241
SNU-213,4259181,0.9824949084518934
HPB-ALL,sirolimus-bortezomib (250-1 mol-mol),0.9475176932995892
COLO 792,sirolimus-bortezomib (250-1 mol-mol),0.2253153763681567
KCL-22,4259181,-0.343701000800128
SEM,9903786,1.5227669871926164
COLO 829,JQ-1-UNC0638 (2-1 mol-mol),3.421195363937727
SW1088,6450551,3.083674413364186
NCI-H460,100016,5.855223104671776
SCC-25,44137675,1.9982871613841056
SNU-1,46926350,-6.1763349728301975
NCI-H650,11485656,2.145946589400594
JeKo-1,9903786,1.7626830163965443
KYM-1,2729026,2.9677400458640815
BT 333,11404337,-0.8508015694655927
A-673,2708,2.956024737310482
L-363,11404337,-0.847854507325903
COLO 684,135659046,3.00478194293248
YH-13,136227924,2.93381240838723
MDA-MB-435S,135984461,3.5983225133232795
HCC1937,sirolimus-bortezomib (250-1 mol-mol),0.6036989015606368
OCI-Ly3,2729026,3.230173142257864
SK-CO-1,654092,0.6285789884023978
TCC-Pan2,9911463,4.063376197709276
Hs 852.T,3815108,3.0678154775752273
TE-9,54618771,0.2399637036570816
Ki-JK,100016,3.514869011895543
HT-1197,4259181,1.1662801512055228
KNS-62,44137675,5.000178062973784
NCI-H2030,135984461,5.0269440888877135
SNU-213,11485656,2.091894408723056
SK-N-SH,135984461,4.272548278190685
GOS-3,JQ-1-UNC0638 (2-1 mol-mol),2.0742730655318233
SNU-398,135984461,5.493775428408586
JVM-3,9911463,2.5369754211947217
LS1034,16013152,4.122151758751403
SBC-5,4259181,0.3536055110585087
TUHR4TKB,654092,0.7849634459377184
Rh41,151289,0.4600093596099174
KYSE-510,11485656,2.507694679939137
SNU-475,374536,-0.5191085484389423
HT-1197,11404337,0.4511848825128766
TT2609-C02,73707371,6.622176862365362
KYSE-30,11485656,2.6374732663532794
LOX-IMVI,2708,5.37123157466964
COLO 205,11485656,2.198859686609949
NCI-H1563,11404337,1.575154147256652
SHP-77,327653,3.224710785820069
PC-14,9911463,4.053685719227892
EHEB,753704,4.57215255992242
HEC-265,136227924,3.2525592636436405
UM-UC-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8990264790704343
SK-HEP-1,10302451,4.165168773877425
RCC10RGB,6918638,2.235907203261483
WSU-DLCL2,JQ-1-UNC0638 (2-1 mol-mol),-0.8307212233100796
BT 482,49766530,0.6927956114386422
SW48,151289,-0.0884278513227002
EJM,10302451,3.688285722224437
NCI-H460,9911830,3.1326305509826824
NCI-H1341,136227924,2.213362476241057
BT 164,136227924,2.714674644422482
RERF-LC-MS,100016,6.56071523320666
DB,2729026,2.131660247929008
SNU-16,6918638,-0.935817634094486
PaTu 8988s,9929138,5.293231117903689
BT 239,9911463,2.823437133731174
HT-1080,11485656,1.905187358604855
RERF-LC-Ad2,54618771,1.6045253072760792
NCI-H28,11167602,1.9666975973252852
EBC-1,24753719,4.292125104938372
DMS 454,49766530,-1.744731880816356
BT 131,156414,1.6229873238165975
SUP-HD1,2729026,3.148344905853263
BT-20,1716436,2.9903345522321065
HEC-1-A,11404337,0.0023043827287881
KP-N-SI9s,1716436,2.9351715451216815
OAW28,4259181,0.9119817479539226
BT 231,11404337,-1.7001463923522222
WSU-DLCL2,151289,0.2309177248673978
MDA-MB-157,6450551,1.4635370045174534
OVTOKO,148198,-1.8970821230832648
SNU-C2A,11404337,1.3290101789179258
HCT 8,6918638,0.8681641222033742
Hs 746.T,9903786,3.9786506562957857
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
SK-MEL-1,9911830,3.4534417148400145
LAMA-84,11485656,1.887389966808588
SH-4,1716436,1.8318663184418928
SNU-61,11485656,2.115016827038527
JHOM-1,10385095,2.4213386194216007
Ri-1,654092,-1.552094077000309
TE-6,1716436,3.433700991132755
FaDu,11167602,1.7467972789730146
MFE-296,11404337,-0.7207303053792228
KE-39,54618771,0.8543301924142261
Fu97,2729026,1.8350366749276383
NCI-H841,9911830,1.1409704574647217
JHOM-1,9911463,3.982223760363972
Kasumi-2,136227924,1.9658135956042504
DV-90,54618771,-0.717052278919437
HCT 15,24753719,1.6813989750926222
NCI-H747,54618771,0.1335600477139397
SW579,54618771,0.7719470301120797
TT,11404337,-1.240692607165932
SNU-840,11404337,1.1450615228869434
COV644,136227924,2.3380958896938147
SNU-387,9903786,4.748130611639421
SNU-61,100016,6.106397388471953
LOX-IMVI,49766530,-3.939815107547984
HEC-151,11167602,1.902436852174608
G-361,1716436,0.8471858472913367
COLO 800,6450551,3.441167501423829
SNU-1079,11167602,4.298137640910785
JHUEM-1,753704,4.792367544517261
Rh18,10302451,3.686530291048044
SNU-8,54618771,-0.2346938322915562
SUIT-2,44137675,5.109302373708494
LS123,54618305,5.7379544122052275
Hs 683,54618771,0.8006472003548896
MCF-7,4259181,0.4892707211739061
647V,374536,1.3902083332621575
BT-20,4259181,1.436733914806858
SNU-398,54639665,-0.6353401826184709
GB-1,135984461,4.369160227652603
PLC/PRF/5,46926350,-4.214679057159525
SR,2729026,2.360140908310978
RKO,44137675,4.282234128328841
BFTC-905,2729026,2.549315443131825
SW1990,10385095,0.931801208429433
HCC1833,100016,6.427561679501585
U-118MG,9911463,4.435757923179886
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
SNU-869,24753719,4.492105093022048
JJN-3,9911463,4.059977429957208
EB1,54639665,4.325181348836959
BT 112,148198,-3.0030353997640074
SNU-489,9911830,2.9687601637923104
JHH-5,54618305,4.218748186690721
NCI-H2122,124202324,4.4352590383146735
SNU-840,4259181,0.9915522893087512
NCI-H196,49766530,0.4460348160421952
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
BT-16,71729975,0.6198063915404473
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683
MDA-MB-453,49766530,3.3081056054922064
EKVX,327653,3.480417258353757
BT-549,2729026,3.014205222238777
Hs 688(A).T,135659046,5.661695633132947
Panc 08.13,1716436,2.0739923298658742
A-172,327653,4.415725505090706
HEC-151,10385095,0.96058203758897
Panc 08.13,2708,4.843594486611493
HEL 92.1.7,2729026,3.1066900664984973
KYSE-150,49766530,2.5375392775981913
SNU-1105,2729026,3.088369036352203
SK-ES-1,151289,0.9090446221481054
CAL-78,54618771,1.2758318023633108
ECC12,3815108,4.682053238397993
MV4-11,327653,2.3639439459269935
AN3-CA,6450551,0.9036335088039008
A101D,10385095,2.1713752730464626
AU565,374536,-0.7311314672583101
HCT 116,9911830,3.306923912235079
UO-31,4259181,0.6677925094271252
COR-L105,10385095,2.1444085139831643
NCI-N87,10302451,0.4744399528749561
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105
EFE-184,11404337,0.1091235831071998
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
SNU-407,135984461,4.363892494969776
ALL-SIL,54618771,-0.3818526805852408
Hs 683,9911463,3.853379830397607
MHH-CALL-4,151289,1.7059090797586212
SBC-5,24753719,5.823724927288436
HOS,tanespimycin-bortezomib (250-1 mol-mol),0.2321152572283642
PE/CA-PJ34 (clone C12),1716436,3.718741146894734
Panc 10.05,9868037,3.845487816364076
AU565,10385095,1.377392665812461
2004,148198,-5.483041404726115
JMSU-1,JQ-1-UNC0638 (2-1 mol-mol),2.7174323853905813
L-428,46926350,-3.640975990173159
EM-2,151289,-0.364431162204513
MOR/CPR,100016,6.350482300205422
A-204,135659046,3.450205324523238
RCC10RGB,136227924,3.611686331312014
OVK18,6450551,2.2297730196936087
VCaP,753704,4.293410250673401
NCI-H1793,156414,1.6720166250209227
TE-11,9911463,3.3577728460138414
HEL 92.1.7,JQ-1-UNC0638 (2-1 mol-mol),0.0764164195315015
PSN1,24772860,-1.244721771981912
KP-N-SI9s,4259181,-0.1617576819472535
BT 187,148198,-3.907036314471468
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
NCI-H358,4259181,1.2799951568169998
SNU-16,10302451,3.753496060515648
SF295,10302451,4.330260751201553
MDA-MB-231,49766530,-1.3973718691388817
SUIT-2,11485656,3.4408604141627763
SNU-119,327653,3.4048649042702364
Rh30,9911463,3.4097101365925786
Panc 04.03,46926350,-3.8788763459733473
HuH-1,11404337,-0.1897413514588927
HCT 15,sirolimus-bortezomib (250-1 mol-mol),0.2078755227007766
TCC-Pan2,11404337,0.04940510816565
L3.3,1716436,3.5741303666735633
LCLC-97TM1,24772860,-2.203105978452304
HCC1833,9911830,3.390320046455881
Detroit 562,148198,-1.4589401504544364
OE21,44493528,4.16320367055504
NCI-H2081,1716436,2.350567267109174
COV362,148198,-3.7747045203467313
YD-8,11485656,2.558902022570011
RD,136227924,2.2627633289805424
NCI-H1869,2708,5.656178474810682
MOLT-16,2729026,1.556828195714271
DU4475,JQ-1-UNC0638 (2-1 mol-mol),-0.579602329914569
KMS-26,156414,1.0739071723028757
HT-1197,JQ-1-UNC0638 (2-1 mol-mol),1.8142501830752336
MHH-CALL-4,156414,0.8136129124457091
YAPC,24753719,5.0641073859888
RCH-ACV,11404337,-3.4886710255299516
GA-10,148198,-7.740276698759935
NCI-H2405,44493528,5.716888607372898
COLO 684,10302451,4.647371569023228
VM-CUB-1,24753719,4.506537888296173
SNU-387,9911830,2.6597454725807954
SK-MEL-30,9911830,3.8203238322037874
NCI-H647,2729026,2.9713708744926803
BT 444,9868037,4.354992099001343
HEC-59,374536,0.818288588895378
BT 359,4259181,0.9043427030240666
HSC-2,sirolimus-bortezomib (250-1 mol-mol),0.058005047365845
CCK-81,24772860,-2.74403802974241
COLO 678,6918638,0.5482139794843425
TE-15,44493528,4.216402167585121
NCI-H650,136227924,4.852289363773007
NCI-H889,11404337,-0.9688065890654572
TUHR14TKB,2729026,3.2797460927715782
SU.86.86,11485656,2.809673440388426
GB-1,124202324,2.5368399054663526
DMS 53,135984461,4.182249903339298
Daudi,9911463,2.4252044126403915
MDA-MB-435S,44137675,3.654856672434476
BT 172,24772860,-2.499522310290921
COLO 684,100016,6.373471933627605
MEC-1,148198,-4.2599268822798955
CAL-62,10385095,1.4296656928583205
ES-2,54618305,5.3150029072751375
22Rv1,9929138,6.22160850617875
Mel Ho,54618771,0.7088013166832736
NCI-H2030,10302451,2.0984974298740484
TE-6,135659046,3.478655108369394
U-BLC1,6918638,0.4166229945457058
BT 172,9911830,2.6787041281495823
Hs 766T,sirolimus-bortezomib (250-1 mol-mol),-1.9217809600428275
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
KE-39,9868037,3.621529869698051
HuT 78,9868037,2.4738144029909908
NCI-H2126,1716436,1.7891898841210383
JM-1,148198,-6.864264453079388
DMS 114,136227924,2.8316140416519664
ACC-MESO-1,9903786,5.156493229165983
OVCAR-8,753704,5.082803972343434
MOLT-16,4259181,-1.509104113024461
Fu97,1716436,2.14956315750728
SNU-668,54618771,1.3172714373164345
IGR-1,6918638,-0.5793236649070632
BICR 6,2708,5.93021689412221
JHH-6,6450551,4.199298246064433
BT 131,374536,3.509300396306415
Hep-G2,9911463,3.8113421260686735
SK-N-SH,24753719,3.5601626189030746
RCH-ACV,2708,1.343547840781128
EFE-184,151289,3.73949654541287
YD-15,327653,3.7258295405325814
Hs 611.T,24772860,-2.634213469371387
SNU-668,124202324,2.386989562875352
CCF-STTG1,2729026,3.1743865852367383
CAL-62,JQ-1-UNC0638 (2-1 mol-mol),0.7641972882616602
LN-229,11485656,2.3407589435877187
M059K,24753719,5.106233937055326
Calu-3,654092,-1.8549340970041088
AML-193,46926350,-4.64469269810993
JVM-2,2708,3.178260514769086
253J-BV,JQ-1-UNC0638 (2-1 mol-mol),1.1238424075883524
TE 617.T,11167602,1.5922008252868003
CAL-29,9911463,3.8262240253801623
RPMI-8226,654092,-1.4408251143659716
M059K,10385095,0.9414832034202614
BT 248,9868037,3.916296675967623
BxPC-3,124202324,2.2278087185314694
Panc 10.05,6918638,1.3073335951613236
SH-10-TC,135984461,4.500134355480999
PC-3,tanespimycin-bortezomib (250-1 mol-mol),1.8125784159372291
HT-55,4259181,0.7351816138960287
P31/FUJ,4259181,-1.476581151251805
OVCAR-8,2729026,3.1012655356888104
NCI-H841,156414,1.5063589508923476
MG-63,10385095,2.7143231062656197
BT 330,9868037,3.503197969188101
NALM-6,4259181,-0.6591478009838272
MPP 89,10385095,1.2849764052084127
SNU-182,sirolimus-bortezomib (250-1 mol-mol),0.3656732555283032
BT 112,9911830,1.5924575123512974
KMS-11,10385095,1.0740998272588806
SR,4259181,-1.822920047050155
MDA-MB-453,136227924,2.410345496671846
SiMa,9911463,2.7480230825613488
SNU-201,136227924,3.0451171975506903
CCF-STTG1,374536,3.462447844633159
SNU-1041,54618771,3.2318145292931195
Caov-3,374536,0.5440863588176847
NB4,1716436,2.2620766324283275
NCI-H2342,11485656,3.078820685414162
NCI-H1105,151289,1.5453843866615082
HT115,selumetinib-BRD-A02303741 (4-1 mol-mol),2.024247876858091
CAL-51,11485656,2.6541256228973773
JHOC-5,2729026,3.1570512062066154
WM266-4,374536,1.144390627150668
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
OVSAHO,2708,5.541826525623808
Rh41,2708,3.8363042057978265
SNB-75,1716436,2.8985683960352815
LN-18,654092,-0.274530143731943
SNU-61,JQ-1-UNC0638 (2-1 mol-mol),2.3060253857026343
BT 172,6918638,2.2314251276093415
RERF-LC-MS,24753719,5.208830602571573
MOLT-16,100016,4.920795787487072
VMRC-RCW,JQ-1-UNC0638 (2-1 mol-mol),2.095788713272592
C2BBe1,44137675,4.629437515661916
COLO 699,1716436,2.333202284864803
SU.86.86,9903786,4.655147385880342
DK-MG,44137675,3.974293307408011
HCC2935,9868037,3.914000615600812
Hs 683,135984461,3.956952055268157
EM-2,10385095,1.5140639606504105
CAL-27,10385095,1.2295716682430473
SK-MEL-3,46926350,-3.109136293232628
TYK-nu,124202324,2.4920636121566475
NCI-H520,JQ-1-UNC0638 (2-1 mol-mol),0.935483306550117
KM12,49766530,-2.0271084274378373
Pfeiffer,753704,3.5971203011161914
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
JHOC-5,11485656,3.0312189412234622
ME-1 [Human leukemia],327653,1.5922481175926897
KMS-27,327653,2.9836297632664905
MCF-7,135984461,4.749341125159992
WM983B,10302451,3.572135082387995
Aska-SS,11404337,-0.8839501993376483
GDM-1,9868037,0.3465772020912164
KE-39,327653,3.149148027412197
SNU-878,11485656,1.7316943988807143
NCI-H661,JQ-1-UNC0638 (2-1 mol-mol),3.1332466289853884
NB4,151289,-0.4557783784169514
NCI-H1299,3815108,3.736133239838136
KMRC-2,54618771,2.1629104463678335
SCC-4,71729975,1.884085179009044
KMS-11,2729026,1.7217444757628868
BC-3C,9903786,3.0556905946174537
HCC15,374536,0.7951987879889547
BT 139,selumetinib-BRD-A02303741 (4-1 mol-mol),7.331254221783839
8505C,10385095,0.6196547026906353
WM88,9911463,3.783818746196605
TE 441.T,46926350,-6.6989678936733705
BT 147,9868037,4.310170196853697
HeLa,11485656,1.8522393336584817
KHM-1B,9911830,2.660270688725906
NCI-H460,9903786,4.057661845653794
NCI-H1341,6450551,0.7872065083402059
FaDu,sirolimus-bortezomib (250-1 mol-mol),0.8335893601460954
HT-1376,654092,-0.1457262155674299
HCC202,44493528,4.2464995661804235
RKN,54618771,1.93479648501244
CL-34,4259181,-1.074921358474701
Kelly,3815108,1.803537497252311
NCO2,JQ-1-UNC0638 (2-1 mol-mol),-0.7692843608444572
COLO 741,1716436,1.7203779720995065
HCC95,54618771,0.2896337021071054
CFPAC-1,136227924,3.3404294087361883
CHP-126,sirolimus-bortezomib (250-1 mol-mol),1.5217609730856023
EFO-21,374536,3.9516494648364273
RERF-LC-Ad2,148198,-4.2716837580451825
CL-11,136227924,2.4405671689998027
G-292 clone A141B1,135984461,1.9916208334171763
Mino,327653,2.450086744090126
Tm87-16,10302451,4.036013672489342
JHUEM-7,374536,2.8371018707127065
KE-37,10385095,0.7123817404194451
NCI-H2110,753704,5.759547446476079
SF539,151289,0.9968622519335693
HCC827,100016,4.431453048958875
A3/Kawakami,54618305,4.415479239877224
SNU-C4,148198,-4.665423205896986
SK-MEL-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3814029113977537
PL-21,9929138,5.81570058531176
EKVX,11485656,2.7917254369423055
B-CPAP,49766530,-2.4408790709837396
OV7,374536,2.8144157956973106
BT 359,11404337,-0.8986671728734847
NCI-H1581,sirolimus-bortezomib (250-1 mol-mol),0.461020209130116
SK-N-DZ,9911830,2.3225536262502096
DU145,11485656,2.5427151524786993
SNU-478,54618771,0.1182109485114638
HEC-1-A,71729975,2.064735790891237
BT 159,JQ-1-UNC0638 (2-1 mol-mol),3.426554722387573
G-401,6450551,1.2745400494425214
Calu-1,JQ-1-UNC0638 (2-1 mol-mol),5.348468381568823
KMRC-2,JQ-1-UNC0638 (2-1 mol-mol),2.613983630437413
Tm87-16,24772860,-1.7330352649250973
LoVo,148198,-1.1147075342847712
HT-55,9911830,2.2687897091778138
G-361,49766530,-1.5432487194919586
SUP-HD1,10302451,3.8687188160674912
Granta-519,46926350,-4.5411361861126
PaTu 8988s,24753719,4.178289167008363
JJN-3,54618305,4.325120216222494
HEY A8,4259181,0.4571473783124858
Karpas-620,3815108,3.862797305490586
SW982,54618771,0.7299689874898085
647V,24772860,-2.7077928128709123
MEC-1,24772860,-3.373533516454776
RPMI-8402,44493528,4.185952710394156
SNU-761,135659046,3.552687853164843
SF268,100016,6.377468220379779
Karpas-620,374536,3.3447028777844383
SR,753704,4.993188399074192
HH [Human lymphoma],2729026,1.1574443699166843
Sq-1,1716436,1.5402498762174937
769-P,sirolimus-bortezomib (250-1 mol-mol),0.7451378442227841
KYSE-70,24772860,-1.2328668610311222
HCC38,9911463,3.9831039186193022
NCI-H1339,9903786,4.835064182647526
BT 416,9868037,3.6297803130488377
NCI-H2291,4259181,0.9093114252123392
DND-41,9911463,3.037480492878027
Hs 888.Lu,753704,6.825626696467265
IGR-39,1716436,1.9124325670442055
SUP-M2,9929138,3.6762665629700177
JHH-1,374536,1.0688564710408754
LUDLU-1,136227924,3.2639698653649254
HCC202,46926350,-4.542109513641967
LS411N,10385095,1.4098978051841675
CHP-212,24772860,-3.0897154891470455
YH-13,46926350,-4.088990629945516
BT 139,136227924,3.476406727957654
RS4;11,9903786,1.046136748247593
MFE-296,9911830,1.8484539115793903
SF268,9911830,1.8163947676875103
SK-MEL-3,11404337,-1.6693959250085673
LAMA-84,selumetinib-BRD-A02303741 (4-1 mol-mol),1.1278755977910544
KMBC-2,2729026,3.016115186069628
MM1.S,10385095,0.5772741744912003
KYSE-410,54618305,4.463720756901811
BT 416,9911830,2.72024665816752
BV-173,156414,1.1309234349715926
A-204,tanespimycin-bortezomib (250-1 mol-mol),-2.803355347845335
BxPC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),1.732263513385207
LN-18,124202324,2.2414886091256476
SNG-M,148198,-2.9777183458451324
Li-7,100016,6.9157107863456915
EM-2,2729026,1.0384588154759091
U-118MG,100016,6.712569444944465
Lu-99,11485656,1.95403594931143
Hs 294T,151289,1.407619906570666
NCI-H2029,11167602,1.636861856546505
SK-MEL-1,9911463,4.223226979936513
YD-10B,tanespimycin-bortezomib (250-1 mol-mol),-2.1326183945103807
JK-1,654092,-0.1626834602451599
GCT,136227924,3.024645180957839
TALL-1 [Human adult T-ALL],sirolimus-bortezomib (250-1 mol-mol),0.4525392365030144
SCaBER,sirolimus-bortezomib (250-1 mol-mol),0.2620178296114504
Jurkat,54618305,4.560601689877131
TC-71,10302451,3.884014223654917
MV4-11,3815108,2.596079919223607
NCI-H1435,JQ-1-UNC0638 (2-1 mol-mol),1.4939095743836657
HT-1376,9911830,2.852403545688706
SNU-503,100016,6.601678520618542
NU-DUL-1,327653,2.423174804132232
SEM,9911463,3.141152403249145
MHH-CALL-4,24772860,-3.3697493416071223
EC-GI-10,2708,4.757858175119829
PF-382,54618305,4.182237982253296
HuG1-N,135984461,3.7113703806960054
IM95,54618305,4.19219470828467
HCC2279,54618771,-0.3569311345677481
TALL-1 [Human adult T-ALL],4259181,-0.2599925665535982
IM95,100016,6.474511795509729
HCC1954,156414,-0.6903981351926928
SK-CO-1,11485656,2.076616779710352
NCI-H69,6450551,0.8448771705043367
MKN74,44493528,4.689150119305487
CAL-51,124202324,2.033990287468598
COLO 829,10302451,4.0322248059619845
SNU-869,46926350,-3.380067956173537
OS-RC-2,9911463,4.41077585460665
GaMG,selumetinib-BRD-A02303741 (4-1 mol-mol),4.93223462699833
NCI-H322,1716436,2.188377838712479
NCI-H1623,10302451,3.5735543079001553
FaDu,156414,1.172585611043198
Hs 688(A).T,11167602,4.095254333798956
COLO 792,9911830,3.1107031023609824
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
Panc 02.03,9911463,4.953148943637795
Namalwa,49766530,-1.8902019897608628
KCL-22,11404337,-1.0119839618424291
ESS-1,10302451,3.294150768882909
HCC1806,151289,0.5766488448921591
KM12,9911830,-0.4437946129171659
ALL-SIL,2729026,2.163276094007301
LS1034,49766530,4.046854400664645
SW1990,2729026,3.047903080615765
SNU-886,11404337,1.5055907567781088
YD-38,9911830,2.6731616519017827
ME-1 [Human leukemia],49766530,-2.233463718889399
NCI-N87,selumetinib-BRD-A02303741 (4-1 mol-mol),3.924319992587928
NCI-H1563,2729026,2.816947080121526
EPLC-272H,327653,3.124560122706516
IGROV-1,44137675,1.8406125640672395
HCC15,11404337,-0.219975280966356
NB1,24753719,3.9501485382605535
MDA-MB-361,54618771,0.6906132618662956
HCC2935,135659046,3.704118522372791
HCC1428,24753719,4.247513508462614
ONCO-DG-1,156414,1.1948780858404957
KE-97,11485656,-0.8260984210127809
BT 224,148198,-3.2746720257013813
U-CH1,9911463,3.7817201694123432
MOLM-13,9911830,-0.5537570191991712
HCC2935,sirolimus-bortezomib (250-1 mol-mol),0.5945661645124948
MDA-MB-231,753704,5.025344697390797
Yamato-SS,11404337,-0.7201649864225125
KMS-34,10385095,0.6181489160442079
SK-MM-2,135984461,1.4318073157862956
Hs 688(A).T,49766530,-1.7217170265307382
L-363,2729026,2.2973557469969053
OCI-AML-2,3815108,3.392223851484051
NCI-H358,44137675,2.7322498332976433
KP-4,54618771,2.957585816818264
VCaP,2729026,3.03966031143251
MOLP-8,44137675,1.775364766844489
VMRC-LCD,4259181,-0.0718042548985789
SCC-4,tanespimycin-bortezomib (250-1 mol-mol),-0.6950216335747628
SNU-213,54618305,4.384098644621688
LOX-IMVI,44493528,4.127526604228942
NCI-H841,44493528,4.365937622754757
COV362,46926350,-4.228044411643396
JHUEM-2,9929138,6.79897920922461
CA46,10302451,0.2515382956842912
KYSE-150,374536,5.74212725466543
RERF-LC-MS,44493528,4.358183394704722
Aska-SS,46926350,-3.8852893541417455
SU-DHL-8,100016,4.106875584244309
UACC-257,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.841403879735701
NCI-H1341,44137675,1.8814222084266512
NCI-H1355,sirolimus-bortezomib (250-1 mol-mol),1.1332482572843785
MOTN-1,1716436,3.137202364206861
JURL-MK1,11167602,0.2204954688746393
A3/Kawakami,9911463,3.9596615304001745
U-BLC1,148198,-4.602164076011155
U-118MG,9929138,7.614097012433896
NCI-H1915,selumetinib-BRD-A02303741 (4-1 mol-mol),2.875701925334503
LOX-IMVI,11404337,-0.9085197853802874
SW1417,4259181,-0.0767370011258741
BT 179,54618305,4.626740556100955
SNU-1196,4259181,-1.0865264109218773
Hep 3B2.1-7,10302451,4.252461968415576
P31/FUJ,24772860,-2.926152167827307
Hep-G2,4259181,-1.079856384384839
L-428,24772860,-1.954013683163763
NCI-H2126,2729026,2.341682566812399
NCI-H1581,11404337,-0.7792985838470738
CCF-STTG1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.572158178952437
HEC-1-A,24753719,4.9584766677320475
SIG-M5,136227924,2.112174988724855
NCI-H1435,148198,-2.750299073281892
IGROV-1,9903786,1.7387584479757865
KP-N-SI9s,6450551,1.713262614164044
Calu-1,135984461,1.7273977102248494
CAL-78,151289,0.1977312195285746
NCI-H520,9911463,3.6961325383043007
JJN-3,327653,3.1728287046324386
AU565,54618771,1.1954147839624212
HEC-108,148198,-2.2464200337513587
HCC1438,135659046,3.8563158871978342
NCI-H510A,6450551,0.7333421824403815
NCO2,374536,2.0610293369811172
OCI-Ly10,49766530,5.527943462019326
KYSE-180,10302451,1.5519577455009292
HCC15,44493528,4.34604946513687
FTC-238,54618771,3.2424899672946195
HT-144,135659046,3.3516643492898477
BV-173,11485656,1.9026592403549776
LUDLU-1,44137675,2.744919767502981
HCC4006,46926350,-4.302485553358069
UM-UC-1,374536,3.5842842335621476
L-363,124202324,1.2677608676039247
HCT 15,151289,0.8012745903695323
SNU-1077,151289,4.212022708260447
WM983B,JQ-1-UNC0638 (2-1 mol-mol),1.0710090735153637
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
M-07e,24772860,-3.1909203278132803
TE-5,49766530,-3.388201082645815
U-251MG,44137675,4.629730956997988
NCI-H1915,10385095,0.8614949927187568
Hs 888.Lu,44137675,4.397068724994713
PLC/PRF/5,11404337,0.67614932520098
PLC/PRF/5,44137675,5.074736311382347
NCI-H1755,54618305,5.372984260776961
A-549,6450551,3.987118649035783
BT 245,100016,6.42627295768896
M-07e,46926350,-4.186843002179152
UM-UC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0032411460887714
PK-1,10302451,3.287223466177899
COLO 829,24772860,-0.7318111690487483
CML-T1,6450551,-1.1017942434712815
SK-MM-2,2708,3.3359140725073595
KNS-62,11485656,3.204340501575354
HEC-151,11485656,2.368331048173754
NCI-H1666,11167602,0.4125799351695397
MHH-CALL-3,2729026,2.649049952541528
HCC1171,3815108,3.214384616302086
NCI-H1573,11167602,1.820662844195984
SW1088,11167602,3.230115211313107
KP-N-SI9s,148198,-2.8651089609704283
NCI-H1355,11485656,1.9876880567524768
GP2d,374536,-4.260499281053746
TOV-21G,4259181,2.223736423310248
Hs 578Bst,10385095,2.557953315757008
NCI-H1395,135984461,4.376761136039875
MHH-ES-1,44493528,5.035499242362303
WM115,16013152,3.8161355323039
U266B1,10302451,2.6421968842395938
HEC-151,49766530,-0.2709325293810298
T98G,9903786,3.9737183240681153
SUP-B15,2708,2.580131496775721
LP-1,1716436,1.8246631876721384
IMR-32,24772860,-2.5862445017450924
P-STS,44493528,4.057634229186882
KYSE-410,136227924,3.831866760516254
JeKo-1,1716436,3.304461536508339
NCI-H2029,10302451,4.07303953263125
NCI-H841,16013152,3.94185708498496
HEL 92.1.7,9903786,1.7249056875700772
LN-18,11485656,1.656863008716467
PaTu 8988s,11167602,2.4534499550927653
KMRC-2,6450551,2.739677229756094
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516
HuG1-N,1716436,3.5930469301948076
NCI-H1838,4259181,0.6400249787419052
KNS-42,11404337,1.3884544485554386
TM-31,46926350,-3.7009513531733993
AsPC-1,9911463,3.4970941612274693
BT-20,156414,1.6027842834064494
BT-20,54618305,4.294432746709741
NALM-6,9868037,2.034741540026143
A-253,10302451,3.496494704914602
MDST8,9911463,4.372295154952754
SK-N-BE(2),1716436,0.8772223789289624
COR-L95,54618305,4.5292428127427575
HOP-92,54618771,0.6588876018328178
NCI-H1435,2729026,1.851030811495612
SNU-1079,10385095,2.438291597532159
BT 216,100016,6.740671439747835
OCI-M1,135659046,3.73314659306938
HCC1438,sirolimus-bortezomib (250-1 mol-mol),0.8076549533300275
SNB-75,46926350,-3.7509447567818497
RT-112,49766530,0.4682015340120261
NCI-H1299,10302451,4.027375771217026
TE-5,44137675,2.3416058648867453
HL-60,2708,3.0814183630807697
SNU-886,24753719,3.844666745133929
TE-14,JQ-1-UNC0638 (2-1 mol-mol),1.1497905104271977
GMS-10,24772860,-2.5786221408063192
SNU-899,9903786,2.4739971743095497
Caov-3,tanespimycin-bortezomib (250-1 mol-mol),-1.0739653599444468
KMRC-20,selumetinib-BRD-A02303741 (4-1 mol-mol),6.461263224770076
SKM-1,10302451,3.713731670018531
Granta-519,10302451,3.667767303482806
JHOM-1,46926350,-4.402821283004844
NCI-H211,136227924,1.9167606171360705
OCI-AML-5,753704,5.127293617772583
CMK,10385095,1.16038597640568
CAL-33,9868037,3.732658877947959
OAW42,148198,-4.166593370065839
DEL,9903786,1.8347897300097875
DU4475,4259181,-0.0830563562754407
KHM-1B,753704,4.849440364052096
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
RPMI-8226,54618771,0.103524211569064
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
L-428,1716436,2.452016579131683
EFO-27,11485656,3.240498776862908
YKG-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.005827491367844
IA-LM,6918638,0.61198230609435
GSS,1716436,2.886558922325692
LOU-NH91,151289,1.7382502757713727
G-292 clone A141B1,46926350,-3.770339068321615
NCI-H661,327653,3.5614910429728295
RPMI-7951,148198,-2.190615440736015
LOX-IMVI,24753719,4.180599025033894
MOLP-2,10385095,1.1784058949266252
PaTu 8902,44493528,4.360494725244959
MOLT-16,selumetinib-BRD-A02303741 (4-1 mol-mol),5.162433876723538
8305C,654092,-1.7291199887149438
NCI-N87,124202324,1.1856737577999816
HEC-6,9903786,3.848299658438586
OS-RC-2,124202324,3.534828047174869
HD-MY-Z,4259181,0.5589884134551424
BT 330,2729026,1.1636644149412527
BV-173,44493528,3.470262409540001
JURL-MK1,9911830,-2.0665605271093357
UACC-257,10302451,3.760959424622009
A-204,136227924,2.1384474587970113
MIA PaCa-2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.7898327574016281
SNU-C1,24772860,-4.173250965875571
NCI-H1341,327653,2.5295846905015655
Hs 688(A).T,9868037,5.465863970600614
TE-8,9868037,2.984578465657965
8505C,44137675,3.966226668762839
ML-1 [Human thyroid carcinoma],327653,3.144384021244803
SET-2,49766530,-3.130186221857788
NCI-H446,54618771,-1.076941007220397
SCaBER,2708,5.188638145474011
MeWo,9911830,2.0123615626983593
DV-90,9903786,1.7610541097937376
D283 Med,24772860,-2.7962047950668345
GCT,10385095,0.729711936953439
MOLM-13,151289,-0.2275053531847663
NCI-H2291,2708,5.823597921935417
NCI-H1869,11404337,1.2362831155289085
SU.86.86,327653,3.751762966250303
L-428,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2562439356557435
ZR-75-30,10302451,2.034029227265065
LNCaP clone FGC,10302451,3.7109646115457418
EKVX,49766530,-0.424915470448776
KU-19-19,136227924,3.1447471190609217
A2780,151289,-0.0035192392559562
647V,44493528,4.175577269384225
NCI-H1105,753704,4.434078133429682
PK-59,327653,2.872249707318676
CL-11,1716436,2.2336953426452557
NCI-H2110,6450551,1.873911800645245
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
IMR-32,JQ-1-UNC0638 (2-1 mol-mol),-0.4447482395606248
MOLP-2,135984461,5.292222187732742
KYSE-150,156414,1.6424559188451335
Ri-1,9911463,2.719411575193649
KNS-60,9868037,3.077370485876798
BT 224,4259181,0.9395634525168084
NCI-H929,2708,3.7525965920977007
SUP-B15,327653,3.106162842969588
Ri-1,44493528,4.227657049972306
SK-LMS-1,9911463,4.31771461226135
SNU-213,44137675,2.701983719716649
MKN74,11404337,-0.8129110599609928
DMS 114,151289,1.3113317697780635
PC-3,9911830,2.771725932038049
A101D,10302451,3.7909822884249498
TE-11,44493528,4.3195742716631615
NU-DUL-1,24772860,-4.542916271315715
JeKo-1,2708,2.9946854941632983
Mel Ho,11167602,5.1060633134996465
BICR 16,135984461,4.382455604132067
NB1,6450551,1.6942293364974348
COLO 800,148198,-3.6591761210846423
BT 228,4259181,1.0401534550854912
GDM-1,100016,5.649529454604957
PE/CA-PJ41 (clone D2),374536,4.452656033627249
IGROV-1,10302451,0.4135234554742116
NCI-H841,JQ-1-UNC0638 (2-1 mol-mol),3.0271327226688167
NCI-H508,10302451,1.1228602001088863
A-172,24772860,-0.6465284850064836
CML-T1,11167602,0.5863351465273275
RPMI-8402,9903786,1.556072952295762
SEM,9911830,1.1725597754210613
QGP-1,136227924,3.0535414774537424
OCI-AML-2,10302451,2.7563880016120113
HCC1588,2729026,2.475726851278227
BC-3C,4259181,1.463523509527546
LK-2,10385095,0.7985519747751707
GMS-10,tanespimycin-bortezomib (250-1 mol-mol),0.0800415609138278
NCI-H2172,54618771,2.767787208774524
KE-97,sirolimus-bortezomib (250-1 mol-mol),0.1118131766190663
SBC-5,148198,-1.371938553790338
BFTC-909,124202324,2.9321657702899295
Caov-3,100016,5.7781449283056645
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
NCI-H1184,3815108,1.2578508406802194
T24,6918638,1.5098375019739547
P31/FUJ,10385095,1.5135865779060806
TE-15,4259181,-0.9180245906878618
KP-3,44137675,4.427212794850303
SaOS-2,9903786,2.3206358959344264
D283 Med,327653,2.8736593168933786
YAPC,9911463,3.901904463732921
BT 333,24772860,-1.07840929976804
MIA PaCa-2,1716436,3.209523428737418
RL95-2,54639665,4.517806910494635
SUP-T11,100016,5.673603064365157
2004,24772860,-1.9984250623639708
IGR-39,24753719,4.202195809310512
NCI-H2196,136227924,2.7386742576768643
SNU-8,135984461,1.5881449503105405
Ri-1,24753719,2.417177193104349
EFO-21,1716436,4.5463629813159185
OVCAR-4,374536,1.4530582918943076
SNG-M,9903786,2.9432381601198427
GOS-3,10385095,1.261141423395055
Ku812,10385095,1.0609410330256543
NCI-H1355,2729026,2.071855548246573
NCI-H1755,327653,2.97570867183818
Hs 944.T,9911830,3.285627635276784
MOLT-16,374536,0.3412179905216601
DEL,49766530,-2.519225091580242
NCI-H196,4259181,0.9744150084112732
HCC1588,9903786,2.112519242014298
Mel JuSo,9911830,3.0067571932730854
LS1034,327653,3.149677799948108
DEL,124202324,2.2225497771740046
J82,10302451,4.267907491334314
SNU-1066,JQ-1-UNC0638 (2-1 mol-mol),2.218057249810781
REC-1,374536,2.3703708600058446
GB-1,9911830,2.9088848274798034
Capan-2,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6733792081565424
JIMT-1,44137675,3.726785357167399
BICR 16,11404337,-0.0303488744380645
SNG-M,24772860,-2.578558193677001
NCI-H929,100016,3.8135603062591
SNU-503,10302451,4.344629987884854
HCC38,46926350,-4.359294014180652
SNU-489,9903786,5.534401948294785
NCI-H838,2729026,3.0517009552177443
LOU-NH91,6450551,3.4853298595759687
GB-1,10385095,1.4774808310590557
Rh41,136227924,2.134040377876842
Hs 934.T,11485656,3.91753732132253
HCC1937,10385095,1.7835531106095328
DU145,374536,1.9068384141255408
Panc 03.27,49766530,0.7469851659716551
MDA-MB-415,54618771,1.363110492584667
HCC95,6450551,1.1966913238363688
NCI-H2171,10385095,0.5588950968794439
Mono-Mac-6,1716436,1.849080052957072
SET-2,100016,6.077577626399248
KP-2,9903786,4.272294010971456
KYSE-140,10302451,0.062632955772706
COLO 699,3815108,3.385508601289039
Panc 10.05,156414,1.819764158032316
U-BLC1,2708,5.288827591526708
SNU-1105,11485656,2.972533962775767
Peer,4259181,-1.5408877519068418
BT 231,54618771,0.7922646437361874
SET-2,11485656,1.7886595096067897
AU565,11485656,2.0156354686346174
OAW42,156414,1.8124502035679988
TALL-1 [Human adult T-ALL],16013152,3.554777733024504
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
SNU-5,selumetinib-BRD-A02303741 (4-1 mol-mol),2.352229398705033
SNU-840,11167602,3.3324863600881756
ChaGo-K-1,44137675,3.810994198806368
CCF-STTG1,54618771,4.049347271840678
JHUEM-7,6918638,0.5834631364682521
RERF-LC-Ad1,10385095,3.535917584536634
L-363,2708,2.573279393410023
BT-16,9911830,1.9516077226292512
HT115,374536,-0.8312380537400716
DMS 273,16013152,3.9042510131977353
L-540,374536,-2.5630337229445224
NALM-6,49766530,-2.146531352978819
HCC1195,2708,5.249061253496257
NCI-H1385,10385095,-0.3639074849589327
IGROV-1,54618771,1.2456991772210466
AGS,10385095,1.3436642130251
SK-MEL-1,9868037,2.6521511264174493
HEC-1-A,2708,5.623434836265297
SW620,753704,5.5138528382046745
Fu97,44137675,2.9012733059818094
SNU-1,327653,3.07634731524816
Mono-Mac-1,654092,-1.4403827648525325
RERF-LC-A1,100016,6.9126876628990885
RD,49766530,-0.4768486017330388
SUP-T11,136227924,2.659905722722051
LP-1,374536,1.8164607644288473
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
Ku812,54618771,-0.0049031848150657
LAMA-84,2708,4.401356654628641
NCI-H2106,753704,4.799322329520615
OAW42,selumetinib-BRD-A02303741 (4-1 mol-mol),5.088300967854449
TOV-21G,sirolimus-bortezomib (250-1 mol-mol),-0.0646182362217989
SIG-M5,10385095,0.6926293967264278
SK-BR-3,10385095,0.7592595065406185
Kuramochi,9911830,3.644451314699112
KMS-27,4259181,-1.1469286160575058
RT-4,10302451,0.2321939311866163
MJ,6918638,-0.2004138762975409
OCI-Ly19,6450551,1.0923207669203523
SNU-C4,11167602,3.0209947329806437
RERF-LC-Ad1,2729026,3.1916819737077544
HCC78,753704,6.778672064118913
DK-MG,24753719,4.624606885184868
Panc 03.27,24772860,-2.519509286862241
NCI-H2452,54618771,2.226699645078912
BT 286,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.8313547577027046
Yamato-SS,9911463,4.3796041086014
NCI-H69,44137675,3.1836447786476434
T24,tanespimycin-bortezomib (250-1 mol-mol),0.0189711730076056
A101D,6918638,2.125640820969418
NCI-H647,24772860,-2.1159584229199897
NCI-H2444,9903786,4.235157669098579
SNU-478,4259181,0.4608976650897066
SKM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.9272317692561286
MHH-ES-1,10302451,2.7656001788565283
SUP-M2,1716436,1.5049512185390057
SNB-75,2708,5.866402502668799
UACC-257,2708,6.754790738422513
T-47D,11485656,3.194758516284648
Granta-519,24753719,3.151565571990212
Hs 888.Lu,9911463,4.373380817731519
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
Hs 746.T,11404337,-0.7817772551225204
HPB-ALL,44493528,4.688141259598365
RMG-I,2708,5.252695457803103
HLF,4259181,0.3097123752626088
NCI-H2110,100016,6.079052375839209
SW48,44137675,1.8984167228990951
RERF-LC-MS,4259181,-1.273108977623296
SNU-398,54618771,-4.947778172038554
OCI-Ly10,10302451,2.566014120606711
BT 440,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4420311432960429
DMS 454,9911830,2.118692548743365
LoVo,54618771,0.7060685526757626
SNU-1079,JQ-1-UNC0638 (2-1 mol-mol),-1.929161892732556
RCC10RGB,11404337,1.763382313076518
COLO 829,9911830,2.286202630624006
NCI-H1915,6918638,-0.1155536778195901
HCC95,148198,-1.75533613321643
NU-DUL-1,9911463,2.736663650607352
NCI-H1755,9911463,3.444248819442768
SK-MEL-30,10302451,3.898557203634669
TE 617.T,9911463,3.539966110266211
P-STS,148198,-3.9239562601130022
KALS-1,10302451,4.196627603085186
SHP-77,54618771,1.054053584588012
253J,2729026,1.835110873061214
OCI-AML-5,4259181,0.0010032377974649
BT 422,11167602,2.104960059691873
LS411N,11404337,-0.9351547419605356
PLC/PRF/5,54618305,4.300403954013755
HCC1195,753704,7.101755185561343
HEC-265,9868037,1.4639639907135185
NCI-H1184,54618771,1.2504018594222124
ONCO-DG-1,3815108,2.196247379841424
COLO 201,9911463,3.786354581854646
BT 224,11404337,0.3604838347782244
KE-39,24772860,-2.1888261700101954
A4/Fukuda,151289,0.1986917338936865
Peer,11167602,0.4701356469892311
OCI-AML-3,6450551,1.20953145501591
KP-2,44137675,4.657561347601513
GP2d,10302451,0.1765662972629052
M-07e,2729026,2.126841336529776
NCI-H211,1716436,2.9898075685138386
HEC-59,44137675,2.539490901372469
LOU-NH91,2708,7.798658787946165
EPLC-272H,11485656,2.043332000791837
CAL-51,4259181,-0.5132501801478601
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
HPAC,11485656,1.4709930999197478
SNU-407,49766530,0.1037791929989153
OVISE,54618771,1.319775250733869
KYO-1,9903786,1.1587901811719317
Ku812,124202324,0.8874162884237986
JHOS-2,1716436,2.6710940365673403
QGP-1,11167602,-0.8392847004817447
Aska-SS,2729026,2.2940081648522246
SNU-685,24753719,4.490553777063157
HCC2279,JQ-1-UNC0638 (2-1 mol-mol),2.741532492426971
KALS-1,124202324,3.1877976113100437
VMRC-RCZ,2729026,3.0350069652329346
BT 286,11404337,-1.6660130116300145
ONS-76,374536,5.32668572402577
SNU-685,9911830,2.4915618314675783
NUGC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),6.647283967483016
KMRC-20,124202324,3.9491419219303943
SIG-M5,156414,1.6593645678315314
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
TUHR10TKB,selumetinib-BRD-A02303741 (4-1 mol-mol),4.948160078832858
Tm87-16,71729975,0.6487443981318528
EBC-1,9903786,3.237672392939453
F-36P,24753719,4.27265638786198
U-118MG,24772860,-1.6558898678420493
NH-6,9911830,1.6859081436729209
GCT,44137675,3.313803522856911
NCI-H2342,10302451,3.274408295183184
SJSA-1,136227924,3.1619398784526176
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
NCI-H1155,654092,0.2735395773301347
NCI-H292,9911463,4.207043029649759
RPMI-8226,10302451,3.242830443900823
BICR 6,1716436,3.054760189721356
PaTu 8988s,9911463,3.6809927178566855
KMS-11,44493528,6.397457291534785
LOX-IMVI,124202324,-1.0064260696023344
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685
KMS-18,24753719,4.574822340106183
Panc 05.04,11485656,2.761392845467755
BICR 16,148198,-1.045482158065907
NUGC-3,9911463,3.217932170312211
U-BLC1,9903786,1.0981923916711085
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054
SCC-25,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6495300948611311
OVK18,148198,-3.802684433582173
GA-10,136227924,1.4612725021832749
KLE,327653,1.7943752773136603
DLD-1,9911830,2.6319056960613136
BT 231,9868037,3.3180720809611137
Yamato-SS,2729026,2.7105096601107506
Daudi,151289,0.3893937359913983
A-375,9929138,5.4250105922665375
NU-DHL-1,6918638,-1.28362156468715
BT 286,10385095,0.5786279467469033
VM-CUB-1,11485656,2.4689983316138076
Namalwa,100016,3.934978584241161
SUIT-2,2708,5.853191341721484
HSC-3,9903786,2.4966748748730025
EPLC-272H,sirolimus-bortezomib (250-1 mol-mol),-1.4049400380442874
Granta-519,2708,2.6467102550113357
SK-N-FI,2708,6.148704448091356
RCH-ACV,100016,4.052738843081589
BT 112,374536,1.8950859806063296
ML-1 [Human thyroid carcinoma],151289,2.136095657957592
TF-1,46926350,-4.394186537492279
Hs 888.Lu,100016,7.863224005148367
EJM,9911463,3.809334952263978
KU-19-19,11404337,0.0275069311149896
CGTH-W-1,654092,-0.2222548268945153
HCC1588,374536,2.9248107345559093
LC-1/sq-SF,148198,-3.4004768458616086
Caov-3,24753719,4.572893640685599
BICR 56,11485656,3.1292110693028237
ESS-1,49766530,-0.3205579652733103
SNU-1076,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2426942657034075
HCC1428,54618305,4.446486653284686
PaTu 8902,4259181,0.9791956381618654
WM115,11485656,3.738489726762909
NCI-H211,11404337,-2.184886204882766
42-MG-BA,54618305,4.3821225148917335
JK-1,10385095,0.9550049798539404
MOLM-13,44493528,3.9608078939228175
NCI-H1581,9868037,1.2648285588909711
NU-DUL-1,9929138,4.2318151055504165
Daoy,10385095,0.8624226642696267
SNU-81,JQ-1-UNC0638 (2-1 mol-mol),0.4433096898383019
TE-8,654092,-0.0197282575025569
IPC-298,11404337,-0.8384519836472744
NCI-H196,3815108,3.850058544040323
PL-21,1716436,2.4873747277093625
NCI-H526,1716436,3.4332713417880365
MDA-MB-415,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8481256698894969
ECC10,124202324,0.8036371832340868
NCI-H2030,54618305,5.554359715807879
RS4;11,JQ-1-UNC0638 (2-1 mol-mol),0.6635473752181785
IPC-298,100016,6.58023685235314
Aska-SS,10385095,1.4450418871576047
MHH-ES-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.342682354223777
NCI-H1092,148198,-7.112179510843006
NCI-H322,sirolimus-bortezomib (250-1 mol-mol),2.3812461676498144
NCI-H2196,11167602,1.792156355999927
RPMI-7951,9911463,4.017661136446782
SU-DHL-8,327653,2.6008762420868425
NCI-H1694,753704,4.193705658258772
SNU-5,11485656,2.318118129500767
TUHR10TKB,135659046,3.511153588074704
SNU-1066,tanespimycin-bortezomib (250-1 mol-mol),-0.148232507345562
RERF-LC-MS,135984461,4.284403636339015
SNU-449,9903786,3.696408358539977
NCI-H1435,9843750,4.405499836644012
HOP-92,327653,3.5254813835673633
ECC12,654092,0.3780426608165622
KNS-42,54618771,1.5414231722108478
SNU-1077,3815108,2.841716747219865
JeKo-1,753704,3.540716531939119
NCI-H2196,2729026,2.4392536017463606
M-07e,6450551,1.8188439597676729
NCI-H526,654092,-2.300063874974603
IST-Mes1,10302451,1.9071808976959603
NCI-H1623,136227924,2.959018127447204
NH-6,6918638,-1.4454078829022647
Jurkat,9903786,1.902939896932713
CAL-54,JQ-1-UNC0638 (2-1 mol-mol),-0.5928367234323316
Granta-519,9911463,3.5000933341892733
EFE-184,6450551,5.350508805088276
SNU-899,9911830,2.8044737059102474
NCI-H747,6918638,-0.0618345557686977
Hs 940.T,6918638,1.7343854780687948
MDA-MB-361,JQ-1-UNC0638 (2-1 mol-mol),-1.4263630025328018
NCI-H460,2729026,3.0609463870825926
HCC-56,9911830,2.5458240358277724
NCI-H358,JQ-1-UNC0638 (2-1 mol-mol),1.8135381283894336
MFE-296,4259181,-0.0272818624735243
HuP-T4,654092,-1.5997454203133548
NCI-H727,9911463,4.409308573364914
SK-N-BE(2),9911830,2.858435058455609
BT 131,148198,-4.140585549230615
NCI-H69,54618771,1.222543289082317
MFE-319,JQ-1-UNC0638 (2-1 mol-mol),2.717075494810569
BHT-101,54618305,6.415368122447373
SU-DHL-6,6450551,1.9173550036200224
NALM-6,9911830,1.7804272403189694
BT 164,JQ-1-UNC0638 (2-1 mol-mol),3.604370289261756
HMCB,753704,4.465795196553446
NCI-H211,JQ-1-UNC0638 (2-1 mol-mol),-0.6547418107404666
NALM-6,54618305,4.100743618247065
SNU-1066,sirolimus-bortezomib (250-1 mol-mol),1.8149944261171216
UM-UC-1,9911463,3.4816748285227055
J82,44137675,5.48430147050939
GCT,49766530,-2.994788722122755
TM-31,374536,4.313807130899848
YAPC,9911830,4.0093640169179325
BHY,100016,6.773898116669002
T24,24753719,4.567748064975528
NCI-H1703,327653,3.173271174813216
WM793,selumetinib-BRD-A02303741 (4-1 mol-mol),2.9195666143098356
SW1271,11485656,2.5257448561020053
MKN74,10385095,1.1692289790304908
PE/CA-PJ34 (clone C12),156414,-2.3095911483351004
HCC44,JQ-1-UNC0638 (2-1 mol-mol),-0.7654241882384312
HCC1419,24753719,4.227307108666
NALM-6,151289,0.3293188390962324
HCC1143,654092,-0.1725481204081408
FaDu,73707371,4.610789382855413
HCC44,10302451,3.4411011911559193
CAL-51,10302451,1.350542324147247
Capan-2,11404337,0.168585594733678
8-MG-BA,2708,4.450542346833904
B-CPAP,6450551,2.6982491790934824
BT 340,71729975,3.403856469682858
VCaP,9911463,3.952912743808643
ESS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.581305001836425
CML-T1,1716436,3.108020123675437
KMRC-20,9911463,4.198821616328526
HCC1395,54618771,2.360286103240852
COLO 800,JQ-1-UNC0638 (2-1 mol-mol),2.522179943938604
COLO 792,6918638,1.1737976996738528
Hs 839.T,374536,3.7758506856596976
JHOS-2,374536,1.0878199765288197
OCI-Ly19,151289,0.3833516174013477
COR-L95,327653,2.664763845896721
HD-MY-Z,135659046,3.544790983777307
SW1710,11485656,3.0628562061109976
WT2-iPS,44137675,3.9053427769834457
Reh,136227924,1.9009503552795357
SR,151289,0.5761072974536511
KU-19-19,11485656,2.7576201496249264
MPP 89,11404337,-0.8971916884586333
TYK-nu,11167602,1.6438072622140507
IGR-37,4259181,-0.1199354810210708
HOP-62,24753719,5.014649450364504
BT 340,sirolimus-bortezomib (250-1 mol-mol),1.036760644305087
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
NCI-H2052,100016,6.8923960055757805
NCI-H716,148198,-5.232540582479685
OVTOKO,2708,4.805252416536996
SW579,46926350,-5.119848963483237
MIA PaCa-2,2729026,2.202536609030734
JK-1,11404337,-1.9979584162277513
LC-1/sq-SF,11404337,-0.155620091081562
LoVo,44493528,4.114958638118981
T3M-10,6450551,4.083044406399896
SCC-25,3815108,3.850950395107492
NCI-H1666,sirolimus-bortezomib (250-1 mol-mol),0.7779430535962837
OV-90,327653,3.1964593006491664
BT-16,sirolimus-bortezomib (250-1 mol-mol),3.18518711060972
MES-SA,selumetinib-BRD-A02303741 (4-1 mol-mol),5.60798628733392
KCL-22,2708,4.385819811737884
BT 271,374536,3.0073931786723342
A101D,sirolimus-bortezomib (250-1 mol-mol),0.247462078551585
HCC1954,selumetinib-BRD-A02303741 (4-1 mol-mol),5.26629947885273
HEC-108,100016,6.393272881400893
NCI-H1944,100016,8.062523558454052
Granta-519,9911830,2.3469616146388033
WT2-iPS,135659046,3.296193945470927
OCI-Ly19,6918638,-1.0527387975754474
SW48,11485656,-1.6768123952056315
T24,73707371,5.671153692245974
SW1710,54618305,-4.785600787088483
A-375,3815108,3.2255108045963694
Hs 294T,327653,3.611148476495374
D283 Med,49766530,-3.2280701678526853
MEC-1,16013152,3.79493479636671
786-O,46926350,-3.892681516270019
SNU-869,327653,3.749735139585272
SF539,11167602,1.5763974980915605
THP-1,11485656,2.379664942460744
A4/Fukuda,9911830,0.8865121451383732
OCI-Ly19,10302451,3.771055498510201
FTC-238,44493528,4.472163529420613
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
JL-1,JQ-1-UNC0638 (2-1 mol-mol),3.4086436187146445
Daudi,54618305,3.9105424608095847
MJ,10302451,4.214297869660198
NCI-H716,54618305,4.001171648016114
Fu97,6450551,3.7830575869847065
U266B1,sirolimus-bortezomib (250-1 mol-mol),0.0143822479563884
KE-39,49766530,-2.0647642539816715
J82,tanespimycin-bortezomib (250-1 mol-mol),2.212384566230415
Capan-2,10302451,3.148442090803562
TE 441.T,10385095,0.7638238428487356
ONCO-DG-1,10385095,1.023258211832854
Lu-65,1716436,3.8267089675065376
MOLT-3,6918638,-1.6571682023232988
TE-14,2729026,3.0361749345722626
AGS,44493528,4.404376645123692
NCI-H226,151289,4.2955165551040535
VMRC-RCW,4259181,0.791876678188995
Calu-6,3815108,2.449318151669159
BV-173,374536,1.3266488371468677
Jurkat,JQ-1-UNC0638 (2-1 mol-mol),1.272922202361248
GSU,10302451,2.3827257374546886
SNU-738,148198,-3.393002799947117
SNU-201,4259181,2.400409530902911
NCI-H2342,151289,4.182189181984095
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067
YAPC,3815108,3.3369752363492315
5637,654092,-0.6550947143991898
NCI-H196,9911463,4.433350594042992
NCI-H526,4259181,-1.5556471073891744
U-937,2708,3.041302248230394
JMSU-1,24753719,3.722529133671782
NCI-H146,10385095,0.6869778017915235
COLO 680N,654092,0.2512711529860184
HCC827,9868037,2.0129298599097227
TE-4,9911463,3.1897003979431093
MDA-MB-453,148198,-6.384072425395857
253J-BV,2729026,2.180381857275924
COLO 792,9903786,2.6845883070851277
HT-1376,9911463,4.13018577448945
SNB-75,10302451,4.014625860461939
NCI-H520,6450551,1.75580273149263
Hs 888.T,11404337,-1.3976008238381223
BT 245,10385095,1.400283775793094
CAS-1,148198,-2.1391789652686324
BT 232,327653,3.71280727706233
CCK-81,10385095,1.2197432593182902
TOV-21G,753704,4.534009133418916
HPAC,753704,5.003257435746307
NCI-H1703,16013152,3.8534262763197726
SUP-T11,JQ-1-UNC0638 (2-1 mol-mol),1.134721943115646
Panc 02.03,6918638,1.5939476449475074
KE-39,JQ-1-UNC0638 (2-1 mol-mol),1.0358339499253313
GMS-10,9903786,4.533895537186943
SNU-626,124202324,4.083837031973643
HCC78,44493528,4.5859040638932385
RPMI-8226,374536,1.3947121275755352
DMS 53,136227924,2.35473496791988
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
NCI-H2342,6918638,1.2820873150212615
SNU-601,sirolimus-bortezomib (250-1 mol-mol),0.628067282313429
OV56,135984461,4.418964616172034
OVCAR-8,654092,0.16913200804849
LS1034,46926350,-3.756188597308826
KYSE-140,9868037,2.3848747025475343
NCI-H727,4259181,-0.7375001764594127
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
RPMI-7951,2729026,0.4139461540992614
PaTu 8902,10385095,2.391345219233966
COLO 668,327653,2.9984375660201037
Hs 611.T,374536,0.8136051559871417
SCaBER,11485656,1.7418324422308689
PK-45H,sirolimus-bortezomib (250-1 mol-mol),2.3044458204241014
HCC-56,46926350,-4.0424260567398145
NCI-H2405,9911830,2.703851499558869
MOTN-1,9903786,1.5262783813128549
SNG-M,124202324,2.9063720619162003
JJN-3,11485656,1.9215217079086016
647V,6918638,0.3753177333233063
U-87MG ATCC,24753719,6.032602189167671
NCI-H2085,54618771,-1.2353665657353068
BT 224,10302451,3.953686323960311
EM-2,54618771,-0.9805043805831684
HPAF-II,374536,3.112140425427783
NCI-H2029,sirolimus-bortezomib (250-1 mol-mol),0.2827623623245045
NCI-H1339,9911463,4.3916675652750925
HCC95,4259181,-0.6650213112421581
DBTRG-05MG,9911463,4.332332359679133
BICR 16,156414,1.6425914491549127
GB-1,9929138,7.490130865110687
KYO-1,10385095,1.0303500905009049
SU.86.86,4259181,0.499470171244999
KMRC-20,11404337,0.8151706043014814
SNU-1196,2708,4.906105842720676
SUP-T11,11404337,-1.4432067175867065
Mono-Mac-1,54618771,1.1455775902832934
NCI-H292,2729026,2.9142630754738037
BT 145,156414,-1.6257906195039402
LC-1/sq-SF,6918638,0.3702997456121862
NUGC-3,10302451,1.9926087789716964
RPMI-8402,10302451,2.410020049442099
RD,1716436,3.548398265717916
NCI-H2081,11485656,1.3595446454141742
VM-CUB-1,44137675,2.824771033508642
CAL-148,9911830,3.4554633310507623
NCI-H1435,374536,2.7591153146999687
HEC-251,sirolimus-bortezomib (250-1 mol-mol),1.5826018331734562
COR-L95,54618771,1.9587299059916856
NMC-G1,124202324,3.5561633651011237
TOV-112D,46926350,-4.26108900516936
EPLC-272H,24772860,-1.6354240837724414
SUP-T11,151289,0.4498596163444748
TE-6,9911830,2.4550424696072803
HOS,9903786,4.58127571794388
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
MOLT-3,135659046,2.7195018879588995
AsPC-1,327653,4.351823995090995
COV362,135659046,4.956551237170632
KMRC-2,2708,5.508421118967876
SNU-46,2729026,3.0718106898368216
EFO-27,100016,6.711163327148508
HCC1195,1716436,2.967271391552162
MG-63,6450551,3.1665435182095387
SJSA-1,124202324,3.6652184442902622
SCC-4,49766530,-0.2029842802375615
JVM-2,10302451,2.502537821329635
BT 216,JQ-1-UNC0638 (2-1 mol-mol),3.643580342627673
SNU-C4,9911463,4.273087904874907
NCI-H2228,136227924,2.998313400459559
SF539,24772860,-2.3648669148494856
CHP-212,10385095,0.0488360201020664
SW620,24772860,-3.3079781931930223
HCC1171,49766530,-2.294988687179399
SK-CO-1,24753719,4.51149350773187
NCI-H2228,11485656,2.3007848748427184
HuCC-T1,10302451,3.2341520564219666
HCC2108,100016,5.291323338255078
DMS 273,2708,4.711982190259564
MDST8,24772860,-2.900176299695688
Sq-1,JQ-1-UNC0638 (2-1 mol-mol),1.315696803078336
NCI-H23,10302451,3.1322195915738167
ECC12,11404337,1.5850993718639097
IGROV-1,753704,6.461140333581179
MOLM-6,2708,2.1648567196779793
CAL-78,24772860,-2.8580816579165735
Caki-1,sirolimus-bortezomib (250-1 mol-mol),1.904717275884016
RL95-2,sirolimus-bortezomib (250-1 mol-mol),1.4009445421830615
KO52,9903786,1.3206822748757847
42-MG-BA,JQ-1-UNC0638 (2-1 mol-mol),0.9757915708073482
HuNS1,10302451,4.039354414327241
EFE-184,16013152,4.662699583144996
MOLP-2,654092,-0.372819355969516
RT-4,54618771,0.6660630053371256
HEC-251,10302451,3.1386971099878065
LS411N,135984461,5.061110843141604
HuH-6,10385095,2.0589740741607496
NCI-H69,3815108,2.1363797983336092
JMSU-1,6450551,-0.0801557770811787
TYK-nu,JQ-1-UNC0638 (2-1 mol-mol),2.8987879826281997
SF268,10302451,2.8525130095274895
SNU-620,11404337,0.4407908814780362
SNU-1041,654092,0.0319383578355842
MIA PaCa-2,16013152,4.154236855192705
KLE,9868037,3.52213609317776
Kelly,2708,3.20113442734723
NCI-H1395,2708,5.386847702037966
Peer,11404337,-1.6679589887046322
KYSE-150,6450551,3.885242413118723
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
8505C,sirolimus-bortezomib (250-1 mol-mol),0.1276397939018833
NCI-H1944,4259181,1.4344113288675724
Calu-1,9868037,4.36020250982657
NCI-H1395,54618771,3.4411900765558125
KMS-18,tanespimycin-bortezomib (250-1 mol-mol),0.4216929170783136
HCC366,151289,0.7341239934597837
SK-CO-1,1716436,3.109025551437123
UO-31,327653,3.5092493872896666
SK-MM-2,4259181,0.7170509806722623
SW1990,2708,4.958099509571108
BT 271,156414,1.5805031871042805
253J,10302451,0.4667603068204772
OCI-Ly10,4259181,0.7781113389195214
UM-UC-3,44137675,2.170440264508956
LXF 289,2729026,2.289348740995074
COLO 201,136227924,3.2878786819809105
OV-90,44137675,4.224070589386322
P3HR-1,9911463,4.040866432648006
Mono-Mac-1,4259181,0.0400691688405866
HMC-1-8,4259181,0.0513839997710658
JL-1,46926350,-3.829610259689843
AN3-CA,24772860,-3.14166980026705
CAL-51,654092,0.82886283906252
SUP-T11,selumetinib-BRD-A02303741 (4-1 mol-mol),5.665671867210259
G-292 clone A141B1,tanespimycin-bortezomib (250-1 mol-mol),-0.2188717779378038
SNG-M,9911830,3.1900089255378865
GI-1,2708,5.218664121239353
SNB-75,tanespimycin-bortezomib (250-1 mol-mol),-1.317235314034222
NCI-H1092,2708,5.052405164442807
RPMI-8226,9911463,3.1535934695934538
JHUEM-3,4259181,0.9034843084512042
GaMG,9911463,3.671296703751626
QGP-1,148198,-2.838050109034932
HSC-2,16013152,3.7121681086513183
NCI-H520,44137675,1.8444425392155637
ZR-75-30,4259181,0.9975762137683212
PE/CA-PJ41 (clone D2),2729026,3.125352392959333
MeWo,tanespimycin-bortezomib (250-1 mol-mol),1.6748762379833977
SNU-C1,2708,5.123836625948914
CFPAC-1,44137675,4.601211295743961
MKN1,44137675,4.5781533866271795
JVM-3,11485656,2.278775985482816
TYK-nu,156414,1.6431806946886447
MDA-MB-157,327653,1.3811083957143218
BHT-101,54618771,-0.9032414416493152
KNS-62,sirolimus-bortezomib (250-1 mol-mol),1.3906693403770916
BT 239,11404337,-1.7707193107124473
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
KYSE-510,11167602,2.041208237103879
A2780,54618771,-0.248592168161829
LCLC-103H,10302451,4.471526391535591
SK-N-MC,136227924,2.70298794492574
SUP-T1,10302451,2.7674350059847344
JM-1,151289,0.6364544108799082
KMS-20,6918638,-0.8366604804869239
HCC15,1716436,2.8917896521916537
HLF,11485656,2.0345771970927924
SNU-761,3815108,1.7333764861252965
VMRC-LCD,2729026,2.93502463443281
MPP 89,6918638,0.8493258123756348
NCI-H727,9911830,2.860892848593743
LC-1/sq-SF,JQ-1-UNC0638 (2-1 mol-mol),2.010039775397688
H-STS,44137675,1.4047344665850907
PE/CA-PJ15,44493528,4.269836707696998
OCI-M1,9911830,2.240767531955393
Namalwa,11167602,1.8297854280338213
NCI-H520,10302451,3.2587774106229146
NCI-H1755,54618771,-0.2834105943747247
KYSE-30,4259181,0.866671634934387
TOV-112D,9911830,1.959668803130746
MEC-1,4259181,0.1927330879761474
NCI-H2342,11404337,1.4757013589007744
Kasumi-1,54618305,3.79646106226917
KYSE-30,9929138,6.4382239569963255
EFM-192A,10302451,2.636572550550667
EFO-27,9911830,3.273850069923984
JHUEM-7,136227924,2.4332957155572688
COLO 678,374536,4.594066847784255
CML-T1,44137675,3.6793288779986377
K-562,46926350,-4.162486097405079
P12-Ichikawa,54618771,-0.5432908489240523
SNU-C4,44137675,4.725176546842053
D283 Med,9911463,2.6227366888943986
8505C,9911830,2.534826327044656
Ku812,10302451,-2.0253572962014617
NCI-H1092,151289,2.971736983161978
HEC-251,JQ-1-UNC0638 (2-1 mol-mol),0.506132014773325
HCC1806,JQ-1-UNC0638 (2-1 mol-mol),1.9982241267395784
A-375,10385095,1.3116334013128008
Calu-3,124202324,1.821479627069513
SK-N-SH,9903786,1.912941590488841
JHUEM-1,11485656,1.8254780068900092
HEL 92.1.7,151289,1.5732312236052408
MHH-CALL-4,44137675,2.180666176963923
RPMI-6666,6450551,1.2485418658090282
KO52,6450551,0.7972942512543331
KHM-1B,49766530,-2.233986045015649
SK-ES-1,9903786,1.417242629772361
NCI-H2291,9911463,4.278294670111937
NCI-H2009,24753719,4.192950544032197
KYSE-450,753704,5.119991159407921
HT115,151289,0.0815395689907048
CHP-212,4259181,-0.6960023833337013
SNU-61,49766530,-2.178873950286192
NCI-H2444,654092,-1.4655171071600053
CAL-27,753704,4.804678514702502
SKM-1,327653,2.256314826375049
RKO,148198,-2.1467795088860875
JHUEM-1,327653,3.274496077374958
NCI-H1915,753704,5.753386335184623
NCI-H322,73707371,6.557252858422983
ALL-SIL,6450551,-1.4599471288533186
L-428,374536,3.179805258000441
Hep-G2,54618771,-1.2901934533941846
JHUEM-7,54618771,2.242796216513649
KYSE-510,1716436,4.648847836345801
769-P,44137675,4.1989970434580455
OPM-2,11167602,1.1745103577473592
MPP 89,9911463,4.3763364691928786
K029AX,54618305,4.3314388492322955
Pfeiffer,11167602,1.364593396360834
HuNS1,6918638,-1.0677458393848085
SNU-61,16013152,3.3306050431250056
EFM-192A,11404337,1.8904479261466252
Hs 729.T,753704,6.282335915726218
SNU-738,11404337,1.0077192926024503
COLO 829,4259181,0.3719311087420013
DU4475,10385095,0.476817246538896
SNU-1,100016,5.685360721271126
BL-41,11404337,-2.6110172879458244
NOMO-1,753704,4.4431191000277375
EoL-1,11404337,-2.4489617476913432
NCI-H1623,1716436,2.729344651836522
NU-DUL-1,151289,-0.400224872966018
OCI-Ly19,54618771,-1.0348518015701054
CL-11,11404337,-0.8805356384482084
NCI-H716,9911830,-1.2258790072222217
SK-CO-1,10302451,2.4520332675877605
SK-ES-1,753704,4.5205882130635615
KE-39,selumetinib-BRD-A02303741 (4-1 mol-mol),5.809798702623815
Hs 766T,54618771,0.4813536193297115
AML-193,16013152,3.8779296801639944
YD-10B,3815108,3.1328445548762653
MHH-ES-1,24772860,-2.9517064275807057
HSC-2,4259181,1.5437953657731505
BT 428,6450551,2.056715014092832
U-BLC1,44137675,2.871487804986424
BT 159,100016,7.101052412805122
8305C,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3531575195936771
ESS-1,46926350,-4.410058245118817
TE-11,10385095,0.8286852440686213
SET-2,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5961531213512834
Ki-JK,11404337,-1.0273669041089517
RT-4,9903786,1.1299984693284726
NCI-H460,753704,5.635234970240753
NCI-H1373,9903786,3.0736149101448893
LK-2,148198,-4.1754104163119505
NCI-H727,49766530,1.5110740555461553
SW620,148198,-3.4206637711010455
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
NCI-H520,156414,1.990276073985292
KMS-12-BM,11404337,-1.6165924780935808
BT 159,9911463,2.981994023267703
NCI-H1355,135659046,3.71812862658832
SNU-685,1716436,3.850550836110469
LN-18,24772860,-2.012194233894248
KYSE-180,148198,-3.2204698770091653
KMS-28BM,44137675,1.515085840344442
BC-3C,16013152,4.130260089787398
NCI-H211,24772860,-2.7774778004350256
BT-549,136227924,3.266068806496957
SW620,100016,5.873144490676751
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248
SUP-T11,44137675,1.4980191116174593
LS1034,10302451,3.8027433677682545
NB4,2729026,2.2920034389072907
NCI-H2087,1716436,1.4600390567088413
NCI-H2286,654092,-1.3320195298565156
SK-MEL-1,327653,3.0009528841881283
EFM-192A,2729026,2.9889365507816654
PaTu 8988s,4259181,0.1562419703255739
YD-15,44137675,1.8126919744251384
MDA-MB-415,24772860,-2.1616942048132706
DK-MG,135984461,4.5873435094388215
SNU-1033,11485656,2.0602946184269917
MIA PaCa-2,10302451,3.7253784601245945
SK-MEL-2,4259181,1.4036951416401309
JURL-MK1,11404337,-0.8501595942866039
A4/Fukuda,100016,4.8831896191852096
SK-MEL-2,148198,-4.089267246303032
HCC1143,4259181,-0.4991941409006941
NCI-H322,151289,1.3112510848191443
MFE-319,9911830,2.7406441465342555
SF295,24772860,-1.4622312055585494
NCI-H2170,JQ-1-UNC0638 (2-1 mol-mol),2.963798633059008
JHUEM-1,1716436,1.754733943954517
Panc 03.27,374536,2.153951960619146
UO-31,54618771,0.667805712786254
OCI-M1,100016,6.862784368685653
HEC-59,124202324,2.530609322042915
5637,753704,5.593811263275536
NCI-H508,10385095,3.2185483792292
SNU-407,tanespimycin-bortezomib (250-1 mol-mol),0.2441686883353643
SNU-182,11485656,2.307342205342044
G-292 clone A141B1,54618771,3.663374867416664
BT 239,2708,3.1410255202002166
CAL-85-1,44493528,4.246011079202567
L-540,148198,-2.923933345267779
SH-4,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.3138389749794577
ST486,54618771,-1.8169523642360077
KYM-1,24753719,4.923463214660134
NCI-H1155,11404337,-0.9864413542688488
Yamato-SS,10385095,1.6025498107671532
L3.3,753704,5.0689754221003875
REC-1,9929138,7.294165808460384
KMS-18,9903786,2.604638475406196
HCC1195,11167602,1.8207467609610304
HCC78,4259181,1.2441508772484942
NB1,100016,5.984902151942781
SUP-HD1,11485656,1.8294636044245336
EFO-27,6918638,-0.5643283195590469
SNU-C2A,100016,6.499335908465164
PL-21,151289,0.4265213506561994
RVH-421,2729026,3.0903981915277283
HOP-92,selumetinib-BRD-A02303741 (4-1 mol-mol),2.579655780459309
SW982,10385095,1.6655541993822662
HCC44,100016,5.500199899639815
OCI-Ly3,tanespimycin-bortezomib (250-1 mol-mol),-0.0739277067008881
AML-193,10385095,0.4941953706733294
LS411N,11485656,1.6093796612349578
SK-LMS-1,24753719,4.4754402870161485
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
NCI-H929,44137675,0.5857297222034469
OVCAR-8,selumetinib-BRD-A02303741 (4-1 mol-mol),6.062332861004591
647V,136227924,2.038450233147295
Calu-1,374536,3.659579318055704
MOLT-3,6450551,0.8379969325746265
8505C,124202324,2.206086681402059
RKN,10302451,3.971829298943927
NCI-H2286,4259181,0.1165074944182298
P-STS,10385095,1.1186168802515164
TALL-1 [Human adult T-ALL],24753719,3.125963092877027
NCI-H322,6918638,1.1027062108790242
Capan-2,2729026,2.9840495631231514
BT 428,6918638,-0.3537388396166394
SNU-308,54618771,1.0411941789938453
NCI-H508,374536,-0.2710368768433586
NCI-H1694,136227924,2.5297757130143887
NCI-H1650,4259181,0.5942836331714245
VMRC-RCW,9911830,2.7315472167375505
HCC44,49766530,3.18026268339199
NCI-H841,tanespimycin-bortezomib (250-1 mol-mol),-1.639550345576176
JJN-3,6450551,2.066926195664891
BT 139,6450551,2.676401003884647
NCI-H2196,10302451,3.953927189909324
OCI-Ly10,tanespimycin-bortezomib (250-1 mol-mol),-1.3027926249404789
NOMO-1,1716436,2.6410194121109773
JVM-3,2708,4.4318653925409
SNU-81,327653,3.5323829695882267
COLO 201,753704,5.616000893216349
NCI-H209,124202324,0.7427053501525159
Kuramochi,24753719,4.390928067478378
HT,24772860,-2.7948925341125435
SU-DHL-8,148198,-4.565516831047941
Karpas-299,148198,-2.4560718310367604
Panc 03.27,136227924,3.110606575361216
OVSAHO,9911463,3.940240147394606
NCI-H520,16013152,4.265918018585053
Becker,2729026,3.1227212581970676
L-363,9911463,3.9565669957446423
NCI-H1341,44493528,3.962775176370478
CAMA-1,327653,2.753376635525665
LAMA-84,136227924,2.847754951874779
HT-29,11404337,-0.847378289342427
THP-1,654092,-1.3607654077976277
U-251MG,9911830,3.888182385382464
SNU-738,327653,3.802831984914698
SNU-387,tanespimycin-bortezomib (250-1 mol-mol),0.93646564215711
HT-55,44493528,4.268967793319167
SK-N-SH,753704,3.7144950614194583
ECC10,9911463,2.6804416943678917
SNU-1272,49766530,0.1675221070029884
SW1088,sirolimus-bortezomib (250-1 mol-mol),0.8011613247197977
Ku812,4259181,-1.0914400455544095
EBC-1,54618771,0.4501558342724816
EM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),1.674677145167808
MOLT-16,44493528,3.7613597484696104
DAN-G,6918638,0.6024749153933902
NALM-6,11404337,-2.6750966527549855
MIA PaCa-2,136227924,2.1731844460154743
Malme-3M,11404337,-1.1089721048886994
LS1034,11167602,2.8357030175070284
Becker,44137675,2.3212832651934043
Rh41,6450551,1.4078658406301874
MEC-1,2708,2.969059307420035
Mino,24772860,-3.581741223453769
JJN-3,24772860,-2.8256809008490986
SNU-C1,11485656,1.873181014714628
NCI-H1651,148198,-3.460824501598599
OE33,136227924,2.987067512543954
KG-1-C,10385095,2.1458285557943
SNU-601,71729975,1.6177539927132347
LOX-IMVI,44137675,3.173066580571396
KMH-2,24753719,2.762394243468006
KE-39,54618771,0.8543301924142261
LS180,135984461,4.839780886141452
LS180,654092,0.275565618798522
SU-DHL-10,2708,3.359360317524635
SCC-4,156414,1.45988580347199
KMS-34,9929138,4.716780019482296
NCI-H2172,54618305,4.356498397814067
G-401,44493528,4.310857122389352
SNU-738,654092,0.4169806092483499
NCI-H460,9903786,4.057661845653794
EFM-192A,49766530,1.9106564421036225
SNU-1,753704,5.041981825332914
SH-10-TC,100016,6.555483038363527
ECC10,2708,3.267140511882252
NCI-H508,2708,5.138457996419572
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
KCL-22,JQ-1-UNC0638 (2-1 mol-mol),0.7941812364317666
HSC-2,10385095,1.233116039516603
SKM-1,11485656,1.846158462004935
BT 416,11485656,1.5705982486329817
HuNS1,24772860,-3.889022340605094
HOP-92,71729975,2.675559908784421
AsPC-1,148198,-3.729188282050714
BT 333,10302451,4.227428623189883
SNU-C4,2729026,3.227225478535941
NCI-H322,JQ-1-UNC0638 (2-1 mol-mol),2.7441380198703853
OE19,tanespimycin-bortezomib (250-1 mol-mol),-3.057865430510972
EKVX,JQ-1-UNC0638 (2-1 mol-mol),3.0900653553873227
NCI-H1734,selumetinib-BRD-A02303741 (4-1 mol-mol),2.401426851406924
KYSE-70,9911463,3.4914249269651307
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
SK-MEL-2,10302451,4.273835624093029
BT 231,100016,7.4946101776766385
GDM-1,4259181,0.8180452048094571
NCI-H508,4259181,-0.090379313964127
NCI-H1581,54618305,4.300256508666718
TE-8,JQ-1-UNC0638 (2-1 mol-mol),2.5517026910070224
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
MDA-MB-453,11167602,2.244240898320102
NCI-H2029,49766530,1.603997264455234
HCT 116,124202324,2.8233410173802467
BT 131,10302451,3.8852877828195007
SaOS-2,156414,1.509432711545826
Calu-3,54618771,0.5501561277635466
CAL-120,11485656,3.0524191278812975
Calu-3,151289,1.962262713263308
BT 422,11404337,-0.0607028130466723
NCI-H1105,135659046,3.0265793516175536
BT 422,46926350,-4.2550712021100985
LN-18,9903786,3.1734737643120696
SYO-1,4259181,-0.5124750518343509
DU145,49766530,-0.0443271676579987
NCI-H810,4259181,0.1893380308844004
K029AX,156414,5.338524173167653
K029AX,136227924,2.929460109593454
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
LOU-NH91,44137675,3.1585262513685612
HuH-6,753704,4.928049338034241
KLE,1716436,1.7262214726363108
L3.3,151289,1.4499844825237675
HCC1954,24772860,-2.865028729045388
Mono-Mac-1,10302451,2.661721795389531
HEY A8,2729026,2.967663596662379
Daoy,654092,-1.5424351166024135
KALS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.613841457820584
EFO-27,136227924,3.515702384882397
BFTC-909,4259181,-0.0277162117211437
697,6450551,0.8652057808307969
KMS-18,11485656,2.411593279183438
L-363,136227924,2.122664399399679
Lu-65,11404337,-0.485331944829254
SNU-886,327653,2.660863736494067
SW1088,11485656,3.080394465182635
SNG-M,3815108,3.1091562873335654
KE-97,9843750,6.147145597858424
SET-2,6918638,-1.854101300935
MHH-NB-11,9868037,2.6095173563675065
CML-T1,10385095,0.9719029483379856
HuH-28,9911463,4.067632897122288
GA-10,6918638,-2.7044389235712187
HCC1833,3815108,2.9955265548617835
SU-DHL-8,11485656,1.738295367016229
HuT 78,54618771,-0.2261201753145263
OVCAR-8,148198,-5.019835125371004
TE-8,54618305,4.365063234353354
KMS-27,1716436,3.601327816256154
NCI-H1703,54618771,1.8200920979055903
TT2609-C02,24772860,-1.5445790765526728
HPB-ALL,6450551,1.4306629065646106
GP2d,100016,6.428285689025714
KALS-1,753704,6.164228266085961
DMS 53,54618305,4.135188182610859
SK-MEL-28,148198,-1.1695105826491254
TE-6,11167602,3.4392943140139676
OVTOKO,2729026,3.053683220291208
MFE-296,49766530,0.1913665198227111
T84,6918638,0.2315605213048026
KMRC-3,JQ-1-UNC0638 (2-1 mol-mol),1.006886152330465
NCI-H841,6450551,1.801936295315678
ST486,10385095,0.6554259467266613
COV362,4259181,0.4253063174036923
HT,JQ-1-UNC0638 (2-1 mol-mol),1.0944994333159177
HuH-1,24753719,4.403946384068282
NCI-H2122,654092,0.5156399977478747
CGTH-W-1,124202324,2.471240347890605
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
NB4,49766530,-2.04129527445394
OVSAHO,11404337,0.0344009814781069
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
HEL 92.1.7,16013152,3.716140753888562
LUDLU-1,44493528,4.4309476749658625
BT 504,6450551,1.2836569274030185
KMS-11,148198,-3.359004885153461
786-O,2729026,3.071419688524856
HCC2218,6918638,-0.2279728548913661
BICR 56,46926350,-3.745757558882726
Caov-3,10385095,2.182007820321694
NU-DHL-1,753704,3.856303412590113
MKN74,148198,-2.653452729835883
KYM-1,9911830,2.312875424950125
JHH-1,10302451,1.603703322709363
M-07e,2708,3.697368711030294
CJM [Human melanoma],9911463,3.8597474778035217
EHEB,JQ-1-UNC0638 (2-1 mol-mol),1.0981019184979366
SNU-216,9911830,2.1398912486664026
HCC1588,654092,0.4901695449145311
BT 112,753704,3.3999292862808077
EB1,46926350,-5.887959287179859
MOTN-1,135984461,3.8565361151501585
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
GaMG,2708,6.841603480834063
HCC366,9911830,3.120648620550164
DB,9911463,2.6003327839693244
BT 333,4259181,1.6387622911370845
NCI-H1694,151289,0.7594399706086015
HCC2935,136227924,3.4382607017764473
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698
AGS,54618305,4.485668809554542
JHH-1,11404337,-0.8045754581071476
Mino,54618305,3.884266825894896
KYO-1,124202324,1.295779957402533
Ci-1,24772860,-2.7019842419974176
IMR-32,100016,6.43791059275997
Hs 944.T,16013152,3.699783105139744
TE 441.T,753704,4.281731848171136
Lu-99,tanespimycin-bortezomib (250-1 mol-mol),-2.7467052265090723
T84,156414,0.0682461753591611
JeKo-1,11404337,-1.0082771831534074
MDA-MB-468,24753719,4.129239306048558
MOTN-1,tanespimycin-bortezomib (250-1 mol-mol),0.3345366577649379
UO-31,10302451,0.869987759961234
CAL-12T,9911830,2.1862745450172576
HCC1954,9868037,6.210309136598162
SNU-1066,374536,4.364044317182547
COR-L95,16013152,4.05038947229277
T84,JQ-1-UNC0638 (2-1 mol-mol),1.1622325492897168
BT 164,100016,6.2228733531949505
SF126,44137675,3.8159192988642414
SNU-407,2708,4.827455835687523
Ku812,9903786,1.763683139425592
KP-N-SI9s,136227924,1.797924144791439
K-562,11404337,1.5978316825317844
KP-2,54618771,1.1956106328766414
MDA-MB-361,2708,5.400273531200033
NCI-H1975,9903786,1.3990648437170825
Hs 944.T,327653,2.9907406502537817
OE21,46926350,-5.252070355990055
BT 239,11485656,1.6389778224376736
HMC-1-8,24753719,4.642702183611676
HT-55,374536,1.2719942945136549
BICR 22,135984461,4.376718251500639
SNU-489,selumetinib-BRD-A02303741 (4-1 mol-mol),5.146106521516418
GaMG,9903786,4.966976399953102
PC-3,135659046,4.742697246450577
IMR-32,10385095,0.2389491055401895
JHUEM-3,49766530,1.26691736539767
DU4475,9911463,2.219274285034518
PLC/PRF/5,11485656,2.5978340800355544
MOLM-13,11485656,-3.968420003132376
253J-BV,136227924,2.6085874458601066
SNU-1105,4259181,0.7884836359109508
Kasumi-2,11167602,2.198810465874189
T84,2708,5.234104359901674
Ki-JK,49766530,-2.8034891942597935
ZR-75-1,2708,7.087802961552248
SW48,10385095,0.7767009249070084
EJM,753704,3.6448847004253055
PaTu 8988s,JQ-1-UNC0638 (2-1 mol-mol),1.1829021924496204
BT 416,1716436,3.683600433980017
NCI-H2196,4259181,0.8420736929714187
Panc 03.27,135984461,6.251236630594111
JeKo-1,10385095,0.5289255976933436
SW1116,156414,1.6393126370911288
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
SNU-5,24772860,-2.552787194445084
SNU-C1,24753719,4.251341478623143
TE-6,54618305,5.254782114960126
SNU-668,sirolimus-bortezomib (250-1 mol-mol),1.8089907805416063
VMRC-LCD,151289,0.8422251353629934
G-292 clone A141B1,9911463,4.73582688224515
NCI-H2172,2729026,2.5458261586186013
SET-2,9911830,2.246088546927402
BV-173,2729026,2.679223402924878
NCI-H358,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.2645225467487684
LS123,9911463,4.230374012673379
BICR 18,selumetinib-BRD-A02303741 (4-1 mol-mol),5.594313860646629
FaDu,9911463,4.044046112259449
PK-1,2708,7.605897390855717
TT2609-C02,9911463,4.397605537094769
KM12,24772860,-2.834807612027484
KYSE-520,100016,6.554858217735662
SYO-1,9911830,2.926835859906529
Calu-6,753704,4.826865958020266
WM266-4,327653,3.1683064460628603
MKN74,54618771,1.3558742291917982
LP-1,46926350,-4.466735427711426
HuH-6,4259181,-0.1636677698512317
ZR-75-30,374536,-2.8504408224851696
KCL-22,136227924,2.6502010503693016
NCI-N87,10385095,0.9731458206829144
TE-1,11485656,2.6145816655687746
HPB-ALL,9911463,3.8574243217658215
BICR 18,4259181,0.3399206996622695
SNU-1196,9903786,3.851159965091799
TE 441.T,6918638,0.7814615450050921
OPM-2,100016,3.804278037815123
Daudi,11167602,1.0022899570414256
HCC1438,6918638,1.5215576875890318
CAL-51,1716436,3.275997904874087
SW1088,156414,2.9727036283929644
VCaP,11485656,1.7583797003884982
SW948,6450551,1.190778779915613
SNU-308,654092,2.765487663234044
Karpas-422,16013152,4.291888200698237
HCC1195,124202324,3.181447677345357
DoHH2,4259181,-0.0115593428473218
IPC-298,2708,5.383783840063184
Hs 729.T,11404337,-0.1228627032694511
SU-DHL-1,11404337,-0.9851913382580488
Capan-1,374536,1.4426497482902372
HCC38,2729026,2.6408505219922147
LN-18,3815108,2.898906648732839
HOP-62,9911830,2.7524936884021223
LP-1,54618305,3.83678249468376
MFE-296,10385095,1.184383964247713
8505C,148198,-2.1728643040186237
HMC-1-8,selumetinib-BRD-A02303741 (4-1 mol-mol),3.824727923245809
P-STS,9903786,4.008586814147432
EFE-184,54618771,1.5466528492822589
LP-1,9903786,3.180613462551036
CMK,136227924,3.317343215770968
OV7,10302451,4.138234745374046
AGS,148198,-2.2056365427591307
DEL,24772860,-3.1071705970657506
JHOM-1,11167602,4.155766274688487
MOLM-6,4259181,-0.6414386252476381
LS411N,9903786,3.6806866285220017
BICR 31,10302451,2.0763164615496232
D283 Med,9903786,1.479416225891386
AGS,24772860,-1.977259159653653
SH-4,49766530,3.958821770259228
HT-1197,6450551,3.5903477337360057
NCI-H1694,9903786,3.3065111756665564
SNU-182,10302451,1.4243170989551428
BT 248,71729975,1.811306833980593
RPMI-6666,327653,3.501914206867195
PE/CA-PJ41 (clone D2),4259181,1.7662808489331707
SNU-878,54618771,0.5665140825302253
OE19,6918638,0.8601306195335003
SNU-245,10385095,2.5153017104707263
KP-3,1716436,2.492121125287185
PaTu 8988t,11404337,-0.5897258437911538
HeLa,9911830,3.0701846369034556
KNS-62,54618771,0.989715202363148
KMM-1,9911463,3.7881854047287113
FaDu,44137675,4.128299782175767
CAL-51,374536,3.1977545561189347
NCI-H209,54618771,0.4504113944457773
DB,10385095,0.676257442329155
Hs 729.T,10302451,3.696071611874436
KHM-1B,135984461,4.335909278526869
BT 231,24753719,4.299852690221636
SK-N-AS,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.2098595134860778
HeLa,151289,0.5666622347793419
HCC4006,374536,-2.768431142262161
RERF-LC-MS,6918638,0.4520678244574614
Calu-1,100016,7.639038839177244
SUP-M2,374536,0.4691112183217765
GMS-10,9911463,4.363409531102835
D283 Med,374536,-5.802881326036661
BT 416,9911463,2.4624621217887457
P12-Ichikawa,54618305,-5.897174424976468
OVCAR-8,24753719,4.601270085518873
SNB-75,11404337,0.4228386005556312
RVH-421,10302451,3.790601078841018
HOP-62,753704,5.052379590990168
BT 416,4259181,-0.2167278617462421
NCI-H1573,4259181,-0.9431239264425192
NCI-H2196,11485656,1.855781545293995
RS4;11,11167602,0.3393907697934239
UM-UC-1,JQ-1-UNC0638 (2-1 mol-mol),0.7748214079335823
NCI-H647,148198,-1.832862483065856
KMS-18,9911830,2.6183763953009023
ME-1 [Human leukemia],136227924,3.8385097232305103
AN3-CA,9911830,-0.0740885579254531
BT 159,selumetinib-BRD-A02303741 (4-1 mol-mol),5.031160210612749
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
RT-112,124202324,2.1045351429687313
Hs 934.T,10302451,3.3765537918569812
BxPC-3,3815108,3.682439325637505
SUP-T1,44493528,4.4942343110915655
OVCAR-5,135659046,3.4462487776762303
NCI-H2009,11485656,2.228831542035607
BT 216,24772860,-1.9184406917252403
HCC1195,4259181,1.5243000319349156
DMS 114,6918638,1.3129980903302014
HPAF-II,2729026,3.067578643747003
NCI-H1105,24753719,4.604645555885144
Reh,44137675,2.1605456018244342
EN,151289,1.360454415262724
WSU-DLCL2,10302451,2.8814430152918717
SNU-719,135984461,4.329152044939095
OCI-AML-2,24753719,3.4649014261279234
HOP-62,135659046,3.835086594204883
NCI-H1755,1716436,1.2187712718205004
BT 239,4259181,0.729080593858997
Hs 888.T,JQ-1-UNC0638 (2-1 mol-mol),1.777823349199604
RERF-LC-MS,46926350,-4.177207395055215
NCI-H520,9903786,3.332228860924169
SUP-M2,2729026,2.2518457878383096
OCI-AML-3,46926350,-6.18212546634352
FTC-238,24753719,4.029317045060616
RD,10302451,3.748222452512195
MV4-11,6450551,0.3926548408259085
Ri-1,327653,2.467525677033306
SH-10-TC,2729026,3.3680995474277937
HCC1588,24772860,-2.19555721291992
MG-63,2729026,3.009754587477254
BT 416,136227924,3.4255307271180726
LOX-IMVI,9911463,3.8715849180913633
2004,sirolimus-bortezomib (250-1 mol-mol),0.3524960836924493
HGC-27,9868037,2.329533656521022
253J-BV,9911463,3.300090280409142
Hs 611.T,2729026,2.5246263779141453
KO52,11167602,0.9021081553845208
A-375,49766530,-0.2051662663719206
PL-21,11485656,1.7729113112041155
SNU-C1,6450551,3.2514425542081637
COLO 201,10385095,1.2644655705332717
HT-1197,54618771,2.611053325854013
MHH-ES-1,9903786,1.586022951185602
Kasumi-2,374536,-0.2175337956908027
HCC1438,24772860,-2.323274018658952
SK-MEL-5,6450551,3.017299477344576
DB,374536,2.2758572216249027
SKM-1,654092,-1.7907532685480716
COLO 829,46926350,-3.959956788388295
HL-60,46926350,-4.297229712742181
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
TALL-1 [Human adult T-ALL],10385095,1.4053466186378143
KYSE-30,9911830,3.463728225083358
BT 224,44137675,3.844663671670179
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
SCC-25,151289,1.000658764001303
OVSAHO,54618771,1.1645898575055549
HCC2279,10385095,2.674099948774722
BL-70,10302451,3.7691675443398247
L3.3,2708,4.48343396675343
BICR 6,6918638,1.0635609098647931
CJM [Human melanoma],4259181,0.5717203642017457
SCC-4,16013152,4.229797591001171
SW579,9911830,-0.5656560030072354
J82,9911463,4.397317703164105
Hs 611.T,selumetinib-BRD-A02303741 (4-1 mol-mol),5.110673163960407
HT-1376,753704,5.259514702224165
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
NCI-H1694,11404337,-1.0250746048431445
SK-LU-1,9911830,2.3624970438658144
MES-SA,6918638,1.1340225754768447
A-204,148198,-5.205432048346018
KATO III,2729026,3.10585902689509
TE-15,9911463,3.694434531668693
YH-13,148198,-2.7695139562786526
OC 314,54618771,0.7264278872863676
JHH-2,11404337,-0.6360298022443034
CAS-1,JQ-1-UNC0638 (2-1 mol-mol),2.042817831323494
5637,6450551,1.21296853635979
23132/87,124202324,1.8271837221807392
SYO-1,54618305,4.368337519568372
NCI-H1666,151289,2.120507058427236
NCI-H1944,46926350,-5.724739419330403
NCI-H2085,44137675,2.878975217875474
Hs 294T,JQ-1-UNC0638 (2-1 mol-mol),2.47578574214357
BT 320,6918638,3.210777195522013
U-BLC1,11404337,-1.495782153452068
SW1088,9911830,2.786109605650585
P-STS,6918638,-1.1348204820090546
HuP-T3,2708,5.229598766149438
SK-MEL-31,10385095,1.516996693340104
EKVX,156414,-0.4483754981833144
HCC2935,selumetinib-BRD-A02303741 (4-1 mol-mol),6.191507029480241
PK-45H,44137675,3.4511003090763515
Karpas-620,1716436,2.4965224124090475
HCC15,4259181,-0.5021574884501439
FU-OV-1,24772860,-2.86759244210788
T84,9911463,2.866030218571942
HDLM-2,10385095,1.1751737013594648
NCI-H1734,4259181,0.3120141556341839
Hs 888.Lu,11485656,2.9342163037973563
HEC-151,654092,0.4022245307281385
MDA-MB-468,136227924,1.762243520931147
Kelly,49766530,-2.0439406855810356
UACC-62,148198,-2.3489315937571016
NCI-H1650,148198,-2.4983400542684895
SNU-719,124202324,2.4880635508648776
HEC-6,9911463,4.040117768715498
DMS 273,753704,5.000496745911757
WM266-4,10385095,0.1508976066416572
SNU-840,54618771,2.041373861449483
Pfeiffer,24772860,-3.084685590627518
NCI-H1650,11404337,0.7802522611526345
TE-14,54618771,0.7402705360744307
GSU,148198,-2.846893382841785
DU145,73707371,4.93745996630941
BCP-1,6918638,-1.8466999206036412
NCI-H69,11485656,2.3871214683206152
NCI-H1092,44137675,4.14698117829052
KMRC-3,4259181,0.7954133623133547
A101D,753704,4.6212680875103365
BT 179,156414,1.740196699219975
786-O,24772860,-2.159067811184435
NCI-H196,10385095,1.1966476706382554
SNU-899,148198,-1.9308055104707893
Karpas-422,1716436,3.743993231733117
AsPC-1,11485656,3.206693439346989
NCI-H1155,753704,6.344575697762946
PK-59,10302451,2.95389022276854
MCF-7,136227924,2.325387172028071
Rh41,54618305,3.8818848297915665
SNU-1077,1716436,3.6351328790412993
FU-OV-1,49766530,-1.0180111021842635
GOS-3,11485656,3.367022375162814
MOLM-13,44494015,-5.247330257185634
COR-L88,JQ-1-UNC0638 (2-1 mol-mol),0.7692475869373364
BT 228,374536,3.476556320735245
CAL-78,10385095,2.2250842594628035
Hs 729.T,11167602,2.295672190190323
LNCaP clone FGC,11485656,1.8681426570872277
TC-71,11485656,1.8010543407786783
NCI-H2087,10385095,1.015430791106066
SK-MEL-30,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4791675415157015
SH-10-TC,156414,3.265122378656891
NCI-H520,44137675,1.8444425392155637
ECC12,11485656,3.0837599564309164
HDQ-P1,JQ-1-UNC0638 (2-1 mol-mol),3.683778207027592
NCI-H1299,136227924,3.5346618762414392
AsPC-1,44137675,4.002233175780649
SCC-25,136227924,2.958495944269512
SNU-16,135659046,3.4263831246491367
OCI-Ly10,148198,-3.382160448081964
COR-L51,11485656,1.4536828113034417
253J,24772860,-2.960223053941961
NCI-H1105,2708,4.646634591621174
KO52,374536,-2.868980977087777
COLO 684,151289,0.7391810353265504
A-673,JQ-1-UNC0638 (2-1 mol-mol),0.3202130450215845
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
KALS-1,4259181,0.4925771943360276
Hs 611.T,10302451,2.003286438841951
HEC-151,9929138,7.082890356746388
RL,4259181,0.4203356092825316
AML-193,6918638,-1.1768920136459526
HGC-27,9903786,1.5115157472800849
COR-L95,11485656,1.8696119642586884
NCI-N87,24772860,-4.531203546207334
BT 333,11167602,2.748002514213894
LAMA-84,44137675,4.810009540468649
Raji,148198,-3.0979012911214077
BT 333,9911463,3.323400968043226
VMRC-RCZ,2708,5.455586217837156
HT115,54618305,4.118965494777058
CAL-85-1,54618305,4.262319524380244
HCT 15,327653,3.42482892968062
MDST8,124202324,2.333625526818204
SUP-M2,JQ-1-UNC0638 (2-1 mol-mol),-1.9549879004060489
SJSA-1,11485656,2.5808954348958797
MKN74,148198,-2.653452729835883
MDA-MB-435S,100016,6.42664314163943
RERF-LC-Ad2,49766530,0.0972135502095861
NCI-H1155,327653,1.739205993239167
TE-11,753704,6.270375694627999
HEC-151,2708,4.535952513422743
Tm87-16,tanespimycin-bortezomib (250-1 mol-mol),-2.1995475163951217
MHH-ES-1,10385095,1.1490063468144698
COR-L88,6918638,-0.7274407096817714
LoVo,136227924,4.6796674015936075
BT 228,selumetinib-BRD-A02303741 (4-1 mol-mol),4.292405714154379
BT 333,selumetinib-BRD-A02303741 (4-1 mol-mol),6.159427361169164
HMCB,374536,3.816146263296923
AN3-CA,2708,5.218139570683085
LOX-IMVI,148198,-2.445772941232649
Hs 611.T,1716436,1.70748477144168
F-36P,11167602,2.0610720557550755
COV644,9911830,2.3933009993345156
BT 216,2729026,1.9073703141426603
T-47D,156414,1.5833515843485626
YKG-1,2729026,3.207992670398629
MM1.S,2729026,2.344981820167116
NCI-H1651,1716436,3.061489308255068
OCI-Ly10,44137675,-1.4710296216819638
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383
SNU-1033,24753719,4.01001604133428
LCLC-97TM1,1716436,2.9898763561132276
Ki-JK,10302451,2.4926538669178977
KYSE-450,24753719,4.912608563377894
AN3-CA,11485656,-0.8274044857319752
NCI-H2023,124202324,4.606458046385771
LOU-NH91,100016,8.416108067142021
SW1710,156414,5.813264772050665
BICR 18,151289,2.420011395674251
OAW28,10385095,1.310156197215646
NCI-H69,151289,-0.1411257772996416
KP-4,24753719,4.448787857438118
EFO-21,9911830,2.599153404560511
SNU-1,9911830,1.637952110808466
CAL-12T,9911463,4.058144807952839
SK-MEL-24,44137675,4.216903314273553
NCI-H1563,4259181,1.88971359243236
MOLT-16,9903786,1.2441798518109255
PE/CA-PJ34 (clone C12),135659046,3.607473265136562
SNU-899,2729026,3.113526969171743
NCI-H1568,2729026,2.4592472427928795
SJSA-1,9903786,3.6249544402257863
K-562,327653,3.3038748071855175
BT 179,6918638,1.1141974557977532
IGR-1,2729026,2.15818057247619
HCC1143,753704,4.831564496260181
SK-N-SH,9911463,3.4426003417788618
HCC1833,9903786,4.187003338939228
Hep-G2,9911830,2.4259359362723147
SK-N-BE(2),9911463,3.2648033538854517
NCI-H2172,9903786,4.970438346504575
KMS-26,11404337,-1.1990569021181443
TE 617.T,JQ-1-UNC0638 (2-1 mol-mol),0.3306309340053746
NCI-H2126,9911830,2.4864005451988787
HEC-265,54618305,4.392591602622262
K-562,374536,0.780579010414565
GDM-1,9903786,1.637599474321908
SNU-213,148198,-1.214073512813324
Karpas-422,11485656,3.579952167071255
SNB-75,136227924,3.131186635449868
COR-L51,374536,2.2801686189335917
KYO-1,2708,2.7482401338371014
HEC-1-A,16013152,4.004730809743108
Kasumi-1,9911830,-5.991531710448216
Ci-1,54618771,0.8239917117342518
PL-21,10302451,3.830293265507133
ECC10,753704,6.011363133623213
L-540,2729026,2.4049236533854836
DLD-1,124202324,2.891435520925823
NCI-H1581,100016,6.5572943300427795
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
KYSE-410,11404337,-0.5095483106694066
EHEB,49766530,-1.6427312921557593
MFE-319,9903786,4.166499809230756
Peer,10302451,1.388599660248698
WT2-iPS,10302451,5.794873655301564
TE-14,10385095,2.0741734466244424
PaTu 8902,124202324,2.5191853508509823
OCI-AML-5,11485656,1.9457799090606884
Kasumi-2,JQ-1-UNC0638 (2-1 mol-mol),-0.8323708292538591
KYM-1,tanespimycin-bortezomib (250-1 mol-mol),-2.3069485733891155
SNU-1,49766530,2.1666853303349245
BT 340,2729026,2.0964042017244355
Li-7,24753719,4.307945424099166
NCI-H838,327653,3.747496502125908
OUMS-23,selumetinib-BRD-A02303741 (4-1 mol-mol),5.206573587113268
SNU-5,54618771,-0.9797108545959382
LOX-IMVI,1716436,2.742191548992314
HCT 8,JQ-1-UNC0638 (2-1 mol-mol),-0.1107733884734019
NCI-H1869,9903786,3.8309501172404734
IGR-37,9911463,4.34930148495989
GaMG,10302451,4.686034849330264
JeKo-1,46926350,-6.039670040356239
HH [Human lymphoma],24753719,3.74360908946732
BT 112,54618771,1.3381626551406447
SNU-8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.2329010527569984
OAW42,9911830,2.253682076539179
PSN1,374536,4.918079296372748
OE21,16013152,5.5838435912248015
K029AX,11404337,1.217288155718472
HCC1428,JQ-1-UNC0638 (2-1 mol-mol),1.1386053047932103
42-MG-BA,sirolimus-bortezomib (250-1 mol-mol),1.266614497912793
IMR-32,9903786,1.34691800492683
LP-1,10302451,3.6686554467714574
OCI-AML-5,135659046,3.671994608621507
ACHN,sirolimus-bortezomib (250-1 mol-mol),2.4619171301455736
PE/CA-PJ49,2708,4.888337248916052
SNU-398,124202324,2.5274702624159713
GaMG,73707371,6.334146465468484
NCI-H211,156414,1.061128990416998
NCI-H1355,9911830,2.640098012656491
CCK-81,10302451,-0.3624920421217548
HEC-265,54639665,4.667688857990006
Kuramochi,1716436,3.5304708794018533
NCI-H2444,44137675,3.689368590529393
HCC1171,9911463,4.341484075283008
DoHH2,tanespimycin-bortezomib (250-1 mol-mol),-0.3609676807954009
SNU-1272,2729026,3.2131573278118015
A3/Kawakami,9903786,0.9564213610990896
FTC-133,2708,3.4116435244290773
SNU-1076,11485656,2.42943122254484
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717
647V,327653,3.5723030126799475
L-428,10385095,1.2929398683818265
HCC4006,9903786,3.3433056456258585
JHUEM-7,327653,3.126202180618715
Karpas-422,selumetinib-BRD-A02303741 (4-1 mol-mol),3.605523049740557
WSU-DLCL2,2729026,2.432364319522447
DMS 114,44137675,3.628624760673075
K-562,151289,0.3703020531314545
Lu-99,3815108,3.127423738533391
RCH-ACV,1716436,1.9567773925658896
5637,10385095,0.6643188027202117
PC-14,11167602,2.3645338141956924
PL-21,24753719,3.7602550214129047
HCC202,156414,2.264042370468709
SNU-475,6450551,2.9312309002977424
SCC-25,6450551,2.660576747441137
NCI-H1184,9903786,1.9169497440885477
SNU-685,136227924,3.487679457544809
PF-382,9868037,2.2881920680680756
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
MHH-CALL-4,49766530,-1.9452729400457551
WT2-iPS,327653,3.084686550525322
MPP 89,1716436,3.6875257649922255
NCI-H522,148198,-5.538025476960186
MHH-CALL-3,374536,0.8383692000154862
SNU-1033,71729975,1.596048380525692
CAL-85-1,11485656,1.9018323097644911
HT,9868037,1.9905523234994904
NCI-H810,10385095,0.4764692150659226
SUIT-2,54618771,1.0369427055295135
Mino,156414,0.9048152948855052
Hs 578T,11167602,4.417478222776911
MOTN-1,54618771,0.6090768126034483
MHH-CALL-4,4259181,0.5177558135201623
DBTRG-05MG,54618771,1.322739647725507
LMSU,46926350,-4.277372765646079
EFO-21,2729026,3.422565089717947
SH-4,10385095,1.3963711964007446
SW1271,156414,2.097129180606755
KP-3,124202324,2.4407993053685413
SNU-C4,4259181,0.9751508347932162
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345
NH-6,374536,1.40627832628925
DAN-G,24753719,4.221870013489763
TE-4,11485656,2.067320929780226
NCI-H460,136227924,3.925006850615035
NCI-H211,tanespimycin-bortezomib (250-1 mol-mol),-2.6494968987318517
HuH-1,100016,6.427674645277276
NCI-H1944,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5338136556671524
OV7,16013152,4.040032015195081
COLO 792,11485656,2.715792347654397
SF126,156414,2.7219935651000395
KNS-60,tanespimycin-bortezomib (250-1 mol-mol),1.2079185483503194
HPB-ALL,11404337,-2.5207664268075676
P3HR-1,16013152,4.399552078454294
T24,44137675,4.665280970793604
NCI-H69,654092,-0.2367038389856957
BT 179,24772860,-1.6254986904273308
U266B1,327653,3.490425774646272
HT-1376,1716436,2.2352154911916826
SNU-601,11167602,2.836035120173089
THP-1,135659046,3.5163432758648256
NCI-H520,4259181,-0.9847708191101096
RL95-2,24753719,4.206948488089824
Karpas-620,100016,5.312019885835398
HCC-56,10385095,2.391265735319104
JHH-1,6918638,-1.2691376417044395
HeLa,1716436,3.4647611056245977
NUGC-3,24753719,4.191075133336168
SW948,9911830,2.1163810502856344
HuCC-T1,44493528,5.528865919674086
KYSE-180,54618771,0.8276624799970426
RL,151289,0.4618736793154854
BT 286,2729026,1.1931369747850211
JVM-2,3815108,2.3619430842314544
A3/Kawakami,44137675,4.3383661148547485
SK-UT-1,753704,5.7414548623534305
SCC-4,9868037,1.8621190248013155
TM-31,136227924,2.988827636595516
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868
253J-BV,156414,2.25351460742166
LK-2,151289,0.6592867848571616
BT 131,tanespimycin-bortezomib (250-1 mol-mol),-1.406336138935124
KE-39,44137675,4.4813975845381755
Rh30,11404337,-0.0362683068466765
A-204,2729026,2.156185261661577
T84,54618771,0.5762306711501146
WM266-4,44137675,1.402360639435635
SNU-620,9911830,2.304095058614006
TE-5,54618771,0.4798060513951584
SUP-T1,9868037,1.5835878510828882
NCI-N87,148198,-3.7864178683693774
GA-10,327653,1.367223510616167
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645
COV434,24753719,3.694828401712744
KM12,54618771,2.3555448487565247
NCI-H1568,11167602,1.5259281753697294
OV-90,54618771,1.0119398680970997
NCI-H1435,327653,3.0967015068004637
HCC1806,135984461,4.428357366686186
COLO 201,148198,-3.731044907420304
YD-15,54618305,4.368712757775692
HT-55,135984461,4.061265813784957
PE/CA-PJ15,135984461,4.416241968173964
NCI-H1581,10302451,4.243802408751907
U-87MG ATCC,24772860,-0.1203860896038
HT-1376,JQ-1-UNC0638 (2-1 mol-mol),4.120192714503884
Fu97,10302451,2.984278073549712
ES-2,3815108,3.0666296154583135
SNU-1196,44137675,3.735013269079477
COLO 678,11404337,1.0934047446888793
WM983B,10385095,1.4622249945753911
COR-L88,sirolimus-bortezomib (250-1 mol-mol),1.8944526230025216
NCI-H929,54618305,4.349731057515986
TE 441.T,374536,-8.101704814309118
SNU-878,54618305,4.855908979136769
MOLT-3,24772860,-3.6103979740065513
JM-1,54639665,5.005029028557516
HEC-1-A,156414,1.6058347893065534
JVM-3,9911830,2.036590776668221
LCLC-97TM1,11485656,2.4293249862604913
BICR 16,tanespimycin-bortezomib (250-1 mol-mol),-2.3692511571094244
IGROV-1,4259181,0.1937358171291443
KP-3,2708,5.865062247079506
COLO 668,2708,2.7556818559848573
BT 330,753704,4.468894642288355
BT 504,136227924,2.4961671253802957
NCI-H1299,44137675,3.903392614600126
SNU-1196,54618305,4.430886852006675
COV644,374536,-3.076109764390594
SNU-1272,JQ-1-UNC0638 (2-1 mol-mol),2.22691909239422
HCC1588,327653,3.013772565246454
RPMI-8226,753704,4.359458497324744
NB4,11404337,-1.1437955432104374
COLO 678,136227924,3.6500617296173288
BHT-101,24772860,-1.2889054366186483
Capan-1,9911463,4.415677524412553
MPP 89,9903786,4.435706117930943
HLF,selumetinib-BRD-A02303741 (4-1 mol-mol),6.05340101106501
HD-MY-Z,JQ-1-UNC0638 (2-1 mol-mol),1.5192486909885528
BICR 22,2729026,3.062923067871907
Mel JuSo,sirolimus-bortezomib (250-1 mol-mol),1.422716190739553
NCI-H747,753704,5.378690702939567
NCI-H146,24772860,-4.237473750878659
SK-MM-2,54618305,4.453861549537744
LAMA-84,tanespimycin-bortezomib (250-1 mol-mol),-0.5777887932469495
KM12,124202324,2.834333663394779
CFPAC-1,10302451,2.7378299397254366
NCI-H520,11167602,5.235788711953261
BT 482,156414,1.6572125651700018
EPLC-272H,156414,-1.0107061840170948
LS123,148198,-1.1889670275766562
NCI-H1693,sirolimus-bortezomib (250-1 mol-mol),0.2355785626536786
SNB-75,2729026,2.9990059683503327
COV644,44137675,4.491487920455428
NCI-H838,24753719,4.505890543607651
SF295,9911463,4.265275017996558
SNU-213,44493528,4.322072480687394
LNCaP clone FGC,10385095,0.9687144663796518
KE-37,654092,-0.5696755652201826
SNU-1214,4259181,-2.0986949595329527
HCT 8,9868037,4.173444279573331
NCI-H446,11167602,1.6852750871191335
VMRC-RCW,654092,1.2304448739202454
TE-10,24753719,4.768956775579738
SNU-869,4259181,1.033647746457788
SK-BR-3,136227924,2.8779705448471975
Reh,9903786,1.595846435725099
SK-MEL-1,44486093,4.944156496715651
BT 498,54618771,3.343910197755889
MG-63,24753719,3.9781774427737617
NUGC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.9739376787395078
HGC-27,selumetinib-BRD-A02303741 (4-1 mol-mol),6.257283698021105
BT 504,9911830,2.9079127670616978
NCI-H1703,136227924,2.979921585365296
OCI-Ly10,11167602,4.287131576849384
HT-1080,11404337,0.3572929158559362
BT 228,6918638,2.21176132394779
HuCC-T1,JQ-1-UNC0638 (2-1 mol-mol),3.464457608774568
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566
LS411N,2729026,2.9791300415919646
Panc 03.27,6450551,3.0934821428896755
SNU-489,JQ-1-UNC0638 (2-1 mol-mol),2.263870322860392
KYSE-150,327653,3.2544951668748845
NCI-H2106,327653,1.9858546242154949
OE19,4259181,-0.6372302154044356
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
HEY A8,44137675,4.171113867931212
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
OAW42,151289,1.5068907411227557
PaTu 8988s,1716436,2.523682098033693
Jurkat,135984461,1.8556253442912225
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
LN-18,10302451,3.663631196190854
HT-1376,11404337,0.7952974713578591
KHM-1B,124202324,1.1821842907851436
PF-382,374536,2.6185584915406137
HCC1428,156414,2.3918754519633754
SK-MM-2,44137675,3.168978175262298
A4/Fukuda,49766530,-0.1813275565198268
EHEB,54618771,1.2042140049426533
SNU-1079,2708,4.865454763333914
DK-MG,44493528,4.356107772315373
NCI-H2110,11167602,4.9824234878437395
SK-MES-1,1716436,1.7524592082452732
PANC-1,11485656,2.097269968494983
BL-41,16013152,3.5256533836077453
Hs 934.T,2729026,2.4016889389930984
A-204,156414,1.2120783499508014
T24,10385095,0.9393437218263464
BT 328,9868037,5.326885818831123
MOLM-6,10302451,-1.8333818669362472
SK-N-SH,24772860,-2.329286483323852
M059K,4259181,1.0338081724694033
CAL-78,2729026,2.9935036521569303
HL-60,44137675,2.716345093326382
PK-59,4259181,0.3924216394548331
MKN45,9911463,4.632909886442526
COLO 829,10385095,0.8100752114980174
BT 286,135659046,3.5488699738704432
T-47D,6918638,0.9017402025049926
GaMG,6450551,3.1344457952854707
U-251MG,6450551,4.54064520209726
BT 145,136227924,2.723434550490864
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838
DEL,44493528,3.9686709959238833
PK-59,135984461,4.560793597848683
NCI-H1184,148198,-3.201792375751558
RL,11167602,4.161997325292916
YD-38,2729026,3.0794771028962753
LAMA-84,4259181,-2.0546008756255767
Hs 940.T,9868037,4.608468279286332
TE-10,10385095,1.858372873249832
BICR 31,11485656,2.9684140094972387
BV-173,124202324,0.9244738211732664
KMS-21-BM,54618771,-0.9009155156599936
BT 328,156414,4.0443464949872645
PC-3,148198,-4.170321827302026
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
SNU-886,4259181,0.9120616711669954
NCI-H1563,9903786,2.6215320097996684
WM1799,49766530,-0.3108809621459331
NCI-H2023,1716436,2.37941848365823
SW1088,11404337,0.4126276779889334
TE-11,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9839830761873625
Karpas-620,327653,1.9362817127308152
BFTC-909,44137675,3.23817368119839
EBC-1,4259181,0.1391394165733286
COLO 668,9911830,2.596021506669569
B-CPAP,10385095,0.9210921841581224
SNU-668,374536,3.0060092865657024
Karpas-422,46926350,-4.5458503553552365
SK-MM-2,327653,1.9835737572628724
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
SK-MES-1,10302451,2.5491443779150273
Hs 578Bst,156414,1.2276952270662207
HCC2218,10302451,2.366058376925374
VM-CUB-1,JQ-1-UNC0638 (2-1 mol-mol),1.0256193946599228
LOU-NH91,54618771,2.8270991446030593
COLO 668,1716436,1.6635028385612682
Panc 03.27,46926350,-4.399892106444009
TE-11,tanespimycin-bortezomib (250-1 mol-mol),-2.7748536147542167
NCI-H1693,100016,7.64063251702684
JHH-6,4259181,1.7336593544042438
DMS 53,9911463,2.8139915060011766
MOLM-13,4259181,-1.5110532495146267
OCUM-1,16013152,4.218803631290333
Hep 3B2.1-7,9903786,2.792162090587101
BT 131,10385095,0.8018228032587859
TE-14,11167602,2.7334128910951514
KMS-27,148198,-3.735247787675698
Detroit 562,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1140925652631815
EC-GI-10,11485656,1.8249313771859752
VMRC-RCW,2729026,2.5998669504721397
EC-GI-10,11167602,1.549524194849354
IGR-39,11404337,1.3258536421281484
NCI-H446,151289,-0.1517403510055047
G-361,9903786,2.8296470400432296
NCI-H1155,9868037,2.157837609238264
MKN7,44137675,4.50249550674296
EB1,136227924,2.1314721571590876
EPLC-272H,10302451,2.306832599815418
Hs 895.T,11485656,3.207979584674572
OCI-AML-5,9911463,4.375280736441336
HCT 15,9843750,4.426307066641918
SNU-1076,4259181,0.5064465956182325
CA46,54618771,1.203400154931592
42-MG-BA,156414,2.3078841237771073
NU-DHL-1,24772860,-2.0670136915752395
2004,9903786,1.8272851025318924
SK-N-DZ,54618771,1.6513533063720298
OCI-M1,24753719,3.8441601097778015
Tm87-16,9929138,6.73537704561969
SNU-620,44137675,3.716844101411008
COLO 699,49766530,0.7999690356188136
SHP-77,2708,5.285997380394386
PaTu 8988t,148198,-4.283282973565046
BT 159,tanespimycin-bortezomib (250-1 mol-mol),-0.0268795114387354
769-P,49766530,-0.8828677111325465
NCI-H2170,9903786,3.56987053348202
KALS-1,10385095,1.3956260866944918
GB-1,24753719,4.75558309806726
CAL-148,11485656,2.5370782509727356
IGR-39,9911463,4.324644624489837
NCI-N87,4259181,-0.3128226187706996
LS513,2729026,2.122830219423553
SCC-9,24753719,4.411411644196846
Ishikawa (Heraklio) 02 ER-,11404337,-0.8066309120452816
SK-N-FI,11485656,1.359995170672745
NCI-H1869,2729026,3.0782751585704684
COLO 201,24772860,-3.128832614385994
CHP-212,374536,1.0120647544578718
HCT 8,24772860,-0.7901849839808864
SNU-175,654092,0.1799535462159149
SNU-410,135984461,4.232022058920155
UACC-257,1716436,3.2160940956115223
YD-8,2708,5.154021841255303
KP-4,11404337,0.6488423054091234
TE-8,136227924,2.7469773037217715
P31/FUJ,10302451,4.186780329312711
CA46,148198,-5.7845042531785
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
Hs 940.T,9911830,4.550926661212335
JHH-4,374536,2.589861930389494
Rh18,11485656,2.5820801285945927
KNS-60,4259181,-1.0001238912945338
MDA-MB-453,9911463,3.8683390626627454
8305C,1716436,2.674556448491312
OCUM-1,753704,4.971583442398356
U266B1,6450551,2.5933119614674864
WM793,44137675,3.8583923269749465
BxPC-3,10302451,2.105262518783424
CAL-33,sirolimus-bortezomib (250-1 mol-mol),0.5156392130456946
T84,327653,3.0918014670068654
L-1236,753704,4.900204182446618
UACC-257,374536,-0.8579988120395282
RD,9911463,4.091242805100522
SH-4,54618771,-1.4714653388751002
UM-UC-1,6450551,-0.1324979828551099
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436
VMRC-RCZ,6918638,0.7764115752639781
22Rv1,135984461,3.7893154959585735
ZR-75-1,374536,0.6252262216507539
HCC15,9911830,1.9028880277746671
MOLT-13,24772860,-3.0854925748842668
NCI-H1568,24772860,2.3104914540479324
SNU-878,44494015,4.4618367491886435
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
SNU-119,selumetinib-BRD-A02303741 (4-1 mol-mol),5.373099730339768
MIA PaCa-2,54618305,4.257702417709433
NCI-H810,44493528,3.9330833724433294
MDA-MB-415,sirolimus-bortezomib (250-1 mol-mol),2.5616194008456916
NCI-H2087,2729026,1.600072577840739
HCC95,10302451,2.261306472696935
HSC-4,24772860,-3.179601965562413
UACC-257,2729026,3.0227984960710104
FTC-238,148198,-4.9024101761285435
BT 187,4259181,1.3411496653636976
CAL-29,654092,0.4010034664883296
LP-1,24772860,-2.4443835432782963
SK-CO-1,2708,2.7526164010571152
SU-DHL-6,10302451,3.370117636140473
MKN7,11485656,2.688559348237845
NU-DUL-1,sirolimus-bortezomib (250-1 mol-mol),-5.630775475246084
MOLM-13,100016,3.967621300341963
SNU-1214,44137675,2.73058467391687
KYO-1,24753719,6.215004432138207
IMR-32,327653,2.318153172774913
HeLa,6450551,1.7537077061926707
SNU-182,JQ-1-UNC0638 (2-1 mol-mol),1.3528437184364657
MDA-MB-435S,10385095,1.8862945201752297
SK-UT-1,46926350,-4.372914941162361
HEC-59,2729026,3.005812203323877
NCI-H1105,10302451,3.9440283019984985
SNU-407,156414,0.885459521528447
PE/CA-PJ15,374536,3.161408900699119
CAL-148,136227924,1.0972662327382037
Calu-6,135984461,4.796785128617679
NALM-6,2708,1.451049590363187
NCI-H2052,2708,4.406363139465694
NCI-H2286,54618771,-1.3554512222972157
BT 147,24772860,-2.543678293116335
MHH-CALL-4,9903786,1.9013313990407976
Calu-3,136227924,3.506459850502243
U-118MG,54618771,1.5788983669789174
KMS-20,10385095,0.7360105255887816
LOX-IMVI,6918638,-0.3729962449079992
639V,4259181,-1.1387945846031091
SKM-1,10385095,0.5930890296191716
OAW42,16013152,3.77909219849116
LS1034,6918638,1.0848877258969036
SEM,151289,0.5470981042649448
OCI-M1,10302451,3.881215030976717
L-428,9911463,3.1303248719612093
PK-45H,2729026,3.067408476207607
NCI-H1092,9911830,2.3624309911243313
RERF-LC-Ad1,9911463,4.614184078770455
Hs 934.T,6450551,4.748453460785923
SUIT-2,44137675,5.109302373708494
NCI-H146,JQ-1-UNC0638 (2-1 mol-mol),-1.369706115362065
C2BBe1,JQ-1-UNC0638 (2-1 mol-mol),1.2582443329637891
WSU-DLCL2,sirolimus-bortezomib (250-1 mol-mol),-6.394861252001346
MSTO-211H,4259181,-0.7585521679245923
Hs 852.T,9911830,2.9837526499964935
U266B1,24772860,-2.6537630456942902
BT 232,JQ-1-UNC0638 (2-1 mol-mol),3.5266256141153756
SHP-77,11404337,-0.9564004867270302
SNU-245,49766530,-2.046420200198333
SK-N-DZ,156414,1.5572743957350466
NCI-H2009,54618771,-0.2233577251443086
SNU-81,1716436,3.163180638308135
HCC1806,tanespimycin-bortezomib (250-1 mol-mol),-1.018724698872974
JHUEM-2,327653,2.730949132575015
SNU-878,11167602,2.6489023898698005
Li-7,2729026,2.126195662574963
MCF-7,JQ-1-UNC0638 (2-1 mol-mol),1.3155075415243511
HCC1588,2708,3.5957801317940437
NU-DUL-1,124202324,0.2567880511133784
KMH-2,148198,-4.1260923744300015
SNU-8,148198,-1.3128761791294046
KMS-34,1716436,1.1144931948018295
CCF-STTG1,1716436,2.5445739903865503
SKM-1,151289,-0.219296204228563
T84,11404337,-0.6580973567556256
A-549,136227924,3.1395144761786486
HCC2108,44137675,4.225822582282624
5637,JQ-1-UNC0638 (2-1 mol-mol),0.1367071972776975
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
Panc 05.04,tanespimycin-bortezomib (250-1 mol-mol),-3.230060411523549
BT 131,1716436,2.5965801221554967
MSTO-211H,49766530,-4.866552298919663
Hs 852.T,1716436,-0.3818808314140783
KMBC-2,11167602,2.9141077523233587
L-540,49766530,-0.200470626398811
OCI-Ly3,11485656,2.9823721346913654
PaTu 8988s,selumetinib-BRD-A02303741 (4-1 mol-mol),1.64163073342872
NCI-H1869,JQ-1-UNC0638 (2-1 mol-mol),2.4399553500641846
SaOS-2,11485656,2.155652122560971
NCI-H1299,2729026,3.118725494880117
NCI-H2196,11404337,1.3261557854884771
NCI-H2452,54618305,4.302077073898344
LS123,327653,1.7087867319352237
KMS-28BM,2708,-0.1097547948790454
COLO 205,11404337,1.3467239664016557
HeLa,10385095,1.105005903985203
NCI-H520,4259181,-0.9847708191101096
SNU-407,4259181,-0.1818409252805557
786-O,9911463,4.177709508458616
SU-DHL-1,9911830,2.4926956672938543
CAL-33,6918638,1.6029165317197565
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
Hs 766T,9911463,4.174180963053701
NCI-H1563,11167602,1.8845981628245831
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
BT 187,6450551,3.23065551508904
SW48,654092,0.3720639788768654
NCI-H2052,124202324,2.716608196100252
KYSE-510,6918638,1.620078603816946
C2BBe1,4259181,0.796166800859259
BT 239,136227924,1.4188260158561712
SNU-398,sirolimus-bortezomib (250-1 mol-mol),0.7620432052454496
Ku812,24772860,-3.654878232310525
HEC-151,54618771,1.151174886462992
HCC1395,374536,3.7621836205411823
CA46,24753719,4.040239779097469
U-BLC1,327653,3.5649632216548897
Kelly,9911463,2.836372345977174
A-204,753704,4.895169257737917
SNU-503,6918638,0.4427810712385108
NCI-H1341,24753719,4.054742398972124
HT-29,sirolimus-bortezomib (250-1 mol-mol),1.8819281446300895
NCI-H1563,374536,0.2181136904884032
OE33,11404337,0.6160671156841868
OAW28,44493528,4.631141764792384
NCI-H1975,10302451,1.3559914628717409
RCC10RGB,2708,5.228545547030361
DEL,654092,-1.633589239308752
HEC-6,100016,5.931518422248653
Namalwa,16013152,3.948657270974704
JHOC-5,327653,3.2802952976184723
OE33,6918638,-0.1523417231642655
PK-45H,11485656,3.836496845860948
2004,10385095,0.7198089210343366
TT,73707371,5.13642580164417
PK-1,54618305,4.508738372274147
BHY,9911463,3.455291934456847
HGC-27,11485656,1.9674233775632803
MDA-MB-435S,151289,0.320427381633344
OCI-Ly10,54639665,5.195826059453437
HCC2218,9911463,3.007199101123831
KMRC-2,156414,1.7005569347395115
DAN-G,2729026,3.2196043937322325
A-549,10302451,3.5203591354698016
SF539,10302451,2.624022513021108
LUDLU-1,4259181,0.5420742085137419
MOLM-13,54618771,-0.6841479707721928
ES-2,124202324,2.9629658374822827
MDA-MB-453,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9656310639147305
CMK,11404337,1.5948104345564638
PE/CA-PJ34 (clone C12),9911830,2.0683867467094657
HOP-62,11167602,2.5582425778829356
NCI-H358,374536,3.263898604003791
NCI-H838,54618305,4.350780627784178
RL,9903786,3.83184195533614
SUP-T1,4259181,-1.9215317609188305
J82,136227924,3.3108045260668564
PF-382,156414,0.6060441396240198
NCI-H2405,49766530,-0.8537478871049897
SK-MEL-31,4259181,0.9819831348689742
NCI-H2141,24772860,1.0769886860974538
OVSAHO,4259181,0.7848451227911502
NCI-H2342,24753719,5.01821313413428
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546
COLO 680N,10302451,2.7755387285317266
CA46,11485656,1.2289823963881294
NCI-H1703,151289,0.5446388688655887
MOLT-13,24753719,2.239197881715532
SNU-620,9868037,3.01129610064575
HuH-6,24772860,-0.2102155293606675
SUIT-2,11404337,0.4217329969696077
AML-193,136227924,2.0129973822753735
SEM,11404337,-1.9668178292815095
TE-4,24772860,-1.6355989869955827
HOS,11404337,-1.3499027331466464
MFE-296,374536,-0.2603389858848113
NCI-H2452,4259181,1.4154165902225178
CCK-81,24753719,4.044065548587902
COLO 684,44137675,1.3888482923745955
IGROV-1,4259181,0.1937358171291443
CJM [Human melanoma],2708,3.472800151523908
HEC-251,327653,2.909784100810203
HL-60,54618771,-0.823810735668653
MOLP-2,10302451,4.280949044542535
K-562,11485656,1.7795111963017332
NCI-H1650,6450551,3.0375179823186804
HuNS1,44137675,3.505602181641379
EoL-1,10385095,0.4720665951427926
HCC44,2708,4.414810265261532
BT 172,11404337,-1.2975012169581652
KYSE-180,9911463,4.116935332494812
KO52,54618305,4.665930774043992
647V,selumetinib-BRD-A02303741 (4-1 mol-mol),6.493425000095871
HCC2108,9903786,2.237017286795856
NCI-H446,11404337,-1.699168171743611
NCI-H69,9903786,3.032908802365876
HT,2729026,2.4704809335978597
GaMG,4259181,0.737386892829234
HCC1937,4259181,0.8390392659445921
VM-CUB-1,54618305,5.052147862407373
SNU-410,24753719,4.971492186165212
NCI-H2110,10302451,3.568351755533758
ChaGo-K-1,24753719,4.520891779779164
BT 271,24772860,-3.1500116531645426
NCI-H2106,3815108,0.9296321427429096
SIG-M5,54618305,4.363479672443714
SNU-719,24753719,4.605269118671092
OCI-AML-2,100016,4.069849166636085
GA-10,24772860,-4.246498427391701
SNU-840,156414,-0.1270098171116787
NCI-H1568,2708,3.449118605167301
COV434,44137675,4.472279708479443
JJN-3,9929138,7.196831688264381
HPB-ALL,10302451,3.903129824192939
BT 440,9868037,4.283687628506758
HMC-1-8,24772860,-2.7352695902473902
MHH-NB-11,24772860,-3.007818713183484
NCI-H747,6450551,4.226135750334484
NCI-H1355,1716436,2.7999315279098425
THP-1,10385095,1.0442319132291376
U-118MG,6450551,3.2627519223477015
SU.86.86,11167602,2.458587249616875
SNU-308,11485656,2.7823829895443657
Hs 578T,151289,1.1375137613734745
SK-N-BE(2),10302451,4.064544845875673
OC 314,156414,1.5893694322605127
Peer,1716436,1.792007104491573
HuH-28,4259181,0.9633418141408334
DBTRG-05MG,2729026,3.0316530984947874
IGR-1,135984461,4.582629731672088
AN3-CA,10302451,3.617635565971862
BT-12,JQ-1-UNC0638 (2-1 mol-mol),2.8592847017227943
OVISE,2729026,3.0624747536258843
COLO 680N,11485656,2.5082408058849945
HCC1588,tanespimycin-bortezomib (250-1 mol-mol),-0.9414361012739926
OE21,9903786,3.8183922804943298
Li-7,sirolimus-bortezomib (250-1 mol-mol),1.648845236287691
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
OCI-AML-3,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.951949053829367
Raji,9911830,2.8944128431666636
KP-3,374536,-3.681172393088042
BT 216,tanespimycin-bortezomib (250-1 mol-mol),-1.562937593098705
RMG-I,124202324,2.0512811393236188
NCI-H2405,9903786,2.53791171783736
ONCO-DG-1,9911830,2.7128459203034105
OVCAR-4,10302451,5.517030030405602
GSS,100016,3.718199006522657
TE-11,151289,0.6734632120064649
MOLM-16,6450551,0.8689914773676627
U-118MG,6918638,1.3922699547909616
SR,9911830,3.2159510774302964
CAL-33,1716436,4.158928278614797
MKN7,6918638,1.0804402687871355
NCI-H2126,10385095,2.2244288571563846
KNS-81,11485656,3.966409180746404
23132/87,6450551,2.954650109972274
LXF 289,6450551,1.9915066986525345
8-MG-BA,6918638,1.6355353194414102
BT 216,753704,4.4790188528203405
MDA-MB-361,16013152,4.138394143698556
L3.3,54618771,1.1558037208399272
NU-DUL-1,2708,1.2024434281513927
FU-OV-1,16013152,4.2048953133679765
ESS-1,2729026,3.152936804917953
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
JK-1,sirolimus-bortezomib (250-1 mol-mol),0.507486963529962
NCI-H1435,selumetinib-BRD-A02303741 (4-1 mol-mol),3.0227259432360203
Rh18,3815108,1.3436730185415249
HuCC-T1,54618771,0.1107160240770854
Rh18,124202324,1.3373011204732177
Yamato-SS,49766530,-1.529274305649153
KYSE-410,24772860,-3.1334090173521156
CHP-126,374536,2.4016434952282535
SNU-C2A,2729026,2.906016985017416
HH [Human lymphoma],9929138,3.344278516856126
LS123,sirolimus-bortezomib (250-1 mol-mol),1.3187092506497549
SNU-878,10385095,2.873231871472218
BT 328,11167602,4.034112762840579
RT-4,753704,6.379934835187104
AN3-CA,44137675,1.4304677853789944
NCI-H28,selumetinib-BRD-A02303741 (4-1 mol-mol),2.807437616744324
KMRC-1,9911830,2.7576147713752532
Calu-3,11404337,-1.5161569407168425
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
BT 159,46926350,-3.662340035103864
NCI-H211,44137675,3.8953391231306624
U-251MG,9903786,4.913889261363981
LMSU,327653,3.6010830884894824
SNU-869,374536,-2.735765999692926
SHP-77,10302451,3.8689423401544447
PE/CA-PJ49,9911830,2.222449473418187
JHH-5,9929138,4.293254911583093
BFTC-909,9911463,4.114346930944119
NUGC-4,9911830,2.666596193346337
D283 Med,6918638,-2.490498776882626
EFM-192A,2708,6.430533680898592
SF268,49766530,0.574843558236966
THP-1,4259181,-0.8754352887844591
IGROV-1,9911830,1.9130562323799436
K-562,44137675,5.346911467461658
TE-6,6450551,2.2161063673912285
MEC-1,54618771,0.2642234138424628
Karpas-299,54618771,-0.1406101617053584
SU-DHL-10,327653,3.666046340161681
BT-12,374536,3.1994702092753338
Li-7,374536,-2.062071039366639
KMH-2,9911830,2.2989781797044313
KLE,11404337,-0.1549034777249487
SUP-T11,10302451,3.4427567109360573
A4/Fukuda,374536,-1.0311095755670416
L-363,10385095,0.7301179506909989
SK-MEL-3,11485656,2.032350870448147
HCC827,54639665,5.801355339134406
OVCAR-4,135984461,4.697392944988172
HCT 116,135984461,4.355158085376645
JHH-4,selumetinib-BRD-A02303741 (4-1 mol-mol),2.1539582848488217
RPMI-7951,11404337,-1.491748801484046
HDLM-2,148198,-3.3078190571311925
MFE-296,6918638,1.6270992147424843
MOR/CPR,148198,-2.5838099224586
42-MG-BA,1716436,3.648101475578934
AsPC-1,11404337,0.3809720735493328
PLC/PRF/5,374536,1.498952017518494
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
Hs 940.T,10302451,2.168659720829093
SK-N-FI,sirolimus-bortezomib (250-1 mol-mol),0.1232342384365411
MHH-CALL-3,136227924,2.519521666896543
SF126,2729026,3.071483364682333
KO52,148198,-6.726627358418003
COLO 668,49766530,-2.8242702060305818
RT-112,9903786,2.0638797497197237
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
MEC-1,44493528,4.02747139301686
KMS-12-BM,54618305,3.825029881117321
SW1990,9903786,3.346032701157222
PaTu 8988s,2729026,2.6444658169673914
P12-Ichikawa,100016,6.391056060940552
LS513,151289,0.7559210943389912
BT 112,2708,2.9934356963189304
IGR-37,753704,6.735926792205307
SU-DHL-10,9911830,2.8677867441941274
HCC15,9903786,1.5576741113339283
MOLT-16,753704,4.3487454811850625
RVH-421,16013152,4.326131796733307
NCI-H1944,9911463,2.563983379964603
NCI-H838,6450551,2.488868756513912
RKO,136227924,3.256787131627037
NCI-H1623,11404337,1.3417738865788873
CJM [Human melanoma],44493528,4.221846100020477
EFO-21,11167602,2.787371694479732
A-673,1716436,1.8403672814357532
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
PLC/PRF/5,10385095,1.1350857797892653
ESS-1,6918638,0.5362706870956574
KALS-1,3815108,3.128776444358639
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
DU4475,54618771,1.1300821286191531
HCC2108,24772860,-2.301082023311665
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842
Kasumi-2,10302451,2.501538159290375
HuCC-T1,374536,1.5420690982945668
KE-39,24772860,-2.1888261700101954
PC-14,54618305,4.281679623383799
RERF-LC-A1,1716436,3.128403126409071
NCI-H1395,46926350,-3.2144597586965515
U2OS,selumetinib-BRD-A02303741 (4-1 mol-mol),2.089267664348928
8305C,54618771,0.5083809192665402
SK-N-AS,16013152,4.281794932367084
HEC-50B,10302451,5.618785073563312
WT2-iPS,24753719,4.2236416503462415
M059K,148198,-3.174973470049168
KHM-1B,54618305,4.409714485426553
HCC-56,148198,-4.2665596925973395
KE-37,9911463,3.0387406165945383
BT 179,753704,4.852726196136981
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
SNU-16,1716436,2.6844563006863265
SK-MEL-28,selumetinib-BRD-A02303741 (4-1 mol-mol),3.6626824854303086
SK-MM-2,10385095,1.5805301391709368
CL-11,156414,1.7503846149108115
8-MG-BA,148198,-4.196871599679804
HGC-27,136227924,2.541882907814414
SKM-1,124202324,1.09229022845767
JHH-5,135984461,6.19105959090805
KMRC-1,6918638,1.621172594092556
NCI-H2196,100016,7.101599749729703
WM983B,49766530,2.209591976361656
Peer,10385095,1.0208585172172266
GA-10,11485656,1.0334565111558187
253J,9911463,2.6444907494378476
KLE,136227924,3.154327848580928
OVSAHO,151289,4.6961403811220865
SK-MEL-5,11404337,-0.86554047446545
NB4,9911463,3.3051650807142514
MOLT-16,24772860,-3.9325712271527977
ChaGo-K-1,135659046,3.4410165185967743
COV644,tanespimycin-bortezomib (250-1 mol-mol),2.484857024985863
KPL-1,9911463,4.601591010161613
COLO 205,3815108,3.1660375806080907
BT 444,327653,3.660965582464104
EJM,11404337,-0.4702991542329423
HCC1806,sirolimus-bortezomib (250-1 mol-mol),1.669162775720282
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
CMK,9911463,3.4147490124520075
YAPC,4259181,0.8211273757017798
NCI-H1092,54618771,1.961811722948082
PaTu 8988s,135659046,3.7225208809385073
SUP-T1,374536,1.6573185247098483
DU4475,11485656,1.359840937957691
Hs 578T,753704,4.6744811674365705
RPMI-8402,151289,0.1088689417752526
SK-N-SH,148198,-4.813749517608016
639V,44493528,5.149647090541137
RPMI-6666,156414,3.6582096652616096
TE-5,selumetinib-BRD-A02303741 (4-1 mol-mol),4.992331170462275
NCI-H1395,374536,5.636718886348253
MDA-MB-468,6450551,1.2361403791581258
A-172,6918638,1.3272545759191037
SK-UT-1,1716436,3.7795606206738337
Hs 294T,148198,-2.1277510633920325
HuP-T4,2729026,2.076110266194105
NCI-H508,sirolimus-bortezomib (250-1 mol-mol),0.7195278231297386
SCC-4,46926350,-4.19834303529602
TTC-709,24753719,4.2386311491710895
L-363,374536,1.881611903174521
RPMI-6666,6918638,-0.5773375343735736
BT 159,148198,-4.153567410174437
NCI-H1581,tanespimycin-bortezomib (250-1 mol-mol),0.5752068727797862
KYM-1,148198,-4.868238794811474
BT 504,54618771,0.7999313784166654
SK-MES-1,73707371,5.7954352649159615
UO-31,9911463,3.1211940874261623
A-253,135984461,4.591715883678831
HMCB,327653,2.816846205013027
TE-4,9911830,2.9722016671255003
JHUEM-2,9868037,1.1428293531660954
NCI-H1339,100016,8.285361450373896
SNU-503,9911463,4.508813956754841
TOV-112D,tanespimycin-bortezomib (250-1 mol-mol),1.1427039773069572
CAL-33,136227924,2.366373998099427
OE21,6918638,0.1632098658801684
Capan-2,11485656,2.4723123479129727
KNS-62,tanespimycin-bortezomib (250-1 mol-mol),-0.0918486546852887
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
SNU-C2A,151289,1.8688563093712731
A-549,9929138,6.139762216307962
WT2-iPS,9911463,4.390053474560322
Lu-65,11485656,2.4652445580433713
EFO-21,11404337,0.1948042890750945
HT-144,135984461,4.033555973965414
PaTu 8902,54639665,4.483683562011812
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
UO-31,44137675,1.1659254812609146
GCT,JQ-1-UNC0638 (2-1 mol-mol),1.972679742350148
KYM-1,374536,2.546315431822373
Tm87-16,1716436,2.364781995345662
Daudi,156414,0.7854974484116999
BT-16,136227924,2.1772162484418924
Hs 578Bst,54618771,0.4145984361233129
KNS-60,156414,1.4823692521947065
CML-T1,54618771,0.285641515878807
HCC4006,11167602,3.2569091350722363
Hs 683,2729026,2.6302099584377534
SNU-478,327653,2.5986094788996668
SU-DHL-8,136227924,2.244700910858823
Pfeiffer,11404337,-3.375841294616924
KMBC-2,1716436,2.8982733087308095
CAL-12T,136227924,2.605918242540546
SW579,6450551,-1.4244086143406036
HT-55,sirolimus-bortezomib (250-1 mol-mol),0.7805175960520967
SF268,11485656,2.1720991191644994
Hs 611.T,327653,2.4585049182672525
MFE-296,JQ-1-UNC0638 (2-1 mol-mol),1.7959494851073396
CGTH-W-1,11404337,-0.3355456944915889
SK-MES-1,44137675,3.79543080483213
SNU-216,156414,-1.34829160644196
JHOM-1,54618771,2.421101396642466
SNU-878,100016,5.516104284834857
SU-DHL-10,tanespimycin-bortezomib (250-1 mol-mol),0.050214335602148
Mono-Mac-1,44493528,3.807460562047893
SHP-77,tanespimycin-bortezomib (250-1 mol-mol),-0.364724393269764
DND-41,151289,1.72402086394252
PE/CA-PJ15,100016,6.230779358531284
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
NCI-H211,44493528,3.775895389954296
2004,136227924,1.8982400348113204
NCI-H510A,11485656,1.795372186053248
MM1.S,654092,-1.4935807523777964
639V,9911463,4.4419540135561
NH-6,44137675,3.242437508697902
OE19,54618305,4.519730581703255
647V,10302451,3.4005631351647807
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
LXF 289,44137675,2.0502885463252665
JURL-MK1,156414,1.0073583637706065
PE/CA-PJ15,11485656,1.9220584297940355
ECC10,JQ-1-UNC0638 (2-1 mol-mol),0.3935002825867998
ESS-1,11404337,-0.7954778123034105
Rh30,654092,-2.14864984699251
NCI-H441,4259181,1.2625810441667016
5637,327653,3.080656495363518
K-562,9911830,-1.954559593888618
NCI-H810,tanespimycin-bortezomib (250-1 mol-mol),0.3768886958286864
U-251MG,135984461,4.456560738711495
SNU-449,2729026,2.998695944617882
ZR-75-30,16013152,4.342882737503205
NCI-H2122,11485656,1.6231046249934602
KP-N-SI9s,9903786,1.8487391330719625
COLO 320,11404337,-1.0914685328703808
SK-MEL-3,136227924,3.573502388362414
LOX-IMVI,46926350,-4.478946540813455
Hs 729.T,24753719,4.079114648455497
U-251MG,10385095,1.5750585422416694
BT 428,11404337,-0.9400136442546092
SNU-C2A,2708,5.56923049045208
NCC-StC-K140,9929138,3.845494861279627
EJM,135984461,5.02990169097732
HPB-ALL,44137675,3.6938894845242167
HT-29,654092,0.650773587447535
SNU-1076,54618771,0.3413327758331145
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504
NCI-H1666,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.225222545207982
HGC-27,100016,3.78981980973908
JHOC-5,753704,5.472551443723303
BT 147,136227924,1.9245142249128984
NB1,1716436,3.0176637301935947
HDQ-P1,11485656,2.7842616734423116
HCC2218,9868037,3.0911136075501253
OPM-2,9911830,2.101419447334853
Ci-1,327653,3.316118649157309
BT-549,4259181,2.4625999028961743
HCC1143,327653,2.9245812810780745
HCC1419,1716436,2.376319726788119
KMS-12-BM,24753719,3.8340594609092
CGTH-W-1,11485656,-0.4433767239008435
WM266-4,6918638,0.8919001534334414
SUP-T1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.210011307070792
FaDu,6918638,1.0818433355899586
CAL-33,4259181,-0.7192046491947381
NMC-G1,54618771,1.359129875373881
JIMT-1,100016,6.5721980857327935
769-P,9911830,3.2901090522207803
OCI-AML-5,9911830,2.11387543619275
CAL-120,4259181,1.5592783373637074
TT2609-C02,4259181,1.5094867892449766
Hs 895.T,135659046,5.409831657927163
HOP-62,71729975,2.57008704117282
Daudi,11404337,-3.064654238522792
COLO 320,156414,1.2064887269229854
RL,11485656,1.724412415409439
THP-1,44137675,1.6786676648951644
NCI-H2023,sirolimus-bortezomib (250-1 mol-mol),2.707809534730406
A-375,11485656,2.720000014361131
NCI-N87,3815108,3.1427265495234513
UACC-257,16013152,4.643590906917523
SNU-503,2708,5.596597286608731
RVH-421,9911830,2.458490224402164
SNU-878,9903786,2.6270705473192644
T98G,4259181,0.7418471761834453
SH-10-TC,2708,5.551188338469828
NCI-H2023,374536,4.522257653411573
HT-1080,JQ-1-UNC0638 (2-1 mol-mol),2.4645518330886764
HCC2935,tanespimycin-bortezomib (250-1 mol-mol),-2.9372994580333947
HOP-92,9868037,3.341339504436607
VM-CUB-1,11404337,-0.7362908779657769
RCH-ACV,3815108,2.1259817413634976
EFE-184,54618305,4.669753195753842
TE-11,1716436,3.733453614162342
CAL-12T,374536,2.685532856391411
ECC10,4259181,0.1069108144174364
NCI-H522,374536,3.894183139895475
SUP-M2,135659046,2.724730541134964
NCI-H446,tanespimycin-bortezomib (250-1 mol-mol),0.8775659669348672
G-401,148198,-4.717755806624399
SNU-761,9903786,5.568583080204817
BT 440,9911830,1.1775891461683867
KYM-1,10385095,1.1469809702882436
U-BLC1,2729026,2.142841988558096
COLO 684,2708,5.146395864122256
NCI-H196,124202324,2.494260717218826
NUGC-4,9868037,2.67095726720747
OVCAR-4,9929138,6.8802220195172525
KYSE-510,6450551,3.3903624171303974
P-STS,24772860,-1.1995805486190882
SNU-503,sirolimus-bortezomib (250-1 mol-mol),1.3381896958753263
8-MG-BA,sirolimus-bortezomib (250-1 mol-mol),0.8530432118926453
HT-29,9911463,4.192139664463844
IA-LM,11404337,0.4340662777154989
Lu-65,10302451,3.851828229272266
T-47D,4259181,1.3653389737772716
NCI-H28,sirolimus-bortezomib (250-1 mol-mol),0.5571270031367631
HCC1954,1716436,3.0971529854376385
KHM-1B,9903786,1.5275790345873377
Calu-6,24753719,4.065149652165168
Mel Ho,11404337,-0.9675830815963552
NCI-H522,753704,4.098243268802601
TE-15,JQ-1-UNC0638 (2-1 mol-mol),-0.5241568674316489
HuG1-N,136227924,2.3836679865505332
NCI-H1355,selumetinib-BRD-A02303741 (4-1 mol-mol),4.73798739415447
OC 314,46926350,-4.367551219593076
AN3-CA,2729026,3.165325615874287
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716
SK-HEP-1,9911463,4.3683168964450125
SEM,156414,0.3224280721453019
22Rv1,tanespimycin-bortezomib (250-1 mol-mol),0.2637398344293039
OE33,54618771,0.6463967742027482
Fu97,JQ-1-UNC0638 (2-1 mol-mol),0.5956311101507841
SUP-HD1,10385095,0.5343363886609982
HCC1833,327653,2.396591228489624
BT 232,10385095,0.8696563866685341
JHUEM-1,24772860,-2.3611872532983895
SNU-869,9911463,4.356989154503334
OV7,24772860,-2.465561706256098
FTC-238,sirolimus-bortezomib (250-1 mol-mol),0.2541232172189812
HeLa,10385095,1.105005903985203
MOLP-2,selumetinib-BRD-A02303741 (4-1 mol-mol),6.467782846581189
SK-MEL-30,11404337,-1.0604812670426378
NCI-H211,151289,0.3336773181227735
SH-10-TC,6918638,1.0653110676660122
OCI-Ly10,9911463,5.153566135827512
Kasumi-2,148198,-6.27183434225638
HuNS1,1716436,2.3756145775517377
SW1990,374536,2.916783298582251
LS1034,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1255865353728395
K029AX,sirolimus-bortezomib (250-1 mol-mol),0.2512522437134671
Lu-65,16013152,4.337400643693818
LOU-NH91,11404337,-0.9599092047687252
SCC-4,11404337,0.119875077583324
Calu-3,selumetinib-BRD-A02303741 (4-1 mol-mol),3.4121608428889543
Hs 944.T,151289,1.3845455989628053
BT 359,54618771,0.98089237051643
HCC38,327653,2.8237453360302576
F-36P,1716436,1.9099514352495048
HPB-ALL,100016,7.357554409535215
GSS,654092,-0.7320945436383166
SKM-1,753704,3.832130750350089
MHH-CALL-4,6450551,1.3719521864217477
NUGC-3,100016,7.160996607387645
U-251MG,JQ-1-UNC0638 (2-1 mol-mol),2.902874039608064
NCI-H520,1716436,3.682324003372517
RPMI-6666,46926350,-4.264317453000159
BT 145,1716436,1.5849390994814347
CAL-78,6450551,1.16536925417244
ONCO-DG-1,151289,0.6701924013507129
LS123,11485656,2.4615924556875575
SNU-245,654092,-0.423533374674049
Li-7,54618771,0.3416557888944573
HDLM-2,3815108,2.835533163920076
NCI-H1944,tanespimycin-bortezomib (250-1 mol-mol),-2.853694695712997
SNU-668,148198,-1.6951870968907452
U-937,374536,-0.2692937352750632
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
VM-CUB-1,9903786,3.0676048433352268
GI-1,374536,1.6948476632992755
CAL-33,11404337,-1.8217571970645148
DU145,JQ-1-UNC0638 (2-1 mol-mol),3.267881594409119
HT-1080,16013152,4.014151854402517
BHT-101,2729026,3.0224996393450216
NCI-H28,24753719,3.964656611316639
TE 441.T,9903786,2.9236317230426465
A-549,2729026,2.9601859660531105
8505C,156414,2.0308239491213693
DMS 114,1716436,2.9856841050333
BT 112,6918638,0.7933014260092189
HEC-6,135984461,4.376035832446469
Hs 895.T,11404337,0.3575168130913553
Panc 04.03,54618305,4.994656380487723
Mel JuSo,10385095,1.6841415744753898
TYK-nu,753704,6.573379454047278
LoVo,3815108,2.2685826541267615
IM95,327653,3.5986348195863957
AN3-CA,374536,2.9665572949501775
Panc 04.03,10385095,1.3607276101908192
TE-10,4259181,-1.9859765021225648
NCI-H929,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497346861051973
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
PC-3,327653,3.578414834441837
RPMI-6666,9929138,7.502464828843475
NCI-H1341,374536,0.9124183239670278
MDA-MB-157,4259181,-0.4671059045276012
CHP-126,10385095,1.0341421510776674
NOMO-1,54618771,-0.7336388686704796
BFTC-909,3815108,3.5118939741133075
NCI-H146,54618305,4.054654997899016
Daudi,374536,1.069903440531545
JURL-MK1,24753719,4.043686822156311
KMBC-2,9911830,3.153897570043922
A3/Kawakami,24772860,-2.350052977986592
CAL-27,135984461,4.281831870560516
KYSE-150,753704,6.13578500604449
NCI-H2342,73707371,6.93398692221968
CHP-126,151289,0.5903300030853611
PF-382,selumetinib-BRD-A02303741 (4-1 mol-mol),5.510058878321319
WSU-DLCL2,654092,-4.29069961842453
SK-N-BE(2),46926350,-4.079576279335985
HPB-ALL,2708,4.227059214198803
Ci-1,151289,1.3314073289517383
Hs 688(A).T,10385095,3.663662193175485
SEM,148198,-7.106649826649242
GP2d,9911463,3.4287638364332333
Toledo,11167602,3.4106313498630305
B-CPAP,654092,-0.163277958019971
HuP-T3,327653,2.4979616286385573
UM-UC-1,11167602,3.102654436447589
OVCAR-5,6918638,0.1206125609110546
KE-39,124202324,2.527643739765998
CCF-STTG1,11404337,1.400188980811807
OCI-Ly19,1716436,3.2470081561620576
CGTH-W-1,148198,-3.7862022669488
BICR 31,6918638,1.4401869695378149
SW48,10302451,2.1638159560649157
NCI-H1435,1716436,1.6624979104512012
SNU-1041,44137675,3.693690220724039
U2OS,654092,0.0376148652500767
IGR-37,2708,4.782271625288022
DK-MG,374536,5.212408294143961
P-STS,753704,4.382359571130778
GaMG,44137675,3.966137678048417
NCI-H522,2729026,3.0595997973682043
BICR 18,9903786,1.845690489746328
BT 164,24753719,3.8785353041176265
KP-4,4259181,0.4203041141920705
DEL,54618771,0.826392883586264
Daudi,44493528,3.680262260756896
L3.3,3815108,3.6939531026178
HT,24753719,3.8914471596117655
SK-MEL-5,10385095,1.0393957169918682
L-1236,11404337,0.7595432314307335
RKN,3815108,2.827407220517517
L-540,151289,0.2339652271479175
HuH-6,135659046,4.749269186947959
SNU-840,11485656,2.295014349130572
Toledo,374536,1.1285648516596567
HCT 8,11485656,2.552597628159539
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303
KO52,1716436,3.4089505729900615
HDLM-2,49766530,-0.915068926729708
NCI-H1339,10302451,4.201130344992501
BT 179,JQ-1-UNC0638 (2-1 mol-mol),3.34350394342904
NCI-H2444,44493528,4.4653307538151354
SUIT-2,124202324,4.338905517601424
EFE-184,49766530,0.8289691461992541
GSU,54618771,1.7980525914601972
TE-5,327653,2.418521663578336
KMBC-2,11404337,0.8852156711792197
AsPC-1,44493528,4.313387127964929
OVCAR-8,2708,5.235879580310838
SK-CO-1,11404337,-0.5084033800481932
BT 216,136227924,4.751796234635162
JHOC-5,124202324,3.0220869267922303
AU565,2729026,2.5804084357046033
PK-45H,54618305,4.240243799773472
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403
KM12,1716436,3.022639030296685
SNU-308,4259181,0.5010319397561465
GOS-3,54618771,2.751038853336045
NCI-H446,1716436,3.200217482907107
Hs 683,327653,4.055715527758498
JHH-5,374536,-2.600420165137709
BT 498,71729975,3.1089495974635835
NCI-H1693,16013152,3.835948578722241
Hs 294T,44137675,3.33603705672087
MV4-11,tanespimycin-bortezomib (250-1 mol-mol),-4.482772377599296
BT 164,6450551,2.4072572816619138
BT 416,9929138,7.415658440710529
A-673,374536,-2.1767869041067462
HuH-6,73707371,5.986852511360619
NCI-H716,10302451,3.670682861692165
SNU-C2A,327653,2.894995491136924
DV-90,6450551,1.875256592033013
SUP-M2,49766530,-5.163044789903349
GMS-10,46926350,-4.105907728510867
Daoy,24753719,4.045268630777391
MOLM-6,44137675,3.611802351260768
GA-10,49766530,-5.511762261884949
SK-N-DZ,4259181,-0.3656613292065959
BT 428,54618771,1.9125909448822425
BT-12,selumetinib-BRD-A02303741 (4-1 mol-mol),5.314315892406306
NCI-H1563,2708,4.82144463266251
JIMT-1,49766530,-0.5672366381322033
Caki-1,4259181,2.4269254621819236
SW1990,1716436,3.676749796387318
GDM-1,10302451,2.035200695060817
TE-15,135659046,3.5275305939343884
SK-ES-1,71729975,2.2996280543016994
HSC-3,100016,6.558832951826536
UO-31,tanespimycin-bortezomib (250-1 mol-mol),0.458183553535823
TCCSUP,JQ-1-UNC0638 (2-1 mol-mol),6.070182975256097
HPB-ALL,11485656,3.05569165174981
SUP-M2,100016,3.7473632933772394
Hs 688(A).T,54618771,0.2687022491152004
NCI-H747,2708,5.466796563881582
RMG-I,4259181,0.9732462035277308
KE-97,9929138,4.212063934652932
MHH-CALL-4,1716436,2.8366370912133565
SNU-1077,136227924,3.612132735883527
SK-MEL-2,54618771,2.1400716929659045
U2OS,2708,5.049965181156516
Hep-G2,136227924,2.2133800896817304
KMS-11,9903786,1.9090096011276083
LS1034,4259181,0.5645346336831063
IPC-298,44137675,3.9862098047735017
TE-15,11404337,-0.7391616924820064
KPL-1,2729026,2.3691733295571407
SNU-1196,654092,0.3707255755633477
CAL-85-1,374536,1.779311009840016
MKN45,54618771,1.1504604366979514
PL-21,753704,4.449261254318299
NCI-H1563,sirolimus-bortezomib (250-1 mol-mol),2.9865151808582615
RERF-LC-MS,753704,5.128075002459309
Hs 852.T,2729026,2.2516919560691218
HCC1195,654092,0.2359930450851447
WSU-DLCL2,9903786,-0.2732990105431844
HPB-ALL,156414,1.6473060747549009
SNU-201,9911463,4.2984017961299035
NCI-H2023,2729026,2.3108971201242863
BT 245,151289,1.3314671382833223
OCI-AML-2,136227924,1.951984345015637
UM-UC-1,11485656,1.563439328929869
NCI-H2196,327653,2.664873729838991
L-363,156414,1.591955840690862
NCI-H1734,136227924,2.5893506458509634
OCI-M1,136227924,3.580987744477365
NCI-H2286,54618305,-3.3822182041905813
RPMI-8402,100016,6.7779334067701145
SW1353,136227924,3.029116785491403
SNU-201,49766530,0.2558718668414946
KE-37,374536,0.6748550156720788
YD-8,124202324,2.8742041026946596
SW1573,4259181,2.0061423198913766
SK-N-AS,135659046,4.543052332569712
HeLa,148198,-3.5416719655217976
NCI-H838,151289,1.203935150082185
BT 112,156414,0.8059624645319847
NCI-H1435,11485656,2.194016648354146
EFE-184,44493528,4.48158845578013
SNU-719,11485656,-1.1383067501667237
PK-59,1716436,2.606347183959893
Jurkat,tanespimycin-bortezomib (250-1 mol-mol),0.7517275719467844
Karpas-299,11404337,-0.9739899309482728
KHM-1B,24772860,-4.094705330536473
HOS,6918638,1.052559651861536
NCI-H23,16013152,3.868275016798934
DBTRG-05MG,4259181,1.5308542109270522
JURL-MK1,3815108,2.3675456551001357
NCI-H727,2708,6.607150814967448
NCI-H1395,11485656,1.9214345391656065
SK-N-FI,6918638,-0.1979002452406887
KP-4,2708,3.142602714561915
SCC-9,100016,6.423023301160456
BT 482,327653,3.2285900790212607
TE-4,24753719,4.832981500993744
SNU-216,9868037,3.645721485009989
SNU-899,44137675,3.5532391963680645
NH-6,sirolimus-bortezomib (250-1 mol-mol),1.143169079314691
CAL-51,135659046,3.6035863494873137
HCC2218,100016,5.089450081937329
NCI-H647,44137675,3.3509534430230223
NCI-H2023,4259181,-0.0798035558401368
ME-1 [Human leukemia],2729026,2.32758372355177
22Rv1,9911830,3.385129780644084
OE21,44137675,3.048058416075801
OAW28,11404337,-1.5682838378564492
RCH-ACV,9911830,2.531185888082776
SU-DHL-10,9911463,2.7102339081267948
RPMI-8226,selumetinib-BRD-A02303741 (4-1 mol-mol),4.634842939238915
THP-1,135984461,4.301295147002072
KMS-11,124202324,1.059090045257408
KMRC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.854846859119752
JHOM-1,24772860,0.9636690885047632
NCI-H526,54618771,1.0633322876543316
CAL-33,9911830,2.6291235129166193
SNU-878,JQ-1-UNC0638 (2-1 mol-mol),0.74441024625304
RPMI-7951,11485656,2.1770384312644246
KMS-12-BM,selumetinib-BRD-A02303741 (4-1 mol-mol),5.565016030045443
BT 172,156414,1.0602728240220436
NCI-H841,4259181,0.3090048316145359
MOTN-1,6918638,-1.3378384389105569
SNU-449,6918638,1.2557717528626495
EPLC-272H,4259181,0.5096759105881317
BT 359,10385095,1.5328383331083568
NCI-H520,374536,3.961767685338683
NH-6,11404337,-1.1373922103777243
SNU-C4,1716436,3.873378774047533
KMS-18,4259181,0.5373331095971873
COLO 320,54618305,4.811274582545649
NCI-H1563,9911830,3.05051820168894
A2058,11485656,1.8402668016957284
NCI-H716,54618771,0.9147566577185032
A-549,49766530,0.1688758689952186
CW-2,9903786,2.9588284510461733
Hs 294T,49766530,-1.3950088307868331
PK-1,9903786,5.672212413868687
LMSU,2708,4.741018084625804
NCI-H2444,11404337,-1.49307136407969
A-673,44137675,3.4578104481213905
SNU-449,11167602,2.762483283064935
COR-L105,100016,7.1590039780101895
SK-ES-1,9911830,2.1477528747801995
Hs 729.T,6450551,2.918742680506986
HCC1195,100016,5.060252338886612
NCI-H1693,151289,3.4977978869635464
MDA-MB-435S,10302451,3.892535997624766
JHH-2,4259181,1.4792964046898105
FU-OV-1,327653,2.5930307991109784
MDA-MB-453,374536,3.68630764751743
JURL-MK1,54618771,0.584482701420473
OCI-Ly10,2729026,3.4683464030847593
OCI-AML-2,151289,0.2541597617045174
NCI-H661,2729026,2.3445725854556696
NCI-H358,9929138,5.930954019944583
Hs 688(A).T,JQ-1-UNC0638 (2-1 mol-mol),1.6866325927768662
HCC1833,10385095,1.4425301929083445
NCI-H2106,654092,-0.7291813574571421
KPL-1,11404337,1.240920910385959
OC 314,16013152,4.0488423627794035
T24,9911463,4.359537886200324
NCI-H2170,9911830,2.189149980323213
HCC1833,135984461,4.342714287426043
KMRC-2,10385095,2.7581688365802917
RL95-2,54618305,4.622487640245331
SYO-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8383808288745799
SNU-8,327653,3.195636469676862
HSC-3,44137675,3.228104265957375
OCUM-1,9903786,1.5374110288154037
MKN74,9911463,3.772186916904206
ME-1 [Human leukemia],654092,-2.40848850663852
BT 112,11404337,-0.2767075951827175
MFE-296,24772860,-2.1857923269463626
L-428,156414,1.5463646666534006
NCI-H1869,49766530,-0.032716755694371
NCI-H322,tanespimycin-bortezomib (250-1 mol-mol),-2.794682738050535
GI-1,46926350,-4.433730948871874
NCI-H1793,135659046,3.4932365475314837
NCI-H1694,49766530,-3.246574682514139
SK-MEL-3,135984461,4.369065349705821
SW1573,10385095,0.5068001344623563
SNU-1105,3815108,5.575838572603571
SEM,136227924,1.2424830449991908
NCI-H747,24772860,-2.2412180041047023
GCT,54618771,1.7991225479555093
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
JVM-3,3815108,2.7653717673769744
MOTN-1,JQ-1-UNC0638 (2-1 mol-mol),-0.6063490336332936
KP-2,374536,4.148229423353044
NCI-H1155,136227924,2.9905910988633653
HT,44137675,0.9298675793144956
HEC-251,54618771,0.8830858807964597
BEN,11404337,0.9203658173456966
BT 145,2708,2.826748004184776
SUP-HD1,148198,-3.3843356772130826
KE-37,54618771,-2.6599690790186425
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
KP-2,148198,-4.1307782439966365
JIMT-1,4259181,-0.6325464626851699
NCI-H1694,46926350,-4.345749734998371
HuCC-T1,6450551,3.048955602427261
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
COLO 201,1716436,2.9872243842061033
SK-LMS-1,374536,5.368903896661628
Lu-99,24753719,4.116519547594059
SNU-119,9903786,3.393165032525661
Daudi,9911830,-0.0057102646081846
KYSE-180,4259181,-2.278337111185809
TYK-nu,3815108,2.3979082793058053
UO-31,135984461,0.7514155990157345
JHUEM-1,JQ-1-UNC0638 (2-1 mol-mol),2.1134146661867694
KYM-1,11485656,2.085980626190086
NCI-H2141,10385095,0.6174596155985671
LS180,10385095,1.937933801431244
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
LS411N,10302451,4.220534629483678
DMS 273,374536,2.442253811681885
8305C,136227924,2.5381850582467913
Namalwa,135984461,4.336205571620734
OCI-Ly3,49766530,-2.896711539543773
NCO2,9929138,5.425530092389558
JMSU-1,327653,2.859834874070776
Hs 944.T,9911463,3.7196895176851608
TF-1,54618305,4.224640520612506
KNS-62,136227924,3.1878911405001236
MG-63,44137675,3.7530565249851273
Panc 03.27,9903786,3.06546007586267
B-CPAP,151289,0.3803775246447248
Hs 578T,44137675,3.9894487866612622
HCC38,1716436,2.920829794336956
TTC-709,148198,-6.610156845026196
HCC44,156414,1.2640813526571373
NCI-H1155,11167602,1.6039885275526522
NCI-H196,2708,6.724723846319038
NCI-H647,6450551,3.4599261787692313
42-MG-BA,374536,3.862806247606052
BHT-101,JQ-1-UNC0638 (2-1 mol-mol),0.5277833243785603
NCI-H2141,44493528,4.465268919484744
HEY A8,selumetinib-BRD-A02303741 (4-1 mol-mol),3.762651136253669
NCI-H2106,11167602,1.6194300633388694
OE21,24753719,4.068797621390331
NCI-H1568,54618305,4.1006341963066255
NCI-H358,151289,-0.4063176930915639
NCI-H1755,sirolimus-bortezomib (250-1 mol-mol),0.7810995530072428
NCO2,753704,3.723590000459205
L-428,54618771,0.5974116891557107
M059K,49766530,-1.828446567556348
MKN74,2708,5.472415372145003
VM-CUB-1,124202324,2.785145356485484
Panc 08.13,selumetinib-BRD-A02303741 (4-1 mol-mol),5.146845737578817
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
PLC/PRF/5,54618771,1.111508720136614
NCI-H508,327653,3.0934975234849604
PC-14,9903786,1.3474672632704163
NCI-H196,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304767119574239
U-251MG,136227924,4.317491880233533
SUP-HD1,sirolimus-bortezomib (250-1 mol-mol),-0.240213465841402
NCI-H1915,24772860,-2.534070786664482
SNU-407,16013152,3.4513278759239077
SUP-HD1,9911830,2.5981111749398704
BT 145,24772860,-3.0836174953012474
EC-GI-10,9911830,2.325941153808089
COLO 792,6450551,1.4468956410713505
NCI-H929,148198,-3.717368743483661
ME-1 [Human leukemia],124202324,1.112372393589629
NCI-H2196,6918638,0.6945006285388182
MHH-ES-1,654092,-1.087777817113658
PE/CA-PJ49,136227924,2.4190721025981987
KMRC-2,1716436,3.689982087798527
Rh30,1716436,3.173940157275495
OCI-AML-3,135984461,4.624808466912499
JURL-MK1,654092,-0.4701979084677903
SNU-1041,4259181,1.3907235712067347
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566
NCI-H2110,374536,1.903561652140828
TUHR4TKB,54618771,1.114218379650299
EBC-1,9911463,2.6275230759379933
Lu-65,46926350,-4.186313662197296
LP-1,44137675,2.223248309466022
HCC1500,10385095,0.8648832931247582
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
A-253,46926350,-4.2440627102158315
DV-90,6918638,-0.7904486688735644
PaTu 8988s,136227924,2.43354349220747
LK-2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.356079379465738
JMSU-1,9911463,3.337278506693628
KYSE-520,46926350,-4.274451044041128
BL-70,24753719,3.6587703277512182
KE-97,10385095,1.0750509177193088
Ishikawa (Heraklio) 02 ER-,151289,0.7029912025232622
CW-2,9911463,3.3999880147048795
Caki-1,tanespimycin-bortezomib (250-1 mol-mol),2.360215695891997
HCC366,10302451,2.822890976985495
TF-1,6450551,2.03436435849497
TE-8,1716436,3.3902352818610524
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291
DMS 53,24753719,3.748235801374395
COLO 680N,54618771,3.898900204814355
JVM-3,6450551,1.016542380982021
A-375,44137675,4.805163792846208
HeLa,54618771,0.9271666044907572
CML-T1,44493528,3.9716542826771297
KHM-1B,9911463,3.1729521589558125
QGP-1,753704,4.956472736697895
Hs 888.Lu,10302451,3.51710263851651
SNU-119,1716436,3.1005632385597237
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
BFTC-905,44137675,3.970993505207768
SBC-5,9868037,1.591902673624677
HuG1-N,54618771,1.617121666996059
786-O,44493528,4.535672196429034
BT 333,11485656,2.747933389336241
L-540,44137675,3.608355301892428
TOV-112D,156414,1.328569515035358
HMC-1-8,JQ-1-UNC0638 (2-1 mol-mol),1.533618968926836
HSC-4,124202324,2.961748327308983
BV-173,9903786,1.323242877126727
UM-UC-3,11167602,1.6394154211216836
NCI-H1299,54618771,0.5506920644788533
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
WM88,327653,3.149247099835907
EB1,156414,0.9475806167822072
Daoy,tanespimycin-bortezomib (250-1 mol-mol),-0.2871492230613796
Hs 944.T,11404337,-1.616812668410186
NCI-H2009,327653,3.1880644035572825
MDST8,24753719,4.799692184779076
NCI-H446,54618305,4.329529638985389
VM-CUB-1,10302451,1.2041316516547516
HCC78,24753719,4.491348672589333
MG-63,374536,3.483295272297847
HL-60,2729026,2.6112489308852656
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
SNU-668,136227924,2.8591825047695925
C2BBe1,156414,1.1308711604086286
SK-N-DZ,148198,-7.727965978529101
SNU-387,135659046,3.67285635575436
F-36P,4259181,-1.8222583165697372
NCI-H647,JQ-1-UNC0638 (2-1 mol-mol),1.437386580925085
KMRC-3,148198,-3.839919535883422
SNU-719,9903786,2.245774395512323
HMC-1-8,136227924,3.367197210687835
NCI-H2172,11404337,1.861894071580906
647V,10385095,0.9897075230174724
OCI-Ly3,54618305,3.9282315260489766
COLO 320,9911463,3.3012856335719096
HPB-ALL,374536,2.6212195728485073
MDA-MB-468,44137675,3.6957552564728897
BT-16,148198,-6.229115557962731
MOLM-13,3815108,3.4784839929418343
SNU-475,46926350,-3.609877747855792
HuH-1,24772860,-0.8615637888623648
KALS-1,44137675,3.7039719175629258
JIMT-1,136227924,4.112902711551938
HCT 8,16013152,4.0423722247285685
SK-HEP-1,148198,-3.434194259121147
NCI-H69,4259181,-0.3416455237063791
SaOS-2,100016,6.565789067704999
AML-193,9903786,0.8964959082150169
KMS-12-BM,9903786,0.6537757100604409
TUHR10TKB,135984461,5.527226516832142
CL-11,54618771,0.9971438816591957
Karpas-422,9911830,2.3048839894494653
SW579,JQ-1-UNC0638 (2-1 mol-mol),0.8333718526339369
Ki-JK,327653,2.5576788593612076
COLO 205,9903786,2.133695985637416
DU4475,148198,-7.890760961486606
JeKo-1,54639665,4.459417646835938
LS180,9903786,2.2166672873522857
SNU-620,10302451,2.660381585705483
SK-MEL-2,9911830,2.439526960003118
IGR-37,11485656,2.5244768295786697
MKN74,124202324,2.507495585721404
NCI-H1650,753704,4.989347418529247
COV434,49766530,-2.1602854851177495
RKN,654092,-2.299209260296745
BC-3C,44137675,3.579747900384603
TE 441.T,156414,0.839328879560188
ChaGo-K-1,11167602,1.7675321969112785
Capan-2,54618771,-0.253287331081348
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
CA46,374536,0.6029387131655304
NCI-H2452,374536,-3.751500666928139
PF-382,2708,3.3018060761805774
KP-N-SI9s,49766530,-2.2767545360017407
DBTRG-05MG,10385095,1.8263505725845104
TE-4,44493528,4.301636360206761
A-549,3815108,3.3223520761089937
BICR 18,11404337,0.2486496925996474
SNU-C1,2729026,2.566730627299013
SK-N-DZ,6918638,-2.181446020930978
CAL-54,135659046,3.5874305591890256
DAN-G,44137675,3.584466795299707
VMRC-LCD,44493528,5.517080304343614
HSC-2,54639665,4.488674454832704
NU-DHL-1,151289,0.4356808259590597
MDA-MB-361,11404337,1.0134082132616506
SNU-840,9903786,4.945950711370254
NCI-H1838,49766530,5.619169884682744
BT-549,11485656,2.9441987555380855
L-363,9868037,2.573634031756044
COLO 829,tanespimycin-bortezomib (250-1 mol-mol),-0.6009535916354974
F-36P,327653,3.3003434117548105
Panc 05.04,2729026,2.8206825666858752
COLO 829,753704,6.871959407727185
NCI-H660,10385095,0.7862786947444187
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
SU-DHL-10,4259181,-0.5480239066602804
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773
SNU-620,2729026,2.2402704016328356
Hs 944.T,1716436,1.5482295269594666
NCI-H1568,49766530,-3.205306991379519
HCC-56,2729026,3.1137098159758723
RPMI-8402,9868037,1.5465007663482742
Hs 746.T,73707371,6.050414271564246
KYM-1,JQ-1-UNC0638 (2-1 mol-mol),-0.606413423438429
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783
CW-2,327653,2.4435241851356646
OAW28,10385095,1.310156197215646
MFE-319,753704,5.840457019000585
NALM-6,11167602,2.3296888483311577
QGP-1,9911463,4.188188217183116
Daoy,3815108,1.9447367768499513
EFO-27,16013152,4.523705738143722
Becker,9911463,4.366530732677302
NCI-H322,11485656,1.7917980555041009
KMS-21-BM,11167602,0.9421858410696404
BT 139,6918638,0.9412017663716644
BICR 16,753704,5.013396663808506
COLO 741,sirolimus-bortezomib (250-1 mol-mol),1.7364314358901989
HEC-151,9911830,2.8637422134890342
LAMA-84,327653,2.986202595396493
HEC-251,11404337,-0.8985576004471967
SNU-449,156414,1.8120811787876097
FU-OV-1,11485656,3.4521578130267336
YKG-1,6450551,3.4208466602547833
DOV13,753704,5.498794134338069
FU-OV-1,2708,5.501261259949465
NCI-H1944,135659046,3.626487516875678
SYO-1,24772860,-2.100285504621332
HuH-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8646931377295993
C2BBe1,136227924,2.0906474270390656
PC-3,49766530,-1.3415324716004575
BT 422,10302451,4.143225986408294
Hs 852.T,9911463,3.443003634084564
UACC-62,2729026,3.094858689525915
COLO 800,6918638,0.9384820746097428
TE 441.T,148198,-7.570550283496053
ONCO-DG-1,135984461,4.389696319058022
IA-LM,151289,3.753931026261757
Namalwa,24772860,-2.8459289590629937
NCI-H226,327653,3.133129409572061
YH-13,10385095,0.585484965582367
SW1417,11485656,1.9814975690953165
GSU,136227924,3.064976264970486
SK-MM-2,9903786,2.9629309693480983
BT 147,135659046,3.464945185211132
NCI-H1581,9911463,2.8150360294016927
KE-37,100016,3.280443906920473
Panc 03.27,100016,6.730276002902577
U266B1,4259181,-0.6063493010445111
VMRC-LCD,JQ-1-UNC0638 (2-1 mol-mol),0.2895932454224424
MKN1,2729026,2.926096340291589
639V,10385095,1.9992924364223104
JVM-3,135984461,4.680195748314229
RD,2729026,2.741599869748359
AN3-CA,151289,0.5319797330722529
SW948,11404337,1.0073661261070797
HLF,sirolimus-bortezomib (250-1 mol-mol),0.7648448061241114
MFE-296,2708,4.224650223761904
NCI-H2087,11404337,-3.0287738757732585
G-292 clone A141B1,49766530,-1.892767942202222
LOU-NH91,1716436,1.3649900096390022
JVM-3,156414,0.7783914285135163
KMS-26,100016,3.884140356330727
Calu-3,374536,4.613856122958837
RVH-421,49766530,0.507430038024508
MOLT-13,4259181,0.0040314779304794
JVM-3,54618305,4.207755520219925
VMRC-LCD,100016,6.5149453048399515
SW1573,49766530,-2.79322841384178
Pfeiffer,10302451,-0.0352778784259099
Ishikawa (Heraklio) 02 ER-,136227924,3.2224664141246806
VCaP,100016,6.449384825808392
Calu-3,9868037,2.901548984515766
SK-MEL-31,10302451,4.277092998076058
Panc 05.04,11404337,1.2043196407136412
Hs 940.T,151289,4.844569960379001
OS-RC-2,sirolimus-bortezomib (250-1 mol-mol),1.663291645677193
COLO 699,54618771,0.7648431477044199
8505C,11404337,-1.4016142280742767
Capan-2,6918638,1.8511012185183664
MOLM-6,124202324,0.8610887035017648
OS-RC-2,2729026,2.963932658392264
Karpas-422,11167602,5.140993072754682
MOLT-3,100016,3.7727587478901734
NCI-H838,54618771,3.458197236352402
LCLC-97TM1,49766530,0.6419783818490065
OAW28,44493528,4.631141764792384
RL95-2,3815108,2.069521082169203
DU145,135659046,3.5568052359419604
OPM-2,374536,1.7033153768622478
KYSE-510,44137675,5.449832828121369
SW1353,JQ-1-UNC0638 (2-1 mol-mol),1.1715747666155536
REC-1,54618305,4.3771111696641185
NCI-H1623,327653,3.600793829240414
Kasumi-2,100016,5.973936097539331
TF-1,9903786,1.2296708534399408
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
KMRC-20,1716436,3.2166067738770603
Namalwa,4259181,0.072491305186228
8505C,136227924,3.0385484032115215
DoHH2,sirolimus-bortezomib (250-1 mol-mol),-6.588812122607576
PK-45H,tanespimycin-bortezomib (250-1 mol-mol),-0.8772986942389263
23132/87,JQ-1-UNC0638 (2-1 mol-mol),1.7794520280299446
HL-60,100016,6.415560767920564
TYK-nu,11485656,2.0591967948441665
P12-Ichikawa,10302451,3.489810984245078
RPMI-7951,10302451,2.662563983337758
MDA-MB-361,10302451,3.796882389957653
SW1271,54618305,4.440463475812739
SK-ES-1,54618771,0.5955874337790977
KMS-26,124202324,-1.474652039404999
HOP-92,10385095,1.1427882638896885
Li-7,54618305,4.449202899028902
LOX-IMVI,44493528,4.127526604228942
RERF-LC-A1,10302451,4.299129878683913
JeKo-1,156414,1.4830831458310074
TF-1,44137675,4.1313661037130345
MOTN-1,136227924,2.565430053126423
MDA-MB-435S,124202324,3.005062827003255
SNU-840,124202324,2.8903093293487956
SK-MEL-5,327653,4.002327934975705
BT 482,JQ-1-UNC0638 (2-1 mol-mol),3.723292015041483
YAPC,2729026,2.7496252904978293
KO52,11404337,0.1772123930911338
SNU-1196,10385095,1.3720330826166771
Sq-1,10385095,1.2921547265885305
Aska-SS,54618771,0.6758112733038071
KMS-12-BM,9868037,1.5063019992906226
OE33,10385095,1.0575455043550728
BICR 56,2708,5.575590072061839
SNU-503,49766530,2.995521329492969
OVK18,tanespimycin-bortezomib (250-1 mol-mol),-0.2590574495112158
HCC1395,10302451,3.312939572545873
SKM-1,44493528,3.979629908351757
DMS 454,2729026,1.3983080491244568
CL-11,49766530,-0.1976824475741571
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
Caki-1,11485656,3.9506876057193456
NCI-H661,10302451,1.6315200392387812
Kasumi-1,2729026,3.087848519495678
OV-90,2729026,3.0860142068005065
SU-DHL-10,3815108,3.134854463619055
Kelly,44493528,4.323987981167799
KMS-11,6450551,0.5213353205908988
OAW42,49766530,2.0594375067340085
NALM-6,44137675,1.3048533129209736
WM793,9911463,3.794379463406426
NCI-H1568,327653,2.9538763640308403
K-562,148198,-4.073315546446919
IGR-1,11404337,-1.4130106945473468
BT 422,1716436,2.4641955502416533
SNU-216,6918638,0.1724072866575592
LOX-IMVI,JQ-1-UNC0638 (2-1 mol-mol),-0.2149277718866578
MDA-MB-468,374536,-0.0978665436371331
786-O,1716436,3.736169898038316
Panc 04.03,11404337,1.3784278741672673
KATO III,4259181,1.5457239282714792
J82,11485656,3.7122630536085137
Hs 888.T,136227924,1.939793098771597
SK-N-AS,148198,-4.149694989731526
BT 131,sirolimus-bortezomib (250-1 mol-mol),-0.1353843120079282
NCO2,11167602,0.0770809640123331
DBTRG-05MG,1716436,3.957814133158666
JHH-6,6918638,2.94778128430583
BT 172,9911463,2.9844378000407543
NCI-H2291,49766530,-0.0984213660928805
BICR 6,10302451,3.560909556549929
NCI-H1651,6450551,4.16056073170771
SK-N-DZ,135984461,1.5493461602233345
BT 216,4259181,1.1483081284027674
BT 440,10385095,1.3562224236695042
Peer,54618771,-0.6256151799638473
SNU-449,46926350,-1.1609870247475182
DEL,tanespimycin-bortezomib (250-1 mol-mol),-1.3033090305095067
Hs 683,9903786,4.056971165383086
TE 617.T,136227924,1.63601430884803
HPAC,10385095,1.6323615748888127
HEC-50B,753704,5.082293731284091
A2780,11485656,1.5628347007454235
SK-N-FI,148198,-6.001619008319419
OVCAR-5,11167602,2.4899386017639302
SW1417,753704,5.04888653390888
HLF,2708,5.205249244910541
BL-70,135659046,3.3949027184182707
TE 441.T,11485656,0.4823826130235241
PE/CA-PJ34 (clone C12),JQ-1-UNC0638 (2-1 mol-mol),1.4419134854320173
MKN45,sirolimus-bortezomib (250-1 mol-mol),2.222344728894145
SU-DHL-4,44137675,0.1175290659764092
Ishikawa (Heraklio) 02 ER-,11485656,3.3351822196084937
KE-37,JQ-1-UNC0638 (2-1 mol-mol),-0.0802813585495624
SF295,44137675,5.032931190928139
CAL-54,327653,3.490763598800991
WM88,54618771,1.141068520778182
Calu-6,654092,-1.678507227577477
NCI-H441,sirolimus-bortezomib (250-1 mol-mol),3.489880905955473
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
NCI-H2196,24753719,4.748637323499507
TTC-709,2729026,2.147747676020344
SNU-1079,10302451,-0.8712691050913255
CAL-51,151289,0.6583498849401344
RKO,16013152,4.038378204585466
KE-97,136227924,2.279256150432482
SNU-620,9911463,2.718235223469864
TALL-1 [Human adult T-ALL],327653,2.1585656138598424
SNU-16,2708,4.518220373610377
SK-UT-1,2708,5.491455066314142
IST-Mes1,6918638,1.4350648787515894
MOTN-1,135659046,3.5203350268102978
SK-MEL-5,44137675,4.284883260277097
HuH-1,9903786,2.716851853041897
BHT-101,9868037,3.7978715471358218
KHM-1B,6450551,1.2159742345507
RERF-LC-MS,49766530,0.7744144603938863
KMS-18,327653,1.4419845630654913
SNU-668,654092,-0.1815867895957556
CAS-1,10302451,3.767754564688996
MDA-MB-361,71729975,1.7674176608144228
HT-55,54618771,1.7226930749216656
SNU-475,54618771,1.821628813352334
YD-8,148198,-3.6074550947406863
KMS-20,374536,-2.9179307309900553
HEL,9911830,3.2406370139452134
Aska-SS,4259181,1.378146825762795
LCLC-97TM1,9911830,3.2250615193472085
KMRC-20,49766530,-1.4976923868030616
JeKo-1,327653,2.5433327541113333
SNB-75,24772860,-1.7482767385470976
JM-1,44137675,3.718094845766921
RKO,2708,5.0364138660049935
A-375,11404337,-0.2038231220320669
SK-CO-1,2729026,2.8886798476744246
NU-DHL-1,327653,2.351197542951544
SET-2,135984461,1.767736462015104
Fu97,9911830,1.8298922650541032
PC-3,10385095,1.1414412954098598
KYSE-410,54618771,1.043731623373752
BT 164,54618305,4.2947586907163275
KMS-21-BM,151289,0.0029890702920009
KATO III,44137675,4.096610345858805
SNU-5,54618305,4.931285968596896
Hs 294T,44493528,4.371769824264516
NCI-H1915,tanespimycin-bortezomib (250-1 mol-mol),-3.029490834381303
NCI-H2085,9903786,1.6610112484663062
SNU-1,sirolimus-bortezomib (250-1 mol-mol),0.1110784277529242
IGROV-1,1716436,3.2816872421007375
NCI-H1869,1716436,2.9410548139521744
Kelly,753704,4.456617914586867
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
Hs 578T,54618771,1.0464366040522988
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
SNU-761,6450551,3.665794934841485
Hs 895.T,6918638,1.92517171748629
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
IPC-298,2729026,2.40588810254723
Hs 729.T,16013152,4.158581437299072
CAMA-1,24753719,4.725261490673885
SK-ES-1,10302451,3.444765090684361
NCI-H1385,11485656,1.967780346674157
MIA PaCa-2,11485656,1.8953661577719088
ONCO-DG-1,1716436,3.3002655066178823
Hs 888.T,10302451,3.1676099375521263
OVCAR-5,49766530,-1.816533160659826
Mono-Mac-1,24772860,-4.461344884032207
JHUEM-1,24753719,3.9307242908195272
SNU-410,10385095,2.9494153659427145
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
SCaBER,10302451,1.638511810966576
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
GaMG,11404337,0.0335653022418154
A-204,49766530,-2.4739709349642083
NCI-H146,54618771,0.1782763900918093
Daoy,136227924,3.329647267316264
NCI-H1299,148198,-1.8449433288311332
SNU-1033,49766530,-1.347246040659949
OVCAR-5,9868037,3.692137842921165
647V,11404337,-2.8105111103232985
Hs 294T,tanespimycin-bortezomib (250-1 mol-mol),0.0201287487075006
OE19,2729026,3.181275716467372
COLO 800,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.5626913311172888
SNU-503,44137675,3.0995671661509365
CA46,24772860,-2.6679944090404035
Ishikawa (Heraklio) 02 ER-,10385095,1.7165210430114106
U-118MG,136227924,3.3662867602003006
KE-39,100016,6.665188081944046
CGTH-W-1,6450551,-1.3488950020215171
GA-10,11167602,1.4173414439490166
OUMS-23,100016,6.512546818056364
HEC-59,753704,5.615717275253642
C2BBe1,sirolimus-bortezomib (250-1 mol-mol),0.281617007338844
HCC4006,10302451,-1.0524765865485184
OCI-AML-3,100016,6.665392900980702
PE/CA-PJ49,2729026,3.098127456645034
KP-4,156414,1.731574968381172
T-47D,148198,-5.010352606662764
A2058,54618771,1.1536818044190116
SNU-387,sirolimus-bortezomib (250-1 mol-mol),0.5952265743447468
SW1710,9903786,3.726951851848614
NCI-H747,4259181,0.8302255965965687
COLO 699,151289,0.8110671153205183
OE33,selumetinib-BRD-A02303741 (4-1 mol-mol),3.869393320615985
COLO 678,JQ-1-UNC0638 (2-1 mol-mol),2.636057743453933
U-937,6450551,2.5029702839874157
BxPC-3,9868037,2.7194108471732243
Hs 611.T,46926350,-4.631315490401831
Kuramochi,148198,-1.655835644166272
SW579,10385095,0.7098346172725386
SW1353,44137675,3.9091502940178047
JHH-5,135659046,3.6151990449321705
Panc 08.13,327653,3.3508049940900437
EFE-184,11167602,4.805641466870204
Detroit 562,tanespimycin-bortezomib (250-1 mol-mol),-0.6563279140280487
BT 231,136227924,3.1954768658582378
SIG-M5,16013152,4.164973931838877
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886
Lu-65,44137675,3.671350913807576
A-549,124202324,3.059134662451402
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
SR,10302451,3.219855694871582
SNU-182,9903786,3.6716358007160546
DMS 273,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1319495853751045
NCI-H2122,44493528,4.295267332742467
Calu-6,44137675,4.988752229728456
KMBC-2,49766530,0.6316468025143787
IPC-298,54618305,4.557481113357753
KE-39,10385095,1.3052459079941114
QGP-1,100016,6.909688760762285
NCI-H1944,1716436,3.943232497997271
HuH-6,654092,0.2351696609911905
PK-59,3815108,2.9593126918265553
K029AX,JQ-1-UNC0638 (2-1 mol-mol),2.1701323864406064
JHH-2,10302451,2.423935123229122
BT 139,24772860,-2.647640860337615
Jurkat,54618771,-0.5483098658584711
TE-14,148198,-4.134736941909179
Mono-Mac-6,124202324,2.0761018586869495
NCI-H1373,10302451,3.0942478784962693
DU145,6918638,0.5820093502251232
OCI-Ly3,selumetinib-BRD-A02303741 (4-1 mol-mol),6.229740793460744
EFE-184,44137675,5.648974976284525
DV-90,24772860,-3.1690074976920073
MHH-ES-1,136227924,2.293763722118734
VMRC-RCW,1716436,2.211675205228934
NCI-H2106,73707371,3.394458746036765
COR-L88,100016,6.409850176158066
OCI-AML-2,44493528,3.8960180300608345
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
HDLM-2,10302451,3.39330830228014
SK-N-SH,10302451,3.675886207337339
HEC-251,100016,6.174926130166858
HH [Human lymphoma],54618771,0.4732630552220457
RKO,9903786,4.184024439899693
TTC-709,71729975,0.2001824127372914
ECC10,3815108,2.3891709571582616
TUHR10TKB,sirolimus-bortezomib (250-1 mol-mol),1.3489758983524096
UO-31,10385095,0.6553455151296144
CHP-126,11485656,2.087458763125066
TT,124202324,2.9658473546281185
CA46,2729026,2.6315261399645755
HCC1419,11404337,0.8171144747312442
COLO 800,9911463,4.009510973901368
OCI-AML-3,44493528,4.354469059332478
TUHR4TKB,tanespimycin-bortezomib (250-1 mol-mol),0.8308277028090468
EC-GI-10,151289,0.7179659441736698
NCI-H2405,151289,4.196208523499125
NCI-H647,9929138,4.265521593960728
HEC-1-B,327653,2.8877285088820694
LN-18,148198,-2.0225880392940043
RCC10RGB,49766530,-1.6086406954404375
HuG1-N,9911830,2.161286986984273
SNU-398,151289,0.5739648742875056
DEL,2708,2.1990288689623094
SK-N-BE(2),374536,2.8574098907731353
L-428,135984461,4.314670254949914
697,9911463,2.5551719944155016
U-937,1716436,2.9286059990247617
Hep 3B2.1-7,4259181,-0.0551178259711273
HCC1438,9911830,3.0081308219016205
YH-13,24772860,-1.8932225377928673
HOP-92,11485656,3.011235199919159
D283 Med,JQ-1-UNC0638 (2-1 mol-mol),3.413583109357789
EFO-27,4259181,1.8274060730963064
NU-DUL-1,11404337,-3.806861406156987
CAL-12T,9868037,3.211288861847722
HCC1588,JQ-1-UNC0638 (2-1 mol-mol),2.247816650776
CMK,10302451,4.010237102082258
YKG-1,4259181,0.3868166013965885
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
WM983B,46926350,-4.3427957401240445
JHOS-2,136227924,2.6850771580880783
OVTOKO,3815108,2.848075927715753
BT-16,24753719,3.652590286088957
LN-229,24753719,4.985619188567169
RD,46926350,-4.233124894528544
KMRC-3,6918638,1.2491038866653728
SNU-387,24753719,6.078615403196679
SU-DHL-8,JQ-1-UNC0638 (2-1 mol-mol),-0.0022987180231062
SK-MEL-28,JQ-1-UNC0638 (2-1 mol-mol),3.2511291788687218
KYSE-150,9911463,4.274881584609526
JJN-3,sirolimus-bortezomib (250-1 mol-mol),0.0133563437119215
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
EFO-27,11167602,3.5204241483481686
T3M-10,JQ-1-UNC0638 (2-1 mol-mol),2.4197095903250423
BICR 31,156414,0.5699919561712937
HLF,9911463,4.995203426264865
Lu-65,9911830,1.689381922499865
NCI-H2170,49766530,5.350715427478364
KP-3,100016,6.07483479536675
M-07e,10302451,3.6544835870370815
KYM-1,4259181,0.2098724165428193
KMS-18,2708,3.807913747432577
PE/CA-PJ34 (clone C12),11404337,0.4327507632811037
FTC-133,11404337,1.1811341910019733
T3M-10,11485656,3.630524872417795
HSC-4,4259181,1.301377168384764
JHOS-2,135984461,4.415400974704629
G-361,sirolimus-bortezomib (250-1 mol-mol),0.933443297731252
ACC-MESO-1,2729026,3.1292375102639194
JJN-3,11167602,2.3976970643938436
NCI-H1563,135984461,5.495757685430573
SUP-HD1,100016,7.0046366432620735
BT 187,tanespimycin-bortezomib (250-1 mol-mol),-2.6862986394516453
Kelly,1716436,2.2015009462692543
SCaBER,JQ-1-UNC0638 (2-1 mol-mol),0.1844479282114638
COR-L51,sirolimus-bortezomib (250-1 mol-mol),0.5050478913341053
KYSE-410,9911830,2.598803177921042
GDM-1,24753719,4.26675838017338
P3HR-1,151289,1.936230724636575
Rh18,JQ-1-UNC0638 (2-1 mol-mol),2.0121122940775504
AU565,71729975,2.800801196457704
A4/Fukuda,6450551,1.0528971846899622
Raji,11404337,2.5048803156599586
CAL-33,151289,0.8931337818953338
NCI-H1155,4259181,-0.3371626256760442
SNU-C5,selumetinib-BRD-A02303741 (4-1 mol-mol),6.484495007390754
TOV-112D,6450551,2.5090159853293024
HCC1438,9903786,3.876774477069639
CAL-51,374536,3.1977545561189347
TE-5,1716436,2.7854996929598053
CAL-51,151289,0.6583498849401344
HCC2279,tanespimycin-bortezomib (250-1 mol-mol),0.9868379448514812
NCI-H716,156414,5.804018273165498
JHUEM-7,6450551,1.7942384478328788
TE-14,11485656,2.3244152057135934
Panc 03.27,9911463,4.350526382797422
TF-1,1716436,3.7195475318501785
LOX-IMVI,3815108,0.0979878025646932
PLC/PRF/5,1716436,3.800525149446647
NCI-H2029,9911830,2.286590910296229
MEC-1,135984461,4.143438780946002
GaMG,11485656,3.146169706850776
OCI-AML-5,9903786,1.179944382770948
U-118MG,tanespimycin-bortezomib (250-1 mol-mol),0.2197944792007267
NCI-H1666,124202324,2.0394879701934556
EFO-21,24753719,4.305542391555895
NB1,124202324,1.3874462338911409
BT 232,71729975,2.114830626945071
HOP-62,16013152,3.830141163681858
OE33,11485656,2.057023759496841
HuH-6,11167602,1.354506813263299
NCI-H1299,4259181,-0.5610817863206101
786-O,11404337,-0.5189034557080271
MKN1,3815108,3.203756873238669
BT 224,24753719,4.793475637464062
HSC-4,10302451,2.384078053411002
OAW28,6918638,0.0048657249331401
LN-229,49766530,-2.6497370695255857
PaTu 8988s,10385095,1.7438856573412385
NCI-H2126,11167602,4.336967628548722
MPP 89,16013152,5.193497521047866
PE/CA-PJ49,6450551,3.0510152388664435
MES-SA,sirolimus-bortezomib (250-1 mol-mol),0.1069072940558757
Hs 888.Lu,9903786,2.210543303670434
HSC-2,148198,-4.582461911697906
Hep 3B2.1-7,327653,3.179957662955071
HGC-27,44137675,1.271307594102974
PF-382,136227924,2.0859082008018084
CAMA-1,10302451,4.701896381708503
SNU-1033,44137675,3.659599107185258
TE-5,6450551,3.4628686308934413
MES-SA,11404337,-4.5203474212928265
BT 248,JQ-1-UNC0638 (2-1 mol-mol),2.2588808320886917
RCH-ACV,9868037,2.145537179112383
JHUEM-3,148198,-4.085540837584063
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823
PE/CA-PJ34 (clone C12),16013152,4.240449393705453
RKN,327653,3.2518035953304434
42-MG-BA,2708,5.094258978861549
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658
HEC-1-A,4259181,0.5667735233157607
Hs 766T,46926350,-3.5321005018206977
TE-6,151289,1.7651774565084712
DU145,136227924,5.593457102459236
Panc 10.05,9911830,3.323160861046792
HuP-T4,2708,5.042342326387298
SCC-25,2708,5.370848535068592
G-292 clone A141B1,9903786,2.9519846446825277
MFE-319,2729026,3.0699087026199696
NCI-H2029,11485656,1.831867006041765
Panc 10.05,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1627440605837034
Mono-Mac-1,9911830,2.1868049767694044
NCI-H841,753704,4.584392246079746
BL-70,9911463,2.445001964287348
KP-4,49766530,-2.33091907235806
PE/CA-PJ49,6918638,-0.873109094603626
DMS 114,100016,6.89872652787532
SNU-61,44493528,4.287806417412906
Kelly,44137675,3.813240628394034
GSU,tanespimycin-bortezomib (250-1 mol-mol),-0.9312032825444012
BT 179,tanespimycin-bortezomib (250-1 mol-mol),-3.1981676947705564
JK-1,136227924,1.8733417156502243
COV362,327653,3.663360057056847
NCI-H747,16013152,1.199391239093201
RL,2708,4.380787529262854
NB1,654092,-1.664179249806113
C2BBe1,2708,7.310620794716233
EC-GI-10,9911463,4.066814548265045
IM95,9911463,3.6531576247852153
TOV-112D,374536,1.5578202835267905
OAW42,2729026,3.0822890019462417
TOV-21G,44137675,4.85593886644752
OVTOKO,9903786,2.0414174754656544
Daoy,124202324,2.7782151086255813
TTC-709,4259181,-0.3591071255089544
Peer,136227924,2.1160969435978303
BT 112,9911463,2.5169416957375015
WM1799,9911830,2.7016436476916623
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988
KM12,11404337,0.0188417949264162
OS-RC-2,654092,-1.6594977242719335
MHH-ES-1,11404337,-1.1882712301989995
BT 145,6450551,1.5545840822139136
KALS-1,11485656,3.631175776194637
HEC-265,11404337,-1.185290223880338
NCI-H146,11404337,-1.5914515878545687
AGS,9911463,3.955796960522849
RPMI-7951,9911830,3.3922230843192778
MEC-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1834550186065348
KE-39,44493528,4.79040409668691
Hs 934.T,135659046,4.578054187652552
Kasumi-1,1716436,2.9962950516569298
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
SNU-201,124202324,3.023604570779493
NCI-H1299,24753719,4.197116792706203
IGROV-1,135984461,4.285945029851472
SNU-398,9911463,3.388057866137583
NCI-H1869,327653,3.4253692354840197
BT 444,1716436,3.281731704539553
NCI-H2029,selumetinib-BRD-A02303741 (4-1 mol-mol),6.401787200056425
TF-1,135984461,1.7189308198167896
SNU-16,24753719,3.78652594456274
HCC1588,9911463,3.721403474338108
Ishikawa (Heraklio) 02 ER-,3815108,3.586440325889441
MDA-MB-468,1716436,2.5901393557075214
NCI-H1651,136227924,3.2782738852919966
BT 216,54618305,4.343548232440738
HuCC-T1,124202324,2.786280828489934
MOLT-16,44137675,2.228006905835291
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
SU-DHL-8,9911463,2.7396964773709764
SNU-878,9911463,2.819735999013875
MEC-1,46926350,-4.494082074530346
SK-N-AS,24772860,-2.9182773308806644
KNS-42,148198,-2.941932964829523
NCI-H358,2729026,2.5281714618618416
TE-15,16013152,5.11463322397938
COR-L51,10385095,0.6951794902881232
NCI-H2087,135659046,3.4152304488602727
HD-MY-Z,24753719,4.079912472521239
GaMG,tanespimycin-bortezomib (250-1 mol-mol),-0.9299125293643992
OC 314,1716436,2.7948629197082244
L-540,9903786,1.612072273929478
Hs 688(A).T,374536,3.0315504288646293
EBC-1,44493528,4.198752101317416
SNU-1079,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1061690504774735
SW1783,selumetinib-BRD-A02303741 (4-1 mol-mol),5.401452883960348
Ki-JK,374536,1.9535972359800315
A-673,54618771,0.7910545462175201
HCC-56,1716436,3.949084606290369
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
JHH-6,46926350,-3.4858088429422422
SK-N-AS,374536,4.009524069127922
Granta-519,11167602,4.36712443545526
TF-1,2708,3.4423402819739106
SNU-489,11404337,0.8809237890954298
TE-14,44137675,3.833594169028412
HT115,2729026,0.316525430040886
BT 416,135984461,1.873658392465374
UACC-62,2708,5.1780029875157725
JHUEM-1,2729026,3.136040969077724
HT-144,73707371,6.328383663746838
LAMA-84,9868037,1.3276253526445787
NCI-H446,9903786,1.878824600883621
KATO III,46926350,-3.864777591688387
H-STS,6450551,1.5253926760198298
HOP-62,9868037,3.695700187533532
HCC1419,9911463,4.378443603359897
BHY,tanespimycin-bortezomib (250-1 mol-mol),-0.455078005089977
Hs 683,156414,1.79593868877012
SJSA-1,148198,-2.7316697840866673
A3/Kawakami,11404337,-1.3571350042405983
JHUEM-1,9903786,2.799765938694702
GI-1,10385095,0.7394831533440679
PC-14,9911830,1.0701556722840508
TE-8,11485656,2.0537902737407348
KMS-11,10302451,3.186469993884299
SW1353,374536,2.4220042537578896
BT 248,11404337,-1.3909400551472375
BT 159,4259181,0.9611359841951334
MM1.S,24772860,-3.323759307224156
SW1353,49766530,-0.8162034464098388
8505C,2708,3.1245113483713225
SNU-878,4259181,-0.5553008083361718
CAS-1,49766530,-0.5285201098219467
SH-4,6450551,3.04937995273092
HEC-1-A,6918638,0.4637384706031703
NCI-H1693,135659046,3.507522004254733
ACC-MESO-1,374536,3.768869201315052
U-118MG,16013152,4.617632893607757
COV362,JQ-1-UNC0638 (2-1 mol-mol),1.8795967971299876
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882
HLF,151289,1.0729106428659076
COLO 792,148198,-2.6366713074255475
FaDu,11485656,1.8671846861559669
HOP-62,JQ-1-UNC0638 (2-1 mol-mol),1.583491465804524
BT 147,1716436,2.544650981546954
HCT 15,9911830,2.1047581294731277
BV-173,tanespimycin-bortezomib (250-1 mol-mol),-0.4619705859834364
BL-41,135659046,2.671916295491686
OCI-AML-2,148198,-4.39978868082379
SaOS-2,9911463,4.168030006572111
NCI-H1869,44493528,4.333760189181675
BT 164,46926350,-4.4285371208173485
SK-N-FI,10302451,3.663337612290572
KMS-26,10385095,0.2941309941627629
PK-59,2708,5.444161268698026
HCC44,sirolimus-bortezomib (250-1 mol-mol),1.406227075762608
CAMA-1,753704,5.5151628623530975
PE/CA-PJ49,374536,1.0284025610078626
647V,24753719,3.7750625934618864
CAL-120,124202324,2.5701904791807157
NCI-H2029,6918638,-0.2360985045568938
KMS-11,24772860,-3.2996643510024386
B-CPAP,753704,5.841811531303964
SCC-4,9911463,4.04011035485065
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
SK-N-MC,10385095,0.8357656726976791
HCC1588,4259181,0.367831162449909
HCC2935,54618771,0.7337310107674532
HEL,10302451,3.814274659252608
DMS 114,10385095,1.113027996437857
CL-11,24753719,3.552982050369589
SW1417,JQ-1-UNC0638 (2-1 mol-mol),-0.5973869584607516
MDA-MB-157,71729975,1.9097389430207852
RPMI-8226,11485656,0.7927893823334488
HPB-ALL,654092,-0.2516937484833985
BT 482,54618771,0.8626033669866102
KATO III,1716436,3.5939451691324424
JHH-5,10302451,1.996624845120403
SK-MM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.244612201047882
ONCO-DG-1,9903786,3.737117521186133
YD-38,44493528,4.189502567524798
NCI-H522,6918638,0.2628749411775776
TTC-709,10302451,3.507934781987639
GaMG,136227924,2.741790754216058
SW1088,2729026,2.4307503104923662
OCI-M1,327653,3.224112962070562
HOP-62,54618771,0.1660184306238314
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242
NCI-H747,49766530,-2.525329800647816
HCC366,11404337,0.8660876212905556
KMS-26,24753719,3.990171932388741
Ishikawa (Heraklio) 02 ER-,135984461,4.462174661404989
NCI-H2444,1716436,3.3406780445388966
NCI-H2087,100016,6.366125554898137
CAL-85-1,135984461,4.357321132215755
SNU-C1,10385095,1.2964940411522758
PLC/PRF/5,16013152,3.911408074975365
UACC-62,9903786,5.03427767143789
PK-59,9903786,2.9850600541065764
RPMI-7951,151289,0.7115875874342479
NCI-H2444,124202324,4.157047549612411
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816
NCI-H2085,327653,2.044327509419636
HEC-265,374536,1.219325352094404
NCI-H2110,46926350,-4.246677806016688
OE21,151289,0.7158800492725989
ST486,156414,0.7820846211489824
NCI-H211,9868037,1.83710145053469
NCI-H1869,135984461,4.367577543921494
KMS-12-BM,9929138,5.078790269314151
CA46,4259181,0.0375174782651609
TE-14,6450551,3.6230287269279224
NH-6,46926350,-4.6397597218039754
LS180,100016,6.005443229591697
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
HCT 8,9911463,3.550140199778626
SH-4,44493528,4.462421273683891
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
IM95,6918638,0.7344376580151405
Panc 05.04,327653,3.66844152859248
HOP-92,9903786,4.828960304549442
CL-11,24772860,-2.5837152388944356
DU4475,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.8539934521473715
BT 239,selumetinib-BRD-A02303741 (4-1 mol-mol),3.733604251898887
MOLT-16,9911463,3.124866313552043
U266B1,374536,2.5678798391104283
A-375,10302451,4.088422063006118
VM-CUB-1,9911830,2.850961180647016
BHT-101,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9345856971387528
BICR 31,1716436,3.7157300626912617
ECC10,151289,0.5574818737537156
BHY,selumetinib-BRD-A02303741 (4-1 mol-mol),3.588005438221076
MM1.S,136227924,2.5395832269167027
RD,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2331026843002184
SNU-201,9903786,3.5619464236544336
COLO 800,100016,6.663651406564157
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
Pfeiffer,148198,-5.248523074657563
SK-N-BE(2),4259181,0.1964139282456021
NCI-H841,11485656,1.425453258199406
COLO 680N,136227924,3.1124323049819003
NCI-H2087,124202324,1.9786049368771377
Reh,2708,3.1002991023175364
BT 444,54618771,3.3386759439235267
HuH-6,2729026,1.3696226717754232
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575
JHUEM-7,24772860,-2.354213215472605
NALM-6,327653,2.2046348778532456
MeWo,10302451,3.531260082767252
EFO-21,9911463,4.46100095082043
Karpas-422,6918638,-0.9922508328121828
NCI-H2087,374536,3.0815602143438063
HEL,135984461,1.7610482730169696
KYSE-410,156414,-0.3480069289117364
SU-DHL-10,753704,4.756037172488439
BT 245,753704,4.7847711717833725
NCI-H292,49766530,5.348764781206105
NCI-H1703,2708,5.201549301089873
NCI-H1915,2729026,3.0523352063214846
IGR-1,9903786,4.216869468062427
ECC10,11404337,0.1866316876880306
L-363,16013152,4.2906066084870895
HuP-T4,sirolimus-bortezomib (250-1 mol-mol),1.161558608864497
COV434,9903786,2.975082903645508
HEC-59,4259181,0.197589789871654
Capan-1,6450551,3.486893590475519
A3/Kawakami,6918638,-1.1948916865846906
SCaBER,44137675,3.1610375192955815
Karpas-422,9911463,4.381699719624804
Hs 822.T,6918638,4.296934000106513
CAL-54,sirolimus-bortezomib (250-1 mol-mol),0.5891301092659956
NCI-H1573,9903786,2.787588976876453
CAL-12T,1716436,3.2034594719688414
OAW42,135984461,3.763630222707139
NCI-H2342,JQ-1-UNC0638 (2-1 mol-mol),1.139996513677478
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
Hs 294T,4259181,-0.3023864007652443
COR-L105,11485656,1.8131666015075352
KMS-34,100016,4.459610626448404
WSU-DLCL2,136227924,1.92257757824623
MDA-MB-453,135659046,3.699316020945489
BT 330,10302451,3.8668829581904944
GOS-3,136227924,2.1351760440562533
NCI-H23,753704,4.247166974278245
HCC1395,9929138,7.007797451102856
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
MOLT-13,654092,-1.7797174091478274
G-401,54618771,0.8582285882331511
SW1271,11404337,-3.6050810245472382
BICR 18,2729026,3.127348113993043
DB,54618771,1.151207273522801
Hs 578T,10385095,1.132741293219766
NCI-H2087,9911830,2.1008077543098045
NCI-H841,49766530,-1.6257988824506011
NCI-H1155,100016,6.5684025185087505
NU-DUL-1,4259181,-1.762578833655516
Namalwa,327653,2.6135050132049167
BT 440,54618771,0.7745514333639397
RS4;11,49766530,-2.8590033120735767
KYSE-150,10302451,5.770989993718531
HCC1569,JQ-1-UNC0638 (2-1 mol-mol),0.5318622210001318
HCC827,11404337,-0.5987268990428054
NCI-H1694,9911463,3.249384626336109
RERF-LC-Ad1,49766530,-0.8755533009144216
Rh30,374536,2.8490376580387355
8505C,54618771,0.8247832120162748
T-47D,2708,5.334876005128675
SCC-4,151289,0.8140775573403206
SU-DHL-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6950122900269923
Calu-1,6918638,2.4930739459862936
NCI-H716,6450551,-2.029898333052656
M-07e,49766530,-2.4452167818324813
GSS,135984461,1.9439618887139551
KMS-20,753704,4.324043656881392
MKN74,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7109698325669793
SK-BR-3,6918638,-0.1564610837276475
KPL-1,10302451,4.018734113992757
TE-11,16013152,3.913689243612703
SNU-449,9911830,2.1326623866395487
NCI-H1869,156414,1.3059713748980704
AMO1,10302451,3.232615102018798
YD-10B,156414,2.388242081473774
BHT-101,10302451,2.8227142275442993
NCI-H1666,11485656,1.1104908410257284
TF-1,9911463,2.560339190284904
RS4;11,54618771,-1.3838955198533192
KHM-1B,136227924,1.9174951940989704
SW620,6450551,2.1795537245615444
BV-173,24772860,-3.2112713005336135
BT-20,2708,5.45036236245344
RPMI-6666,11485656,1.824028622976644
CFPAC-1,2729026,3.1416159588231474
HCC366,4259181,-0.2253216072179903
DEL,136227924,2.1995562608544494
SNU-1214,9911463,3.639683247778992
TOV-21G,2708,4.899436861603095
NCI-H446,327653,2.68114451363679
JMSU-1,54618771,0.1163446167769653
Rh18,156414,2.0348797540110093
JURL-MK1,148198,-3.3107104288363027
AsPC-1,24753719,4.618559637878285
UO-31,6918638,1.142003131035845
EKVX,71729975,2.4747545863344325
NCI-H1755,753704,5.009084038166691
8-MG-BA,24753719,4.263352567955377
TE-10,2729026,2.9943705903567053
TT2609-C02,46926350,-4.130181705825257
CAL-148,44137675,1.7744450114359958
Caov-3,9903786,2.8083030393929276
Hs 611.T,753704,3.904676648691391
TUHR14TKB,49766530,-0.541882480263748
A-549,10385095,1.3823205412091923
SF126,654092,-1.4956439650198734
CAL-85-1,JQ-1-UNC0638 (2-1 mol-mol),-0.0027334252566826
NCI-H23,tanespimycin-bortezomib (250-1 mol-mol),-3.070808400033709
LS513,2708,4.266746171463368
JJN-3,JQ-1-UNC0638 (2-1 mol-mol),-1.0977069501353425
SNU-46,4259181,1.2898600996653962
EC-GI-10,24753719,4.306483835560299
MDA-MB-415,374536,4.903502609935023
NCI-H727,2729026,3.015864992302643
NCI-H2110,135659046,4.755266203031495
SNU-423,148198,-4.2261536044419765
BT 428,44137675,3.735819095896295
SNU-620,136227924,2.4539673197881444
BT 504,11404337,-1.134155028298889
BT 172,327653,3.4070255129044114
KYSE-140,124202324,3.024555177585928
U-251MG,24753719,5.108579480796019
BICR 6,tanespimycin-bortezomib (250-1 mol-mol),-0.3653020091427266
BT 228,11404337,0.5365763312483942
AML-193,11485656,-1.7272529013303597
SU.86.86,6450551,3.982755322239038
HCC1588,11485656,2.115335412589631
Hs 766T,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2694834452640316
SW1271,24772860,-2.1080107772753607
THP-1,151289,-0.1124946056164376
MOLP-8,16013152,3.9032026583920656
TUHR14TKB,135659046,6.015555099108438
NCI-H2126,10302451,3.9683881221380495
NH-6,11167602,2.105969587149216
A-204,1716436,1.794013780290166
KYO-1,100016,4.086276175586104
BICR 22,44493528,4.288893884195869
A2780,10302451,4.067201499125142
KMS-20,4259181,-0.0713242382704696
BT 248,135659046,3.5168747963796636
TCCSUP,124202324,2.3353692726600173
PF-382,10385095,1.1317259097020056
KMS-27,9911463,4.115013696687494
UO-31,148198,-4.317632208433169
SNU-1,44493528,4.533433840242425
A4/Fukuda,148198,-4.99238512913244
Li-7,9911830,0.8718891387559716
OCI-AML-3,10302451,3.3891751896775655
KP-3,9903786,3.3194843074548843
NCI-H2405,24772860,-0.5090131657891489
Karpas-620,selumetinib-BRD-A02303741 (4-1 mol-mol),4.977306868747473
GB-1,2708,3.2004391753903
5637,44137675,2.992571551747784
SCC-4,9903786,2.916722616299938
DMS 53,148198,-4.7992801457563665
Jurkat,10385095,1.1081293360903846
JHUEM-7,148198,-3.5780143567355336
Jurkat,2708,3.7919131541457025
KYO-1,4259181,-0.6060384488599356
SW982,sirolimus-bortezomib (250-1 mol-mol),1.8750003849027723
NCI-H1373,2729026,2.565484772910143
NCI-H889,753704,4.984248383413316
KYM-1,753704,5.0286431681761705
NUGC-4,124202324,0.5833003772903234
COV434,6918638,0.3564723109557184
HuP-T3,49766530,1.2218451996302029
GOS-3,6918638,1.663921744527482
SK-N-BE(2),11485656,1.869214340930476
TT,2729026,2.807583491273779
RPMI-6666,136227924,2.5880592922669097
KG-1-C,11485656,3.6519605363240495
MDA-MB-231,4259181,0.3992270922523126
Ci-1,11485656,1.9220141721466868
OCI-M1,16013152,4.0645728421106755
P12-Ichikawa,9911463,3.30531247754742
NCI-H1703,6450551,-4.2065019016994585
KLE,124202324,2.798176787230371
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
DMS 114,11485656,2.3249247552624936
Mel Ho,tanespimycin-bortezomib (250-1 mol-mol),0.3102733441080628
Mino,11404337,-2.29299189538819
GDM-1,9911830,1.163129304540652
NCI-H841,2708,5.849102924659256
NCI-H2171,10302451,3.986494326049399
T84,2729026,1.918430404815631
A-204,6918638,0.7578791197634218
KMS-20,10302451,2.7224697614535662
YD-15,100016,6.01418803247364
G-402,6918638,0.7835735464626096
HCC1195,24772860,-2.3787070450720393
Reh,100016,6.483959173055827
NCI-H1693,156414,0.918301243900346
SU-DHL-1,10385095,0.4695713178913991
NCI-H23,JQ-1-UNC0638 (2-1 mol-mol),-0.5368279016109785
NCI-H1355,151289,0.1475814940750423
SK-N-FI,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5427319376742217
KP-3,54618305,4.754928976610576
RVH-421,135659046,3.595946771540715
SaOS-2,10385095,0.9171223668306429
8505C,11485656,2.524843425328081
DAN-G,753704,5.9244695291506195
SK-MES-1,49766530,1.8908947653330492
PSN1,9903786,4.143013374018909
SaOS-2,374536,3.743747938767685
Karpas-299,9911830,3.0958071479181104
SNU-407,151289,1.1711092577377158
ECC12,148198,-2.5550218392093624
Karpas-422,44493528,4.27188958418413
PaTu 8902,9911463,4.390925153080421
HLF,148198,-4.949405415415342
BT 504,24772860,-2.6137650480581818
MOLT-13,753704,3.342517986596702
KATO III,9903786,1.8271137188030744
A4/Fukuda,6918638,-1.9449982869755031
A-204,selumetinib-BRD-A02303741 (4-1 mol-mol),5.09764318645237
UM-UC-3,16013152,3.6165950175924104
PK-59,54618305,4.329681142974429
COV362,6450551,3.74435755130184
SK-N-DZ,151289,1.290119239829968
JK-1,9911830,-2.4986203746696245
AGS,24753719,4.906480809834557
JeKo-1,4259181,0.4142441656313368
SNU-C2A,654092,0.0600239977392283
HSC-4,2708,2.9878251305615477
OV-90,6450551,2.090758926368768
Hs 852.T,2708,5.34978035780296
BT 139,11404337,0.9723364970795382
MHH-CALL-3,49766530,-2.9861059393678766
EoL-1,9929138,2.1880692859665984
DK-MG,2708,5.630816979409335
Caki-2,11485656,3.849014723207123
DMS 53,151289,2.264842610359673
HT-1197,1716436,2.64185975168639
BT 216,9911463,3.0589370422001494
SNB-75,sirolimus-bortezomib (250-1 mol-mol),1.678317962717081
Aska-SS,10302451,3.2025437422649796
HT-1197,11485656,1.6876827017729057
COR-L88,24772860,1.0547842418052655
NCI-H1395,6450551,6.187307607667542
NH-6,148198,-5.967790177292145
FTC-133,156414,2.701071854154092
EPLC-272H,9911830,2.69139875314517
MDA-MB-361,11485656,3.163991716829106
NCI-H1299,9911830,3.0840556106234653
CJM [Human melanoma],44137675,3.742312209060101
G-292 clone A141B1,10385095,0.9697207611364824
Daudi,54639665,4.383406013207389
ES-2,9929138,5.3077403629794
A-204,54618771,0.0789139316749608
23132/87,148198,-2.6574855185514816
KYSE-180,24772860,-1.944704874720706
RKN,44493528,4.408823872302737
JIMT-1,135984461,4.835908287513633
OVCAR-5,71729975,3.1805617630253806
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
BT 444,136227924,3.5279486847576886
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
Capan-1,148198,-2.3520537722391075
JHUEM-1,16013152,3.7061091021254624
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
Panc 04.03,6450551,3.8538949310121353
RKN,9929138,7.419607622812729
Rh41,9903786,2.3999141751709763
NCI-H747,9868037,3.413430732582287
NCI-H650,44493528,4.3603009222588645
P3HR-1,124202324,5.448955153472202
SR,327653,3.5781508881575426
TE-15,11485656,1.960576997256463
SNU-449,100016,6.350050439021361
NCI-H322,10302451,1.3901154750786564
NCI-H1355,tanespimycin-bortezomib (250-1 mol-mol),-4.485986367397168
OPM-2,10302451,3.176323712036339
HT-55,3815108,3.683519396270642
TE-8,148198,-4.4276968910766525
M059K,11485656,3.642862127299764
SW1990,10302451,2.528677635613451
SNU-C2A,54618771,1.0947392287826
B-CPAP,2729026,3.008270694147531
KCL-22,151289,-0.1923636710600486
LS180,3815108,3.93048377981505
TE-9,9911830,2.430802089645133
PSN1,135984461,4.283628399888077
SNU-5,9929138,6.321300531012286
Caov-3,1716436,1.4049169731703333
EoL-1,11485656,-6.598388814450544
42-MG-BA,327653,3.7293022074682343
NCI-H1341,100016,3.8327529210726903
HCC38,24753719,4.142998608855599
NCI-H2291,11485656,3.4201367707893424
CCK-81,9911830,2.89026136478977
SUP-B15,9911830,0.1632296563268915
DB,49766530,-1.6801310295102778
SNU-466,54618771,0.431904700089911
DMS 114,sirolimus-bortezomib (250-1 mol-mol),-2.6988548245768387
P-STS,327653,2.8911465905529674
SNU-182,54618305,4.364644108861178
HCC1428,44137675,6.467290461368659
MSTO-211H,44137675,1.9879298255329003
ACHN,1716436,3.725059449192881
Capan-1,4259181,0.8226555222701868
Becker,6918638,0.8308628231051842
U-BLC1,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.387521569845494
PC-3,44137675,2.7612484225936575
OPM-2,11485656,1.3184852346481954
SW1271,44137675,2.993655891868926
639V,selumetinib-BRD-A02303741 (4-1 mol-mol),6.505329464360968
Calu-1,71729975,3.676587841113591
UACC-62,11485656,3.7372530211489057
22Rv1,54618771,1.0786787609274302
NCI-H1703,9911463,3.2274875516011257
AsPC-1,49766530,-1.5554439905221051
GI-1,16013152,4.335829138505061
NCI-H1339,6918638,0.2750671891608724
BFTC-905,124202324,3.18489698235773
Aska-SS,136227924,2.71481465035111
MDA-MB-435S,148198,-3.0522052699566613
BT 179,1716436,3.2908736268151273
HCT 116,9868037,2.1391599474791394
CGTH-W-1,9911463,4.280692853658182
OE19,156414,6.025174328305522
D283 Med,1716436,2.988422279265608
EFM-192A,156414,-2.907944851521074
KNS-62,71729975,2.374101917788608
NCI-H929,3815108,2.046773234087797
SNU-16,9911463,2.3292898367461823
HPB-ALL,9903786,2.3044154759834847
U-251MG,11404337,1.3506850952063736
LOU-NH91,3815108,3.3787088400125422
KE-39,11404337,-0.6939323202576905
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
COLO 741,9843750,4.3643408029455575
GaMG,2729026,2.3819630367272833
HCC1419,135659046,5.048116193224175
HCC95,1716436,4.215473770893188
EFE-184,4259181,0.9634883435103218
NCI-H716,9911463,3.7061520966996033
SUP-M2,6450551,0.568054526815742
MM1.S,54618771,0.954891721558104
IM95,JQ-1-UNC0638 (2-1 mol-mol),-0.0841499500306187
NCI-H520,24753719,4.403096106170392
MKN45,4259181,2.854305904234322
MDA-MB-157,46926350,-4.132103643787292
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012
GDM-1,24772860,-2.079937188411744
NCI-H1838,44137675,3.833016063280043
KMRC-20,136227924,3.298573049161518
P31/FUJ,327653,2.543614095842417
L-428,135659046,3.7649753981582137
HL-60,4259181,0.2304044272519446
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862
SaOS-2,11167602,3.026359974607451
HCC1143,9911830,2.6182666070844447
TE-10,54618305,4.872996569288002
T-47D,11404337,0.5836773446504185
Capan-2,24753719,4.630444613431859
BT 172,9903786,4.891040343072455
JHUEM-7,100016,7.782886537779513
SNU-1079,4259181,0.5490184048770516
WM115,9911463,2.5241618652619007
ChaGo-K-1,2729026,2.395257991695926
UACC-257,44493528,4.38032126564653
HEY A8,100016,6.30003295297675
DU145,16013152,4.600431994901221
BT-12,71729975,1.5254863401847427
PK-45H,JQ-1-UNC0638 (2-1 mol-mol),2.1005257041780996
RT-112,9911830,2.2305398910427288
YD-38,151289,-0.2665025738669385
G-292 clone A141B1,753704,4.441418025664585
FTC-238,selumetinib-BRD-A02303741 (4-1 mol-mol),6.259656287083202
NCI-H1793,100016,7.252403961124031
LS513,136227924,2.4637797835127793
MHH-CALL-4,10302451,3.4549917451264376
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
JHH-4,753704,5.630354299771487
HH [Human lymphoma],10385095,0.7495240150076384
B-CPAP,374536,5.570137344225874
RCH-ACV,135984461,1.5871533406295049
2004,374536,3.151343721973936
NCI-N87,11485656,1.873926788766734
G-402,374536,3.3118953536021443
COLO 792,1716436,1.47891952025817
EC-GI-10,148198,-5.102000128684168
U-937,9911463,3.0033248654394944
SNU-423,73707371,4.995198662873275
EB1,54618771,-0.3915386993254522
KMS-11,11167602,1.9167472278241215
COLO 668,24753719,3.586871518456208
KYSE-150,9911830,3.078794736817172
C2BBe1,2729026,1.3519144481609873
NCI-H810,49766530,-1.6477038589154638
DB,136227924,2.1225886217744376
MKN74,654092,-0.1302621958962137
LMSU,100016,7.332455698517509
SNU-1105,124202324,3.028866256115163
JHOC-5,136227924,3.178485175637893
KYSE-410,9911463,3.4542799068802696
T84,148198,-4.2219788227955855
KHM-1B,374536,2.314533071976094
HGC-27,148198,-6.389013328136406
KG-1-C,JQ-1-UNC0638 (2-1 mol-mol),1.1416258522555915
NCI-H650,11404337,0.16531704112611
HEY A8,2708,4.000499864511426
HH [Human lymphoma],148198,-7.602984000747502
TTC-709,1716436,2.751323232376299
MDA-MB-361,9903786,4.233301337396568
HCC38,148198,-4.709757817936847
RL95-2,148198,-3.5486250738118654
BICR 56,151289,2.0525499225903276
SNU-1214,9903786,2.1258190574569955
42-MG-BA,54618771,0.7266363256889177
HCT 8,71729975,1.128062253260744
NCI-H1944,374536,-0.9194195982212272
CAL-120,654092,0.2531016121786819
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
Rh18,selumetinib-BRD-A02303741 (4-1 mol-mol),3.8322113899507593
HPB-ALL,9868037,2.0330145425513044
Panc 10.05,11404337,0.4030412000723416
CAMA-1,54618771,-0.4577950074396519
NCI-H1694,54618771,0.8096670876443307
HSC-2,54618771,1.8867567266847771
OV56,11485656,3.4702075496289018
BT 164,10302451,3.8869135930428063
SBC-5,10385095,2.1758850118167077
CAL-33,54618771,-0.7874087703723603
GP2d,6918638,-1.154935446775354
DLD-1,JQ-1-UNC0638 (2-1 mol-mol),2.3834003327656106
NCI-H520,374536,3.961767685338683
SCC-9,6918638,0.4192666549800527
Karpas-299,2708,4.305167645098767
KNS-60,24772860,-2.333204701942312
IGR-1,16013152,4.734305283876607
LS513,148198,-2.3506631812777945
REC-1,11404337,-2.3807065169464336
BICR 22,24772860,-1.3590035600374548
Ci-1,sirolimus-bortezomib (250-1 mol-mol),0.4066762870237297
G-402,2729026,2.9506328296160538
T24,9911830,3.4233816907191468
HMC-1-8,2729026,3.117630144159494
COLO 678,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.5486574416503305
KYSE-410,753704,5.6578219631905435
IST-Mes1,136227924,2.313131576565863
KYSE-450,10385095,1.1558983027763154
TE 617.T,151289,0.8146404071058262
HCC1937,9911463,4.268340075854012
BT 216,11404337,-0.0425915422639234
HCC1419,151289,4.277767066492441
MOLM-6,24753719,3.7913017933628095
TE-8,tanespimycin-bortezomib (250-1 mol-mol),1.1915545878263378
SK-LMS-1,54618771,1.3800871170557885
KE-39,9929138,5.605001473491643
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
KG-1-C,4259181,1.5706679551779288
ESS-1,753704,4.74318722205844
LS1034,151289,1.126767178980463
HCC1395,selumetinib-BRD-A02303741 (4-1 mol-mol),5.692953690184119
CHP-212,10302451,0.4952332551332477
SNU-840,tanespimycin-bortezomib (250-1 mol-mol),2.584361399969364
TE 617.T,753704,4.601983889014857
A-673,11404337,-2.7698937773977033
HCC2108,9911463,3.889332679655138
GSS,24753719,2.4096224758736895
U-CH1,sirolimus-bortezomib (250-1 mol-mol),-0.0071193636307831
Kuramochi,49766530,0.1496678654084536
SNU-8,9903786,3.356408381726989
MHH-CALL-4,24753719,3.3862640639647457
NCI-H647,327653,3.987842659559465
SNU-886,374536,0.8487393236537821
Mono-Mac-6,JQ-1-UNC0638 (2-1 mol-mol),0.5979133117921847
MHH-NB-11,10302451,3.700428006456128
Hs 839.T,9911463,4.51823555869199
Fu97,sirolimus-bortezomib (250-1 mol-mol),-0.4373916466224739
SW1088,73707371,5.94401914486068
Ri-1,2708,3.183708199317031
NUGC-4,135984461,2.7361037757189184
SK-BR-3,1716436,1.7727999999856203
HT-1197,9903786,4.0222787047996915
MOLT-3,54618771,-0.579298933394039
Ki-JK,44493528,3.660755145624423
BT 159,44137675,3.532588611747076
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
JHOC-5,3815108,3.342637520565801
SUP-HD1,6918638,-1.2091323464126156
Ri-1,151289,-0.1682876676947949
BT 147,9911830,2.6524389287493877
P3HR-1,1716436,3.580413329672806
CL-11,10302451,4.255690428034535
SKM-1,148198,-3.315233928127138
BT 504,148198,-4.360319644130701
NALM-6,654092,-1.5387957069435814
KP-4,9911830,2.4137773940538487
BT-549,selumetinib-BRD-A02303741 (4-1 mol-mol),5.411757040622344
Mono-Mac-6,151289,2.3800118330041906
PK-45H,9911463,4.054004002243204
DND-41,10385095,0.8865843835874836
SNU-761,44493528,3.842181398457216
G-402,44493528,4.750595450232596
BT 232,54618771,0.7442415190466014
KYSE-410,6450551,3.839411878776235
BT 228,2708,5.054368462520845
NCI-H1792,10385095,1.4616161754759327
U-CH1,2708,5.695463781004824
UM-UC-3,156414,2.172219545817744
Lu-65,135659046,2.9879940161565206
JMSU-1,10385095,0.0262593871982068
MeWo,10385095,0.7159237438593402
KYSE-450,44137675,3.8479858767038944
NCI-H2106,9903786,3.304741679115025
HT,4259181,-1.5614808878704516
BT 145,4259181,0.7441300921960503
H-STS,2729026,3.2634172065243656
KE-97,2708,2.9242344266523403
ECC12,24753719,4.634678850895111
JVM-3,9929138,5.001902882551054
LP-1,11485656,1.1058923195648849
KG-1-C,6918638,1.2884838473807014
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939
SNU-1076,100016,6.986031941643801
JHH-5,16013152,3.4982974541686747
SW1088,JQ-1-UNC0638 (2-1 mol-mol),4.014540552696005
BT 271,1716436,1.992340472058266
A3/Kawakami,9843750,4.466820425723187
Ri-1,135984461,2.0671055438536547
JHUEM-1,9929138,5.0527545997933085
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
IGROV-1,654092,-1.340387623873854
DV-90,44137675,1.9121955233836976
GMS-10,6918638,1.6892515574733475
DMS 273,44493528,4.2569430545307725
WM1799,54639665,4.532721587133595
NOMO-1,654092,-2.6158486127541343
HSC-2,753704,5.573860992106069
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923
NCI-H2170,11404337,0.5827033431431107
SW982,selumetinib-BRD-A02303741 (4-1 mol-mol),5.410789991409923
A-498,54618771,1.1394352833671273
NCI-H1105,24772860,-1.7578471268895912
BT 248,54618771,0.8718785044821341
SHP-77,24772860,-1.9277925415891628
JK-1,135984461,2.6256690501392717
SW620,151289,1.0335596732218923
MOTN-1,100016,6.2802968176710445
AsPC-1,6918638,0.7071735542476161
SK-MEL-5,24753719,4.331970921396319
BT 145,11167602,0.8188247230307861
OVK18,2729026,2.286365970906436
OVCAR-4,3815108,2.3665707085609067
Hs 729.T,6918638,2.1064288612965205
THP-1,6450551,3.0807257542982636
JURL-MK1,49766530,-0.182637071574771
THP-1,2708,2.7673960013267225
TALL-1 [Human adult T-ALL],9911463,3.188580812335009
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574
U-937,16013152,4.102273538157163
EN,2729026,3.2089189669232834
HPB-ALL,10385095,1.4399710108120187
Malme-3M,11485656,2.111075680137388
WM115,1716436,2.084402062067542
KMRC-20,4259181,0.4653117276954742
L-540,2708,1.914317051935521
DU145,10302451,3.708227843551259
A2780,148198,-4.120801514793353
5637,136227924,2.876940542257041
OUMS-23,4259181,0.3066462533812187
NH-6,10385095,0.738045984427429
Mel Ho,9868037,3.9124116875783654
23132/87,9903786,3.7145887754512414
EB1,49766530,-2.446229475307264
SNU-1041,9903786,3.9190312975923822
CAL-29,2708,5.397174021936936
SCC-9,9903786,2.6448761987997917
AN3-CA,4259181,-0.2663396960548074
OCI-M1,46926350,-4.328196649183949
NCI-H1755,156414,1.1123592928072572
TE-9,24772860,-1.8093581945519477
NCI-H441,148198,-1.1442516258972526
SCC-9,148198,-2.735497552895971
HCT 8,46926350,-1.563060962710222
NCI-H226,2708,3.732700087347359
KP-4,JQ-1-UNC0638 (2-1 mol-mol),4.144719102429264
Hs 746.T,135659046,3.4161599287064925
RT-112,9911463,3.6857409910721337
Rh30,6450551,2.3909694704118847
WSU-DLCL2,11485656,1.973652823958906
SW1710,3815108,3.2178733219189746
MOLP-2,2708,3.0116727174639593
SUIT-2,9911830,3.581224696062468
NCI-H23,73707371,4.579624275698916
P3HR-1,44137675,3.063811429234895
DOV13,44493528,4.286577642766648
HPAC,selumetinib-BRD-A02303741 (4-1 mol-mol),1.811082430330792
SK-MEL-24,24772860,-2.6355490777595927
SNU-1077,2708,5.365576184997209
RERF-LC-MS,151289,1.06337646711186
COR-L51,135659046,3.365467483108773
HEC-50B,44137675,4.593068224443476
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
NCI-H1703,2729026,2.991608985442274
KNS-42,6918638,2.1232444554437926
RPMI-8226,24753719,3.634689092662078
Panc 10.05,44137675,4.611225703938574
CGTH-W-1,2708,4.355375738196256
KNS-81,JQ-1-UNC0638 (2-1 mol-mol),2.86806328389835
BT 172,753704,4.1775737618431
COV644,JQ-1-UNC0638 (2-1 mol-mol),0.5328052372407789
HSC-4,156414,0.4374127066870092
A101D,136227924,2.7929516463081123
T-47D,10302451,3.768986766263313
HT-55,54639665,4.445414545651382
IMR-32,10302451,3.1192672729398407
SK-ES-1,374536,0.6379492950462292
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202
MOLM-13,654092,-2.113392174262404
BT 328,9903786,4.817171686681598
SNU-423,156414,1.5595439535021
786-O,54618305,4.390272666676528
Mono-Mac-1,156414,-0.6734994653601284
KYSE-450,9903786,5.350068255808832
FaDu,JQ-1-UNC0638 (2-1 mol-mol),2.46837466908542
WSU-DLCL2,44493528,4.16645945517617
HGC-27,1716436,1.9925217715249943
LN-18,374536,4.541321830034445
QGP-1,24753719,4.344903542576564
SW1271,10385095,1.244878723840673
MOR/CPR,10302451,3.971849586071082
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
SNG-M,49766530,1.2190782800499038
NCI-H841,54618771,1.7073628985349325
RERF-LC-MS,327653,4.17889189356682
BT-474,1716436,2.941904750150848
BT-20,2729026,3.106511260429172
NCI-H1299,24753719,4.197116792706203
KG-1-C,2729026,3.0216103587164076
CML-T1,4259181,-0.9247208790621684
PK-59,654092,-1.052424839232504
SNU-601,11404337,-0.2592209107038837
TYK-nu,135659046,3.766078033019111
OCI-M1,JQ-1-UNC0638 (2-1 mol-mol),0.2446293289587729
NCI-H2081,327653,2.703400517065932
BICR 56,156414,-1.5673977335728184
SNU-423,11404337,0.0022687984612849
AML-193,49766530,-0.6507980760292754
CAL-85-1,6918638,0.0860999805829631
Mono-Mac-1,24753719,5.146647018593083
NCI-H1944,9903786,2.6495499411680785
MOLP-8,1716436,2.7387406442001287
ST486,9911830,1.5676247278610147
Hs 766T,2708,7.822531048236224
NCI-H2452,11167602,2.565240148317103
NCO2,2708,3.570381614353573
HCC1937,3815108,3.372835110301023
KMRC-1,11404337,1.3121470144090095
RERF-LC-Ad2,100016,6.703705933143471
SK-N-BE(2),sirolimus-bortezomib (250-1 mol-mol),1.0543507239868668
KYSE-150,71729975,3.5482159106819284
CAL-85-1,10385095,0.8490063817191821
KMRC-3,10302451,2.024147098710192
GSU,selumetinib-BRD-A02303741 (4-1 mol-mol),1.782878314958815
OCI-AML-5,JQ-1-UNC0638 (2-1 mol-mol),-0.3080122277817761
Lu-65,24772860,-2.8621529229367417
HuP-T4,151289,1.2442769074771742
LS1034,148198,-4.061801759513543
NMC-G1,9911463,4.44969477965095
HEC-6,24772860,-2.1147636731176425
MHH-CALL-4,9911830,3.172534584054814
NCI-H2228,374536,-0.3055726924014714
JeKo-1,136227924,2.4041415853814687
AU565,156414,-1.7188953203880928
SK-N-SH,46926350,-4.468052842347633
SU-DHL-10,24772860,-4.527987238157927
SK-MEL-5,148198,-1.053859411744173
PE/CA-PJ41 (clone D2),148198,-3.3597343554635652
COV362,9911830,2.6382082801445934
SNU-869,135659046,3.721754177816309
JHUEM-2,49766530,-1.5038121113070972
Panc 03.27,11404337,-0.4411804077325879
THP-1,148198,-1.1701008098943837
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416
Hs 683,1716436,3.2273737363260286
SNU-213,9903786,2.2891232968098887
YD-10B,sirolimus-bortezomib (250-1 mol-mol),0.8194985120964778
EKVX,24753719,4.757500855044641
HH [Human lymphoma],1716436,2.7878800566699664
MDA-MB-435S,753704,4.9572773555472125
BT 422,54618305,4.804608461276929
BICR 18,10385095,1.2849545463227945
JeKo-1,9911830,1.55296695781185
MOLP-2,24753719,4.994343973462867
A-375,10385095,1.3116334013128008
CAMA-1,sirolimus-bortezomib (250-1 mol-mol),0.4180423517556048
FTC-133,2729026,3.353273516564875
WM115,44137675,0.4260207876885596
SK-CO-1,151289,0.7492352886663923
YH-13,24753719,4.493928762122736
SNU-1196,1716436,3.1713740391856837
CAL-33,24772860,-2.540191062603137
YD-38,100016,6.21667674155364
KATO III,tanespimycin-bortezomib (250-1 mol-mol),0.4150623185921985
KE-97,24772860,-3.282122401862631
23132/87,44137675,2.2914926249519394
SU-DHL-8,1716436,2.416129141802664
Hs 683,selumetinib-BRD-A02303741 (4-1 mol-mol),4.926542916228776
DLD-1,10302451,3.8037310408669502
JM-1,753704,3.307600856766594
OCI-Ly10,JQ-1-UNC0638 (2-1 mol-mol),-0.9699344940979768
NCI-H2291,2729026,2.29263677591743
SUP-B15,49766530,-0.1643365136132614
NCI-H1299,374536,3.9842434621370497
QGP-1,2729026,3.107984215941164
CAL-33,2729026,2.606583016762846
TCC-Pan2,1716436,2.254161215153679
Pfeiffer,151289,-0.0122499964592767
KMRC-1,374536,2.325099751463231
MOLP-8,6918638,-1.572747132532541
HT,124202324,1.547104680729267
NCI-H292,10302451,3.577296661602114
ACC-MESO-1,54618305,4.946353791859653
HPAF-II,54618305,4.6332328382766255
KMS-34,11404337,-2.4295348311340375
KYSE-30,24753719,4.589617632068179
SK-MEL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.1247246947880956
HMCB,9903786,3.962700823971229
L-540,156414,1.45352527783077
PE/CA-PJ49,9903786,3.1609136015972847
Hs 688(A).T,11404337,0.289109562279099
Li-7,JQ-1-UNC0638 (2-1 mol-mol),0.570705451225086
639V,9903786,3.738179934930431
RERF-LC-A1,10385095,0.5926472650541055
OV-90,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1658227100528741
TE 441.T,73707371,7.119622486558907
VM-CUB-1,54618771,0.9006396829235269
Hs 944.T,100016,5.802201252997301
LOU-NH91,11485656,3.2972382499502935
COLO 680N,11404337,-0.1735930732643658
Calu-3,100016,7.471917827082483
JHUEM-7,24753719,4.234902187840303
NCI-H1975,2729026,3.230090140889425
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
Panc 03.27,148198,-3.6739287682620967
BT-20,374536,-1.1960194426953608
LS180,11485656,2.0322073649322716
PE/CA-PJ34 (clone C12),49766530,5.059286998332617
HEC-108,654092,0.6558774071347439
SNU-1272,1716436,3.918709850381952
TE-9,9911463,3.937916951140395
OCI-AML-5,9868037,3.637294932872617
NCI-N87,2708,3.9537199090854673
REC-1,9868037,0.961521370423606
BT 145,11485656,1.8093295586372804
MEC-1,136227924,1.9415739350117864
SNU-46,136227924,3.2751090842747637
BICR 16,JQ-1-UNC0638 (2-1 mol-mol),1.394316277253976
DU4475,tanespimycin-bortezomib (250-1 mol-mol),-2.7587555584503853
SU-DHL-1,11485656,1.6397040363022437
F-36P,151289,0.0975773513046307
MOLT-13,44137675,3.9662665856125727
Ishikawa (Heraklio) 02 ER-,374536,4.692637268182497
GA-10,73707371,4.727167870834429
AsPC-1,24772860,0.3605797719579043
MFE-319,4259181,1.4040440632214766
NCI-H524,10385095,0.2578965254075426
L-540,1716436,2.735928792970983
BT 147,6918638,2.7935207721855764
BT 172,tanespimycin-bortezomib (250-1 mol-mol),-3.8739618006203655
CL-11,sirolimus-bortezomib (250-1 mol-mol),0.3846215058454166
BT 359,100016,6.547217450499836
JIMT-1,9911463,4.046723460616858
22Rv1,24772860,-2.4049010133383466
CAL-54,10302451,-0.9489487854638172
RPMI-8226,1716436,1.1843863311212022
HCC1438,1716436,3.635382973970673
COR-L105,10302451,1.2881684147693646
KYSE-180,136227924,3.113518519432139
NCI-H322,10385095,1.0506033340780307
MG-63,11404337,1.2234517903826516
HCT 8,54618771,0.896470905316868
CAL-54,11404337,-0.6827741736439762
CJM [Human melanoma],24753719,4.233213241561211
Hs 294T,6918638,1.5500466074402643
SNU-620,124202324,1.9829980782232024
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
SK-MEL-30,10385095,2.651721039374687
Capan-1,44137675,4.743022816778694
BV-173,2708,2.033430168210048
RCC10RGB,4259181,1.719089746142662
BICR 6,327653,3.165378082168026
SNU-1076,148198,-1.9796071848582624
HCC1588,11404337,-1.2064927748047265
GSS,9911463,2.6255650357234797
SNU-423,6918638,0.4106402962761268
NCI-H28,9911830,2.204330269310846
RERF-LC-Ad1,9911830,3.638980358065119
HSC-2,44137675,1.1078591616814062
SNU-626,1716436,3.5555443266706868
NCI-H1693,327653,3.096149325349242
COR-L51,6918638,-0.9148184553572968
NU-DHL-1,6450551,1.9014057000217284
THP-1,54618305,4.264664624638681
KP-N-SI9s,327653,3.066152107627383
T3M-10,6918638,0.3791169249150829
Ki-JK,54618771,0.0695093081370742
BICR 18,136227924,3.2249717702756486
TE-9,4259181,-2.1230941225382325
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
KP-2,4259181,1.1635750066542332
HEC-6,tanespimycin-bortezomib (250-1 mol-mol),0.7644617965871396
SNU-475,1716436,2.9802772923147915
NCI-H2452,10302451,4.286596307748033
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
GaMG,sirolimus-bortezomib (250-1 mol-mol),1.2428919572047608
NCI-H1944,151289,1.305761059241279
ME-1 [Human leukemia],10385095,2.9677233185394094
NCI-H1299,11404337,0.8410914432786373
EPLC-272H,374536,4.1913470226989435
MIA PaCa-2,46926350,-5.336909626139248
LP-1,753704,4.125531625528972
MSTO-211H,10385095,1.0224754227931234
SK-N-FI,54618771,1.4169008036751305
DB,44493528,3.818238435779709
OPM-2,9903786,2.6412283094975657
J82,2729026,3.1665706529556124
IMR-32,46926350,-5.503879322272109
TALL-1 [Human adult T-ALL],54618771,-0.8815186258752705
KYSE-150,46926350,-3.485124006958098
VMRC-RCW,10302451,2.6470473544508675
A-204,10302451,2.421522636520457
Hs 729.T,44137675,5.118241548337857
Hs 746.T,100016,6.2249168538435
EHEB,9911830,3.0366000052999893
TE-1,10385095,1.326067613707214
SUP-T1,11404337,-1.5860390885647615
BT 172,10302451,4.033913731030382
EoL-1,49766530,-3.8413897802106014
42-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),-2.385025804605588
KMS-34,148198,-3.0196318169893224
PL-21,3815108,3.3544867308557973
GCT,151289,0.967701265618246
Ki-JK,136227924,2.2053195341815424
SNU-620,54618305,4.1885361455168155
U-937,654092,0.4006788517059984
YD-10B,9929138,5.087034787927538
IGROV-1,9911463,4.195269991960018
KMS-26,54618771,-0.1721472849955331
SK-MEL-24,44493528,4.28603676822274
SNU-213,654092,0.3556134430950528
EFM-192A,327653,3.185830081020507
HEL 92.1.7,54618771,1.044267286847691
HCC2279,49766530,-1.2949504069495965
Detroit 562,54618771,-0.8917291521267056
NCI-H1395,2729026,3.1697601093173136
MCAS,16013152,4.123178903224857
BT 239,374536,2.369267766826018
A2780,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4355880611725125
CFPAC-1,9911463,4.23074803596426
ALL-SIL,136227924,2.439460537978413
A-172,4259181,0.7217216416710104
OV7,135984461,1.9074868372682827
U266B1,9911463,4.2942847065196394
HuH-28,54618771,1.3880976899184387
MDA-MB-361,4259181,1.4337162255627849
Lu-99,654092,0.2219131850633032
JeKo-1,6450551,1.453437977029318
ZR-75-30,24753719,4.255400986755656
JHH-5,73707371,4.797871848443707
Calu-6,9911830,2.8671270572829153
Li-7,44137675,3.109817424293199
OCI-AML-3,4259181,-0.2993738011260952
BT 187,sirolimus-bortezomib (250-1 mol-mol),0.4911829416060825
SK-BR-3,327653,3.1347096083864816
VCaP,1716436,2.7852941713599058
Hs 578Bst,4259181,1.388540800141387
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
NU-DHL-1,54618771,-0.7819429035186433
U-BLC1,11167602,2.1562651935387636
BT 340,753704,4.8303370479760614
SNU-119,9868037,3.103417825493656
SU-DHL-10,100016,5.73425222116556
SK-MM-2,tanespimycin-bortezomib (250-1 mol-mol),1.2255908255092252
MFE-319,11167602,3.3061519307992944
SNU-1,136227924,2.7041604085298205
LMSU,6918638,1.4149573073550044
NCI-H2291,136227924,3.7471032532575457
CCF-STTG1,374536,3.462447844633159
SNG-M,135984461,3.667931124820979
A-204,327653,2.705970152182007
BT 228,54618771,0.9979024036150752
SNU-626,9911463,4.505405872194439
BT 498,6918638,3.833356013639187
Hep-G2,148198,-2.3541136469085493
NCI-H522,24772860,-1.6489481573528793
BT 147,54618305,4.434824757436184
ONS-76,124202324,3.376244033970937
SNU-503,11167602,5.027457454632991
JURL-MK1,44493528,4.152814926042147
NCI-H526,2708,3.1193436366595733
BT-20,16013152,4.180428329825768
TUHR14TKB,4259181,1.635938781538023
SNU-1033,54618771,0.4334411730243536
KMS-18,10385095,1.016735810068119
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
Detroit 562,4259181,0.0640792531234673
OPM-2,6450551,0.7106995413225735
SNG-M,44493528,4.902033087695682
PK-59,9929138,7.561658238332544
NCI-H2052,selumetinib-BRD-A02303741 (4-1 mol-mol),0.5669563302801333
NCI-H2196,135984461,4.343785074544861
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
NCI-H460,10385095,2.2920897819597896
BHY,148198,-2.089764447227438
NUGC-3,124202324,2.1262185340944844
BT 112,327653,2.6431646979441012
SW1417,148198,-3.336621640572291
EJM,JQ-1-UNC0638 (2-1 mol-mol),-0.7989999630217455
NCI-H69,11404337,-0.840898512834909
HCC1500,16013152,3.952751911590144
NCI-H716,11485656,1.4384613287076216
MFE-296,136227924,3.1639946768284672
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
B-CPAP,54618771,-0.888157328254987
VMRC-LCD,11404337,0.4104249926978496
T3M-10,135984461,4.376961457869337
CHP-212,6918638,-1.8920767869906776
SNU-1105,sirolimus-bortezomib (250-1 mol-mol),1.4785919320575531
PF-382,148198,-4.947878541405711
ChaGo-K-1,4259181,-4.05678240495267
CL-11,11485656,2.5570502281521263
RS4;11,4259181,-0.6298577009855054
NB4,sirolimus-bortezomib (250-1 mol-mol),0.8498736120929098
SNG-M,11485656,2.558394091061047
HCT 15,11404337,-1.6671544641516778
NCI-H2081,2708,2.8987838262857264
SNU-5,tanespimycin-bortezomib (250-1 mol-mol),-4.499312047026259
HCC1428,11404337,-0.7676967113695158
SNU-C1,9911463,2.5734182022274763
UO-31,9868037,3.0642898749383627
NCI-H69,sirolimus-bortezomib (250-1 mol-mol),0.0331466406346395
YD-15,6450551,1.6800422349774025
EFE-184,11485656,3.681714040860518
HCC202,44137675,2.9739530203269373
Calu-1,44137675,6.04640754301181
MHH-CALL-4,753704,3.500329018890042
RL,11404337,-1.4009299024824362
TE-11,11404337,-0.8497822409936865
NCI-H1573,9911463,3.324628771870272
8505C,JQ-1-UNC0638 (2-1 mol-mol),2.5685342897633356
HCC95,11404337,-1.0962465907307095
PE/CA-PJ34 (clone C12),753704,4.689094474093603
SNU-886,3815108,2.9264370464975817
NCI-H2170,16013152,4.3639517520428
NCI-H211,9929138,5.380776985298909
MIA PaCa-2,9903786,3.251255785633491
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
AM-38,11404337,-0.5610335090567212
TE-4,44137675,3.0521806703865617
BT 340,24772860,-1.6354091842343903
WT2-iPS,73707371,5.081190869373536
HCC78,2729026,3.12043826138373
NCI-H2228,1716436,2.2198888898812275
Becker,327653,3.7069027046220024
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544
NCI-H2141,49766530,-3.0033448616594174
KYSE-450,49766530,0.7642756518369849
Calu-3,148198,-3.0650277227090643
SNU-308,124202324,2.379759434386111
JVM-3,100016,3.63486720200834
DMS 273,54618771,0.8675837195237585
769-P,124202324,2.608763341581254
SJSA-1,54618771,0.8793199356074002
PE/CA-PJ34 (clone C12),10385095,0.6586777190246488
FTC-133,11167602,2.051836472120041
EB1,11485656,1.3368120139710602
NCI-H1869,9903786,3.8309501172404734
SK-MEL-24,9903786,3.6296294578661494
OS-RC-2,11404337,1.5898749393998126
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837
Hs 294T,136227924,2.369017342053728
EJM,100016,6.634092198961092
H-STS,44493528,4.270078015163244
SNU-719,9911463,3.4585682156791555
Capan-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.4062427567503657
A3/Kawakami,49766530,-0.4479480669957117
SUIT-2,10302451,3.8519201138639
SH-4,24772860,-0.9771319642071076
HEC-6,selumetinib-BRD-A02303741 (4-1 mol-mol),5.353505109771409
SNU-C4,6450551,3.7080174387510265
Panc 02.03,2708,5.654354843286421
IGROV-1,9903786,1.7387584479757865
SNU-503,selumetinib-BRD-A02303741 (4-1 mol-mol),2.94362667014591
5637,54618771,0.8259357118151949
OVSAHO,753704,4.824118930214815
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
DU4475,136227924,1.4993153773488237
KNS-60,9911830,2.602703450863029
MOTN-1,327653,2.846795073413381
HCC366,100016,6.086233690393214
MOLM-6,135984461,3.5601883048539635
HMCB,4259181,-1.3658440890199388
Detroit 562,11485656,1.622258504820096
HPAC,10302451,3.6769046300144543
SNU-478,44137675,1.3099151712823185
Caov-3,2708,3.728843742516865
HOS,1716436,3.5899763236450593
HuNS1,10385095,0.4099305568454984
SYO-1,100016,3.831378840669671
RPMI-8402,2708,2.863796641655521
BT 147,156414,1.567734128398706
L-363,151289,1.465625827353854
SNU-387,4259181,1.2933701792403325
MDA-MB-435S,327653,3.1762289377434665
KLE,10385095,2.1345695418673354
HT-55,tanespimycin-bortezomib (250-1 mol-mol),-1.2155769519281892
NCI-H69,9911830,2.8600960756398868
BT 131,11485656,2.37569711489929
UO-31,24772860,-0.4583319547568072
MOLT-16,11485656,1.9305016234574737
GCT,156414,1.5367233529561777
Hs 895.T,24772860,-1.6271729412239022
SNU-489,124202324,3.080010881435731
SCC-25,9903786,1.6185741180598072
P12-Ichikawa,44137675,3.0994370686994968
HPAC,1716436,2.4885599057590797
SBC-5,9911830,3.21689826570876
KYSE-410,11485656,2.2435649092934775
BFTC-909,136227924,2.3418993883842134
TT2609-C02,tanespimycin-bortezomib (250-1 mol-mol),-2.374986906427309
CADO-ES1,11167602,2.670854143653412
DMS 454,1716436,1.093890450302096
Hep-G2,124202324,1.2953785205676314
COR-L95,151289,3.0372683791028705
RL,135659046,3.5403288851191927
EBC-1,sirolimus-bortezomib (250-1 mol-mol),-3.1620626490759633
NCI-H2126,54618305,4.7899642645933636
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
CAL-51,2708,4.939881356462198
KMS-20,100016,6.235059528000449
P3HR-1,1716436,3.580413329672806
A-172,11404337,0.9074451848226016
HEC-108,10302451,3.916028655528669
SNU-1196,2729026,3.091209664052268
TE-9,374536,3.320331000283951
NCI-N87,9903786,2.403456427338335
TT,24753719,4.601878873576192
G-402,148198,-5.197807449941822
OCI-AML-3,151289,0.4572055287124533
DOV13,2708,5.968049472639417
HCC1395,11485656,2.290865171040868
NCI-H661,9911830,2.711917815790479
BT 359,1716436,3.1925856613838755
8-MG-BA,9903786,3.978061546376923
JHUEM-2,24772860,-2.5238722810003487
DMS 273,24753719,4.257561408038297
SW48,100016,6.031440310304127
HT-1197,9911830,3.1425347559811967
MDA-MB-231,44137675,4.992024983933654
MEC-1,24753719,1.7642423252934831
L-363,327653,3.0030098417967883
MOLP-2,9911463,4.414943905167103
HEC-59,654092,-0.3182456575828493
KYO-1,sirolimus-bortezomib (250-1 mol-mol),0.6931512347685437
OVISE,10302451,2.747913318530857
SK-N-FI,24772860,-3.337038844243738
EN,753704,4.795580607733231
Kasumi-2,2729026,2.278256361901275
BT 179,374536,3.663045168943452
KMS-34,654092,-1.6087303936223454
COV434,100016,6.159872289007743
HCC366,44493528,4.3832061934270445
ZR-75-1,24753719,3.331653955858336
A-549,4259181,-1.4635956785215285
SNU-1033,2708,5.22281661109988
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
CJM [Human melanoma],11485656,2.6899904123540037
G-292 clone A141B1,24772860,-2.2890732574877974
EM-2,124202324,0.3964760545868884
KMS-18,3815108,1.8641991057440523
SW1271,16013152,5.485365595141675
HDLM-2,327653,3.054457178723177
PE/CA-PJ34 (clone C12),151289,0.5971679831137401
OCI-AML-3,135659046,3.507210713812752
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
CAL-51,49766530,0.4609697007955676
SF539,2729026,2.548731779898503
A-549,753704,5.476427774826246
OCI-AML-5,10385095,0.6242077157368962
NCI-H810,11167602,1.4687825393723717
SK-LMS-1,327653,3.1438411129584933
JMSU-1,100016,3.921608363156487
NCI-H2126,4259181,0.5525556659927066
Panc 04.03,1716436,3.048029385411991
Hs 766T,4259181,0.4904873414900543
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
M-07e,selumetinib-BRD-A02303741 (4-1 mol-mol),2.9315477953458657
HT-29,10302451,3.535161937635636
RS4;11,10385095,0.7199215311682879
HuP-T4,9903786,1.2000554865922293
NCI-H1869,100016,6.8338343579730285
RD,24753719,4.598359093575622
Hs 944.T,136227924,3.55320847384718
Kuramochi,2729026,2.9205428146962067
SU-DHL-8,3815108,1.7159996794705086
KMH-2,24772860,-2.338344331022242
SK-N-DZ,9843750,4.495009979213685
KMS-20,24772860,-2.355954669463017
SK-N-BE(2),135659046,3.712639827240539
THP-1,753704,4.7716435276456
HPAC,2729026,1.6597744308968356
Mel JuSo,11485656,2.451512427332153
NCI-H1299,2708,5.932138587127141
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
KMH-2,44137675,5.057620935637761
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245
OCI-AML-3,136227924,1.3599145322416812
B-CPAP,148198,-2.876725444252461
Hs 729.T,10385095,0.8500631053471632
JHUEM-1,49766530,0.8981374764595749
HCC1833,4259181,-0.2637882544292723
JHH-2,49766530,-3.049401978968413
JK-1,124202324,0.0523875935509967
SEM,4259181,-0.7975863762048068
Daudi,1716436,1.8661291896859675
YD-38,selumetinib-BRD-A02303741 (4-1 mol-mol),1.726529060394152
SNU-387,6918638,0.7332887261776959
SNU-213,selumetinib-BRD-A02303741 (4-1 mol-mol),0.82373667635177
RERF-LC-Ad2,136227924,3.207411157267862
Mono-Mac-6,9868037,1.4226493594623044
JJN-3,2729026,2.9584941058801246
SW1417,1716436,3.250516025288929
PL-21,654092,0.0187981704535481
LS513,54618771,0.3815245482334266
LUDLU-1,9911830,2.1966438359182767
JHH-5,11485656,1.7028166663809423
KALS-1,24753719,4.821139206280144
HL-60,sirolimus-bortezomib (250-1 mol-mol),-0.1037456225306153
OCI-AML-2,9868037,1.5356230496639076
SCaBER,136227924,3.000538162090115
WM266-4,sirolimus-bortezomib (250-1 mol-mol),0.2916280413347675
NH-6,49766530,-1.655296315308959
Hs 294T,11485656,2.7928532706785143
BT 333,2729026,1.360114427815681
SNU-475,selumetinib-BRD-A02303741 (4-1 mol-mol),6.852928294011391
SNU-182,4259181,-0.711046785415259
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122
NCI-H292,136227924,3.1886204590132654
SNU-61,24753719,3.71513491278392
NCI-H1563,71729975,3.728929615722834
TE-14,100016,6.976624848230786
MeWo,2729026,1.856309483824865
SK-N-SH,151289,0.5034884939141393
Ri-1,4259181,-1.255290292535843
YKG-1,54618305,4.389332697073838
Granta-519,135659046,3.900512348834848
NCI-H650,654092,-1.3319052782215612
HPAC,327653,3.5480126625924804
BHY,10385095,2.088020241498876
SNU-886,24772860,-3.3986263976004913
SNU-869,148198,-3.291202366312453
HOP-62,4259181,1.6890698920595109
HCT 15,1716436,3.1085651618320345
Ku812,54618305,3.744773275517672
PE/CA-PJ15,2729026,3.0133380592288073
HuCC-T1,4259181,0.6983061177841803
OUMS-23,JQ-1-UNC0638 (2-1 mol-mol),2.230056297972509
SNU-685,24772860,0.3606334835863674
KYSE-30,11167602,2.2363334961957784
SNU-449,49766530,-0.9876450445747244
TCC-Pan2,2708,5.89661991117769
SU-DHL-8,24772860,-4.493511043930486
Mel Ho,654092,0.2132222153273508
HCC827,9911463,4.568230901721179
SNU-C5,9911463,3.786526891589904
Hs 578T,2729026,2.9288913287231617
NCI-H526,9911830,3.0143515863679955
Becker,148198,-3.822753548425191
ECC10,100016,5.627610035010204
SNU-738,1716436,3.403818540405202
NCI-H1155,2708,2.2751426584532712
NMC-G1,4259181,1.051938223963876
LN-18,136227924,2.6730717807576347
SW1990,4259181,-0.3516567866303933
HCT 8,2729026,3.1754643331206975
WM266-4,11167602,1.5442126726614676
BT 416,9903786,2.244954394725016
8305C,10302451,3.0116833270498677
SNU-216,11485656,2.7250861397389463
Panc 02.03,2729026,3.1511226959620715
Ku812,11404337,-0.6784609129861706
Yamato-SS,JQ-1-UNC0638 (2-1 mol-mol),1.002582258013646
T98G,148198,-3.089381534593653
COLO 792,24753719,4.174759207225883
Granta-519,24772860,-2.616849709254195
BT-474,10302451,1.6230602382563992
BT 498,1716436,3.5174688270474923
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
Lu-99,151289,0.5111279121816025
NCI-H2286,1716436,0.8285157069462787
RPMI-6666,10385095,0.628840005049414
5637,11404337,-1.271939426582808
NCI-H2452,124202324,3.032884210730814
HOP-92,136227924,3.2563886907656725
Panc 04.03,148198,-3.912302089259141
KMS-11,54618771,1.142705350534528
SNU-387,1716436,3.603611310223183
SU-DHL-1,3815108,2.229733806447586
H-STS,753704,4.594437808877669
NCI-H2023,54618305,4.354066699280693
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941
KP-N-SI9s,44137675,3.373466779729461
RPMI-8226,6450551,2.0030581809592145
BICR 16,54618771,0.7733031407883998
SK-MM-2,sirolimus-bortezomib (250-1 mol-mol),1.09289711908984
P12-Ichikawa,6450551,0.3915523338001739
BT 172,11167602,1.9084752133750955
RT-112,151289,0.7912998684701085
U266B1,2708,4.9215786341136925
Jurkat,4259181,-1.4685498518927522
NCI-H1341,10385095,0.443628618091825
YD-8,136227924,3.733712180219105
HOS,9911463,3.9584214760624
HCC1438,54618771,1.468368103137055
RL95-2,JQ-1-UNC0638 (2-1 mol-mol),1.926774366428175
HT,11167602,5.369824507711039
SNU-387,selumetinib-BRD-A02303741 (4-1 mol-mol),3.3881493888904664
JHUEM-1,156414,1.11415290016218
Lu-99,9911830,2.0700119767872285
RPMI-7951,156414,1.6471654307541064
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
Rh41,374536,2.3988552309389304
RD,sirolimus-bortezomib (250-1 mol-mol),0.3715826338530998
MeWo,327653,2.8778071428357612
BICR 6,sirolimus-bortezomib (250-1 mol-mol),1.9744607450620832
A-549,10302451,3.5203591354698016
HEC-251,49766530,-1.4787018176624072
UO-31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.8017816303068437
NCI-H1568,6918638,-0.3782949656582497
T24,49766530,-0.3473877754234792
MCF-7,54618771,-0.7262011969078179
GP2d,44137675,2.0472874992496273
L3.3,10385095,1.3503663642800654
BT 164,selumetinib-BRD-A02303741 (4-1 mol-mol),3.20072619274904
SNU-8,4259181,-0.24228140638784
Calu-6,148198,-2.2255623368633746
WM793,49766530,-0.085641441031448
CCK-81,44137675,3.07130776678673
TE-15,6450551,2.7867234571621804
SNU-407,374536,4.583862520088917
SK-N-SH,11485656,1.632835295559006
KYO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.6126043022381977
NCI-H1395,9911830,2.6279117929683142
BT 231,46926350,-3.728380335496617
BT 179,148198,-4.821830179812891
HCC1395,24753719,4.820074852548623
JIMT-1,11404337,1.30553025443882
KNS-81,10302451,3.4109366208206904
SNU-761,54618771,-1.251470969575028
TE-6,4259181,-1.870862501193427
BT 112,10302451,3.727610987508193
SK-N-DZ,16013152,5.095833237468897
HeLa,46926350,-4.360313819517292
EBC-1,753704,4.820116465801008
SW1271,11167602,2.369450835450289
HCT 15,16013152,3.9831380106348417
DMS 53,49766530,-0.8601617685974926
COLO 668,10302451,4.094573947065704
U-937,24772860,-3.641012570456186
HMCB,11404337,-1.2429546984634874
NB1,374536,2.328474585300686
SR,156414,1.2315139202463783
KMS-34,24753719,2.278848453246231
MDA-MB-435S,54618771,0.9964394209064932
HDQ-P1,10385095,2.7310210144681544
SNU-601,9903786,4.302030389769322
SUP-T11,654092,-1.6677568110323533
EFE-184,tanespimycin-bortezomib (250-1 mol-mol),1.3257452416243327
Hs 839.T,11485656,3.884634476915026
TT2609-C02,2729026,3.1562922481063285
ZR-75-30,9911830,2.006954783053178
Hs 578Bst,151289,4.340204338665288
253J,sirolimus-bortezomib (250-1 mol-mol),1.7518558579799193
IGROV-1,124202324,2.2563058955522157
MPP 89,54618771,3.5839559613282916
SNU-1079,2729026,1.1459648996656209
A2780,1716436,1.933630716197044
Li-7,24772860,-2.246359969447727
BFTC-909,54618771,2.8225313881877545
KALS-1,135659046,3.8631943181286
TE-10,136227924,2.8479301717793435
Mel JuSo,10302451,3.755800024002333
LXF 289,10302451,1.735451917587997
MOLT-13,327653,2.351844946347274
NOMO-1,24772860,-3.4546209155075687
LS123,11404337,0.6660636167955499
EJM,24772860,-3.292775584200783
M059K,9911830,3.9545777880747974
ONCO-DG-1,4259181,-0.0855284825830974
NCI-H1666,3815108,2.768364272268705
SUIT-2,11404337,0.4217329969696077
SUP-M2,tanespimycin-bortezomib (250-1 mol-mol),-1.1687996119846569
KYSE-510,136227924,3.267869272747249
UACC-812,148198,-2.7739066615342236
T84,9903786,2.2055003104833553
ChaGo-K-1,10302451,4.275291921166029
ECC10,selumetinib-BRD-A02303741 (4-1 mol-mol),3.380284003905944
NCI-H446,24772860,-4.412479954255731
NCI-H1092,6918638,-0.0011423595466388
JeKo-1,24772860,-2.615674298718556
NCI-H1944,6450551,3.1937510159131883
KYO-1,9868037,1.678802312904593
FaDu,selumetinib-BRD-A02303741 (4-1 mol-mol),7.433604734939834
SEM,49766530,0.1216347460182048
HuH-1,sirolimus-bortezomib (250-1 mol-mol),2.2926354506042497
NCI-H2170,135659046,3.716321979563838
Mono-Mac-6,tanespimycin-bortezomib (250-1 mol-mol),4.2631567174447556
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
HEL,49766530,-2.395534265113236
WM793,2729026,2.380057317950378
KMS-20,151289,1.001427412715124
BT 422,9868037,4.234688123695473
HCC1143,11485656,1.8564802256291268
SIG-M5,327653,3.3709040199841445
KYSE-30,24772860,-2.3560533584421104
SNU-738,6450551,2.530835098881582
Aska-SS,374536,3.2564720470478887
NCO2,49766530,-4.92824321728858
BHY,11404337,-1.9155741795554864
Rh18,44137675,3.144370096125486
SNU-407,2729026,2.3214989300149735
Panc 02.03,10302451,3.706546166543765
RS4;11,148198,-5.281642952931228
A-375,124202324,2.6101978787823223
BT 245,2729026,1.7990947371771515
EFO-21,10385095,2.378784787122908
LCLC-103H,124202324,2.6387819161311548
JHUEM-2,136227924,1.8669676160402808
HDQ-P1,sirolimus-bortezomib (250-1 mol-mol),1.8478988823662197
Capan-1,135659046,4.622208259682843
SNU-245,327653,2.306144869873458
RS4;11,1716436,2.4697587177073097
Raji,327653,2.879098254460797
CW-2,2708,4.8158946244021
SK-N-DZ,136227924,0.9645463461515836
NCI-H1339,2708,5.014409852934372
NCI-H522,JQ-1-UNC0638 (2-1 mol-mol),-1.3225503189993402
NCI-H1299,9911463,4.155040762407167
CAL-62,4259181,-0.4453978178523717
SW48,11404337,-1.6842588085779022
SF295,2708,4.6592874760103795
SNU-886,11167602,1.491891520160987
EN,10385095,0.9687928929720704
RT-112,753704,4.930561061500425
HEC-251,124202324,3.187641539977696
KYO-1,156414,0.9411257556473772
PL-21,100016,4.334695208074886
DV-90,4259181,-1.0070098224756132
LAMA-84,11404337,0.2635139900443839
OE33,44493528,4.497258048563181
BICR 31,11404337,-0.6318210319309021
HCC44,124202324,1.420427843676108
YD-38,4259181,0.0281637492495702
SNU-16,9911830,-1.4367424571286636
KMS-20,46926350,-4.252708447125384
Ri-1,2729026,1.3989648629345883
KMBC-2,2708,4.865695204708852
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
BT 179,136227924,3.760107948072088
NCI-H929,10302451,2.7551907478934465
SNU-175,10302451,-1.3432217773837662
GSU,24772860,-3.0435807516953255
ALL-SIL,11485656,1.390704841990788
JHH-5,selumetinib-BRD-A02303741 (4-1 mol-mol),2.252006515264721
Daoy,9911830,3.4961153277182184
CAL-27,11404337,-0.0180137116406381
KP-4,1716436,3.507941691131362
ChaGo-K-1,6450551,3.266612737246024
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
SK-LU-1,9903786,1.4733207164642357
SNU-449,11485656,3.58452534173841
SNU-C1,327653,3.4971944416112795
Becker,44493528,4.387044567791122
ChaGo-K-1,11485656,1.7653957410813437
Hs 852.T,9903786,1.6008538749226255
JK-1,2708,1.5877320987122825
TE-11,2708,5.046590383665754
Li-7,10302451,2.1466540090014994
NH-6,24753719,3.897266044321257
LNCaP clone FGC,24772860,-1.3292601865972158
SH-10-TC,10302451,4.984172634394984
ALL-SIL,9911830,-2.857836139869332
HCC1937,1716436,4.077133089479445
TYK-nu,6450551,3.282936086468093
BICR 18,6450551,2.127125375303599
TUHR4TKB,49766530,-1.753828688422756
Rh41,11404337,-1.1237512240479817
SU-DHL-4,9903786,1.90197998733756
HuCC-T1,9929138,1.9586255988809151
BT 359,10302451,4.23092370201577
BHY,2708,5.370982385259242
WSU-DLCL2,54618771,1.0658572900197
Karpas-422,327653,2.503082809882216
SF268,71729975,2.1709507856328543
CMK,1716436,3.604770849824905
A-375,2708,5.21419095899306
LMSU,1716436,3.7603795285051818
BT 504,135659046,3.5842907457354376
JVM-2,151289,0.6441622306631438
ZR-75-30,6918638,0.8461701725499111
SF268,6918638,0.7896548541911668
COR-L105,9911830,1.908645944756667
BT 359,selumetinib-BRD-A02303741 (4-1 mol-mol),5.7605430179794865
NCI-H727,54618771,2.7901712320729333
DMS 454,sirolimus-bortezomib (250-1 mol-mol),0.5194696170938634
OCI-Ly3,44493528,3.993360395088613
SNU-761,49766530,-1.6667197408090684
LoVo,9911830,1.9062113768292104
NCI-H1651,sirolimus-bortezomib (250-1 mol-mol),1.0347909654714795
253J,9903786,1.7805297403151377
42-MG-BA,11404337,0.5565192143599668
SK-LU-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.1752036402953365
NALM-6,tanespimycin-bortezomib (250-1 mol-mol),0.0910863571713514
NCI-H2405,sirolimus-bortezomib (250-1 mol-mol),-0.6741915043369825
SUP-B15,selumetinib-BRD-A02303741 (4-1 mol-mol),2.1566465764603686
IGROV-1,124202324,2.2563058955522157
8505C,49766530,-3.896310533039643
F-36P,156414,1.5553832514314012
RKO,1716436,3.795795915163565
MKN7,9911463,4.336260113916537
LS1034,44137675,3.921842638984984
SK-N-SH,374536,1.3416374449140271
ES-2,2729026,3.009799911387396
A2780,654092,-1.3080416104753447
BL-70,11167602,1.611057170206316
RPMI-7951,136227924,2.219680452566263
IGR-37,9903786,4.593363058361211
BT 286,2708,2.460649932488337
THP-1,374536,1.5833400971750082
JHH-1,24753719,3.7906138687565343
SNU-216,2729026,3.021777506017218
MSTO-211H,136227924,2.717505566177341
BT 359,46926350,-3.456381249156783
647V,49766530,0.7545140228303677
LN-229,10302451,3.828508416143536
IGR-39,2729026,3.015295893858543
BT 216,135984461,5.695741813463895
Ki-JK,9911830,1.963510545330546
Panc 08.13,sirolimus-bortezomib (250-1 mol-mol),0.500337549713312
Hs 729.T,151289,1.1208279746019094
8-MG-BA,135984461,4.363641187325639
ONS-76,24753719,3.8801096922841656
WM983B,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6718503574539278
NCI-H2029,100016,6.638892611020326
Capan-1,54618305,4.4097719000547135
MOR/CPR,654092,0.1879882423568602
YKG-1,44137675,3.325068196687256
ECC10,1716436,2.0488728279066852
HT-144,10385095,0.494228786741112
COLO 678,327653,2.991494950010625
MFE-296,151289,1.5541291621079911
JHUEM-7,49766530,-0.0352390480057696
BDCM,selumetinib-BRD-A02303741 (4-1 mol-mol),2.8093845296954862
PE/CA-PJ34 (clone C12),11485656,1.7983954039931191
TT,10385095,1.3981899222512604
GOS-3,11404337,1.2142789078350222
MKN7,11404337,0.0072923391755458
SK-MEL-24,151289,1.6251009077666367
HuG1-N,151289,0.9566222906506467
KYSE-410,JQ-1-UNC0638 (2-1 mol-mol),2.635802003886042
MDA-MB-415,49766530,3.102282172182342
PaTu 8902,11404337,0.5155229173062875
OVK18,124202324,2.1663619434065846
NCI-H28,11404337,-2.031510536668559
TCCSUP,9911830,2.7321009507297727
SW1088,9911463,3.760639555360148
SaOS-2,327653,4.165382989627235
HEC-59,9868037,3.1649055297895483
HOP-62,148198,-4.07466395157971
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
BL-70,44137675,1.137889636668751
MKN74,24753719,4.72692215200023
REC-1,654092,1.1648734902582711
NALM-6,10385095,0.98891927621668
22Rv1,44137675,3.0984987484400017
NB4,654092,-2.016593766824197
SU-DHL-8,2729026,2.1433823953001023
CCF-STTG1,136227924,3.7108552267199504
BT 422,753704,4.76217384600288
SNU-1076,1716436,3.8740247163527193
SCC-4,1716436,2.0998927070559983
HCC366,44137675,4.451752801731066
Hep 3B2.1-7,11485656,2.176020084132011
SF539,71729975,3.876423931998654
LOX-IMVI,24753719,4.180599025033894
Kasumi-2,10385095,0.5473944457717855
NCI-H1341,11167602,1.3962971674420526
A-549,654092,-0.0816351868861503
Aska-SS,selumetinib-BRD-A02303741 (4-1 mol-mol),5.7728850622560755
LoVo,100016,6.001395250082881
SCC-25,100016,6.900174579464034
KMS-20,24753719,3.26753514652521
TE 617.T,156414,-2.5018662250676713
JHH-1,151289,0.92898011685306
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
Mel JuSo,44137675,3.719577196158613
NCI-H1105,11404337,-1.3453817375837114
DBTRG-05MG,10302451,3.813801584534872
NUGC-4,374536,-1.4010934911416792
TC-71,JQ-1-UNC0638 (2-1 mol-mol),2.8562026221796635
A-172,9911830,1.400166382809974
TE-5,JQ-1-UNC0638 (2-1 mol-mol),0.2275880872920169
Calu-3,sirolimus-bortezomib (250-1 mol-mol),-0.667685459302334
SU.86.86,1716436,3.0606497084101525
253J-BV,tanespimycin-bortezomib (250-1 mol-mol),1.5580913101671798
HH [Human lymphoma],4259181,-0.4800103115462393
PE/CA-PJ49,135659046,3.5549002552522175
HEC-59,11404337,-0.8184180849969249
U-251MG,1716436,3.606459162538152
BICR 6,24772860,-2.7534677832900325
IMR-32,49766530,-2.845366137118504
SNU-1033,4259181,1.0677542833514009
DBTRG-05MG,753704,5.008107092810978
RL,135984461,2.130872276325595
AML-193,10302451,3.844676833149803
DMS 53,10302451,3.896774436876792
PaTu 8988t,46926350,-4.145321949318386
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
UM-UC-3,148198,-2.7030111325228594
NCI-H2023,11485656,2.100922570819449
EFO-21,sirolimus-bortezomib (250-1 mol-mol),2.2010900590086595
SK-LMS-1,44137675,4.668720860798916
SUIT-2,136227924,3.4861054974924133
SK-LMS-1,148198,-3.2983357402975484
BT-474,71729975,2.721564385291622
KYM-1,327653,3.3203819587904757
KMS-18,151289,2.194880585223594
42-MG-BA,10302451,1.5465274092689412
COR-L51,9903786,2.9541793607693267
NCI-H1299,49766530,-0.517142624612936
OV7,753704,4.941535593857602
HPAC,148198,-2.210118845880014
SUIT-2,654092,0.2357143964079242
SW1271,135659046,3.922158232881772
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
NALM-6,9903786,0.8985317533889718
BT 498,11404337,1.4735257645837956
FTC-238,tanespimycin-bortezomib (250-1 mol-mol),0.0088820138944574
KMS-34,124202324,0.7354107190907876
NCI-H1341,4259181,-4.062950123550263
Hs 683,49766530,0.8674069188410214
COR-L51,156414,1.7388629163468807
NCI-H1563,6918638,2.248675960717125
TC-71,46926350,-5.737308373443815
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739
SNU-201,6450551,2.1280306234882107
MOLP-8,9911463,4.2009596294807245
OE21,2708,5.840495936667117
Rh41,327653,2.4549598700342
BL-70,374536,0.8763353219715858
EFO-21,49766530,0.1419770754491262
SEM,100016,5.238818929389881
GOS-3,100016,7.242262816552233
CHP-126,6450551,0.4991218291084953
HT-144,46926350,-4.399797246918953
HEC-6,11404337,-0.461352025950454
BC-3C,327653,4.094698905019423
BICR 18,tanespimycin-bortezomib (250-1 mol-mol),-0.1167236068858008
MOLT-16,136227924,1.8334417676190544
KYSE-510,10302451,5.138407368996928
SNU-1041,2729026,3.2053417812735585
THP-1,136227924,2.5094113505430737
TM-31,327653,3.2329205368266347
JIMT-1,3815108,3.508389548977638
KMS-11,156414,0.7669613928251784
JVM-2,24772860,-2.532830878221141
SW1417,54618771,0.6384319893864374
KYSE-180,11404337,-0.9460930401604244
MOLM-6,3815108,2.596187158612348
T84,49766530,-0.5596671678676561
RL,1716436,3.3080305234789344
WM115,2708,4.839353437835411
MV4-11,9903786,0.7441932169203459
IGR-1,9911463,4.350306132693756
HEL 92.1.7,sirolimus-bortezomib (250-1 mol-mol),0.1862867514845364
NCI-H526,2729026,2.7518980248482396
L-540,327653,3.067159538807824
TF-1,327653,3.0642738579154383
G-402,10385095,0.4806633165796566
SNU-1196,6450551,3.534525867974014
HD-MY-Z,24772860,-1.8685967663558516
JHOC-5,10385095,1.1914017073923984
NCI-H1694,71729975,0.352695559809615
NCI-H2126,9911463,3.5992006521825317
B-CPAP,9929138,3.6088246512600457
SK-N-MC,selumetinib-BRD-A02303741 (4-1 mol-mol),5.365592849876266
HEC-1-B,11485656,2.1491894336103123
SF268,24772860,-1.7632843689870032
BT 498,9911463,3.937995526968798
NCI-H520,73707371,5.011389013315215
SNU-601,135659046,3.8023044437748417
PSN1,753704,4.9506251945601125
IPC-298,tanespimycin-bortezomib (250-1 mol-mol),1.4855938894276637
MDA-MB-468,9911830,2.3908610927357876
NCI-H1650,136227924,4.84526698521074
COLO 792,54618771,0.4942463473126465
Lu-99,100016,4.341210602126273
SNU-5,sirolimus-bortezomib (250-1 mol-mol),-0.1680239232280146
HEC-59,2708,5.041277924172512
2004,9868037,3.4947449671991735
NCI-H1650,16013152,4.657086825261544
COLO 205,54618771,0.9873734762739949
HSC-4,1716436,3.018983829466311
NH-6,tanespimycin-bortezomib (250-1 mol-mol),0.3512808047097303
KNS-81,9868037,4.212770476057123
Kasumi-1,11404337,-1.4406380230714082
HCC1428,6918638,-0.4708375932365498
ZR-75-1,124202324,3.0571796075308937
TE-11,6918638,1.4188732058945317
WSU-DLCL2,4259181,-1.5160973088782748
TE-4,54618771,0.5260278074732754
A-253,tanespimycin-bortezomib (250-1 mol-mol),-0.0985571483289859
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
Hep-G2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1901606503524278
UACC-257,136227924,2.920939130155667
KG-1-C,2708,5.403860778067846
CAL-62,124202324,2.3785686458143607
SNU-201,148198,-1.525453793244306
KMS-27,9929138,5.026853283311406
KYSE-180,44137675,3.5547718056396
BT 147,71729975,1.448259142382041
DB,135984461,3.626527837681527
KE-37,sirolimus-bortezomib (250-1 mol-mol),-5.227534595798211
NCI-H747,54618305,5.694022652224505
SNU-C1,11167602,4.838873863189907
NCI-H1339,11485656,3.447182893453246
IM95,2729026,2.577038318139433
JM-1,44493528,3.997956862382446
SK-OV-3,1716436,3.636442167288748
SR,24753719,3.424862135799519
ZR-75-30,136227924,3.5756469644058613
Tm87-16,10385095,1.868855301750613
A-172,sirolimus-bortezomib (250-1 mol-mol),0.3443286616456003
Granta-519,10385095,0.7144131323279258
G-401,9911830,0.6760173642929876
HCC1438,753704,6.123464396613945
RD,9903786,3.633793884549444
Ishikawa (Heraklio) 02 ER-,9868037,3.205963776347529
NCI-H1339,1716436,3.037375145615222
JHH-2,327653,2.7833537082553055
BT 333,54618771,1.0971803659169013
CJM [Human melanoma],9911830,2.07393035004485
HCT 116,10302451,4.1839510650516365
HCC44,4259181,-0.6862286642496935
SNU-1214,54618771,-0.4857643216446591
NU-DUL-1,9903786,0.8090083924855098
A-498,4259181,1.547873530266754
NCI-H520,10385095,1.0283003388284149
LN-18,9929138,4.994470479876054
LUDLU-1,6450551,3.866037912282932
A-375,54618771,0.2489032260565352
HCC44,9929138,6.424680472987345
TE-8,11167602,2.1649297116968484
EJM,2729026,3.2130088601508247
NB1,9911463,3.710884488807899
Panc 05.04,9903786,4.601199939689659
HuH-28,2729026,2.3275341188762764
Jurkat,44493528,4.481797817086125
BICR 6,44493528,4.427648512148668
CJM [Human melanoma],156414,1.7180992271166762
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
NCI-H838,1716436,2.9924694068830764
SK-MEL-31,654092,0.7690461064671399
KNS-42,4259181,-0.17232882278181
KMS-11,9911463,3.370246429208364
KNS-42,11485656,3.6641636837314873
SUP-HD1,46926350,-5.464959780791099
NCI-H520,6450551,1.75580273149263
HEC-1-B,49766530,0.5619128655889829
KP-2,sirolimus-bortezomib (250-1 mol-mol),1.2004115712626864
HCC-56,44137675,3.824889760774024
AGS,11404337,0.6854213320992603
NB4,9868037,2.03614451589969
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
FaDu,tanespimycin-bortezomib (250-1 mol-mol),-2.9915431159716603
NCI-H522,4259181,-0.2456063667287351
BT 216,10385095,1.421919147273648
OVSAHO,3815108,2.3704544152601956
Rh41,9868037,1.7289800807892195
Namalwa,46926350,-5.521834277640312
SU-DHL-8,4259181,-1.1396168062766951
SNU-C5,11167602,2.179649924577758
SK-N-BE(2),151289,1.2952543264877463
A-253,9903786,4.10726286628635
HuP-T4,9911830,2.218307107656478
KNS-42,49766530,0.1123105929795226
BV-173,10385095,0.9438349957623432
CMK,2708,2.9739927538401822
YD-38,654092,-0.0694963905270349
Capan-2,136227924,3.162135891621308
SU-DHL-4,10302451,0.5258227793179377
RERF-LC-MS,148198,-3.5927713028936834
KP-4,44493528,4.395451461814576
8305C,135984461,1.979761055337833
P3HR-1,2708,5.242129752027139
A-673,753704,3.1138845387287657
AsPC-1,135984461,3.722049898583642
YD-8,24772860,-1.4663739289558224
TE-15,54618771,1.8265153099983404
P31/FUJ,135984461,4.1454221372139894
ACC-MESO-1,11485656,3.7436435043406
NCI-H1838,24772860,-1.7057337610996663
SCC-4,24772860,-2.353374010187858
COV644,135984461,4.368014985644984
SiMa,10302451,2.75637165309626
U2OS,124202324,2.414187335863177
Granta-519,156414,1.3767921664113123
HT-1080,6450551,1.9435793388965343
MFE-296,54618771,1.0202577840468772
BT 422,sirolimus-bortezomib (250-1 mol-mol),0.5835017840972496
VMRC-RCW,tanespimycin-bortezomib (250-1 mol-mol),1.6092697528768949
LS513,10385095,1.5532641665833944
NCI-H1838,9911463,4.286629824505249
NCI-H1944,10302451,3.756494167528543
KPL-1,4259181,1.2075981381395555
MKN74,9911830,3.231160876799454
SW48,3815108,2.5063295630391806
NCI-H2081,135984461,4.3718384438901285
RPMI-8226,3815108,3.232375202311748
VM-CUB-1,654092,0.4619840371580373
697,10385095,0.7645414684782499
VMRC-LCD,1716436,2.860905064789495
EFE-184,2708,5.301507577344888
U266B1,tanespimycin-bortezomib (250-1 mol-mol),-0.8017004823688043
OV-90,44493528,4.327625554130725
MOLP-8,46926350,-5.986975596425451
SUIT-2,10302451,3.8519201138639
DLD-1,9868037,3.074628293738507
BT 422,135659046,4.905108449533952
SK-N-AS,2729026,2.713089087181556
JHUEM-7,1716436,3.3976454809646426
MOLT-16,9911830,2.5212447547414696
JURL-MK1,124202324,1.248129463912241
HCC2279,selumetinib-BRD-A02303741 (4-1 mol-mol),5.118707030032762
Mel Ho,24753719,4.678102855184008
ESS-1,9911463,4.377027533841143
MDA-MB-157,151289,0.3130009139891556
VMRC-RCZ,753704,5.556337041985689
NCI-H28,9911463,4.1891652273823015
JHH-4,6918638,0.0313135424356484
A3/Kawakami,148198,-4.4977809283586865
YH-13,9911830,3.324457602349572
AU565,1716436,0.9342430141979629
NCI-H2286,11485656,2.9598645626124576
RT-112,9929138,6.4480300033203095
Capan-2,6450551,4.17587713404907
HuNS1,327653,2.9841027206252693
Hs 839.T,2729026,3.052706966288499
NCI-H810,148198,-5.648047602621706
JHH-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4744243777527712
RCH-ACV,327653,1.139116328551912
T98G,6450551,5.307419790138827
SW1463,11485656,1.9271812519349985
KP-2,9911463,4.372716241316865
5637,10302451,0.7873719567933962
NUGC-3,54618305,4.228237436999806
HGC-27,4259181,-1.3994815184637035
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
KYSE-30,JQ-1-UNC0638 (2-1 mol-mol),3.4848744488060275
TOV-112D,11404337,0.1450388001924293
HT115,10385095,2.886361535276013
NCI-H841,46926350,-4.206327708947363
NCI-N87,374536,0.3041613365805376
HSC-2,9911830,2.2689102344436787
SW1088,44137675,3.1595534023236116
HEC-151,136227924,2.850288220591168
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
SNU-869,11404337,1.139832869567116
L-428,11485656,2.209073620058958
HCC202,753704,4.923677333910469
COLO 792,44137675,2.742867658739329
NCI-H2196,1716436,3.3123845350009056
NCI-H508,54618771,1.4622256000794474
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
RS4;11,9911830,1.8582637769181332
HEC-1-A,9911830,2.9415015270085254
BT 239,24753719,3.429710725233414
SW1353,10302451,4.375388652736272
SNU-182,148198,-3.912494487684412
NCI-H1944,24772860,-2.160652430904611
Caki-1,1716436,3.715573906796059
KMS-21-BM,100016,3.297202365361246
SW948,6918638,-0.8188756331889222
HCC1395,3815108,2.5394556958425696
NCI-H661,136227924,2.7818959309662183
COLO 320,1716436,2.0318434703646435
NCI-H1666,2729026,1.416422779567064
NCI-H2141,6450551,1.2645086559888523
MOLT-3,10385095,0.6724792762753087
MEC-1,100016,3.995806762220144
VMRC-LCD,10302451,3.928958385850413
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
CAL-33,11167602,3.101269278162525
KG-1-C,11404337,-1.389816436065637
IGROV-1,3815108,1.915722485757852
NALM-6,sirolimus-bortezomib (250-1 mol-mol),0.084215684734826
VCaP,46926350,-4.298897066771076
TE-6,156414,-0.6190347638694889
NCI-H146,148198,-5.323171419653744
PE/CA-PJ34 (clone C12),6918638,1.3328388585954094
Ri-1,1716436,1.3694183290635549
SNU-1272,54618771,3.136436186338116
BICR 22,148198,-3.168643556299537
Kasumi-2,1716436,2.2552230484948477
SW1783,9911463,3.515685844560525
NCI-H810,44137675,3.688658119269916
HCC1954,2708,6.10602541202181
SK-N-DZ,2729026,1.8440326207831783
JK-1,9929138,4.47533502757398
HCC2218,156414,-3.7494092331236497
NCI-H522,327653,3.011425661783578
WT2-iPS,sirolimus-bortezomib (250-1 mol-mol),0.4538341173925034
HCC2935,24772860,-2.9954621915234827
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
BHT-101,tanespimycin-bortezomib (250-1 mol-mol),1.2601290483730383
COLO 800,11167602,4.238548502616999
RPMI-7951,selumetinib-BRD-A02303741 (4-1 mol-mol),5.015404158676352
NCC-StC-K140,6918638,1.6255556223865495
KMS-11,135984461,2.862381632910091
NCI-H1155,6450551,2.0099986372237777
HCT 8,11167602,3.4597414266317443
BT 444,2729026,2.2716536449427647
RT-112,148198,-2.2564798144286597
EFE-184,10302451,2.785285352409803
SNU-201,2708,5.983864957841762
LS123,6450551,2.909206551299489
SW620,1716436,2.3227189956464787
A101D,11485656,3.576115374437905
SUP-HD1,2708,2.744279779526215
Granta-519,9843750,4.294258272153345
KYSE-30,327653,3.5492828171510937
NCI-H1573,1716436,2.6081042128384353
OCI-Ly3,11167602,4.156606603429628
NCI-H460,11485656,2.6212830818798065
Mino,4259181,-0.1308029844207646
CCF-STTG1,9911830,2.0742504991173103
PF-382,4259181,-0.6205773881868614
Hs 294T,selumetinib-BRD-A02303741 (4-1 mol-mol),3.6715254708283216
NCI-H322,9903786,4.921113869322727
NCI-H2110,JQ-1-UNC0638 (2-1 mol-mol),2.777765951368402
RERF-LC-A1,654092,-1.2602553133835417
Sq-1,3815108,4.42096029169889
KMRC-1,148198,-3.0121915653316953
HOP-92,6918638,0.7630598951940987
MDA-MB-231,sirolimus-bortezomib (250-1 mol-mol),1.1512355372843297
NCI-H2171,24772860,-3.209318985857815
G-361,44137675,3.2433747979373884
KMS-28BM,9911463,2.9492767057904583
Mino,10302451,2.7399249984312863
NCI-H2106,1716436,2.379403155015517
NCI-H716,4259181,-1.4668256372956798
Panc 04.03,selumetinib-BRD-A02303741 (4-1 mol-mol),4.320411537707366
A-673,44493528,4.641329710074662
TYK-nu,54618305,4.312286550254365
TCCSUP,156414,2.0603521073886952
TUHR14TKB,9911830,0.5860992883874008
KYSE-450,136227924,3.5350495950730645
AM-38,2708,3.551367715612804
SK-N-DZ,374536,1.7251811735896347
SNU-1076,24772860,-1.4640960648796273
Sq-1,654092,-2.4175201775527255
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
SNU-601,151289,1.1810951573582
NCI-H1693,11167602,1.7330490995258525
COV644,11404337,-1.0337314183791615
HPB-ALL,JQ-1-UNC0638 (2-1 mol-mol),1.2458168484382015
2004,selumetinib-BRD-A02303741 (4-1 mol-mol),5.0714423787094205
B-CPAP,44493528,4.579013970980452
Hs 729.T,2708,5.1111914958769304
NCI-H2452,44137675,2.6709050374584846
Hs 683,44137675,2.697665290818916
F-36P,54618771,0.2911241423131909
SU-DHL-8,374536,1.734945624430663
DU4475,6450551,0.9376948196453444
PK-59,2729026,2.543125862606278
SNU-1077,135984461,3.620374859792411
HT,11404337,-1.0705366474134053
NCI-H1694,10302451,3.86716164825304
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
SW1463,2708,3.597321448088185
HT-29,9911830,3.6715943685585097
KYSE-150,11485656,2.368580585817062
NCI-H647,10385095,0.97952933951215
NCI-H2106,4259181,0.3116133761629641
LS513,374536,2.871037986520063
SNU-886,9903786,2.951492144984292
BT 504,9903786,2.1257740171546717
SaOS-2,6450551,2.5324870379200113
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
SNU-1033,1716436,2.198719748586455
SU-DHL-6,2708,3.434249932793118
YH-13,49766530,-0.8723369372860722
SUP-M2,9903786,1.0371489832457852
NCI-H460,1716436,4.318712917611328
HPAF-II,136227924,3.1547615754637
MEC-1,9903786,1.8402940604427764
MOR/CPR,24772860,-1.8560844046473408
PaTu 8988s,6918638,1.3708196410669105
ME-1 [Human leukemia],54639665,4.516656391788249
PL-21,54618771,-1.4027013448904684
BT 239,10385095,0.554561661848966
LS180,2729026,2.858515315971793
COLO 678,sirolimus-bortezomib (250-1 mol-mol),2.474512114208449
EB1,11404337,-3.430704628521276
LS1034,6450551,3.890510734310852
JHH-6,selumetinib-BRD-A02303741 (4-1 mol-mol),5.246579789729029
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642
Malme-3M,156414,1.628797695516341
A-549,1716436,2.5951939484521724
Ci-1,JQ-1-UNC0638 (2-1 mol-mol),2.849000363039887
HT-1197,6918638,1.042258659945556
MCAS,selumetinib-BRD-A02303741 (4-1 mol-mol),1.302698878227716
BC-3C,6918638,1.5868731043226476
BV-173,6450551,-0.5144259220962393
KLE,2708,3.7521843050752457
NCI-H1339,4259181,-0.3541173382827977
NCI-H510A,151289,0.4915146131816537
BT 164,9911830,1.9009455606432144
BT 428,148198,-5.072102147760655
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
RVH-421,148198,-2.605625112425235
TE-15,24772860,-1.8392832942259
JVM-3,11404337,-0.5913580396426641
NB4,148198,-3.6503523996612617
Rh41,11485656,2.1642426716140877
SNU-1,135659046,4.075705949169052
HCC1395,9911463,3.7308184139789855
BxPC-3,9911830,2.611582201474507
SK-LU-1,10385095,2.41706615965267
SR,selumetinib-BRD-A02303741 (4-1 mol-mol),5.709183816089496
RPMI-8226,2708,4.540956353711143
NCC-StC-K140,100016,6.431860837963816
WM983B,135659046,3.887851853089627
AN3-CA,73707371,5.974433333213384
NCI-H1694,327653,2.2817152980884265
NCI-H841,1716436,3.2856484347431096
UACC-812,46926350,-4.425607795744521
NCI-H2291,54618771,2.606874288662127
YD-15,54618771,0.7976995145825885
8305C,4259181,-0.8520805569418024
AN3-CA,10385095,0.1159584530929505
NCI-H460,11404337,1.7201854837770862
MOLM-16,10302451,2.1186807134276795
NCI-H1915,9911830,2.093118330249274
BT 164,9911463,2.6939037161672617
SaOS-2,4259181,-0.1317601722396107
Panc 05.04,654092,-1.5160463984847965
P12-Ichikawa,148198,-4.791017453717943
MDA-MB-157,753704,5.007751734334353
HCC78,124202324,2.3967217428064616
OV-90,6918638,0.8312701026022422
GI-1,44137675,1.4685406858415466
AM-38,54639665,-6.281262655351625
Panc 05.04,10385095,2.321131550463211
IGR-37,11404337,-0.93778882861888
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
BHT-101,374536,1.6558315927095053
NCI-H1755,11404337,-0.8825666312095473
MKN74,44493528,4.689150119305487
697,JQ-1-UNC0638 (2-1 mol-mol),-1.993219996810132
TYK-nu,tanespimycin-bortezomib (250-1 mol-mol),-0.3612776377127862
JHUEM-7,44137675,1.945241597383145
RPMI-7951,54618771,0.8844591471525661
TM-31,11485656,2.0452435879602087
KMS-26,10302451,3.168611946824231
Daoy,selumetinib-BRD-A02303741 (4-1 mol-mol),6.220419115532172
SW620,24753719,3.88955545054986
RERF-LC-MS,6450551,1.967154760545028
786-O,54618771,1.0235126095922562
NOMO-1,327653,2.81345515165661
BT-16,2729026,2.469717284595148
BT 320,2729026,2.399631543883215
KYSE-150,9868037,4.171183799285216
IGROV-1,148198,-2.659972993252853
HT-29,54618771,-0.2374080700541868
OE19,JQ-1-UNC0638 (2-1 mol-mol),3.1936427802526595
MHH-CALL-4,10385095,1.014467804729014
SK-N-BE(2),6918638,-0.1264166594674796
NCI-H526,10302451,4.161847197543937
SNU-46,11404337,0.6593840830544361
NU-DHL-1,44137675,1.8440314002595644
Mel Ho,151289,1.0487604746113093
Hs 729.T,49766530,-0.2266090443337086
ST486,6918638,-1.4802112864016868
THP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.8606200300603457
T3M-10,327653,3.9520223783948185
A-549,54618771,0.0374822867627876
KALS-1,374536,4.42928404322089
Hs 839.T,54618771,1.980967408775539
L-428,151289,0.9075799974193208
COLO 668,9911463,2.6985000382715567
HEC-1-A,9903786,5.533982095458378
HCC366,73707371,5.080487571628641
C2BBe1,135984461,4.331505253640542
NCI-H358,3815108,3.141152706478049
EJM,10385095,0.7131434808495797
KMS-21-BM,9911830,1.8558490159042795
SCC-9,54618771,0.4910288003516506
DOV13,selumetinib-BRD-A02303741 (4-1 mol-mol),5.89979315519759
KP-4,124202324,2.9493285207276436
NCI-H2081,2729026,2.0154063962132676
WSU-DLCL2,1716436,3.0441225398557723
KNS-60,11485656,1.5594601831806838
L-540,136227924,2.3931383545900524
NCI-H2444,16013152,4.319671658043677
SF295,2729026,3.154243256509534
HT-1080,49766530,-3.575770083541022
EB1,9911830,0.792353471304689
PK-59,374536,3.3895651049795483
Daoy,9868037,3.1554114600396725
HCT 116,11485656,2.5700211491492593
HDQ-P1,44137675,4.588017489887056
JHH-2,9911463,4.025209032029127
IM95,6450551,3.2989725825003178
Panc 04.03,11485656,3.4698409381110435
ECC12,100016,5.969737428755433
MeWo,11404337,-0.4455476930760103
U-BLC1,9929138,7.10057481888197
SK-N-MC,100016,6.319948334432407
H-STS,135984461,1.3384437031548353
NCI-H810,2708,5.00507545278024
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
Hs 746.T,9911463,4.2317998219247785
A-375,54618771,0.2489032260565352
SNU-840,6450551,5.2278065983184785
SR,9911463,3.2455364597382075
Caki-1,44137675,5.7464476488798235
SCC-25,156414,-1.9517374046491416
NCI-H460,1716436,4.318712917611328
NCI-H358,2708,5.448534799187689
KLE,156414,1.5892150248130086
KYO-1,753704,4.923309459572583
Kasumi-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.464770515691229
U266B1,135984461,4.925134147369508
HEC-6,sirolimus-bortezomib (250-1 mol-mol),1.9105485577838577
647V,4259181,-0.0179068575968908
HOS,2708,5.203469112616677
Pfeiffer,9911830,-0.4100154279991107
SUP-B15,753704,3.5771472422275585
SNB-75,24753719,5.895430313636729
COLO 678,49766530,0.1111976795656789
L-428,136227924,2.9759698761374795
Calu-3,9903786,3.8990782508172495
OVSAHO,327653,2.515747107547292
Panc 08.13,54618771,0.3340259245614503
D283 Med,44137675,1.6630116690363648
WM1799,9911463,3.918930617108345
LC-1/sq-SF,selumetinib-BRD-A02303741 (4-1 mol-mol),6.361880540510948
SNU-182,44137675,3.078178944735025
KMRC-2,6918638,2.530608433892335
NCI-H2172,9929138,5.835125788077067
NCI-H1299,1716436,3.790585406368508
SNU-886,54618771,-0.5899639628082597
NCI-H1869,156414,1.3059713748980704
NCI-H1341,49766530,-3.266288365391744
P12-Ichikawa,sirolimus-bortezomib (250-1 mol-mol),0.3718187399928814
JJN-3,156414,1.5641574452872378
HEC-59,11485656,2.515586983262965
HEY A8,3815108,3.717423754810201
CAL-27,327653,3.557257248242371
Caov-3,sirolimus-bortezomib (250-1 mol-mol),1.7880451090258302
DMS 53,6918638,-0.2331882953997054
NCI-H1915,374536,4.028476134129211
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
YH-13,selumetinib-BRD-A02303741 (4-1 mol-mol),4.816369737179264
TE-5,753704,4.796222674831156
TC-71,44137675,4.065441428743714
BT 224,10385095,1.2514270685942803
COR-L105,1716436,2.5827881779858797
CCF-STTG1,JQ-1-UNC0638 (2-1 mol-mol),3.4637042850719095
NCI-H2172,24753719,5.109863925049923
SNU-899,sirolimus-bortezomib (250-1 mol-mol),1.691778664572397
NCI-H146,1716436,1.8968095332546364
KALS-1,6450551,3.5286143047169514
SNU-216,24772860,-2.09837085727617
TE-11,2729026,3.088714972519933
JHH-4,10385095,1.4023288225703123
NOMO-1,2729026,1.9247353379999697
KYSE-520,135984461,4.658716640693311
MOR/CPR,24753719,4.642511920808052
EHEB,148198,-2.104475544842142
BHY,sirolimus-bortezomib (250-1 mol-mol),0.9100094711799346
COV362,100016,7.994124175315401
MOLT-3,11167602,1.5637048458250953
TC-71,2708,3.815322018076648
SW1990,135984461,4.558882799669272
Mel JuSo,1716436,2.5385513753153033
BFTC-905,11485656,2.1700639053341666
SK-MEL-28,1716436,3.730773917114669
ES-2,24753719,4.95493894106221
DU145,11485656,2.5427151524786993
KE-39,2708,5.6188157628289925
GA-10,6450551,0.7466330463317521
G-401,151289,0.7906130786084481
COLO 678,44493528,4.3871500555160035
MDA-MB-435S,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4505243366937175
HEC-108,9929138,6.458847770997077
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
SW579,1716436,3.0483965879643296
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
Ki-JK,151289,-0.4586373406075946
T3M-10,156414,2.016640265656968
NCI-H526,9911463,4.043981545768548
HeLa,10302451,4.286472451875936
HOS,151289,1.1175899254252772
EKVX,136227924,3.396888883126824
ALL-SIL,3815108,1.81429533281988
NCI-H460,136227924,3.925006850615035
TE-15,374536,3.2802674358624926
NCI-H1838,10302451,2.6735726337808052
NCI-H1299,24772860,-1.8114387917097616
EHEB,24772860,-2.594982066939884
KMH-2,2708,3.3421744997007856
SEM,JQ-1-UNC0638 (2-1 mol-mol),-2.509155551335313
COR-L95,136227924,2.879022500990784
KE-39,4259181,-0.84210776373342
CCF-STTG1,6450551,2.47123391002199
NCI-H1869,44493528,4.333760189181675
HL-60,1716436,3.15217309783848
Detroit 562,124202324,2.271191676069168
NCI-H28,49766530,-2.0478449077556826
SK-ES-1,156414,1.5792793420660831
CL-34,24772860,-2.9881768396421733
SNU-668,2729026,3.038431130829104
PSN1,148198,-4.413280426545966
Sq-1,tanespimycin-bortezomib (250-1 mol-mol),0.5619260521481989
IGROV-1,1716436,3.2816872421007375
ECC12,2708,4.87886648974626
NCI-H889,151289,0.7687945000833852
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
P12-Ichikawa,24753719,2.55959592126112
DU4475,11167602,1.0956541119687018
OCI-M1,135984461,1.8150878916625208
SCC-9,11404337,-1.771041191231111
TT,9868037,3.136972915519422
A-549,11485656,2.1977599259975764
COLO 320,11485656,1.5000331440446593
Caki-1,9911463,4.3928078257810785
SK-ES-1,24772860,-2.907631086271041
PSN1,11404337,-0.8573645663798306
A-375,2729026,2.589509771776737
NCI-H28,156414,1.3812121222696463
MHH-CALL-4,9868037,2.145138443959549
Lu-99,4259181,-0.6805384637349173
SK-MES-1,6918638,0.2897648687563215
RL95-2,2729026,2.4928273824540588
BT-20,44493528,4.336473935891848
KU-19-19,654092,0.6096416345891582
BEN,54618771,1.4690006980639003
Peer,654092,-1.8684665443416852
HCC1937,654092,-1.5364751502909524
NCI-H716,9903786,1.532038090064473
A-498,2729026,3.0720683032694827
NCI-H508,6450551,1.0747839088475075
NCI-H446,6450551,0.4370963461571335
SUP-T11,54618305,4.5643588933895956
U-87MG ATCC,2729026,3.1536377310543595
SK-MEL-24,135659046,3.636205861193986
Karpas-299,10385095,0.9106183768206608
HCC2279,11485656,2.9593776026466756
Panc 08.13,11167602,3.0281577588813966
HEL,54618771,0.7283869495698151
KP-3,11404337,-0.3315209931001077
BT 228,9911463,2.83539892477779
B-CPAP,11485656,2.2559715729134204
NCI-H1563,10385095,2.0577358054307453
NCI-H520,136227924,2.065702540466464
OAW42,11404337,-0.3833970130425348
WM793,44493528,4.356787444460569
KATO III,11485656,1.9735561216219804
BT 232,374536,3.676465900501084
SU-DHL-1,753704,3.8222320630358344
NCI-H1573,tanespimycin-bortezomib (250-1 mol-mol),-1.6539350682626517
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
Hs 611.T,151289,0.7556153766832656
NCI-H209,11404337,0.938734555574242
H-STS,10302451,3.908664464224374
Hs 888.T,49766530,-2.634429263371643
SUP-M2,4259181,-1.314414971411119
BT 245,71729975,1.93645259628117
DMS 53,sirolimus-bortezomib (250-1 mol-mol),0.155507409478016
KE-39,9911830,2.572250482212608
G-402,49766530,-4.676070864633351
DOV13,9911830,3.767973968860044
EKVX,sirolimus-bortezomib (250-1 mol-mol),1.945724198864232
IGR-37,1716436,2.867371514105322
JHOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),6.467277808865126
BT 139,2708,5.853118570413443
OAW42,11485656,1.8505528524867976
SNU-423,9911463,4.2882741176819446
HuG1-N,148198,-4.107954267026698
CMK,44137675,3.8130479046615697
PF-382,24753719,2.156979591404902
HT-1080,2729026,3.057533696290176
MHH-NB-11,44137675,3.5274446989190795
HCC1500,46926350,-3.99988450675712
BHT-101,3815108,4.3911577719311214
MHH-NB-11,9911463,3.881225823923783
NCI-H1792,selumetinib-BRD-A02303741 (4-1 mol-mol),2.8720404024900037
A101D,46926350,-3.997526060219706
SiMa,24753719,1.4793957520378191
LoVo,10385095,1.3603816893768768
JHUEM-7,10385095,0.8646007643870881
MOTN-1,54618305,4.123984854180418
AsPC-1,10385095,2.76496705920137
GCT,10302451,2.4573372812580354
NCI-H526,sirolimus-bortezomib (250-1 mol-mol),1.536405299935234
SNU-626,4259181,1.842335226683514
HEC-265,9903786,3.4431873939131536
HCC95,151289,2.498619007903118
U-118MG,10385095,1.6981951861544773
TE-11,148198,-3.0538183571053183
KMRC-1,9911463,4.4126092990485395
HCC38,9911830,2.511221746544401
BICR 18,54618771,1.6226277377850309
5637,4259181,-0.6992610249902801
U266B1,6918638,-0.6016513516102697
NCI-H889,10385095,1.4076394224078
NCI-H1666,135659046,3.3700367762048877
NCI-H358,327653,3.0661628388292623
MKN1,156414,2.004674973176418
Detroit 562,9911830,2.4329173444372176
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324
Hs 940.T,156414,1.05658076311892
SIG-M5,9911830,1.8905574063855235
RERF-LC-A1,11404337,-0.8149390042058701
LS123,1716436,1.4991371361801833
QGP-1,11485656,2.192012938394494
EM-2,JQ-1-UNC0638 (2-1 mol-mol),-0.957296000160211
COR-L95,11404337,0.1032061359669597
BxPC-3,11485656,2.0481416814216375
RD,73707371,5.346025757218591
OAW42,10302451,3.168446299952244
LCLC-103H,11485656,2.3573418350596644
M-07e,9911463,2.8967882241025995
IGROV-1,9911463,4.195269991960018
F-36P,44137675,4.491528939355425
JVM-3,654092,-1.6493593539016949
L-540,6450551,0.923455461224153
CAL-51,44137675,3.485867182081199
ST486,10302451,3.4096383084955004
SW579,6918638,0.7272456776623913
NUGC-4,2729026,2.660880232135923
YD-15,374536,0.3727262379763149
Calu-1,11485656,3.860482320905327
P-STS,tanespimycin-bortezomib (250-1 mol-mol),0.1209880905816519
IGROV-1,654092,-1.340387623873854
SNU-423,11485656,3.131370831257297
SK-MEL-28,9911830,3.7902815277231663
HEC-151,16013152,4.101963115676647
DU145,9911830,2.1364996794005395
SUP-M2,46926350,-7.362561494919288
DU4475,44137675,4.11915323119938
DMS 79,10302451,4.069045121514552
L-540,tanespimycin-bortezomib (250-1 mol-mol),-0.491280358264631
JHH-4,1716436,3.321521278325833
OVCAR-4,124202324,3.1621842443618053
BT 232,2729026,1.7676166146417314
OVCAR-5,2708,5.2300162900924985
COLO 792,374536,3.524367807366727
BCP-1,11404337,-1.851006569506268
SK-ES-1,46926350,-4.280637285281333
HSC-3,4259181,0.6256880265153872
COR-L95,1716436,2.176954941746147
VMRC-RCW,11485656,3.110603770288861
TE 617.T,selumetinib-BRD-A02303741 (4-1 mol-mol),2.6480104459269596
RCC10RGB,135659046,5.776465120313546
L-1236,9903786,-0.7492109399697982
P12-Ichikawa,44493528,4.170368058365218
A2058,46926350,-3.978222435854085
Reh,11404337,2.5289524412183964
PE/CA-PJ34 (clone C12),44137675,3.7024298491160095
T84,10385095,1.394973696850744
TOV-112D,151289,0.6242291225630527
SR,9903786,1.863499016732126
Hep 3B2.1-7,BRD-K13185470,4.484971730521959
UACC-257,156414,3.1876914879153984
Daudi,10302451,1.2926011902861492
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
MOLM-6,sirolimus-bortezomib (250-1 mol-mol),0.6452652216759648
NCI-H2110,9911830,2.0378965069300112
KE-97,24753719,3.3445945063938676
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
HD-MY-Z,11485656,2.631776760715326
CAL-27,JQ-1-UNC0638 (2-1 mol-mol),0.4999626254545491
P-STS,11404337,-0.4703645434055084
Hs 944.T,24772860,-0.1067427188820003
SCC-4,11167602,2.493488675880142
CAL-78,124202324,2.5462257652866644
697,24772860,-3.68835465215316
MOLM-6,JQ-1-UNC0638 (2-1 mol-mol),0.5458751448222761
OV-90,tanespimycin-bortezomib (250-1 mol-mol),-2.825248650811712
OE33,44137675,3.2640779547469436
Mono-Mac-1,9911463,2.4863663707883723
DLD-1,10385095,2.044160408314856
WM793,24772860,-1.904667330479004
EFO-27,JQ-1-UNC0638 (2-1 mol-mol),3.1988831496339536
NCI-H2110,44137675,2.993470299595554
DMS 53,1716436,2.268817295611628
GA-10,46926350,-6.51404105527081
KMS-34,11485656,1.6591350008263417
BT 228,71729975,1.921164195711999
MOLT-16,JQ-1-UNC0638 (2-1 mol-mol),0.2017740251828374
NCI-H1299,148198,-1.8449433288311332
TOV-112D,1716436,3.5270636825321007
LS180,136227924,2.415770069388299
SEM,6450551,0.3475016834415761
HT-29,148198,-0.9587327064995448
KMRC-2,10302451,2.956766072446153
SK-N-MC,6450551,1.1914487101413471
PSN1,9911463,4.382520563111527
T3M-10,374536,4.55938128523712
RL95-2,136227924,2.901366933043705
HeLa,JQ-1-UNC0638 (2-1 mol-mol),3.737781350527659
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
HMCB,11485656,2.0030375268355116
NCI-H1734,9911830,1.9349371485534383
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
HCC1143,148198,-3.881060339055355
A-375,9929138,5.4250105922665375
ECC12,24772860,-2.9950189291393223
CAL-85-1,16013152,4.184180426022501
HEC-265,3815108,3.62306671240499
Mono-Mac-1,374536,0.5970051529194348
CJM [Human melanoma],24772860,0.5663076409782207
NCI-H1581,11167602,0.5039767071361789
CHP-126,tanespimycin-bortezomib (250-1 mol-mol),1.029486462123943
CJM [Human melanoma],sirolimus-bortezomib (250-1 mol-mol),0.403265479261487
LCLC-103H,9911463,4.367340887441101
LOX-IMVI,148198,-2.445772941232649
HSC-2,24753719,3.8368377039493726
RCH-ACV,44493528,4.3115996529369705
MeWo,46926350,-4.863869204790377
NCI-H522,49766530,-2.92412408259348
OE33,148198,-2.7707811749574196
GA-10,9929138,4.091985168387067
CAS-1,9911463,4.201825913266076
BFTC-909,11485656,2.882750602975944
U-BLC1,753704,4.532043997158847
KYM-1,16013152,3.4032765148640824
697,46926350,-6.203196459248636
HCC15,124202324,2.163317754038658
ST486,135659046,3.2413267660830316
BT 164,24772860,-2.611685693462682
HuNS1,2708,2.9738358315202102
K-562,4259181,-0.7813149193344907
SNB-75,9868037,4.435778123125775
TM-31,6918638,1.2377309655221411
RERF-LC-A1,124202324,2.535691492402962
LOU-NH91,9911830,2.650870613913377
SK-N-AS,135984461,4.344661124927598
CMK,4259181,-1.112181067165922
JL-1,4259181,2.008998320795158
KYSE-450,4259181,0.2433830255631184
Namalwa,151289,0.4825051830903394
SNU-16,4259181,-2.706381398418005
REC-1,9903786,4.191167368609226
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
SW1417,2708,5.372600855625441
Calu-6,9903786,1.9563383465911224
NOMO-1,44493528,4.211717002525977
Lu-65,2729026,3.1489264055636164
KM12,654092,0.3279318202256465
WM88,2708,4.944801067626519
RL95-2,100016,4.898266673475204
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133
JHOM-1,6918638,0.1301206862216937
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
BT 271,11167602,2.00091705558841
Ri-1,9868037,1.6681879870423917
NCI-H446,selumetinib-BRD-A02303741 (4-1 mol-mol),3.4601688194103635
BT 131,49766530,-1.5740647020909493
SUP-M2,10385095,0.380584113735729
MDA-MB-453,54618305,5.448966988850886
YD-8,10302451,2.519210773741685
23132/87,136227924,2.929197271565677
GSU,124202324,2.780061954137442
DB,10302451,3.614342806330988
NCI-H2029,151289,1.8190441191745672
MOLM-6,753704,4.406487467550241
SNU-61,1716436,2.6740680266491763
NCI-H727,54618305,5.896457883643312
ES-2,9911830,3.057885215196293
Hep-G2,374536,1.5546394927769718
Caov-3,654092,0.1564232434183242
HCC202,tanespimycin-bortezomib (250-1 mol-mol),-2.788227280084804
IM95,374536,2.065392174596007
NCI-H661,1716436,2.7606212382296205
RKN,124202324,3.704376342602573
NCI-H28,10385095,0.5737685165722669
Pfeiffer,2708,3.9765868601320977
PE/CA-PJ34 (clone C12),10302451,1.6517506382371558
SW1573,124202324,3.209850220678193
PF-382,11404337,-1.5613133934389778
SNU-C4,135659046,3.741001197926473
CAL-54,24753719,3.5155753888160306
MHH-NB-11,2708,2.152769010319116
SNU-387,100016,7.682207014450764
SNU-668,4259181,-0.218852080929754
TCCSUP,9911463,4.056352676279941
SNU-387,2708,5.486466704897997
TE 441.T,49766530,-1.0459972469347878
SK-N-BE(2),selumetinib-BRD-A02303741 (4-1 mol-mol),-0.3724660304794471
A-204,54618305,4.912767381988994
TE-11,9903786,1.6089543664279713
NCI-H1693,46926350,-4.334605033684338
NCI-H727,136227924,3.2179651731130585
WM266-4,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.3463709543064918
LOX-IMVI,6450551,2.208346013373947
2004,tanespimycin-bortezomib (250-1 mol-mol),0.7644529480942643
HCC1438,374536,3.52610599418498
COLO 680N,9911463,4.286168198207007
NCI-H1568,46926350,-5.085925204635643
Raji,10302451,3.856690135156121
KNS-62,9911830,3.616191106750715
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356
NCI-H2122,9911830,3.1197421381222212
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
SNU-1077,54618771,3.2500418975361347
U-BLC1,16013152,4.29696335846276
SF126,124202324,3.5732685140224034
A-204,44137675,1.916117949028625
EM-2,11167602,0.236246568519281
SYO-1,151289,1.0970568367477176
HT115,124202324,0.992712180002578
OCI-M1,54618771,0.2801133336374899
HCC1143,1716436,2.8430583337953284
NB4,44493528,4.205501797319906
LK-2,49766530,3.215264234500344
NCI-H1184,124202324,1.0522080128834868
NCI-H1623,44493528,4.638812765070766
LCLC-97TM1,44137675,2.6535109564984403
NCI-H2106,11404337,-0.0060242090595341
FaDu,1716436,3.6113717747072536
LUDLU-1,46926350,-5.660232069293139
DOV13,9911463,3.6581619709101383
CA46,44137675,2.206940954689562
SNU-1066,54618771,0.6033249887552533
Hs 852.T,135984461,4.050524376376727
Peer,49766530,-3.815848082576589
GSU,9911463,4.305557619693962
BICR 16,1716436,3.4626012586313837
SH-4,148198,-4.104582342720325
Kasumi-2,49766530,-3.7396811929647513
U-937,49766530,0.8721430649798465
HSC-2,73707371,5.668721920442689
KMS-18,9911463,3.17333222126381
KYM-1,6918638,-0.4482897804277287
DV-90,2708,2.9417201545533445
NCI-H647,16013152,3.849127993281392
NCI-H226,9868037,3.726769382585606
NOMO-1,10385095,1.0593467546243338
SNU-423,46926350,-3.9937351080347314
DMS 454,tanespimycin-bortezomib (250-1 mol-mol),2.8093099362578746
HCC1588,124202324,2.4073486319101773
BICR 56,10302451,1.081670718064007
SNU-1196,49766530,-0.055725374284701
SK-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.5276941672655032
COLO 680N,2729026,2.999244266440617
HuH-28,44137675,3.4111922570635933
SNU-423,54618771,0.8845738276291084
SU.86.86,135659046,3.4966511693155637
BICR 31,54618771,0.3365869204450262
HuP-T3,9911830,2.533690069517969
CHP-212,54618305,4.169241448375394
KYSE-180,124202324,3.3270800786084154
KMS-34,151289,0.1258662940208345
COLO 205,44137675,4.278416904864482
BT 440,4259181,1.1118800854766548
VMRC-RCW,44137675,4.442234123211725
SK-MEL-3,44137675,4.543805058147876
ECC12,1716436,3.994805561698325
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
A-253,6918638,0.9016181172742443
EFO-27,1716436,3.5844471141038823
NCI-H810,11485656,1.6227483490056236
J82,148198,-3.1437568832553837
COV434,11404337,-1.4918185868147884
NCI-H2170,2729026,3.1765148243253365
OVCAR-8,10302451,4.012280315973911
SF295,148198,-2.5868327776728517
OVK18,136227924,2.593591625928113
NCI-H23,selumetinib-BRD-A02303741 (4-1 mol-mol),2.1667070426254744
KYSE-70,10302451,3.1884398798129525
HT,136227924,2.3517784191427613
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
OAW28,148198,-3.8662210541116977
GCT,tanespimycin-bortezomib (250-1 mol-mol),0.7186181372238337
AM-38,24772860,-3.095778211842113
SNU-216,9911463,4.000497828097352
SU-DHL-1,2708,2.612747958759665
JMSU-1,11485656,1.6924908794215956
BV-173,11404337,-1.6839007353956104
WM115,10385095,0.3137764342063494
DMS 53,71729975,-0.2481700133897925
U2OS,11404337,1.5271724700309952
Caki-2,11404337,2.178214779259819
TC-71,9911463,4.31174852976799
HCC2108,11404337,0.8287580393905775
HSC-4,11167602,1.6360881716966182
HD-MY-Z,11404337,-0.4126072630667986
PaTu 8988s,9903786,1.8009975173036927
KYSE-30,selumetinib-BRD-A02303741 (4-1 mol-mol),1.39827641750971
MKN7,2729026,3.19440712849709
BT 248,4259181,0.8166391520482507
SF539,156414,1.5385171897873895
647V,JQ-1-UNC0638 (2-1 mol-mol),0.1694365233116214
UM-UC-3,44493528,4.3547377371063405
SNU-449,9911463,3.778924364931394
RPMI-8226,49766530,-1.9522692121049856
M-07e,9868037,1.7477051770285184
AGS,3815108,3.328577804050937
PE/CA-PJ41 (clone D2),10302451,2.698134533156883
SW1417,44137675,3.428826694017991
NCI-H211,24753719,2.286443941284737
NCI-H358,9911830,1.5651647293107356
SU.86.86,9911830,2.616935639947117
TOV-112D,24772860,-1.1319386630207378
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402
COLO 678,10302451,3.4236206649832797
ST486,753704,2.940686834415163
A2058,11404337,-0.7992092997258325
Hs 888.Lu,6450551,3.3688344005781743
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924
HGC-27,49766530,-2.870861488456396
SK-MEL-1,54618771,1.3594910944295866
SNU-5,2708,4.351499770984395
SK-BR-3,4259181,-0.0321422954421751
Namalwa,selumetinib-BRD-A02303741 (4-1 mol-mol),5.907304131340107
Mel JuSo,24753719,4.834599240822851
PaTu 8988s,11404337,-0.6739371473320328
SF126,11167602,2.368623287420037
IGR-37,9911830,3.620959954917233
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
RT-112,54618305,-4.692727933409511
NCI-H1650,9903786,2.8320144189469385
SUP-T11,2708,2.153197900582886
PL-21,124202324,1.2604691388605709
EFO-27,10385095,0.896347771716858
2004,100016,6.70935199674954
OVSAHO,10302451,4.086009367153599
SK-MM-2,24772860,-2.852475043829413
OCI-M1,148198,-4.87600979079706
UACC-257,6918638,0.5878135089282499
SK-N-SH,JQ-1-UNC0638 (2-1 mol-mol),1.3255309651974876
KNS-60,selumetinib-BRD-A02303741 (4-1 mol-mol),5.855945043746639
TE-8,156414,0.8617736604769611
HCC38,49766530,0.1078777234170871
TT,11485656,1.9272227240338475
NCI-H2081,9903786,1.5566694513779922
A-375,4259181,-0.8072558556065395
Pfeiffer,135659046,2.6558992288544725
LOX-IMVI,4259181,-0.9241838451669104
NCI-H526,100016,5.298819017471169
PK-59,9911830,2.647954789959704
P-STS,156414,3.8931257076797623
HT-55,124202324,2.579238879623368
SH-4,9903786,3.356674972156618
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673
SNU-119,49766530,-2.6347810345662785
23132/87,sirolimus-bortezomib (250-1 mol-mol),0.0673890059049479
SK-MEL-24,4259181,0.7896386879367492
NCI-H1694,JQ-1-UNC0638 (2-1 mol-mol),0.0881504882895817
SK-MEL-3,54618771,0.906293998556286
KMS-27,374536,1.0390671300660683
PaTu 8902,148198,-2.774580136562139
NUGC-3,327653,3.534710126050335
BT 482,46926350,-4.141278195942794
KMRC-20,JQ-1-UNC0638 (2-1 mol-mol),2.8287414261232744
TM-31,11404337,0.421952078244741
TT,24772860,-1.772595910213383
SW982,151289,3.0263381962420373
OPM-2,753704,3.6202062566191984
Yamato-SS,44137675,0.7061000685428093
HCC15,2708,6.122532058448304
Calu-3,49766530,-1.5198016619838384
BT 482,9903786,3.918124147791562
IPC-298,54639665,4.406895640456026
EFM-192A,374536,-0.9283202564063844
UACC-257,4259181,0.0904604772087934
D283 Med,10302451,2.6795990859409695
Hs 578T,6450551,1.3860110692780143
HuT 78,JQ-1-UNC0638 (2-1 mol-mol),-1.5524452367081547
DLD-1,3815108,3.4023651323989883
SNU-C2A,9903786,2.8672741986738193
JHOM-1,9911830,2.1522341035817685
HCC95,11485656,2.1465787672402104
RKN,24772860,-0.333409077824626
HuP-T3,9903786,4.0743016574038915
HPAC,124202324,2.956256349444794
JJN-3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.951248838852545
CAL-27,44137675,2.658526384891045
HEC-59,49766530,-0.0916228108387451
NCI-H647,374536,-1.0414949031211966
SaOS-2,9868037,3.691858985861763
NCI-H1694,100016,6.457618599357896
Hs 888.T,11485656,1.7034904053704143
DB,24753719,3.8531105532779697
YH-13,10302451,3.810654470358069
KMS-34,3815108,1.634942071081216
BT 187,11485656,2.779756722479281
DMS 114,148198,-6.558131209279394
DB,135659046,3.355027747328138
SK-MEL-5,49766530,5.144736864268162
42-MG-BA,136227924,3.1509029182486845
YD-8,1716436,3.08383873816405
DU4475,6918638,-1.1708823120268763
KYSE-450,54618771,1.2705031609145587
SNU-119,10302451,1.573205462567535
SK-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.3293932534534852
CAL-148,10385095,1.1693047418499267
TUHR14TKB,327653,1.6819178430584345
SNU-213,9911463,3.827165589896959
HCC2108,124202324,2.908828368060783
JHOC-5,54618771,0.913993677886488
OCI-Ly10,6450551,3.5251222690228063
Li-7,4259181,-0.2793015764264818
RS4;11,135984461,1.068681958562837
ACC-MESO-1,136227924,3.807440016829928
MSTO-211H,9911463,2.6842905920893108
SUP-B15,24772860,-1.9238493660656315
MIA PaCa-2,9911463,3.5885490135085663
OCI-AML-2,44137675,3.7416497190358977
Ci-1,9903786,3.745611899218518
NCI-H2452,9868037,3.199558399493599
BT 187,156414,1.5104615677540767
NCI-H508,44137675,3.3974289753140736
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
SNU-46,654092,-1.2892331501439938
SK-BR-3,135984461,4.752422329058812
ChaGo-K-1,54618305,4.246058769958448
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
PE/CA-PJ41 (clone D2),selumetinib-BRD-A02303741 (4-1 mol-mol),2.2896148913317087
NCI-H1092,11485656,1.8493866648869597
Ri-1,9903786,-0.2937603570790111
NCI-H1792,2729026,2.847867829447252
UACC-62,136227924,3.255935919058072
SiMa,24772860,-1.8701421725813647
TF-1,24753719,4.143029120811382
RS4;11,9868037,1.846875847822728
K-562,73707371,5.645446798773975
KCL-22,54618305,4.906689630190886
KYSE-150,1716436,3.7207894580698087
SUP-T1,3815108,1.917592883396542
LOX-IMVI,9903786,2.476339692878584
YD-38,136227924,2.6123275605059075
SNU-685,46926350,-4.193022285850987
RL95-2,44137675,2.955159899049689
L3.3,4259181,-1.5745308976200183
MV4-11,11167602,-2.091462426837002
Panc 02.03,1716436,3.766168811644757
PL-21,10385095,1.1291915165256132
PK-1,4259181,0.605699115942288
BT 444,tanespimycin-bortezomib (250-1 mol-mol),-3.2528888157944684
Hs 936.T,100016,5.806135174623166
HL-60,49766530,1.1453309836966632
EFO-21,44137675,4.323476416291745
SK-N-BE(2),2708,3.2917354937886234
SF268,6450551,3.3887116489887203
JHOC-5,sirolimus-bortezomib (250-1 mol-mol),1.676278524948005
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172
ACC-MESO-1,100016,6.4652465436588775
G-401,135659046,3.5574575455214608
EN,11485656,1.3924868534559591
AML-193,100016,3.9854178308912074
PC-3,4259181,2.3252170813684763
SNU-1196,JQ-1-UNC0638 (2-1 mol-mol),4.081575779357341
KYO-1,9911463,3.8919177559591542
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
HCC1806,4259181,-1.395545790075546
NCI-H647,1716436,3.3784040261144805
OCI-AML-2,49766530,-2.1429855478008975
SNU-81,4259181,-0.3131255720640173
JeKo-1,44137675,2.372546178562621
Mel JuSo,135659046,5.566553580989515
HEC-1-A,10385095,1.0280280082495876
SNU-475,sirolimus-bortezomib (250-1 mol-mol),1.5218514057883192
A-549,3815108,3.3223520761089937
SK-N-BE(2),10385095,0.6921659768247342
SNU-5,136227924,2.8950932658181876
MOLP-8,49766530,-0.668776240648524
Caov-3,2729026,2.186742675230839
Hs 578T,9903786,3.085679401941195
NCI-H460,2729026,3.0609463870825926
BT 231,10385095,0.727650114829806
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
IGR-1,sirolimus-bortezomib (250-1 mol-mol),1.4068933313589211
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712
MM1.S,44137675,2.286622980046456
OCUM-1,tanespimycin-bortezomib (250-1 mol-mol),-1.6786100630480447
LS1034,54618771,0.9023023463820332
LXF 289,100016,7.121965810949268
DOV13,9903786,3.8407513521100975
KU-19-19,1716436,3.531012736022478
KMM-1,2729026,3.1721074429192004
NCI-H716,46926350,-4.439844597077301
LUDLU-1,10302451,2.8134983513482363
GB-1,9903786,2.9752485766111936
SW620,54618771,1.1689155284524844
A2780,135659046,3.385733838662662
SNU-1077,2729026,3.1553914055465047
Hs 578T,327653,3.3344882806614304
NCI-H2342,327653,3.668550441144792
WM266-4,16013152,3.674551282240355
LN-229,selumetinib-BRD-A02303741 (4-1 mol-mol),4.018808677153098
639V,JQ-1-UNC0638 (2-1 mol-mol),5.31195628478876
TE-11,6450551,2.070534171912583
LS180,9911463,3.681535048080384
OCI-Ly3,136227924,2.2750950031645885
KCL-22,11485656,1.0950104532816525
SW948,156414,1.6424995325300082
KYSE-410,10302451,1.6161895544560456
SCC-4,JQ-1-UNC0638 (2-1 mol-mol),0.6854400799687678
CL-11,374536,2.86011260301761
UO-31,11167602,1.0241794251111431
Kasumi-1,6450551,-3.1740874491593294
OE21,100016,6.577886119924336
BT 112,24753719,4.155930680700891
Hs 766T,24753719,5.233332005240799
NCC-StC-K140,6450551,1.628923351147111
SW1710,753704,5.183276719259122
NCI-H1869,9911830,2.4210721600025344
HCC1438,tanespimycin-bortezomib (250-1 mol-mol),-1.8197339175047005
Ishikawa (Heraklio) 02 ER-,148198,-2.3973242740422407
NCI-N87,136227924,3.040461203265333
EC-GI-10,6450551,2.061878856661527
PE/CA-PJ15,JQ-1-UNC0638 (2-1 mol-mol),2.4300148232580647
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
769-P,9903786,3.979605140448373
Pfeiffer,tanespimycin-bortezomib (250-1 mol-mol),-0.0267896609776724
IGROV-1,49766530,-0.195540678413639
CA46,11404337,-2.4021967063511434
NCI-H1373,135984461,4.3853156416266
NCI-H1623,9903786,3.0418604220511436
MKN1,49766530,-2.302116655830655
SHP-77,24753719,2.943112918593436
2004,49766530,-2.057712290576902
Panc 10.05,11485656,2.563143068622914
DMS 454,54618771,0.8095302292114137
SIG-M5,753704,4.127265712911682
G-401,156414,1.0662464633968871
HL-60,6918638,-0.8041494190093976
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551
SNU-407,54618771,0.7273608158174886
UO-31,2729026,2.120202709260179
NCI-H322,54618771,1.4640514819881318
EJM,327653,3.072072044008088
L-428,9903786,1.2681458902985745
Tm87-16,136227924,1.7990989939748585
Li-7,1716436,2.5343902301661005
NCI-H661,151289,0.3755226510544496
JHUEM-3,44137675,2.2239893259289456
BC-3C,54618771,1.3234339265863326
SF539,9868037,3.16067122997076
JHH-1,148198,-5.058972904251947
NCI-H661,2708,6.321788786635088
TE-1,327653,3.068282437027353
NCI-H1299,100016,6.953805951258825
Hs 822.T,327653,3.4451810935599925
SNU-C1,49766530,0.3403545416536475
NCI-H1651,9929138,6.746067047112118
KYSE-180,9868037,4.629723429656334
G-361,9911463,3.257776789856645
HEL 92.1.7,11404337,-1.5262741770805954
YD-8,49766530,-2.0839194852213976
DMS 114,JQ-1-UNC0638 (2-1 mol-mol),0.1820059154531149
SNU-119,148198,-2.509458516530883
SK-MM-2,1716436,2.4040294861227176
CAS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.534806631832582
TE-15,136227924,4.530652264188515
ONCO-DG-1,100016,7.582922943410799
COLO 684,11485656,1.9881024376461365
Hep 3B2.1-7,54618771,-0.219926675598239
BT 271,sirolimus-bortezomib (250-1 mol-mol),0.1057701535973337
COLO 201,44493528,5.016521655582729
PE/CA-PJ34 (clone C12),374536,3.765928674441179
U-937,JQ-1-UNC0638 (2-1 mol-mol),2.429393524186576
L3.3,11404337,0.7171912876466348
NCI-H2286,9911830,2.040869356534873
HCC-56,49766530,0.5665552829970477
HCC2108,327653,2.5162191828052713
MDA-MB-415,9911463,3.632692855147505
786-O,2708,4.916944711081505
SW579,135659046,3.634666498260953
CAL-78,sirolimus-bortezomib (250-1 mol-mol),0.4097773819170223
A-549,11485656,2.1977599259975764
HCC2279,327653,3.624968533475722
MOLM-6,6450551,-1.210592139491749
SU-DHL-1,135984461,1.9491307161872016
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958
JHH-1,1716436,3.829942104019316
GI-1,1716436,3.3697427678564273
Namalwa,54618771,0.6847017954935718
CAS-1,9911830,2.812931698425885
L-1236,100016,5.644363792904431
Kasumi-2,54618305,4.391643278203803
NCI-H2081,374536,1.9264579533537656
SNU-1041,136227924,4.256354114890169
YH-13,11404337,1.1602704800571209
BT 422,9911463,3.7605478097150704
MV4-11,24753719,3.2063608225430618
KYSE-180,54618305,5.290256883782679
FU-OV-1,9911830,2.8434321082933773
MEC-1,6450551,2.4689710762141575
SNU-475,49766530,3.8108218409500063
SNU-620,tanespimycin-bortezomib (250-1 mol-mol),-1.6605884966990527
Calu-1,11404337,1.1287217214353569
NCI-H2452,100016,6.6405878618594985
IGROV-1,9929138,6.483056540257463
BT 340,148198,-3.6521537693808654
LCLC-103H,11404337,0.85397290991948
HCC44,11485656,1.7726273089694435
NCI-H1105,136227924,3.5995085606393955
CAL-120,selumetinib-BRD-A02303741 (4-1 mol-mol),4.953113114488385
PK-1,54618771,1.395529069214854
CA46,11167602,1.6890466560929325
OE19,374536,3.858849639301116
SK-MEL-1,3815108,3.1523911920687726
A2780,136227924,2.141563547945887
RMG-I,374536,2.9625918708767025
KO52,49766530,-2.9689315906411413
ZR-75-1,3815108,2.6946236586051504
TE-5,9843750,6.210993434088976
JHUEM-3,11485656,2.0558841747808776
NCI-H2172,9911830,3.117247767846657
NCI-H2405,9868037,0.0658407711920554
JHUEM-3,6918638,0.235039867332202
KCL-22,9911463,3.4603287312388415
HEC-251,11485656,3.0067875712953
MHH-ES-1,JQ-1-UNC0638 (2-1 mol-mol),0.7408680741377575
BxPC-3,24753719,4.274594841538204
KALS-1,654092,0.1045779137887777
PLC/PRF/5,49766530,1.3653713216930163
LC-1/sq-SF,9911830,2.3973798476022985
SNU-620,4259181,-1.486057650268119
JIMT-1,24753719,5.242052344798916
COV434,1716436,2.2246217728290145
SK-N-AS,151289,0.954369852434549
SNU-C5,124202324,2.0022509252625116
CMK,49766530,1.0776761429399353
LAMA-84,9929138,5.193234250593021
KP-2,49766530,0.3701885896643133
A-673,46926350,-6.171938943197618
JL-1,374536,-0.2690303159673372
NCC-StC-K140,11485656,0.9204064726485376
Karpas-620,135659046,3.5237997077765275
Hs 294T,10385095,0.86114024133981
HCC1806,49766530,4.996924493962182
KP-2,24753719,4.333444273795511
NH-6,11485656,1.6969072995394532
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
T84,11167602,2.5996752416167492
HCT 15,11167602,1.5955189866784438
SUIT-2,136227924,3.4861054974924133
HCC2279,374536,4.248636774196492
CAL-51,4259181,-0.5132501801478601
FU-OV-1,124202324,1.4335087059128786
ST486,148198,-7.753163237406848
FTC-238,135984461,5.145147478477925
253J,136227924,2.473625062581448
SW1353,24772860,-0.9669202709751876
SNU-449,24753719,4.452712705797618
SK-MEL-31,tanespimycin-bortezomib (250-1 mol-mol),2.560525845699468
LoVo,2708,4.2308362163689415
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
SNU-46,sirolimus-bortezomib (250-1 mol-mol),2.213576797303729
BT 428,1716436,2.552784613335119
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567
DK-MG,10302451,2.909618519065636
Caov-3,135984461,4.111460769399049
CW-2,136227924,3.283467391951437
Mel Ho,124202324,2.0685538955296803
NCI-H446,135984461,1.479932164265367
697,135659046,2.7406453886964837
NCI-H1395,10385095,0.8966814857932361
SW948,9903786,1.6902329933335576
Namalwa,11485656,1.3808834074055636
HPAC,3815108,2.792966622495164
KO52,24772860,-1.0448231719232914
HuH-6,16013152,4.071601906125075
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
RPMI-8226,148198,-2.569854341665414
A-253,24753719,4.312803034067271
NCI-H520,24753719,4.403096106170392
TCC-Pan2,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.0029448842689352
JL-1,6918638,1.5598435396772805
SNU-C5,136227924,3.8791329718590264
KNS-81,9911463,4.180814120115767
NCI-H727,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2513080779268564
TC-71,100016,6.681443396825605
P31/FUJ,11485656,1.9746673234827223
OVCAR-8,11404337,-0.7516792511202276
NCI-H226,156414,2.826440859061599
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
EC-GI-10,54618771,2.241833399474009
TE-11,sirolimus-bortezomib (250-1 mol-mol),1.0808686364833595
OS-RC-2,9911830,2.682411797844001
CJM [Human melanoma],6918638,1.423162618874033
NCI-H2085,10302451,1.3740847824002096
Panc 10.05,24772860,-1.0858494442238409
SNU-5,9903786,3.415136592873371
BHY,654092,0.4317851601610876
SNU-761,73707371,4.589848481837525
U-937,10302451,3.755425141733516
NCI-H1869,1716436,2.9410548139521744
Rh30,11485656,2.766839981757524
COV362,1716436,3.4302562022001326
TC-71,374536,1.285029194537173
253J,54618771,1.0062396076481863
PE/CA-PJ34 (clone C12),24753719,4.157355819781257
KO52,135659046,3.503950077041595
NCI-H524,JQ-1-UNC0638 (2-1 mol-mol),0.6440823727781521
BL-70,49766530,-0.8526727850489186
ONS-76,11485656,2.5953354109263262
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
SNU-308,44137675,3.0382663195493382
SNU-213,2729026,3.0209743245550587
CMK,6918638,-1.0640278448730467
SF268,10385095,0.0686798865721721
Kasumi-1,46926350,-4.414359832231656
TOV-112D,135659046,3.4067984131913938
EFO-27,6450551,4.042476340029328
NCI-H2228,135659046,3.319323346147118
Kelly,2729026,1.581052419198738
HPAF-II,sirolimus-bortezomib (250-1 mol-mol),1.6842797227364328
CAL-12T,11485656,1.8742108242710025
HEC-1-A,JQ-1-UNC0638 (2-1 mol-mol),2.1573321504892347
T24,151289,1.4658329777119563
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
NCI-H727,44137675,3.902640688581202
NCI-H460,10385095,2.2920897819597896
SJSA-1,44137675,3.018518229427906
OAW28,753704,4.708152366597851
HT-144,10302451,3.8668226201155873
EN,148198,-4.716132059388744
COR-L88,24753719,4.4645681423957715
PK-45H,11404337,1.3434585990232362
BICR 22,2708,5.160276397343071
Hs 746.T,10385095,0.9219781932462268
DB,44137675,3.706161403126065
SYO-1,sirolimus-bortezomib (250-1 mol-mol),0.8994859794760022
DK-MG,1716436,3.4757216048100643
WSU-DLCL2,3815108,-0.0836346608185108
KHM-1B,151289,0.8227956110380268
TCC-Pan2,135984461,4.348420574958303
FTC-238,9911463,4.0725433031762694
Ki-JK,753704,4.059248290807939
TT,9911830,2.7097540561392637
JMSU-1,654092,-0.2061795174649266
NCI-H1666,54618771,-1.5571959335462928
A-673,54618305,4.212251300263772
SNU-601,374536,0.4765918853136777
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433
FaDu,148198,-4.955627855681465
SK-N-BE(2),11404337,-0.1394184505793084
SU-DHL-8,2708,2.3904841180515244
VCaP,2708,6.137380986386661
NUGC-3,11404337,-0.7682490419788565
A-375,654092,-0.3575589694408204
COLO 201,9911830,2.293891105725039
ECC10,49766530,-0.6021024707846206
SNU-840,9911463,4.425436668411372
BT 286,327653,3.383263992676688
HMC-1-8,3815108,3.4457105229038683
Hs 746.T,54618771,0.5763857654673513
NCI-H1355,11404337,-0.5901548623910822
MOTN-1,156414,1.1092606915389736
A4/Fukuda,10302451,3.353566161735505
COR-L105,49766530,-0.5480688242609842
NCI-H292,374536,1.098561227965989
T98G,16013152,3.710932124367844
SNU-61,654092,-1.5451038120184588
WM115,24772860,-3.130789858430774
NCI-N87,100016,7.118039999797619
EFO-21,44493528,4.429307418549765
BT 159,6450551,2.80770411679687
WM88,9911830,1.6479325280433286
GI-1,11485656,2.981503140786654
Ishikawa (Heraklio) 02 ER-,9911830,3.5571735826815827
NCI-H1373,44137675,4.085083200227041
BT 328,11404337,1.5843001055688009
Hs 822.T,46926350,4.267730507169214
SW948,4259181,0.2292867461834122
HuP-T4,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.571696137230899
SU-DHL-1,151289,-1.0536473601541108
CFPAC-1,24753719,4.623602158880275
SF539,10385095,0.5044778211988786
A-498,10302451,3.720340150939392
OCI-AML-5,1716436,3.7983029660077015
Peer,44493528,3.441371603588331
Hs 822.T,9868037,5.178466658447283
SNU-601,10302451,3.762945529134958
NUGC-4,10385095,2.5267185642809498
CAL-148,151289,0.9521897992950412
HT,753704,4.4132889749934625
Karpas-299,3815108,1.5368571938201931
BT 271,9911830,2.9198320046580952
A-204,100016,6.602223097366851
SNU-466,9911830,2.2807383829055077
CAS-1,11167602,3.00714266116136
BC-3C,151289,1.3111890606245775
T24,100016,6.183675550900896
KYM-1,136227924,2.3887987595454594
LS513,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.2232600430378815
DV-90,1716436,2.476674048176274
NCI-H446,49766530,-2.3059028658542116
COLO 680N,124202324,2.7512269386164583
H-STS,100016,5.985929376611731
NCI-H23,148198,-4.855451387960017
BT 164,10385095,0.5505711348294146
NCI-H650,10385095,0.8249157569073927
LCLC-97TM1,4259181,-0.2611730486969081
SNU-761,2708,3.6947734743756033
TF-1,9911830,1.994265773553068
BT 224,2708,7.101612259272804
RPMI-8226,2729026,2.332105768203265
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
Hs 766T,136227924,2.630952750368734
MOLM-6,10385095,1.035160122785837
UACC-257,54618771,0.929112305561946
Caki-1,10385095,2.9849389864820473
SUP-T1,136227924,2.470227214750311
MeWo,44137675,3.1693512854645096
Mono-Mac-1,6450551,2.178466389519658
ST486,100016,6.384120256869386
EoL-1,73707371,4.554484660299208
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
QGP-1,4259181,-0.6804082450631646
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
LoVo,11404337,-0.8407014552816361
MDST8,654092,-1.4293910300938224
NCI-H28,148198,-2.5352174155891234
K029AX,44137675,3.712157106363775
WT2-iPS,6450551,3.4273977563972435
NCI-H1755,JQ-1-UNC0638 (2-1 mol-mol),1.5841130496523692
NCI-H23,6450551,2.663042420758727
BFTC-909,6450551,3.0302116860685886
HuH-6,374536,-0.5041178583364099
BT 440,1716436,3.0638178772704663
Malme-3M,sirolimus-bortezomib (250-1 mol-mol),2.279282073181017
HEC-108,374536,1.892261126227868
Hs 294T,9911463,4.3958964450734594
Hs 729.T,148198,-2.5851950903835834
KPL-1,11485656,3.597830436123724
NCI-H2444,136227924,3.2293818919988153
Hep-G2,10302451,3.0105378640601037
HeLa,9911463,4.222129751403694
BT 504,327653,3.327628019841459
J82,9911830,1.861677357904933
NCI-H1385,135984461,3.701163403463682
CML-T1,2708,2.830885116766648
COLO 792,10302451,3.8709383103233095
CCF-STTG1,11485656,3.67410233042364
JMSU-1,9903786,1.2487858864951975
NCI-H2444,JQ-1-UNC0638 (2-1 mol-mol),3.79796844842386
2004,753704,4.592630200430432
SNU-489,654092,-0.0581491777135673
PK-45H,24753719,6.262848613391698
Hs 683,11485656,3.0003726107919437
COR-L95,49766530,-0.268325836176492
TE-8,24753719,4.333493803280939
TE-1,11404337,-0.7530649857442655
EN,4259181,-1.2410580135175182
SU-DHL-10,148198,-3.583469156036767
KP-4,24772860,-2.8953644342348683
WM983B,24753719,6.015635762527396
COR-L95,2708,4.088828930735336
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
NCI-H1155,151289,-0.2120642724394082
COLO 320,6918638,-0.2537054006659544
RKN,2708,5.19327789915259
SBC-5,54618771,0.9612938071948806
A-253,sirolimus-bortezomib (250-1 mol-mol),0.2141066423714133
OCI-Ly10,1716436,4.263870299156349
NCI-H747,9911830,2.514395107340635
MOR/CPR,124202324,1.15767013274831
OE33,2708,6.821069396590593
OE33,46926350,-4.3039480497161335
KP-3,9911830,3.156441375051414
QGP-1,49766530,0.3270238560259029
OCUM-1,6450551,3.442247602172522
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256
KMS-26,49766530,-5.317731060061128
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
ONS-76,11404337,-0.4259392266769182
RL,10385095,0.7021691282485717
COLO 829,9903786,4.931323632089431
CAL-33,10302451,1.3669984318824204
HCC15,54618305,4.644823264977023
GDM-1,2708,3.82136646690024
SW1573,9911463,3.734935340044018
RPMI-7951,49766530,-2.0352614049405178
SUP-HD1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.026579145847232
Pfeiffer,156414,0.4848945589525521
DMS 273,10385095,0.5027476993233067
COV434,10385095,0.8854468588798045
UM-UC-3,24753719,3.867864319815473
Ki-JK,3815108,1.8199119246642073
CHP-126,9929138,6.335241995637564
697,9929138,3.2982563407186447
CML-T1,54618305,-5.881736901302383
NCI-H647,46926350,-4.287716947966526
5637,9929138,6.240532566215687
CAL-85-1,54618771,1.8439388085147956
NCI-H2122,10302451,3.7465874333262654
U-937,10385095,1.0203935809420186
OCI-M1,11485656,1.896897846334656
NCI-H2023,753704,4.94431355419524
8-MG-BA,44493528,4.684736338919144
SET-2,54618771,0.9858111819135928
NCI-H520,54618771,1.0653077757718592
NCI-H1184,10302451,3.191848520716454
Panc 08.13,46926350,-3.802842626609358
EFO-21,54618305,4.527789159608335
HEC-1-A,9911463,3.802015322835987
ALL-SIL,24753719,3.3195109491118635
Calu-1,6450551,3.8205786383410136
KM12,54618305,-4.709576860439217
K-562,54618771,1.1969173800987956
SNU-840,2729026,2.996261188349731
SNU-5,4259181,-0.7448784030448398
CAL-62,151289,0.7848018794817876
PC-3,2729026,3.2008196051952216
EJM,16013152,4.173303948908386
NCI-H1792,100016,5.097619126157972
BT 330,10385095,1.0976852552783771
BT 440,71729975,2.1411771875170196
Calu-1,4259181,1.7629989147872749
TT2609-C02,148198,-4.067682377200374
SU.86.86,sirolimus-bortezomib (250-1 mol-mol),0.3340737576471567
SW1353,2729026,3.1505287571497194
KMS-18,1716436,1.9545175367701793
Hs 936.T,44137675,5.160581447890313
KMS-11,9911830,1.2501583095851283
Hs 683,100016,6.526692615081327
SU.86.86,124202324,2.8842475215476
Daoy,135984461,2.2950744051926497
COLO 684,sirolimus-bortezomib (250-1 mol-mol),-6.565635252448311
BT 482,2729026,1.4695356007856668
HCC1428,54618771,4.504577297987602
COV644,11485656,2.222554358198117
SNU-869,6918638,0.8592076478427688
SW48,24753719,4.052743892866938
Ri-1,10385095,0.3591008967084118
YD-8,9903786,2.667696713101927
SCC-9,11485656,3.6663619913543446
NCI-H1915,156414,1.5545026473918255
HOP-62,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7687331733710137
IGROV-1,2729026,2.3541792737160296
NCI-H1623,JQ-1-UNC0638 (2-1 mol-mol),2.6843347454635604
SH-10-TC,11167602,1.8651287635055684
SNU-738,9903786,3.5811355233288773
NCI-H1793,9868037,4.171600355487511
SNU-398,44137675,3.852210992232677
MDA-MB-415,JQ-1-UNC0638 (2-1 mol-mol),1.7664030622918387
SK-MEL-5,4259181,0.9764517115857632
FTC-133,148198,-1.6568063805549866
OCI-Ly3,9911830,2.1983538699669394
ESS-1,9903786,1.7886366060040666
PSN1,16013152,5.253344146537083
HCC202,9911463,4.016113462481005
SK-N-MC,54618771,0.9306599486262166
Hs 611.T,16013152,4.086907930455013
SNU-81,124202324,-1.5604837877349913
PE/CA-PJ15,10302451,1.647301447843495
A-253,135659046,3.360976512621253
RERF-LC-Ad2,9911463,4.319203395941844
NCI-H1623,9911463,3.95788841498078
NCI-H2023,54618771,0.8725356592337147
L-540,124202324,1.013707692299372
A-375,654092,-0.3575589694408204
U-BLC1,10302451,-0.4891280402389555
HEC-265,tanespimycin-bortezomib (250-1 mol-mol),-1.1174681512441365
NU-DUL-1,49766530,-3.828248490513479
EJM,44137675,3.342808530148661
KE-37,44494015,-5.121109783937924
SNU-1196,11485656,2.2971817788007183
RERF-LC-Ad2,374536,3.127585092037682
K029AX,10302451,3.727811549907541
BT 228,JQ-1-UNC0638 (2-1 mol-mol),3.833257728613677
Mono-Mac-1,2708,2.725116801773413
CAL-12T,654092,0.1410668572660321
TE-9,135984461,4.389815989870175
OCI-AML-3,JQ-1-UNC0638 (2-1 mol-mol),-3.448312405561265
CHP-126,54618771,-1.2207824703172212
BT 333,sirolimus-bortezomib (250-1 mol-mol),0.4281916150518835
TYK-nu,49766530,-1.9829356479605205
RERF-LC-Ad2,753704,5.049271110646248
HOP-92,100016,6.879559613863246
DEL,374536,2.814632882734084
SK-N-MC,24772860,-2.897057398461603
ECC10,156414,0.8829858531470315
TE-15,100016,6.263488161224716
SNU-C1,4259181,0.4442529184524438
COLO 668,54618771,1.2538028479070895
HCC1419,11485656,3.3617833706326277
BT 428,135659046,3.573763038343519
MSTO-211H,100016,4.243846732059744
HEL,44137675,4.224171499328968
MOLT-16,135659046,3.348397173147883
BT 498,2708,6.0510362109636455
NCI-H1651,54618305,4.375363168358667
PL-21,2729026,1.8760846479647657
697,11485656,1.0677587184410018
SCC-9,10385095,1.4052834583911455
HCC1143,44137675,2.963488174732173
COR-L88,10385095,2.957735311196338
NCI-H727,327653,3.8552398443183193
WM1799,753704,5.085990862428736
NCI-H2444,54618771,3.319337103675071
SU.86.86,156414,2.3553345636516148
647V,753704,4.656615756633524
HEY A8,327653,3.456207211282535
NCI-H526,135984461,1.6602336964556588
8505C,100016,6.577733697234268
NCI-H1355,148198,-3.013300378590096
A3/Kawakami,selumetinib-BRD-A02303741 (4-1 mol-mol),4.954304172385198
ChaGo-K-1,JQ-1-UNC0638 (2-1 mol-mol),1.6534960397455791
BT 187,11404337,1.604866987850638
Tm87-16,9903786,3.2568482334104587
JM-1,11485656,1.6613246077420758
SNU-5,24753719,4.11741377949036
BCP-1,374536,-5.774604213392271
SK-N-BE(2),753704,4.527123945585127
Mel Ho,136227924,2.792099034627563
NCI-H2081,24753719,4.037731991107883
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
BICR 6,11485656,1.8767182695378195
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
SCC-25,11485656,1.624439793066487
HOS,100016,6.425173790511516
OE19,100016,6.21408400033578
CML-T1,327653,2.5732071532781866
HCT 116,sirolimus-bortezomib (250-1 mol-mol),1.7104818148268468
SaOS-2,10302451,5.268852772808677
VMRC-RCW,124202324,2.4564470912885352
SW579,24753719,4.045318345169703
MDA-MB-361,49766530,-1.160190626946109
CAL-27,6450551,1.4655896829923214
BT 271,11485656,2.2293362300863016
EM-2,100016,3.5566389909433913
SNU-213,135984461,4.435605101205859
LNCaP clone FGC,753704,4.7408710893467525
FTC-238,100016,6.441740826290021
DK-MG,sirolimus-bortezomib (250-1 mol-mol),0.0484701224362502
HCT 116,151289,3.8957555216898583
VMRC-LCD,11485656,1.8176321806721345
Kuramochi,327653,3.5969647053028297
HCC1588,11167602,2.5321103891623755
HCC4006,9911463,4.4581598628848385
Hs 611.T,11485656,1.370862895697381
LOU-NH91,4259181,1.0248896787271708
LMSU,4259181,1.0604093757007595
HCC2935,JQ-1-UNC0638 (2-1 mol-mol),3.63252992063401
IGR-1,44137675,4.323354790424998
BFTC-909,654092,0.6323398211983356
OC 314,11404337,-1.3108205145467993
Kasumi-1,148198,-3.174700681388165
GP2d,135984461,3.863711386365813
KM12,2729026,2.453423866897574
CW-2,2729026,2.4099488143203116
LN-229,124202324,2.5208349006679827
NCI-H1435,tanespimycin-bortezomib (250-1 mol-mol),-3.816394464229111
Granta-519,327653,2.833903719231272
HT,156414,0.9679138644870768
Sq-1,2729026,2.6827501636169004
RCH-ACV,9903786,1.555646026251057
TALL-1 [Human adult T-ALL],3815108,1.9685855062616469
NCI-H1755,3815108,3.108378734333356
NCI-H1435,10385095,2.199410869757901
BT 440,24772860,-1.8405005285147795
MDA-MB-157,10385095,0.7848337329764868
HEL,11485656,1.96241131365886
Hs 683,73707371,5.528718161611099
AGS,4259181,0.9678254613735656
SW1417,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.799480774710106
LNCaP clone FGC,9911463,2.657029606210989
SYO-1,44137675,5.406900612459481
BT 340,1716436,2.972691956161054
RERF-LC-MS,73707371,5.9060077591992375
BT 216,9868037,4.409348845364788
SU.86.86,JQ-1-UNC0638 (2-1 mol-mol),3.064236587137807
SJSA-1,11167602,3.0869867358954126
BT-16,4259181,-2.0652151566273687
CAL-120,sirolimus-bortezomib (250-1 mol-mol),1.988882229228272
TE-5,135659046,3.5312451731544887
MOLT-13,9911830,2.6271761500921436
ZR-75-30,2708,6.723700578110757
TE 617.T,327653,3.0456722347172738
A2780,753704,5.064252843259393
Lu-99,10302451,3.8598080136614463
HCC2218,135984461,4.242222575016064
KMS-28BM,54618771,-1.095324315742339
NUGC-4,49766530,-0.8370280457407315
HSC-2,374536,3.9447081032501825
K-562,2708,5.362475494708341
NB4,6450551,1.1025758880526084
RS4;11,10302451,3.317269387656833
MFE-296,2729026,3.010402072792925
TT,9911463,3.632649980547299
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
HMC-1-8,11485656,2.285231442211603
NUGC-3,2729026,2.522310882878487
HT-144,6918638,0.3712139680778337
SNU-245,11485656,2.4335561364098073
SNU-1079,9903786,0.8372132722803839
CAL-85-1,1716436,3.5334952917768856
23132/87,tanespimycin-bortezomib (250-1 mol-mol),-3.0777539592464227
Kelly,135984461,4.326005791878528
A-673,2729026,1.806074207860909
HGC-27,374536,0.7475716320500141
BT 248,2708,3.971792549478314
CAL-85-1,tanespimycin-bortezomib (250-1 mol-mol),0.6735355915529317
TE 441.T,selumetinib-BRD-A02303741 (4-1 mol-mol),6.646410101697854
22Rv1,136227924,2.1207718843699
EKVX,10385095,1.522200885711341
Calu-1,49766530,-2.4151861357185056
CAL-51,10385095,1.0305027810027567
SNU-407,10385095,1.195722316637187
NCI-H1944,148198,-1.2530067367581603
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268
SNU-216,11167602,2.868305973285908
BICR 22,44137675,4.05989667865121
SW1710,44137675,3.907026448323467
CJM [Human melanoma],10302451,4.063448301727013
SNU-503,tanespimycin-bortezomib (250-1 mol-mol),2.9801728047374527
Lu-65,6450551,2.7504557030292536
DMS 79,44493528,4.912262221382906
NCI-H146,4259181,0.4591034911128469
OPM-2,2708,4.148168261065231
EFE-184,73707371,5.433385653304443
Hep 3B2.1-7,2729026,3.0424078117099222
BT 340,9911463,3.653234979635605
NCI-H2452,11404337,-0.3859535574072682
MDA-MB-468,46926350,-4.282337065844575
SW1710,54618771,1.2075824947863512
BICR 56,selumetinib-BRD-A02303741 (4-1 mol-mol),5.22627055175062
HSC-3,135984461,4.3923039521515985
LC-1F,6450551,3.424607175453027
ZR-75-30,46926350,-4.10892674979014
CAS-1,73707371,4.546843317727394
SU-DHL-1,124202324,2.3695119203399906
COV644,1716436,3.269175067284096
PE/CA-PJ41 (clone D2),46926350,-4.147494245167489
MHH-CALL-3,654092,-0.940977571817736
BT 320,4259181,1.858689674297262
SNU-201,11485656,3.6136965071696903
HCC1833,9911463,3.7741336364868943
Panc 10.05,148198,-3.9084182720611618
NCI-H2030,73707371,5.115486799100736
UO-31,6450551,3.102412451997309
COLO 320,135659046,3.560187032006994
SK-MM-2,10302451,2.9274692632191543
DND-41,1716436,2.5980902531596883
L-540,24753719,2.8573995264136256
CAL-85-1,24753719,4.0831645287035325
MV4-11,151289,-0.1098301284382294
HD-MY-Z,2729026,3.067112619160507
RPMI-6666,2708,3.0627163689715613
JHUEM-7,11485656,1.7197285505227566
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453
ZR-75-1,4259181,0.5908023263806823
EJM,6450551,3.4833257379535967
NCI-H1694,374536,0.570269277791063
DLD-1,2729026,3.174702403711638
KPL-1,156414,2.530967902679832
SK-LMS-1,6450551,3.8959522130422135
Peer,9911463,2.710753746966499
DMS 454,73707371,2.8662833767759786
VMRC-RCW,3815108,3.3563092043526157
HEL 92.1.7,tanespimycin-bortezomib (250-1 mol-mol),0.3488899515335228
MG-63,136227924,3.2795436313273685
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957
KNS-62,49766530,5.605619598661556
NCI-H23,44137675,3.221248046420083
TYK-nu,100016,5.6630271022409495
KP-N-SI9s,654092,-0.9816572532590764
NCI-H1184,9911463,3.5599804039419225
SNU-478,9903786,1.906264308135136
NCI-H1944,136227924,3.273500409836235
SNU-489,sirolimus-bortezomib (250-1 mol-mol),1.5186743345934282
LP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.242971676361593
Capan-1,46926350,-4.595989334301445
KYM-1,10302451,3.948612855520952
Daoy,156414,1.891767382024244
MeWo,49766530,4.570214778123743
SW48,124202324,1.4616392816877528
PL-21,2708,4.165678032261031
KP-2,2729026,3.0056741053331377
Hs 766T,6918638,1.6874780240509222
RERF-LC-MS,11404337,1.609147033115388
AGS,100016,6.525427767108566
NCI-H661,148198,-4.235070372495308
SK-N-FI,16013152,4.075385579936114
NCI-H1395,54618305,4.493399620925908
Ishikawa (Heraklio) 02 ER-,124202324,2.794171738884469
KMS-28BM,654092,-1.459893973234386
NH-6,753704,4.160922023274414
OE21,54618771,-0.7908986466721764
647V,sirolimus-bortezomib (250-1 mol-mol),0.3544770314623594
OCI-Ly19,49766530,-0.0820002075595115
LS180,54618305,4.3130332958468385
Granta-519,54618771,-0.1786557603441652
HEC-151,9903786,2.765131251863377
NCI-H292,54618771,0.019803014891406
UACC-62,135659046,3.5566231675799123
8-MG-BA,374536,1.214919650479023
KMS-20,44137675,3.5747690218783075
MDA-MB-453,44137675,2.41330993625909
HT-1197,136227924,5.329383648142769
NCI-H2023,100016,7.201065180404722
SNU-1076,6450551,4.360703980354651
KO52,44493528,4.373207696272561
MOLT-13,44493528,3.6363745725597663
OPM-2,156414,0.898749748032719
NCI-H1915,54618771,0.2887330377515757
COV434,151289,1.2832904679997172
KP-N-SI9s,753704,4.460022149702615
HEC-151,100016,5.913951457428463
SW1271,4259181,0.7411137136724786
A-549,24772860,-0.5810344959117316
HEC-151,44137675,3.543841403432853
COLO 792,753704,4.976174772483224
JHUEM-3,16013152,2.973379149638453
Hs 578T,9911830,1.8415488310129824
HCC1395,44137675,3.8634466393744606
SK-MEL-1,10385095,0.7361766454760428
SUP-B15,148198,-7.712554258926361
SW982,JQ-1-UNC0638 (2-1 mol-mol),2.2517531956964874
TC-71,6918638,-0.2365825415632411
JURL-MK1,2708,3.040283967961394
U-118MG,selumetinib-BRD-A02303741 (4-1 mol-mol),5.543616378384047
MDA-MB-453,6450551,2.407686053683273
Panc 10.05,9911463,3.4870522809555653
OVCAR-4,654092,-1.524113428099166
NCI-H441,10385095,1.8039460773304927
GMS-10,136227924,3.0615637003217433
NCI-H1975,tanespimycin-bortezomib (250-1 mol-mol),-1.468609028011694
NCI-H23,9843750,4.3522177613699835
DLD-1,11485656,2.3568944712776565
BICR 31,46926350,-4.294934659479777
MKN74,16013152,4.862549736803779
T-47D,2729026,3.099579676504044
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
A-673,11167602,2.442600782118551
SNU-738,10302451,4.376715699203647
NCI-H647,135984461,5.580010344943138
42-MG-BA,24753719,4.475529386283597
COLO 699,44137675,3.5806655418846636
MSTO-211H,10302451,2.2723798321327826
HCT 15,2729026,3.0390465390214225
CAL-54,156414,1.1305015543844827
COLO 205,654092,-0.5640958842557027
OV-90,9911463,4.122087400059479
HOS,10385095,0.7815307414607308
JHH-1,9903786,3.3314474186941987
IGROV-1,156414,1.4212019235656712
NCI-H889,54618771,1.1876594721233993
NCI-H1694,6450551,1.5149240168918323
PE/CA-PJ41 (clone D2),6918638,0.5938730898283403
YD-15,9929138,6.969661467519232
NCI-H1694,135659046,3.770401283474136
TE-1,44137675,5.095183237584548
HCC1588,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.5372537543338085
SUP-T11,6450551,1.3442368973585788
LN-229,sirolimus-bortezomib (250-1 mol-mol),1.3963325511705935
Hs 839.T,100016,7.045878686884313
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
HuH-1,73707371,5.142027294343785
TTC-709,151289,1.6959630420615608
OC 314,JQ-1-UNC0638 (2-1 mol-mol),-0.4231280527900947
A-549,54618771,0.0374822867627876
HeLa,11404337,0.8471506482049684
MCF-7,11485656,1.7556597591503045
TE-15,6918638,-0.5881050446638335
BT 248,6918638,2.3802175448525844
OV56,54618771,2.692220458386417
VM-CUB-1,136227924,2.7643713240945016
NCI-H2342,374536,3.5966969725242532
DBTRG-05MG,654092,-0.1282191189097445
RKO,124202324,3.4391315101947386
Capan-1,6918638,0.6786915212188055
NCI-H1581,156414,1.3302428949057634
NCI-H747,156414,0.8289328165343802
MeWo,156414,1.6220701053299502
BT 330,6918638,2.094290704712354
NH-6,135659046,3.541103193914359
IGR-1,136227924,2.467918205864833
HCT 15,selumetinib-BRD-A02303741 (4-1 mol-mol),5.020493243180709
RD,9911830,2.165941328253821
Ki-JK,135984461,3.4417965783615414
HDLM-2,9868037,2.9118865294279943
KMRC-3,54618771,0.1504826951638593
253J,151289,0.7360862504865807
Rh30,327653,2.580303479692579
NCI-H211,654092,-0.8419559848167115
SCC-4,135659046,3.853752534308609
NU-DUL-1,3815108,1.7852562222380772
SK-N-SH,2708,3.033337957101563
Ri-1,148198,-2.551976890306858
TTC-709,11404337,-1.0402819998142765
TF-1,10302451,4.088876235696949
JHH-5,1716436,2.617876714183929
Mel Ho,sirolimus-bortezomib (250-1 mol-mol),-0.1905502812400849
22Rv1,151289,1.007598941295024
NCI-H2228,44137675,3.05590881483147
J82,9903786,4.0002373465355054
BT 330,11485656,2.0154555749445486
HCC1500,1716436,1.6304357372897462
TCC-Pan2,9903786,4.661219913833123
BC-3C,1716436,3.821199681154137
OCI-M1,24772860,-2.497308212893185
Hs 729.T,100016,6.726636381823557
NCI-H2228,124202324,2.308556333234916
PC-14,654092,0.4321002454947655
Hs 936.T,9903786,5.166198075920313
SNU-423,24772860,-1.7391670370922852
PK-1,1716436,3.838140183214959
SUP-M2,24772860,-3.89720654432188
23132/87,100016,5.572734576179291
HMC-1-8,54618771,0.1355198199402433
HEL 92.1.7,753704,4.2757489499650525
SW579,4259181,-0.0150146553014248
KYSE-520,2729026,3.0173309744028196
GI-1,49766530,-2.6650453503199776
OAW28,374536,3.018534312402979
NB1,148198,-3.561565130564965
SNU-1105,54618771,1.067302549999792
OV56,9903786,4.181691762553772
Calu-3,tanespimycin-bortezomib (250-1 mol-mol),0.4939757205414833
NCI-H747,2729026,2.053786919010379
AsPC-1,44493528,4.313387127964929
LNCaP clone FGC,JQ-1-UNC0638 (2-1 mol-mol),-1.7433469805632364
MOR/CPR,3815108,3.469612221368349
NCI-H647,11404337,-0.2592601702494094
HCC4006,327653,2.5941924214272865
NCI-H2052,54618771,-0.8339738497532683
697,327653,2.345786210451013
HCC2935,2729026,1.191634718672708
NCI-H1299,136227924,3.5346618762414392
G-402,24772860,-2.5668390274147415
KU-19-19,44493528,4.383684457454455
T-47D,753704,4.432702778350492
A-204,sirolimus-bortezomib (250-1 mol-mol),0.1160777276351835
TE-1,148198,-2.725381459547287
B-CPAP,100016,6.506572981316216
DMS 273,148198,-4.27913692458833
IGR-1,156414,5.315978843201624
C2BBe1,10302451,1.7353429150256774
A-549,9929138,6.139762216307962
DU145,136227924,5.593457102459236
OUMS-23,10302451,4.74180958679891
CAL-85-1,2729026,3.0179701538052455
LS123,3815108,2.3851817980469545
HPAF-II,selumetinib-BRD-A02303741 (4-1 mol-mol),3.335118796081211
NCI-H2228,654092,-0.9138323045853112
Hs 940.T,135659046,5.2418708204303615
NCI-H1581,9911830,1.518181983178349
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
RS4;11,6450551,-0.4660502813041963
Yamato-SS,9843750,4.1271157082045375
CAL-148,54618771,-0.772242663626429
CW-2,374536,-1.5063066517786443
NCI-H716,2729026,3.0409126954919414
JJN-3,2708,4.419987177972876
SNU-620,100016,4.241219903285237
HCT 8,156414,1.6609441441146586
Rh18,327653,2.9723981454496404
CAL-12T,selumetinib-BRD-A02303741 (4-1 mol-mol),5.796843924178018
HuP-T4,135984461,3.493927750187572
UM-UC-3,11404337,0.461237449604962
SCC-4,6450551,2.9380821383591185
SNU-119,124202324,4.249664634956003
NOMO-1,2708,4.2098167660909525
SU-DHL-10,156414,1.2604313113542105
TF-1,JQ-1-UNC0638 (2-1 mol-mol),-0.4066741470585596
BICR 22,100016,6.157225392196351
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956
JM-1,136227924,1.2038413750130548
JM-1,9911463,2.675259516581914
TE-5,9911830,2.198323188623282
Hs 578Bst,11404337,-1.6472861367813505
BT 245,1716436,2.617302091979337
BT 245,6918638,0.7917501577559235
TUHR10TKB,44137675,4.387078504898507
HEC-151,156414,1.2927614693415013
BT 330,1716436,2.18293804812622
M-07e,374536,-3.22677285376951
HuP-T4,44137675,2.7567980527482763
HDLM-2,374536,3.478917347860707
HCC202,148198,-2.7548108602388783
697,6918638,-1.9247711806790853
TE-5,156414,0.9303560194010824
RPMI-7951,9868037,2.673802488787611
LCLC-97TM1,151289,0.9235530786043882
KE-39,44137675,4.4813975845381755
MCAS,151289,1.3537471569868331
SK-MEL-31,374536,2.694632695170766
JHOS-2,sirolimus-bortezomib (250-1 mol-mol),0.7378509581797704
FTC-238,24772860,-2.9652982756023194
NCI-H747,71729975,1.7234631040792847
PF-382,10302451,0.8944755236764494
SW948,54618771,1.4567685239775812
Kelly,4259181,-1.3379091263134828
NCI-H2170,selumetinib-BRD-A02303741 (4-1 mol-mol),5.329785204243137
MV4-11,9911463,2.299906972293434
MDA-MB-231,654092,-0.9679229004760505
CAMA-1,44137675,2.12204386162964
GI-1,9911830,2.041005178400821
A-673,49766530,-3.0139632371957705
BT 482,148198,-3.9999181754289097
NCI-H292,654092,0.1209701484650686
JHH-1,16013152,4.166786996648378
SNU-886,6450551,0.4843129346186465
SUP-T1,9903786,2.605502996973438
OV56,1716436,3.767597006113701
NCI-H1092,4259181,1.0265302606919988
NCI-H2122,753704,5.668476615331939
SNU-423,753704,4.654692815537345
Tm87-16,2708,6.486698549602038
COLO 678,9911830,2.0775371202718875
COLO 680N,2708,4.980904093376421
NCI-H1975,9911463,3.169797897462341
Lu-65,136227924,3.620246561182502
HuNS1,753704,4.229822290375821
RERF-LC-Ad2,2708,5.54880563564346
SNU-5,100016,6.769356825304223
DoHH2,10302451,0.9453834851119745
RL,9911830,2.0994910319073155
ESS-1,151289,1.069450318701332
Caki-2,54618771,1.2625964957313875
NCI-H1373,3815108,4.25035955627324
HCC2279,2729026,2.6899610652169716
NCI-H1184,9911830,2.231711312227627
OCI-M1,6918638,-0.7125786973139969
FaDu,4259181,1.098018003238
OAW42,135659046,3.5713429692189447
JHOS-2,49766530,-2.972328777920352
TE-6,16013152,4.103621982412376
SNU-1076,24753719,4.547023810572654
Hs 822.T,10302451,3.767077439801767
HT-144,44137675,4.046911171775455
NCI-H1869,11167602,4.37189538269334
EPLC-272H,49766530,0.3578946183960979
NCI-H661,124202324,2.0891928025286943
HEY A8,10385095,0.768983308384478
HSC-3,148198,-2.120282407341815
FaDu,24753719,4.130411465313579
HCC202,sirolimus-bortezomib (250-1 mol-mol),0.0889077055626295
KMRC-3,9903786,5.172590154682236
NCI-H1650,24772860,-2.3612813040452147
HuG1-N,9903786,2.6577848330965
SF126,9911463,4.3238091091620525
G-402,135659046,3.518784307973502
OVISE,4259181,0.909929291036465
B-CPAP,9911463,3.799628401356715
HLF,9903786,4.061487019079308
HT,tanespimycin-bortezomib (250-1 mol-mol),-0.5308149065627191
786-O,148198,-3.6446785838934352
T84,4259181,-0.5082694903070305
HH [Human lymphoma],46926350,-6.137158282929891
MDA-MB-453,327653,2.9444810987281533
SNU-119,9911830,2.5015276348474424
SNU-1076,11404337,0.2265563836106352
NCI-H1341,54618771,1.0375359960566886
SNU-213,24753719,4.370347771119096
GCT,2708,3.615816707689656
SCaBER,10385095,0.9747050381713424
SK-N-BE(2),49766530,-3.9007408252768503
BT 444,135659046,3.767514231738307
A-673,11485656,1.6006257465541904
T98G,11404337,0.3579674680524426
BICR 56,4259181,1.025220358351184
Hs 611.T,JQ-1-UNC0638 (2-1 mol-mol),0.315420207793623
MCAS,6450551,3.1349872094378815
NCI-H838,9911463,3.605104029249328
COLO 684,327653,2.638490754589221
DAN-G,11485656,1.7552086859966678
Hs 895.T,4259181,1.7875337393373951
OE21,9911830,2.128262086485743
NUGC-3,24772860,-2.0289992156764147
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
EHEB,9903786,1.657877258917439
KNS-42,24753719,5.430301045770774
WM266-4,24772860,-2.793648167135358
SNU-8,11485656,2.474151094807621
NH-6,2708,2.9539506204544517
NCI-H2030,11485656,2.3036086259885526
BT 231,1716436,2.0638446522523175
NCI-H1092,1716436,2.458293295551776
OVCAR-5,tanespimycin-bortezomib (250-1 mol-mol),0.8786451228856517
COLO 205,24772860,-2.720843670436546
FU-OV-1,9911463,4.1305925074662575
HCC1588,44493528,4.903297648657414
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007
Fu97,9903786,2.3049271395078827
CAL-12T,24753719,4.611079410668424
MHH-NB-11,11404337,-1.8746153403956665
MOLM-13,124202324,0.9453642044256088
SEM,9868037,2.0923686689232137
MOLP-2,54618771,0.3344993744663657
UACC-257,11167602,2.6462198424244465
SNU-466,1716436,1.9944947082053208
YD-10B,9911830,1.8444860220568733
RERF-LC-Ad2,46926350,-4.2991338588257815
KP-4,10385095,0.8824730127283659
MOLP-2,49766530,-0.7894264806393523
TUHR10TKB,10302451,3.6459208870681774
BT-549,151289,0.9825598768305964
MHH-ES-1,54618771,0.4734030568205798
SNU-620,54618771,0.0782224190169237
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702
KP-N-YN,1716436,1.9811580159156368
SNU-1077,148198,-1.03431054543621
BT 224,11485656,3.221483556518939
LOX-IMVI,374536,3.2599798177927823
A2058,151289,0.8041283994361386
A-673,73707371,5.345141037142936
MKN1,654092,0.1266025871499362
HMCB,44137675,3.1016831628423542
SNU-1196,54618771,1.539198282600217
SK-MEL-3,24753719,4.863122553951076
CAL-29,tanespimycin-bortezomib (250-1 mol-mol),-0.8282025305629461
Karpas-422,374536,2.0966843525351173
KP-3,10385095,2.538896937216095
BT 330,11404337,-0.3310722205999429
Peer,44137675,4.2459102696028665
OVCAR-5,10302451,1.4379569920438735
SNU-886,9911463,3.862708319776098
SK-MEL-30,4259181,-0.1828887975932634
Daudi,49766530,-5.535187194073846
Toledo,10302451,4.132316597371657
KYSE-140,9929138,7.103811482735402
SK-LMS-1,1716436,3.783902076496232
T-47D,374536,0.9137914608986668
J82,6450551,3.1736079155057846
LUDLU-1,sirolimus-bortezomib (250-1 mol-mol),0.877597095580597
A-549,9911463,3.875766071211208
NCI-H1693,4259181,0.7986342395932161
HLF,54618771,-0.5261928492303469
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
CAL-78,JQ-1-UNC0638 (2-1 mol-mol),0.3534032765270657
NCI-H2286,753704,4.8417122166411755
HEY A8,sirolimus-bortezomib (250-1 mol-mol),1.5777182717045015
NCI-H526,11485656,2.2032947019554627
BxPC-3,136227924,2.62858882862477
JHOS-2,9911830,2.474516020576313
Panc 08.13,11404337,-0.6282112311194213
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
HGC-27,6450551,0.2313594097283057
B-CPAP,3815108,2.49779395406492
NCI-H889,148198,-2.8403688866942804
DV-90,374536,-3.5396006666048327
Mino,135984461,1.4657661855370687
BT 286,49766530,0.4498348011542866
KMRC-1,10302451,2.629362111325239
MKN1,JQ-1-UNC0638 (2-1 mol-mol),3.2416236707502275
KALS-1,148198,-1.8271090842643645
A-253,49766530,4.327253973822055
GOS-3,4259181,0.7347951046145877
SNU-466,49766530,-2.375695720565105
Granta-519,44137675,2.975150065736677
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
BT 179,2729026,3.0643152711455217
A-549,73707371,7.165992114804081
HEL,148198,-3.399100076616297
MIA PaCa-2,24753719,4.169307227992716
HEC-1-B,JQ-1-UNC0638 (2-1 mol-mol),1.0642498805913303
SHP-77,9911830,3.164376441687973
OCI-AML-5,11404337,0.1912186748994763
BHT-101,10385095,1.3780896504603424
Rh41,54618771,-0.2470499473038629
SK-HEP-1,374536,4.396616434658188
BT 231,2729026,1.6518737008758786
SJSA-1,24772860,-1.903502039124242
BT 164,11404337,-0.5496255890882706
BT 147,11485656,1.8934022107121244
Kelly,151289,1.2684639369225048
SNU-8,2729026,3.1220208939977097
M-07e,10385095,1.243871367579541
SNU-668,44137675,4.2364408003019625
MDA-MB-231,2729026,2.85794890916613
SNU-878,tanespimycin-bortezomib (250-1 mol-mol),-0.1499782135858746
JHUEM-1,6918638,0.9428418212694492
U-87MG ATCC,4259181,-0.4824960484366338
IPC-298,10385095,1.5595446684536465
RCC10RGB,9911830,4.5526597563763795
HuG1-N,2729026,2.2032708053150176
A4/Fukuda,2708,3.0461577581065007
RPMI-7951,2708,3.6014757516050113
DV-90,9911830,-0.2837927843427922
VMRC-LCD,24753719,4.020316071517673
KMM-1,11404337,0.5617812148360622
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
NCI-H838,10302451,3.657499852045878
SNU-119,11404337,-0.1265251374759644
SK-CO-1,148198,-1.1611262776602205
786-O,44137675,4.0266638763483655
GI-1,11167602,4.291743377924148
JHUEM-3,11404337,-0.7844272598135029
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
DOV13,11485656,2.572121506597987
SKM-1,9911830,2.174138233230932
SW1417,135659046,3.701977348188013
SKM-1,3815108,3.188772071922917
Daoy,148198,-1.968278269262657
ZR-75-30,sirolimus-bortezomib (250-1 mol-mol),1.7584870714322065
NCI-H2405,selumetinib-BRD-A02303741 (4-1 mol-mol),0.2653153459542231
JHUEM-1,9911830,1.6062370327593674
SH-4,136227924,2.5718168505003693
Hep-G2,3815108,3.2270973506014182
MEC-1,753704,3.419868373227565
Jurkat,sirolimus-bortezomib (250-1 mol-mol),-2.067381581487011
NCI-H2030,9903786,2.824655549380346
MES-SA,2708,5.44545893774711
MHH-CALL-4,124202324,0.2696769767665354
EB1,374536,1.4973094684424462
FaDu,54618771,1.2079595597502673
HMC-1-8,tanespimycin-bortezomib (250-1 mol-mol),-0.5086629381230219
A2058,4259181,-0.6082432544796528
Panc 02.03,49766530,0.9655059796360064
MSTO-211H,327653,2.467891014920142
NCI-H211,11167602,1.4659047290410885
NCI-H1573,10302451,3.1946799190013815
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
JHOC-5,11404337,-0.7952540156360246
U266B1,46926350,-4.253015418178667
TE-14,9911463,3.9221721376636816
NCI-H1792,654092,-0.130155577401603
SK-BR-3,6450551,3.8359924945243367
HEL 92.1.7,24772860,-2.789346714806017
HSC-4,654092,0.2566378579351391
YD-8,44137675,3.4700993938772324
SK-MEL-1,11485656,2.5093092817296307
NCI-H1373,54618771,1.0971026728505908
WM115,24753719,4.6734048968266775
LXF 289,54618305,4.64176895308047
TE-6,10302451,0.423575511897082
ONS-76,10385095,1.1655527010487017
NCI-H211,sirolimus-bortezomib (250-1 mol-mol),1.3707117645726492
SK-MEL-5,2729026,2.1390901716806865
NCI-H1650,11485656,2.650722608935496
NCI-H1339,54618771,2.498525802737919
TALL-1 [Human adult T-ALL],2708,1.483650098293815
BT 131,9911463,3.3950142124992113
AsPC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3046725635070757
NCI-H2081,54618771,1.045855982244366
EHEB,24753719,3.508920403296929
OAW28,44137675,4.561686598527574
F-36P,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9142285794551278
MKN1,136227924,3.2741698595271025
Panc 04.03,JQ-1-UNC0638 (2-1 mol-mol),2.939045539650312
MOLT-3,JQ-1-UNC0638 (2-1 mol-mol),-1.0424273511456958
NCI-H2405,124202324,2.7300246819843355
SK-MEL-24,6450551,3.748531235116882
HCC15,10302451,3.767869991537956
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
HSC-2,327653,3.1172666689208555
8505C,9929138,7.301174384982561
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542
Capan-1,2729026,3.1785431768913353
L-363,24753719,4.154726318334622
KYSE-450,148198,-3.4919685284150876
MOLP-8,148198,-4.437033387624053
HCT 15,24772860,-1.8532569127892276
COR-L47,9843750,4.220866071661453
WM115,9903786,3.894434750277636
Ku812,327653,2.6105949863285436
NCI-H2029,135984461,4.315213112140467
NCI-H1666,4259181,0.6541151201213545
Lu-99,136227924,2.52697800854745
NCI-H2106,44137675,4.841563425394738
U-251MG,9868037,3.950547423154838
HMC-1-8,sirolimus-bortezomib (250-1 mol-mol),1.238114753866591
COLO 699,JQ-1-UNC0638 (2-1 mol-mol),4.317622525068594
Calu-6,374536,3.323021286560931
TE-5,2729026,2.7497735318576693
HCT 8,4259181,-1.1037245280904695
BT 245,148198,-4.884445563516914
HEC-108,151289,0.8721533950647946
SU-DHL-1,374536,2.32669265560356
MDA-MB-231,44493528,4.662027918960356
A-673,136227924,1.815433973878695
D283 Med,148198,-7.782574988452476
SH-10-TC,9911463,4.344994867688331
WM1799,148198,-2.113504584612542
SNU-840,44137675,0.7446103317404902
DAN-G,148198,-3.4486802184893386
KYSE-410,11167602,2.662008040827567
MDA-MB-361,374536,-2.176826869846278
GP2d,11485656,0.5695398212792343
BT 328,2729026,2.3236347104871924
Rh41,9911830,4.108812674081707
697,10302451,0.2291087598985289
RPMI-8402,1716436,3.3778333955163284
NCI-H1373,selumetinib-BRD-A02303741 (4-1 mol-mol),4.145806413569232
BV-173,9911463,2.9939973484009608
SNU-478,135984461,4.6270303617123165
769-P,4259181,-0.9555012683593715
HT115,1716436,3.914098952110256
U-CH1,11485656,3.664474394273293
SK-N-MC,1716436,2.753978849900703
SW1088,151289,2.595867384779865
NCI-H2009,9911463,4.220122302208283
253J-BV,44493528,5.814016422877873
SF126,24772860,-1.5379843161077322
JURL-MK1,753704,5.402099532772615
HCC1438,2708,5.281928884043319
Panc 03.27,2708,5.153947575521185
KYSE-140,4259181,-1.5506571157207716
A-253,374536,2.847674818418614
Namalwa,374536,0.8945549847595208
NCI-H2106,10385095,2.0087546591640413
JHH-6,sirolimus-bortezomib (250-1 mol-mol),2.5293285021396277
KE-97,753704,4.960351655876437
D283 Med,136227924,2.613464686393682
HCC202,136227924,3.1235993915196723
UACC-62,9911463,4.3555610990342615
CAL-51,49766530,0.4609697007955676
SK-MES-1,100016,6.467052003541006
KYSE-70,54618771,1.1170424016733127
WM983B,2708,5.43325523760452
WM1799,327653,3.531373142867038
CGTH-W-1,JQ-1-UNC0638 (2-1 mol-mol),4.874729229673918
MHH-ES-1,44137675,2.8977058570463705
TE-4,136227924,2.9171247501964945
U-937,753704,4.931104718028994
NCI-H1651,4259181,-1.783038847618123
SK-N-DZ,10385095,0.8733492382150887
SK-N-AS,11485656,1.7301696835910343
GB-1,6450551,4.3566270770883015
OAW28,327653,3.155680016062074
SK-N-DZ,9903786,2.0344840639265787
BHY,753704,5.323341234107422
DND-41,100016,5.882204784714585
SH-4,tanespimycin-bortezomib (250-1 mol-mol),0.1503763926907838
Sq-1,100016,4.274424361552861
CAL-54,9903786,1.6300874124823186
PLC/PRF/5,327653,3.1034760000853994
Yamato-SS,6918638,0.9950789040001992
Mel JuSo,3815108,3.490140222988044
Hs 683,11404337,-0.8094527425397864
CAL-33,24753719,4.340545120601804
SK-MEL-30,2729026,2.4447403365375715
PC-14,54618771,1.2873092129984136
OAW28,654092,-1.8070222863139416
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284
SNU-620,1716436,3.839091558804087
MOLP-2,JQ-1-UNC0638 (2-1 mol-mol),1.6321098431865753
RKO,2729026,2.3662843020346753
MOLM-6,148198,-4.479963053870103
U-251MG,9911463,4.11693061123882
8305C,44137675,4.053707567803645
Kasumi-1,136227924,1.874085610777816
NCI-H211,54618771,-0.4464011185148343
NCI-H1703,54639665,4.494588545198389
NU-DHL-1,11167602,2.239253055046329
JL-1,11404337,1.0856357490679192
SK-UT-1,54618771,2.629062811355061
HCC2935,6450551,4.972376297606074
NALM-6,10302451,2.2736336019353147
NCI-H322,44137675,4.008813388569141
DU4475,49766530,1.1450328858367227
SH-10-TC,148198,-3.7737897444404993
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
NCI-H322,374536,3.6685617740876006
EFM-192A,46926350,-4.321615091017845
OV7,148198,-4.147703554410761
T84,9929138,6.3577776039121465
OUMS-23,49766530,1.123776679749195
OCI-Ly3,10302451,3.8277705801604656
MDA-MB-468,4259181,-1.7554481906549335
Reh,sirolimus-bortezomib (250-1 mol-mol),0.0012430835565731
HuT 78,10302451,3.5523158684911764
HLF,6918638,1.351490313619424
COLO 829,148198,-3.4268778382536715
DMS 273,9903786,1.811418424711566
UACC-257,6450551,3.6276601238369537
COLO 792,tanespimycin-bortezomib (250-1 mol-mol),-2.234001402971202
Granta-519,753704,4.381381177541046
Panc 02.03,4259181,2.0313571914007604
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
KNS-42,1716436,3.9263528887651775
EFO-27,9903786,4.039986452778869
SK-MEL-1,654092,0.0671829755376614
U-118MG,11167602,5.665581577338733
SK-MES-1,11404337,-1.915365805563204
SNU-1076,9911463,3.975744841196654
OS-RC-2,3815108,2.4210530860957205
UM-UC-1,9911830,0.2097316778170632
BT 440,6450551,0.3928045904666091
BxPC-3,JQ-1-UNC0638 (2-1 mol-mol),0.9591872546469856
DLD-1,374536,3.2680730725929537
SEM,24772860,-3.2932991831821767
MCAS,11404337,-0.3191442981427469
NCI-H1792,9911830,3.3043796692893923
Hs 940.T,2708,6.789195150027302
LoVo,327653,2.9108064375514604
SNU-387,44137675,4.729483054701681
NCI-H2196,46926350,-4.167074628499051
MIA PaCa-2,100016,4.223400842588871
NCI-H1693,54618771,1.322684232768969
SNU-201,24772860,-0.9879678739727498
NCI-H660,46926350,0.2757188733697991
EM-2,156414,0.7048874875207918
RT-4,654092,0.6230468978254379
LS123,49766530,-4.7920009691109
T24,sirolimus-bortezomib (250-1 mol-mol),0.798518469796891
Panc 10.05,JQ-1-UNC0638 (2-1 mol-mol),2.1670482791591223
MV4-11,49766530,-2.278829084327519
JHOC-5,654092,-1.658527515839424
ChaGo-K-1,16013152,4.057243427628333
OCI-AML-5,2708,3.5050212712565947
ONCO-DG-1,9911463,3.9906358040746417
KMRC-3,11404337,1.0527621044793514
8505C,44493528,4.8824892045042585
CAL-27,44493528,4.330239029111345
HPB-ALL,327653,2.9231212258836696
JURL-MK1,2729026,2.1211813057065725
UACC-257,11485656,3.6556840450615065
NCI-H1694,9868037,2.26987701984991
HuG1-N,4259181,0.6205305384183885
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
MeWo,11167602,1.655491206149829
NCI-H2087,11485656,1.6190221901711597
GA-10,9911463,2.3483289589885135
OAW28,2708,5.3328257603707545
TE 617.T,2729026,1.8529578734685528
TE 441.T,1716436,1.8501117419808528
HDLM-2,151289,-0.7419604478541427
RERF-LC-Ad1,54618771,3.6047591405088673
RL95-2,11167602,5.300847360137522
GCT,327653,3.242786384875356
Hs 294T,6450551,3.379912948278439
MM1.S,selumetinib-BRD-A02303741 (4-1 mol-mol),3.755901339608387
A-673,9911463,3.7053308577681583
RCC10RGB,374536,3.743226525407361
HD-MY-Z,16013152,4.01310052191103
U2OS,44137675,3.690576793723843
HCC-56,100016,6.404810900486153
COLO 829,6450551,3.549452746317016
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
DoHH2,44137675,1.3041320355772226
KMRC-1,2708,5.927603665606935
NCI-H1581,24753719,4.397195007836128
NCI-H520,10385095,1.0283003388284149
NCI-H838,9903786,3.3354692149309124
PE/CA-PJ15,24753719,4.1461682769332615
MIA PaCa-2,54618771,1.4864580952045414
Ishikawa (Heraklio) 02 ER-,2729026,3.1323352085072553
SNU-878,9911830,1.8816958115291476
HEC-108,9868037,3.1019775097215554
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744
BT 340,11485656,3.382353579781301
HMC-1-8,9911463,4.100955658112126
Calu-3,24772860,-2.6919888987790164
NCI-H650,4259181,-0.4685648042874594
BT 159,327653,3.49992313005632
BT 232,11404337,-0.4479930144977115
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
CAL-85-1,44137675,3.5833220677438087
SNU-213,10302451,1.063572133551757
COR-L51,151289,0.4684328334276437
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
JK-1,4259181,0.2041006169508442
BL-70,11485656,1.5979505669049718
NUGC-4,654092,-0.229711252696206
COLO 320,9911830,2.9659936700173506
GMS-10,11485656,3.67523785200594
COLO 792,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.5315281256880211
BxPC-3,753704,5.46289082133378
KYSE-180,selumetinib-BRD-A02303741 (4-1 mol-mol),6.582201455750035
TE-11,46926350,-4.447385036948032
KYSE-410,135984461,4.6292418393207235
NCI-H2291,124202324,2.285315015830654
NALM-6,374536,-0.1205445604705443
EFO-27,11404337,1.0583908830182924
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008
KMS-26,6450551,0.444543699535665
IPC-298,11485656,2.382322261654795
HCC1833,10302451,4.238662713191706
SNU-182,11404337,-2.4504456684550475
NCI-H2081,135659046,2.9715500062667455
NALM-6,54618771,-1.340027714929621
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
KMS-12-BM,327653,2.270237785805321
SaOS-2,44137675,2.8908105588075537
Daoy,100016,6.878604021612681
A-375,9903786,2.3118659059614877
LUDLU-1,2729026,3.215729419809345
CAL-148,6450551,1.7553208617042402
CAL-51,9911830,2.6702149728757343
BV-173,10302451,-0.5891104475601698
TE 617.T,374536,1.0085284501370833
HCC1419,sirolimus-bortezomib (250-1 mol-mol),0.331590407982584
Ri-1,9911830,1.4351255803096743
OVCAR-4,9911463,3.705471110886421
SK-N-BE(2),327653,1.124959303799422
OV7,1716436,3.40008308108482
Karpas-620,9929138,4.250879016380974
IA-LM,4259181,2.3536383664390734
HCC78,151289,1.501889299090623
BT 422,11485656,2.164930986451698
NMC-G1,654092,0.9623197548350486
BT 328,10385095,1.6482003129933624
KMRC-3,9868037,4.35268371291099
NCI-H2170,11485656,1.87102057919161
A-204,11485656,-0.4332502433044572
SNU-8,10302451,3.487044127075749
HEC-1-B,10385095,1.4850589250139663
WM88,151289,0.8302819682103205
CAL-85-1,46926350,-4.870817090417163
TE-5,151289,1.4315530896927984
CML-T1,24772860,-2.9357343941167713
A-549,9911463,3.875766071211208
BICR 31,44137675,3.031084694210408
DOV13,JQ-1-UNC0638 (2-1 mol-mol),5.816352257567233
Lu-99,54618771,-0.746886748911533
CAL-148,selumetinib-BRD-A02303741 (4-1 mol-mol),5.253371692039645
P31/FUJ,6450551,0.3392586382091512
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514
PSN1,tanespimycin-bortezomib (250-1 mol-mol),-1.4884042212108968
G-292 clone A141B1,sirolimus-bortezomib (250-1 mol-mol),-0.3022581749422651
P31/FUJ,136227924,2.3905530687579497
ZR-75-30,100016,8.126082181881081
HCC95,JQ-1-UNC0638 (2-1 mol-mol),1.1564000533050334
BT 416,11167602,2.2298904272575686
TCCSUP,753704,5.368261344163991
PLC/PRF/5,753704,4.749989409543222
Raji,24753719,3.12822311930087
OCI-AML-2,9903786,1.7653976313293729
JHOS-2,100016,8.119351788295337
HDQ-P1,4259181,0.9497481254036038
NCI-H520,753704,5.066347662071548
JHUEM-3,24772860,-1.1550826746578151
LXF 289,9929138,7.38651684018349
NU-DHL-1,135984461,1.11873859248707
NCI-H1755,selumetinib-BRD-A02303741 (4-1 mol-mol),4.24347408344691
KMS-26,654092,-4.098201806835606
NCI-H2030,24772860,-1.256504466195007
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918
HSC-2,tanespimycin-bortezomib (250-1 mol-mol),-0.2988768157355406
TALL-1 [Human adult T-ALL],9903786,1.5190576712457438
HCC1954,327653,2.7726038968609847
MFE-319,44137675,3.760778415788738
A-172,54618305,4.515283659977801
FU-OV-1,4259181,1.2776952629591818
Kelly,374536,1.9036940245988112
JVM-3,9903786,0.2351218463531885
U-937,135659046,3.9710319401622063
NCI-H1563,1716436,1.5572856903812382
SK-MES-1,9911463,3.432548166775373
HEL 92.1.7,10385095,0.8888746409107244
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815
HCC1143,9911463,3.749174224015704
Calu-6,sirolimus-bortezomib (250-1 mol-mol),1.0438055867495408
SNU-601,2729026,3.129688251420371
SK-ES-1,6918638,0.0671447143005349
DU4475,374536,1.9392637790686769
HCC78,9911830,2.672892482708517
TUHR14TKB,156414,1.545939775410448
BT 239,151289,3.5125938613927965
JeKo-1,11485656,1.8076114759672557
NCI-H2081,49766530,1.2305991234309177
HEC-151,327653,2.9802978395573123
NCI-H1573,54618771,0.5890663299030774
NCI-H2444,11167602,2.3165888125394796
SNU-C5,11485656,2.423735661577291
NCI-H2452,136227924,3.4253193575490695
NCI-H1869,JQ-1-UNC0638 (2-1 mol-mol),2.4399553500641846
HEC-1-B,10302451,0.3109333075515339
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
YAPC,135984461,4.395865755985396
G-402,100016,6.451749665500501
TE-10,3815108,3.574449383987529
SK-MEL-5,11485656,3.020253832456298
IA-LM,6450551,2.2909353415785403
UM-UC-3,9903786,3.957731160225435
Rh30,54618771,1.1038289315266856
KATO III,6450551,1.4607318866086103
SK-MEL-3,135659046,3.5354638551340756
HEL 92.1.7,2708,2.82403873095502
MDA-MB-231,124202324,2.418755352718907
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555
A2780,9929138,3.988043631552867
CML-T1,151289,0.34759640697574
MFE-319,11404337,1.7191748497396555
DMS 454,6450551,2.145567976605063
SNU-685,6450551,3.59155520840724
SEM,11167602,1.6764895293096356
SK-MES-1,151289,1.1000923553452364
CAL-120,9911830,3.1779958908995125
L-363,54618305,-2.6619495669373383
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
HCC44,151289,0.3112444140157845
TALL-1 [Human adult T-ALL],6450551,0.3801795288647774
NCI-H650,10302451,2.7441741696304223
A3/Kawakami,2729026,3.162354903301809
Rh41,124202324,1.0222878079480788
KE-37,148198,-3.992364419056407
JVM-3,2729026,1.8845040162931592
KP-N-YN,6450551,2.7889379092848943
5637,100016,5.253062593048346
NB1,24772860,-3.31828936328398
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
SCC-25,374536,3.416517907222855
MOLM-13,49766530,-2.4914272268054107
BT 422,374536,3.9366089287605193
SK-MEL-24,16013152,4.78147670893862
TUHR10TKB,11485656,1.859700421768517
PSN1,135659046,3.366359260152028
RKO,9911830,2.9376280530386123
KYSE-30,9911463,3.831121744516391
HCC1806,753704,5.367884058566692
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
BL-70,6450551,2.0470532076134105
M-07e,9903786,0.8629482504426611
JURL-MK1,9911463,3.2271794119199293
SUP-B15,6450551,0.7649469227943367
OVCAR-8,3815108,3.051483641213493
NCI-H929,1716436,3.574402272281363
EoL-1,6918638,-2.889280053807362
IGR-39,10385095,1.5292077021390125
HT115,9911830,2.3719194937966583
NCI-H522,10385095,0.7404415633977295
OAW28,11485656,3.2643123414600645
TOV-21G,327653,2.366074038804648
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
23132/87,24753719,4.2798195859801575
NCI-H2052,tanespimycin-bortezomib (250-1 mol-mol),2.581253190791589
HCT 15,6918638,1.0583340950733469
VMRC-LCD,2708,5.678057458304435
KNS-42,11167602,1.769656279065476
LP-1,327653,2.8727954788037575
NCI-H661,753704,5.093119647973415
BT-20,9903786,4.2067479925704925
COLO 792,54618305,4.394702528877574
P12-Ichikawa,10385095,0.2155062736179899
Caov-3,54618771,0.7751702842643667
BT 498,135659046,3.899086642972748
OCI-M1,151289,0.925603021609817
2004,44137675,2.6941074393905384
A-498,148198,-1.0809020747576437
HGC-27,9911830,1.4787770441539565
COV434,6450551,1.844596373893179
NCI-H2172,10385095,4.224975285900289
COR-L51,44137675,3.055164429902011
CL-11,2708,4.413219773717047
A-204,71729975,0.3618319780655016
SK-N-AS,JQ-1-UNC0638 (2-1 mol-mol),0.8581123748547943
SIG-M5,4259181,0.1435014224884159
L-1236,10302451,4.314783956287455
Kelly,124202324,0.890588217365058
KHM-1B,2708,5.139604125220885
HCC44,11404337,-1.974038980762408
Li-7,136227924,3.3307357238068818
Rh18,9903786,2.6471801174141625
BCP-1,11485656,1.531241298696853
SF539,49766530,-1.8483208282069583
OVCAR-8,1716436,3.34049269567275
OVCAR-4,49766530,-2.103044081091216
OAW42,100016,6.607597097790758
OCI-M1,11404337,-0.1677571096937809
SK-MEL-31,124202324,3.0266963819805452
NCI-H292,10385095,1.2562128411100733
KYO-1,44493528,4.460522325437717
BT 440,2729026,1.3918697008275802
NCI-H747,10302451,1.853109889502639
KMRC-20,2708,5.098804144930118
KLE,135984461,1.6662233005465323
DU145,151289,1.500711267308436
Hs 294T,2708,5.173886184647166
BT 216,71729975,2.473533741990692
697,24753719,1.7067732585289954
AN3-CA,6918638,0.8350174262489668
HCC366,2729026,2.9739445481850453
REC-1,49766530,2.1728933829794395
EB1,6450551,1.074192386464657
DV-90,753704,4.896009121667326
Mel JuSo,2729026,2.5631995386343607
Detroit 562,10385095,0.9539498650756362
PK-45H,54618771,1.4553505750064293
WSU-DLCL2,tanespimycin-bortezomib (250-1 mol-mol),-0.4826072076602557
LC-1/sq-SF,54618771,0.7298922583446973
COLO 699,11404337,1.232943062942203
T24,6450551,3.7073278570553776
KMH-2,2729026,1.9828733907594425
Hs 940.T,sirolimus-bortezomib (250-1 mol-mol),2.1873747359763613
HT-1376,124202324,3.2333902540923756
SNU-16,49766530,-2.8368517260847304
BT 440,2708,5.697152569142541
HSC-2,24772860,-2.6910620449365688
SNU-685,374536,4.005536021308822
HMC-1-8,11404337,-0.9366100909278564
COR-L105,6918638,0.8528151020185122
P31/FUJ,151289,0.3376751835645198
CHP-126,2729026,2.036683873951712
YD-15,9911830,2.5298238484943463
HT-1376,10302451,2.517064396144774
NUGC-3,148198,-1.9201503205114672
G-361,JQ-1-UNC0638 (2-1 mol-mol),0.3117912399743853
253J-BV,10302451,1.5827039358802202
MDA-MB-468,2729026,2.976879667705581
Calu-6,9911463,3.814763109547714
VCaP,10302451,3.859651840021036
Mel JuSo,124202324,3.0197048118542105
MOLT-3,327653,2.355499733998213
NCI-H1373,sirolimus-bortezomib (250-1 mol-mol),1.9040141833310924
KMS-27,49766530,0.6819698946698491
HCC1954,136227924,3.208934620428715
MOLT-13,136227924,1.9107910741830303
OCI-AML-5,136227924,1.61818972770755
SW579,136227924,2.120211379000796
COR-L95,148198,-4.800055382400855
ST486,selumetinib-BRD-A02303741 (4-1 mol-mol),4.959791809996256
MOLT-13,9868037,1.8039325171319247
REC-1,9911830,2.634781008938807
TCCSUP,2729026,2.469162640243315
MOR/CPR,11485656,1.924898920968698
Rh18,4259181,0.3186625896881334
NU-DHL-1,46926350,-4.283271721572929
DMS 114,2729026,3.0275914532256754
SUP-M2,11404337,-2.6173632126758313
KMS-27,100016,3.811410813700335
NCI-H1341,9911830,-0.0779226397197478
TF-1,136227924,2.8858592548660766
YAPC,1716436,3.308380745751715
HCC-56,sirolimus-bortezomib (250-1 mol-mol),0.5000391743337353
HT-55,654092,0.1142679637509619
RKN,11485656,2.343665915939472
Ki-JK,JQ-1-UNC0638 (2-1 mol-mol),-0.3831772557255544
NCI-H1869,10385095,1.0868363203730835
SNU-387,JQ-1-UNC0638 (2-1 mol-mol),1.5816240714884733
BT-474,6918638,-0.8202779774932777
HuH-28,JQ-1-UNC0638 (2-1 mol-mol),-0.759092767813931
ONCO-DG-1,327653,3.0746646431128655
SU-DHL-10,10302451,3.176970574358631
GA-10,135659046,2.94673518989487
COLO 668,100016,7.809114037996309
D283 Med,24753719,3.1316348069328357
HT-55,54618305,4.362307873110049
EM-2,9868037,1.5238018435010934
SUP-T11,374536,1.8325318181406132
MSTO-211H,24753719,3.2448003358152286
DV-90,49766530,1.92724859659278
BT 248,9911830,3.0671224453630326
KMS-34,9903786,0.5468687794140459
MG-63,selumetinib-BRD-A02303741 (4-1 mol-mol),5.957190095047904
KYO-1,11167602,1.4429278451618828
HOP-92,16013152,4.828289855403531
Rh18,1716436,2.1682605305208433
Calu-3,9911830,2.7294588365608305
KMS-12-BM,136227924,1.841540408480291
OUMS-23,327653,3.655730641174575
BT 164,753704,3.0917093818392116
FaDu,9911830,2.7395037864167446
JK-1,44493528,3.0964737259791812
MES-SA,16013152,4.186831952456974
BT 482,10302451,4.2072229982706135
H-STS,JQ-1-UNC0638 (2-1 mol-mol),1.212466073546629
NCI-H2052,10385095,2.956469806402845
MOLM-13,2729026,2.3347481789683564
OCI-AML-2,327653,2.738179275353154
CAL-85-1,9911463,3.700883327445061
SNU-182,11167602,1.968372521302316
SK-N-AS,11404337,-1.03684068328029
COR-L105,9903786,2.948812050867326
RERF-LC-Ad1,3815108,3.6891446241117873
SNU-407,3815108,2.897812435273454
MCAS,10302451,3.470287420983729
A3/Kawakami,1716436,3.761082437930757
RPMI-6666,4259181,-0.2234932602766142
HCC1500,49766530,0.4188049276678212
SNU-C1,9911830,1.8520542621425748
Hs 688(A).T,selumetinib-BRD-A02303741 (4-1 mol-mol),7.2215407174902815
AsPC-1,1716436,2.9196038383716205
HEC-1-A,1716436,3.2739103921749826
SW982,100016,3.947877721573723
PC-14,6450551,1.723712317687973
YKG-1,11404337,0.7038073229533129
SNU-8,2708,5.486542141379691
SNU-245,4259181,1.448365127133337
IMR-32,11485656,1.530549227150807
SK-N-FI,JQ-1-UNC0638 (2-1 mol-mol),0.6582199922376251
SNU-620,9903786,1.530835439194961
Mel Ho,135984461,4.333479355055791
KMS-20,2708,3.4127805917695095
IPC-298,sirolimus-bortezomib (250-1 mol-mol),0.7212424962654913
BT 147,2708,7.479014966632047
NALM-6,100016,5.173644166821544
OV-90,11404337,1.6888356686840926
MV4-11,10385095,0.4660551916464017
HuP-T3,753704,5.56041062328625
GP2d,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0828698318616823
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
LCLC-97TM1,327653,3.202975625508304
SET-2,JQ-1-UNC0638 (2-1 mol-mol),-1.9472372996283749
KE-37,2708,1.829852599667702
SW1353,124202324,2.199856271603199
OCI-AML-5,6450551,0.7484185711404807
AGS,9868037,3.4891422873048046
HuP-T3,1716436,3.1901993610711092
HT-144,44493528,4.6392793264326
COV362,11404337,0.8285013906094965
MOLM-13,10385095,0.2048351805935088
NCI-H1184,24772860,-3.360348296731845
EBC-1,JQ-1-UNC0638 (2-1 mol-mol),0.8534308417125144
SNU-1,54618305,4.180407236417695
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448
8-MG-BA,49766530,-0.054737716744796
JHH-2,11485656,3.3849117399649513
TE-1,54618771,1.3906017960660586
TYK-nu,2729026,2.0346372904085324
KP-N-SI9s,9911830,2.32550504994579
DAN-G,6450551,3.252553110637724
CCF-STTG1,44137675,4.772154618477063
GP2d,46926350,-4.393153997744706
SW579,11404337,-1.5327232138346547
SBC-5,11485656,2.2866280503579812
NCI-H1869,327653,3.4253692354840197
HCC1588,24753719,3.2489503799535653
Toledo,4259181,1.5062320886092213
MDA-MB-415,tanespimycin-bortezomib (250-1 mol-mol),-3.006075352171784
HSC-4,11404337,-0.2351979780524762
HT-144,9911830,2.047294493227566
SNU-308,10302451,1.9995275040024083
JHH-5,9903786,3.1481910076888684
HCC1954,54618305,4.294285323035425
SNU-466,654092,-1.2716466370030295
LS513,24753719,2.61980978763879
P-STS,JQ-1-UNC0638 (2-1 mol-mol),0.635580978946054
A-253,44137675,4.239398332294613
Peer,tanespimycin-bortezomib (250-1 mol-mol),-0.7923610578586646
KM12,9903786,1.2751766913602836
BT 228,1716436,2.8343338794517305
NCO2,9868037,0.9893364674462136
NCI-H211,54618305,4.463856903344854
EN,11404337,1.8995795363110224
IGR-37,136227924,2.9944260233382667
HT-55,148198,-2.6616245414762996
SEM,71729975,0.1111350195233953
KP-2,753704,6.765230184334968
KMS-18,54618771,-1.0350203667424809
NCI-H28,654092,-1.3294019790210672
NCI-H2087,9911463,3.2205698375383935
BT 271,44137675,2.8026735515845984
TE 617.T,11485656,1.686521614831033
ECC10,6450551,0.9149959081084976
KNS-62,10385095,1.9317410054344168
COLO 829,1716436,2.77831702928036
IGROV-1,2729026,2.3541792737160296
SCC-4,10385095,0.7698990433535621
HSC-4,753704,4.983094182740762
G-361,124202324,1.930373027148199
TT2609-C02,10385095,1.344780053059808
BC-3C,6450551,3.704028205237641
SNU-182,9911830,2.537024143397294
NCI-H1694,11167602,2.150711211230678
HMCB,2708,5.151962818613397
OCI-M1,2729026,3.1407056879266304
ChaGo-K-1,49766530,-1.5426741425236086
YD-15,9911463,3.7436865426032786
BHY,24753719,4.126050347648706
IGROV-1,148198,-2.659972993252853
Li-7,654092,0.650858107124621
OE21,156414,-3.0417448997848857
KMH-2,10302451,3.711688985022062
MOLT-3,135984461,3.930713176256541
PaTu 8902,10302451,3.9687769441396608
BV-173,100016,4.070459829867503
Karpas-620,11404337,-0.9098676733651666
Jurkat,11167602,4.314009231868755
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226
G-401,1716436,2.4290804430946547
HEC-1-A,11167602,2.1676131013886946
SH-4,sirolimus-bortezomib (250-1 mol-mol),0.5100564849810528
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
DMS 273,46926350,-4.333780789364997
HCC1438,16013152,4.363660787024778
Li-7,151289,0.6303821364197232
AM-38,10302451,3.7847088255145978
639V,24772860,-1.7610957887843326
HT115,10302451,-0.0451065093220725
FTC-238,2708,4.719279184114701
Hs 578Bst,6918638,3.629464164319933
HGC-27,10302451,1.8923411487775068
DB,24772860,-4.258182716020474
AML-193,71729975,1.760380788116278
SK-CO-1,44137675,3.0714779264964074
LXF 289,24772860,-1.828128181459349
Hs 578Bst,374536,3.188754970899081
Hs 746.T,6918638,0.8539034237562276
BT 328,6450551,3.790902491385394
SEM,135984461,1.5883939694151252
K-562,2729026,2.90327889883348
A-375,2729026,2.589509771776737
ACC-MESO-1,654092,0.4220956302588627
JHH-4,44137675,3.680889333845543
HEC-59,136227924,4.443118393205084
G-401,9911463,2.712760379614347
BT 239,71729975,0.2676872338583978
OPM-2,24753719,4.370940438199297
LP-1,2729026,2.210568382658554
BT 239,9868037,2.51635002205042
KMBC-2,10385095,2.342587870752789
BxPC-3,9903786,2.126136875029704
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
DoHH2,327653,-0.1636746029828067
JHOS-2,44493528,4.374607827213095
PE/CA-PJ15,10385095,0.8645470546748426
HCC1171,9911830,3.390740346398818
LoVo,11485656,1.8604760547282393
AML-193,9868037,1.69446413413849
AN3-CA,156414,1.36110068717594
Daoy,2729026,3.0319830157635144
BT 164,tanespimycin-bortezomib (250-1 mol-mol),-0.668704186369019
Daudi,327653,2.694862581871668
SNU-478,49766530,0.8968210676937323
FTC-238,753704,4.388372512268626
PC-3,1716436,3.772073129649105
DK-MG,151289,1.224218064725738
SNU-899,10302451,2.6572990559771856
MDA-MB-453,2708,5.180783048838842
Rh18,sirolimus-bortezomib (250-1 mol-mol),0.7964593742547511
HuH-1,54618771,1.0275459281807533
HCC15,54618771,1.6567762934530044
SNU-869,11485656,2.9373298298731463
PE/CA-PJ49,11404337,0.0513303948007028
NCI-H1869,46926350,-4.282958086808661
UACC-257,9903786,4.920300978966239
NCI-H1105,148198,-5.386518056256114
COLO 678,11485656,1.706527066043961
KYSE-450,24772860,-1.687862811669867
HCC1954,124202324,2.392226128988432
LOU-NH91,10385095,0.9698085069900604
CAS-1,9868037,3.4810587934023363
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
23132/87,327653,3.3687565906187387
MOLM-16,753704,4.426348379162992
BICR 56,sirolimus-bortezomib (250-1 mol-mol),1.89463967365671
DU145,9911830,2.1364996794005395
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
CAL-51,24753719,3.9981702522006257
SNG-M,selumetinib-BRD-A02303741 (4-1 mol-mol),5.460968301020372
NCI-H2452,44493528,4.324080951064212
MDA-MB-157,374536,-0.5698586384338129
NCI-H838,11485656,2.6537102203842613
RVH-421,24772860,-1.5382600655912224
CAL-54,46926350,-3.951291675548732
SET-2,11404337,0.2728842638306079
Capan-1,1716436,3.46729831255585
HLF,10385095,1.177724307805522
KPL-1,11167602,3.344088823698267
LOX-IMVI,10385095,1.0613031288741694
DMS 273,151289,0.7083247440682101
RPMI-8226,100016,4.270983790022636
LN-18,9911463,3.9395482508876714
NCI-H810,100016,4.22640705156995
Karpas-422,151289,0.9778807831289208
KE-37,9903786,1.3543500174719385
MEC-1,1716436,2.594123196458805
A-375,11404337,-0.2038231220320669
VM-CUB-1,2708,5.385707184354032
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531
BT 444,9911463,3.786370986996904
2004,6918638,1.2985206929345292
RL95-2,49766530,-1.414659307229874
BT-549,9911463,4.268645247281358
OVCAR-8,54618771,0.8925254662704427
SU-DHL-8,9903786,1.70511202729143
TE 441.T,11404337,-0.8068289898007032
BL-70,9911830,1.8003743616060963
Caov-3,9911463,3.58522921506602
CAL-85-1,10302451,1.9167496661673895
HT-144,11404337,-2.6736353860165054
MHH-CALL-3,9911463,4.211712369373876
HeLa,11404337,0.8471506482049684
SNU-C5,1716436,0.8792609053529251
SHP-77,148198,-3.620060060675933
HSC-4,16013152,3.4985623845199956
SIG-M5,24753719,3.8499837054147656
A-549,6450551,3.987118649035783
TYK-nu,10385095,0.5187167095917287
NB4,9903786,1.7786072365174606
LN-229,654092,-1.7345622132805432
NCI-H2009,10385095,0.2451756361843044
Granta-519,2729026,1.8472912754822493
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837
NCI-H508,2729026,2.4072353683261416
CAL-29,136227924,2.032112399542908
T-47D,136227924,3.374798567013006
Hep 3B2.1-7,374536,3.6821717267000103
HSC-2,49766530,-2.22152995059399
KMS-26,136227924,1.9705002365993127
COR-L105,135984461,4.336047626093702
NCC-StC-K140,46926350,-5.709475514929838
NCI-H322,16013152,4.2613063489209715
SiMa,4259181,-0.990958559837322
WM793,4259181,0.9321312927301734
UM-UC-1,sirolimus-bortezomib (250-1 mol-mol),0.2883897871436763
G-361,148198,-1.9326173225508625
MDA-MB-361,9868037,3.9951939200325057
PE/CA-PJ15,156414,0.0244775870569668
OS-RC-2,44137675,2.1101080312953235
MDST8,44137675,1.8173250203578384
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
CAL-51,136227924,2.079284078064279
HPB-ALL,49766530,-0.2881554297817815
BC-3C,11485656,2.025268186046356
P3HR-1,124202324,5.448955153472202
HuP-T4,6450551,4.99789332174828
TC-71,24772860,-2.359845249946639
F-36P,135984461,3.5381976593553444
MG-63,6918638,1.818394000557256
LS1034,9911830,2.3866368813346175
Pfeiffer,49766530,-5.33360369117745
THP-1,9911830,3.0400846204578262
DLD-1,9911463,4.0801300312150115
CAL-33,tanespimycin-bortezomib (250-1 mol-mol),0.6625956930764642
T3M-10,selumetinib-BRD-A02303741 (4-1 mol-mol),3.502409940690511
ZR-75-30,753704,6.227734648186956
KMS-20,9929138,5.867169727564362
HCC1833,24753719,5.582495333758276
NCI-H520,2729026,2.308184531900117
LAMA-84,9911463,3.2110209522938247
COR-L95,9903786,3.7357721387912513
KP-4,148198,-2.7737316499717353
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
OE19,10385095,1.3050426260801358
HCC1588,49766530,2.4669861757295832
KNS-62,9911463,4.346358947523489
IGR-1,148198,-3.4768573180396496
697,1716436,2.722788107349179
SNU-685,6918638,-0.5860605595397334
HEY A8,148198,-3.070106200413562
SNU-503,46926350,-4.03251378312178
CAL-62,3815108,3.3902082817743837
NCI-H508,9911463,3.6080758528024055
BT-12,sirolimus-bortezomib (250-1 mol-mol),1.3345146082799952
HCC2218,10385095,0.9355515453003532
CAL-51,124202324,2.033990287468598
HCC15,654092,-0.5163256778254894
A-673,16013152,4.069813049540754
NCI-H2106,10302451,3.9378582499714576
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
BT 231,10302451,3.095881087225805
SaOS-2,46926350,-4.2820912559124995
LUDLU-1,6918638,0.1404084517596252
Panc 08.13,tanespimycin-bortezomib (250-1 mol-mol),-2.574326454795975
HuT 78,9903786,-0.2471360619469426
EFE-184,654092,0.4361428073781121
NCI-H810,1716436,2.735615150941608
ACHN,135984461,1.8041050140456245
Mono-Mac-6,49766530,-0.8039148598736047
LN-229,9929138,5.025043627599637
MFE-296,44137675,3.493734363732107
NCI-H1155,9903786,2.7353298872083984
Panc 08.13,9911463,3.6396018844852662
HCC202,54618305,4.256678019929169
MDA-MB-157,44137675,2.4962707088889524
MHH-ES-1,24753719,3.7932935338290954
KCL-22,374536,1.6756994484867809
LOX-IMVI,9903786,2.476339692878584
JeKo-1,135984461,1.9350471702678365
GOS-3,24753719,4.687766883023854
JM-1,2729026,2.071801783442454
TE-6,654092,-0.0469762509912274
SUP-T11,124202324,1.9765054457795648
G-361,4259181,0.5311792597043482
SU-DHL-10,6450551,1.0782837951395454
KG-1-C,tanespimycin-bortezomib (250-1 mol-mol),1.8442829762863937
T3M-10,sirolimus-bortezomib (250-1 mol-mol),0.4109261861139289
CAL-12T,JQ-1-UNC0638 (2-1 mol-mol),4.781213623371684
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744
LK-2,JQ-1-UNC0638 (2-1 mol-mol),1.3586529366444606
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573
HuH-28,49766530,-2.3300741099072937
Lu-65,selumetinib-BRD-A02303741 (4-1 mol-mol),0.2536220160137153
CML-T1,2729026,1.0181320426336582
NUGC-4,44137675,3.715287681165846
LOX-IMVI,54618771,-0.8031507578309087
Lu-99,sirolimus-bortezomib (250-1 mol-mol),1.6973589425418654
SF268,sirolimus-bortezomib (250-1 mol-mol),0.3840315084108963
OCI-Ly19,JQ-1-UNC0638 (2-1 mol-mol),-1.0178565343122092
Hs 294T,1716436,3.3238019128926504
NCI-H1573,24772860,-3.8678435124395247
J82,selumetinib-BRD-A02303741 (4-1 mol-mol),5.997011824490154
DU145,10302451,3.708227843551259
KP-4,44137675,3.4268273488123393
OCUM-1,1716436,2.2769665789736635
NCI-H1184,44137675,0.6567498041405646
ONCO-DG-1,9868037,1.829035514218224
TUHR10TKB,9911463,3.273764915717201
PK-1,46926350,-4.313102219783032
SNU-466,44137675,4.02716725445436
AML-193,11167602,1.123439400433108
HEC-151,73707371,4.4632705727221245
BC-3C,24772860,0.1904167062107548
NCI-H460,24772860,-0.596461213785507
Ku812,9929138,4.0796690015060095
HCC-56,6918638,0.2361722846831457
TE 617.T,6918638,0.5415631808582457
Daoy,24772860,-2.4103024343615806
MDA-MB-453,151289,1.613318506724072
HLF,54639665,4.499757528178239
SNU-C5,6450551,3.303965645334938
NCI-H1944,2708,5.3439016314457835
COV362,151289,0.5692830942088547
HEC-151,3815108,2.591309919436277
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
BT 232,49766530,1.9852556236627383
NCI-H1581,24772860,-1.3092826739436123
JVM-3,44493528,3.702239764390707
TE 617.T,46926350,-4.642766988271582
RS4;11,11404337,-3.5879317876288956
CAMA-1,11404337,0.4907502800478153
YH-13,54618771,3.881155680896358
SK-MEL-30,54618771,0.8383532620392692
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
NU-DUL-1,135984461,1.2586249642588896
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
T24,11485656,2.4283497682817945
HOP-62,136227924,3.3249367186884564
KNS-60,654092,0.1353224755177926
SNU-719,136227924,2.577096412948206
WM266-4,54618771,1.3867437118908044
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
YKG-1,49766530,1.555111020821771
SU-DHL-10,24753719,3.959524589589147
KYSE-510,148198,-4.124050195334788
SNU-182,151289,0.5518786613847638
BHT-101,9911830,3.1338358933473716
SNU-601,selumetinib-BRD-A02303741 (4-1 mol-mol),3.287701862577533
WT2-iPS,54618771,5.206944426983613
HEL 92.1.7,6918638,-1.1828451874252928
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
G-402,selumetinib-BRD-A02303741 (4-1 mol-mol),4.598917412758955
IPC-298,9911463,3.847943729471794
Malme-3M,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.8318541060475535
COR-L105,374536,-3.312479831607182
BxPC-3,49766530,0.5943123243750338
ACHN,49766530,-1.8563203862098
TC-71,24753719,4.206568050184285
HCC44,9911463,3.3099390770105748
Kasumi-2,4259181,-0.4186991216348978
GSU,1716436,3.328588382964227
OCI-AML-5,selumetinib-BRD-A02303741 (4-1 mol-mol),2.485441558692337
CFPAC-1,9903786,2.8562781406669653
KP-N-SI9s,2708,4.51660366386497
SNU-1079,24753719,1.4594897792984398
PE/CA-PJ34 (clone C12),2729026,3.095265123820331
TCC-Pan2,11485656,3.231735678762206
PE/CA-PJ49,151289,0.769726200239813
SK-ES-1,24753719,4.536634843325145
SW579,148198,-4.901581686812131
DOV13,sirolimus-bortezomib (250-1 mol-mol),0.9080087228698384
Li-7,148198,-2.409975630589331
NCI-H2030,4259181,1.1105893163636829
Sq-1,4259181,0.8325863064672886
KP-N-SI9s,54618771,1.0229229118908414
HT-29,136227924,3.5079295938152706
RVH-421,sirolimus-bortezomib (250-1 mol-mol),0.2798149280233217
HCC2108,135984461,3.878993075429708
P3HR-1,9911463,4.040866432648006
NCI-H441,100016,5.015174861435744
A-549,9903786,1.8644448309659765
HEC-1-B,11404337,0.5872322910444284
HL-60,10302451,4.087381229377661
NCI-H2286,2729026,2.4793745953320125
YKG-1,10302451,4.0412794748223835
TE 441.T,6450551,2.8437483634937215
SK-N-AS,9911463,3.98556434214228
Panc 08.13,44137675,3.0884008396127336
OUMS-23,54618771,-0.8110473327008938
JK-1,9903786,1.7060026782988165
SNU-601,9911463,3.648706440193743
KMS-21-BM,9903786,1.778157023990249
EKVX,54618771,-0.0209843896322389
KMS-20,9868037,2.1280335543005293
LNCaP clone FGC,374536,-0.7618428530873494
RCH-ACV,654092,-0.6191884154872385
Reh,753704,4.307940657245249
KYSE-30,148198,-4.331453900167214
BT 271,4259181,0.1680419141045905
NCI-H1092,JQ-1-UNC0638 (2-1 mol-mol),3.1709081396689496
KMS-34,9911830,1.4656867224439092
NCI-H2452,9911463,3.657985193851277
KMRC-20,6450551,3.0929190017182058
NCI-H520,9903786,3.332228860924169
MOLM-13,2708,1.6215518677504634
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
SU-DHL-10,9903786,1.7653767834986365
PL-21,148198,-2.77177529672749
SK-MEL-24,10385095,1.8433665427575583
WM88,16013152,4.077750665107336
SKM-1,24772860,-3.5610280198331705
KP-N-YN,selumetinib-BRD-A02303741 (4-1 mol-mol),5.886613370248735
HOP-92,JQ-1-UNC0638 (2-1 mol-mol),1.4677820054229196
HCC2218,11404337,1.2593455770198374
SU.86.86,54618305,4.404788411078512
JHUEM-1,135659046,3.513270809180088
NCI-H1651,11485656,2.5009504795873516
RERF-LC-A1,11167602,2.3879562150409788
BT 440,10302451,3.8215818132063233
SNU-668,24772860,-1.830865685873739
VMRC-RCW,11404337,-0.70484816503425
HSC-2,6918638,1.1394559383012468
SNU-1214,11404337,-1.0088442164692528
IGR-37,148198,-3.2890285430700064
LNCaP clone FGC,16013152,2.5423309014724076
A3/Kawakami,11167602,1.5696684185546212
Ri-1,11404337,-1.810959317313917
MG-63,1716436,3.976078718087745
SNU-C4,374536,3.2982485507289976
OCI-Ly19,sirolimus-bortezomib (250-1 mol-mol),0.0855079956722299
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
NCI-H1651,44137675,5.684612562483685
CCF-STTG1,44137675,4.772154618477063
MDA-MB-468,9903786,1.7748497481459855
NCI-H1651,6918638,0.1812573070199931
COV434,54618771,-1.0404001935191405
SNU-16,10385095,0.9288452386070228
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884
KYSE-520,9903786,4.522923988599173
BT 239,327653,2.683807943934812
HD-MY-Z,10385095,0.804290449533917
JHH-2,1716436,3.1491012806057133
42-MG-BA,11485656,2.199214577741701
CW-2,124202324,1.3249854441310416
NCI-H28,9903786,3.2913179081195776
SEM,135659046,3.5193041881341087
NCI-H1339,24753719,4.233509766860094
IA-LM,10302451,4.177351274859187
HT-1197,135984461,4.813315019512045
MHH-CALL-3,327653,2.339703359599371
SK-N-FI,1716436,2.64126523998074
GP2d,54618771,1.3284936518837778
UACC-62,156414,2.6255417580681923
JHH-4,sirolimus-bortezomib (250-1 mol-mol),0.3887655009012536
DoHH2,49766530,-6.954726736729235
HCC2218,2729026,2.847632009198406
NCI-H1915,sirolimus-bortezomib (250-1 mol-mol),0.5181778086955178
BT-549,11404337,-0.1293922368150601
CAL-12T,11404337,-1.0513453542481006
SF126,tanespimycin-bortezomib (250-1 mol-mol),0.701676185557571
VMRC-RCZ,10302451,3.843539163355995
SKM-1,54618771,0.6725959366795358
NCI-H1299,selumetinib-BRD-A02303741 (4-1 mol-mol),4.60550863412006
Peer,2729026,0.8965628038421862
SCaBER,54618771,2.268737587506627
FU-OV-1,1716436,3.524722071533676
SR,2708,2.6440450408992007
BT-549,374536,3.1184462544943363
NCI-H2087,148198,-2.1193068046896255
SW620,2729026,3.18854295811742
Kasumi-2,6918638,-1.1951505869280743
HGC-27,24772860,-2.344763599796839
NCI-H2009,654092,0.0283248260105453
KYO-1,24772860,-3.6461087544286817
KMS-34,44493528,3.6227585741611
HCC1500,9911830,2.253316240952314
SK-MM-2,374536,-5.124113354523147
SNU-620,151289,0.0646360818098963
JVM-3,49766530,-1.001889961758068
PLC/PRF/5,4259181,1.1684219933563562
EFM-192A,sirolimus-bortezomib (250-1 mol-mol),-0.607233737838293
NCI-H1650,9868037,3.338275078682257
ALL-SIL,124202324,0.3755400921280209
PC-14,11404337,-0.86699452338107
L-1236,374536,1.6729260372926786
MDA-MB-435S,2729026,2.3631791858565694
ME-1 [Human leukemia],11404337,1.0093638821614643
OCI-Ly10,54618771,1.2684517844951826
BT 248,10302451,3.817813130063646
Panc 03.27,16013152,5.37387418697898
G-402,44137675,2.6672833935817266
GA-10,2708,1.911787871083676
SNU-449,10302451,2.626140201612578
BV-173,9929138,5.5371919710520325
Capan-2,9868037,4.081009798039869
KLE,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7158414512435143
EM-2,327653,2.703948215233707
NCI-H1355,54618305,4.816261952475267
MDST8,10302451,4.267643132743765
5637,9868037,3.3749998871313127
SNU-1214,24772860,-2.6292403304682197
HCC1195,16013152,4.536200934700984
SK-N-AS,44493528,4.35131115030736
COV362,2729026,2.7148626999256473
TOV-21G,16013152,3.792939847774952
TTC-709,6918638,1.4201492579902153
MOTN-1,4259181,0.2801438460901613
SNU-5,327653,4.191247706787995
Rh41,10302451,3.6529049739678983
NU-DHL-1,2729026,2.5099936780211674
RERF-LC-A1,JQ-1-UNC0638 (2-1 mol-mol),1.161874917603771
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
OV56,tanespimycin-bortezomib (250-1 mol-mol),1.0708573891285402
JMSU-1,44493528,4.427701991229088
Karpas-422,6450551,2.30422397059455
SK-N-AS,6450551,2.700309329484188
NCI-H2452,327653,3.049758242791241
NCI-H1734,374536,-2.2193511932613297
HuCC-T1,10385095,1.350448743277585
NCI-H2110,2729026,3.135711176833809
TC-71,9903786,2.1601140442915736
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
NCI-H716,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0513049093415066
HT115,135984461,1.7227419077735964
Calu-6,10302451,3.8675948224164873
HL-60,24753719,4.3122950153676065
CML-T1,24753719,1.910679313408318
TYK-nu,24772860,-2.5745011949772207
SK-MEL-24,156414,1.646633050519371
Panc 05.04,4259181,1.0154249000610034
A-549,654092,-0.0816351868861503
Ku812,11485656,2.1573639541519474
ChaGo-K-1,54618771,2.4705381408155183
NCI-H1563,100016,6.550294719377214
TE-14,9903786,3.4903828938175354
BT-474,54618771,0.7682511511531626
LNCaP clone FGC,6918638,-0.3198952238594262
KMS-12-BM,54618771,-0.8802136937205215
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
LP-1,151289,0.9279604149633623
HT-1197,2708,4.735159242056589
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
SNU-1041,10302451,3.993130950847062
SW1417,9911463,3.860832052888163
HSC-2,9911463,4.049895427785984
SW579,156414,1.6193105728841577
GSS,4259181,-2.284174243977743
SNU-668,tanespimycin-bortezomib (250-1 mol-mol),-0.1123433935372655
BT 422,2729026,1.1501104277969243
SNU-620,24772860,-3.371873217760827
HCC1143,24772860,-1.4749293698634824
BC-3C,46926350,-4.115294296697457
NCI-H2170,374536,3.564638925731233
SK-MES-1,24753719,3.7681083522004464
NCI-H322,9911463,4.3692718252233895
COLO 800,54618771,0.8952139014407665
SU-DHL-8,49766530,-1.150122303282486
KP-2,1716436,3.749939599359823
KYSE-450,6450551,3.3363850258393124
NMC-G1,2708,6.453873517728225
NCI-H1435,9903786,1.8372314189682823
NCC-StC-K140,156414,4.00821298519003
Ishikawa (Heraklio) 02 ER-,2708,5.818927723833249
KMS-20,54618305,3.8048007259852543
HuP-T3,4259181,1.3598984416642497
BT 232,4259181,1.35980761769268
MES-SA,46926350,-4.447583095369432
SNU-C5,73707371,7.140222451283232
KMS-26,9903786,0.9658613723306017
GCT,148198,-3.923024510865304
253J,654092,0.546612195336959
SK-MEL-28,654092,0.5441939646786474
HCC1500,753704,5.032412058463686
RKO,10302451,3.926970734642152
BT 440,148198,-3.676636651938413
SW620,73707371,5.0663964173086615
U2OS,11485656,2.250878225413065
LP-1,135984461,3.5540732743417665
IM95,1716436,3.4374544546496812
LS513,tanespimycin-bortezomib (250-1 mol-mol),-1.0041137629262296
SK-MEL-1,4259181,0.7052646872097644
BL-70,2708,4.5281737147612375
GA-10,11404337,-3.9267202398834167
SK-MEL-3,10302451,3.716398360245668
H-STS,54618771,0.7523066402016166
YD-15,148198,-2.3396960553231456
LCLC-97TM1,156414,1.5907536031970133
CL-11,151289,1.4232759200402938
Hs 895.T,49766530,-0.4019815670420401
SU-DHL-8,156414,0.996109901273004
LMSU,44137675,3.873281140485592
LUDLU-1,49766530,4.558190853315777
PaTu 8988s,10302451,4.079091129858146
8505C,BRD-K13185470,4.4652623592187775
SNU-16,2729026,1.781929686512559
BT 159,11485656,3.350505147528576
COLO 205,151289,1.1383493526244235
YAPC,10302451,3.503177254309001
HSC-3,24772860,-2.421030928901566
SEM,10385095,0.8510184643991832
RL95-2,1716436,3.236357803833817
HCC2218,136227924,2.978872567688762
SNU-601,44137675,4.747200321205292
SJSA-1,11404337,-1.5700525200999282
MM1.S,11485656,1.9684027845110144
NCI-H1869,10385095,1.0868363203730835
Hs 934.T,11404337,-0.0491167451592997
KMS-27,124202324,1.1714757425485065
CCK-81,2729026,2.309755654843286
CAS-1,136227924,2.284810237581045
CAL-29,124202324,2.323813615882948
SCaBER,46926350,-4.262812165026071
SK-MES-1,9911830,2.0090126357404334
RD,JQ-1-UNC0638 (2-1 mol-mol),0.9111340017166628
EBC-1,124202324,2.141509662208694
OCI-AML-5,49766530,0.2957365675241968
Hs 294T,135984461,3.742416066345508
22Rv1,100016,5.084356097831624
SK-HEP-1,1716436,3.791424957504218
A2780,4259181,-1.27299012623329
OCI-AML-2,9929138,5.333806393496855
NCI-H520,135659046,3.9949277821053704
OAW42,1716436,3.6467595531417833
NCI-H460,374536,2.933441634270558
SNU-216,54618771,-0.3617470583099299
PE/CA-PJ15,1716436,3.7079819536891554
TE-8,10302451,0.966485483628724
SNU-1079,124202324,-0.2127872852264718
SNU-478,2708,4.633427575017928
SW1088,selumetinib-BRD-A02303741 (4-1 mol-mol),5.681347136501141
KMS-18,10302451,3.935362839755576
HCC1428,selumetinib-BRD-A02303741 (4-1 mol-mol),6.547126293605875
JURL-MK1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.8951759192437535
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
NCI-H522,135984461,5.248212763135773
TCC-Pan2,148198,-2.533769262654455
COV644,2729026,2.6458172970290903
DV-90,136227924,1.3959750608222408
PK-45H,148198,-3.448845301231553
Panc 03.27,11485656,1.610276290455132
RPMI-6666,2729026,3.062574057139019
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
SNU-C4,49766530,2.185419725240328
639V,sirolimus-bortezomib (250-1 mol-mol),1.801043547803399
HEC-108,4259181,0.4931043474853455
TM-31,24753719,3.823866411765544
LN-229,327653,3.598788059447135
HCC78,100016,6.366939598030235
Hs 729.T,selumetinib-BRD-A02303741 (4-1 mol-mol),5.442432569347765
LS1034,156414,1.930466609004537
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
KNS-42,6450551,3.612698511679203
EKVX,9911830,1.6241739664909705
RL,374536,3.07407253211684
KMRC-3,44137675,4.978623373986589
Becker,4259181,1.0240306217869668
SUP-T11,3815108,2.540491338453958
Calu-3,156414,-2.1411931104090964
TF-1,tanespimycin-bortezomib (250-1 mol-mol),0.3682708588950815
JURL-MK1,9868037,1.498600945744401
SNU-1214,24753719,4.20428044650039
MV4-11,sirolimus-bortezomib (250-1 mol-mol),-0.4533727146594301
NCI-H1373,4259181,0.2366885194586986
NCI-H1341,24772860,-3.4681788885912774
DB,753704,3.769075477090176
SF268,753704,5.081908767441593
FTC-238,9903786,3.4467406025771705
NOMO-1,4259181,0.2459758371125145
BT 164,6918638,0.5981127471787415
HCC78,44137675,3.7342056972339326
SK-CO-1,44493528,4.973545843770428
Fu97,24772860,-2.629612833125868
EM-2,6450551,-1.4760490148777723
SNU-478,124202324,1.56870161721205
NCI-H196,1716436,5.019622183878195
SW1710,9911463,3.971766424444902
HEC-1-A,753704,5.322373362675289
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
EFO-21,46926350,-4.110942740118918
AsPC-1,135984461,3.722049898583642
SNU-1077,44137675,3.7361071963131858
SNU-899,9911463,4.136676393958991
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
Aska-SS,9911463,4.275261976243402
SNU-601,54618771,0.1352260287728254
SK-MEL-3,2729026,3.1225614639515356
TUHR4TKB,JQ-1-UNC0638 (2-1 mol-mol),3.1417830283386783
FU-OV-1,JQ-1-UNC0638 (2-1 mol-mol),1.6948403130228156
HuT 78,49766530,-1.6423396691241603
KNS-81,11404337,0.4763039315570028
NCI-H1581,327653,2.5433406837267416
DMS 114,753704,5.313820346815706
DMS 454,10302451,3.267964851725962
SNU-119,374536,-1.8347712072853533
KHM-1B,24753719,3.787412928700261
SH-10-TC,374536,-2.970225566327119
Hep 3B2.1-7,44137675,3.4497824153941528
JHH-2,6450551,2.944248859258473
RERF-LC-A1,2708,3.8751525126166113
KM12,9911463,3.8225148805957465
OCI-AML-2,9911830,2.3602217978284816
SJSA-1,3815108,2.466173296048475
BxPC-3,100016,6.453363473458683
HCC2108,10385095,1.3545455997149978
NCO2,10302451,-2.218182882660743
RL,6918638,-0.8458065739236997
MOR/CPR,10385095,1.3001404643624
SUP-B15,44137675,4.3443341940818785
NB4,3815108,1.6881189464733786
Reh,9868037,2.2106606169750824
GA-10,9911830,0.6286737251156136
M059K,selumetinib-BRD-A02303741 (4-1 mol-mol),5.050831494288079
CAL-51,10302451,1.350542324147247
HCC1143,2729026,2.66692124656069
A-498,10385095,3.0502652475567347
EHEB,2708,3.688555693681277
OVK18,2708,4.094418491305804
ST486,11404337,-3.35080317485283
SEM,54618305,4.259603919662889
8305C,JQ-1-UNC0638 (2-1 mol-mol),0.0486401346144068
KU-19-19,151289,4.45756440863607
HEC-1-B,2729026,2.8189200411344837
IMR-32,151289,-0.4127478685653054
CAL-54,2729026,2.9673108447132965
NCI-H1299,49766530,-0.517142624612936
Caki-2,6918638,1.5363275788764994
MOTN-1,sirolimus-bortezomib (250-1 mol-mol),-0.1578046305827232
WM983B,9911463,4.352284884356164
JURL-MK1,151289,0.2684721095201931
ME-1 [Human leukemia],sirolimus-bortezomib (250-1 mol-mol),1.2847340597652257
UACC-62,11167602,1.57164687093679
NCI-H2141,11485656,1.4987808894190335
UO-31,136227924,2.530889708332206
NCI-H441,9911463,4.313275778321212
HCC1937,11404337,1.0839462166923302
JHUEM-2,54618771,-0.9670015993235072
SW579,selumetinib-BRD-A02303741 (4-1 mol-mol),3.8805121592661727
NCI-H1563,10302451,2.8247496437227473
Rh41,3815108,3.048052076314017
HeLa,2729026,2.7909248989081346
P3HR-1,9868037,3.788082301181329
Karpas-620,9903786,4.2683089971609265
NCI-H2170,6450551,3.766259442502189
DMS 273,1716436,3.74376938939547
Hs 294T,24753719,4.268891526182451
SK-UT-1,49766530,-1.8212556826920157
Pfeiffer,4259181,-0.2784459130692439
CW-2,54618771,-1.320149123720888
UM-UC-3,100016,5.625806405184742
CAL-120,JQ-1-UNC0638 (2-1 mol-mol),3.133645927895246
HGC-27,151289,0.3987729432700477
MOLT-16,148198,-4.088839016877876
769-P,54618771,0.1291484559700657
SNU-466,selumetinib-BRD-A02303741 (4-1 mol-mol),4.6774460035352625
LN-18,6450551,4.815256941868662
OCI-AML-5,54618771,0.4264677614075425
HEC-6,JQ-1-UNC0638 (2-1 mol-mol),1.750547411525194
NCI-H520,16013152,4.265918018585053
BV-173,9911830,-1.2786691567817767
A-549,selumetinib-BRD-A02303741 (4-1 mol-mol),2.307828661203879
Rh41,tanespimycin-bortezomib (250-1 mol-mol),-0.5617508290284754
A2780,9903786,1.372407357095215
DMS 114,tanespimycin-bortezomib (250-1 mol-mol),-0.0529426000704769
MOLT-16,9868037,1.8123148849264936
SNU-449,10385095,1.0986031812390589
LCLC-97TM1,9929138,5.774162864206733
HEL,3815108,1.7280464955300685
HCC15,6450551,1.6627728253820353
L-428,2729026,2.3480482601547568
TUHR14TKB,6918638,1.3183057311971391
JMSU-1,10302451,2.622801309403871
CL-11,654092,-0.1320247934133204
MDA-MB-435S,11404337,0.4937179544357896
HMC-1-8,151289,1.1581685572139058
UACC-62,16013152,4.060590547250853
SUP-T11,10385095,2.0290179128287007
TE 617.T,24772860,-3.1791034277666164
HEL 92.1.7,9911463,3.2489228387503486
HCC44,3815108,3.464501853282022
SW1271,6450551,2.703162256598128
KNS-62,6918638,1.7300620365189876
COLO 699,24753719,3.4559713951503475
TOV-112D,selumetinib-BRD-A02303741 (4-1 mol-mol),6.893791338526886
HCC202,6918638,0.9094073905237152
KMBC-2,327653,3.602242571352684
KNS-42,JQ-1-UNC0638 (2-1 mol-mol),3.4759204532002603
WM1799,11485656,2.91398377958601
NCI-H2122,9911463,3.941857850856705
BHT-101,44137675,5.556753061676296
SNU-840,10385095,2.2002748270654533
647V,tanespimycin-bortezomib (250-1 mol-mol),0.053073240777135
HCC2279,10302451,2.443076216566613
Ki-JK,tanespimycin-bortezomib (250-1 mol-mol),-1.1406777464208224
NCI-H446,100016,4.920277084242614
HMCB,24753719,4.311459213197197
KYSE-30,1716436,3.547929455379654
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977
SNB-75,10385095,1.6720674409271052
NCI-H2405,100016,6.531050125500204
NCI-H1869,11485656,1.8296978789565703
RPMI-8226,4259181,-0.2249156450925163
Capan-1,10302451,2.5563331533364373
BT 112,136227924,2.645928432247734
RD,44137675,4.129600971234558
U-118MG,2729026,3.257708185027529
HOP-62,2729026,3.06200446811759
UACC-62,1716436,3.4264026845383615
MOLP-8,2708,2.5820066460748015
SUP-T1,24772860,-3.5014548125708473
OCI-Ly10,24772860,-2.474768790742219
BT 245,44137675,3.3906511834655517
EBC-1,136227924,2.637152829802991
MES-SA,6450551,2.5670466149732394
RPMI-7951,654092,-0.1798670044623603
HDQ-P1,2729026,3.0281895459380377
OVSAHO,49766530,-1.4771294887146182
GB-1,44137675,3.6861417864777217
JeKo-1,2729026,2.7554494361122335
OAW42,9903786,3.91324183381597
NCI-H1755,124202324,1.9452073190099353
NCI-H1703,sirolimus-bortezomib (250-1 mol-mol),-0.4256415561025075
RKN,2729026,3.0549768432694377
SNU-213,136227924,3.1812992174761696
NCI-H1184,JQ-1-UNC0638 (2-1 mol-mol),0.2682275466719458
PC-14,2708,4.06004152790413
Calu-6,54618305,6.226054590267507
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
CHP-126,3815108,1.939165810994336
KMS-21-BM,9868037,1.4447274996214214
ONS-76,24772860,-0.9083480450936676
ME-1 [Human leukemia],24772860,0.3730254347024007
GMS-10,sirolimus-bortezomib (250-1 mol-mol),0.908148060868429
SNU-1076,10302451,0.3385976785731625
NCI-H889,136227924,2.7199111384597447
HCC1937,9911830,3.374692037294104
KU-19-19,2729026,3.069520174525383
KMRC-1,1716436,3.642710819139985
KMS-21-BM,3815108,1.8997692353311173
TE-1,9911830,3.113760912947507
HEC-108,11485656,3.338600175698492
JHOC-5,148198,-2.0741521634031033
KMS-21-BM,49766530,-1.7820478851785848
OCI-Ly3,11404337,-1.6616072452432793
KMS-27,10385095,0.2784313447424752
EN,135984461,4.3188637411869255
SK-N-DZ,49766530,-5.670578617317044
CAL-29,9911830,3.5730657559572183
SNU-61,54618771,-0.470226071786205
LUDLU-1,73707371,6.22592441442636
Lu-65,49766530,1.0861089243329392
HCC1395,2729026,1.652245896591493
BT 416,46926350,-4.365459454867529
HD-MY-Z,136227924,3.0737298330446103
YD-15,11404337,-0.8850670977234124
Caki-1,49766530,-2.8134564290994346
DMS 454,156414,1.5492997606467644
LN-229,136227924,2.284287102346984
ES-2,654092,-1.5109695276067932
ACC-MESO-1,9911463,4.148709224081578
EFO-27,156414,2.3785601677308215
WM115,73707371,4.316198918387243
Kuramochi,135984461,4.688112275810485
GI-1,327653,3.210184617717175
A2780,11404337,-0.8981705286722745
RL,tanespimycin-bortezomib (250-1 mol-mol),0.0166541585574005
HEC-108,54618305,5.558551802909847
HEC-265,24772860,-2.0812954484461037
HCT 15,374536,3.214873014711252
DMS 53,4259181,0.5080002769116885
SK-N-BE(2),24753719,4.532912367616784
T-47D,9911463,4.083486296646728
BL-70,151289,0.2907862937624431
HLF,JQ-1-UNC0638 (2-1 mol-mol),3.5852306848896367
OVTOKO,54618771,1.1892418619446876
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
Hep 3B2.1-7,124202324,2.4115397020619453
P3HR-1,9911830,3.3679619343165452
RD,6918638,0.5242831454740873
NCI-H1105,1716436,2.990520366528564
MKN74,JQ-1-UNC0638 (2-1 mol-mol),2.7560912901322645
769-P,151289,1.1572933868845543
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
WM983B,1716436,3.668602444293646
NCI-H1703,24772860,-2.835107527850158
NCI-H2170,11167602,3.042196123088182
Fu97,151289,0.890371681578247
GSS,54618771,-0.6166501734641827
SCaBER,100016,6.423492154596734
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018
Daoy,11404337,-0.8590348859055235
HOS,sirolimus-bortezomib (250-1 mol-mol),0.4034549730700768
MOTN-1,44137675,4.996395489197887
KYSE-410,135659046,3.770855239455897
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
SNU-1076,3815108,3.559015803150915
RERF-LC-A1,24772860,-2.54974532107594
EKVX,4259181,-0.1949078091115229
SUP-B15,11404337,-2.134584192149202
BT 422,tanespimycin-bortezomib (250-1 mol-mol),0.0760958733861235
KYSE-150,11404337,1.3102560246616723
HEL,10385095,1.0320529067741009
HCC1500,24772860,0.2838196702204312
KMS-34,9868037,1.4276182493949865
KATO III,sirolimus-bortezomib (250-1 mol-mol),0.9695085232942704
MIA PaCa-2,327653,3.0320730676471572
HCC1428,10302451,3.907203878611604
NCI-H2126,11485656,1.628640715546943
U-118MG,sirolimus-bortezomib (250-1 mol-mol),0.338671350803902
BT 239,2729026,1.0074649695027698
A-172,10302451,3.8410002428676737
SNU-245,sirolimus-bortezomib (250-1 mol-mol),2.143003825797964
UACC-257,JQ-1-UNC0638 (2-1 mol-mol),2.372210563753238
NCI-H1299,2708,5.932138587127141
BT 428,24753719,4.392925021958881
Capan-1,156414,1.6052662486376672
HCC1500,374536,2.8802619944250765
NB4,10385095,0.7773344099741176
Detroit 562,49766530,-0.0466351352244022
LCLC-103H,54618771,0.2983505798341654
KMBC-2,11485656,2.7390953396220588
SNU-C5,10385095,1.2057512834065311
Lu-99,44137675,3.2421104472512456
TF-1,9843750,5.6573375323003185
TE-5,11404337,-1.6640351718537505
KYSE-410,654092,0.1859492790790137
SCaBER,49766530,0.3491318819905442
Daudi,24753719,1.7041863717102288
PK-1,JQ-1-UNC0638 (2-1 mol-mol),4.5303725923568035
DMS 53,9929138,3.8205898252518393
LOX-IMVI,11485656,1.9351920109561
SK-N-FI,46926350,-4.52275820755057
NCI-H28,2729026,3.0583022742124575
PSN1,44493528,4.302980688159976
COV362,24753719,4.739913484239243
MDA-MB-468,148198,-4.179391115817734
KMS-27,156414,1.1434862066422389
EJM,11485656,1.52616093441074
RPMI-7951,100016,4.945357769827656
U-87MG ATCC,sirolimus-bortezomib (250-1 mol-mol),1.5742671980534302
SH-4,6918638,2.256041037231368
KMS-20,11404337,-1.24048912938788
SK-MEL-3,6918638,0.5772610172488114
NCI-H446,11485656,1.965301254432185
KMBC-2,9911463,3.851747430991294
T24,2708,4.86498780705172
A-549,10385095,1.3823205412091923
HCC1419,9911830,2.011265025097353
EFM-192A,151289,1.0282444292229314
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
NCI-H1299,10385095,1.4970328026397637
HCC2108,49766530,-2.150620999142696
SNU-878,2729026,3.017105189863621
SNU-601,148198,-4.403803461658863
U2OS,136227924,2.232158663555595
MOR/CPR,11404337,-0.964531919151295
FU-OV-1,654092,-1.6613932676517214
KG-1-C,9868037,4.232023281385857
SK-N-SH,1716436,3.5809098311972996
EFO-21,6918638,1.430978330266965
YKG-1,11485656,3.6397536658143865
LUDLU-1,11485656,1.892840713859796
LCLC-103H,9903786,3.9967722976793696
ACC-MESO-1,151289,4.084741165182866
BT 172,151289,0.987976717612563
LAMA-84,24772860,-2.739208636177764
HEC-151,54618305,4.2925699084671525
SCaBER,6918638,-0.2327063934194413
HuT 78,148198,-3.964995663982544
HCT 8,tanespimycin-bortezomib (250-1 mol-mol),0.9236703838462946
HEC-251,136227924,4.831338089277502
5637,24772860,-2.843023997771185
WM266-4,24753719,4.092945854895752
SNU-46,374536,3.6282738328269257
A-375,9911463,4.039687099931349
PE/CA-PJ34 (clone C12),54618771,0.3330928840466188
BT 228,24772860,-2.116396582484206
NCO2,327653,2.297487174577918
NCI-H23,2729026,3.1814387665389736
NCI-H810,135984461,4.558480725303822
NCI-H1650,54618771,3.34176248194117
SNU-182,327653,2.4311558058235443
SF268,16013152,3.758214615432608
SUP-B15,4259181,0.1387948880885041
BT 224,136227924,4.003699925469014
HuT 78,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.768713578692631
MDA-MB-453,11485656,1.765591398344026
SCaBER,24772860,-3.5917485766257755
HDLM-2,9911463,3.4490026877809674
SK-N-DZ,10302451,2.4315640963811496
HCC1395,124202324,2.811259406423157
SU-DHL-10,135984461,3.8302995434103138
HDLM-2,2708,4.535521013132918
FTC-238,46926350,-4.15026030625884
YD-38,54618771,0.1066197400708346
SK-N-FI,151289,0.6710497777475463
786-O,49766530,-1.7436393019266725
CAL-51,11404337,-1.4033364127444676
EFO-21,6450551,3.8952169106942143
SHP-77,9903786,4.085318424686739
SNU-1033,156414,1.6354285292334745
NCI-H2029,327653,3.052005292522305
YKG-1,JQ-1-UNC0638 (2-1 mol-mol),2.7051806168218153
NCI-H1395,9903786,3.8864807174358984
HCC4006,49766530,-3.027931972438472
RKN,44137675,5.459450119186335
TUHR4TKB,2729026,3.0497139959769393
NCI-H841,24772860,-2.385477831854826
SR,654092,-0.3678705706298014
SW1710,654092,-0.118328833722811
NCI-H1623,4259181,0.7011384719609343
TYK-nu,151289,3.2170313546447504
CML-T1,9903786,2.526700219209825
PC-3,JQ-1-UNC0638 (2-1 mol-mol),3.942317112816739
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
PSN1,49766530,-0.1944189543037747
HCC2279,148198,-1.731390144529653
Hs 940.T,11167602,2.6924993673578688
SK-UT-1,6450551,2.944918696564172
KMRC-20,24753719,4.050847735561683
TT2609-C02,135984461,4.527681424871781
JK-1,148198,-4.68047289678299
NCI-H1373,44493528,4.762290588865201
DU145,4259181,1.409412257624231
Lu-65,4259181,-0.4284059095013066
SNU-C2A,124202324,2.388865450360117
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
NCI-H522,46926350,-4.757002390021422
P31/FUJ,2729026,1.895106624580685
MDA-MB-453,11404337,-0.3002498088297632
Raji,24772860,-3.1428664616860615
AN3-CA,49766530,0.9400447576922468
Hep-G2,753704,5.097151878686146
MDST8,10385095,1.2575537617816142
BT 187,24772860,-2.3163103100218736
CAL-27,151289,0.7234216457505269
BT 172,374536,3.5368388627798
Malme-3M,2708,5.053276908689557
A-549,1716436,2.5951939484521724
MOLT-13,1716436,2.5495374926870933
HEC-1-B,100016,7.817681002018073
WM88,135659046,3.481693995509175
LK-2,100016,5.670732740144693
HeLa,6918638,0.9489193596088062
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
BT 328,374536,4.943552861027733
C2BBe1,10385095,1.7021974015652714
HSC-3,10302451,2.6157222782287795
SNU-5,44137675,1.9805769271328184
OV-90,1716436,3.296930763756102
COLO 320,49766530,-1.8814026432492763
SK-LU-1,135984461,4.3992720133799725
JHH-2,24772860,-2.437642350387178
PLC/PRF/5,151289,1.433153813655942
NCI-H838,49766530,-0.8492681792296649
MFE-296,71729975,2.4966082012225663
BT 245,46926350,-3.489677690297977
SUP-HD1,44137675,3.2641090592395843
KYSE-410,44137675,3.6487631222802337
COR-L105,24753719,4.356648297258706
MM1.S,1716436,2.248600681663511
T98G,24772860,-0.8753356838785967
SW948,10302451,4.082058519290096
LS411N,24772860,-2.6286287692739587
COLO 800,753704,5.179072521518824
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
BV-173,9868037,2.047976501818227
JJN-3,151289,1.1425287839414455
BCP-1,46926350,-4.222211395168876
VM-CUB-1,44493528,4.312275176745317
Panc 08.13,9911830,3.187524729125814
HEC-251,654092,-1.0645922890579338
Tm87-16,sirolimus-bortezomib (250-1 mol-mol),0.5846669503763354
Caki-2,9911463,4.333503624350426
MOLT-3,54618305,3.785701581176766
KNS-60,327653,2.1094204928561053
HLF,16013152,4.103989759396265
769-P,136227924,4.180099818093012
JM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.175928698896838
SIG-M5,100016,4.056618507771364
ES-2,135984461,1.833276143203305
Yamato-SS,11485656,2.8272369805427435
MKN74,JQ-1-UNC0638 (2-1 mol-mol),2.7560912901322645
NCI-H1915,2708,6.418868117208512
COR-L279,6918638,-1.2783041826308352
SUP-T11,24753719,3.652693276768125
UACC-62,6450551,3.6605824642296008
Yamato-SS,sirolimus-bortezomib (250-1 mol-mol),1.899815056583121
NCI-H520,156414,1.990276073985292
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
SCC-4,10302451,5.608388675584183
HCC1588,148198,-2.081842945352174
KYSE-410,1716436,2.7110967894013847
LS513,sirolimus-bortezomib (250-1 mol-mol),0.1168577806704952
SK-MEL-1,11404337,-0.7875528095472949
VMRC-RCZ,9911830,3.099943996543876
IPC-298,327653,3.3909286727424552
THP-1,327653,2.1571810935411313
Yamato-SS,148198,-5.276509118521361
DU145,54618771,3.337458824494602
NCI-H522,10302451,3.5044820085806645
BT 179,4259181,0.8094186534058477
Mono-Mac-6,156414,0.1379269816160407
A-204,135984461,5.548637311180796
SK-N-MC,tanespimycin-bortezomib (250-1 mol-mol),0.3614874661050979
BT 139,54618771,0.6654274606551459
Raji,100016,6.465762715187829
SK-MEL-3,54618305,4.885800889564964
BT 159,151289,1.233873045341917
SUP-T1,135984461,2.153486266323967
SK-N-FI,135984461,4.351093738178911
TE-9,44137675,4.052565788089007
EoL-1,156414,-3.3085458408804556
BV-173,sirolimus-bortezomib (250-1 mol-mol),-2.492930235496017
BT 131,24753719,4.828449358654909
BT 330,135659046,3.618868703955065
IGR-37,2729026,2.763080318961624
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885
CGTH-W-1,1716436,3.601011203119016
A-549,9903786,1.8644448309659765
KMS-18,24772860,-3.140548388952044
Peer,54639665,4.400120880800027
HuP-T3,9911463,3.677427040789425
LP-1,9911830,1.9669881995597704
KP-4,374536,4.362306924413596
769-P,654092,0.4387504543780833
NCI-H841,9911463,3.5951842135342145
KCL-22,9911830,-0.7546255295012573
HEC-151,4259181,-0.935569196791714
ChaGo-K-1,156414,1.5604886005920922
L-1236,44137675,1.4044761168196107
HGC-27,JQ-1-UNC0638 (2-1 mol-mol),0.4820693582404344
KO52,2729026,2.182339538385487
HT-144,156414,1.6783717188308007
SNU-489,1716436,3.59509927921362
NCI-H1694,2729026,2.270080026574319
NCI-H841,73707371,5.684293420876387
BT 239,10302451,3.768420544812393
KO52,327653,2.901066573817011
SUP-T1,654092,-1.915570989960676
SNU-878,654092,0.9734327583737667
NCI-H2172,11485656,2.8163630892876212
DEL,9911830,1.9134272494312208
BT 147,10385095,0.6839896048308689
2004,10302451,2.3376922055983957
BL-70,10385095,0.3917305885216868
NB4,44137675,2.778809921328377
OCI-M1,6450551,3.0584588669256147
NCI-H929,9911830,2.939236367729051
YD-15,10302451,0.0740355498774049
SF268,54618771,0.7113827759626075
VM-CUB-1,sirolimus-bortezomib (250-1 mol-mol),1.5945782994961089
COLO 699,sirolimus-bortezomib (250-1 mol-mol),-0.458397325764597
NCI-H441,9903786,3.5452366409305887
REC-1,3815108,4.528116845485933
LK-2,24753719,4.196249511971625
SF126,11485656,3.3837301563498894
NCI-H2170,44137675,3.58244056247176
M059K,sirolimus-bortezomib (250-1 mol-mol),0.4105527890909189
MDA-MB-157,100016,3.517936084480814
OVCAR-5,100016,6.797399029850292
HDQ-P1,1716436,3.593566539256361
SNU-C4,11404337,1.6015292344690046
MOLT-16,124202324,0.7121527724256916
GB-1,tanespimycin-bortezomib (250-1 mol-mol),0.6130587014327358
NCI-H661,44493528,5.823125515558819
Hs 940.T,44137675,4.798190657947831
TUHR14TKB,54618771,1.495898324291793
MOR/CPR,44137675,3.971164202003896
PaTu 8988t,136227924,2.49705731140334
JHUEM-3,11167602,2.7925879803312386
SIG-M5,10302451,3.7315924612449134
MKN7,6450551,3.8724144396360978
NCI-H1755,2708,5.433340426296521
Kasumi-1,JQ-1-UNC0638 (2-1 mol-mol),-2.0858188538723796
PaTu 8988s,11485656,1.7881493862367523
KMS-11,selumetinib-BRD-A02303741 (4-1 mol-mol),4.141198307278321
OVISE,654092,-1.3076939787912127
HT-144,24753719,4.5313758383114875
KE-97,54618771,-0.8035636826323382
LP-1,100016,3.986438392754067
SNU-1214,9929138,6.834852342367116
NCI-H1650,9911463,3.9017952806831313
EFO-21,135984461,3.9887102664802807
TT2609-C02,9911830,3.947893664595907
LOU-NH91,9911463,4.226439837654448
HT-1197,10302451,4.026289624888813
OVCAR-5,2729026,2.40713806778787
LoVo,1716436,2.86184708699294
L3.3,100016,6.042484334243821
MEC-1,135659046,3.430654530654597
Hs 578T,148198,-5.652583246713905
DB,11485656,1.836409608032291
MOLT-3,9843750,4.365153951440419
DU145,2708,5.064027511683006
NCI-H1573,16013152,3.3151547997579933
BT 231,JQ-1-UNC0638 (2-1 mol-mol),1.753830985652589
8-MG-BA,selumetinib-BRD-A02303741 (4-1 mol-mol),6.5691369117244145
CJM [Human melanoma],148198,-2.9746080822797754
VCaP,49766530,-0.3741263874855742
KCL-22,2729026,2.384614040092888
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
OVCAR-4,sirolimus-bortezomib (250-1 mol-mol),0.1609764343460656
VMRC-RCW,54618305,5.1504502435726005
TYK-nu,148198,-1.9214322639595771
KMBC-2,24772860,-1.3622286012164393
A-549,24753719,4.621771717936227
MV4-11,9929138,5.135177780047251
NB1,10385095,0.6202993417039071
VMRC-LCD,46926350,-4.334636914427668
Mel Ho,10302451,3.2236880748887007
MOLM-13,9911463,2.5287579203643986
HCC44,9911830,2.2098918595222696
WM266-4,11404337,0.1712081153064202
NCI-H1105,6918638,-1.2664288249273916
BT 504,374536,2.887745172362633
YD-10B,24772860,-3.21463968812656
SNU-1033,9868037,4.1632978097237014
DK-MG,11404337,-0.0389749694048802
HCT 8,6450551,3.929480453184804
NCI-H508,3815108,3.486423172547318
JHUEM-2,9911830,0.7349841579012222
Hs 888.Lu,54618771,0.7485520203089981
KYM-1,9911463,3.4885377293018154
HCC1438,100016,5.852637802531623
CHP-126,2708,1.9757959583992288
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
KCL-22,9868037,2.068563427073688
OC 314,136227924,3.246361398875885
SNU-466,10385095,0.6686430469836288
MDA-MB-231,9911463,3.910290396938666
OUMS-23,124202324,2.322779740636284
KYSE-140,9911830,2.9872527631338324
BICR 6,136227924,2.7894508880651485
HCC1954,9911463,3.8607019439121046
CAS-1,44137675,3.6829248617464616
SF539,JQ-1-UNC0638 (2-1 mol-mol),0.3445992267657
Calu-6,136227924,5.658776934081175
NCI-H28,6450551,3.024681796363158
NCI-H28,24772860,-2.672982526609418
KYSE-520,44137675,3.10398683006373
NCI-H1693,148198,-4.945805473712113
MDA-MB-231,2708,5.811109801446837
HuG1-N,10302451,3.905861877386106
MFE-296,9911463,3.764855426656665
NCI-H1869,136227924,3.4575085361719955
A2780,3815108,2.053113262637462
CAL-51,24772860,-2.425084956958233
NCI-H1734,24772860,-2.412462155763586
U-251MG,6918638,1.4300554442043
KE-97,3815108,2.582161380752425
DOV13,124202324,3.5313285068131166
MHH-CALL-4,JQ-1-UNC0638 (2-1 mol-mol),0.030742461546213
BT 328,135659046,3.8583019402961343
HEC-251,151289,0.9526148412276718
D283 Med,44493528,4.1397828788754465
Hs 888.Lu,4259181,1.7811754959132586
PE/CA-PJ15,46926350,-4.278267218938167
MHH-NB-11,10385095,0.6613180284209285
NUGC-4,54618771,0.2838784179231751
SF126,148198,-2.289398797231852
EFE-184,1716436,2.8207387351830553
HT-1197,16013152,3.860675395835584
U-937,44493528,4.3838606909350055
OCI-Ly10,sirolimus-bortezomib (250-1 mol-mol),-9.44158843717878
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
NCI-H2141,54618771,0.6862443380441183
SNU-1076,2729026,3.035873761330114
SU-DHL-8,54618305,3.6427143953976593
Pfeiffer,374536,2.278079895199173
L-363,100016,4.553463106890726
NH-6,2729026,2.0760155578602637
BT-12,11404337,-1.312123383148081
Hs 934.T,11167602,3.4668382200412453
NCO2,148198,-4.272732589139003
SK-N-DZ,327653,2.3999084058011033
JHH-5,100016,5.964491744827364
KMS-20,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4575031822908706
LC-1/sq-SF,136227924,3.5583860131764835
A-375,9903786,2.3118659059614877
COLO 320,148198,-6.470964602076055
Mino,2729026,2.549193377947816
Panc 02.03,136227924,3.0839082623333387
HOP-92,9911463,3.5299931958283093
NCI-H358,10302451,1.3117331281372162
LOU-NH91,135659046,3.4412725013745336
MOTN-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.30430216128798
PK-1,148198,-3.6704242534149296
SW1990,9911463,4.278474352365717
KO52,9911463,3.5355164060453004
OCI-AML-3,11485656,1.6382059446521733
DV-90,327653,2.8172961812508057
OVCAR-8,10385095,0.9629487477547042
HOP-92,156414,1.5048646511910324
NCI-H2141,JQ-1-UNC0638 (2-1 mol-mol),1.3375418962128351
IM95,24772860,-2.82377270219045
BL-70,136227924,2.857298369944604
NCI-H526,136227924,1.9152739000663332
SCC-4,11485656,2.4110004255244153
Rh30,136227924,4.165333500464175
MHH-ES-1,49766530,-2.35946817477404
CAMA-1,124202324,2.96276232639673
SK-MEL-28,9911463,4.538912500786334
HOP-92,49766530,-2.5153256499879517
OAW28,2708,5.3328257603707545
NCI-H1299,54618771,0.5506920644788533
SIG-M5,1716436,2.9519652680350137
TALL-1 [Human adult T-ALL],156414,0.6536773010311714
Caov-3,JQ-1-UNC0638 (2-1 mol-mol),0.2063879906234439
MFE-319,49766530,0.80428041774597
T24,16013152,4.835427531655397
SH-4,11485656,1.4824886275930502
BT 330,54618305,6.276995186966791
SW48,148198,-2.7635683141359277
BICR 6,374536,3.103633030144327
RKO,4259181,-0.4049041326260317
HCC1588,9868037,2.925382992818106
SK-MEL-5,9911830,3.188235338246222
NCI-H1703,JQ-1-UNC0638 (2-1 mol-mol),0.9507624280862104
NCI-H661,44137675,3.7576040576240257
SNU-C1,1716436,2.3519669507062866
ONCO-DG-1,2729026,2.8917597497377177
Rh30,124202324,1.8013183476923256
JVM-2,sirolimus-bortezomib (250-1 mol-mol),-7.352032858936448
KO52,11485656,1.6797102251271416
SKM-1,2708,3.277988117116173
CW-2,24753719,3.5794357651557407
OVK18,24753719,3.9291794932307336
DMS 273,11485656,2.8704893197930272
PC-3,11404337,1.6869548437610449
NOMO-1,9911463,3.1879476164010243
SK-UT-1,148198,-4.4190978779578565
LC-1/sq-SF,2708,5.445158654608407
TE-8,sirolimus-bortezomib (250-1 mol-mol),1.0878251503851162
JHH-6,10302451,4.243008176668727
NCI-H1869,11167602,4.37189538269334
OCI-Ly19,9903786,1.1452071440663905
BT 145,753704,3.624017653712031
SNU-16,753704,4.543735733646046
DK-MG,148198,-2.831494942566311
CGTH-W-1,24753719,4.548095547879149
SNU-1214,1716436,5.314529066322949
BT 216,374536,3.7486368578743767
MKN74,6918638,1.410948460236771
CAL-78,9903786,2.899593269782219
HuP-T3,374536,4.193584653265312
HEY A8,753704,4.9868804513894105
BT 131,24772860,-2.0877146175211223
LS123,2729026,2.45850054627719
HEC-151,24772860,-1.663502215408852
H-STS,11485656,0.1079902200809361
SNU-475,2729026,3.0607220043646524
GaMG,24772860,-1.611632772346343
NCI-H508,24772860,-3.2088722662998874
CCF-STTG1,100016,6.985278157575169
LS1034,tanespimycin-bortezomib (250-1 mol-mol),0.2308030361348307
SNU-398,2729026,2.5617520165975316
HCT 116,selumetinib-BRD-A02303741 (4-1 mol-mol),2.794492345634902
HuP-T4,10302451,-0.1170952178700548
LOX-IMVI,327653,3.424274817584711
BICR 16,9868037,4.084276624251401
SUIT-2,11485656,3.4408604141627763
CHP-126,44493528,4.776388586076308
Calu-1,9911830,3.594040176900685
RPMI-8226,136227924,2.992898649350054
TE-11,11167602,1.8271765665442756
SNU-1076,44493528,4.4421057189980875
Capan-1,10385095,2.965633532815102
BT 286,JQ-1-UNC0638 (2-1 mol-mol),2.9164898287399432
COR-L95,24772860,-0.7858558168975444
PLC/PRF/5,2729026,3.0680044306331853
HOP-62,10302451,2.804324049095648
Kuramochi,sirolimus-bortezomib (250-1 mol-mol),2.121194092694626
HuP-T4,4259181,0.3179741116426117
HCC-56,tanespimycin-bortezomib (250-1 mol-mol),1.6383234075963011
MKN7,10385095,2.2658881450110604
G-401,2708,4.061322582720861
HT-1197,24753719,4.164524114468767
AN3-CA,11404337,1.5621280335523782
SK-MEL-3,9903786,4.6944360721993545
JHOC-5,10302451,1.853023270405576
NCI-H1734,11485656,2.0530229474698194
5637,tanespimycin-bortezomib (250-1 mol-mol),-0.6809849161541731
BT 164,4259181,0.8270070515242077
KMRC-2,11167602,4.424264905666824
MKN1,11167602,3.133021795040565
DAN-G,2708,5.475275472008414
TT,44137675,3.592539662385471
OCI-Ly19,11485656,1.5733827974679646
SNU-761,11485656,2.6338171581508494
PaTu 8988t,6918638,2.256433939948275
A-498,374536,-1.3715174839162405
SUP-T1,124202324,0.3623950223938539
AU565,9911463,3.1332064122278687
NCI-H1299,654092,0.2998187501521066
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
SNU-1196,sirolimus-bortezomib (250-1 mol-mol),2.2031976803647075
A-549,16013152,5.649530462974007
YD-10B,4259181,-1.8718625004308556
WM115,156414,1.595819692541897
MOLM-13,44137675,1.768154079183361
TE-15,9903786,2.5325936452806723
SNU-878,44137675,3.103113973551644
HuT 78,71729975,0.9717002340056357
DU145,2729026,3.1081628566564024
NCI-H2122,9929138,6.815327786842329
BT-474,49766530,-0.1663339170498422
Ki-JK,44137675,2.943947019807207
Rh18,11167602,3.1947375247166976
SNU-C5,11404337,-0.8246866486472284
HOS,54618771,1.216646065025966
A-549,49766530,0.1688758689952186
A-253,16013152,4.427318696478261
Hs 940.T,4259181,1.2767093386920751
TC-71,156414,1.5752060003210238
HD-MY-Z,327653,3.7321262442272567
COR-L95,10385095,1.3959867651371194
SNU-182,9868037,2.968787964623164
DoHH2,24772860,-3.5012959934347188
HL-60,JQ-1-UNC0638 (2-1 mol-mol),-0.2790594096408071
BC-3C,9911463,4.117920402638588
WM88,100016,6.2407728308576
DOV13,tanespimycin-bortezomib (250-1 mol-mol),0.5750258227871521
NCI-H647,10302451,1.873701044619417
HSC-3,2729026,3.0997094123177527
HOS,46926350,-4.3757633275110415
KYM-1,sirolimus-bortezomib (250-1 mol-mol),0.1122184014552232
ST486,24772860,-1.8273515776506504
NCI-H650,3815108,3.0766576960885197
HOP-62,11404337,-1.0489074115392232
DAN-G,4259181,0.4456475787831931
SNU-407,6450551,2.3884749702802592
ChaGo-K-1,374536,0.6604540670834225
FU-OV-1,2729026,1.7636424043101242
SNU-840,2708,5.512894490894999
A-204,46926350,-4.503154740745886
J82,100016,6.509431143115434
NUGC-3,2708,4.650156734517159
NCI-H524,3815108,0.2165793716086151
SK-MEL-1,2708,4.852230966340039
TT2609-C02,151289,3.634541678889111
SaOS-2,1716436,3.427239396926117
SW620,tanespimycin-bortezomib (250-1 mol-mol),-2.1840810190060287
GaMG,1716436,2.9462822327317175
KPL-1,9929138,5.414616490149542
Mel JuSo,24772860,-1.0038272585341623
23132/87,4259181,-1.287795100395303
HCC1500,54618771,1.4039271563223086
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
NCI-H838,6918638,0.9107836938551492
HCC1419,2708,5.557261419723449
CAL-27,148198,-3.939292770233757
K-562,10385095,0.5975872383647969
JM-1,1716436,2.291915875842717
NH-6,16013152,3.885766796085428
HSC-3,44493528,4.631982422980787
Hs 294T,9911830,2.199413930106796
COLO 829,11404337,0.9914366451901834
NUGC-4,11404337,-1.0911037435760411
TC-71,54618305,4.321118108161562
DMS 53,11485656,2.0694415183010317
HuH-1,10302451,3.651882936765564
K-562,100016,4.034095210213227
RMG-I,10302451,1.8334248355675016
NCI-H23,10385095,0.5302597946113806
NCI-H1944,73707371,4.986148043865074
Daudi,6918638,-1.8107043721369585
Ri-1,49766530,-2.264065529315868
DU4475,24772860,-4.182729575848438
KYM-1,9868037,3.127577125862836
NCI-H2081,JQ-1-UNC0638 (2-1 mol-mol),0.2107025154126548
HSC-2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.12246533495894
HCC202,49766530,0.0708249995809799
SNU-308,9911830,3.1003297251909845
NCI-H2196,10385095,0.8172347164501069
ZR-75-30,54618771,0.9428020193636316
Hep-G2,11404337,0.9907256098180968
RVH-421,44493528,5.192740669556376
SK-MEL-28,10302451,4.268902771891611
SNU-C5,3815108,2.8131930479044978
NCI-H441,11404337,1.4464911476472675
PC-3,11167602,2.0015823323074264
Kasumi-2,9903786,1.7296917357536032
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
SNU-1077,9911463,3.723863128468891
MV4-11,9911830,-0.0631549000021615
LS123,24753719,4.285942546954198
SH-4,4259181,0.97599802103587
SEM,6918638,-1.2521894984782256
CCK-81,9903786,2.4008516567284848
ACC-MESO-1,24753719,6.460305862241897
T3M-10,44493528,6.393646010300226
HLF,100016,6.001250521147636
TE-15,9911830,2.3751205563534064
L-363,11485656,1.816293106463241
SK-MEL-30,1716436,2.3331585350308504
NCI-H2196,9911830,2.2031508018887775
22Rv1,44493528,4.251423815919127
YD-10B,148198,-3.6118455313709186
SW579,11485656,-1.098369360988347
TTC-709,9911830,1.1400887698585542
SNU-61,156414,1.6812768260110038
ECC10,9903786,0.6869958735378703
5637,2708,3.836149546400543
MFE-319,selumetinib-BRD-A02303741 (4-1 mol-mol),6.819757336701224
A2058,44137675,4.076586285430081
SU-DHL-1,9903786,2.5464454731205777
BT-16,tanespimycin-bortezomib (250-1 mol-mol),-2.3872852877546062
MM1.S,9911463,3.396498541948332
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
NCI-H28,2708,3.8771790604148864
NCI-H69,10385095,1.3596271471395216
KMS-34,54618771,-0.7533215739464646
KMS-21-BM,JQ-1-UNC0638 (2-1 mol-mol),-1.7415773830887826
MOLT-3,151289,-0.0814767462720164
SW620,sirolimus-bortezomib (250-1 mol-mol),0.6778769985308863
647V,54618771,-0.1034366562319205
COLO 699,374536,3.763388478133999
SNU-C1,136227924,2.406947195401098
KMRC-20,9903786,3.936421872110463
OS-RC-2,9903786,3.8385821896684433
JHH-1,10385095,0.9212963748686652
KE-37,49766530,-2.520266355553242
NCI-H1650,10385095,1.420214094943267
CMK,327653,3.684751642752481
SNU-1041,9911463,4.300045729883578
GP2d,151289,0.6601815691383748
NB1,11485656,1.5825359819360478
WT2-iPS,2708,4.10110944298932
GaMG,148198,-2.2602125846072627
CMK,6450551,1.35276306077588
WT2-iPS,9911830,2.3630165212515917
Peer,135984461,1.6438359963470832
MPP 89,selumetinib-BRD-A02303741 (4-1 mol-mol),4.36140034743486
KMS-21-BM,10385095,1.1305886144467554
COLO 678,9911463,3.776615868788405
MOTN-1,24772860,-2.7851582594959226
CMK,24772860,-2.933029342494611
JHH-4,151289,0.6699757237529873
RPMI-8226,10385095,1.042981164600271
PC-14,156414,-5.707063313851652
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393
NCI-H1092,753704,4.364704525984801
MCAS,1716436,3.309095084683311
KMS-20,71729975,0.4297208720314417
RPMI-8226,124202324,0.902663859920639
COR-L95,4259181,0.8580425806970188
FTC-238,10302451,4.1572624644011
HOS,44493528,5.3157890671440855
LOX-IMVI,JQ-1-UNC0638 (2-1 mol-mol),-0.2149277718866578
TE 441.T,2729026,1.9676389921183184
HCC1395,4259181,0.1311462895447667
NCI-H23,24753719,3.636573192136899
AN3-CA,327653,2.9289784088078177
OCI-Ly10,11485656,4.400930200004774
SU-DHL-4,9868037,3.0850955865320695
SUP-HD1,374536,1.9510363776757544
OCI-Ly3,10385095,0.3067517365379972
GMS-10,24753719,4.855734491232824
JIMT-1,2729026,3.062977615792191
U-251MG,156414,1.68139049823068
KO52,16013152,3.657905355539016
HCC4006,156414,4.088400381737083
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
SNU-1066,654092,0.219352428945368
A-204,9868037,2.4016455234321694
Panc 05.04,1716436,2.6809397726701194
AML-193,11404337,0.8563534093329411
HCC1833,2729026,2.8692697578003155
NCI-H1563,9911463,4.06391181051362
SK-N-MC,135984461,4.087273122460901
HCC1588,sirolimus-bortezomib (250-1 mol-mol),0.5991119753615496
KMS-12-BM,151289,-0.2601572179099301
NALM-6,24753719,2.2035307503634782
SNU-387,54618771,3.696671727532153
TOV-21G,49766530,-3.499964939979177
Reh,148198,-5.109999259943676
GOS-3,9911463,4.370946765627494
P3HR-1,9911830,3.3679619343165452
TF-1,24772860,-1.6896200076497905
EBC-1,24772860,-3.4659811778613387
MJ,2708,2.9106731157178194
GI-1,100016,6.475829804009189
OV56,327653,3.693872160162438
SNU-620,135984461,2.973595726933627
BT 187,2729026,2.5937758596350933
A-172,44137675,4.794427902015393
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
PLC/PRF/5,9911463,3.7898292588985862
KMS-12-BM,9911463,2.0749809508981256
SIG-M5,24772860,-3.9797980314379098
CAL-33,44137675,1.9405492829302795
SNU-308,3815108,4.426401095088581
COR-L95,24753719,4.203119149122614
COV362,11167602,2.1491075464188816
NCI-H2405,148198,-1.980170877151075
GCT,6450551,2.900405434897802
TUHR10TKB,124202324,3.064306722936736
UM-UC-3,327653,3.3553409260124827
L-540,753704,4.770397210291591
Detroit 562,44137675,1.31028593774358
COV644,16013152,4.1070918882366945
EFO-27,9911463,4.361076045114702
SNU-407,136227924,2.9703344519672785
LC-1/sq-SF,10385095,1.4235715068677564
KE-39,6918638,0.3873788369468276
NCI-H23,54618771,-0.0460259250887816
HCC2218,753704,5.019549906399212
Hs 888.Lu,24753719,4.75417176582107
MOLM-6,tanespimycin-bortezomib (250-1 mol-mol),0.1329164696894222
SF539,6450551,0.8241072018867992
MeWo,sirolimus-bortezomib (250-1 mol-mol),0.5468033899342802
GSU,11404337,1.2682774414342974
WSU-DLCL2,9911463,3.171565801022685
HT-55,11485656,1.9068584581515573
253J,148198,-1.8697055950254904
JMSU-1,11404337,-0.9331464485977649
HEY A8,tanespimycin-bortezomib (250-1 mol-mol),-0.6734038900503383
HT-1080,100016,6.676268064255503
SK-UT-1,151289,2.928498055248494
ACHN,6918638,1.020041941526732
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363
OV56,11404337,1.1969378200934953
M-07e,24753719,3.1748367378954025
A-549,9911830,2.245916242551202
OVISE,9903786,4.69480560533159
CAL-148,2729026,2.3392364448816876
ONCO-DG-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1798955899961833
MDA-MB-157,54618771,3.1146330047846877
KP-4,11167602,1.7428553982677493
DU145,24753719,4.348475848084312
BxPC-3,2729026,2.140647578797141
KP-4,9903786,1.7495953596701077
SNU-668,10385095,1.1222457232110925
G-361,10385095,0.8073927778155511
OS-RC-2,10385095,2.54718391477598
BT 340,selumetinib-BRD-A02303741 (4-1 mol-mol),4.248989420913827
HCT 15,46926350,-3.758095563235892
KYSE-180,9903786,3.667884143051944
GCT,11167602,2.068911089346331
G-402,tanespimycin-bortezomib (250-1 mol-mol),-2.2331450772750285
NCI-H2452,1716436,2.783046357832639
SW1353,10385095,1.4015944143459336
KYO-1,44137675,4.31196957987956
M059K,tanespimycin-bortezomib (250-1 mol-mol),0.2006380895510879
HOP-92,753704,5.097901193864493
23132/87,9911463,3.696162581982579
EC-GI-10,2729026,3.0995535684996622
TTC-709,136227924,1.406309539576174
GaMG,11167602,2.454786240978928
KMS-11,2708,3.6326980145846295
SK-OV-3,49766530,0.1985460846164677
VCaP,9903786,1.7887289169146705
L3.3,44137675,3.3686484205760783
GCT,24772860,-2.050626263686016
MDA-MB-157,136227924,3.402219650297347
RERF-LC-Ad2,2729026,3.074324067766426
DMS 454,135659046,3.663027273300578
HSC-3,327653,3.9955925666561263
A-172,148198,-5.088269215681032
NCI-H1666,10385095,1.243907749807907
COV434,10302451,3.159485757996385
NCI-H1563,327653,3.2472621502852985
RPMI-8402,24772860,-2.3486934861709847
L-428,sirolimus-bortezomib (250-1 mol-mol),-6.443786074450703
MES-SA,9911463,4.310178106628171
NCI-H2009,6450551,1.0382100121131883
DU145,54618305,4.450294310090801
Reh,9929138,6.102767885928958
DMS 273,100016,5.677769516399485
HEL,24753719,3.7144242054355985
GB-1,2729026,2.59341942552884
HT-1376,327653,3.1831063450087265
Ci-1,54618305,4.280250718208194
23132/87,10385095,1.3644671590937965
Capan-2,JQ-1-UNC0638 (2-1 mol-mol),2.586897942288785
TF-1,151289,0.5213415501294593
AU565,JQ-1-UNC0638 (2-1 mol-mol),2.17780253884304
CML-T1,100016,5.302267949835527
HuCC-T1,654092,-1.172065262065219
MKN45,148198,-2.2480188061666913
Pfeiffer,6918638,-1.780695741068461
LoVo,4259181,0.2045859597859785
NCI-H2286,148198,-0.7964524113963312
NCI-H650,49766530,-1.7972837938587842
HSC-4,10385095,0.4573663196580717
KMS-21-BM,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5158040085901563
SIG-M5,9903786,1.9849552317824917
ONS-76,54618771,0.5276024038238057
VM-CUB-1,6450551,3.502247867699159
NCI-H1755,654092,-1.207636367365399
BT 286,10302451,3.989436421266635
NCI-H1650,JQ-1-UNC0638 (2-1 mol-mol),2.998819393429346
Hs 294T,11404337,-1.3657699869791882
HEL,11404337,-0.835651629585067
NCI-H810,sirolimus-bortezomib (250-1 mol-mol),0.258624131959815
C2BBe1,1716436,1.9705748968358128
HPB-ALL,148198,-3.7758492829938857
NCI-H2052,135984461,5.580046564229557
OVISE,11404337,1.793635825025173
MeWo,100016,6.619977613887792
SaOS-2,49766530,0.3706728408995327
SNU-8,6450551,4.187914273502316
ACHN,24753719,4.196398568680715
BT 504,11485656,1.8828721795315295
C2BBe1,9911830,2.216190650017955
HCT 15,9911463,2.535565798999095
CAL-85-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.855422883635694
SUP-HD1,11404337,-0.4036873763873929
ACC-MESO-1,54618771,0.8381740730227087
NCI-H810,753704,3.68089506494823
P31/FUJ,124202324,0.9428129005296164
A-172,6450551,1.2561449299990903
HuP-T4,tanespimycin-bortezomib (250-1 mol-mol),-1.134384257023078
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691
NCI-H1373,148198,-1.3691101479869838
RERF-LC-Ad1,136227924,3.427007002266959
SW1573,2729026,2.4001203305493397
OCI-AML-5,151289,1.2016464671740443
HCC-56,374536,0.4621220772427525
TCC-Pan2,4259181,-1.5549335256713654
BT 271,136227924,1.335352033885486
GCT,6918638,0.9621268988100647
SU-DHL-1,327653,2.51842673185387
L-540,9868037,1.7753670524076954
MC116,9903786,4.909292458120856
HEC-265,54618771,0.9168316740799288
SNU-61,2708,5.501133929338057
YD-15,10385095,1.276053613139171
IGROV-1,2708,4.438419625543199
YKG-1,10385095,1.6490747273170454
HCC1588,54618771,0.4261259622820442
A4/Fukuda,54618305,3.964460418875751
647V,44137675,4.298290002136217
NCI-H2196,2708,5.089402115486791
TE 617.T,44137675,3.915947346314195
ST486,2708,3.2849722669757617
NCI-H2342,54618771,3.373010202836016
BT 330,9911463,3.351892794022171
BT 172,JQ-1-UNC0638 (2-1 mol-mol),3.83046233399234
HuP-T3,2729026,2.9922624267509317
BICR 56,54618771,-1.9015282957289323
TE-4,9868037,3.2663312680184227
TTC-709,46926350,-4.2896695695473275
Hs 294T,2729026,3.0127311548934834
TOV-112D,148198,-4.684933210891632
FU-OV-1,9903786,2.8592788804010936
GI-1,44493528,4.237962570742694
Hs 822.T,JQ-1-UNC0638 (2-1 mol-mol),2.252284522074896
Mono-Mac-1,10385095,1.4007420160965849
NCI-H2087,136227924,2.807670387816286
TCCSUP,148198,-2.229154528716237
DV-90,156414,0.1906274562396029
AML-193,135659046,2.987496818828137
Kelly,selumetinib-BRD-A02303741 (4-1 mol-mol),5.188962429167598
23132/87,selumetinib-BRD-A02303741 (4-1 mol-mol),3.3058144123363644
RPMI-7951,24772860,-2.8129043414212633
Hs 683,16013152,4.045589709203498
SW1271,136227924,3.2074421772411372
NCI-H1734,654092,-1.4600686972528751
HEC-59,10385095,1.2806197233190435
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
HOP-62,24772860,-2.449488462755842
HCC2108,2708,7.692601684388862
HEL 92.1.7,54618305,4.735432222315623
CAMA-1,11485656,2.6355660526495672
KMRC-1,10385095,1.0697515150450725
JHH-4,54618305,5.480642450312855
SNU-8,10385095,1.1888093081137228
OC 314,10385095,0.8203105692397765
NCI-H1184,selumetinib-BRD-A02303741 (4-1 mol-mol),4.097737819427965
NCI-H23,2708,3.0284751461685735
COLO 829,49766530,1.364396620526625
MOLM-6,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.2358351730823807
TE-10,9911830,2.740981336326426
PC-14,4259181,0.4148318229863006
BFTC-909,10302451,3.622269240471498
SNU-423,1716436,3.438303267646366
KMBC-2,4259181,1.3883022744442572
A-375,24772860,0.9436662834694136
OE19,136227924,3.1692952710595557
LS1034,24772860,0.5146136135709558
SF126,24753719,4.936829746635371
SNU-869,sirolimus-bortezomib (250-1 mol-mol),1.7458276464025495
UO-31,156414,0.6514349111127984
BT 145,327653,2.8678553441980386
MDA-MB-231,24772860,-1.607223191421813
MOLP-2,156414,1.6168750174701296
SF126,49766530,-2.4401287268273135
AML-193,135984461,4.549999355322756
SEM,327653,3.0255719016474605
SK-N-MC,54618305,4.415419037379575
MOLM-6,9929138,4.00608246192175
HCC78,11485656,2.324868520427576
SNU-1196,136227924,2.95634276982207
JHOM-1,156414,1.7115419644586811
SNU-213,11404337,0.895138111314107
ECC10,11485656,1.639857171829123
NUGC-4,151289,0.9128130386057416
SW1088,4259181,0.6363648282246106
HeLa,24772860,-1.5744056360755827
BT 159,sirolimus-bortezomib (250-1 mol-mol),0.8786451932311966
J82,54618771,2.0781543911386264
BT 504,10385095,1.155084659325028
DMS 53,24772860,-0.9566570649316452
Daudi,54618771,-0.114332288085178
OCI-AML-2,2708,3.053658778647868
L-540,sirolimus-bortezomib (250-1 mol-mol),-4.16248218477803
KLE,9911463,3.5004519168580828
TE 441.T,44137675,2.4216853844667985
A-673,9911830,1.9751375507094395
Peer,54618305,3.921049020117824
CW-2,135984461,4.848993009779452
KMS-34,54618305,3.5477903418914214
BT 139,4259181,1.714008353576017
OV7,9911463,4.355611595134673
P31/FUJ,753704,3.2802738483106766
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
SYO-1,49766530,0.9236587906089132
SNU-C2A,136227924,3.0438027551295352
SEM,54618771,-1.6874791122177024
HSC-4,327653,3.5197711195347434
H-STS,46926350,-4.349495266854958
LMSU,54618771,1.0017714306772694
ESS-1,2708,3.2385388289614583
SNU-899,44493528,4.57982118171392
ME-1 [Human leukemia],44493528,4.9966517088046345
GDM-1,sirolimus-bortezomib (250-1 mol-mol),1.1359317053602838
COR-L51,327653,2.7444851925182325
HOP-92,11167602,2.8847454841740108
UACC-62,4259181,2.382328213158055
MOLT-13,3815108,1.5495693764366936
SK-LMS-1,16013152,4.349323816725978
COLO 792,24772860,-1.5504869109828168
MDA-MB-415,10302451,4.0233818677308735
U-BLC1,JQ-1-UNC0638 (2-1 mol-mol),1.2651325369809692
SK-N-SH,136227924,2.487245372945198
MDA-MB-453,9911830,2.483477791354312
MKN1,135984461,5.649993285948901
SUP-HD1,54618305,4.039800109038852
Hs 822.T,11485656,3.9087962472344744
MEC-1,151289,0.7874454664734211
NCI-H1155,tanespimycin-bortezomib (250-1 mol-mol),-1.3476430950240228
OVCAR-8,sirolimus-bortezomib (250-1 mol-mol),1.6177185023966834
BT 440,9903786,3.1498376271679533
RL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.293867746441263
TALL-1 [Human adult T-ALL],753704,2.3517401394486765
OCI-AML-3,24753719,3.7261949702489496
NCI-H508,124202324,2.080659438278281
GSS,148198,-4.278267230656994
Hs 578Bst,selumetinib-BRD-A02303741 (4-1 mol-mol),5.916963073959706
HD-MY-Z,44493528,4.44799186118661
OCI-AML-3,6918638,-1.4001290252615282
KMS-12-BM,135984461,1.7287315424792562
HCC1195,136227924,3.859466477996048
JHUEM-3,135659046,3.4797526976334003
NUGC-3,1716436,1.962970882075595
CJM [Human melanoma],100016,5.681499096329984
A-375,24753719,4.237865986535525
NCI-H1755,9911830,2.70191525352941
Hs 839.T,4259181,2.177978802351787
HT-144,2708,5.347328039421257
JVM-3,JQ-1-UNC0638 (2-1 mol-mol),-0.3897463797227661
U-251MG,135659046,4.3313031112664095
HuP-T3,16013152,4.473149012747972
OVCAR-5,156414,1.505266249063237
SK-LU-1,2729026,2.4446296185956253
YD-10B,136227924,2.2440881554064105
SNU-16,9929138,2.9075870655199836
FU-OV-1,44137675,3.1043101525841377
HuNS1,54618305,4.275761416742284
JIMT-1,10302451,2.8331671466366957
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
NCI-H446,2708,3.829349083121097
NCI-H358,100016,4.0854531303861155
Kasumi-2,11485656,1.64011250363507
KP-N-YN,374536,2.0150210126698433
Becker,6450551,3.994700694716569
CAL-51,JQ-1-UNC0638 (2-1 mol-mol),2.957186158032418
SET-2,2729026,2.5950867985485813
MIA PaCa-2,135659046,3.7193443303471727
MV4-11,100016,3.584878230644963
RL,54618771,1.0204483724933282
GCT,71729975,2.9904933164687533
NCI-H661,11404337,-0.0954545894437525
KP-4,136227924,3.1314573836961235
NALM-6,3815108,2.1984642321149233
JHH-5,JQ-1-UNC0638 (2-1 mol-mol),0.9734165475541764
BT 416,2729026,2.370588405546605
NCI-H747,44137675,1.799157786315849
CGTH-W-1,54618771,1.2189927241974945
HEC-251,10385095,1.0476635397176672
MIA PaCa-2,156414,1.6924569137824248
22Rv1,1716436,3.1378612398471284
PANC-1,6450551,3.244005315313389
K029AX,6918638,0.9688280539035616
EPLC-272H,11404337,-0.7906068386477291
EC-GI-10,sirolimus-bortezomib (250-1 mol-mol),2.282726808437879
SCC-4,44137675,3.298798611509121
NCI-H2110,4259181,-0.2511035825060961
TE-8,54618771,2.0990725036496123
COR-L105,46926350,-4.1614749205792565
HCC4006,151289,1.0218484027462331
KMRC-3,2729026,2.905177915731235
Kasumi-1,73707371,5.021212476016113
KMS-21-BM,24772860,-3.020788150238138
DEL,24753719,4.131064863651074
HH [Human lymphoma],11167602,3.579332325804806
CAL-148,100016,6.461133409351435
NCI-H292,9903786,2.498172259524573
Hs 888.T,135659046,3.9979664612811354
SBC-5,124202324,2.6085939591802307
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
HuH-6,6450551,2.064518890888157
KE-37,124202324,0.8728787971460634
NCI-H1299,selumetinib-BRD-A02303741 (4-1 mol-mol),4.60550863412006
MKN7,9911830,2.5817691322370315
OCI-M1,44137675,4.09475804170257
TYK-nu,2708,2.7231448546709367
CAL-51,148198,-3.728190383000159
NCI-H2110,11485656,1.6105476919050796
NCI-H211,753704,3.733524629874775
MOTN-1,2708,3.1246262538590837
EM-2,148198,-3.744081167157371
LMSU,49766530,-0.1291663690745916
KM12,100016,6.486077549174115
Hs 944.T,654092,-0.7833228451784585
COR-L105,11404337,0.9270352493146456
COLO 699,10302451,3.829088600781648
SNU-478,9911463,3.926310960218254
SF539,374536,1.1024692735749633
SW982,71729975,2.8024599978984233
TOV-112D,9911463,4.387944714861712
SNU-1066,9911463,4.257839675478274
KE-39,135984461,4.3782777468955745
NCI-H1666,136227924,2.19834773760599
IST-Mes1,10385095,2.3784865098232255
NCI-H2141,753704,3.4097183249500227
MOLT-3,46926350,-4.5178634327956555
AML-193,9911463,2.567392494652272
CML-T1,49766530,-2.849769761760908
BT 416,54618305,4.383399525094827
OCI-Ly19,2729026,3.124507534532074
HCT 15,2708,5.248911674588611
NCI-H2023,44137675,3.845996571488956
NCI-H2030,10385095,2.209603603161303
KMS-11,654092,-1.4554570807590403
MDA-MB-468,54618771,2.476122879099443
CAL-120,10302451,4.646213124669908
EHEB,9911463,3.619047359567488
COR-L51,4259181,-0.0812090576856881
TT,tanespimycin-bortezomib (250-1 mol-mol),-0.7119220274254645
HCC1143,100016,7.122041956726765
RERF-LC-Ad2,4259181,0.9500738030007112
RPMI-6666,54618771,0.781806189170932
EHEB,327653,2.436506136039934
DMS 53,16013152,3.04903927190062
OCI-AML-2,sirolimus-bortezomib (250-1 mol-mol),0.9467040078581898
ALL-SIL,4259181,-1.3200126273341632
NCI-H1299,54618305,4.3112203505981554
HCC1833,49766530,-1.3796186102265957
COLO 684,6918638,0.5443329565313224
BT 139,11485656,3.131336333287838
MOLM-13,11167602,-1.7638454235436123
OCI-Ly3,6918638,-1.72449157217465
HCC1171,24753719,4.346022619119034
SNU-1105,9911830,2.1691133985089195
IGR-37,6918638,0.9669989882697694
SNU-668,10302451,1.5008708259848218
RKN,148198,-1.0178445286580065
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
NCI-H810,6918638,-1.4946550265349503
PF-382,3815108,1.747404185306998
EFO-27,24753719,4.6250624916483405
CA46,44493528,3.81061502276679
NCI-H1869,4259181,0.9705477170328122
A-375,2708,5.21419095899306
COLO 320,9903786,-0.1996043978745841
Karpas-422,44137675,-1.3828937962979793
SNU-761,374536,-0.4722863229817567
HeLa,151289,0.5666622347793419
RS4;11,tanespimycin-bortezomib (250-1 mol-mol),-0.3918084072183652
SNU-1,11404337,-1.6591941972461035
SNU-407,9929138,5.973449763391868
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
KYO-1,9843750,4.476938898535735
HT,327653,2.456712877727426
SU-DHL-8,6450551,1.2616685463141522
JHUEM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.7919569288892525
Kuramochi,124202324,3.5446851415779004
DoHH2,2708,2.96897384871746
SNU-5,49766530,-2.0910598582068776
MOTN-1,9911463,3.133435605539891
EJM,374536,1.880245992175634
EN,9843750,4.462351435726487
Daoy,10302451,4.756484214423896
SNU-475,9903786,5.095134957133182
KE-37,11404337,-3.142013141834162
SW620,9903786,1.7872370567942188
NCI-H1568,136227924,3.032081072579533
NCI-H1650,49766530,-2.350106011815308
SNU-1214,selumetinib-BRD-A02303741 (4-1 mol-mol),2.175511889017324
Detroit 562,100016,6.391000104824681
HCC1195,3815108,4.310456633781601
MES-SA,tanespimycin-bortezomib (250-1 mol-mol),-2.9811279867981635
KMRC-2,44137675,4.642823566259911
SK-LMS-1,10302451,4.013028906163852
DND-41,11485656,1.1468177046699728
Ci-1,44137675,3.866014257602404
SK-LU-1,24772860,0.448488937654672
HT-55,2729026,2.2587126747464876
CAL-29,10385095,2.379885316927196
Hs 888.T,54618771,0.4236563431262232
NCI-H2110,9903786,2.318107893964858
MDA-MB-231,54618771,1.2900163685753538
Hs 294T,100016,6.337209257885702
NCC-StC-K140,54618771,0.2055366704850876
EHEB,100016,6.596024177667571
NUGC-4,100016,6.130178573368833
ONCO-DG-1,10302451,1.357943287176287
GSS,JQ-1-UNC0638 (2-1 mol-mol),0.1184072695888955
KYSE-30,2729026,3.090986240428151
HT,2708,4.457895303761916
HL-60,10385095,1.2256262065084265
BICR 6,24753719,4.141296069645995
HCC2279,24753719,6.029621521681119
HT-1080,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5207690980831075
HCT 116,4259181,1.0304730701082
COV644,sirolimus-bortezomib (250-1 mol-mol),0.1029805647741307
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266
LS1034,136227924,1.69162800732405
KHM-1B,3815108,2.9895861179131704
Tm87-16,4259181,0.4584407885070141
IST-Mes1,6450551,1.123519877762822
SNU-398,11485656,1.495673016865192
NCI-H1155,49766530,-2.3327778818126244
A-172,2729026,2.946605908431196
SNU-1196,3815108,3.3959812038828563
HCC1806,11485656,2.35396149601903
SUP-B15,24753719,3.508993666231369
SK-MM-2,54618771,0.349796062936111
ES-2,100016,6.579379467241575
Calu-1,11167602,2.6874692075040816
SNU-1076,156414,-2.8336489406052037
SNU-1214,10302451,0.3178594253094901
Granta-519,11404337,-2.8078628280004048
SUP-T11,4259181,0.0925220155978016
OC 314,9868037,3.4198698834926553
KPL-1,JQ-1-UNC0638 (2-1 mol-mol),3.4480764849998136
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935
OVCAR-5,1716436,2.9971338502111227
Mino,1716436,1.8287087640560211
AN3-CA,24753719,4.3754867797298544
TE-10,49766530,0.4613217391985113
BT 428,selumetinib-BRD-A02303741 (4-1 mol-mol),0.7772774830085131
SNB-75,6918638,2.2878300521074246
JeKo-1,6918638,-1.1344735337684004
RT-4,135984461,3.767018649492271
L-428,9911830,2.739326607569416
HCC4006,JQ-1-UNC0638 (2-1 mol-mol),3.4733823754650612
BICR 31,374536,2.383890315264743
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
8-MG-BA,46926350,-3.877714565221432
EoL-1,374536,-1.7433445254821776
A-549,136227924,3.1395144761786486
UO-31,49766530,-5.258539330368952
T3M-10,10302451,2.8903780681865636
SNU-620,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.875686346197236
Karpas-299,9929138,6.330957122742023
A-172,54618771,1.0559368295396556
ESS-1,24753719,4.181647881164435
YD-10B,124202324,1.9669483932145977
HCC1438,44137675,4.068983284126404
COLO 829,2708,4.858860231631698
JHH-1,46926350,-4.122363827806502
COR-L105,9911463,4.222864246171191
SU-DHL-6,9868037,3.231553190440303
KP-N-YN,753704,4.764814889948165
OCI-Ly3,9911463,2.5217077768511635
KMH-2,11485656,1.7580590050514375
NCI-H661,4259181,-1.4326329693308524
BT 179,selumetinib-BRD-A02303741 (4-1 mol-mol),5.25595576909876
NH-6,selumetinib-BRD-A02303741 (4-1 mol-mol),6.814430871877007
KLE,49766530,-2.017018761794788
KMS-11,24753719,4.269419300798277
COR-L88,49766530,3.4984546409835016
PF-382,124202324,0.9608672552424454
JHUEM-2,151289,-1.101128946774114
CAL-33,46926350,-3.618526383070051
HuH-6,54618771,-1.3988584380495144
NCI-H929,10385095,0.7754305798230204
ONS-76,JQ-1-UNC0638 (2-1 mol-mol),1.9548647661287404
SNU-668,1716436,4.288131107720451
UO-31,11404337,-1.2748998268508818
BICR 56,11404337,1.611918044632369
CAL-54,1716436,3.7692693501535985
Mel Ho,4259181,-1.9031340337885552
KP-2,327653,3.783815914238096
PK-59,24772860,-2.599285390225259
Mel Ho,148198,-2.080740439053791
BT-549,156414,4.402880659642667
TCC-Pan2,124202324,2.580715700616676
OUMS-23,136227924,2.42742246798026
COLO 792,11404337,-0.504163589197378
NCI-H508,135984461,1.3950567746266993
HOP-62,2708,4.639919882442816
KYSE-180,2729026,3.0243505230230565
Rh41,24772860,-2.8378631146286235
CAL-120,9911463,4.415772964133076
NCI-H1155,JQ-1-UNC0638 (2-1 mol-mol),0.7193098672860484
VCaP,151289,1.162278045432246
SW48,1716436,3.2732206570492512
LoVo,9911463,2.8816718818913176
SK-N-MC,44493528,4.172598643795567
RS4;11,54618305,4.215230625357053
SK-N-FI,9911463,4.1976793255914275
NCI-H1341,10302451,3.6932298221436737
HEC-59,54618305,4.716446309240821
HCC78,sirolimus-bortezomib (250-1 mol-mol),1.3217046818023197
MDA-MB-231,148198,-1.1637706942171424
IGROV-1,374536,0.7022324251593053
GI-1,148198,-4.209323868036209
NCI-H2196,54618305,4.391453781837025
Tm87-16,selumetinib-BRD-A02303741 (4-1 mol-mol),5.212376911826034
KO52,10302451,3.962918157421803
T84,151289,1.2633487720507646
NCI-H2052,2729026,2.698724849595223
DMS 53,54618771,0.8665759166845977
786-O,10302451,3.590808927034644
Reh,135984461,1.6180740266430926
PaTu 8988s,6450551,3.88448828563756
NCI-H1341,JQ-1-UNC0638 (2-1 mol-mol),1.026278547403367
NCI-H2009,44137675,2.9238442509206606
YAPC,2708,5.2324194580289065
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319
JHUEM-3,54618771,0.1338872502491787
U2OS,374536,-2.20014520241274
MDA-MB-415,327653,3.1618995665355327
JHUEM-3,151289,0.5456663488306489
K029AX,10385095,1.9655495624947168
NCI-H460,11404337,1.7201854837770862
Karpas-299,24753719,3.062088598517528
LK-2,9911830,2.2744958535827227
KE-39,71729975,0.1981470064909886
PL-21,11404337,-0.8522775208697388
SCaBER,9903786,2.6079380846248568
Hs 895.T,9911830,2.789284500785935
DMS 79,148198,-2.9658771448885197
NCI-H2122,1716436,3.623036492667551
PK-59,selumetinib-BRD-A02303741 (4-1 mol-mol),2.988609115043863
HuH-28,10385095,2.5639170726190867
SNU-175,100016,4.815284438481943
JHH-2,2729026,3.074463008329222
MOR/CPR,9868037,3.699217434711235
HSC-2,135659046,3.2324626300653465
SNU-719,2729026,1.8232816497721136
Ki-JK,654092,-1.8847547855970908
HT-1080,9911463,3.8798634306890105
SK-HEP-1,44137675,4.549525792934436
OCI-AML-3,10385095,0.7580975177780899
SNU-761,JQ-1-UNC0638 (2-1 mol-mol),1.7746876266452134
KE-97,49766530,-2.2252000601337456
BT 286,24753719,5.642521821790082
Hs 944.T,selumetinib-BRD-A02303741 (4-1 mol-mol),0.3613173382655219
IGR-1,2708,6.710305158419027
NCI-H1355,44137675,4.040914939171177
KCL-22,9903786,2.593050827774072
Rh41,148198,-4.585289739604842
COLO 684,46926350,-4.923320265645216
EPLC-272H,3815108,2.980385356199904
RD,148198,-4.957696360654166
Kelly,9868037,2.3025407636761197
NUGC-4,11167602,1.8627836788845913
KYSE-410,3815108,3.2500534674852743
KP-4,9911463,4.220672229227994
UACC-62,tanespimycin-bortezomib (250-1 mol-mol),1.2383620234994217
HT-1080,1716436,3.8377653501032007
RL95-2,327653,3.1108836073008868
SNG-M,11404337,-0.7896933791605669
MSTO-211H,2708,3.2234156242084073
SF539,44137675,2.552438639753458
Lu-99,124202324,3.092268713153441
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
NCI-H1355,11167602,2.0680047351334254
VMRC-RCZ,148198,-1.950525301286011
HEC-1-B,sirolimus-bortezomib (250-1 mol-mol),1.0526143004361572
KO52,24753719,3.780928273062828
KALS-1,11167602,3.631671875961461
TE 617.T,49766530,0.7219936029633269
Calu-6,151289,0.5232485466721156
AsPC-1,136227924,3.2025742465891938
BICR 56,9903786,4.170821075739504
TOV-112D,sirolimus-bortezomib (250-1 mol-mol),0.8859708240687075
Ri-1,24772860,-4.365675374144319
ONS-76,44137675,3.612845962454732
OCI-M1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.203621790797241
VMRC-RCZ,24753719,4.580216363961944
SW48,2708,3.1864056833879726
TE-10,tanespimycin-bortezomib (250-1 mol-mol),0.6297749244951121
HEC-59,3815108,2.3440811095363157
SCC-4,4259181,1.7871165076569986
NCI-H1755,24772860,-0.4346512427988319
NCI-H1838,tanespimycin-bortezomib (250-1 mol-mol),0.7534040164239657
MeWo,24753719,4.301435629078812
DK-MG,49766530,-2.542495237652574
SK-MES-1,16013152,3.696018232946635
JVM-3,1716436,3.106701885335571
SJSA-1,tanespimycin-bortezomib (250-1 mol-mol),0.871032127395642
MV4-11,10302451,1.7320919236125134
HuP-T4,753704,4.958746098251536
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
SK-MEL-1,JQ-1-UNC0638 (2-1 mol-mol),-0.549212264797066
MOLM-6,156414,-0.040429989059546
SNU-5,9911463,3.488493689315011
BHT-101,136227924,2.4401355841785173
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
JIMT-1,6450551,4.001452562661689
KE-39,24753719,4.8851025960405074
SNU-840,9911830,3.7774475917507657
DMS 114,71729975,0.2806768604384594
TT2609-C02,49766530,0.6648763661012455
NCI-H1838,136227924,4.034071845409975
NCI-H1975,3815108,2.8799674803441597
HCC4006,11404337,0.6477756071897834
BT 482,tanespimycin-bortezomib (250-1 mol-mol),-0.9105363094795508
SBC-5,49766530,2.674414744921775
HCC1954,49766530,-2.49359957075404
MCF-7,44137675,2.538602137792227
Kuramochi,11404337,-0.4054139611353435
CL-11,44137675,3.88146174393044
MDA-MB-468,2708,3.697515823688523
LN-18,2729026,2.484879486455843
Daoy,54618771,2.692188489844714
WM1799,44137675,3.0103042743674995
NCI-H446,16013152,0.5358827768090925
NCI-H1792,44137675,4.592022862607409
KMRC-1,49766530,-0.1675164065777726
Hs 729.T,54618771,1.7662519209313146
SNU-5,11404337,-1.177028079516049
5637,3815108,2.938229962587705
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
SNU-869,10385095,2.393805938113789
TOV-112D,11485656,3.0452540655775473
KALS-1,9929138,7.477924351122795
Kasumi-1,151289,0.6206089229735229
VMRC-RCZ,4259181,0.656084510348254
UACC-62,10385095,1.0513221751606243
JM-1,24753719,1.6485500810507543
KE-39,11404337,-0.6939323202576905
SNU-213,124202324,3.2763512137021173
SUP-B15,374536,-2.3912743890500803
Mono-Mac-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.6474160384820955
NCI-H1915,73707371,5.8816284956620795
NCI-H1299,3815108,3.736133239838136
HuP-T4,1716436,2.4206601449045726
NUGC-3,4259181,-1.671238825802355
PF-382,1716436,4.358638458244471
HEL 92.1.7,selumetinib-BRD-A02303741 (4-1 mol-mol),6.020090499122493
Panc 10.05,136227924,2.25248962667623
BICR 6,44137675,3.920397991602848
KG-1-C,11167602,3.59062870021396
IGR-1,JQ-1-UNC0638 (2-1 mol-mol),-0.4717790418241841
BT 112,44137675,3.190081046640756
BT 416,156414,1.0194631441188509
BT 444,71729975,3.234515004304685
J82,11404337,-0.1967629252441953
PE/CA-PJ49,44493528,4.271726954290608
BT 228,9868037,3.723299534994555
HCC4006,16013152,3.4291956119829976
JK-1,6450551,-2.306215789673556
HCC38,10302451,4.063640338050707
GDM-1,1716436,2.438361589667446
GP2d,9903786,1.6186361299968774
OCI-AML-5,11167602,2.461233339824551
JVM-2,9903786,-0.0734034903257133
OAW42,374536,-0.8010162168150948
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
TE 617.T,54618305,4.435147460279245
KLE,11485656,3.08308998793154
K-562,9903786,3.6050720376028105
OAW28,2729026,2.5871569751548047
HPB-ALL,124202324,0.6635296528094242
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
HCC38,44137675,2.198094439035749
Reh,151289,0.4716705888599068
Panc 10.05,135659046,4.933394914057929
NCI-H1869,10302451,1.963256574225826
RPMI-6666,10302451,1.9523998069896955
NCI-H28,9868037,2.6779673338971826
HCC1419,2729026,3.216775354028136
DV-90,JQ-1-UNC0638 (2-1 mol-mol),-1.393908605998866
F-36P,9868037,2.720274888315988
SH-10-TC,49766530,2.645691737420763
Tm87-16,9868037,4.7880424925648715
CAL-120,9868037,3.5025734894646656
253J,124202324,1.838620021177064
KYSE-450,374536,3.719128608597957
RPMI-7951,11167602,2.502155495655697
NCI-H1734,49766530,-2.088624168616933
BICR 18,24772860,-1.8084039581127216
MPP 89,46926350,-4.409902732909314
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
DMS 53,6450551,2.2692659346104365
Hs 729.T,2729026,3.0718072336805515
K-562,135984461,3.2548026411837787
Mel Ho,2708,5.2092501932024025
SiMa,JQ-1-UNC0638 (2-1 mol-mol),1.2793373149394494
HCC78,11404337,1.202138123239975
NCI-H1793,9911463,3.76780025503232
Li-7,2708,4.421963229077478
MDA-MB-157,11404337,0.0143481506183785
U-251MG,tanespimycin-bortezomib (250-1 mol-mol),-1.2552870435525063
BT-20,54618771,4.093139907883374
NCI-N87,654092,-0.6954721735465327
AU565,24753719,4.632017214490639
NCO2,44493528,3.738913102707939
HT-1376,2729026,3.035704676475354
OV7,24753719,4.262942269756317
NCI-H446,44137675,2.1974370000694248
RL95-2,10302451,2.0027308413664735
OVCAR-5,54618771,0.5295799029989672
CGTH-W-1,49766530,-0.0096054874021786
HCC827,11167602,3.770310113048885
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
BT 172,11485656,1.8257973782589136
NCI-H211,2708,3.300567601136303
HLF,2729026,2.963908497595112
JHUEM-2,2729026,0.9479802445067816
CL-11,2729026,2.038540756240653
Ku812,2729026,1.365537555600546
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
Daoy,151289,0.7677352491175258
BT 228,46926350,-3.6951487252010367
42-MG-BA,10385095,1.3787421167269815
OV-90,24753719,4.229565281891426
SW1417,6918638,0.2566537635355694
HCC1954,148198,-1.209657619864023
NCI-H2052,1716436,3.995152919485672
SNU-503,JQ-1-UNC0638 (2-1 mol-mol),1.7937037188361675
L-540,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2085943716807
SK-N-AS,156414,1.537017755514308
SUP-M2,54618771,0.2858718534698647
MPP 89,24753719,4.361684711095618
NCI-H2228,4259181,0.2163071151070651
NCI-H522,9911463,3.273817127322074
KYSE-510,9911463,4.240688148771923
PSN1,151289,1.6053792802469196
OVCAR-4,136227924,3.1468518699477097
Karpas-299,136227924,2.4546473500331576
SNU-1066,135984461,4.396874081929567
UO-31,9911830,1.1104518342354128
NCI-H211,3815108,1.948602849524941
RL95-2,54618771,0.9471315050617304
LAMA-84,10385095,1.2024516707569957
NCI-H1651,24753719,4.9084535596395025
Namalwa,24753719,3.8228113675826063
HT-1197,10385095,1.8216995461668084
HuH-28,654092,-0.1115393399354003
COLO 684,44493528,4.258277772173305
OVSAHO,24753719,5.057101087958629
U-BLC1,374536,3.48938370269045
CGTH-W-1,136227924,3.107802787848976
CAL-51,2708,4.939881356462198
GP2d,10385095,1.144770275016541
SNU-C5,2729026,2.164475711355227
MEC-1,73707371,5.922862989109616
Ci-1,148198,-4.220925638162102
NCI-H2029,4259181,0.664419407815879
Ri-1,136227924,2.363884089308993
SK-N-DZ,sirolimus-bortezomib (250-1 mol-mol),0.4176185816300255
HT115,11485656,1.923791762912221
HEC-1-B,753704,4.9256455182017955
NU-DUL-1,1716436,2.338540492393301
HCC1195,10385095,1.8165824213163204
A-172,9903786,3.6235991814079545
HCC366,2708,4.70261080130224
BICR 22,54618771,-1.5156377594303725
BT 232,selumetinib-BRD-A02303741 (4-1 mol-mol),5.055929245658767
SNU-869,selumetinib-BRD-A02303741 (4-1 mol-mol),5.334964681931593
BT 428,24772860,-2.503252436850905
OVCAR-4,11404337,-0.6423478354429553
SNU-620,44493528,3.907657594721087
NCI-H747,JQ-1-UNC0638 (2-1 mol-mol),-0.4828975390676294
G-401,10302451,3.1015289114526774
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
DMS 273,9911463,3.7655644930376257
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
KMS-34,10302451,3.7054012110712464
KLE,44137675,4.105797549386638
GCT,374536,3.723693026664198
SNU-8,3815108,0.8679959369818034
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
HCC1806,54618771,-0.2864222176978986
COR-L88,374536,-0.3675667402656398
BT 231,2708,5.0363775155854915
KYSE-140,10385095,1.6004896195430536
SNU-1079,374536,1.7363083886043131
KYSE-520,10385095,1.041852724573902
BFTC-909,10385095,0.9839595624316404
KLE,3815108,3.3721583314849695
GA-10,44137675,0.8453491724509868
NCI-H2085,selumetinib-BRD-A02303741 (4-1 mol-mol),2.455371733631147
ONCO-DG-1,sirolimus-bortezomib (250-1 mol-mol),0.4937178485517417
NCI-H292,4259181,-0.3596950747779806
P12-Ichikawa,374536,1.6259341849120483
ESS-1,374536,5.146738438727042
HT-1080,54618305,4.346285801076027
BT 245,JQ-1-UNC0638 (2-1 mol-mol),5.423120004675633
HCC1195,54618305,4.470862582727534
SW982,1716436,1.6854697963496972
HCC4006,44137675,2.2043409590453393
NCI-H2030,11404337,0.8105383061900018
COR-L105,6450551,3.13458936271996
CMK,24753719,4.095257030332969
U-251MG,11485656,3.6122724638227184
NCI-H28,tanespimycin-bortezomib (250-1 mol-mol),-3.05578817250867
NCI-H1299,10302451,4.027375771217026
HCC1419,6450551,3.249487625998732
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322
NU-DUL-1,54618771,-1.656554068738758
UACC-812,49766530,0.2629782697340875
EPLC-272H,54618771,2.195123762717199
HuT 78,135984461,1.9427901339992903
JHH-4,24753719,4.1634800672109
NCI-H211,10385095,1.0017780744512903
PE/CA-PJ34 (clone C12),46926350,-5.351224463970161
DMS 53,135659046,3.734074928791185
NCI-H1838,JQ-1-UNC0638 (2-1 mol-mol),1.2723184386239716
2004,4259181,-0.1301142592462394
HCC44,24753719,4.095734182241044
NCI-H520,11485656,2.0255953186148674
RPMI-7951,3815108,2.5391159267765144
DMS 114,54618771,0.497932875253643
SNU-1,24772860,-3.16682117598847
LOX-IMVI,4259181,-0.9241838451669104
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
TTC-709,24772860,-2.218847020638614
BC-3C,10385095,2.7598083039620764
TCCSUP,selumetinib-BRD-A02303741 (4-1 mol-mol),5.6777204255641305
YH-13,JQ-1-UNC0638 (2-1 mol-mol),2.8302570708443757
COLO 800,136227924,2.9949932078985437
EN,9903786,3.730384858671513
SU.86.86,11404337,0.6097421920639037
KMS-34,sirolimus-bortezomib (250-1 mol-mol),-7.371271931180508
HDQ-P1,9911463,4.421902621869527
PE/CA-PJ41 (clone D2),44137675,3.861270231400088
A-204,374536,1.3338115287150722
SK-MEL-5,9911463,3.724914838124911
SK-N-MC,9911830,0.996799882730039
HEC-151,135659046,3.7740160846468
SK-MEL-24,24753719,3.524117271265627
SNU-1079,654092,-0.1986700262896328
HMC-1-8,9903786,2.873770542760651
BxPC-3,9911463,3.950256717526944
SNU-C4,24772860,-1.5422785694789662
AGS,654092,0.5136383137416367
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903
DU4475,sirolimus-bortezomib (250-1 mol-mol),-1.4046623953130444
SCC-9,46926350,-4.135183666473923
G-402,11167602,-0.1731760245539544
SU-DHL-8,654092,-0.3160279340370641
GSS,9911830,2.005456861006021
OCUM-1,11404337,-0.1568634600047591
PaTu 8988t,10385095,1.1295524511895831
BT 139,71729975,2.9783826602427017
NCI-H2452,9911830,3.1691750432917645
COR-L95,100016,6.620829555802918
LOX-IMVI,24772860,-2.5240469828526804
OVTOKO,10385095,1.0137593094154838
SW948,16013152,4.211275799279611
HSC-4,9903786,4.262681016067309
OE19,44137675,4.468310014589393
COLO 684,24772860,-2.088469606092815
JHUEM-2,6450551,-0.6170871445435329
PLC/PRF/5,2708,5.513863316789198
NCI-H460,753704,5.635234970240753
SK-MES-1,9903786,1.5074557756101594
GP2d,156414,-1.495990520647441
MG-63,327653,2.9545446221362797
JHUEM-1,6450551,2.124268641635045
SNU-466,327653,2.6893389012281834
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
Panc 03.27,151289,0.9445463147016118
GCT,2729026,2.778276979589125
KALS-1,49766530,-2.069599194374988
L3.3,selumetinib-BRD-A02303741 (4-1 mol-mol),5.501199697080603
LUDLU-1,9903786,3.064378057627616
OPM-2,10385095,0.6586756349946576
SNU-1076,136227924,3.042119222699605
RCH-ACV,49766530,-4.0327200092354305
DMS 454,16013152,3.618544083596966
KNS-81,11167602,2.9643139944480517
PF-382,11485656,2.17330616168877
Calu-1,24753719,4.36133444781149
BT 328,148198,-4.14614868661324
NCI-H1693,24753719,4.303581161701555
NCI-H2085,9911463,4.028733410205104
SaOS-2,24753719,4.762341084721446
WM115,135659046,3.4373276092449667
KMS-21-BM,136227924,2.0166655260293487
NCI-H292,148198,-2.0841293800573446
SW1417,6450551,4.317065591087458
CCK-81,44493528,2.4329753489883106
LAMA-84,124202324,1.4313539938181654
SU-DHL-6,9903786,1.8029536633965553
MHH-NB-11,136227924,1.3020282745517038
FTC-238,6918638,0.6994122204113324
SNU-46,JQ-1-UNC0638 (2-1 mol-mol),2.454584764616526
JL-1,136227924,2.288232757655929
BICR 22,11404337,-1.5250786338229352
NCI-H1435,9929138,6.22270971673178
NCI-H1568,54618771,0.8004506686595156
Lu-99,11404337,-1.2042664696883392
WSU-DLCL2,44137675,1.1435243108723432
NCI-H2342,54618305,3.816194262243341
BT 482,135659046,5.385969156386867
RVH-421,9911463,4.042729397827981
SW982,49766530,-0.9510465454534272
BT 333,136227924,4.6219554593863075
SW1710,44493528,4.456885248291854
OE19,1716436,3.7581962676016474
NCI-H23,136227924,2.7523480468192254
Hs 852.T,JQ-1-UNC0638 (2-1 mol-mol),2.225726404528326
MM1.S,9903786,2.841249590923514
Hs 944.T,tanespimycin-bortezomib (250-1 mol-mol),0.6097209222741542
SNU-840,654092,-0.2291832182378336
LNCaP clone FGC,135659046,3.5330322853898957
BT 416,374536,3.9740957780448474
HCC95,3815108,3.2922167796829664
OVTOKO,136227924,4.392974848141837
HEC-1-B,148198,-2.293611900914974
BT 179,46926350,-4.056285496961634
DV-90,135984461,4.374368296493772
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
HT-144,1716436,3.5829286821503348
NCI-H441,54618771,2.015817613413058
NCI-H1869,753704,5.662993512213298
BT 359,tanespimycin-bortezomib (250-1 mol-mol),1.7721099348871308
NCI-H716,151289,1.5659482246281846
BT-20,6918638,1.2073069769548774
KYSE-140,54618305,4.517279868327929
TTC-709,JQ-1-UNC0638 (2-1 mol-mol),0.9402926082516788
HT-1080,9911830,2.5405256134571044
BT 333,1716436,2.664948713998315
Hs 852.T,148198,-2.877314307810341
NCI-H810,2729026,1.5418483370483698
TALL-1 [Human adult T-ALL],9911830,2.2392612574573865
Hs 944.T,sirolimus-bortezomib (250-1 mol-mol),1.3396818337224137
A-204,11404337,-1.0491261061944723
TF-1,sirolimus-bortezomib (250-1 mol-mol),0.3198417316245446
OCI-Ly10,9903786,3.2654189555082493
HCC1195,tanespimycin-bortezomib (250-1 mol-mol),0.0531375858676879
SJSA-1,sirolimus-bortezomib (250-1 mol-mol),0.9111785812193088
YD-38,11485656,2.58437498447116
ECC12,6450551,2.9426080733003603
AGS,2729026,3.006836247567266
HOP-62,156414,1.5376490539390024
HEC-151,148198,-1.7915860378087891
JHUEM-3,46926350,-4.346385852376475
HCC827,654092,-1.5557808958029646
LXF 289,9911463,2.935801973679381
SNU-398,2708,5.622309749693013
KMRC-2,135659046,5.230232657074779
MOLP-8,11485656,1.8270206697288176
KMRC-20,654092,-1.274296745742125
YAPC,124202324,3.68667481758741
MHH-CALL-3,1716436,2.034714664306083
RPMI-7951,6450551,3.1050149829691787
LUDLU-1,100016,6.796390484470128
MDA-MB-468,54618305,4.506986368363062
NCI-H292,9868037,4.01216306257403
T24,11404337,0.0422226925382746
Hs 611.T,6918638,0.1647262246694485
COR-L88,9911463,3.307213706947891
HT-29,124202324,2.974895351971929
SH-10-TC,151289,1.3827614252819718
KHM-1B,10302451,3.4740404834517156
SNU-216,11404337,-0.7436610925810526
DU4475,46926350,-5.563753386157135
JK-1,24772860,-4.239102731291314
OCI-Ly19,9911463,4.156908261510834
Daoy,4259181,0.1994205747840131
BT 440,753704,4.950533803828191
BICR 31,49766530,2.6564815829329236
TTC-709,9868037,3.9116830012775816
Calu-3,9929138,6.17100330774615
NCI-H2029,9903786,4.7445314067007
NCI-H647,11485656,1.881364727029594
HGC-27,46926350,-4.418488659081001
KMRC-1,54618771,0.2036698487849761
KYSE-410,49766530,0.2031131423748078
BT-16,9903786,2.8143760707131347
BT 416,6450551,2.1117138883617304
SHP-77,9911463,3.880568712678563
SCC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),6.856075579972567
KYSE-30,71729975,1.1746330975815606
LoVo,124202324,1.6089295836770297
HT,9929138,4.348342572684797
BFTC-909,374536,2.594742723017773
HPAF-II,24753719,4.7373633717585975
CCK-81,135984461,3.9266881520309247
P12-Ichikawa,11404337,-1.993052837563161
JHOS-2,11404337,1.6734890105758244
TE 617.T,9903786,3.301651498076641
PE/CA-PJ34 (clone C12),24772860,-2.582582767798194
WM793,9911830,2.975609583515234
SK-N-AS,46926350,-4.132726643488665
JK-1,151289,0.4998330171806102
D283 Med,54618305,4.176148849074149
GCT,46926350,-4.283460070542012
T-47D,JQ-1-UNC0638 (2-1 mol-mol),3.900366642093122
CAL-27,9903786,1.9830233496778105
HeLa,24772860,-1.5744056360755827
AsPC-1,374536,-1.7506249493921369
U-937,100016,4.26159584690163
NALM-6,9929138,5.239590555889495
KMS-27,3815108,2.4440705350233856
BT-549,327653,2.9888914918454854
NCI-H841,24753719,4.206007237159814
G-292 clone A141B1,44137675,2.171423763585016
BT 248,10385095,1.1706577035646757
YKG-1,148198,-3.345136621371903
KMS-21-BM,10302451,2.292063608939571
SK-BR-3,156414,3.9903950038310354
JVM-3,selumetinib-BRD-A02303741 (4-1 mol-mol),3.695264349297203
BT-12,6918638,1.843242029093903
SNU-668,9911830,2.5629729195971955
NCI-H211,124202324,0.2775744704691547
SW1088,135659046,4.039700337753171
NCI-H2106,9911830,2.5796124451187943
KMS-20,9903786,1.7377090782754483
T-47D,54618771,0.7815754342030017
Hs 688(A).T,1716436,3.2775474412391827
769-P,374536,1.2518924811017582
NCI-H1568,374536,1.2941902477204823
KYSE-140,3815108,3.2147475210926117
RL95-2,11404337,0.2119113216403357
CAL-54,tanespimycin-bortezomib (250-1 mol-mol),2.1097630424969593
IGROV-1,2708,4.438419625543199
KNS-81,4259181,0.9523122682170628
CGTH-W-1,11167602,0.1199165911910428
SR,sirolimus-bortezomib (250-1 mol-mol),-4.8079752577906625
RCC10RGB,327653,3.228661308812885
HDQ-P1,374536,1.347083335745754
NU-DHL-1,1716436,2.341384326057666
MFE-319,24753719,4.037071783419627
NCI-H2228,JQ-1-UNC0638 (2-1 mol-mol),3.1763231521874133
Karpas-620,136227924,3.0310478312116467
KMRC-2,11404337,1.481375710238033
Hs 578Bst,11485656,3.9030782427040247
MKN74,327653,3.1147590669580847
Sq-1,24772860,0.0131044846514279
PK-59,54618771,0.2590305123117813
OVCAR-5,151289,2.494017358434926
HCC1428,374536,0.5031007732275531
SNU-878,3815108,3.853142334691998
786-O,9903786,3.782252181935989
Namalwa,9911463,2.7572577056870022
Jurkat,753704,3.381150717732776
NCI-H2052,9903786,2.0027287626066297
KE-97,6450551,1.4064795123135134
SNU-216,44137675,2.116529403425987
SNU-601,156414,1.6952343284910505
NCI-H526,10385095,0.7237833055240664
BT 320,156414,4.178952757446285
SU-DHL-10,124202324,1.3539178305489112
EJM,44493528,4.28788220416213
NCI-H520,148198,-5.585206831860286
M-07e,156414,1.4173221971225267
U-251MG,4259181,1.0740354308159887
HT-1080,24753719,3.879973652696449
BT 428,327653,2.894003003794866
SNU-1214,124202324,2.007945459844625
SF268,148198,-4.335293772909402
PE/CA-PJ15,4259181,0.664963818132981
Karpas-620,2708,5.669891596913208
CL-11,9911830,2.834464588234205
HuP-T4,11485656,1.6012031852576112
AsPC-1,6450551,4.162604073037061
G-401,4259181,0.5796012369716917
8-MG-BA,54618771,3.7934452714384954
NCI-H2286,135984461,2.8625340358152247
T98G,9911463,4.1746073665153105
LK-2,9911463,3.718268646522675
NCI-H322,135659046,3.4659012632221695
CA46,156414,1.2808873732328336
KE-97,54639665,4.464069438264846
CW-2,JQ-1-UNC0638 (2-1 mol-mol),2.006653756060627
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
Peer,9903786,1.0379810938538272
MHH-ES-1,6450551,0.4270898216004571
ST486,46926350,-6.183062780221234
CAL-33,JQ-1-UNC0638 (2-1 mol-mol),1.4055129433338664
MDA-MB-468,11404337,1.423282205986455
NCI-H2030,9911463,4.399921690700774
HCC4006,2729026,3.0296963964849826
BEN,11485656,2.522824701097711
Ri-1,124202324,-0.3559734542715176
KMRC-2,2729026,2.995912943656125
Daoy,49766530,-2.465455878883475
NCI-H1734,3815108,2.8827043761362283
SHP-77,2729026,3.0587143779614236
BT 232,9868037,4.279293873867471
BL-70,6918638,-1.5969799068966968
DND-41,44137675,3.581308638241923
KYM-1,1716436,2.994320416800547
MOLP-8,135984461,3.690365922940533
SNU-182,124202324,1.3234894211551849
TE-5,11485656,1.9147399940941343
HMC-1-8,54618305,5.430829922421115
SiMa,tanespimycin-bortezomib (250-1 mol-mol),0.5523677352528538
Namalwa,6918638,-1.4599496749108598
GOS-3,49766530,-1.0492623989714644
BT 428,2729026,1.1838320666199753
EKVX,46926350,-3.3994748478001906
SF268,tanespimycin-bortezomib (250-1 mol-mol),-0.3321278091609868
TE-5,9929138,7.538066804414881
EoL-1,JQ-1-UNC0638 (2-1 mol-mol),-3.3299111912655563
SUP-HD1,49766530,-3.081720899400098
NCI-H441,9911830,3.026174605149711
HD-MY-Z,753704,5.145907515598795
BT-474,4259181,0.7470813596666142
MOLM-13,6450551,0.4092106163446157
OCI-AML-3,148198,-5.6942586662557035
JHH-2,10385095,3.4516856743936866
NCI-H1869,100016,6.8338343579730285
BICR 16,9911463,4.5254282277171045
HCC1195,327653,2.9574226117277416
Hs 888.T,100016,7.920695284419831
SNU-16,9903786,1.405581496282783
23132/87,10302451,3.316540966620256
SNU-175,124202324,1.5499054633640368
TE-15,24753719,4.009686025079942
786-O,73707371,5.867511767715901
TOV-112D,2708,2.7733347835791977
Ku812,44137675,4.859064076132382
TE-9,124202324,3.210654639580487
HuP-T3,148198,-3.5090934063696153
DU4475,100016,3.3182611876021157
HEC-1-A,24772860,-1.7230820514176135
EM-2,654092,0.2037691142536942
KP-3,654092,-2.1271165007576323
WT2-iPS,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.3333237982789763
CAL-78,44493528,4.952058712183874
647V,151289,1.0326670871948216
NCI-H2029,46926350,-4.397170476500672
Fu97,374536,-1.5662260024220964
NCI-H647,selumetinib-BRD-A02303741 (4-1 mol-mol),4.730456309374106
NCI-H2009,49766530,0.9767616789625324
BT 145,sirolimus-bortezomib (250-1 mol-mol),-0.145853867426896
Hs 852.T,10302451,3.071934801488988
HH [Human lymphoma],sirolimus-bortezomib (250-1 mol-mol),-8.470809124767328
SNU-C2A,1716436,4.909406061303966
NCI-H2085,JQ-1-UNC0638 (2-1 mol-mol),3.529062464367997
YD-8,11167602,2.315498397427602
SNU-1272,11485656,2.6947903691441795
Sq-1,54618771,1.1991492698184876
Hs 822.T,4259181,1.579664777569875
NCC-StC-K140,49766530,-0.6974859837361669
Kuramochi,tanespimycin-bortezomib (250-1 mol-mol),2.338671099156103
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
SK-OV-3,10385095,3.0219456492917485
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
MOLT-3,156414,1.112574242693939
NU-DHL-1,100016,6.7557445252971355
SET-2,24772860,-2.44164092451758
RL,148198,-4.279305385936642
PF-382,100016,3.957595275699552
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485
MKN74,44137675,3.641659568739547
NCI-H2106,9911463,3.3350071984194356
CAL-54,100016,6.472919480601912
AN3-CA,54618771,2.457771155909442
ST486,6450551,1.145972312308334
769-P,156414,6.134448587786172
KE-39,49766530,-2.0647642539816715
JHH-1,100016,6.434861287132587
CAL-148,124202324,1.2419277184230273
AsPC-1,1716436,2.9196038383716205
GSS,54639665,4.407333409116942
TYK-nu,9911830,2.956364674147038
NCI-H2029,156414,1.6965559140057698
Pfeiffer,9903786,-0.8773679724419216
AGS,11485656,1.9276189109477695
NCI-H1838,9868037,3.6730401154480767
SET-2,10385095,0.921007815514528
NCI-H446,9868037,2.387486859676029
NCI-H810,54618771,0.890127008742605
NCI-H2106,44493528,4.52361018349812
IM95,selumetinib-BRD-A02303741 (4-1 mol-mol),2.526029279230293
Hs 611.T,156414,0.8748600228800256
Capan-2,9911830,3.0690916513278665
KYSE-150,100016,4.009775484830176
GP2d,9911830,1.2685523875748046
BT 232,10302451,4.010899903190945
JHOM-1,2729026,3.097245310455292
NCI-H1355,49766530,-0.7127402307257245
SNU-216,10385095,1.0317587818104637
SNU-16,73707371,4.724357740543645
JHUEM-3,10302451,0.6588208189074596
TE-10,124202324,1.833513457567128
BT 131,327653,3.395185423161247
G-361,100016,5.501390716782531
SBC-5,11404337,1.1992857421773124
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
BT 340,2708,4.945423521294746
KYM-1,11167602,2.068998786913783
COR-L95,2729026,2.664378744829576
MHH-CALL-3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.5055684907035936
DOV13,654092,0.5195858702328126
SUP-T11,24772860,-2.3071005995680047
BHT-101,2708,5.347856470959317
BT 416,54618771,0.7344198776151593
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782
SNU-478,54618305,4.7061307072475405
JMSU-1,54618305,4.2290636516001285
2004,9911830,0.791169368139958
NCI-H1341,151289,0.4608685392075345
Daudi,135659046,3.1156448500687923
REC-1,54618771,4.304155025574206
A4/Fukuda,44137675,1.307300702935143
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
BT 286,9911463,3.0735360087935364
BT 271,2729026,1.04904243551692
HCC1438,148198,-4.23267201662653
CAL-51,44137675,3.485867182081199
SNU-8,24772860,-2.786404079111214
BICR 16,151289,1.062892131046102
BEN,9911463,4.573978563534662
HT-55,11404337,0.898087242487133
HeLa,9911463,4.222129751403694
U-118MG,327653,2.9357126354671363
RS4;11,24772860,-3.363558063361939
NCI-H2023,10302451,4.238288673269683
A-549,124202324,3.059134662451402
TF-1,4259181,-0.4142995072345916
JHOM-1,1716436,2.6370249898581335
DMS 79,tanespimycin-bortezomib (250-1 mol-mol),0.386728913048693
SNU-308,2729026,3.0372932862375692
OCI-AML-3,753704,3.688765224325768
SW982,10302451,5.246123536863423
JHH-1,2708,5.306413315637736
BICR 6,46926350,-4.339470897177743
SNU-C1,sirolimus-bortezomib (250-1 mol-mol),0.1319095851992196
GB-1,136227924,3.951727784027331
PE/CA-PJ15,2708,4.901414773558016
ONS-76,10302451,3.399700001459874
COR-L95,6450551,2.8920154707175776
BT 147,6450551,1.6615924309309036
YAPC,327653,3.117178905090827
NCI-H2030,3815108,5.353671583033201
KYM-1,151289,0.8503411663281449
M-07e,4259181,-1.9035117365658276
NCI-H2030,2729026,3.166677954271788
MFE-319,148198,-4.2483014049358685
LXF 289,9911830,2.045852319971143
SNU-16,24772860,-4.245270197469195
AU565,9868037,3.1053436778875843
JHUEM-3,2729026,3.1174609282377643
SCC-9,2729026,3.0647326637868573
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
JHH-5,11404337,-1.7016316561461169
NCI-H2081,136227924,2.7498424735477913
OVK18,753704,4.89263199036064
HCC1419,54618771,0.889402864117146
NMC-G1,136227924,2.469359539544405
KP-4,151289,0.3587584967433216
REC-1,10385095,3.1459726814165205
ECC10,44137675,2.4549822664560357
OE19,11485656,2.020762016730455
NCI-H838,374536,0.1860181262174047
KMS-28BM,9903786,-0.1585542654155638
SW1990,49766530,-0.1486325613650474
CW-2,11485656,2.601974992122327
U-BLC1,24772860,-2.52128932774433
Hs 936.T,1716436,2.450119741918197
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
BV-173,selumetinib-BRD-A02303741 (4-1 mol-mol),2.9777430523816424
L3.3,9911830,2.6705572013337195
PL-21,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.2651691142170538
JVM-2,49766530,-4.705274253962015
M-07e,71729975,0.4243989535522631
BL-41,sirolimus-bortezomib (250-1 mol-mol),1.1503434998526136
RL95-2,9911830,2.3107530510389016
MeWo,6918638,-0.7125250805485809
BICR 31,148198,-3.2373882564770513
NCI-H660,148198,-5.84244418437934
PaTu 8988t,9911463,4.367264855700764
NCI-H2170,156414,1.4288887895689582
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
EHEB,136227924,2.586993854279513
BT 112,54618305,3.877432993303292
Jurkat,3815108,2.600020722949873
KMS-20,9911463,2.8485967740948284
DAN-G,24772860,-0.1517899648925601
NCI-H446,136227924,3.5012378178100487
TM-31,sirolimus-bortezomib (250-1 mol-mol),0.5260626662043751
TE-5,9911463,3.65954938557894
Granta-519,9903786,1.2937892753152922
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
TTC-709,44137675,3.849724835732186
MFE-319,135984461,4.655775210040696
GSS,124202324,0.8676764714076153
NCI-H1869,6450551,4.274729428464116
NALM-6,JQ-1-UNC0638 (2-1 mol-mol),-1.8555560974353031
SU-DHL-10,9868037,2.3348220475042343
SNU-1214,10385095,1.848528700998056
KCL-22,10302451,0.4054501902818456
SBC-5,151289,0.3068057764327633
Mino,44493528,3.6548963085027
SET-2,9903786,0.1058309934713531
DK-MG,9911830,1.6041327482191914
KYSE-520,11404337,-0.584711234415048
Sq-1,44137675,2.0251948511118805
MES-SA,49766530,3.67980126905318
HCC1500,2729026,1.749867272011919
SK-MEL-2,6918638,1.2677051834629418
NCI-H716,JQ-1-UNC0638 (2-1 mol-mol),0.1161677167722541
JHOM-1,44137675,1.7407470487253982
TE-4,10385095,1.682137029626504
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365
OVCAR-5,16013152,4.161544703685677
OAW28,9911830,2.567685352724645
ESS-1,148198,-4.109415572856481
KMH-2,136227924,2.758064098306969
NCI-H1573,44137675,4.29917802578531
B-CPAP,1716436,3.297193822138579
BT 271,JQ-1-UNC0638 (2-1 mol-mol),2.66075649365595
NCI-H1975,selumetinib-BRD-A02303741 (4-1 mol-mol),0.5235179978418644
NCO2,10385095,0.8572094806219551
HCC1806,24753719,5.03925473475155
NCI-H1373,9929138,7.584401812075051
CAL-54,4259181,1.011746502902974
J82,24753719,4.250519286572852
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
ECC12,sirolimus-bortezomib (250-1 mol-mol),1.6381290256709142
SUIT-2,4259181,1.8331520084863369
BHY,6450551,3.35343289875713
FaDu,49766530,4.291089764816537
Hs 888.Lu,JQ-1-UNC0638 (2-1 mol-mol),4.627243624321547
KMS-28BM,135984461,2.268189755697481
SF268,9868037,3.0654827755113203
RPMI-8402,2729026,2.122177717633357
RKN,753704,4.966407297087677
PK-1,44137675,3.885064586842958
NCI-H446,9911830,2.308414710364549
BHY,10302451,1.481147701409921
U-BLC1,6450551,1.436411892394185
OCI-AML-3,374536,-2.867379826725216
SNU-1214,100016,6.334633199659308
SK-OV-3,654092,-0.1739817534251795
Raji,2729026,2.2038396204117503
Hs 729.T,11485656,2.9602548110779145
NCI-H660,6918638,-0.1001418926217168
BT 228,148198,-4.966222395978798
GA-10,24753719,1.5492278869101457
NCI-H1581,6450551,-0.0173686275629065
HMC-1-8,10385095,1.010587069715564
SK-N-DZ,tanespimycin-bortezomib (250-1 mol-mol),0.4242122917353423
SR,44493528,4.089009709270584
GaMG,54618305,5.206463564133868
CCF-STTG1,10385095,1.287783842967002
TE 441.T,10302451,3.78756460057488
NCI-H1581,9903786,1.8918310652044057
BT 333,JQ-1-UNC0638 (2-1 mol-mol),4.424083167073066
WM88,44137675,2.7368794575153297
SK-BR-3,54618771,0.9510207607432342
SNU-899,10385095,1.2944139738105107
RD,100016,6.5954800872388155
Calu-1,2729026,3.1806773344369454
OVISE,374536,3.768512931442208
SW1417,sirolimus-bortezomib (250-1 mol-mol),0.2535776257809292
Panc 10.05,10385095,1.5878322903216917
LoVo,654092,0.3814222362545946
YD-38,9903786,2.8631306213752103
WM115,46926350,-4.284670953339827
P31/FUJ,11404337,-0.879305702132212
SR,11485656,1.4152988007368743
SNU-407,148198,-3.549575176870091
SNU-61,374536,-1.8297483787291275
CAL-51,2729026,2.5757432896171517
K-562,24772860,-2.920105669473321
TE-8,2708,3.8837560660010033
Hs 888.T,9911463,4.2898422169426285
HeLa,100016,5.8653655502295
MOLP-8,11404337,-0.9705317414577028
Ku812,148198,-4.150507844489635
CAL-78,tanespimycin-bortezomib (250-1 mol-mol),-2.747028808134876
HEL 92.1.7,135984461,3.406492111199009
BT 330,24772860,-2.5000585413753815
SK-CO-1,3815108,2.810447278858876
UACC-62,49766530,1.0622286299463806
SYO-1,9868037,3.815139234423316
BT 504,10302451,4.044770274527245
HT-1080,tanespimycin-bortezomib (250-1 mol-mol),0.0826003622808549
BT 231,753704,3.5842016877882945
OAW42,6918638,1.325262653338047
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
VM-CUB-1,2729026,2.952577229339844
NCI-N87,44137675,2.149558923433186
HCC2108,3815108,3.7436297083403938
NCI-H1838,2708,5.352371700411639
Ci-1,24753719,3.143659983929841
NCI-H1651,9868037,4.401411250995596
NCI-H1184,654092,-1.7531803401326804
MHH-NB-11,9911830,2.1273093193707697
639V,11485656,2.1157835371974287
Reh,2729026,2.132083938872596
Sq-1,9903786,4.063753255024067
BFTC-905,9911830,3.3547693597668524
HT-144,54618771,1.2488424909624232
LS411N,54618771,1.0517408544895162
OCI-Ly3,753704,3.5257579596599573
MM1.S,54639665,4.38877596087519
NCI-H1666,44137675,3.54194276713544
LC-1F,11485656,1.8871769166571817
COR-L95,46926350,-4.41571269577794
PL-21,6450551,2.5394365591018455
KE-37,tanespimycin-bortezomib (250-1 mol-mol),-0.6256036553504546
G-292 clone A141B1,374536,3.0210670758899765
IST-Mes1,9911830,1.5716425903239464
P-STS,46926350,-4.257774436682865
IST-Mes1,4259181,1.4706848514509867
SK-UT-1,9903786,5.78516391020833
Ishikawa (Heraklio) 02 ER-,654092,0.6103847361282962
NCI-H522,11485656,1.866098793785005
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
M059K,135984461,3.9567991778438247
U-CH1,9911830,3.557998201307897
CAL-33,11485656,2.164016105074951
A-375,10302451,4.088422063006118
SK-MEL-24,54618305,5.4405077428340345
HEC-1-A,135659046,3.907670889087363
42-MG-BA,148198,-6.365227331542155
IA-LM,1716436,3.827820678542469
LXF 289,9903786,1.8485652979864533
IGR-1,24772860,2.471908672686385
SNU-719,4259181,-1.3711079243063935
JHUEM-7,135984461,4.346774383555173
NCI-H2081,44137675,3.995852216137384
Hs 940.T,71729975,3.8110134748051823
BHT-101,100016,6.007811941047966
H-STS,327653,2.5353230161110014
IMR-32,9911463,2.6287307610589172
NCI-H1666,9903786,3.302889272478758
SNU-423,9911830,2.1086837652762473
HCC2218,44137675,3.038492049158943
CMK,selumetinib-BRD-A02303741 (4-1 mol-mol),7.144571141139445
HuNS1,9903786,1.9338093787028072
JM-1,135659046,3.550517545140938
TE 617.T,54639665,4.38998607843506
SNU-1079,327653,3.396967278535857
BL-70,1716436,2.25517721544058
OVCAR-8,9911463,4.194046142536917
A-204,151289,0.859121969806818
KMS-11,44137675,2.440984339658121
SW1783,44137675,4.848183688866269
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905
CAL-148,10302451,3.8567185397619728
NCI-H2023,9911830,3.443492401360393
LS180,44137675,2.850653785387247
KCL-22,24772860,-2.9952778586938824
HT-1080,151289,0.8947083846280688
MDA-MB-231,10385095,1.360021419508986
WSU-DLCL2,2708,2.6079886033718087
NCI-H508,654092,-1.4183597090905342
JHUEM-3,9911830,1.9490536022519651
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
CAL-62,100016,6.567555445612565
A-549,11485656,2.1977599259975764
23132/87,1716436,1.6651500133835146
BT 159,11404337,0.5861575458896715
DoHH2,6450551,0.9673496809653044
SNU-216,753704,4.505570675332015
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
DK-MG,46926350,-4.423205823507473
HCC1588,10302451,3.078678072526936
NCI-H1666,9911830,2.3243808572594
MOTN-1,10302451,3.257929179100611
BT 172,71729975,1.259779207760812
G-361,2729026,2.267590028517623
PK-59,11404337,0.8851709837592256
HCT 8,24753719,4.305781458021924
CAL-62,136227924,2.2921842664772996
NCI-H1792,24753719,5.861700790005554
LC-1/sq-SF,44137675,4.219906236718743
COR-L279,46926350,-4.847976915080726
CL-11,9929138,5.374540786580353
OPM-2,54618771,0.7318105179081044
SU-DHL-1,9868037,1.568771805047012
Raji,11485656,1.8853842234896017
NCI-H2126,9903786,3.129084376626642
NCI-H661,374536,3.546483103952357
SNU-761,16013152,4.644295554252924
DU4475,327653,2.541237154607322
KM12,tanespimycin-bortezomib (250-1 mol-mol),-0.2034233372604618
SYO-1,24753719,4.366499494987805
HCC1937,11485656,3.1070041038533835
BT 328,327653,3.5942697932581344
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
SNU-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4388459409221928
HEC-1-B,2708,6.388339522960753
TYK-nu,374536,2.3944963205864327
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
NCI-H2081,73707371,5.9412545737381075
NCI-H650,54618771,-0.8168884104410387
EFO-27,46926350,-4.056205960361391
MKN74,1716436,3.075916204140164
NCI-H2110,54618305,4.481600360500252
8-MG-BA,9911463,4.3776650964828985
A-673,24772860,-3.1744597884682997
BV-173,11167602,1.519259403160705
MDA-MB-231,selumetinib-BRD-A02303741 (4-1 mol-mol),3.721341362414383
SW1353,151289,2.6582308170560887
SNU-213,374536,4.5761002458249695
BT 179,151289,1.2191731755064577
TE-14,9868037,4.140324513825515
ME-1 [Human leukemia],2708,4.86274828494282
MKN1,148198,-2.187340578141158
KNS-60,9903786,2.981782520240843
EFO-21,JQ-1-UNC0638 (2-1 mol-mol),2.892386470008615
KYM-1,6450551,3.1474816843525364
AGS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.248655822614194
BT 504,11167602,1.7922968046934435
NCI-H358,9911463,4.09003122269505
JURL-MK1,9903786,1.1530539492536125
VMRC-LCD,327653,2.851210955556481
T98G,10302451,3.1795793433623634
BT 179,11485656,3.2813483165810218
MDA-MB-453,54618771,-0.4179555738274852
SW982,327653,3.5055694306340484
KHM-1B,44137675,2.3063788474236957
CFPAC-1,4259181,0.9556133546094158
SK-MEL-30,sirolimus-bortezomib (250-1 mol-mol),1.4325338004264097
DAN-G,46926350,-4.089396955972127
SW1271,9911830,2.7072275961126997
Karpas-422,JQ-1-UNC0638 (2-1 mol-mol),-1.394772143472039
MKN1,4259181,1.0548548306280776
HEL 92.1.7,100016,4.201358504841771
HCC1937,JQ-1-UNC0638 (2-1 mol-mol),2.0246414968177713
DU4475,135659046,2.7286473029025675
A-253,9911830,3.0996294325120464
TE-5,6918638,0.0730063512653744
BT 139,9903786,4.553274987644657
PE/CA-PJ34 (clone C12),selumetinib-BRD-A02303741 (4-1 mol-mol),2.3443290551447173
NCI-H1299,9911463,4.155040762407167
UM-UC-3,135659046,4.064951020836241
HCC1954,135984461,4.275090239717432
HCC1195,9911463,4.371247220655063
LCLC-97TM1,11404337,-1.4043223473519348
RPMI-6666,100016,5.822007631719843
SK-N-MC,sirolimus-bortezomib (250-1 mol-mol),-0.0028242639035691
COR-L105,44137675,1.808161252080405
JHUEM-2,9911463,2.885358490635734
Caov-3,327653,2.7768695220445685
ME-1 [Human leukemia],374536,1.3511992885024209
SK-MEL-2,6450551,4.058466448990368
SW982,6918638,1.6388429790879695
BT 330,71729975,0.6660991074128464
SK-MEL-3,9911463,3.4367416892485556
SNU-61,3815108,2.973673139417603
NCI-H2009,11404337,-0.0657811746758558
Capan-2,374536,0.803735825202659
Calu-3,JQ-1-UNC0638 (2-1 mol-mol),1.5562452724736866
ONS-76,1716436,4.404636467874722
Mono-Mac-1,327653,2.35680812589116
SCC-9,2708,5.420316309291021
Ki-JK,124202324,0.8587867376831408
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
ONS-76,4259181,0.68334491499701
HuT 78,46926350,-4.333378092380672
Raji,44493528,4.013963979075194
SK-MEL-28,11485656,3.743045528473451
CAL-33,156414,0.5278665840065395
JVM-3,753704,4.637119746855345
BT 286,11167602,0.1521684661712007
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226
SUP-T11,11485656,1.9960376933984711
LNCaP clone FGC,24753719,4.279348645230378
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
OAW42,2708,4.774017339067302
SNU-119,10385095,1.2447707748514782
HSC-2,156414,-0.6500382909370143
ONS-76,654092,-0.1261556450149646
BHY,4259181,-0.4140726497204193
KE-97,9911830,1.897580149964957
HEL,2729026,2.9938268289747394
Hs 294T,11167602,6.170800692067223
647V,46926350,-4.052659367251053
MKN7,374536,3.598849077956326
HL-60,11404337,-0.9575342155378792
NCI-H1869,753704,5.662993512213298
WM266-4,11485656,1.8350601891994096
MDA-MB-435S,44493528,4.3922375921749195
TE-8,49766530,-2.1976290152657114
TE-11,136227924,3.028335758763499
PK-1,11485656,1.889467088034988
TC-71,6450551,1.358788910777725
RL95-2,374536,3.4311000147524067
JK-1,JQ-1-UNC0638 (2-1 mol-mol),0.7881637535650861
DEL,73707371,2.748394467029823
TCCSUP,10385095,1.359914637472657
MDA-MB-453,6918638,-1.2403270134347248
NU-DUL-1,9911830,2.1462587269693225
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
L-363,6450551,1.969497941118369
BT 428,9903786,3.72207082245763
SNU-61,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6699368728217061
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
SNU-601,327653,3.505640392145212
BT 112,49766530,0.144276899282749
KCL-22,9929138,6.476952108797493
HMCB,46926350,-4.187449030083668
LUDLU-1,16013152,3.96122567220864
SR,100016,4.130694890660373
CCF-STTG1,46926350,-4.2806807633593325
RL95-2,44493528,4.087337574657741
HCT 15,100016,6.694419225032017
PE/CA-PJ15,136227924,2.633948596133963
GDM-1,3815108,1.1695816398883936
NCI-H1650,sirolimus-bortezomib (250-1 mol-mol),1.0715909350533408
KMS-11,11485656,1.7244109146012885
OV56,6450551,4.6167550857894195
MFE-296,327653,3.238444781740251
PaTu 8902,11485656,3.4031855994132663
KNS-62,11404337,0.0351027480224998
8505C,327653,2.966511809444347
HL-60,9911830,2.2176306511968327
NCI-H1355,374536,3.3599086475450157
HPB-ALL,753704,4.344396211213476
SUP-B15,JQ-1-UNC0638 (2-1 mol-mol),-0.1893902364051108
NCI-H1793,10385095,1.202499235212937
Hs 936.T,3815108,3.6018027704932676
BT 245,9911830,3.123552720106954
EN,6918638,1.0700608344727125
NCI-H322,156414,-3.694752457878393
NCI-N87,151289,0.0450530603050232
SNU-601,46926350,-4.222683427951298
Ki-JK,10385095,0.8839794805977479
BT 131,4259181,0.5995842251057973
647V,2708,4.067627207706111
SH-10-TC,54618771,0.3960881038412169
Panc 08.13,9903786,3.5519515597880646
Caov-3,10302451,2.9252761280004513
LCLC-103H,24753719,4.521159399126971
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
SUIT-2,4259181,1.8331520084863369
KMBC-2,44137675,3.7082057495512095
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259
SNU-46,54618771,3.9719869663653578
GSS,44137675,2.88816125980243
AML-193,4259181,-0.4145932893303466
OV-90,24772860,-1.443649503411102
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
H-STS,9911463,3.056276034663577
WM983B,11485656,1.9141384633865923
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808
OAW28,10302451,2.68651474445359
NCI-H647,49766530,1.518533488741799
COLO 205,9911463,3.950435193023514
NCI-H2452,654092,0.1220899319284023
KYSE-510,135984461,4.447866088850815
COV434,136227924,1.351853150285656
Rh30,9903786,2.553175737800522
NCI-H1385,156414,1.4779200200526772
NCI-H1573,11404337,-0.6417516749678569
DLD-1,11404337,-0.813522825038391
RD,6450551,4.217305267779179
NCI-H2286,6450551,1.3482864281985665
BT 232,11167602,3.700775508233816
NCI-H1341,9911463,2.510960457156186
NCI-H1838,1716436,3.662899486385777
U2OS,1716436,0.8932462912826141
KYSE-140,9903786,2.4605743135261653
B-CPAP,24772860,0.4550512643264998
BT 231,156414,0.9770079511825466
SK-MEL-31,2729026,2.8435569701840246
NCI-H1792,3815108,3.721495102266197
YAPC,54618771,0.5686030675412354
M059K,24772860,-1.809508311399413
NCI-H520,44493528,4.24259211168764
HDQ-P1,11404337,1.6870707002815033
SNU-407,124202324,2.234848853731748
NCI-H1581,10385095,0.301303893898011
A-673,4259181,-0.6373852614685119
SF295,3815108,3.3473077124451063
BT 224,sirolimus-bortezomib (250-1 mol-mol),0.3912560811158826
BT-20,JQ-1-UNC0638 (2-1 mol-mol),4.637152890258517
NCI-H1373,9911463,3.627616196356772
HEL 92.1.7,46926350,-4.211318202284742
D283 Med,135659046,3.420100505846104
DMS 114,11404337,-0.5972709505558575
ONS-76,9911830,2.941904202808556
ECC10,9911830,2.8495761448668944
NCI-H2452,156414,1.7996451609117237
MOR/CPR,136227924,3.350851412370925
SNU-899,JQ-1-UNC0638 (2-1 mol-mol),1.344220266508414
SU-DHL-8,10302451,3.070493160453354
HuCC-T1,11485656,1.9622878399892336
DV-90,54618305,4.068440382040456
KMS-18,753704,4.831950088850774
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
DND-41,135984461,3.0712550622908643
NCI-H1869,148198,-2.251684124095355
NCI-H747,148198,-4.03542032091069
SH-10-TC,46926350,-4.411036590095516
Karpas-299,sirolimus-bortezomib (250-1 mol-mol),-3.935889732903339
SK-MES-1,2729026,1.974378492879576
HT-1080,135659046,3.530042119705326
NCI-H838,11404337,0.7986935268513927
SNU-503,135659046,5.578031724761291
HCC1937,10302451,4.416854871626928
Hs 888.Lu,2729026,3.137993585153864
U266B1,71729975,0.980519966806054
TE-11,135984461,4.268125230338474
OCI-Ly19,10385095,0.8757541357960408
NCI-H292,11485656,2.2579953762585725
H-STS,24772860,-2.67708885899535
T98G,2729026,3.1993029783526854
Kasumi-1,4259181,0.5778195803788477
NU-DUL-1,6450551,0.7566059945179737
SUP-B15,151289,0.9454111758813027
BT 333,6450551,3.1801374415487755
NCI-H23,54618305,4.28685943340946
CAL-62,9911463,4.371192134502622
NCI-H1869,9911830,2.4210721600025344
MOLM-6,9911463,2.9457292800178605
IGR-1,9911830,2.4963005826428533
HCC1569,2729026,1.5480430811384225
SNU-410,374536,3.1902909330484985
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
GOS-3,10302451,4.10350760632464
OV56,10385095,1.4769772001806318
RCC10RGB,1716436,3.489109378341682
IPC-298,124202324,2.824842538198749
BT 131,46926350,-4.245263801537404
G-361,10302451,3.636127166828417
BICR 6,100016,5.983099357165641
SNU-C1,151289,1.4139657608656644
SK-MM-2,136227924,3.42367167276636
Granta-519,49766530,-2.591856607816134
HCC2108,11485656,2.4652137706419137
U-CH1,2729026,3.100881377502206
YAPC,11404337,0.4717703732171429
NCI-H2172,1716436,2.3088273241910686
RKN,49766530,-3.8574490235665584
Jurkat,11485656,1.7204006951846988
SK-N-MC,24753719,3.5641231091057652
NCI-H2087,JQ-1-UNC0638 (2-1 mol-mol),0.6551767293331621
FaDu,327653,3.4598790914984017
RL95-2,654092,-1.5915633800953697
HCC38,136227924,2.8991930932960983
HCC44,654092,0.2448035497966521
SH-10-TC,1716436,3.746754898957073
TALL-1 [Human adult T-ALL],9929138,6.59900307589284
Karpas-620,49766530,-1.8063473095000468
Capan-2,9903786,4.9592857340128385
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
SJSA-1,9911463,4.067531678479842
BT 416,148198,-4.446669528218965
TE-8,9911463,3.6899987590816687
SCC-4,6918638,-0.3136358743623781
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
CMK,11485656,1.9879747340083027
SUP-B15,1716436,2.5578920971272177
NCI-H2452,3815108,3.5712952235347455
Hs 766T,100016,6.453782329995662
HCC1500,2708,5.151987441269929
MDA-MB-453,1716436,1.6727209102312437
NOMO-1,9903786,1.612481289648159
CAL-78,654092,0.0744293680705691
RCH-ACV,44137675,1.3480250220639034
SU.86.86,148198,-1.8590332811796892
OPM-2,49766530,-3.767684481967312
NCI-H2029,24753719,4.110032115019825
K-562,6450551,-0.0734681627771844
LCLC-97TM1,44493528,4.18527882332477
HCT 8,148198,-5.465944443336747
NCO2,6450551,-1.8088387094117775
SK-MEL-30,44137675,4.115781416595097
NCI-H292,24772860,-1.7688616980402292
RPMI-7951,135984461,1.8350083594586524
SNU-5,9911830,2.804822100655287
COLO 829,2729026,3.053751013940432
GMS-10,54618771,2.907722210856396
MFE-319,11485656,1.6496792677763226
RPMI-6666,tanespimycin-bortezomib (250-1 mol-mol),-0.2887832089561175
CW-2,tanespimycin-bortezomib (250-1 mol-mol),2.6313334952159844
JHOC-5,tanespimycin-bortezomib (250-1 mol-mol),0.5504047070747966
TE-1,1716436,2.983158791850208
HCC1588,753704,5.0598971868293505
42-MG-BA,9911830,3.146515897881783
KNS-60,54618771,0.379873149864298
OE21,24772860,-2.401866774595391
Calu-6,124202324,2.545321982992492
ACHN,148198,-2.704969639683015
TYK-nu,sirolimus-bortezomib (250-1 mol-mol),0.7718318576607361
KE-97,100016,5.841816758085698
SNU-C1,54618305,4.256785506246939
MCF-7,11404337,-0.4787544229741591
MEC-1,49766530,-2.6442058003130806
HCC1588,100016,6.591658390404969
SK-N-SH,6450551,0.9413664563785176
OV56,46926350,-2.316835008797377
KMS-26,3815108,-0.3373961907949976
HCC1428,11485656,3.1033366258565938
NCI-H1651,54618771,4.521553313874046
SNU-423,136227924,3.242018782370702
SK-MEL-24,49766530,0.9936370719790436
NH-6,4259181,-0.1363698113178426
KATO III,54618771,1.8555498660455492
SNU-407,9911830,2.653274681227129
Hs 683,9911830,1.9641699230536744
HCC1428,1716436,2.4381456100510603
JHH-4,2729026,3.03868080722385
SK-CO-1,10385095,1.4661007046294967
K-562,11167602,1.4540526159902811
TE 441.T,54639665,4.381195082349918
A-673,156414,1.4246196000990916
MDA-MB-361,1716436,2.5570522242297686
ST486,44137675,3.63325509805092
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
NCI-H460,9911830,3.1326305509826824
LS1034,374536,-2.222654875268653
U-937,124202324,2.153713207948823
SK-N-MC,10302451,3.713832355063549
Panc 04.03,2729026,3.1546590032208948
LOX-IMVI,11485656,1.9351920109561
VMRC-RCZ,16013152,5.542482309124593
THP-1,9911463,2.82598855830453
OVCAR-4,54618771,1.8457330551632656
HSC-3,11404337,-0.7786873247989411
P12-Ichikawa,selumetinib-BRD-A02303741 (4-1 mol-mol),6.798293398124145
HT,11485656,2.2235968294792534
PC-14,11485656,2.0369141609233656
YD-10B,54618305,4.478486027530094
EB1,JQ-1-UNC0638 (2-1 mol-mol),0.1085444566940209
HT-144,4259181,0.9881663979403672
IPC-298,54618771,-0.94588727453768
SNU-C5,374536,2.885447392662485
OV56,2729026,3.17820429702703
COLO 699,44493528,4.4403065738336345
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
NCI-H1666,2708,5.098105061610172
SW620,11404337,-0.8120361907901654
B-CPAP,9903786,2.2781712830719316
A-549,16013152,5.649530462974007
HuH-28,136227924,3.512267666844948
CAL-54,10385095,1.4205494165748902
Ki-JK,24753719,2.999848182641454
HL-60,16013152,3.957403485177991
Hs 294T,374536,1.1322433367257645
NCI-H929,11485656,1.7872822459041733
NCI-H1435,9911463,2.965679998241422
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
NCI-H1568,10385095,0.5241849666466598
HT-55,327653,2.92353631762882
NCI-H727,10302451,3.178772538514987
SNU-16,44137675,3.7321956298489214
NCI-H2170,100016,6.477443817994488
CAL-120,tanespimycin-bortezomib (250-1 mol-mol),1.8647047986889285
NCI-H1915,135659046,3.854368010615629
SNU-C4,tanespimycin-bortezomib (250-1 mol-mol),0.700839751007814
TCCSUP,1716436,3.07523463483741
Hs 852.T,374536,3.5139491020524214
HEL,124202324,1.0355607531680788
BxPC-3,151289,0.5689607060021993
A2058,136227924,2.613575897416718
SNU-1033,6918638,0.9929294920003592
DAN-G,11404337,0.1874495042654069
SW620,654092,-0.1720377122722382
LAMA-84,54618771,0.5560134201720579
DU145,135659046,3.5568052359419604
BICR 6,JQ-1-UNC0638 (2-1 mol-mol),2.052539418805438
Pfeiffer,46926350,-6.093166360147153
KYSE-180,151289,0.6004966681509784
TE 617.T,9911830,2.045260681155165
JHOC-5,selumetinib-BRD-A02303741 (4-1 mol-mol),7.31357748396289
NCI-H2023,2708,5.040533361306498
KYO-1,374536,-0.1677553844184101
HCC1833,54618771,1.9776792637653005
M059K,753704,4.507300179045794
OAW28,2729026,2.5871569751548047
SNU-1272,9911830,3.883073952142102
COLO 668,4259181,-1.074551036430991
SK-N-BE(2),71729975,0.3736996923345157
OV7,tanespimycin-bortezomib (250-1 mol-mol),-1.2936042067435187
HCC2108,10302451,4.138705922344902
BxPC-3,148198,-2.171424706341701
PF-382,9911830,1.7810920372451895
MOLM-13,10302451,1.7245492330691454
TUHR4TKB,11404337,-1.470690034731614
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
SW1417,9911830,1.9711863745883549
HH [Human lymphoma],49766530,-3.061520130360288
Mono-Mac-1,1716436,1.8382110406537744
MSTO-211H,654092,-1.1984807631004837
Kasumi-2,46926350,-4.426429724391801
SNU-1105,10302451,4.249277468468409
A-204,4259181,0.5128413523484529
PK-59,9911463,3.8863333115764416
SNU-216,100016,6.2010021575017085
HCC1395,9903786,3.009593050669707
PK-1,11404337,1.355004976466392
KYSE-450,9911463,4.540289012412596
NCI-H1666,1716436,2.2796790549532524
OCI-AML-3,9911463,2.5081471019206014
EJM,49766530,-0.6352274600767028
NCI-H747,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.855653139561796
HPAF-II,9911463,4.010750287703811
MOR/CPR,9903786,3.5279183844640305
GB-1,11167602,1.6517342289553878
MeWo,JQ-1-UNC0638 (2-1 mol-mol),1.4036681220307905
PANC-1,135659046,3.591022095575617
MKN74,2708,5.472415372145003
NCI-H2106,9868037,1.1316953676895871
RPMI-7951,24753719,4.344653463611892
NCI-H2141,148198,-5.2509826148997725
OVK18,3815108,1.3433486037979865
NCI-H196,11485656,3.8330163114503337
Hs 944.T,44137675,3.088087167313417
SNU-182,49766530,-3.329297087517195
A3/Kawakami,9929138,3.117210627279925
NCI-H2196,9911463,3.768579820818315
ChaGo-K-1,1716436,2.640307012974755
ME-1 [Human leukemia],135984461,2.3168305015054793
SW1573,11404337,-1.3449252751203844
HCC4006,4259181,2.039618139148504
HT,1716436,3.046652269634994
NCI-H1792,148198,-0.2067375055401052
KNS-60,136227924,2.463930704521007
L-540,654092,0.1282869266138044
U-937,9903786,1.2748798795403693
LMSU,10302451,4.092585001279765
U-CH1,11404337,0.9399047306468424
OVSAHO,44137675,5.250137839910153
KPL-1,3815108,2.3775517667577466
Ku812,156414,-0.0936884682974776
WM266-4,6450551,3.2448932499683525
RPMI-8402,54618771,-0.5360819718373795
OVCAR-4,1716436,3.028111269022624
Kuramochi,10302451,3.780871192852023
OVISE,49766530,-2.0570642495309004
SF268,54618305,6.182660593063807
HCC1143,10385095,1.0799280769088206
Karpas-299,4259181,-0.4823463002937178
PF-382,24772860,-3.0726224407745435
Pfeiffer,JQ-1-UNC0638 (2-1 mol-mol),-1.7119151726586337
CGTH-W-1,24772860,-0.5639974254634832
CJM [Human melanoma],selumetinib-BRD-A02303741 (4-1 mol-mol),6.330992289488057
MOLM-13,24772860,-4.1681928866236415
OVCAR-8,11167602,4.778235565433844
SNU-119,24772860,-1.5346173858714742
EB1,24772860,-2.7839607060978793
HOP-92,4259181,1.0738738060955595
KMRC-3,374536,-1.6331624048909732
786-O,9911830,2.361754210186343
YD-15,24772860,-2.654794947206065
TC-71,753704,4.484790267591646
Namalwa,44493528,4.097758002058851
Hs 729.T,9911463,4.317623145839552
OVK18,9911463,3.86173311118799
RKN,9911463,4.114615883902867
C2BBe1,54618771,1.7187966275352082
PaTu 8988t,24772860,-1.5593380796956875
RPMI-6666,753704,4.417718443958655
HLF,11404337,-1.3063321678597395
P31/FUJ,156414,0.8249508749632878
T24,135659046,4.4485705776291935
NCI-H28,124202324,2.220405996983969
HCC2108,selumetinib-BRD-A02303741 (4-1 mol-mol),4.391486059277941
BT 187,selumetinib-BRD-A02303741 (4-1 mol-mol),6.287083049730917
REC-1,136227924,3.1866861789415855
SNU-1079,11404337,-1.3798089381866616
TE 441.T,151289,1.049398071450078
WM88,4259181,-0.1240754339586
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
Capan-2,sirolimus-bortezomib (250-1 mol-mol),0.8521756904723038
RERF-LC-A1,54618305,5.82239682454832
RERF-LC-Ad2,11404337,1.0614824386793822
NCI-H226,54618771,1.8675416009470285
KMS-20,1716436,2.462007785368903
Detroit 562,327653,3.5229256866831955
SUIT-2,2729026,2.930269762051551
Panc 08.13,2729026,2.9969019730611755
HuH-1,374536,1.710138949682516
SUP-T1,1716436,2.1561518100375627
SNU-1,24753719,3.752863299707876
BT 145,54618305,4.4037541633391735
JVM-3,327653,2.8356821004059967
Jurkat,136227924,2.4803602069258712
Hs 683,136227924,2.524769704566026
Mono-Mac-1,100016,3.734497226962008
SNU-685,2708,5.376251290516726
TUHR14TKB,2708,3.6479814899160954
TE-14,135984461,4.3356196573929
BHY,54618305,5.6036447645776315
NCI-H2141,1716436,2.722494708848303
EFO-21,11485656,3.611716212098542
HCC1569,tanespimycin-bortezomib (250-1 mol-mol),-0.2642860947186173
NCI-H1650,54618305,4.618622661976623
SK-MEL-30,9911463,3.9366573262978473
RERF-LC-MS,10302451,4.085913110869725
A4/Fukuda,11404337,-2.650657466190433
C2BBe1,16013152,3.9012134273154686
L-540,135984461,3.746123506346987
HCC1171,136227924,3.688896594319452
SNU-478,10385095,0.9475992892849324
BT 340,11404337,-1.0592377517699567
NCI-H810,135659046,3.1719200378755055
YD-8,4259181,0.3383272267042485
EHEB,151289,0.953950234753323
SK-MM-2,100016,6.381158442456996
KHM-1B,54639665,4.391144139421017
HDLM-2,11485656,1.650668651442868
BT 271,selumetinib-BRD-A02303741 (4-1 mol-mol),4.979162116038742
SNU-407,sirolimus-bortezomib (250-1 mol-mol),0.8562288670922468
NCI-H2030,124202324,3.552041324911957
ACHN,9911463,3.895747404778365
SU-DHL-8,16013152,3.728195526980079
COR-L279,4259181,1.4928439848867712
OC 314,10302451,3.0087201367098033
K029AX,753704,6.825324025014884
PE/CA-PJ41 (clone D2),10385095,0.9808392410745812
BV-173,4259181,-0.0019973314195643
Hs 294T,753704,4.350033204238196
SK-MES-1,156414,0.4265793069571684
Granta-519,6918638,-1.0102021398050984
FTC-238,374536,2.941610718268421
KYM-1,46926350,-4.230607512102018
JHH-2,2708,4.58932231450951
DAN-G,JQ-1-UNC0638 (2-1 mol-mol),3.242379176839976
NCI-H2405,10302451,2.493326553695985
SW1710,10302451,1.3013355107012203
SW1990,9911830,1.8136131351030251
SCC-25,135984461,2.1535341859506776
SF268,11167602,2.138708916654699
BxPC-3,2708,4.650566781622339
ME-1 [Human leukemia],9911830,2.858593636818479
SNB-75,148198,-3.914832369251688
AsPC-1,2708,5.587707055847425
8-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),0.0897901825982692
SK-N-AS,24753719,3.666987280744212
YKG-1,54618771,1.607640245193468
HT115,sirolimus-bortezomib (250-1 mol-mol),0.8189257476447475
COLO 792,135984461,4.281305530768826
HCC827,selumetinib-BRD-A02303741 (4-1 mol-mol),3.677065802471199
SK-N-MC,44137675,2.2968939325847195
SNU-1076,151289,0.4536585828493739
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
RT-4,11485656,2.1371904728142
TE 617.T,44493528,4.329408184341151
MDA-MB-468,tanespimycin-bortezomib (250-1 mol-mol),0.8210992476411649
COLO 684,4259181,-0.8601005109751864
BT 224,selumetinib-BRD-A02303741 (4-1 mol-mol),6.198486409025932
SU-DHL-8,10385095,0.5850869783930369
SNU-398,3815108,1.724869272694048
JJN-3,54618771,-0.9152585642725306
DB,46926350,-6.06565639942856
WM793,3815108,3.0627718438622487
NCI-H1568,135984461,4.216726883570129
Sq-1,16013152,3.600713390591425
BT 232,136227924,3.5495643934514223
DAN-G,11167602,4.211033544620549
KU-19-19,24772860,-1.0696999794461075
Caov-3,148198,-1.1153010896864872
Panc 05.04,374536,1.776770813433613
ZR-75-1,1716436,2.812770343081025
RS4;11,selumetinib-BRD-A02303741 (4-1 mol-mol),5.8474619315808285
MG-63,151289,0.9705584187460594
LOX-IMVI,136227924,2.635687863612288
MDA-MB-361,100016,6.5281042722822145
SK-ES-1,11485656,2.2128952684348286
SNU-410,4259181,1.1619078924950006
SNU-C2A,selumetinib-BRD-A02303741 (4-1 mol-mol),5.593116453183739
SNU-503,11404337,-0.7009485730992275
OV7,54618771,3.08705703189789
Pfeiffer,54639665,4.400648169756794
SJSA-1,49766530,-1.4703185273344612
SR,16013152,4.311669284733776
L-540,11485656,1.982100275891034
CHP-126,44137675,5.888601311083409
SW48,9911830,1.5953282800372102
MOTN-1,148198,-6.162698623617939
SNU-C5,sirolimus-bortezomib (250-1 mol-mol),1.5938355123050036
HPAF-II,11404337,1.4025289203850997
Li-7,9868037,2.00817394504418
HOS,11485656,1.9269410367905917
8505C,10302451,3.51911742997967
AsPC-1,374536,-1.7506249493921369
22Rv1,654092,0.3290226402009307
NCI-H660,JQ-1-UNC0638 (2-1 mol-mol),1.9918415111583765
PE/CA-PJ49,156414,1.3413488116629748
YKG-1,6918638,1.332910318202703
SBC-5,11167602,1.6319389998554443
SIG-M5,151289,0.8663605917838532
SUP-B15,46926350,-5.387920691541583
KG-1-C,374536,1.2251126143517732
EPLC-272H,124202324,1.9147566569481425
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
WM115,2729026,3.0250773642114175
OCI-AML-5,10302451,3.871014497085743
MG-63,11485656,3.0709685561149076
SK-N-BE(2),JQ-1-UNC0638 (2-1 mol-mol),-0.3862774099886715
Hs 888.Lu,6918638,1.6527379036504295
ZR-75-30,6450551,3.1210162775275783
SNU-1,374536,3.417295861996877
Hs 746.T,2729026,3.0660188808380613
BT 504,753704,4.931350289967595
MCAS,44493528,4.628123206531076
HCC15,11167602,2.587200682435675
MFE-296,9868037,3.862165464380283
HL-60,24772860,-2.652543488310207
NCI-H2029,1716436,2.804955069094506
SF295,327653,3.6466695589164857
MHH-CALL-3,9903786,1.8198372830428096
TOV-21G,1716436,2.4740018250536275
NCI-H1792,10302451,2.867241366253955
Hs 934.T,151289,3.236329442226155
RMG-I,3815108,2.3645022387301244
JHH-4,46926350,-3.8219467951460833
HT-1197,2729026,3.074740900920968
SNU-869,2729026,3.2182764868765017
NCI-H1373,100016,4.430083600999957
Ri-1,3815108,1.201236864182909
MM1.S,327653,2.336208515323047
LMSU,24753719,4.829555677738913
Caki-2,44137675,3.6404364178614976
KYSE-450,2729026,3.1949435983644414
SNU-61,11404337,-0.7844361329588494
NCI-H2106,sirolimus-bortezomib (250-1 mol-mol),0.8781181431398268
PLC/PRF/5,148198,-2.947936464140587
GSS,374536,1.1695844636083927
KMS-18,11404337,-2.191729984555339
OV56,49766530,0.3841868356522632
TCCSUP,100016,6.5110410318476575
Ci-1,49766530,-2.656825005830753
DMS 454,44137675,2.9814722514024217
Capan-2,135659046,4.498205375540461
KYSE-520,136227924,3.1208401396418592
KE-39,10302451,3.0941257531868858
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
SK-MEL-3,49766530,1.022989661604762
Karpas-422,2729026,2.7362492758301187
HCC2218,374536,1.547515633749918
NCI-H2081,11404337,-2.077246389622244
HCC1438,24753719,4.380159840100211
SK-N-DZ,2708,5.617028999751697
MKN74,9911463,3.772186916904206
RL95-2,10385095,1.1225720295363144
JVM-3,24753719,3.3641173434244345
KE-39,11485656,2.227722528153515
A3/Kawakami,54618771,0.7801439877237109
SNU-478,100016,6.124719500368946
GDM-1,135984461,4.082680160500648
SCC-25,11404337,-1.9627814938837227
LCLC-97TM1,2729026,2.4668071198749555
SNU-1,2729026,3.0056530100015793
KNS-42,9911463,4.405771521475071
CMK,2729026,3.0616332169959866
HCC1500,6918638,0.5709126385335386
JK-1,9911463,2.3192555000733197
YH-13,4259181,0.5149162893859401
LNCaP clone FGC,54618305,4.126133237949938
SNU-8,1716436,3.464795989893741
COV434,54618305,4.486199329327327
ACC-MESO-1,135984461,6.029797163877839
CHP-126,148198,-3.388805594241749
IM95,11404337,-0.2020778805418927
HEL 92.1.7,9911830,2.248752452098022
CAL-51,9911463,4.251278022142156
COLO 201,2708,6.910283672182638
DMS 53,10385095,0.6872712876062782
TC-71,136227924,2.205314859996721
Hs 578T,46926350,-4.561402428949595
SNU-387,49766530,-0.0337981818562327
NB1,44137675,2.773157378752232
WM266-4,148198,-3.639294781182272
KATO III,9911463,4.145072857900557
RPMI-8402,11485656,1.7497353972694758
SK-N-SH,327653,2.3985684531965887
MHH-CALL-3,11485656,2.28461838550351
BT 159,753704,6.2082076348270006
HEL,24772860,-2.0205510075596425
LN-18,10385095,1.390416786921598
VCaP,9911830,1.9599655969154228
COLO 678,44137675,4.639385561342904
Pfeiffer,24753719,3.8974563263323145
SR,10385095,0.7110611878101281
Ci-1,135659046,3.670902573768625
SU.86.86,49766530,0.3418469510818301
HT,49766530,-2.438744411324034
CAL-51,10385095,1.0305027810027567
NCO2,3815108,0.944486956694321
Hs 746.T,49766530,-0.4715984788298692
SK-MEL-28,11404337,1.5828408993005263
HCC1806,156414,1.552269130109232
U2OS,54618771,2.9736494040757924
Peer,327653,2.3341587781609405
BICR 18,6918638,-0.187981376082111
EKVX,6918638,2.279509875261518
UACC-62,44493528,4.51687103541405
Hs 888.Lu,49766530,-2.122811696802074
MPP 89,JQ-1-UNC0638 (2-1 mol-mol),1.5024473487873111
AsPC-1,6450551,4.162604073037061
SNU-61,9903786,2.1391845181717373
NU-DUL-1,100016,4.060799847781438
BHT-101,9903786,3.039821260092269
ECC12,4259181,-1.5873031517089868
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485
SK-CO-1,4259181,-0.2853622975740302
DV-90,135659046,3.4000463050083582
Ci-1,9911463,3.2890552525793395
NCI-H2081,148198,-5.584711698479823
SK-N-FI,tanespimycin-bortezomib (250-1 mol-mol),-0.0515208796010249
SNU-308,1716436,5.086826833735244
NCI-H1651,11404337,0.2113643612214112
EN,54618771,2.591553593247422
OCI-AML-2,24772860,-3.745731299088752
HuH-6,1716436,1.234135557259373
HCC366,124202324,2.4845394835739776
ECC10,44493528,3.789717888225728
KALS-1,151289,1.722131739052175
Mono-Mac-1,9868037,1.9108517803242744
HEC-1-A,46926350,-4.023655734151019
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
PC-3,11485656,3.836663422003702
HEC-1-A,2729026,2.912357604536061
RL,JQ-1-UNC0638 (2-1 mol-mol),-1.7514883970513238
NCI-H841,135984461,4.323824309438455
HuP-T3,11404337,1.0495167124251128
NCI-H1581,JQ-1-UNC0638 (2-1 mol-mol),3.003809463739794
PC-14,24772860,-3.422596924284342
SU-DHL-1,654092,-1.6609972231677514
SK-N-BE(2),9903786,2.0499315562907627
M-07e,JQ-1-UNC0638 (2-1 mol-mol),-1.0196845692665113
NCI-H1581,124202324,1.886956743280074
EFO-21,selumetinib-BRD-A02303741 (4-1 mol-mol),4.73165406615872
JM-1,46926350,-6.131969810114727
SNU-410,3815108,3.585710847718894
NCI-H2171,151289,1.4157771037164255
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
SNU-119,9911463,2.8532899111041385
HEC-265,151289,1.0367268145954769
HEL,327653,2.969363674974165
KP-3,135984461,4.664901942241971
COV644,6918638,0.0395517386882894
SW1710,135984461,3.1161178091197863
SK-ES-1,135659046,3.743123640282263
LP-1,9911463,2.6220620880442773
SH-4,54618305,4.155942321597448
NCI-H2196,44137675,3.3056043252593
MKN74,54618771,1.3558742291917982
MPP 89,11167602,2.1738819968252607
AN3-CA,1716436,2.9241172946515963
SUP-T1,10385095,1.0302013641160523
HCC38,100016,6.688694515924342
OVISE,3815108,2.0996140723315913
RMG-I,54618771,1.320928613305781
SCaBER,148198,-2.8787440610496806
SF539,9911463,3.3415175792660854
KM12,16013152,4.369457932947519
AsPC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3046725635070757
KM12,4259181,0.925682230598446
Peer,9868037,0.9246335266521049
U-251MG,24772860,-1.8650444573358
KE-39,9911463,3.415693188275342
BT 145,54618771,1.0324414673710869
CAS-1,156414,1.815264077415652
RD,10385095,1.2570153977648164
BHY,54618771,-0.7807984758131394
Peer,151289,-0.1629508744531414
BT-12,10385095,1.681177963714551
BT 482,1716436,2.8822419772700454
OCI-Ly3,100016,3.877117461004623
HD-MY-Z,374536,1.289019372407008
T3M-10,2729026,2.9193549785403405
NCI-H2170,tanespimycin-bortezomib (250-1 mol-mol),-1.8178915881298592
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
NCI-H1105,2729026,3.007696930177733
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
HCC2279,2708,5.840103583402967
UM-UC-3,1716436,2.73277976251059
NCI-H647,24753719,4.184864317200406
NCI-H28,327653,3.1152294532579523
P31/FUJ,9911463,3.6551866379259743
KYSE-510,2729026,3.215813928876562
BICR 22,9911463,4.403388511465592
SNU-16,374536,2.403293597136798
LMSU,9903786,3.928631993031556
OCI-AML-2,11485656,1.8915689976488803
ZR-75-1,2729026,2.7557963569747805
SK-N-AS,1716436,3.256457603512173
OVISE,135984461,1.6429740508824469
EHEB,9868037,2.9297052804513934
TALL-1 [Human adult T-ALL],654092,-1.4887473556576492
EFM-192A,11485656,2.8514070088200527
SNU-61,151289,1.0402759766313254
DU145,49766530,-0.0443271676579987
CAL-54,49766530,-3.2730005692653803
A-253,selumetinib-BRD-A02303741 (4-1 mol-mol),7.224963739546854
HLF,24753719,3.674130875270684
PK-45H,24772860,-1.7999603047136108
MJ,11404337,2.657052353931515
23132/87,9929138,5.470109790622619
HEC-6,49766530,-2.047471555214632
HSC-2,2729026,3.0278318567671416
HEC-151,135984461,3.687449100902744
ME-1 [Human leukemia],9911463,3.822532388207368
SNU-398,4259181,0.6622148934831026
BT 187,44137675,3.9540199768738846
A3/Kawakami,135659046,2.928957386337573
CAL-51,9911463,4.251278022142156
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
SK-N-MC,2729026,3.0418865586227333
FTC-238,136227924,2.431059366258334
KP-3,9868037,3.7824186326212494
8505C,4259181,0.207440893124338
DLD-1,24753719,4.894891523802126
HSC-4,11485656,2.41592786996926
Hs 895.T,JQ-1-UNC0638 (2-1 mol-mol),2.922041904345165
COLO 800,10302451,4.008038630888801
NCI-H727,124202324,2.79148434895864
SNU-46,10385095,2.8766156258526565
NCI-H1184,11485656,2.662632991644762
FaDu,2729026,3.1243978591839663
HuNS1,9911830,1.8724721971945
ChaGo-K-1,9911463,3.7968497419655094
COR-L279,44137675,0.8796623830361907
NCI-H1563,JQ-1-UNC0638 (2-1 mol-mol),5.111288666521791
SF126,2708,4.749008214312488
EFO-21,tanespimycin-bortezomib (250-1 mol-mol),0.1444768142311704
COLO 792,44493528,4.179590114468014
NCI-H520,124202324,1.8713450531154936
DMS 53,100016,7.1608088069035185
Rh41,24753719,3.827279335828554
U-87MG ATCC,753704,6.993610642373299
NCI-H1793,6918638,1.6746912031469072
SK-MES-1,46926350,-4.205718042329977
NCI-H520,73707371,5.011389013315215
TE 617.T,4259181,-1.3173271639424509
MFE-296,10302451,3.5887459847705996
COV644,9903786,3.8438435409952456
SR,44137675,3.944638371921947
SW948,2729026,3.020599067804879
DOV13,374536,1.1706996668619445
NU-DUL-1,10385095,0.7003289664231471
DU145,11404337,1.4411442495527176
SK-MEL-31,16013152,4.289113074174334
BT 231,selumetinib-BRD-A02303741 (4-1 mol-mol),4.927656372252654
BT 482,4259181,1.1102562042329451
K-562,136227924,2.737847329779252
KMH-2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.760290198732975
G-401,46926350,-4.213486210672068
NCI-H2009,124202324,1.390796248932456
NCI-H1944,54618771,0.5378192056232364
WM793,24753719,4.8266947199238786
HSC-4,54618771,2.9865797342969564
BICR 18,49766530,0.9372744186265172
NCO2,124202324,1.1484680593102412
JHUEM-1,54618305,4.244696493525863
NCI-H1792,9903786,2.6645651408291227
YD-38,3815108,3.839333644300384
DU145,4259181,1.409412257624231
PSN1,44137675,4.954234435115152
G-292 clone A141B1,6918638,1.851561084162043
OV7,2729026,3.0425053430951228
NCI-H211,11485656,1.3378939159503729
G-402,6450551,-1.7863158182956207
TOV-112D,44137675,4.300273258257539
GOS-3,148198,-2.930015056129616
NUGC-4,11485656,2.4536140227741776
NCI-H647,11167602,1.715536193581494
OAW28,46926350,-3.936437112233884
NCI-H460,654092,0.4612941847378306
A-549,9911830,2.245916242551202
KP-2,156414,1.9292190738661952
OE19,327653,3.724127212615087
Lu-99,JQ-1-UNC0638 (2-1 mol-mol),1.3908941119714266
A-172,9911463,3.965281913049293
IGR-39,44137675,4.074660154562018
JL-1,100016,8.572446789328106
Ku812,1716436,3.2496939057778738
MOLT-13,11404337,-0.8509497692060022
HCC4006,6918638,1.1355769823914148
COR-L88,44137675,3.756935364803348
BT 112,46926350,-4.347811941752451
SNU-1041,10385095,2.492918478264542
PLC/PRF/5,9911830,2.188550604148889
OV7,9911830,0.5134876234799554
SNU-668,11404337,0.2383012933548859
UM-UC-1,44137675,3.5628387817150964
Hs 766T,1716436,3.6336693562548863
CFPAC-1,148198,-1.2933950729349923
DU145,2729026,3.1081628566564024
OCI-Ly10,374536,3.355857468631984
COLO 201,44137675,4.296354030889156
BT-549,JQ-1-UNC0638 (2-1 mol-mol),2.8120688111855845
SF268,46926350,-4.290032188214327
NCI-H810,6450551,1.5207467165227238
Hs 936.T,753704,5.008807553432126
SNU-16,tanespimycin-bortezomib (250-1 mol-mol),-3.234515138053412
DMS 79,136227924,2.929954381299975
JHOC-5,9911463,4.507364247607918
SNU-1077,selumetinib-BRD-A02303741 (4-1 mol-mol),4.189870854212877
BT 482,11404337,-1.3517535636718878
OVSAHO,2729026,3.0681643152668445
RL,24772860,-2.421315026712717
MOLM-6,9868037,1.47878958691074
HCC38,24772860,-1.637699125532294
KNS-60,JQ-1-UNC0638 (2-1 mol-mol),2.7251506925666553
FTC-133,4259181,2.1331002918337925
CHP-126,9911830,2.5647606386705566
HCC38,JQ-1-UNC0638 (2-1 mol-mol),0.8349394699375743
HT115,24772860,-2.549539556242631
UO-31,24753719,4.2224866834082135
KMS-18,selumetinib-BRD-A02303741 (4-1 mol-mol),3.721545770561797
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
SW579,tanespimycin-bortezomib (250-1 mol-mol),-2.6338348381850283
KE-37,24772860,-4.048059872778488
RKO,3815108,2.4813915623878264
JM-1,10385095,0.4126425157623973
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
DV-90,44493528,4.133930960270083
TE 617.T,54618771,-2.3163435045847436
BT-549,44137675,4.586830027774197
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
Detroit 562,sirolimus-bortezomib (250-1 mol-mol),0.7815437350354109
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981
BICR 16,136227924,2.8848408076895393
NCI-H2170,10302451,1.7626824552831668
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
Caki-1,9911830,3.4330876709464904
HuH-6,54618305,4.039870782585062
SYO-1,9911463,4.053570521016679
NCI-H1869,selumetinib-BRD-A02303741 (4-1 mol-mol),5.006102326506844
SNU-503,10385095,1.5497117451451905
NCI-H2081,151289,0.7108361073513202
G-361,327653,2.592983282576285
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705
REC-1,9911463,3.153332853315619
NCI-H1299,11485656,2.4848432250614843
KMS-34,753704,4.548298214223671
WM793,654092,0.4910491362613845
OVK18,9911830,3.2751037063298623
M-07e,135984461,4.142111283006845
COLO 201,54618771,0.4783318937698353
AsPC-1,44137675,4.002233175780649
COR-L279,9911463,3.362678282511464
BICR 16,6918638,2.6722716810347205
NCI-H2405,54618771,0.0947860267625534
MOLM-6,24772860,-3.84643520077393
TE-8,44137675,2.9570976748072977
Hs 683,10385095,1.154404132181591
U-CH1,1716436,3.339482090153446
KP-2,9911830,2.158273821155512
ChaGo-K-1,151289,0.8276592767141736
SF126,4259181,0.0859599023411325
WM266-4,9911830,1.496270687043537
CCF-STTG1,6918638,2.2635117256438835
DMS 114,9868037,3.4094491088437633
MPP 89,4259181,0.6927128674187937
HCC202,10385095,1.5376384579545057
NCI-H1693,tanespimycin-bortezomib (250-1 mol-mol),0.5051860079997127
Raji,753704,4.744566564298066
OVK18,11485656,1.7406304929162535
TUHR4TKB,4259181,0.882373605987028
SW1710,6450551,3.447935376393617
MeWo,9911463,3.6919226890378942
Lu-99,327653,3.062690908551929
ZR-75-30,10385095,1.0547762324766166
SW948,46926350,-4.641976408237662
NCI-H1341,11485656,1.4261548687553274
NCC-StC-K140,136227924,1.8113931494957989
BFTC-909,1716436,3.115342072857748
HCC95,124202324,3.246572440274437
NCI-H2087,156414,0.9461657177021514
NCI-H526,327653,2.6188673903561805
SNU-685,4259181,0.9546595561294612
CL-34,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6635750277499894
DMS 53,11404337,-2.5635745994207677
Mono-Mac-6,11404337,-0.9088442855658504
CAL-33,135659046,3.957573500074978
KYSE-140,49766530,-0.5324613674424623
Mino,2708,2.604362376523167
MDA-MB-415,6918638,0.6587420657172316
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
MOTN-1,9911830,1.9978990566511137
JHUEM-2,JQ-1-UNC0638 (2-1 mol-mol),0.8927043841340346
BT 416,100016,4.165407662771479
RCC10RGB,9903786,5.708919982977709
Panc 04.03,374536,2.376032280196277
SH-4,46926350,-4.4629839583417406
NCI-H650,124202324,3.179377931640711
DMS 273,135984461,4.327877942465965
HuH-6,124202324,1.2702789255511149
LXF 289,1716436,2.59582131383783
JMSU-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.751547861818365
JHUEM-7,10302451,1.7373663186818131
OS-RC-2,136227924,4.587923384885118
RL95-2,2708,6.884217656927741
HCC44,24772860,-3.074248032320312
L-428,4259181,-0.74991169769426
HPAC,44137675,5.4512513150593
NCI-H508,11404337,0.8891896977969643
HCC1588,3815108,4.506595750309267
TE-4,11167602,2.9393987233558807
Caki-2,10385095,4.329135402221186
BICR 16,10385095,2.1459054309975523
NCI-H1105,54618771,0.6246243373087411
M-07e,11404337,-0.615837130994534
SNB-75,11167602,3.6380121611156007
HEC-151,selumetinib-BRD-A02303741 (4-1 mol-mol),4.0698233593046735
RPMI-8226,sirolimus-bortezomib (250-1 mol-mol),-1.8682631606171884
KE-37,9868037,1.7348034211084984
COLO 699,2729026,2.7324200580811784
ChaGo-K-1,73707371,4.824221553271621
HCC366,54618771,1.7092661743346285
SF268,135659046,3.3969248782419608
Mino,6918638,-1.9893642721575304
DOV13,4259181,0.7388628793294447
A101D,11404337,-0.7377742007243514
Rh30,9911830,2.2640217333409693
JM-1,6918638,-1.945896791217812
UO-31,9903786,3.174003298065322
BICR 18,44137675,2.8028145896687353
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152
OCI-AML-3,44137675,1.272952344759978
NU-DUL-1,44137675,-0.03549437877124
NCI-H1373,124202324,3.605364319041334
BT 131,JQ-1-UNC0638 (2-1 mol-mol),3.536818996845523
TE-4,2708,4.087180937326526
LCLC-97TM1,124202324,2.4863882679536133
MM1.S,3815108,1.971538783457294
MCAS,9911463,3.99734234256231
SNU-410,9911830,3.211976341536433
A-549,9903786,1.8644448309659765
NCI-H1623,10385095,1.1256497169747182
BT-474,753704,5.766357478861722
KYSE-70,124202324,2.186627813347476
NCI-H1792,753704,4.818178477467103
TE-4,11404337,-1.2952896861413017
KATO III,11404337,-0.4970359765575001
HGC-27,6918638,0.210335220598235
NCI-H841,374536,4.581547708823472
BL-41,9911463,3.564176203754708
SK-BR-3,54618305,4.3856791246446365
BT 416,327653,3.217588277124403
PL-21,9868037,2.018011914645477
SK-MEL-3,327653,3.685418998479267
HT-144,100016,6.638904024373049
BICR 18,44493528,4.352077883289458
LS1034,9903786,3.887461634575776
HGC-27,54618305,4.217377303978183
BICR 22,136227924,2.105383482893856
SUP-T11,156414,0.8844395337826703
Panc 04.03,16013152,4.359497957481629
NCI-H2171,2729026,2.1337054337121466
BT 482,10385095,1.2210220764323911
647V,6450551,1.6995890972009229
Karpas-299,135984461,4.585524824228754
HSC-2,9929138,4.82243538291714
KNS-42,10385095,2.5512346184474444
MDA-MB-453,24772860,-3.354356853525474
KYSE-70,11404337,0.2060464556058333
SCaBER,9911830,3.3117474506944253
SK-MEL-24,11485656,3.6100646887708305
OUMS-23,10385095,2.9007183392939626
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
NCI-H520,2708,5.51683926365148
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
A-253,753704,5.038904579856388
SNU-407,11404337,-0.3690454337107759
P3HR-1,136227924,2.9304577514896466
PaTu 8988s,327653,3.661431131961154
786-O,tanespimycin-bortezomib (250-1 mol-mol),0.0938204565808633
WM1799,sirolimus-bortezomib (250-1 mol-mol),0.8718810301114039
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
NCI-H889,1716436,2.936392023282493
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
NCI-H1435,124202324,2.8430584841923867
HuG1-N,6918638,0.9009310032915192
JJN-3,24753719,4.0858319271855175
SNU-387,9911463,4.312383544863764
PK-1,24772860,-1.503943368507487
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158
SW1990,11485656,1.987828191145096
Aska-SS,1716436,2.2467196259646114
NCI-H2106,6450551,2.052383754230519
PL-21,4259181,-0.9263969170856944
MOLM-6,9911830,-0.7023129144143456
SK-MEL-3,10385095,0.9651343435449692
ES-2,49766530,-3.8492688352561055
SET-2,151289,0.8976963811504413
HOS,selumetinib-BRD-A02303741 (4-1 mol-mol),5.974916837922651
TUHR14TKB,11404337,-1.071885756009756
T3M-10,11167602,2.9337684641616404
KNS-60,124202324,1.624016323449446
5637,151289,0.1049278258777732
NCI-H2228,9911830,3.4174310144841087
OV56,2708,4.624293420738628
SNU-C1,148198,-4.322316579096634
MM1.S,JQ-1-UNC0638 (2-1 mol-mol),0.1865642255881416
RKO,100016,5.817852214634293
NCI-N87,24753719,4.36387060101307
WSU-DLCL2,11404337,-1.1416325362941906
HEC-59,44493528,4.437244076863349
HuG1-N,11404337,-0.1697567004462442
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
AN3-CA,9911463,3.862780684019093
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
Hs 888.T,6450551,3.8608198460330216
IST-Mes1,151289,3.762568892374828
OAW28,1716436,3.318226269910468
BT 245,24753719,4.292609421440975
DMS 454,54618305,4.403504439808318
RT-4,9929138,7.578104590024713
LK-2,tanespimycin-bortezomib (250-1 mol-mol),-0.1134545910607498
JeKo-1,100016,6.219930850058466
MV4-11,11485656,-4.658244572129019
LN-229,9911463,4.132714937024961
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
SK-MEL-31,49766530,-1.960215058686701
NCI-H1838,2729026,2.346465429264529
VCaP,136227924,2.2790218879563255
TOV-21G,46926350,-4.067761686482335
SNU-C1,44137675,3.435804897585521
SW1417,54618305,5.216526082263956
HEY A8,1716436,3.501696943925982
RERF-LC-Ad2,11485656,2.920676874689175
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243
AsPC-1,9911830,2.936776162598985
BT 228,327653,3.1357639702509865
HEC-251,44137675,3.95925133813706
U-BLC1,46926350,-4.262471326245694
NCI-H1155,9911830,2.618743833039648
KYO-1,11485656,2.321902105017357
YD-10B,10385095,1.1055417407476955
NB1,54618771,1.1360692536684358
SW579,49766530,0.2032240599458712
NCI-H2405,11485656,2.273940058944612
SNU-201,54618771,1.5381558224082674
KYSE-520,tanespimycin-bortezomib (250-1 mol-mol),-1.1109729915268285
SNU-8,9911463,4.350153434001515
NCI-H526,24772860,-2.35761928008778
A101D,24753719,4.3282257905645185
TE-4,16013152,4.906129423274357
SNU-308,10385095,3.412893840135653
SW1710,24753719,4.404471197340268
NCI-H1435,4259181,0.804399177362606
KMM-1,10302451,4.497512097117774
CAL-78,44137675,4.687319581983899
Hs 852.T,10385095,0.7954814716288584
HCC1500,9911463,3.4774936591741703
KU-19-19,4259181,2.3072251676522835
SHP-77,124202324,2.846074809652671
DLD-1,11167602,2.7796925101079015
HCC827,54618771,-0.2286942378672794
NCI-H1435,44137675,2.6118874771497342
M059K,136227924,2.883059674155944
GA-10,100016,3.803284916821312
NCI-H1573,10385095,1.001955726752377
SU-DHL-1,9911463,3.067527187401269
BT 231,71729975,0.8289046061054816
TE-4,4259181,-3.177196127545685
ME-1 [Human leukemia],44137675,3.4316726311578365
NCI-H1792,4259181,0.0387421076392515
NCI-H2452,10385095,2.425738192808243
HDQ-P1,654092,0.7882588687291454
JL-1,6450551,3.699633089041984
SW1271,148198,-2.630785543453804
SK-N-SH,10385095,0.0454755158879893
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576
NCI-H1793,11404337,1.9243754153186607
RT-4,24772860,-3.0358788359895543
639V,1716436,3.7400216023915434
BT 330,374536,3.220978821427871
Mino,46926350,-6.0874143472177105
SK-OV-3,4259181,0.9080230343390464
42-MG-BA,24772860,-2.6994895821327782
EFM-192A,24772860,-2.4416951970012932
JURL-MK1,374536,-1.513115093700493
NCI-H1792,1716436,4.298967705308985
DB,6918638,-1.1770450338568663
COLO 829,16013152,4.309942056064194
EC-GI-10,4259181,1.6950184604495684
EKVX,11404337,-1.1482953673467733
OV7,49766530,-5.15064199643512
NCI-H2141,9903786,2.15851319161548
2004,2708,5.402710550781194
SK-MEL-2,2729026,2.9654254504210296
LCLC-103H,10385095,1.2650204488740564
RERF-LC-MS,1716436,4.437154842045929
RL95-2,4259181,-1.9396193877623535
KNS-62,24772860,-2.0568015195972458
IM95,148198,-3.3737610727905056
COV434,JQ-1-UNC0638 (2-1 mol-mol),0.2859435042143003
VCaP,44137675,3.0959256502494625
WM983B,9911830,2.107261735137238
MCAS,24753719,3.982586102388834
AGS,2708,5.6312935034283
Hs 766T,11485656,2.6459826736539376
T24,327653,3.499336447271142
LK-2,54618771,0.9625218695691432
HD-MY-Z,156414,1.5591920607935952
PSN1,100016,3.987578982943132
PE/CA-PJ41 (clone D2),11485656,2.035669448740327
NCI-H1755,11485656,2.6347035901065654
SKM-1,24753719,3.966974937988049
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
IMR-32,6918638,-2.6640844779638244
CGTH-W-1,4259181,-0.763565573127493
LUDLU-1,1716436,3.748952832547232
COLO 678,54618305,4.289136510205439
Ku812,753704,4.676427896259273
EKVX,9911463,3.45817686520516
OVSAHO,654092,0.3663371242990512
NCI-H2196,135659046,3.3895978567837073
LP-1,JQ-1-UNC0638 (2-1 mol-mol),-1.7651848226430418
NCI-H1694,9911830,2.67356882591853
DND-41,136227924,1.87568318170164
NCI-H211,49766530,-2.3844555763934707
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
HGC-27,9929138,5.812966492872734
SNU-119,4259181,-0.8929687482279648
QGP-1,9903786,2.781324092534045
HuH-28,11485656,3.308019517544549
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
RPMI-8226,9929138,6.391388582144063
NH-6,9903786,1.6690533510154009
HD-MY-Z,6450551,2.872544030844523
L-540,10385095,1.0338327990377625
MOR/CPR,151289,0.7265783100580379
NCI-H810,9911463,2.4681079610517394
BHY,44493528,4.130126082796934
NCI-H196,11404337,0.5983725190796483
GI-1,JQ-1-UNC0638 (2-1 mol-mol),0.1681383324339191
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
NCI-H889,124202324,0.843883098435538
Hs 729.T,135659046,4.671594069025629
DMS 53,44137675,3.684241689008083
HMC-1-8,654092,-0.8956517941240419
HCC1419,16013152,4.204291173642249
U-118MG,753704,5.035523919498925
G-402,4259181,1.0577669619122276
GaMG,JQ-1-UNC0638 (2-1 mol-mol),2.708397895774386
HOP-62,100016,6.313498249886369
HCC1954,374536,2.555483406120198
SNU-886,49766530,-1.8017914460493445
697,11404337,-3.514095221219387
HCC1171,327653,2.9925965105482737
MCAS,44137675,2.939638990664671
JHH-2,tanespimycin-bortezomib (250-1 mol-mol),1.6682234532456457
DLD-1,327653,3.308553284717408
SNU-C4,136227924,2.9928621999202467
SU-DHL-8,44137675,3.243313020766357
Mino,44137675,2.4793232831617944
NCI-H1395,44493528,4.373197971838804
L3.3,11485656,2.040790548836277
BT 131,selumetinib-BRD-A02303741 (4-1 mol-mol),5.021792990803708
SNU-398,156414,3.5585517115959395
F-36P,148198,-5.732875507822739
HT115,24753719,3.8979668457059873
NCI-H2085,1716436,2.106701222841103
OVSAHO,135984461,5.613445307833131
HOS,9911830,2.3433546648440275
SNU-1066,24753719,4.394571548693749
Mel Ho,2729026,1.1040426705433388
SK-N-FI,9903786,1.217997719739724
T84,136227924,2.5199027398538707
HeLa,374536,4.0035832763140995
SBC-5,3815108,2.9831729144642956
CAL-27,6918638,0.7140007001592554
CCF-STTG1,10302451,5.711005870244634
DEL,156414,1.3129358492392238
BT 112,11485656,1.9046121738712176
BT 428,9911463,3.0361887786890693
RD,24772860,-2.349116754181968
YD-8,327653,2.805787909326678
JHUEM-7,9903786,1.8726211891462523
BT 286,9911830,2.3367947096317927
Hs 940.T,JQ-1-UNC0638 (2-1 mol-mol),0.5665392809799625
JK-1,100016,6.141145240463154
KYSE-30,136227924,3.298083829392356
WM793,1716436,1.7539283172933289
SW579,54618305,4.4190036596404925
OVSAHO,374536,1.2747809253561495
BT 179,44137675,3.3660623856799035
UO-31,135659046,3.3569813740472267
NCI-H716,6918638,0.7980253522475573
Calu-3,44137675,3.046251908081422
BEN,2729026,3.2288794951502333
SNU-1196,327653,3.765750014421376
BT 187,1716436,2.5353668200506405
PE/CA-PJ15,9911463,4.11474968197752
HPB-ALL,151289,0.3034060370797204
SW982,24772860,-1.921963855915912
SEM,2729026,1.911580026509944
639V,54618771,0.9699506907820744
DMS 273,JQ-1-UNC0638 (2-1 mol-mol),0.3284926048856003
CJM [Human melanoma],11404337,-0.6079802482567472
Daudi,10385095,0.347773175212431
Lu-99,1716436,3.2192530152962626
HEC-251,9911463,4.214524932841787
BT 482,2708,5.160910334854844
NCI-H889,6450551,2.2960181544581912
Kelly,10302451,3.349528438105202
RPMI-8402,11404337,-1.8259507324161124
LoVo,374536,3.1459286411718055
SNU-1041,24772860,-0.8525392758250607
Ku812,135984461,1.927355885078453
SW1088,374536,4.25830525974367
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
AML-193,54618771,0.4173774880605814
OCI-AML-2,6450551,1.017413752580538
ES-2,11404337,1.4427511575724656
U266B1,11404337,-0.4739361104309206
U266B1,49766530,0.1325204149265123
EPLC-272H,9929138,6.961893442416843
HD-MY-Z,6918638,0.9232072898358828
SF539,selumetinib-BRD-A02303741 (4-1 mol-mol),4.342387271248252
Hs 895.T,9911463,4.380073854320694
253J,100016,6.267948749211356
CAL-12T,54618771,2.0833735357091077
Becker,1716436,3.8374444305943514
G-292 clone A141B1,9868037,4.069169616789992
NCI-H2126,54618771,2.112004674949257
SNU-1033,136227924,2.5540912421490387
SNU-601,6918638,1.0757828818218795
CL-11,327653,3.118050165737185
JJN-3,148198,-4.237204763630457
F-36P,6450551,1.828299759657417
HCC1428,4259181,0.4892648147549973
Hs 888.T,9903786,1.8376079408341344
SNU-869,9903786,4.230852859752073
HGC-27,11404337,-1.4323340614808602
NCI-H2170,54618771,1.1991545038550235
639V,2708,4.249221660403493
QGP-1,44493528,4.309319516194894
MOLT-3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.707057457928699
EM-2,24753719,2.7416621660310767
YD-10B,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.1658594622992005
BxPC-3,654092,-0.3546902897816355
COLO 792,JQ-1-UNC0638 (2-1 mol-mol),0.6700886390868303
SW948,11485656,1.7814283284456571
GP2d,6450551,1.298037230241124
OUMS-23,sirolimus-bortezomib (250-1 mol-mol),1.7172624252600015
KMS-26,2708,2.401901430039457
NCI-H2087,2708,4.08112740143676
SK-BR-3,151289,1.0234996498381732
SNU-626,654092,0.4669198120386104
KMS-20,JQ-1-UNC0638 (2-1 mol-mol),-0.883173015839936
SU-DHL-10,44493528,4.09014780948348
SF126,3815108,1.9954302504257757
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084
KMS-26,2729026,0.5474788672880985
JHH-1,sirolimus-bortezomib (250-1 mol-mol),0.3653196480685532
NCI-H1792,11404337,0.0016171974821283
RERF-LC-A1,753704,5.469921396897314
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
SNG-M,sirolimus-bortezomib (250-1 mol-mol),0.843195777913948
U-BLC1,49766530,0.1451945306283898
L3.3,124202324,3.558321901620073
SK-N-AS,10385095,0.6911222834259994
SYO-1,46926350,-4.350284338424305
MHH-ES-1,327653,2.792753552455636
BT 145,46926350,-5.338638424430291
LS123,374536,2.7980169954073757
Hep 3B2.1-7,6450551,2.1727853612128394
GI-1,136227924,2.879759291125734
DV-90,10385095,0.6570221400102684
NOMO-1,148198,-5.33573798573566
JHH-5,9911463,2.4505780103780563
ACHN,4259181,1.2233693378983428
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
SNU-387,11485656,1.781894419315086
SNU-213,54618771,0.1807958320323681
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
BT 159,24772860,-1.2224078898665365
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402
RPMI-8226,9903786,1.7655422214301637
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196
HCC827,10302451,-2.500583972750256
NCI-H2052,11485656,3.009511423148426
KMS-34,9911463,2.3879833599840934
NCI-H1623,374536,0.6337427379168257
Karpas-299,9911463,3.0084205212852724
NCI-H358,9868037,2.709462311550209
NCI-H292,2708,4.789540620747355
PE/CA-PJ34 (clone C12),9903786,2.211143495082886
TE-6,124202324,2.8251213442472256
BT 359,44137675,4.852697619977082
SK-MEL-3,9911830,2.957131772222056
A2058,10302451,3.911777548937271
769-P,2729026,3.129717387324291
EM-2,2708,2.8295072845715867
SNU-C2A,10302451,2.484478658072876
EJM,1716436,2.8546888693070818
ACHN,327653,3.2830997989663566
SNG-M,327653,3.199895940413603
ONS-76,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0736426571342059
Granta-519,4259181,-0.7648884727300508
L-428,10302451,3.6101692915617303
MOLM-16,9903786,-0.0890634921772537
JHUEM-3,selumetinib-BRD-A02303741 (4-1 mol-mol),2.5511489796807
A-549,2729026,2.9601859660531105
DV-90,148198,-5.605719832518081
MOLP-8,4259181,0.2540996075245788
SNB-75,6450551,3.508075997734575
NCI-H2087,327653,2.6573092193564665
TCCSUP,24772860,-2.3994622500716503
LP-1,6450551,1.5102038696536717
THP-1,156414,0.8804557135559825
SNU-1079,9911463,2.811910172991152
P12-Ichikawa,4259181,-1.1700719944860911
HCC1954,151289,0.7542277118901753
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
AU565,46926350,-5.126810871510528
SNU-869,54618771,1.00410575890065
Hs 688(A).T,10302451,3.7061911654839816
TE-15,10385095,0.8889950613802687
SH-10-TC,24753719,4.195244142324667
HuNS1,2729026,2.0878998091198846
RMG-I,654092,-1.692324548352683
SNU-601,4259181,-0.4833088686637755
CAL-120,136227924,2.519967645750226
GCT,11404337,-0.3437943087587521
KP-3,24753719,4.638034647169119
TE-5,sirolimus-bortezomib (250-1 mol-mol),-0.3603080832286391
UACC-257,148198,-2.410232304331187
U266B1,11167602,2.309921698105226
GaMG,151289,2.4526520293571807
BL-70,135984461,4.106594232964942
G-361,54618305,4.649093637663993
SK-MEL-2,11404337,0.550817025493175
HPB-ALL,54618771,-0.7909644269662123
NCI-H2029,6450551,3.0574636743787225
ST486,11485656,1.65014245999224
GMS-10,44137675,3.685879451339411
NCI-H1869,6918638,1.090174259453097
DMS 454,11485656,2.8091900448674196
TYK-nu,4259181,0.6188832613269896
SNU-C5,54618771,0.8135546853425193
OVTOKO,11485656,2.8396644957108923
SNU-407,11485656,1.7989255802763466
LP-1,16013152,3.391607745925794
Calu-6,24772860,-1.5502584327968172
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678
SNU-1105,11404337,0.7156656202798479
8305C,24753719,4.566230945327615
SNU-119,136227924,3.0573258202750253
KMS-11,136227924,2.4847849493179406
KMS-34,135984461,4.175936368885124
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
LCLC-97TM1,374536,2.574075324433214
HT-1376,2708,5.152410367592072
HEC-6,3815108,3.650512361424165
SNU-387,11404337,1.3618084362793803
PF-382,654092,-2.265760863591032
CL-11,3815108,3.453360863089368
SHP-77,10385095,1.0239488478640744
RPMI-6666,148198,-3.3774260453354015
HCC4006,9911830,1.6135942696828955
SK-MEL-28,4259181,1.166453283270818
CADO-ES1,4259181,-1.6015743983343371
NU-DUL-1,10302451,1.4160930813102384
BT 228,11485656,1.932859050078464
PE/CA-PJ34 (clone C12),54618305,4.348682714943588
LUDLU-1,374536,2.1914267035458175
253J-BV,54618771,0.8699065308229518
LN-18,100016,6.511039950794577
Mino,374536,1.2898948128821337
Capan-2,9911463,3.916008821715387
WM266-4,4259181,0.7940608146362106
NCI-H211,9911463,2.7267014601738575
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412
HCC202,54618771,2.3790685785467964
SW1710,1716436,3.5789524312084233
HCC44,11167602,1.0616844624356492
DMS 454,selumetinib-BRD-A02303741 (4-1 mol-mol),4.499273918619134
CAL-51,3815108,3.0623029951861396
LOX-IMVI,2708,5.37123157466964
Panc 08.13,10302451,2.252874393046268
HuT 78,11485656,1.3035734242835073
KMS-28BM,24772860,-4.367450009622082
SNU-668,24753719,4.518564993175217
SK-MEL-30,11485656,2.585249816423364
HCC2279,151289,0.8325609255931475
NCI-H2444,9911830,3.5265930099912017
BT 340,327653,3.529753308565155
KMRC-1,9903786,4.024109374851969
JeKo-1,24753719,3.5760839503149873
COLO 205,2729026,2.721293495605007
RL95-2,9903786,1.393609544351605
T84,753704,4.360093650278708
GDM-1,654092,-1.6359740537068057
MOLP-8,100016,7.090961588333011
LN-18,44137675,4.423406892864545
GCT,sirolimus-bortezomib (250-1 mol-mol),1.1354554226801
NH-6,54618771,1.535066774557613
A-549,44137675,4.013710884820414
SNU-C1,9903786,1.6227295920089169
CAL-29,10302451,1.6338243981500025
SNU-1077,10385095,2.8092985891088444
Hs 888.T,1716436,1.9821752580044991
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
NCI-H929,9868037,2.724281418576466
EM-2,136227924,2.1746228564853864
PE/CA-PJ34 (clone C12),148198,-4.8428586798807265
SU-DHL-8,44493528,3.935387311306229
NCI-H2087,49766530,-1.9829819346209112
SF268,44137675,4.403137137127122
Toledo,11485656,1.9100858445006503
KMS-11,151289,0.0007214149150021
IM95,9911830,1.757633783471113
HGC-27,16013152,3.670809937068983
SET-2,24753719,3.747338164648229
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
JHOS-2,2708,5.40501545651502
YAPC,44137675,4.160217990140765
ZR-75-1,11485656,2.2776825234983087
SNU-1214,148198,-3.317197477709626
NCI-H1838,10385095,1.4314827828981946
YH-13,374536,3.765039330811098
Hs 578Bst,135659046,3.7214456124706543
8505C,135984461,1.800698479354495
MOLP-8,24753719,3.861578571306771
RD,16013152,4.213516299034048
P-STS,4259181,0.7192752907491521
HuH-28,124202324,1.7729081186139335
RL,136227924,2.481613482211788
VM-CUB-1,3815108,3.406704428732013
HEC-6,44486093,3.78046192996842
TE-6,JQ-1-UNC0638 (2-1 mol-mol),2.52168563955839
BT 164,1716436,2.4327241056471425
NCI-H1581,44137675,2.733587106471521
Ki-JK,6450551,0.9492270969951898
IGROV-1,10385095,1.0670946713416192
HEC-251,tanespimycin-bortezomib (250-1 mol-mol),0.0186342591611023
COR-L105,11167602,4.878993593502554
A-549,24753719,4.621771717936227
SNU-119,11485656,2.5966291939022192
RERF-LC-A1,136227924,2.978723056085531
SK-BR-3,374536,-1.7923241970053383
CJM [Human melanoma],49766530,-0.5091083947600985
UM-UC-1,49766530,3.4095372136602147
HCC1143,374536,1.384467639208202
U-118MG,148198,-4.8447991211514685
A-673,151289,0.5990139557366498
CAS-1,tanespimycin-bortezomib (250-1 mol-mol),1.4677187949031796
SET-2,44137675,2.73543784848982
SHP-77,151289,0.6589095173046445
RT-112,sirolimus-bortezomib (250-1 mol-mol),0.4814883462366654
PL-21,374536,2.1392581024511657
HCC1833,9868037,3.329588957496932
A-375,124202324,2.6101978787823223
GP2d,2729026,3.232429489761131
NCI-H520,11404337,-0.911000559838952
TF-1,374536,-3.028230632879563
BT 147,44137675,4.184709820084355
A2780,100016,4.757543521992015
Fu97,11485656,0.7885414844371695
COLO 668,selumetinib-BRD-A02303741 (4-1 mol-mol),5.572397944872751
KMS-18,9868037,2.273728459676758
COLO 699,9911830,3.503135242779156
G-402,1716436,3.4544112939801543
C2BBe1,54618305,4.283741235825971
SF126,54618771,1.1174524755985609
U2OS,10302451,3.9149293289232343
IGR-37,54618771,0.3967957480696406
SUP-B15,54618771,-0.7938935218437335
SNU-C2A,44137675,3.472575790162701
SNU-620,JQ-1-UNC0638 (2-1 mol-mol),-0.5954680759755305
MeWo,2708,4.799521102123656
BT 179,sirolimus-bortezomib (250-1 mol-mol),0.6409612230554944
BT-20,100016,6.680150665921765
WM88,9903786,2.087799458877892
VMRC-LCD,9911463,3.586787073438602
OV7,10385095,1.1258332285506143
NCI-H1650,9911830,2.190997122296158
OS-RC-2,753704,5.098155824831672
NCI-H226,374536,0.6765765515793748
HGC-27,327653,2.307850951814526
RERF-LC-A1,49766530,-2.6105960143319487
RPMI-8402,136227924,2.2526718879349694
NCI-H322,6450551,4.121131305277266
HCC1954,sirolimus-bortezomib (250-1 mol-mol),-8.401031472525755
SKM-1,1716436,1.3420802961199974
NCI-H2126,44137675,4.018590769938772
MDA-MB-157,135984461,1.8807242402896556
BT 248,1716436,2.58950342299198
NCI-H929,9903786,1.9183912305018265
NCI-H660,135659046,3.42543751190604
NCI-H2081,9911830,1.4932773015429426
IGR-37,151289,0.9445598463800874
MOLT-16,6450551,0.8501924748294045
PLC/PRF/5,6918638,0.9074037907911854
OVISE,753704,5.218614122812972
EFE-184,selumetinib-BRD-A02303741 (4-1 mol-mol),6.264327341620771
G-402,11404337,-0.2966965164109829
SNU-761,10385095,2.457168715913424
OCI-Ly19,24772860,-2.992612872916111
OCI-AML-3,9903786,2.1236549190588097
HEL 92.1.7,1716436,3.087424910848658
HCC1588,1716436,2.845840578958635
RCH-ACV,753704,6.389654405522462
OVK18,10302451,3.76566042423923
CHP-126,24772860,-4.213615773797708
OVSAHO,44493528,4.8098678105580674
HCC38,54618771,2.492060866479401
BT 416,2708,3.2848788777475755
JIMT-1,148198,-2.4064236907207786
IGR-1,10302451,3.763998441817216
KP-3,54618771,0.4281141975114925
OC 314,9903786,3.545915763256713
NCI-H2030,100016,6.672614959068411
DMS 53,327653,2.8933864584670217
YKG-1,24753719,4.608335607306647
NCI-H520,54618771,1.0653077757718592
TE-6,9868037,2.429153883082853
EHEB,10302451,2.5081035375606295
HDLM-2,9911830,3.146801382603546
NCI-H2052,10302451,3.419992680957008
FTC-238,JQ-1-UNC0638 (2-1 mol-mol),2.371356889788982
SK-MES-1,24772860,-1.2690024047047594
CHP-126,9903786,1.6217083088403044
LN-229,54618771,1.209787731976597
SNU-869,156414,1.5646436752769155
MKN74,9911830,3.231160876799454
EM-2,11485656,1.7010188292526576
AML-193,151289,0.234280169646735
BT 248,9911463,2.7908107916357436
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
Mino,24753719,3.6621526674985416
OCI-AML-3,9911830,1.5756891476630688
BFTC-905,9911463,3.2243947261734114
NCI-H2085,10385095,0.9549878752429372
D283 Med,46926350,-5.859080576387131
OV-90,4259181,0.8863073345893967
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
NCI-H1650,156414,1.3380397033219464
SK-BR-3,100016,6.79119351825136
BT 179,16013152,4.709101446855322
SNU-8,654092,-2.3977544496906624
NCI-H747,11485656,1.912245155570418
KMS-28BM,124202324,0.8141037205027928
JL-1,49766530,2.587242207366064
KYSE-450,11167602,4.298081277499996
EB1,2729026,1.7822006488511937
HCC2935,9911830,2.2154288658991597
RVH-421,54618771,0.9846410856532696
HCC1195,24753719,6.180231383527519
SF295,124202324,3.278195850827405
DV-90,11485656,1.6337920005269289
NCI-H522,24753719,5.009376195679754
RERF-LC-A1,9903786,4.61839139463389
OCI-Ly3,151289,0.7395782323156547
NCI-H292,124202324,2.857386903129287
WM88,6450551,3.000697940838796
NCI-H1341,2708,3.2909336525008293
OCI-AML-5,374536,1.0007173198232775
OAW42,54618771,1.2241554078015442
NCI-H889,327653,2.919177288427523
MOR/CPR,54618771,0.4872515527398967
Ki-JK,sirolimus-bortezomib (250-1 mol-mol),-5.576010633092176
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116
HT-1376,54618771,1.723140489486428
SK-N-DZ,44137675,3.3782607289666524
Kuramochi,136227924,3.2782581577037964
SNU-216,46926350,-4.054835664798021
NCI-H358,124202324,2.6802951319777373
BT 145,2729026,2.820371306946128
Daudi,6450551,1.0042642679666238
JHH-6,tanespimycin-bortezomib (250-1 mol-mol),2.875959809379233
NCI-H2444,10385095,2.9742620314108255
JHUEM-2,124202324,2.514541541001261
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
BT 333,753704,5.259573686612156
TOV-21G,6918638,1.3242301911997263
SK-N-FI,100016,6.445734787344034
Rh30,2708,3.4393006223316744
NB4,54618771,-1.2377399281525494
CHP-212,156414,1.607333676424714
KMH-2,100016,3.8705403745512017
SNU-182,654092,-1.6698737771311911
HCC38,4259181,0.7320315366357028
U-251MG,49766530,1.0855724910741882
BT-16,10385095,1.306973954118471
U266B1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3369747384808495
HDLM-2,654092,0.8598005315948002
Mel Ho,24772860,-1.489285832764918
HT115,148198,-3.4561057287776653
Hs 729.T,46926350,-4.15521024826416
U-251MG,148198,-4.2062260455061535
GDM-1,9911463,2.550889213910243
KMH-2,124202324,0.6842828421146526
KE-37,136227924,2.0912429237758796
RT-4,11404337,1.401838262846579
HT-1080,6918638,0.2598453428268436
SW1990,156414,1.6914107782596666
RCC10RGB,11167602,3.5267453541831695
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
NCI-H2444,2708,4.83086540968755
SW982,9843750,4.310456758406852
SNU-719,10385095,1.1651309868833004
NCI-H661,9903786,4.646166413465223
IST-Mes1,9903786,2.7623614356082458
NCI-H2106,2708,4.612208599682051
CHP-212,2729026,2.2835805648547742
KE-97,374536,1.5304894333418524
CAL-78,9911830,2.1826660302701058
JHUEM-1,148198,-4.791795021050916
G-292 clone A141B1,2729026,3.2555844339939095
SUP-HD1,9911463,3.4202590539145836
KYSE-510,24753719,4.343319490515707
Kelly,11404337,-0.935685652893764
SNU-C5,49766530,0.4105480750830131
CCF-STTG1,10385095,1.287783842967002
U2OS,100016,5.485609538675787
HCC4006,135659046,3.6436381784680494
KYSE-30,16013152,4.94293089584889
TYK-nu,selumetinib-BRD-A02303741 (4-1 mol-mol),4.021411554483099
Calu-3,1716436,2.9642563351634807
LS513,4259181,0.279340511847143
FTC-238,44137675,3.740192168130054
Panc 04.03,9903786,4.611047286699123
UO-31,100016,6.129898752942045
NCI-H2110,10385095,0.9459448618339928
NCI-H1299,9911830,3.0840556106234653
NCI-H2170,1716436,3.6231575838179473
Hs 688(A).T,2729026,3.120587075849194
NCI-H929,49766530,-2.4737600180853385
A2780,327653,2.026169684275287
TC-71,151289,0.7196413570938871
NCC-StC-K140,151289,0.1414375705342119
TE-5,44493528,4.238536644603732
SW1116,11404337,-1.048062477762995
OV-90,54618305,4.337650139847183
JMSU-1,136227924,3.0914793862161747
IST-Mes1,374536,3.187270781803884
HCC366,10385095,2.3646693511925214
HCC1428,49766530,1.5674588812368278
KYSE-70,148198,-2.193158047226166
DB,9903786,1.8629742307315609
L-428,148198,-4.114855824463333
NCI-H1339,44137675,3.1401606981690646
TUHR4TKB,10302451,3.4604204193373387
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
HOP-92,9911830,1.5727433833284383
MHH-NB-11,4259181,-2.6012580075129494
U266B1,2729026,2.9616385766500493
DAN-G,1716436,3.859098453592593
IGROV-1,49766530,-0.195540678413639
NCI-H522,100016,6.692385014202011
L3.3,2729026,3.1026966432102863
Kasumi-1,10385095,0.9710021907970404
SNU-601,1716436,2.9730225023765953
A101D,54618771,1.2420685416826056
SUP-B15,10385095,1.069894879797162
TT2609-C02,6450551,3.061777788585352
YD-38,24772860,-2.3179042011152355
SR,148198,-2.916135396785668
MG-63,49766530,-2.6108444064120686
OCI-Ly10,10385095,2.1916577267775006
MHH-CALL-3,3815108,1.911121361906249
L-428,753704,4.544734972897839
A-375,1716436,3.1281155383353556
EFE-184,156414,6.238077429363588
8-MG-BA,9911830,4.587743718068256
TTC-709,2708,4.813026515837837
SK-N-FI,327653,2.9446631388146383
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
Becker,11485656,3.616159279519061
RPMI-6666,374536,2.3397569996880514
Panc 03.27,2729026,3.0654719444491554
SK-N-SH,44137675,2.5276726665822755
Calu-6,11404337,-0.8915888703545986
AM-38,11485656,3.1018952301837155
SW1710,2729026,3.284219030750959
HuP-T4,124202324,1.528661037842092
A3/Kawakami,10385095,0.4168450235753773
KYSE-140,11404337,-0.0921040105213257
COR-L51,tanespimycin-bortezomib (250-1 mol-mol),-1.1077118907846166
Kasumi-1,49766530,0.877947367225252
VM-CUB-1,10385095,1.1194240757711134
ONS-76,100016,6.019166856387977
TE-4,10302451,0.8279627071260693
RCC10RGB,24753719,5.18895385781671
HT-1080,10302451,3.8413298591430247
AU565,44137675,3.533476650788096
C2BBe1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.6108414428394
WM88,11404337,0.2884415241135956
COV644,4259181,0.9348750432369554
KYO-1,136227924,2.5889716651569614
MHH-ES-1,148198,-5.108564856367707
Hs 944.T,JQ-1-UNC0638 (2-1 mol-mol),2.95953416238611
GI-1,6450551,3.117270375332117
NCI-H446,3815108,3.0217170106537283
Lu-99,24772860,-2.6821215713062947
SU-DHL-1,49766530,-4.824875359994143
P3HR-1,2729026,2.5966857903671032
CCK-81,100016,4.4296308435579554
RERF-LC-Ad1,11404337,1.7320849295693297
SNU-475,148198,-3.401436847771516
NCI-H2087,4259181,-0.0076353302505686
LC-1/sq-SF,1716436,4.350365957206059
SNU-119,3815108,1.8360895016279837
DMS 114,11167602,2.9651501039197385
AU565,4259181,-0.781957409712965
TCCSUP,11404337,-0.4859326706611666
BT 328,9911463,3.726223215474182
KPL-1,654092,2.372810826307559
Li-7,9903786,1.4917500852360135
SK-N-FI,4259181,-0.7300767100983097
JeKo-1,151289,0.3743876727186704
A-375,1716436,3.1281155383353556
GDM-1,11485656,-1.9414124993158248
YD-8,11404337,-1.7651477779753342
MHH-CALL-4,327653,2.3339923757908028
Hs 683,10302451,3.704535359284315
KE-39,156414,4.025830312298652
JHUEM-3,135984461,1.6896934055741442
COLO 668,10385095,1.0235931260248912
NCI-H1944,327653,4.691187068736962
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
MOLT-3,9929138,4.064754061766862
BEN,4259181,0.1509293562542142
BT-474,44137675,3.8167632328478343
BT 139,10385095,0.5327849644676411
A-549,3815108,3.3223520761089937
T98G,54618771,1.1759260656480666
U-118MG,10302451,3.818968943715853
FTC-133,16013152,4.199465293191842
SNU-466,24772860,-2.303285143000836
JJN-3,44137675,3.886328573561134
HEC-151,10302451,3.224057282004677
LN-18,sirolimus-bortezomib (250-1 mol-mol),1.6485166407126024
NCI-H929,327653,2.3561667456594986
SK-MEL-28,3815108,3.819854777392354
SK-ES-1,16013152,4.188069793461146
NCI-H28,4259181,-0.5153819717152983
NCI-H146,2729026,1.2131739481587438
MOLM-6,11167602,1.1493810873642791
WM266-4,46926350,-4.608642735903853
OCI-AML-2,4259181,-1.46222192980106
Hs 611.T,73707371,4.8158547045226605
BT 231,327653,3.38465300707193
Hs 766T,JQ-1-UNC0638 (2-1 mol-mol),-0.988028643129068
HT-1197,148198,-3.334872937201218
NCI-H2405,2729026,3.00734287599657
SNU-201,753704,6.85124399622587
NCI-H747,100016,6.898929440027426
NCI-H2141,44137675,3.3995034631285472
CML-T1,9911830,-1.528510322337235
HuG1-N,2708,5.795781149620577
WM793,11404337,-0.7690985454206903
AML-193,1716436,2.357068271611697
HCC827,3815108,2.5741213333743813
RERF-LC-MS,10385095,0.7812016081678173
LS123,135984461,1.5979297518000015
COLO 320,46926350,-3.597722849680177
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
SK-N-BE(2),6450551,1.7815571518717288
NCI-H2228,selumetinib-BRD-A02303741 (4-1 mol-mol),3.35496746895886
639V,10302451,4.153653577935064
MOLP-2,11404337,-2.275467470037822
Panc 05.04,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3819086148277078
NCI-H1623,2729026,3.210868522276231
DU145,9911463,4.064467262158392
L-540,16013152,3.29822317625127
RPMI-8402,374536,1.7667437897249685
TE-14,136227924,3.1216716097465365
G-402,54618771,0.638636579266015
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
NU-DUL-1,2729026,1.8294339366794576
OAW42,44137675,4.364942945062635
COLO 800,44137675,3.68003122180458
COR-L105,24772860,-1.435746068442861
NCI-H2172,44137675,4.33723657992909
L3.3,374536,1.2868097755844614
COLO 668,6918638,-0.3397215553853323
NCI-H2029,tanespimycin-bortezomib (250-1 mol-mol),1.6756703480673036
HuT 78,16013152,3.8354573431378185
BT-474,327653,3.3375355192094025
SW48,4259181,-1.8199657809061969
HuT 78,374536,0.782001012085031
OVSAHO,sirolimus-bortezomib (250-1 mol-mol),1.2333727480896128
Namalwa,1716436,3.476053043060672
OVTOKO,1716436,3.092374095872758
SNG-M,10385095,0.7800412283889386
KMS-20,156414,1.093109837922788
TE-4,156414,-0.7706955367597111
SNG-M,9929138,6.049726158148494
MOR/CPR,374536,0.9958456867984684
DEL,11404337,-1.8098726855093707
TTC-709,135984461,4.327447366032638
DU145,151289,1.500711267308436
COLO 668,2729026,2.488132581964294
OVCAR-4,4259181,-0.8572472959044465
Rh18,49766530,-3.897407053636511
Aska-SS,11485656,2.660522165344914
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
TCC-Pan2,tanespimycin-bortezomib (250-1 mol-mol),-1.7030002887525872
RS4;11,44137675,1.884308808751349
HCC-56,135984461,4.583376296349448
SNU-1077,44493528,3.708438186415119
NCI-H2126,124202324,1.5303792300115464
Sq-1,2708,4.211338025780759
MDST8,11485656,2.867381561993162
Hs 822.T,1716436,3.6580142859117366
RL,10302451,3.733722680982209
KO52,2708,3.123821220671842
JHUEM-7,9911463,3.659236793496393
CAL-51,9911830,2.6702149728757343
22Rv1,2729026,2.5542227314350328
NCI-H1944,2729026,3.1299004413701947
LK-2,46926350,-4.378046983964051
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641
KYSE-150,24772860,-2.4043188491088094
SNU-8,JQ-1-UNC0638 (2-1 mol-mol),0.8314654213146081
LCLC-103H,136227924,3.302464114309801
NCI-H1755,6450551,2.385026897281168
BT-474,11485656,2.39208559559141
NCI-H1184,10385095,0.4197461741705012
RKN,10385095,1.0188882527918253
BFTC-909,11167602,2.8757137848929006
K029AX,11485656,3.468308407397126
COLO 668,753704,5.291415895651897
HCC78,2708,3.515548279567806
KYSE-150,tanespimycin-bortezomib (250-1 mol-mol),-0.0451263891138861
LAMA-84,135984461,1.7013411112248076
A-204,24772860,-2.4053342440510064
WM115,6450551,3.3231751041078086
SF539,11485656,1.8649737443723855
NCI-H661,10385095,0.8549868667974337
Calu-6,2729026,2.4814417004984897
T3M-10,73707371,5.866247646711037
NCI-H460,4259181,-0.2054535095090753
LNCaP clone FGC,54639665,5.111125595868773
KP-N-YN,9911830,1.0744667275955389
ME-1 [Human leukemia],6450551,2.7353400934575003
CADO-ES1,11404337,-1.7839684618435203
NCI-H929,54618771,0.737310556758401
A2780,54618305,3.781380565087532
A-549,10385095,1.3823205412091923
VMRC-RCW,9903786,3.331782716085826
NB1,2729026,3.0335829277000013
MOLP-2,6450551,3.1309595069450515
NCI-H1694,44137675,2.890985541444827
MDA-MB-468,151289,0.3759529530158061
SIG-M5,49766530,0.6577937335718277
HPAC,4259181,0.8473544462478222
Raji,9903786,2.8365362494251394
SiMa,9903786,1.5237540856212457
HPAC,24753719,4.331008763420313
ZR-75-30,selumetinib-BRD-A02303741 (4-1 mol-mol),5.283537509696469
SNU-869,49766530,0.4790816119449209
Caov-3,3815108,3.916079871800691
Hs 888.Lu,1716436,4.090717262014949
JHUEM-7,156414,1.092092573669373
SNU-1,4259181,0.1990520766980941
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
G-401,753704,3.840031862409327
HOP-62,73707371,2.551931688807385
SNU-C2A,4259181,-0.464833946452518
HCC366,49766530,-0.9103930727197836
SU-DHL-8,9911830,2.2532460750044385
MDA-MB-453,100016,6.0730906594859215
PF-382,327653,2.393380485895892
DU145,9911463,4.064467262158392
MDA-MB-415,46926350,-3.841611842561015
LS513,9911463,3.8575108406588705
KP-4,6450551,1.734325636888487
DOV13,44137675,3.8702015893296537
MSTO-211H,148198,-2.180219295506665
BHY,135984461,4.3306625702035575
COV434,46926350,-4.307649554867889
OE21,374536,3.562547341164509
BT 422,156414,1.8271774190955228
HEC-59,9911463,4.219022102468233
TM-31,9911463,4.397855159833588
SNU-449,148198,-4.785889264279132
PC-3,2708,5.489434438085633
BT 131,11404337,-0.6302190073571774
MKN1,9911463,4.154655732863371
NCI-H1838,54618771,1.6121528318079854
SNU-201,10302451,2.8885993041273643
BT 172,10385095,1.1313035697005236
NALM-6,148198,-4.9316309610595335
HEC-6,44137675,3.8804034478093743
NB1,4259181,-0.7936923568602017
YD-8,9868037,3.0733964994503244
Ku812,3815108,1.773113304227131
OAW42,4259181,0.8701798956954508
Calu-6,54618771,1.0169937306444143
FaDu,54618305,4.56300350667308
BT 359,71729975,2.280853164629277
Pfeiffer,136227924,1.7936916860357504
Daudi,2729026,1.2833432455886875
NCI-H2110,24753719,4.19042786016423
PSN1,10385095,0.8827094939681907
A4/Fukuda,2729026,2.569130626356953
RPMI-8402,54618305,4.0465755097564555
COLO 320,9868037,3.042611566071044
LAMA-84,9903786,1.7036046577565669
TE-5,100016,6.463093527046919
HEY A8,124202324,2.8289592889546835
HCC44,9868037,1.8192522790953956
CAL-62,2708,3.5133428978920636
NCI-H2228,sirolimus-bortezomib (250-1 mol-mol),2.3578690583328887
A2780,10385095,0.5603604864283975
A2780,6450551,0.1349302943593443
PE/CA-PJ49,54618771,0.7503164660158113
HCC1569,135984461,4.511721689442577
JHOS-2,10385095,1.2172987811190692
NCI-H2342,sirolimus-bortezomib (250-1 mol-mol),2.0659171352443204
SCC-25,9911463,3.418657228936731
NCI-H358,135984461,4.245060558791378
MKN45,654092,0.6286127401912006
ECC12,54618771,2.554935234255265
BT 245,9868037,3.6125967873896543
IM95,2708,6.391807236940828
REC-1,54639665,4.455967355102018
KMH-2,3815108,2.5903945820626006
Panc 03.27,6918638,1.3027265452400043
DK-MG,4259181,0.7593257500018887
NCI-H1341,6918638,-0.9178094299381953
HCC1171,11404337,-0.0693231628102016
Karpas-422,148198,-3.5709854147128843
JHOS-2,148198,-3.889513078207594
CCF-STTG1,148198,-4.129311374884182
NCI-H446,9911463,3.3081231442060304
NCI-H1666,tanespimycin-bortezomib (250-1 mol-mol),-4.94228815381926
TE-4,654092,-0.0838136924829596
Raji,4259181,-0.4985032966889935
KE-97,2729026,2.583807687401206
NCI-H716,44137675,3.004543555964594
TE-6,2708,3.758464668583618
KG-1-C,selumetinib-BRD-A02303741 (4-1 mol-mol),6.574604456328899
SNU-61,124202324,2.5924607447988643
KYSE-510,46926350,-3.440649021989863
A2780,24753719,3.5545225878481745
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
KMRC-2,136227924,3.1141635996197183
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
SYO-1,10385095,1.1678960163185943
LUDLU-1,151289,1.691044782215016
KCL-22,11167602,4.15023513027457
A-549,9911463,3.875766071211208
KMRC-1,753704,4.9867166993089365
EB1,135659046,2.7495616978120543
NCI-H2171,9903786,1.7901794952315444
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
P31/FUJ,9868037,1.2869642230829814
HEC-108,9911463,4.37199271437254
AML-193,24772860,-2.6394717232741254
SK-CO-1,374536,2.850215581982446
P12-Ichikawa,156414,1.5852391665710248
HEC-6,136227924,2.983713037764577
KYSE-30,156414,3.85489578456772
Kelly,11485656,1.664007289934324
EPLC-272H,148198,-1.1949908417722128
SW948,151289,0.9927868711009586
NCI-H1105,9911830,2.511018805637994
M059K,46926350,-4.2099408016769715
Malme-3M,49766530,0.5606234787009209
NU-DHL-1,11404337,-3.826325924415509
ChaGo-K-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.484510987120187
BFTC-905,151289,1.8622690358809315
SU-DHL-10,11485656,2.298266624508031
KNS-60,3815108,3.9158573557509344
U2OS,tanespimycin-bortezomib (250-1 mol-mol),-0.4956813125549447
Kasumi-1,44137675,1.5209976370824865
MOLT-13,9903786,1.350785557130732
JHOS-2,10302451,3.465482157276917
RT-112,654092,0.0489095267041795
JHH-1,753704,4.548943495144122
JHUEM-3,156414,0.1798690531293942
NCI-H1155,54639665,4.4838841081587555
EoL-1,148198,-7.742780807176134
U-BLC1,24753719,4.182183061493439
KP-4,2729026,3.051860412513106
SNU-398,10385095,0.96314398435141
KMS-28BM,151289,1.6627477972565845
KMS-21-BM,9929138,2.832243377547389
HSC-4,136227924,4.2199200707906845
Raji,54618771,-0.1378575615243227
OVISE,327653,2.506626214633075
LoVo,151289,0.7390860710542093
NCI-H1915,1716436,3.4947613548193996
SNU-685,10385095,1.2325598072827673
Li-7,10385095,2.245762871379806
KATO III,16013152,4.72350665828083
OAW28,24753719,4.434201172795376
RPMI-6666,11404337,0.2298054354312977
Panc 02.03,6450551,4.166761052507323
GA-10,10385095,-0.1867233293810926
DV-90,9929138,3.266607070409867
HPAC,11404337,1.5796437577977354
L-1236,654092,-1.195344315515342
DMS 273,9911830,2.0619640796568848
SiMa,9868037,1.987643785401739
A-549,54618771,0.0374822867627876
KNS-42,44493528,4.291598351645838
HCC2935,9911463,4.226502617966516
Panc 03.27,24753719,4.289669652814175
SIG-M5,2708,2.8636968215796
NCI-H508,tanespimycin-bortezomib (250-1 mol-mol),-0.2037245877334007
JHUEM-1,10302451,3.0563523137347386
U-87MG ATCC,44137675,4.205473904053381
OCI-Ly3,24753719,3.800130789629197
NCI-H838,11167602,1.8804093923167309
SNU-449,11404337,-0.5921655065432572
SUP-HD1,136227924,3.4836971225000735
NCI-H1703,tanespimycin-bortezomib (250-1 mol-mol),-3.1681297716810692
ES-2,2708,5.377409443179492
COV434,2729026,1.5957081695456368
BT 245,10302451,3.8870647023268448
LS180,24753719,4.21554861148433
UM-UC-3,24772860,-2.8118151490947136
SK-MEL-24,54618771,0.9964231192757652
EoL-1,24753719,1.9160330711500224
AN3-CA,46926350,-5.100633637937967
HuT 78,151289,1.040242806613575
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
NB1,9903786,2.052998466280315
DV-90,54639665,4.358893407876041
HCC2935,16013152,4.391641177840689
CAL-85-1,4259181,0.3435211839049084
NCI-H2029,JQ-1-UNC0638 (2-1 mol-mol),1.2573845942835524
SNU-C1,16013152,3.829248046463001
UM-UC-1,327653,3.640505495969521
SNU-C5,2708,5.146339972720114
HCC827,9911830,0.6669309541853267
Reh,10302451,3.67985775333445
CAL-62,654092,0.6280086801569372
COLO 699,9903786,3.444453349709646
Karpas-299,753704,4.830505554008166
IGR-1,6450551,3.5707083562268984
Hs 895.T,2729026,3.0633771961193266
NCI-H1155,24753719,3.3116025060765955
BT 340,10385095,1.3886421901194472
KMS-26,54618305,4.443948888927761
OCI-Ly10,100016,6.418038918193145
WM88,46926350,-4.237061889252627
RPMI-8402,49766530,0.2151937728897686
G-401,44137675,2.141460704144857
C2BBe1,151289,2.825456258115428
DBTRG-05MG,9903786,2.261180783210366
SNB-75,9911830,2.263725415615307
MES-SA,374536,-2.821815546547392
SNU-1076,tanespimycin-bortezomib (250-1 mol-mol),1.399348377657982
ST486,136227924,1.8715049257554837
HT115,136227924,1.4968152830691424
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
DEL,327653,2.5091773560390553
NCI-H1666,148198,-1.1369965956899613
CFPAC-1,49766530,5.350694813461272
KYSE-410,9903786,4.00816844948711
HGC-27,135659046,3.397555397732454
JHUEM-3,10385095,1.0184545903744842
CAL-78,11404337,0.3095011123947553
Mino,10385095,0.494040271373144
ChaGo-K-1,11404337,1.1508536619225571
SNU-61,24772860,-2.9174361907600592
NALM-6,136227924,1.937403591420271
NCI-H1793,4259181,1.6864937175392107
NCI-H727,1716436,2.7605133955676178
TYK-nu,1716436,2.369142992112512
KMS-11,327653,2.770747014844883
NCI-H2110,6918638,0.2299759669474582
ONS-76,3815108,3.0019527232257555
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
Sq-1,49766530,-3.572585466463728
SEM,374536,-3.4278771787335107
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
NCI-H1693,9903786,3.776760773308461
AsPC-1,327653,4.351823995090995
SNU-1033,24772860,-2.288475118116987
LK-2,136227924,2.893153940116167
U-BLC1,1716436,2.6251881995647
L-1236,49766530,-2.927530009447525
KHM-1B,11485656,1.807132568777105
A2780,44137675,1.3252793631369038
AN3-CA,9903786,1.5268103297033566
TUHR4TKB,9911463,4.0914884316210145
BICR 16,6450551,4.0016117820786725
WM1799,54618771,2.4607401092815677
OAW28,4259181,0.9119817479539226
HuCC-T1,11167602,2.489104894066524
NCI-H196,156414,2.0892379474459037
SW948,49766530,-0.6875988061214425
MeWo,6450551,3.386511299203061
BFTC-909,9868037,3.24226767674478
Ci-1,6918638,-0.1267659134210231
TE-8,135984461,3.955481797487968
OE21,136227924,2.0991161235844404
RPMI-8226,44493528,3.728684145979083
SIG-M5,2729026,3.0719954327746164
MCAS,124202324,3.0914896284438225
QGP-1,11404337,0.7683818583115465
D283 Med,2708,2.7389036189058156
SNU-886,156414,1.8221946579264756
BT-12,54618771,-0.2566375632021986
JJN-3,1716436,2.793329073333592
SET-2,2708,2.464948015256483
CMK,135984461,1.8069857121104629
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
769-P,tanespimycin-bortezomib (250-1 mol-mol),0.3785474363326266
NCI-H2196,6450551,2.5404484034900894
SK-MEL-5,124202324,2.6727039143365148
CAL-12T,124202324,3.198828632505746
OCI-M1,10385095,0.871946369037786
SK-MEL-28,10385095,3.2557901504831306
SNU-685,54618771,0.6420391462722509
PK-1,374536,2.728983903486566
SNU-C5,654092,-0.4802386657833024
SNU-175,11485656,1.332587487801819
Kasumi-2,156414,1.0465549823430256
Caov-3,9911830,2.8215627878948566
Rh41,2729026,1.8213715894051272
BICR 18,10302451,1.8866317281326117
OE33,4259181,0.9178629586058104
Kuramochi,10385095,1.4788010869499648
NCI-H211,9903786,1.4038112191361545
OE21,135984461,4.867121216346128
BT 224,753704,4.516112508901238
MDA-MB-453,9868037,1.568237926564538
OCI-Ly19,24753719,3.7362509862240194
THP-1,sirolimus-bortezomib (250-1 mol-mol),0.3217250845673337
BT 444,11167602,2.4668021270212086
BL-70,54618305,3.7838693082643977
OVCAR-8,124202324,3.0102436780348394
PE/CA-PJ15,11404337,-2.320439466084731
SYO-1,2729026,2.66259137122084
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
WSU-DLCL2,9929138,4.197789309677048
NCI-H1395,4259181,1.90835331362123
RT-4,4259181,0.4956946540898031
LoVo,9903786,0.6551100591729495
647V,135984461,4.277931256809204
NCI-H1650,2708,4.095647047225123
BxPC-3,54618771,0.182098153600537
OVK18,4259181,-0.6799661458777646
SF126,9868037,3.6473603445619
SNU-478,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4383144596848765
RS4;11,11485656,1.5968543308992733
SCC-9,10302451,2.205114392498864
EM-2,44493528,3.698991403338848
NCI-H1703,135984461,4.378199750715437
KMRC-3,1716436,3.0177776022941303
DLD-1,136227924,3.626313463652563
P31/FUJ,100016,5.4217002529902185
NCI-H2029,54618771,1.4933886789628814
Hs 940.T,1716436,1.9115584636384724
LUDLU-1,JQ-1-UNC0638 (2-1 mol-mol),0.12538061325918
HT-1080,2708,4.664951686751722
JHUEM-1,54618771,0.4332987252464321
G-292 clone A141B1,1716436,3.4546824508984244
HCT 15,4259181,-1.3945666977280595
8-MG-BA,11485656,3.634324102236689
ChaGo-K-1,2708,6.0017156260200375
769-P,24753719,4.182312209848352
SUP-T1,54639665,5.160624619206478
CL-11,9903786,2.342392371257784
IGR-1,selumetinib-BRD-A02303741 (4-1 mol-mol),1.592279235494749
OCI-Ly19,44493528,4.78987758485686
Panc 10.05,sirolimus-bortezomib (250-1 mol-mol),0.3447430037578218
SNU-1041,124202324,2.8233510593349433
OS-RC-2,2708,5.814759358577747
NCI-H1105,156414,2.2634806702955768
NCI-H1693,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1565995482532956
IGROV-1,11485656,1.900409616013456
SW579,24772860,-2.441011124202714
SNU-407,10302451,0.9943081022244468
YH-13,11485656,3.672447929172867
SK-N-BE(2),54618771,0.9594673871894048
SNU-407,9903786,2.2079678485918977
MCF-7,24753719,4.58802126050849
JJN-3,6918638,-0.7413603432623325
PE/CA-PJ41 (clone D2),2708,5.346353434531731
697,54618771,-1.411266128730911
BT 245,11485656,1.931183051045247
NCI-H1793,11485656,2.9016215508551064
NCI-H2171,4259181,0.2390230285316857
HeLa,6450551,1.7537077061926707
MDST8,9911830,3.786562744766562
M059K,151289,1.451795415775966
HCC1806,10302451,1.9356856115865475
KO52,100016,6.24417827042609
MOLP-8,10385095,0.909191851453096
BT 112,2729026,1.695580673596315
COR-L95,9911463,4.18924595414168
SF268,9911463,3.2093311468755843
HuH-1,JQ-1-UNC0638 (2-1 mol-mol),1.5566373871813006
TALL-1 [Human adult T-ALL],10302451,3.2797456534828364
Hs 852.T,24772860,-2.827165213419933
COLO 829,54618771,1.3486725115535303
ACC-MESO-1,4259181,0.8154176587876882
TE 441.T,JQ-1-UNC0638 (2-1 mol-mol),1.283080729500337
Hs 839.T,136227924,4.248389123686858
SUP-T1,9929138,6.13855096958909
BT 498,10302451,4.23204741279201
CHP-212,135984461,1.9564066999314385
NCI-H520,JQ-1-UNC0638 (2-1 mol-mol),0.935483306550117
MOTN-1,151289,0.7277827395357226
A-204,16013152,3.789080400403009
SNU-601,100016,6.491707225104745
NCI-H1838,156414,0.9997225683484908
NCI-H838,46926350,-4.193608062093322
HT,9911463,3.44376520524061
HEC-151,11404337,-0.8422867477352739
OCI-AML-3,156414,1.0676156487977742
BT 224,24772860,-1.3625795634994409
SR,54618305,-4.49006394356538
SNU-423,2729026,3.1858852581930197
DK-MG,tanespimycin-bortezomib (250-1 mol-mol),0.5926006673391784
Tm87-16,44137675,4.0681957749514694
SK-N-MC,11404337,-1.4271046508781242
OVCAR-5,9911830,2.2712250942356143
RS4;11,374536,-3.7339807264413656
KLE,10302451,4.42053427640389
HCC1438,151289,0.8192975277861294
HCC1195,sirolimus-bortezomib (250-1 mol-mol),1.8421532111980472
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715
P31/FUJ,9903786,1.0734919883099745
KMBC-2,135659046,3.5104960306219155
OVK18,selumetinib-BRD-A02303741 (4-1 mol-mol),4.397417158092712
NCI-H716,10385095,0.9651730847529224
HCC2218,46926350,-3.897277890341576
CHP-212,54618771,1.2694957147058317
A3/Kawakami,6450551,2.468844987550313
NCI-H1869,46926350,-4.282958086808661
BT 145,100016,5.857999875396141
U-937,11485656,1.9475205448486337
SNU-1077,374536,4.4212076979679305
SEM,10302451,1.800985187016429
KMS-26,11485656,1.8786999049789332
SK-N-MC,151289,0.2893156683237518
647V,9903786,2.919786568637495
FTC-133,44493528,6.31419839504633
Granta-519,1716436,2.7310795448836904
Aska-SS,327653,3.2557442863738033
NCI-H1694,24772860,-2.3184878195526633
KMS-20,9911830,3.122947091608452
KATO III,10385095,1.4582736988543066
COLO 678,135984461,4.384387771979114
JHUEM-1,136227924,2.224041693066133
GMS-10,374536,3.3525919830687023
SaOS-2,136227924,4.496792726095474
NCI-H460,9911463,4.421747687015995
K029AX,1716436,2.6372984190246753
ONCO-DG-1,49766530,-2.0037340634863
SNU-61,9911830,2.7749851076050187
TF-1,73707371,5.5092201735565665
DAN-G,54618771,0.722967916386815
EM-2,3815108,2.3099159021163858
HCC2935,148198,-1.8652602121018471
HuH-1,11485656,1.6610003065842192
TE-10,44137675,3.2838471293728126
BT 333,6918638,1.7862101251077225
NCI-H1703,46926350,-4.184765123367124
HCT 15,148198,-4.831487376237021
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264
NCI-H358,9903786,1.2866771615699664
NCI-H2106,selumetinib-BRD-A02303741 (4-1 mol-mol),5.248855482523753
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
Reh,327653,2.319625668296167
Reh,11485656,1.8045158177085707
TE-15,10302451,0.955725633878595
JHH-4,100016,6.356907567320683
OCI-Ly19,327653,3.3059226153173835
RCH-ACV,136227924,2.5365542828193957
SNU-620,148198,-2.4774771616722573
A-673,9903786,1.5948741514342302
TE-11,44137675,3.3851372376966444
OVTOKO,100016,8.078720974707625
LOU-NH91,2729026,2.877851429076431
A-375,135984461,4.563596493696721
HEC-251,24753719,3.820812144153033
A-673,327653,2.521292352419487
COV644,49766530,0.2349932620082565
KYSE-140,44137675,3.7184605530968065
RT-4,6450551,2.2362160436961314
Hs 611.T,6450551,2.170846858416241
NU-DHL-1,4259181,-0.8877351143250455
U2OS,4259181,-0.2674268404210034
Hs 895.T,selumetinib-BRD-A02303741 (4-1 mol-mol),5.587099889381879
HuP-T3,136227924,2.888640375816574
BHY,11485656,2.162098397654175
AML-193,2708,3.1870505459991803
OCI-Ly3,6450551,3.15533955167994
U-937,44137675,2.951921300999105
BICR 56,71729975,2.9310367815747336
SHP-77,3815108,2.053386814970847
OE21,4259181,-0.2444735464140802
SH-4,11404337,0.8208570932203854
BHT-101,sirolimus-bortezomib (250-1 mol-mol),1.6700358071481498
EPLC-272H,151289,1.2147973719085037
EPLC-272H,6450551,3.033733402135294
NCI-H2228,10385095,1.4041117697661651
NCI-H2023,10385095,1.104290975738384
NCI-H1581,3815108,1.7397533010249664
FTC-238,151289,0.8179859848115041
Yamato-SS,selumetinib-BRD-A02303741 (4-1 mol-mol),7.109534852285599
SK-LMS-1,54618305,4.344599681263995
HCC38,11404337,0.6997124930449434
EB1,10302451,0.5796206365832764
OCI-Ly3,16013152,3.915899530769814
JHUEM-1,46926350,-4.530422385663853
SNU-869,10302451,3.2820222285741134
Hs 888.Lu,11404337,0.6569012069034585
Li-7,selumetinib-BRD-A02303741 (4-1 mol-mol),2.938579796159755
SU-DHL-1,10302451,2.2731723403274535
MIA PaCa-2,24772860,-2.8067404690630435
Caki-1,6918638,0.9504524779019108
MFE-296,135659046,3.966575901006911
SK-N-FI,753704,4.166089767873969
COLO 792,4259181,0.9728594463326096
SU-DHL-10,1716436,3.276012577495743
HSC-2,11485656,1.6817242340457108
L-540,10302451,2.597758054262249
RT-112,2729026,2.9058294565658147
BT 504,151289,1.3085497128348884
OE33,10302451,2.926424279202946
HuCC-T1,11404337,-0.917560199382238
TE-8,9911830,2.369831244931197
TUHR4TKB,148198,-1.0832218520186652
K-562,753704,4.7227938780788525
HT-1197,327653,2.757208589680578
BT 231,9911463,2.979244544193708
ME-1 [Human leukemia],JQ-1-UNC0638 (2-1 mol-mol),1.384667773951087
NCI-H1944,JQ-1-UNC0638 (2-1 mol-mol),2.6372609269831653
OVCAR-8,tanespimycin-bortezomib (250-1 mol-mol),0.6249256155417496
SK-MM-2,151289,2.283788630852206
TT,9903786,2.2571281683889253
JL-1,54618771,3.703254873905745
NCI-H1563,135659046,3.636669670188891
GSU,4259181,1.034622044405449
HEC-59,24753719,4.79630184603725
U-BLC1,135984461,1.880488153301068
SF539,2708,3.2874630457066103
NCI-H520,148198,-5.585206831860286
TCCSUP,11485656,2.4858219651419966
MeWo,148198,-4.218734376362087
HEC-1-A,9868037,3.1210515206348246
OC 314,135659046,3.480860974794082
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
JHH-5,2729026,2.9734098886241727
SNG-M,753704,5.06084817200139
NCI-H1693,1716436,3.085325002807724
KYSE-70,9903786,2.353212274658888
SNU-478,151289,-0.2018569733276466
A3/Kawakami,16013152,3.65671304304695
KE-39,54618305,4.948156947347383
NCI-H1694,135984461,1.8368991431523527
COV362,sirolimus-bortezomib (250-1 mol-mol),0.7278420573421237
HuT 78,6918638,-1.8650927856269544
PLC/PRF/5,135659046,3.5172360380546084
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
OAW28,9911830,2.567685352724645
TT,136227924,2.992692937715844
Hs 940.T,2729026,2.2876475671032326
RPMI-6666,1716436,3.3103286240659893
TE 441.T,54618771,1.354234974700439
BT 330,49766530,-1.7517349908544686
HEC-151,9868037,0.6566472366149405
NCI-H1734,11404337,-1.6493245767646154
NCI-H2122,4259181,0.8798448055972885
BL-70,54618771,0.7229646502566096
RL,327653,2.642918590817601
Mono-Mac-6,10302451,3.81015516051213
NCI-H747,24753719,4.371264768005184
H-STS,1716436,2.174736460628774
786-O,4259181,0.4460597057437915
SNU-489,4259181,1.5212826565077282
EB1,151289,0.2177407716656138
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
WSU-DLCL2,100016,5.8333868406138585
PK-1,136227924,2.8943441164421633
8505C,9868037,2.6963732773492572
Hs 888.T,71729975,4.142965736284462
NCI-H2110,151289,0.7148300319898179
SK-CO-1,54618771,-0.118181134306818
RKN,9911830,3.6623648245681744
SW1990,24753719,4.9557561363455624
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
SK-MEL-30,148198,-1.6076704799075907
HMC-1-8,124202324,3.206443124506372
MPP 89,100016,6.902779011713528
SF126,753704,6.881904907123801
COV644,753704,4.684666204482018
MDA-MB-453,753704,5.23059705064669
HT,10385095,0.5448968972509004
NCI-H2126,135984461,4.348748825653974
MCAS,148198,-2.0312221156390717
ME-1 [Human leukemia],24753719,3.9162148348734385
EBC-1,6450551,2.313688982675792
SNU-886,124202324,2.9202052759291024
GaMG,54618771,-0.7184169257406299
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
NCI-H1623,2708,5.67986318014104
Hs 611.T,24753719,2.639825501985761
ZR-75-1,24772860,-1.6053779723284431
SCC-4,54618771,3.088112117698249
VMRC-RCW,sirolimus-bortezomib (250-1 mol-mol),0.7357158276025152
HuP-T4,3815108,3.43024601150893
OCI-Ly3,135984461,1.8190519261994496
BT-16,46926350,-4.152800323330838
Panc 03.27,1716436,3.682679734224979
EB1,10385095,0.173257887720905
NCI-H1915,54618305,4.271520986839047
L-1236,sirolimus-bortezomib (250-1 mol-mol),1.403422736729983
SK-N-AS,44137675,4.147290712781994
CAL-33,9911463,3.5337307884792213
WM983B,11404337,0.2030951424899205
DB,6450551,1.8033210097959944
TE-14,4259181,-3.298060588196884
8-MG-BA,10385095,0.96743723287677
BT 224,46926350,-3.979471800870512
SaOS-2,16013152,4.240825830990255
MDST8,2729026,2.783400494590182
KYM-1,54618771,0.695388101268428
K-562,16013152,3.768503882504226
EB1,1716436,2.0553035928258105
SNU-407,753704,4.951001921580863
SNU-61,2729026,2.4451253635155106
CAL-51,6450551,1.9748462748620472
PK-59,136227924,3.43326158684526
HCT 116,9911463,4.389845100856259
BT-16,11485656,2.0917795824799787
SNU-478,11404337,-0.3528320268789623
BT 147,374536,3.704628021077044
SNU-182,44493528,4.330541683560017
Detroit 562,11404337,-0.2286733429262966
BT 164,374536,3.148110942238188
NCI-H2228,327653,3.7326635355564024
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557
NCI-H810,136227924,1.6901408020045232
SNU-16,JQ-1-UNC0638 (2-1 mol-mol),-1.6086197947782372
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
NB1,49766530,-2.158662190283236
Panc 05.04,54618305,4.5822328451886465
MKN74,1716436,3.075916204140164
LNCaP clone FGC,6450551,3.014319559444335
L-428,71729975,0.2762170847451443
HuH-6,156414,1.109377454710629
SNU-5,654092,-1.5006367757250765
BT 328,71729975,3.0990455270892365
NCI-H2291,100016,7.4079580735543695
BT 228,49766530,0.5150432807946567
NCI-H2122,9903786,2.7991091527294216
L3.3,654092,0.3260809528195456
U-CH1,JQ-1-UNC0638 (2-1 mol-mol),1.6932909816412225
MCF-7,2729026,2.9627808607073955
SCLC-21H,46926350,-4.457827394922709
UM-UC-3,6450551,3.0850983792383597
IPC-298,654092,0.4631159607474375
CAL-54,44137675,1.730264548973589
JeKo-1,374536,1.812128388098807
COR-L95,753704,4.781559661696253
Sq-1,11404337,0.5164739159658084
Hs 578Bst,49766530,-2.7319147514875124
EKVX,2729026,2.505622441142412
CHP-212,9903786,1.1399886841606115
PK-45H,49766530,-0.0429860028998506
NCI-H2110,327653,3.7242823172188815
786-O,6918638,1.6864492481746118
NCI-H146,44493528,1.3818057906729433
LMSU,156414,1.5302250641749746
Calu-3,4259181,0.5687129223574867
SNU-1214,11485656,2.376217579776436
Hs 683,24772860,-1.8987479201847817
KYO-1,3815108,2.546507542338442
UACC-62,9911830,2.15398802425272
Hep-G2,JQ-1-UNC0638 (2-1 mol-mol),2.605795560708836
HCC1143,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9300366262923152
PLC/PRF/5,44493528,4.794092403972537
KO52,44137675,4.99436004315741
Calu-3,9911463,3.153404929849599
P3HR-1,JQ-1-UNC0638 (2-1 mol-mol),0.3076428493942975
DMS 114,6450551,3.181878797276555
BT 428,54618305,4.316661671711245
VMRC-RCZ,54618771,3.963095950994299
ESS-1,24772860,-2.7433674764679097
LAMA-84,54618305,4.386276896438661
NUGC-3,54618771,-0.8642995608201182
Mono-Mac-6,44493528,3.657931267862179
DK-MG,selumetinib-BRD-A02303741 (4-1 mol-mol),3.931215642833847
OAW28,11485656,3.2643123414600645
WM1799,124202324,2.6650079309412655
Panc 03.27,753704,5.926668113139356
HCC1588,44137675,3.7107536716886464
ZR-75-30,2729026,3.2234777100859433
22Rv1,24753719,4.182881339762408
SW48,24772860,-4.097111396936187
BT-12,136227924,2.3126118312621404
COR-L105,16013152,4.074366111138725
HEC-6,54618771,0.3851736338204913
PaTu 8988t,10302451,4.044762571435361
BT-16,selumetinib-BRD-A02303741 (4-1 mol-mol),5.127730402871712
NCO2,151289,-1.3886335739441034
COV644,6450551,4.1321442198663085
BT 179,9911830,2.311189147842498
BT 482,44137675,4.460016561734515
Mono-Mac-6,4259181,0.7662701795751813
RT-4,2708,5.689057420087821
MOLM-6,44493528,4.505995981059325
TUHR10TKB,9868037,2.493221827195661
Kuramochi,JQ-1-UNC0638 (2-1 mol-mol),2.0782674655791347
BICR 31,10385095,1.3759128494100044
SYO-1,11404337,-1.0421940088856276
SNU-216,24753719,4.261315806086272
HCC1428,2729026,2.949299462707024
BL-70,156414,-1.981902345453731
MDA-MB-468,156414,1.2288207962265136
COR-L51,54618771,1.1553419440915085
CHP-126,10302451,3.625484511715841
SNU-1,54618771,0.7827346323778329
TUHR10TKB,1716436,3.4738555466227035
M-07e,1716436,2.8997519254930335
8305C,151289,0.4594772731955576
CAL-78,374536,5.162304413120322
ES-2,54618771,2.1434167327207954
HEC-151,124202324,2.4256348200617452
GSS,11404337,-1.198572034455594
OV-90,sirolimus-bortezomib (250-1 mol-mol),0.2139978702426217
JIMT-1,10385095,3.3257762843711913
DEL,11167602,1.5971782344142085
NCI-H1568,11485656,1.8106242285910237
SK-MEL-24,tanespimycin-bortezomib (250-1 mol-mol),-0.1831765254782449
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
NCI-H522,151289,0.0217168787144745
HuG1-N,6450551,3.236520710471782
PK-59,11485656,2.1797490126169823
NCI-H2106,156414,1.3861609981337029
CAL-85-1,156414,-0.3486658434502303
KNS-81,tanespimycin-bortezomib (250-1 mol-mol),2.206166956375568
NB1,327653,2.937642307777295
NCI-H2196,54618771,3.689475396494767
NCI-H716,374536,2.3104255721837
NU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),-1.1533967446161832
HeLa,1716436,3.4647611056245977
F-36P,71729975,0.6879338879700845
KMH-2,9929138,5.036636108742583
RPMI-6666,44137675,1.1074676661302914
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
G-402,327653,2.539319278350871
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
PL-21,44137675,2.003889769632495
HT-1080,73707371,4.569989134873035
COLO 320,sirolimus-bortezomib (250-1 mol-mol),0.8564336763022389
FU-OV-1,10385095,1.480245925499038
AsPC-1,6918638,0.7071735542476161
KE-37,3815108,1.9388629041700445
MOLM-6,11485656,1.973328141098863
BT 159,9868037,4.039671954943351
MeWo,16013152,4.135441553769969
SNU-761,9911830,2.50367716238648
JM-1,JQ-1-UNC0638 (2-1 mol-mol),-2.068621419812743
BT 340,10302451,4.165470025380085
COLO 668,156414,1.3268968619485253
HCC2218,2708,4.7571446912258395
MHH-ES-1,2708,2.996158869291761
Ci-1,1716436,2.3255811444669843
SUP-T1,44137675,3.1902941192136165
NCI-H28,136227924,2.9733016664554155
SNU-738,2708,4.549165569573415
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
HCC1500,44137675,4.199849963716895
NCI-H460,24772860,-0.596461213785507
TE-5,tanespimycin-bortezomib (250-1 mol-mol),-0.0271595153409523
Sq-1,9911463,3.467859950121971
SJSA-1,2708,4.3213435516385355
HD-MY-Z,148198,-4.870979577806884
SR,136227924,2.657612515566446
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723
BT 330,327653,3.419413627791973
COLO 792,10385095,1.0234389393888734
CAL-85-1,6450551,5.196199490269626
Hep 3B2.1-7,9911463,3.814987656182777
CHP-212,46926350,-4.472460351842097
Hep 3B2.1-7,10385095,2.639944911413333
NCI-H2030,136227924,3.923759704530775
NCI-H1734,327653,2.957290702730057
HT,151289,0.263776795518258
ACC-MESO-1,6450551,3.561931878479919
PE/CA-PJ41 (clone D2),24753719,4.254731595705647
M059K,10302451,3.367449874877144
CAMA-1,2729026,2.8603251504006053
NCI-H747,11404337,-0.8176088644523414
SH-4,JQ-1-UNC0638 (2-1 mol-mol),1.1332632530781164
SK-N-MC,753704,3.494645891296261
TALL-1 [Human adult T-ALL],44137675,3.1525084921214175
SK-LU-1,2708,4.169228034592907
TE-1,2708,6.647766589077568
WM793,135984461,3.5730556754970175
NCI-H1703,10302451,1.82214372973452
MCAS,54618771,1.3372810495752594
SNU-620,654092,0.4240066407899038
RERF-LC-Ad2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.235970238895281
SF268,136227924,2.8034077121566967
SNU-1066,4259181,0.2629374761746411
DMS 114,24753719,4.208202347185018
RT-112,44493528,4.644994177683236
NCI-H2110,selumetinib-BRD-A02303741 (4-1 mol-mol),4.4516534452427505
T84,24753719,4.006529455935125
BT 145,6918638,0.0582257419032156
RPMI-8402,10385095,1.0671050599141887
PK-45H,10302451,3.483149431364428
T-47D,100016,6.980531714745858
23132/87,11404337,0.4022152079144664
OE21,selumetinib-BRD-A02303741 (4-1 mol-mol),1.5962384018267015
LN-229,4259181,-0.7508188735233954
TT,10302451,1.8777264782629384
SNU-869,16013152,5.337481971601807
Hs 895.T,sirolimus-bortezomib (250-1 mol-mol),2.0562146171637723
HEL 92.1.7,4259181,-1.2698112333682838
KMS-12-BM,3815108,1.5057478423514148
Rh18,9911830,2.105757574516919
DV-90,46926350,-6.097417198285645
COLO 668,24772860,-1.9878405043988363
MKN74,16013152,4.862549736803779
NCI-H1355,136227924,5.68794295830134
RKN,11404337,0.6786980557761386
DMS 454,9911463,3.0407786288723475
KYO-1,654092,-0.6581584338999737
A3/Kawakami,4259181,0.5157779937872828
639V,24753719,4.6896933942293835
M-07e,148198,-7.025596172971479
A-549,selumetinib-BRD-A02303741 (4-1 mol-mol),2.307828661203879
OUMS-23,24753719,4.226902193250076
HCC78,54618305,4.419168434433716
KE-97,tanespimycin-bortezomib (250-1 mol-mol),-0.1953255566925064
HCC1833,124202324,1.8679152106423855
LC-1/sq-SF,46926350,-4.123377735043783
OCI-AML-2,9911463,2.4773286761058992
DOV13,148198,-3.763867663702191
OCI-Ly3,54618771,0.9426860423184806
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
KMS-20,2729026,2.385777395539285
COLO 320,374536,2.5990927841752813
WM1799,10302451,3.849791642303361
RT-112,6450551,0.8050466682255544
LS513,JQ-1-UNC0638 (2-1 mol-mol),2.1730904282726966
EN,sirolimus-bortezomib (250-1 mol-mol),1.0494581662942
NCI-H1793,54618771,0.9383287956329432
Malme-3M,1716436,0.856451726804313
SNU-407,327653,3.0225030327462017
Panc 10.05,4259181,0.030271279252648
KYO-1,148198,-3.141944756892253
HCC1419,44137675,3.166461155010495
BT 145,148198,-5.145484796849837
GI-1,54618771,0.7325470873707357
VMRC-RCW,9911463,3.519354422119686
MOLM-13,9868037,0.9756233042827712
Caov-3,124202324,1.7666975754917589
SNU-C5,327653,2.2876763505063566
CW-2,selumetinib-BRD-A02303741 (4-1 mol-mol),6.96554705441528
SW1417,tanespimycin-bortezomib (250-1 mol-mol),-2.5738545143684064
NCI-H522,11404337,-1.4542746262182442
WM983B,4259181,-0.5261677537027811
8505C,9911463,3.9204213231071527
MCF-7,11167602,4.300198069535502
DEL,9868037,2.284164309985857
JHH-1,2729026,3.0090297936217363
HEL 92.1.7,49766530,-2.6866934842186234
HuG1-N,753704,4.999759060632691
EBC-1,44137675,2.1323510423946574
MHH-CALL-4,100016,6.461754156645112
NCI-H226,11404337,0.9721595611674808
JHOM-1,24753719,4.3491159440390925
DMS 114,selumetinib-BRD-A02303741 (4-1 mol-mol),6.420143017756254
Detroit 562,374536,3.759475556269608
SUP-T11,1716436,0.2243543965505923
COR-L279,JQ-1-UNC0638 (2-1 mol-mol),0.1506201474631729
IGROV-1,327653,3.667792542405671
COR-L47,9903786,1.6785820828918676
CML-T1,136227924,1.8923919385229255
TOV-112D,4259181,-2.185686568259274
K029AX,2729026,3.0461901866655494
J82,10385095,1.0430089520475925
NB4,24772860,-3.668841966653596
NCI-H508,9903786,0.5730721211303239
MDA-MB-435S,4259181,-1.4410759013373908
SW620,11485656,1.8999997266011384
SW1710,9929138,6.751654764196259
BICR 16,46926350,-3.5558375417205994
IGR-1,11485656,3.283043378063367
Daudi,9903786,1.3988461789185107
SNU-308,9903786,2.008516122429012
RCH-ACV,selumetinib-BRD-A02303741 (4-1 mol-mol),3.748980634786139
NCI-H1339,327653,3.7168174136495735
CAL-27,11485656,1.6862238781390195
BT 498,2729026,2.5400165852939196
OCI-AML-2,753704,4.414326507675589
SK-N-MC,9903786,1.1605258193445984
MDA-MB-468,16013152,4.042706257592217
FU-OV-1,148198,-3.302287500778492
PE/CA-PJ49,10302451,1.2868329863340626
LK-2,9903786,3.191424869539257
SNU-466,9903786,3.45397809087946
PK-1,6918638,1.0537426259825138
CHP-126,136227924,2.2251507312000576
COLO 800,9911830,2.243468062819411
HCC1954,4259181,-0.064962892952742
MHH-CALL-4,654092,0.0029240394584913
MIA PaCa-2,6918638,-0.2858557386208528
BL-70,148198,-4.761980486191778
HT-144,24772860,-1.8009979212655205
AML-193,2729026,1.1401001297307822
Pfeiffer,9911463,2.288637526190458
NCI-H647,156414,2.1873385810737043
KYSE-520,24772860,-1.4410815174652234
COLO 678,10385095,1.3568398033930142
MCAS,2708,5.102956403259028
NCO2,2729026,1.2481670026079306
Hs 895.T,11167602,4.982461660939475
KYSE-520,44493528,4.570249805498521
HCC1937,54618771,3.213475189198509
PE/CA-PJ41 (clone D2),135659046,4.325865774807889
MES-SA,44137675,3.5857700617277612
SK-MEL-5,JQ-1-UNC0638 (2-1 mol-mol),3.706409053077637
A-549,4259181,-1.4635956785215285
SW48,136227924,1.7122170056378203
NCI-H522,2708,5.085998334781725
RT-4,1716436,2.9161940059185985
NCI-H1395,9911463,3.814426972193391
Lu-99,9911463,4.284576210673527
U-CH1,tanespimycin-bortezomib (250-1 mol-mol),-2.1423466451005524
THP-1,54618771,0.1282958307593316
A-253,6450551,3.7780088878886207
NCI-H358,11485656,2.220633179446384
F-36P,JQ-1-UNC0638 (2-1 mol-mol),-0.2349092718581727
OE21,11167602,2.1998769764079884
BT-474,136227924,2.4914554847870187
RPMI-8226,327653,2.456845163980657
SNG-M,2708,4.76153087824274
DoHH2,10385095,0.4781545014335026
BT 416,753704,7.086994634992296
SF268,24753719,4.152631547377157
Jurkat,2729026,2.637547078407677
BT-549,54618771,1.4883156908959423
BL-41,10385095,1.158422194070115
HEC-1-A,tanespimycin-bortezomib (250-1 mol-mol),-0.4943806740107087
U-CH1,156414,-1.9415090197307168
Fu97,156414,3.415711676319674
TOV-112D,24753719,4.1939686401691265
KP-2,151289,2.0709202048211575
HEC-151,2729026,2.502599167536784
SU.86.86,9911463,4.35911979104002
P31/FUJ,24753719,3.279397605233023
NCI-H1299,374536,3.9842434621370497
KYSE-150,2708,5.225995331895731
SNU-869,JQ-1-UNC0638 (2-1 mol-mol),2.244213275085387
COLO 800,sirolimus-bortezomib (250-1 mol-mol),0.359649452523933
NCI-H1105,46926350,-5.457617155124092
BT 164,327653,2.84640046206339
BT 216,148198,-4.022421369072414
MOLM-6,9903786,1.0024208305438098
Mel JuSo,11167602,6.074489946927437
Hs 888.T,156414,1.6153983574814628
P-STS,54639665,4.398592450418463
TE 617.T,148198,-5.570836708197065
BFTC-905,10385095,2.0978900554642275
Hs 729.T,1716436,3.5931313044432107
TE-14,46926350,-3.484137029842133
KYM-1,156414,1.5083149541884115
IGR-39,10302451,3.7276422504611024
GSS,151289,0.3152471574412673
Rh41,4259181,-0.3079102815907465
RS4;11,44493528,4.150848985906847
G-401,136227924,2.3105932180874365
RD,374536,2.810565135396686
MV4-11,135984461,1.5625386820387543
NCI-H2085,11485656,3.209743954630266
SNU-761,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9273758693433116
Rh18,148198,-3.372937628836821
Mino,49766530,-3.2030154452064696
DU145,148198,-3.066698935751989
SUP-B15,tanespimycin-bortezomib (250-1 mol-mol),0.1434284566489843
MHH-CALL-3,156414,0.7888389372381419
Jurkat,9929138,6.106641752412507
EHEB,654092,-1.857578615070723
KO52,6918638,-1.0658834160946808
CA46,6918638,-2.155597959241919
HuG1-N,tanespimycin-bortezomib (250-1 mol-mol),-2.4884631877439207
L-428,16013152,4.307336841634765
OAW28,1716436,3.318226269910468
PE/CA-PJ15,6450551,3.117610470620624
LS513,11404337,-0.9008701596149395
SNU-840,49766530,1.025296962572851
MJ,374536,1.9717818313070976
ALL-SIL,135984461,1.7193250250744925
PLC/PRF/5,10302451,4.036530527642544
RPMI-6666,selumetinib-BRD-A02303741 (4-1 mol-mol),6.003904148362135
JM-1,54618771,-0.5043757930015165
NCI-H1435,135984461,4.625083763194788
MEC-1,374536,1.5204758486228809
SF126,sirolimus-bortezomib (250-1 mol-mol),1.2366353132911738
T24,44493528,4.3959417909273215
TE-5,9903786,3.304893690679265
RMG-I,9903786,4.466562574504816
HCC2935,4259181,1.139501635941419
NCI-H446,10385095,-0.4257133247784896
BT 330,24753719,4.584303652526146
WM115,9929138,6.7694003006369226
SW948,148198,-4.802987893737634
WM115,4259181,1.0090630393378868
OVCAR-8,9911830,3.0266621981898307
Hs 766T,6450551,3.6261253208314006
BT 112,10385095,0.9487594139156588
SNU-61,9911463,3.407728451470452
NCI-H1341,11404337,-1.9361621115679644
BT-16,24772860,-1.9305481234361872
HCC15,136227924,3.0147456858017923
HL-60,tanespimycin-bortezomib (250-1 mol-mol),0.1959762790136793
Kasumi-1,753704,3.5011406248382593
PL-21,9903786,1.6725311379491856
Kasumi-2,71729975,0.1244547207122276
UM-UC-3,4259181,0.3214411925726369
HT-144,6450551,3.273762781177103
COLO 680N,24753719,4.633194138255632
MCAS,3815108,2.6795391503759607
TE-5,374536,0.7839483394330725
ES-2,9903786,4.393151500832027
SNU-C5,54618305,4.2620968898118665
DMS 273,136227924,2.538513279360657
639V,11404337,-0.9671981800309744
EC-GI-10,100016,6.57909581265972
NCO2,54618305,3.6684730669441152
NCI-H1184,374536,2.491569591887116
CW-2,100016,4.445901991176778
NCI-H1650,3815108,2.3303128498089034
JHOM-1,49766530,1.1391722298569036
ZR-75-30,9911463,4.362849921974398
SNU-738,4259181,-0.68989187934339
Ki-JK,9903786,1.8002187553993072
SNU-C1,374536,3.297525921451146
A-172,24753719,4.737896512470815
MKN74,11485656,1.8439400608742984
BT 359,11485656,2.534841639455838
BT-12,46926350,-4.231666515808639
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798
MKN7,54618771,2.9720813941878577
SNU-449,135984461,4.468051833024593
BT 112,100016,6.504213631006025
Daoy,11167602,1.994230067492168
VMRC-RCW,49766530,-1.510963658016383
HuG1-N,49766530,-0.3535010251675565
GI-1,tanespimycin-bortezomib (250-1 mol-mol),0.3009698031973534
LS1034,2708,4.940432901509908
Rh30,selumetinib-BRD-A02303741 (4-1 mol-mol),3.819108813893848
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
HOP-62,54618305,4.329207399796136
A2058,sirolimus-bortezomib (250-1 mol-mol),2.018085480755274
NCI-H2170,24753719,4.072230001387307
SNU-869,6450551,3.8770511742330385
SH-10-TC,11404337,0.4880521649819775
SK-N-BE(2),100016,5.117046374692038
KYSE-450,1716436,4.321900870881558
NB4,11485656,1.2735256596960405
NU-DHL-1,9911463,3.294428726772871
BT 159,10302451,3.9427474616205527
SNU-1,10385095,0.3695201358363642
KMS-27,151289,0.3978275019277482
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
U266B1,136227924,2.814695997301776
WM266-4,1716436,2.740580067311599
NCI-H2452,151289,3.721937933525537
NB1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.017643189253372
TE-10,151289,0.6754777670610279
SJSA-1,1716436,3.146722908521096
CAL-12T,10385095,1.410088866478716
EM-2,24772860,-3.2482957293088535
PSN1,selumetinib-BRD-A02303741 (4-1 mol-mol),1.1398794427750998
HCC95,tanespimycin-bortezomib (250-1 mol-mol),-0.0613788307173083
PSN1,2708,5.370866677012956
JURL-MK1,327653,3.1753414176725374
BT 328,54618771,1.300712581347958
Namalwa,148198,-5.5603375502023
HCT 8,11404337,0.7757331501446172
Rh18,2708,5.233616259037217
KHM-1B,4259181,-0.2095303903157825
Mel Ho,9903786,4.6138306230888615
OE21,753704,4.973993702825942
JHOM-1,4259181,2.459176547146831
BHT-101,11404337,-0.8780725416326395
GA-10,156414,-0.0566742081865969
OE19,selumetinib-BRD-A02303741 (4-1 mol-mol),5.591368203731572
LS513,44137675,3.5208919037438435
MOLT-3,2729026,2.0706507776909797
HCC2108,9911830,2.581322243172156
HCC15,9868037,2.5640614102548556
BT 228,10302451,3.762994795422787
OCI-Ly3,46926350,-4.710215818226045
LC-1/sq-SF,6450551,3.948634568614427
NCI-N87,9911830,2.159086109533926
SR,1716436,2.2936310361494368
MOLT-3,49766530,-1.2433717650560063
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296
CGTH-W-1,10385095,-0.093106341441523
RERF-LC-A1,3815108,2.7626146820147106
NCI-H810,327653,2.789807305040245
NCI-H1355,10302451,3.9139868052709303
MeWo,11485656,1.6470015852450477
MPP 89,tanespimycin-bortezomib (250-1 mol-mol),-0.3809360105117337
CCF-STTG1,9911463,4.668972921835481
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379
HuP-T4,24753719,4.326193689938818
EPLC-272H,1716436,3.1377848134665203
TUHR10TKB,16013152,4.142525368060884
L-363,10302451,3.481450543195112
HuG1-N,9843750,6.4310827796090075
BC-3C,11404337,0.8699913882296267
SW1271,124202324,3.327062905972079
5637,9911463,3.863072039147436
SNU-C1,44493528,4.07827245501809
MM1.S,124202324,0.7291888929578118
DB,2708,3.211942033655551
VM-CUB-1,4259181,-1.4163454013046757
NCI-H2052,9911463,3.999991108260545
Karpas-299,44137675,3.8369112400120553
Hs 729.T,135984461,4.562955987712422
JHOM-1,2708,5.502724538420759
Li-7,11404337,-1.093112923264353
EPLC-272H,tanespimycin-bortezomib (250-1 mol-mol),-0.4152033872226455
NCI-H650,2729026,3.043812935842183
HEY A8,654092,-1.3845416589168795
SW1271,2708,3.697662973501111
OCI-Ly19,374536,-3.0279943028606024
TE-6,148198,-3.788482057513412
SNU-16,44493528,3.7043478102813543
BT-474,6450551,3.807989218091122
BT 239,9903786,2.77679173166366
253J,9911830,2.3790820688592915
KP-4,3815108,1.1665243369015572
PE/CA-PJ41 (clone D2),6450551,5.006652312044534
TALL-1 [Human adult T-ALL],49766530,-2.2368967155466586
SNU-5,1716436,4.364299480680524
A-172,135984461,4.014453553183264
NCI-H1869,9911463,4.397307517913515
FaDu,44493528,4.321653522203767
HEC-108,124202324,3.003291050730973
ALL-SIL,24772860,-3.38763553354356
LAMA-84,49766530,-2.2840485371109907
253J-BV,9903786,4.2891414604158395
BT 131,71729975,2.0207516769977176
DMS 273,10302451,4.121656528900648
LUDLU-1,10385095,0.8860258407517785
UM-UC-1,148198,-3.090298410357246
OVCAR-4,148198,-2.4399206848241852
SNG-M,24753719,4.6329108840502755
P3HR-1,151289,1.936230724636575
WM1799,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.1935195553798367
SW1710,sirolimus-bortezomib (250-1 mol-mol),0.811654459506224
CAL-27,156414,-2.8765071974836753
HCC2218,24753719,4.203747077764167
DMS 273,6918638,-0.6329393875591668
VMRC-LCD,148198,-4.056335514777046
A3/Kawakami,11485656,1.2537678238706411
ST486,151289,0.2759705434939
AsPC-1,148198,-3.729188282050714
SNU-886,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1159003486040796
NCI-H2228,2708,3.666598889984178
LS1034,sirolimus-bortezomib (250-1 mol-mol),1.3157999694585985
EJM,4259181,-0.0332233948997356
NCI-H2228,10302451,2.892697345966427
PE/CA-PJ15,24772860,-3.9275354144637222
K029AX,46926350,-4.28635172102327
NCI-H810,10302451,3.713085374892607
Becker,selumetinib-BRD-A02303741 (4-1 mol-mol),6.881234663908775
HEC-59,54618771,1.4246899684638197
KMS-21-BM,54618305,4.311138878515908
CL-11,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.554171496062592
NCI-H508,selumetinib-BRD-A02303741 (4-1 mol-mol),3.0934600568027864
T84,10302451,1.5341654621205278
8505C,selumetinib-BRD-A02303741 (4-1 mol-mol),4.971702874349743
KMH-2,374536,2.08598760334219
SNU-119,156414,0.2348404717120807
BICR 22,10302451,3.218470138701286
NCI-H1184,4259181,-0.769318878882707
NCI-H1975,24772860,-2.845061547756311
CCF-STTG1,9911830,2.0742504991173103
JHH-2,16013152,3.957868737669592
RKO,24772860,-3.046302255649564
VCaP,11404337,1.1855429552753238
BT 482,11167602,2.215432858582155
SNU-761,1716436,3.0934568789933308
TE 441.T,327653,2.387297951651056
TOV-112D,54618771,0.882664692368087
SW1271,9868037,2.9396003878324857
VMRC-LCD,156414,1.548496680895589
IGROV-1,11485656,1.900409616013456
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
253J,JQ-1-UNC0638 (2-1 mol-mol),1.8166446177570423
LK-2,11404337,-2.7548250863089367
YKG-1,11167602,4.915993662125618
DEL,151289,-0.9305674038268488
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
TT2609-C02,135659046,5.602741752641771
SNU-216,1716436,2.816824645868314
RT-4,9911463,3.5197462916355073
SNU-738,9911463,3.7270128558697664
JHH-1,9911830,2.2823579854201235
KE-39,4259181,-0.84210776373342
SNU-1,156414,1.4754796967551809
TT,654092,0.2859680463833356
NCI-H929,54639665,4.443848049019438
CAL-148,24753719,5.136890260522855
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925
WM793,11485656,2.688663515558037
SW1710,24772860,-0.5797350423509153
NCI-H2342,4259181,1.1305245498799386
NCI-H2444,156414,2.4052737888176132
OVTOKO,9911463,4.1019339858754025
ACHN,54618305,4.302999530390601
CAMA-1,3815108,3.384323981440758
HCC1500,44493528,4.240662848371031
LNCaP clone FGC,9843750,5.190823020080022
YD-15,54639665,4.469393901086846
CCF-STTG1,4259181,1.4943010127790817
LN-18,24753719,3.9269044306428262
SNU-216,135984461,4.361470667524811
COLO 800,2708,5.15913131558728
NCI-H441,11485656,2.293217978905633
HPB-ALL,tanespimycin-bortezomib (250-1 mol-mol),1.0478674895496405
HPB-ALL,135984461,3.5745681488529693
SK-BR-3,10302451,2.9491683435141045
BT 172,selumetinib-BRD-A02303741 (4-1 mol-mol),6.01258127045578
OPM-2,54618305,3.930022905522119
NCI-H1339,49766530,0.922676999768476
FaDu,46926350,-3.852894078330531
BFTC-905,10302451,3.466344338322821
KG-1-C,9903786,3.898193715125589
MDST8,753704,4.923832713886697
NCI-H520,9911830,1.0152339024945511
SNU-175,151289,0.0022937809462513
RT-112,44137675,3.8654107229768897
Pfeiffer,2729026,1.7827557426641891
VMRC-RCZ,374536,-1.0336559118569313
HOS,2729026,3.100562687689208
HGC-27,71729975,-0.2607747724253211
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
KMS-34,136227924,2.5847633588950147
LS123,selumetinib-BRD-A02303741 (4-1 mol-mol),3.0706575682689174
HCC1954,54618771,-0.9668163478355224
GSU,654092,0.6224255250093333
Sq-1,156414,1.0754801574574806
SW1990,24772860,-2.504887320110065
FU-OV-1,3815108,2.287889788505342
UO-31,JQ-1-UNC0638 (2-1 mol-mol),1.3610006056805275
HCT 116,2729026,3.064656005481419
LS1034,JQ-1-UNC0638 (2-1 mol-mol),0.8932296490817896
Jurkat,44137675,2.726096797292076
NCI-H226,9911463,4.360420570038796
WM115,54618771,0.9043395114740442
HEC-1-B,44137675,3.049138227269371
Capan-2,4259181,1.3752260367329712
HCC1806,654092,-0.2463930989489459
MV4-11,4259181,-0.4542476315721023
Hs 936.T,24753719,4.451311160426746
BT 239,44137675,1.9017616531684407
SNB-75,JQ-1-UNC0638 (2-1 mol-mol),2.745721244255198
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
SNU-626,2708,4.930969216601779
PaTu 8988t,44137675,4.243997881661858
SK-ES-1,10385095,1.064305584268687
NCI-H2196,selumetinib-BRD-A02303741 (4-1 mol-mol),5.255349745605376
T3M-10,54618305,4.952668323160926
HuH-28,selumetinib-BRD-A02303741 (4-1 mol-mol),4.5989236312045
MKN74,327653,3.1147590669580847
PC-14,124202324,1.9145516901942
DMS 273,54618305,4.272082763698834
SF539,16013152,3.768432455806556
ChaGo-K-1,10385095,0.7525502719591264
NCI-H1793,2708,4.737546379777548
RCC10RGB,10302451,3.839480938635774
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
DoHH2,151289,0.6010521550193085
HCC15,10385095,2.335943691067567
Calu-6,100016,6.484915939204548
COR-L105,2708,5.5167338716905885
BFTC-909,100016,5.8134150302243865
BT 416,10385095,0.9416016414331604
NCI-H889,9911830,3.240123701287177
SK-N-FI,6450551,1.4898603974739086
CCF-STTG1,54618771,4.049347271840678
MHH-CALL-4,2708,1.3963127799025794
GI-1,6918638,0.0741451008048908
8505C,2729026,2.673040534656342
CAL-85-1,135659046,3.2911060115493487
SNU-81,9843750,-0.6437789188002867
SUP-B15,9911463,4.29291953210489
COLO 205,49766530,-2.229597593802736
RS4;11,654092,-1.6972495587318472
SK-LU-1,11404337,-0.1113986286493255
LK-2,10302451,3.925181253698499
MDST8,135984461,4.124255066625015
MOLM-6,1716436,2.6829311509731797
HCC1438,11404337,0.7174449174884908
Hs 611.T,9911463,2.4472090052981104
MKN1,1716436,3.450749639836205
U266B1,JQ-1-UNC0638 (2-1 mol-mol),0.9600521873558716
OCUM-1,sirolimus-bortezomib (250-1 mol-mol),2.078884953433103
NCI-H1915,9911463,4.383927524299923
NCI-H446,654092,-1.9395075355692484
CCF-STTG1,11404337,1.400188980811807
COLO 201,11404337,-0.0610215360634596
22Rv1,4259181,0.07486128932158
RPMI-6666,151289,0.8903730451716652
KMRC-20,148198,-1.1031106323256945
PC-3,sirolimus-bortezomib (250-1 mol-mol),0.5730469414273184
A2058,10385095,1.1585362440671565
KMS-20,148198,-4.371887061655697
COR-L47,tanespimycin-bortezomib (250-1 mol-mol),1.2425942007865165
COLO 205,10385095,2.547390594330649
Namalwa,9903786,1.5886639412240358
HPB-ALL,4259181,-0.2921614648601848
T3M-10,tanespimycin-bortezomib (250-1 mol-mol),-3.2480319159922515
HuCC-T1,156414,2.9876112232007515
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
SET-2,374536,-5.775259114630841
A-375,100016,6.005492870785018
NCI-H460,654092,0.4612941847378306
Mono-Mac-6,selumetinib-BRD-A02303741 (4-1 mol-mol),4.195228753694928
MDA-MB-231,9911830,2.6293157507295746
Li-7,9911463,2.7835624344387924
CA46,46926350,-5.311040218420036
SUP-B15,135984461,1.5774458339349344
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
KMS-18,124202324,2.0191806538819224
TUHR4TKB,11485656,2.4946743864247467
SK-OV-3,9911830,2.8997016876614863
JHUEM-3,1716436,2.9039249840267747
Sq-1,151289,2.759472511238145
Detroit 562,9911463,2.662493501158816
FaDu,2708,4.658776711592835
HCC2935,1716436,2.8932811056898697
LK-2,6450551,2.8956143866735338
P-STS,54618771,0.5747646300183281
SNU-899,9868037,2.9097531186900536
A-673,6450551,1.2504532759531255
LXF 289,24753719,4.56569970094865
DOV13,11404337,1.060894937445875
SNU-C1,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.76614850741295
NCI-H1869,6450551,4.274729428464116
253J,1716436,2.969182413994948
U266B1,753704,4.6411705093857005
ESS-1,16013152,5.626524469878935
SCC-4,2708,5.106870438034181
HCC2218,49766530,-1.6679502221604972
T3M-10,4259181,1.4457109010794826
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
BT 187,10302451,3.7784364345624666
P3HR-1,136227924,2.9304577514896466
8305C,24772860,-0.6370432072089216
DLD-1,9903786,2.1877560593252343
Panc 02.03,44493528,4.298055948100647
SNU-668,3815108,2.788366008406377
GSS,44493528,3.3523152661805526
ECC10,10302451,3.62041349864807
MSTO-211H,9911830,2.3480580098381747
HEC-251,3815108,2.201909583743895
Yamato-SS,9911830,3.158388861386652
Hs 934.T,1716436,2.941878367711625
CFPAC-1,9911830,2.8943763648289833
A-549,44137675,4.013710884820414
SW1710,2708,4.81615149375294
SU-DHL-10,374536,2.341912047075354
SK-MES-1,135659046,3.5561232881246805
SF539,135984461,4.130188481564332
AsPC-1,4259181,1.083384461798112
TT,JQ-1-UNC0638 (2-1 mol-mol),1.9064293595627344
MOLT-16,11404337,-3.721146983736032
Jurkat,24772860,-2.2420188698826733
SK-N-BE(2),156414,1.4719636932362017
HEC-265,2708,5.750566704438098
697,tanespimycin-bortezomib (250-1 mol-mol),0.0075427877175817
Yamato-SS,46926350,-3.736768153292348
HuH-28,327653,3.326177611407744
Calu-3,11167602,2.8347339607086117
KMS-11,4259181,-0.7092027923860437
MES-SA,156414,-2.755878180461248
SF126,54618305,5.7910239418696
SW48,9911463,3.374803590447597
Daudi,73707371,3.866210661620395
CAL-148,3815108,3.5144314808440806
BT 328,1716436,3.653949071950038
U-118MG,9903786,4.127288494791117
ZR-75-30,11404337,1.0158794681512644
SNU-620,24753719,4.282331882564318
GSS,136227924,2.0459518542117983
NH-6,9911463,4.337318302270048
JHOC-5,44137675,3.644360656624991
SNU-1077,327653,3.4488214544204108
Reh,24772860,-3.438365226229883
EFO-21,4259181,0.6056333672996519
SK-MEL-24,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.125185655381191
YD-15,11485656,1.939430156438133
SF268,135984461,5.451116229998117
BT 504,4259181,0.909538881723855
MSTO-211H,124202324,2.766151060695559
HCT 15,tanespimycin-bortezomib (250-1 mol-mol),-0.1755556188950918
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
NCI-H2171,44493528,3.677120674941258
EFE-184,2729026,2.4968560542539984
A4/Fukuda,24772860,-3.4983689572797307
MKN74,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7109698325669793
LS123,16013152,1.645228407626886
EFO-27,327653,2.4330037956805133
AU565,753704,4.59624742359194
MCAS,24772860,-3.031835508256121
KMS-28BM,374536,1.33916030519521
AU565,9911830,3.457946854316075
NCI-H292,156414,1.4083938325335852
Hs 611.T,44493528,4.184302816514897
SF295,654092,0.0189018784899866
BT 216,327653,3.657240159217869
Daoy,374536,0.0101858248128639
BT 245,6450551,3.220292002142508
Granta-519,148198,-4.763660659469611
BICR 31,151289,1.9519908762907336
OCUM-1,11485656,1.6413054231904327
Hs 895.T,tanespimycin-bortezomib (250-1 mol-mol),2.1359790138247674
HMC-1-8,9911830,2.6920274268432904
NCI-H2444,11485656,3.180889910704459
NCI-H1184,1716436,1.9697120433933637
NCI-H2405,44137675,4.346148489861756
JMSU-1,44137675,3.06767675443052
SNU-16,6450551,-1.2447265158477867
JM-1,54618305,4.117087010604098
Toledo,1716436,2.6728361005146284
COLO 678,1716436,2.018628549705393
CJM [Human melanoma],1716436,3.903910024968164
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
NCI-H1869,24753719,5.307545419394006
SNU-175,24772860,-3.38201311177162
Panc 04.03,24753719,4.39873379823384
IMR-32,753704,3.2585074945074233
MOLP-2,sirolimus-bortezomib (250-1 mol-mol),0.2890446382441622
BT 179,2708,5.426251712522789
SCaBER,tanespimycin-bortezomib (250-1 mol-mol),-1.0690096997886145
COR-L51,46926350,-4.664758709189539
MDA-MB-361,6918638,0.2584524690871702
CAL-78,3815108,4.123763041744017
SU-DHL-6,11485656,1.7981230616770194
KALS-1,11404337,0.5593043385497104
JHUEM-7,753704,4.187441379139962
NCI-H2122,selumetinib-BRD-A02303741 (4-1 mol-mol),4.482032862339771
SNU-478,9911830,2.418817051969649
IGR-39,151289,1.6538315766938465
HMCB,54618771,0.8772324111806863
MM1.S,753704,4.513964984168999
NCI-H1435,11404337,-0.2240916752478429
U-87MG ATCC,124202324,5.150271150953114
KNS-81,54618771,0.6221036403024617
KCL-22,tanespimycin-bortezomib (250-1 mol-mol),-0.2876767287286612
COLO 320,tanespimycin-bortezomib (250-1 mol-mol),1.191439437056519
SUP-B15,136227924,1.2725004934322246
SNU-886,44137675,2.6120412235311856
KMS-12-BM,2708,2.6805418133728747
SK-N-FI,11404337,-1.561187150233845
IGROV-1,10385095,1.0670946713416192
Mel Ho,44137675,2.4182541037062566
NCI-H1915,49766530,3.459700063272212
COR-L51,9911463,3.8563370562199286
HCC1438,4259181,-1.3511895743455689
SNU-182,10385095,1.0621508368080206
CAL-51,24772860,-2.425084956958233
TUHR10TKB,9911830,3.088546123697112
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
SNU-626,44494015,6.327875246768692
BT 228,10385095,1.1315778331384152
RCH-ACV,10302451,2.577047280767927
HCC15,156414,2.365134958139565
253J,11404337,0.3224352985838272
Lu-65,148198,-3.5921377356072397
CAS-1,654092,0.2345900659347102
Hs 578Bst,sirolimus-bortezomib (250-1 mol-mol),2.6578506949502416
BHY,9903786,2.1017831140065844
HT-55,2708,5.174129695408029
SNU-216,6450551,3.3089706641589887
JK-1,10302451,-2.112051383463461
NCI-H1792,sirolimus-bortezomib (250-1 mol-mol),1.8777414374963155
SW1116,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.3819919735240309
OVISE,9929138,5.66720682434708
HT-1080,sirolimus-bortezomib (250-1 mol-mol),0.4645124048276262
Kasumi-1,156414,1.0680106868971504
NU-DUL-1,24753719,2.364592509391835
MSTO-211H,9868037,1.9157833543052896
HCC1569,374536,1.6130630003676834
SNU-C5,4259181,0.2951385005953514
KNS-62,6450551,3.7675596691575537
Lu-99,9868037,3.2143966099709655
FaDu,6450551,3.6483034086827297
P-STS,374536,1.7080340780268333
D283 Med,2729026,2.489679691216484
OVK18,11404337,-0.9122714237451722
KMRC-2,9903786,3.847767222952075
K029AX,374536,-1.2686573332771414
DMS 273,11404337,-1.7233190830375906
BICR 16,2708,7.582238347132434
TOV-112D,16013152,4.3674059519639545
HCC827,2729026,3.023197447819954
NCI-H1944,16013152,3.5569100382628926
A-375,374536,3.591388157416232
NCI-H1734,151289,0.4160680095145431
Jurkat,49766530,-1.3206088246448346
OVCAR-4,9903786,4.586941705699431
DV-90,2729026,2.362573149905267
HCC1500,73707371,6.057238887548947
MDA-MB-157,1716436,1.1718034720311097
Toledo,6450551,3.66759171222362
KP-N-YN,11485656,3.2850291914647345
SK-MM-2,9929138,0.5464010335439101
JHUEM-7,JQ-1-UNC0638 (2-1 mol-mol),-1.108952996086482
Hs 746.T,44493528,3.791108114559063
ACC-MESO-1,148198,-2.036295291578454
NCI-H1838,9911830,3.483637720340384
SNU-308,9911463,4.030831002886429
SK-MEL-24,327653,3.7561333766375817
TE 617.T,6450551,3.191526585759877
Hs 611.T,10385095,0.6904393672995198
CA46,9903786,1.650432742323398
HEC-1-A,6450551,2.908473726529578
NCI-H1573,6450551,3.3228810006892284
MV4-11,156414,-0.848547238114129
PF-382,2729026,0.5855884852341721
KHM-1B,148198,-5.169783546510426
MG-63,4259181,1.2675663544534232
NCI-H526,151289,0.4804646759260215
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
LAMA-84,654092,-1.6487523157463664
NALM-6,9911463,2.9275320549499613
SUP-M2,11485656,1.133597782869627
HEC-6,753704,5.015357925865091
Karpas-620,9911463,4.471669059123084
SEM,selumetinib-BRD-A02303741 (4-1 mol-mol),2.811165590219853
Calu-6,1716436,3.3014069554755965
EB1,2708,1.6331378886358063
NMC-G1,JQ-1-UNC0638 (2-1 mol-mol),2.869330384712891
A4/Fukuda,9903786,0.7546004224414102
LAMA-84,JQ-1-UNC0638 (2-1 mol-mol),0.5418649930302746
Ishikawa (Heraklio) 02 ER-,24772860,-2.041697460836392
VMRC-LCD,9903786,1.8330708335593808
KMM-1,374536,2.279265842330542
SNU-761,11404337,-2.3232289106427695
HuT 78,11404337,-1.1966282759274738
VMRC-RCW,54618771,0.4533300000402974
SNU-C2A,374536,4.103445525441604
HEC-1-B,135984461,4.439754583263078
OV7,sirolimus-bortezomib (250-1 mol-mol),0.4269208814409986
LS513,654092,0.4595403342784717
HCC38,6450551,3.434449022219302
KE-39,selumetinib-BRD-A02303741 (4-1 mol-mol),5.809798702623815
DU145,10385095,0.949692238641196
TOV-112D,100016,6.758334848108728
BT 239,11167602,1.6889728447058876
H-STS,148198,-3.664450029895992
NCI-H1944,9911830,1.980153865987294
KYSE-410,148198,-1.166924431681682
OPM-2,135659046,2.7260896342727396
MOLP-2,374536,2.3162575999055703
RERF-LC-MS,2708,5.106155932743474
KE-97,135984461,3.5565388757369014
HuH-6,148198,-4.2090148459879275
P-STS,10302451,3.885100498730175
HGC-27,2708,3.3376859351468258
MDA-MB-157,6918638,0.523436976846598
NCI-H1693,9911463,3.5933449659927477
MOLT-16,10302451,3.2248246991129985
HPB-ALL,136227924,2.35435467065409
TUHR14TKB,JQ-1-UNC0638 (2-1 mol-mol),-0.3020120756544653
NUGC-3,10385095,1.1907439183905275
HuT 78,1716436,2.3325786548339207
G-361,135984461,4.251520371382919
BFTC-909,44493528,4.370300807083883
HCC1143,3815108,2.289037887638348
HuH-28,1716436,3.2483302673256618
HL-60,6450551,2.149378932754994
NCI-H1563,46926350,-4.086090317875099
SK-N-AS,9903786,2.5201816871089653
A-375,4259181,-0.8072558556065395
OVCAR-5,sirolimus-bortezomib (250-1 mol-mol),0.9753915222823988
GA-10,10302451,1.250963043335676
Caki-1,2729026,3.1585086948923156
CCF-STTG1,2729026,3.1743865852367383
BT 330,148198,-5.294661964865024
WSU-DLCL2,135984461,1.5451272149334774
SW982,2729026,3.015191283827158
U2OS,9903786,2.225601394928473
MCAS,9911830,3.0082836124394214
SNU-387,24772860,-2.2483207474426927
SUP-T11,753704,4.064127852197216
SNU-C5,156414,1.5922286954824516
LOX-IMVI,100016,4.319089113839007
Kasumi-1,24772860,-3.862442633433672
253J-BV,4259181,-2.41881896756534
JHUEM-2,44137675,2.3051773346998305
MHH-CALL-4,136227924,1.8406000029443903
NCI-H1838,148198,-2.358170233860321
KNS-62,11167602,2.252686967098562
Calu-6,10385095,1.5195799432137909
JJN-3,9868037,2.860227740471185
SNU-1,148198,-4.8344466851703425
MEC-1,11485656,1.7582938847723142
BDCM,10385095,0.3905687055307765
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167
A-549,654092,-0.0816351868861503
KYSE-180,2708,6.074726642360877
OCI-AML-5,44137675,3.8877087798647474
SIG-M5,JQ-1-UNC0638 (2-1 mol-mol),-1.803321584067572
NCI-H1092,6450551,2.2597381563726433
AN3-CA,753704,4.635041156511698
MDA-MB-361,9911463,4.323497130466389
NCI-H1339,6450551,3.0443618718545244
FaDu,136227924,3.658135500280057
NU-DHL-1,9868037,1.5827566273106026
SNU-410,JQ-1-UNC0638 (2-1 mol-mol),3.2392922104580766
BT-12,49766530,-0.9440868950031468
Detroit 562,JQ-1-UNC0638 (2-1 mol-mol),0.4482298253487032
HCC366,JQ-1-UNC0638 (2-1 mol-mol),2.1294275322909475
OPM-2,136227924,1.7425170628423947
A101D,135984461,2.9923151826586474
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
Jurkat,151289,-0.796589527346247
Jurkat,124202324,1.1043432928164305
PaTu 8902,2729026,2.7803221257085884
KE-37,151289,0.5163783146310148
EN,54639665,4.409810078244538
CGTH-W-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1580124006071881
NCI-H1755,2729026,2.388158634259483
JMSU-1,1716436,3.313739239236942
Ku812,9911830,-2.227591069329418
NCI-H2170,753704,5.63386961112453
NCI-H526,24753719,4.440370143489617
DND-41,49766530,-2.480417892949832
SU-DHL-1,136227924,2.1802521862386395
EKVX,selumetinib-BRD-A02303741 (4-1 mol-mol),1.7379075309725052
Rh30,44137675,2.780115728259252
JHOS-2,2729026,3.3384835076547135
RPMI-8402,654092,0.4039840016168103
NCI-H2023,11404337,1.2221631791218432
KYSE-140,2708,5.479342492589101
DV-90,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.2426858750448604
NCI-H1734,44137675,3.226902719762834
BT 504,2729026,1.2282846763144355
TCC-Pan2,sirolimus-bortezomib (250-1 mol-mol),2.6812327412010095
MOLM-16,11485656,1.7000856268128752
SW1990,44137675,3.438362060135723
JHH-4,2708,5.006903548419954
SK-N-MC,148198,-7.75937089514698
OCI-Ly19,4259181,0.058208585019133
VCaP,135659046,3.61578581295777
NCI-H1568,44493528,4.1542795967274175
HCC1195,151289,0.8205922093906763
SET-2,6450551,2.11700475180411
SET-2,10302451,3.517530060309579
YD-10B,2729026,2.0989728783137993
SW1353,54618771,0.8265365902772687
Rh18,654092,-2.3019636784174455
G-361,2708,4.8285296644355595
BT 245,4259181,0.4559580659670063
TE-8,4259181,0.2121873060682536
BT 340,4259181,1.6823623787475968
Namalwa,6450551,1.7730795901303054
SK-UT-1,10385095,1.6809894125740852
KMS-28BM,3815108,2.0328084120219
KO52,753704,4.242778315458095
TCCSUP,136227924,3.28330337763218
JHOC-5,24772860,-1.7902174083578295
NCI-H841,2729026,3.1178481776148295
NCI-H1339,46926350,-4.1465404502416146
RERF-LC-A1,44137675,4.267374816283445
SW579,11167602,0.0492455153665494
Namalwa,2729026,2.9646999473246125
Kuramochi,654092,0.2501049831905006
EFM-192A,6918638,-0.4995491162684927
SUIT-2,9911463,4.378510442631056
PF-382,49766530,-3.617209334662046
IM95,156414,5.105742065185946
GaMG,10385095,3.009741881830446
CAL-27,46926350,-4.2922639647524425
SNU-C2A,11485656,2.2484892549692104
8505C,151289,0.9798338365794952
SNU-478,sirolimus-bortezomib (250-1 mol-mol),0.1595579698583019
Hs 578T,4259181,0.6901225496008685
HH [Human lymphoma],9911463,2.7803451597373887
COLO 668,374536,0.5499518350304913
A-253,11485656,0.5769754234687416
EJM,9911830,2.3498846254734267
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
VCaP,JQ-1-UNC0638 (2-1 mol-mol),-1.5454078219453378
T-47D,tanespimycin-bortezomib (250-1 mol-mol),1.663799380230643
SCC-25,44493528,4.171746510853467
AGS,44137675,3.630969000882386
C2BBe1,49766530,1.671103573384802
COV362,9911463,4.09854826662349
COLO 792,136227924,2.7402829929938908
NCI-H2126,11404337,1.7929049534978918
LMSU,11485656,2.410376154528579
SK-MEL-24,2729026,2.477411451791523
G-401,11404337,0.5096427987118028
KNS-60,135659046,3.5033473079997273
NCI-H1155,374536,1.41714695965557
IGROV-1,6450551,2.579641476451469
2004,1716436,1.9908951151800849
Panc 02.03,54618771,1.0884531427161812
BT 164,2708,3.2547153455011832
CL-11,JQ-1-UNC0638 (2-1 mol-mol),1.1259372923073527
CAMA-1,49766530,0.0581457358273481
DU145,44137675,4.668364290879563
DEL,100016,3.851368536137221
Ku812,136227924,2.6493599225721742
SNU-C4,9868037,3.980442058485963
SNU-387,10302451,4.6164991918458345
HuG1-N,44493528,4.884146273169327
TE-5,73707371,4.917581074631227
NCI-H2405,tanespimycin-bortezomib (250-1 mol-mol),-0.894001775676426
KMS-21-BM,54639665,5.788754853748425
NCI-H2106,374536,2.411561545631662
NCI-H1355,156414,1.6377498317213597
KYSE-520,sirolimus-bortezomib (250-1 mol-mol),0.4067313196424638
Li-7,tanespimycin-bortezomib (250-1 mol-mol),-1.0040061775367006
AU565,54618305,4.305835133395234
JHH-4,9911830,1.3195614392380235
MOLP-8,54618771,0.2679151571300236
HCC827,sirolimus-bortezomib (250-1 mol-mol),1.7939037148295924
MPP 89,148198,-3.0572841720054007
OE19,148198,-4.200030852664729
HCC366,654092,-0.28350378697772
EPLC-272H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.892167182082727
DLD-1,156414,1.998485037364128
SNU-478,148198,-2.0757049952791835
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
NCI-H2081,9911463,2.5760332235225016
BICR 6,selumetinib-BRD-A02303741 (4-1 mol-mol),4.4751769614011865
KNS-62,46926350,-4.070612360095535
TE-4,tanespimycin-bortezomib (250-1 mol-mol),-0.9407472033022316
NCI-H211,148198,-5.011927941581449
RERF-LC-Ad2,135984461,4.955680046889378
NCI-H1651,9911463,4.060056657134865
SNU-601,49766530,0.5786542106679428
SNU-81,374536,-2.2172994025671877
Rh41,49766530,-2.538268095723461
RMG-I,9911830,2.9966783912607142
CA46,100016,3.773189878640827
D283 Med,9911830,1.6953738838285617
VM-CUB-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.657662931888384
8505C,3815108,3.3849185391970944
NCI-H2081,46926350,-4.428589866932994
U-251MG,10302451,3.867935268510184
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
COLO 668,JQ-1-UNC0638 (2-1 mol-mol),1.8955970953532864
CJM [Human melanoma],9903786,6.367293868352352
TF-1,49766530,-3.109454480053962
SNU-182,100016,8.076902029611453
TCC-Pan2,9929138,7.681781953750215
HPB-ALL,9929138,6.3136934521225445
T98G,44137675,3.425827674042774
NCI-H1694,11485656,1.9484050464829303
HEY A8,9911830,2.4689943419760687
AML-193,6450551,1.196223607769039
SNU-475,6918638,2.175803719234096
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
KMS-27,9868037,2.1445614612253614
YD-10B,9911463,3.649905942597577
GP2d,1716436,0.8160283183138299
LNCaP clone FGC,49766530,1.5259250948267933
TT,2708,6.69045821862985
253J,11485656,1.976874132149827
OV56,148198,-3.008820928663164
DOV13,156414,2.3224096962852325
OCI-Ly10,11404337,-0.1929706540387932
NU-DUL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.4841470415007147
KE-39,2708,5.6188157628289925
RMG-I,sirolimus-bortezomib (250-1 mol-mol),1.380025279026371
NCI-H23,9903786,3.588944874892838
RL95-2,6450551,1.7191079543797163
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425
8305C,3815108,1.9679171924578576
SNU-182,156414,-0.1626152970445549
Panc 10.05,54618305,4.6350576039907265
JHUEM-1,151289,0.7541922737991524
JHUEM-7,46926350,-4.455736364930407
SNU-1077,100016,6.64200464659652
ChaGo-K-1,9903786,4.114689259573735
Becker,11404337,1.8814700373648592
SH-10-TC,44137675,4.3516313621704
SK-BR-3,9911463,3.827340075959426
KYSE-510,2708,4.949325553929874
UM-UC-1,16013152,4.041148382411694
FTC-238,327653,3.128570376507189
SNU-410,49766530,1.0142633339399836
H-STS,selumetinib-BRD-A02303741 (4-1 mol-mol),5.187355615985605
BT 216,2708,5.209601241164954
TUHR4TKB,151289,0.8312650243989317
COLO 205,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9070380036728692
RPMI-6666,sirolimus-bortezomib (250-1 mol-mol),-5.127028405484722
WM793,148198,-1.495249919530428
HEC-1-A,11485656,2.952835409818289
SW1088,654092,-0.0168133650995458
SKM-1,100016,4.336407790429152
GB-1,11485656,2.586323751918647
SNU-878,selumetinib-BRD-A02303741 (4-1 mol-mol),2.996807120880874
EBC-1,135984461,4.240736230766537
Ki-JK,9911463,2.4210836276003755
639V,654092,0.5076819198225069
HOS,49766530,0.1670768985244303
NCI-H727,10385095,1.3903964913374658
HEL 92.1.7,327653,3.068543405394667
HMC-1-8,9929138,7.281868070980933
P12-Ichikawa,2708,2.1552268801633105
Hs 822.T,54618771,1.097463284906687
SK-UT-1,24753719,3.8954683516034194
IM95,136227924,1.5571875137371276
Hs 746.T,16013152,3.957984678898451
Rh41,sirolimus-bortezomib (250-1 mol-mol),0.2633406530968948
FaDu,10302451,3.713000367024148
UM-UC-3,2729026,2.968747651855842
NCI-H1563,44137675,3.3766434828153584
SK-ES-1,JQ-1-UNC0638 (2-1 mol-mol),1.0646046319460858
SNU-685,10302451,2.9829097141985583
SNU-423,49766530,-2.309056121887604
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
BT 504,9911463,3.2688065154654287
KMS-27,2708,3.181722849238598
RCH-ACV,10385095,1.3487937317088552
KMS-34,374536,-3.949404861281771
KMS-34,selumetinib-BRD-A02303741 (4-1 mol-mol),4.194143728542757
BICR 56,tanespimycin-bortezomib (250-1 mol-mol),-1.185151115756176
SW1417,151289,3.207792590849106
MES-SA,9911830,2.0754479009679065
LCLC-103H,2729026,3.1579084327212277
G-292 clone A141B1,11485656,2.845386478997394
A-498,6918638,1.620608219340894
SNU-16,54618771,0.522197701958757
TE-15,1716436,2.6611332853088316
786-O,136227924,4.54082640186513
SK-OV-3,44137675,2.687297746540291
KMH-2,44493528,4.009016955634305
SW948,44137675,3.8395253943289553
L-428,11167602,1.8021338177269608
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
EB1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.096386446893736
253J,6450551,2.7942420088985176
UACC-62,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0225979417231087
OAW28,3815108,1.950790900509605
NCI-H2342,10385095,1.222992790887497
DEL,44137675,4.269264900234762
SU-DHL-6,753704,4.418086475877281
SNU-449,2708,5.735631765174737
COLO 800,327653,4.002837585261912
NCI-H661,156414,0.2928474479064595
ME-1 [Human leukemia],9868037,1.581753710265031
SK-MM-2,49766530,-2.0965316269775816
Ci-1,4259181,0.2080497901890623
Hs 944.T,2708,3.266968835815505
VM-CUB-1,156414,0.5841257025928078
EB1,4259181,-0.1411659668037445
HCC1833,136227924,3.0159379881399895
KMS-21-BM,753704,3.635259602882489
MG-63,148198,-4.931736282287541
COLO 684,136227924,2.900562305918871
BL-70,100016,3.880189960258483
CAL-51,654092,0.82886283906252
FaDu,24772860,-3.440821793085649
KNS-60,151289,0.4163724298565523
697,135984461,1.702307522694506
SNU-738,10385095,0.1021175037849084
KMS-28BM,1716436,-0.4701026062568833
SNU-761,327653,2.9832598132977495
JHUEM-7,2729026,2.278155757312377
Mono-Mac-1,136227924,2.2269797620359864
NCI-H2342,753704,5.024341242620725
SNU-407,9911463,3.2824377830352818
NCI-H226,tanespimycin-bortezomib (250-1 mol-mol),2.419002105970759
VMRC-LCD,6918638,-0.8957275762534151
HCC1419,46926350,-3.9197313332616783
MV4-11,374536,-4.847254946430215
SK-MES-1,10385095,1.1316059221084596
U2OS,49766530,3.607044221214865
CHP-126,4259181,-0.3751518469974201
NCI-H1299,1716436,3.790585406368508
SNU-449,54618771,0.9697829427454708
HuH-1,6918638,1.1599636412838177
Aska-SS,49766530,-1.4586728518943333
L3.3,148198,-4.142602322676729
NCI-H1568,9903786,2.4011050725962115
NCI-H841,148198,-4.970110895605647
Hs 944.T,49766530,-0.7107074816486109
Ri-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.018523415252616
WSU-DLCL2,374536,2.1487656529276262
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
Hs 944.T,11485656,2.842031194485269
SNU-1196,124202324,2.726621487823768
DU4475,9911830,1.6292365330787766
CAL-85-1,136227924,2.9828253747888067
NCI-H1155,148198,-4.37557893691535
HCC38,156414,1.3056275729955638
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
WT2-iPS,100016,6.129452507999119
HCC1569,124202324,2.4222662027174766
DAN-G,9911463,4.055561075678672
NCI-H1155,44137675,3.039100649957252
CAL-33,selumetinib-BRD-A02303741 (4-1 mol-mol),4.927863269111553
SNU-719,JQ-1-UNC0638 (2-1 mol-mol),0.5787915675611492
OAW42,10385095,1.3430576612490104
U-118MG,24753719,4.187893090926533
BICR 6,9911463,4.323874314228029
EC-GI-10,136227924,3.398194138185936
EM-2,49766530,-1.2569750425961423
DMS 273,327653,3.1988672985426847
NCI-H1568,44137675,2.485428235347338
SNG-M,1716436,3.311927931412026
SW620,3815108,1.8173169020243352
EFO-21,2708,5.336289711775282
JK-1,374536,-2.860875470569632
VM-CUB-1,tanespimycin-bortezomib (250-1 mol-mol),-0.9212762336148834
CMK,100016,5.771362707779288
SNU-899,3815108,3.9221973620075823
MIA PaCa-2,4259181,-0.2210176227464965
HuH-6,9903786,2.683606252138214
HCC44,2729026,0.9293111830450362
G-292 clone A141B1,10302451,2.810763561923894
KP-3,136227924,3.03068470875373
KMS-11,1716436,2.328417513252821
EFM-192A,9903786,5.377742197319564
WM266-4,44493528,4.3133023998571565
NCI-H211,374536,3.262780618589496
SNU-840,1716436,3.160077175279895
SK-UT-1,2729026,3.1641569062038997
NCI-H358,44493528,4.323169379797207
Hs 852.T,327653,3.018176559338961
COLO 678,100016,6.808142270815235
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
JJN-3,9911830,3.4095867158278623
HH [Human lymphoma],24772860,-3.7929818915101423
MDA-MB-361,327653,3.3179134221439344
SNB-75,11485656,3.1834770923218065
NCI-H1373,49766530,-0.1297725913169194
NU-DHL-1,9903786,2.0090459538270298
AU565,selumetinib-BRD-A02303741 (4-1 mol-mol),5.383276880115408
SNU-878,6450551,1.192898083777014
BT 239,49766530,0.6116447613594903
HeLa,4259181,0.2156486881613415
Toledo,selumetinib-BRD-A02303741 (4-1 mol-mol),4.912140235603594
NCI-H1395,selumetinib-BRD-A02303741 (4-1 mol-mol),5.369939363502549
G-292 clone A141B1,4259181,1.2731839652194843
NB4,2708,3.2833567294686774
HPB-ALL,9911830,3.048089074029996
DV-90,10302451,1.181624513697412
KYSE-510,24772860,-2.0467548586209947
DK-MG,753704,4.4246407664220015
LS513,1716436,2.522692970072741
WSU-DLCL2,124202324,0.8615873548230671
SF295,49766530,-1.8796707032595965
TF-1,135659046,3.556796547128311
NCI-H838,100016,5.521581837907123
TE-15,156414,-3.941980071268382
CAL-51,54618771,0.0049145289548569
DAN-G,sirolimus-bortezomib (250-1 mol-mol),0.114309742904921
SW982,44137675,3.600099959310863
NCI-H1703,100016,6.215140096774371
EoL-1,151289,-0.2057900839976434
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
BT-16,9843750,4.264600863320917
HCC1937,124202324,5.1984002603831225
LXF 289,11485656,2.2610473771175847
BHY,24772860,-2.8890416545825746
OV-90,135984461,4.4198301628710475
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
HSC-3,54618771,0.6642536113718133
CAL-148,sirolimus-bortezomib (250-1 mol-mol),-6.661160669337239
KYSE-70,44137675,3.4677446622108925
ECC12,2729026,3.0883591632349376
SNU-489,9911463,4.33052136373557
PE/CA-PJ15,54618305,4.31153259720802
D283 Med,11485656,1.7629558217294734
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
HCC1937,49766530,-0.8756565380330879
Hs 852.T,54618305,4.90334205576894
LCLC-103H,4259181,1.0955663651185623
23132/87,151289,0.6686464911072719
NCI-H810,9911830,1.0779216490046777
K029AX,9911463,4.292366302219474
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011
A-375,24753719,4.237865986535525
ME-1 [Human leukemia],11485656,2.505616015022391
Pfeiffer,sirolimus-bortezomib (250-1 mol-mol),-8.074968240863114
NCI-H1373,11404337,0.111453942184986
COR-L51,135984461,4.507897023169623
HD-MY-Z,73707371,4.880777210281508
RS4;11,151289,-0.2442447537227974
HT-1080,4259181,0.789296595746634
Ri-1,100016,4.838113149785687
DK-MG,2729026,3.0716491528324736
Rh30,10302451,2.982588909550782
MOLP-8,374536,-0.3332412159105151
COLO 800,156414,1.5989345686547471
42-MG-BA,4259181,0.1313298908519999
HEC-265,4259181,0.9428766197604146
MKN74,3815108,2.6465484465006823
ONCO-DG-1,11485656,2.8081349041133663
LS411N,9911830,3.118029057589745
NCI-H2081,24772860,-1.2700497080166275
NCI-H460,100016,5.855223104671776
TE-11,24772860,-1.8116281749466867
SNU-1214,327653,3.7315085171271742
IPC-298,4259181,-0.8006210931556415
8305C,49766530,-2.6247792402938086
CAL-29,151289,0.88023539806143
NCI-H727,654092,0.4388886539996767
BDCM,9911463,2.647772913572023
TE-15,151289,-0.165043524143007
TALL-1 [Human adult T-ALL],1716436,1.827089585200138
T84,44137675,2.6159408103724044
Ku812,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.5255380430209794
HEL,9868037,2.50949616555346
SNU-C1,135659046,3.6498249144750656
PE/CA-PJ34 (clone C12),4259181,0.3767954059641493
KP-2,6918638,1.246532088214889
BV-173,148198,-4.631322243168152
RL,6450551,3.2260230673117603
MDA-MB-468,10302451,2.6008680877418286
CAL-120,148198,-2.0212341580767283
AU565,148198,-3.941648532890003
Mono-Mac-1,124202324,0.5742000490261943
UM-UC-1,46926350,-4.971373716613503
SK-UT-1,11485656,2.414217391257394
Hs 578Bst,1716436,1.8608036024196664
KYSE-30,11404337,-1.4511722042502642
BT-20,11404337,0.6443596092093807
NALM-6,6450551,-0.2810623402277315
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
ESS-1,6450551,2.4356422182289106
NU-DUL-1,753704,4.199398921983466
MV4-11,11404337,-1.0129181206141806
Ku812,151289,0.0229500128579697
NCI-H2087,54618305,4.263137730985128
LUDLU-1,54618305,4.859130009384722
KYSE-180,11485656,1.9289585779871232
GI-1,9903786,1.7362048371434178
MPP 89,2729026,3.0880816356615757
MJ,49766530,1.2980181747447994
RS4;11,156414,0.6227944177183616
NCI-H1341,54618305,3.7343593679242417
Mel JuSo,148198,-2.598455094519584
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
Caki-1,11404337,2.102506471634507
HT-55,10302451,2.4391322098866213
KU-19-19,24753719,4.40371401160258
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
BT-12,148198,-4.094223347380762
NCI-H28,3815108,2.614410323150269
SUP-T11,9911463,3.242593830976794
SNU-308,selumetinib-BRD-A02303741 (4-1 mol-mol),5.178063267003013
NCI-H2342,2729026,3.046383838232462
PK-45H,6918638,1.185943066859981
NCI-H647,54618771,1.14773606602027
L-428,44137675,4.235079357694567
Rh18,11404337,-0.8453979019724388
NCI-H460,11485656,2.6212830818798065
HSC-2,2708,3.921847471231066
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421
MHH-CALL-4,11485656,2.372182753461333
BT 216,6918638,1.5591874228981395
KMS-34,24772860,-4.522682350047776
ALL-SIL,9843750,4.4328493438561845
SIG-M5,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.947705202344947
SNU-8,124202324,2.521017615962926
ONCO-DG-1,2708,5.115501552499887
BT 330,4259181,0.5985885076364172
OCI-Ly19,11404337,-3.477649976578423
BT 224,54618305,4.648547319057684
NCI-H889,10302451,4.256727329670886
EFM-192A,136227924,3.313769329286525
MDA-MB-468,9911463,3.8192810544536058
TOV-21G,2729026,3.1233119447646476
NCI-H647,4259181,0.924115846720778
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482
TUHR14TKB,10385095,1.3771420408488644
NCI-H2081,10385095,0.3312851708861742
TE 617.T,16013152,3.960391652735795
SNU-46,9911830,2.761121036862751
BICR 18,148198,-1.2308146568318987
KMS-11,9868037,2.8057737885411855
SCC-25,4259181,-0.0888101612247617
COV434,71729975,-0.4230181362615555
Karpas-620,9911830,2.708216754691897
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
SK-N-BE(2),2729026,2.512403179352802
ACHN,11485656,3.39588605431362
LOX-IMVI,selumetinib-BRD-A02303741 (4-1 mol-mol),2.511900136094648
KYSE-520,2708,5.776859725943127
DMS 114,46926350,-4.142969626849748
LS411N,1716436,3.6051806229528394
Hep 3B2.1-7,24772860,-2.4877708229560698
NCI-H647,54618305,4.3213835050384315
SNU-5,44486093,4.493037102747639
NCI-H1703,11485656,-1.2144145653920837
JHH-5,54618771,-0.2658300379563106
BT 482,sirolimus-bortezomib (250-1 mol-mol),0.6907201532102293
TE-15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.531240951960659
HEC-6,10302451,3.7773798053956367
NCI-H841,10385095,0.5087858353581881
BT 248,24772860,-1.8114686790878316
SNU-466,10302451,3.698428690338159
KO52,151289,-0.2495262689960944
SW1353,654092,0.01790145307113
TT2609-C02,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.580497364934568
ESS-1,54618305,4.255754792589274
EB1,753704,3.929557319773159
NCI-H196,54618771,3.538687286650074
BICR 18,156414,1.618645532999343
PSN1,54618771,1.0833304445253575
ZR-75-1,148198,-2.6538383263533674
Mono-Mac-6,753704,5.09105064209999
JHH-5,sirolimus-bortezomib (250-1 mol-mol),0.7972150153767945
KE-37,44137675,3.018088159826334
LOX-IMVI,327653,3.424274817584711
SU-DHL-1,44493528,3.922242735424854
SW620,9911463,4.067252618204241
NCI-H650,sirolimus-bortezomib (250-1 mol-mol),1.8480757652183293
TE-15,2708,3.2297865949089024
CFPAC-1,11485656,2.6116197546865663
Hs 944.T,9868037,2.6864916829697703
JHH-4,10302451,2.056735539702947
SEM,46926350,-4.492601003803031
MDA-MB-435S,654092,-1.5658365078691905
SNU-761,124202324,2.7361737530390196
NB4,135984461,4.636533285990447
OV56,4259181,1.5870297119020984
MOLM-13,9903786,0.7109980532390177
KMS-21-BM,2708,2.7964566719352044
Hs 729.T,4259181,0.497890264731072
TUHR10TKB,49766530,-0.1624329738440981
NCO2,11404337,-0.941549986556875
786-O,6450551,1.7895808154480335
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
TF-1,11485656,1.7797633161963615
MOLT-13,10385095,0.963304038916334
KMS-28BM,6450551,1.4045110877340072
SW948,9911463,3.099005262739027
MKN45,11404337,2.918608562534022
DAN-G,135984461,4.367213077467543
NCI-H1944,49766530,4.020768643988838
U-118MG,2708,6.076017983984888
SW1990,100016,6.759971253936254
JHH-4,9911463,3.8474740585863785
UM-UC-3,654092,0.4382099294978069
L-363,9911830,2.8051693886681557
CAL-51,11485656,2.6541256228973773
Karpas-299,44493528,4.12106151938678
VMRC-RCZ,54618305,4.302419161500339
TE-8,11404337,-0.0552230225351692
SNU-685,sirolimus-bortezomib (250-1 mol-mol),0.4201840468382607
ST486,11167602,3.831852392866298
IGROV-1,24772860,-3.2892316801587835
SCaBER,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6222556737563611
KYSE-410,151289,3.1282412096438477
BT 328,2708,7.776890663910961
KYSE-70,44493528,4.735176242945038
MEC-1,JQ-1-UNC0638 (2-1 mol-mol),-1.3951989149183417
Hs 852.T,100016,3.86747930561629
COLO 205,9911830,2.3516835684506945
IMR-32,selumetinib-BRD-A02303741 (4-1 mol-mol),5.67541975977436
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
NCI-H2052,136227924,3.050038230910341
Rh41,9911463,2.849226951569497
KMRC-3,11485656,2.7708610077746036
SIG-M5,44493528,4.118953354797346
2004,54618771,0.1677615799091476
BICR 22,1716436,3.778329286476686
PaTu 8902,156414,2.7243668654536206
SNU-C1,11404337,-1.600990625985275
Calu-3,327653,2.745193676578601
BT 271,327653,3.0157636823080187
HGC-27,156414,1.4531209246757668
42-MG-BA,9911463,3.88998551993186
NCI-H1869,54618771,2.934235316942264
HCC2108,54618305,4.9170237432018435
CCK-81,2708,4.674952891879179
BT 330,9911830,2.954651946077228
TE 441.T,9911830,2.062678121502997
KMS-12-BM,156414,0.8404794203086158
Capan-2,2708,5.633325901817307
HGC-27,73707371,2.267476734354563
KMS-27,11404337,-1.6812910673716006
Hs 746.T,24772860,-4.073131112062665
PSN1,10302451,4.4471631718961335
MG-63,54618771,1.3665941956425405
CAL-85-1,sirolimus-bortezomib (250-1 mol-mol),-0.0188849543206935
8-MG-BA,4259181,1.4277626204907208
NCI-H69,10302451,3.5556757771647653
A-549,6450551,3.987118649035783
Sq-1,327653,2.3606693919052737
MKN7,327653,2.5611177198729447
Calu-1,327653,2.6340275004388856
LN-18,151289,0.1965204771523982
OCI-Ly10,6918638,-0.7396222686177214
NCI-H2030,54618771,3.292263250244386
ECC10,54618305,3.9917932371163696
JHH-4,54618771,-0.357256318884579
Detroit 562,24753719,4.8099067031484894
Hs 895.T,54618771,2.243323536930484
KYSE-520,JQ-1-UNC0638 (2-1 mol-mol),3.4721417872209774
TE-4,9903786,1.7247018760374746
Namalwa,156414,1.5666485323210588
SK-N-MC,9911463,2.6824462579046755
8305C,10385095,1.3364399031185752
PE/CA-PJ49,49766530,3.753784618730391
Karpas-620,654092,-1.028807414027094
B-CPAP,44137675,4.622984618218968
HMC-1-8,148198,-2.948355719333101
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961
KYO-1,1716436,2.896767068472359
JHOM-1,100016,6.419236010839144
C2BBe1,24772860,-2.2320886331562493
HL-60,9903786,1.6430909188137364
MM1.S,9911830,2.728285435741644
BICR 56,24772860,-2.3670328679939394
CMK,sirolimus-bortezomib (250-1 mol-mol),0.3522446092805081
SK-HEP-1,11404337,1.0852289139958715
RPMI-8226,54618305,-4.544324517561474
KYSE-510,4259181,-1.303373724971253
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
SEM,24753719,1.9867479465315392
OVCAR-8,9903786,3.64408364733759
OE33,2729026,3.172703771276418
EFE-184,9911463,4.31832221914332
HCC-56,24753719,4.191949755437233
SNU-1214,136227924,2.9720785133706213
DMS 454,24753719,4.1661343014864824
Mono-Mac-1,11404337,-0.2219879905670924
SW579,44137675,3.3547993435400674
GA-10,JQ-1-UNC0638 (2-1 mol-mol),-1.726408829948699
GSS,11485656,1.8292349527382337
TCCSUP,11167602,2.834914441950803
SCaBER,151289,0.5136507682743061
Ri-1,16013152,3.7158961348364654
CGTH-W-1,10302451,2.4566200048574265
Panc 02.03,148198,-4.053337817942692
CAS-1,10385095,2.6335228393539944
HuP-T4,327653,2.942842262184186
BT-16,11404337,-1.376831419013344
IM95,16013152,3.957634062785062
SK-ES-1,44137675,2.450115669703572
L-540,11404337,-2.0629027797963664
LNCaP clone FGC,46926350,-4.319899748167567
SNU-626,selumetinib-BRD-A02303741 (4-1 mol-mol),5.202020037102138
SNU-886,10385095,1.1038149480439057
GP2d,49766530,0.1592380212690584
SNU-761,54618305,5.766464917094291
CHP-126,753704,4.5154677353684916
HH [Human lymphoma],6918638,-1.7974497688929272
Ku812,9911463,3.2535027234043428
RCH-ACV,4259181,-1.0090631503985652
KP-N-YN,9903786,5.5444671223667825
NCI-H2029,136227924,2.308767464525173
LAMA-84,9911830,-1.7379301723094578
EPLC-272H,2729026,2.773940342852679
HPAC,100016,6.325474069382135
P12-Ichikawa,9868037,1.7340437958552062
NCI-H2286,100016,5.552985583261177
Panc 04.03,10302451,3.874200048588579
GCT,9868037,3.729944078778933
COLO 320,selumetinib-BRD-A02303741 (4-1 mol-mol),5.346798014094522
KE-37,2729026,1.0354838502369843
TTC-709,753704,4.304313213179598
HuG1-N,9911463,3.1610800611840366
OVTOKO,654092,0.0519966375568953
Jurkat,9911830,2.1111759475111027
OVK18,54618771,0.5319615878172647
LCLC-97TM1,9911463,3.937478558519083
WM983B,44137675,3.997585569822008
Caki-1,6450551,3.786249459137126
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
EHEB,4259181,-0.3918316132670805
RERF-LC-A1,4259181,-0.0269897105807535
Mel JuSo,654092,0.4150072119432613
SF268,374536,4.999455744118379
SU-DHL-1,54618771,0.3433661921186922
U-BLC1,9911830,2.345404263930682
HSC-3,49766530,-2.4571890524447553
JHOS-2,JQ-1-UNC0638 (2-1 mol-mol),3.5506472120155617
NCI-H441,1716436,1.6045835009527984
Daoy,11485656,1.6776877831097698
Namalwa,44137675,1.71079520317736
F-36P,753704,4.385108951205176
NCI-H1703,49766530,-3.0493553752695783
YKG-1,151289,1.726340360462664
Panc 04.03,9911463,4.4327726522455855
OVK18,44137675,2.2934957709824735
CAS-1,3815108,3.126828750255454
THP-1,2729026,1.9733763763926104
KCL-22,124202324,1.8330090199856768
DAN-G,44493528,4.283490884814904
CAL-29,11485656,2.151813126384455
MKN1,selumetinib-BRD-A02303741 (4-1 mol-mol),6.743662510734921
NCI-H1755,9903786,1.073033240421295
KMH-2,6450551,0.9471042683627704
LC-1/sq-SF,11485656,2.9810268276277267
OVTOKO,49766530,-2.319379422934269
CL-11,44493528,4.354621073890832
NCI-H1694,1716436,1.578403410395759
RERF-LC-Ad2,6918638,1.8472690467547748
OCI-AML-5,24772860,-2.398738215353767
RCH-ACV,24772860,-4.5180020483726455
SYO-1,2708,3.6720881556321
COV434,2708,5.008233924887111
VMRC-RCW,151289,2.7744864647699385
BT 498,46926350,-3.9030297935889737
Yamato-SS,tanespimycin-bortezomib (250-1 mol-mol),-1.0267358122656502
SBC-5,654092,0.9915803206550192
KATO III,24753719,4.4209901608966
BT 271,71729975,1.0965831941128574
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
A3/Kawakami,46926350,-5.375609263703226
Ri-1,10302451,1.5393417915178893
KP-N-SI9s,10385095,0.9567135101145878
Rh41,selumetinib-BRD-A02303741 (4-1 mol-mol),5.7463988047122045
SF268,2708,3.607022787905304
Kasumi-1,tanespimycin-bortezomib (250-1 mol-mol),0.2568876868109762
CADO-ES1,3815108,1.9420641149624005
OC 314,9911830,2.778444895405951
NCI-H838,753704,5.061858194376133
Ri-1,54639665,5.943871116773062
ES-2,9911463,4.341533806603841
BT 482,753704,4.469346092674199
KE-97,9911463,3.4009628133959713
Namalwa,10302451,0.420511059814922
BT 159,54618771,0.7710223588064036
EFE-184,124202324,3.1206891563831745
EFO-21,148198,-3.998028917288756
KNS-60,10302451,3.3900395940904464
MHH-ES-1,11485656,2.0026914663439648
HT115,9911463,3.084067678745635
PE/CA-PJ41 (clone D2),11404337,1.298340763398175
SaOS-2,11404337,-0.7935370479535776
RL,24753719,3.794775355260619
NCI-H2291,11404337,0.0259813589502385
KYO-1,151289,0.4772848270971578
Mel Ho,10385095,1.46898666860575
BxPC-3,374536,3.0351492595764347
MDA-MB-435S,JQ-1-UNC0638 (2-1 mol-mol),3.2842765506965947
QGP-1,54618771,1.891890541476157
Mono-Mac-1,151289,0.6331917318262559
SiMa,11167602,1.9833509975334416
Hs 294T,24772860,-1.2735292848188264
RERF-LC-MS,44137675,3.373454428855253
SK-MEL-1,9903786,3.576716533884559
LoVo,24772860,-3.380615847351667
NCI-H23,1716436,1.8311330149737883
BICR 18,9911463,4.416579979715041
RS4;11,327653,2.354289829060074
L-428,24753719,2.0145740660886045
Ishikawa (Heraklio) 02 ER-,54618771,0.8456906583173794
U-118MG,9911830,2.523465793576531
CCK-81,654092,-0.0904631429604618
SBC-5,2729026,3.0750341046070933
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
SNU-46,10302451,2.4087587881907324
NCI-H2171,6918638,-1.5146784294865197
SNU-8,151289,1.199400027159569
NCI-H211,9911830,2.242620960008613
NCI-H647,136227924,2.9483035397305164
SW948,10385095,1.3660359707166476
A-253,2708,5.248574485650739
CAL-29,54618771,1.1722146209139084
BICR 22,156414,1.4774483319728589
SCC-25,49766530,-2.1571219685765195
COLO 668,136227924,2.7222662640570356
Ku812,6450551,-2.2531779420040694
SUP-HD1,151289,0.5840582095615435
NCI-H889,sirolimus-bortezomib (250-1 mol-mol),0.2656480378384786
MV4-11,9868037,1.3692321377880616
BT 440,135659046,3.614381775691437
BT 164,2729026,2.207971452588792
SK-MM-2,654092,-1.4217246925488645
KMS-28BM,136227924,3.12099798130619
HCC1195,9868037,3.635348829335935
LS513,49766530,0.4821695528273116
NCO2,654092,-3.498430696051644
HuP-T3,10302451,3.3244038223924868
P31/FUJ,654092,-2.277731190350674
HeLa,10302451,4.286472451875936
JMSU-1,4259181,-2.230603891690396
MV4-11,44137675,0.0062766610839332
SCC-4,sirolimus-bortezomib (250-1 mol-mol),1.5371967281247725
NCI-H1373,654092,-0.0352094434915347
BT 231,11485656,1.3713674681165906
NCI-H1105,tanespimycin-bortezomib (250-1 mol-mol),0.6948185089061538
5637,124202324,1.9285513096651317
JM-1,9903786,1.587415218469425
RPMI-8402,44137675,2.3852684213151925
Rh30,9929138,6.636453392237079
Li-7,6450551,1.2474842665125694
Panc 08.13,71729975,2.9671143911011724
ZR-75-1,11404337,1.062777047801886
Caki-1,16013152,4.00098761955123
BT 286,4259181,0.6646990868644945
NCI-H2029,2708,5.889392669258117
HuNS1,24753719,3.3564356231301997
HGC-27,11167602,1.8077063625690304
BT-12,9911463,4.073120813742317
MM1.S,44493528,4.254687888851587
NCI-H2087,16013152,3.311573331362872
HD-MY-Z,135984461,4.3982026911884455
A-673,10385095,1.0544598585596625
KMRC-20,54618771,1.1098897337437623
OCI-AML-3,1716436,3.2650114354586446
SYO-1,136227924,1.0009147925604558
NCI-H747,136227924,2.5739387589966265
GB-1,156414,2.115103103424402
RT-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.18220229095385
EFM-192A,148198,-2.4678841503843363
KATO III,6918638,0.282003219023021
Karpas-620,6450551,3.4508630003667897
KMRC-20,11485656,3.1191450490376673
HCC1195,6450551,2.9578607918293316
SK-N-BE(2),9868037,2.6667298506556447
HD-MY-Z,9911830,2.287012187948462
HH [Human lymphoma],JQ-1-UNC0638 (2-1 mol-mol),-2.1098965352527492
BT 286,136227924,1.3356746395497436
COLO 684,49766530,-2.0010350026906787
Kelly,9911830,2.7875551161159615
NCI-H358,1716436,2.8403346585570173
Caki-1,54618771,1.6306245872023055
HEC-151,374536,2.760377421474409
SIG-M5,44137675,2.1511971527738796
HCT 8,selumetinib-BRD-A02303741 (4-1 mol-mol),4.099504750141216
KYM-1,9903786,3.7679848907863738
HEC-108,9903786,3.9980769668892706
HuH-6,11485656,2.2399247025675084
NCI-H2009,24772860,-3.0306018162615342
NCI-H1373,9911830,2.7658266130985036
SCC-9,49766530,0.4117706354329887
COLO 205,136227924,2.4867417586096416
F-36P,100016,3.924028764616067
IGROV-1,135984461,4.285945029851472
NU-DHL-1,16013152,3.387087199942325
A-549,selumetinib-BRD-A02303741 (4-1 mol-mol),2.307828661203879
Rh30,2729026,2.434020683854525
HuH-28,2708,4.96017019279685
NCI-H1869,2729026,3.0782751585704684
U266B1,156414,1.6071696370367765
HuT 78,10385095,0.3743213193570641
SK-MES-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.5310781440623344
COR-L279,11404337,-2.7299136771765102
BT 224,JQ-1-UNC0638 (2-1 mol-mol),5.390044304637816
PSN1,11485656,1.8304064123419443
ME-1 [Human leukemia],10302451,5.046375843615016
SNU-1105,753704,5.705317896969165
Lu-99,2729026,2.7086273009511004
Lu-99,10385095,0.9808054093296624
UO-31,1716436,3.042772816716236
TE 617.T,10385095,0.7381710373926665
L-1236,9911463,2.598114748272053
42-MG-BA,9929138,6.505508084195067
SCC-25,2729026,1.6391649158792652
LUDLU-1,135659046,3.627701709010381
K-562,24753719,4.107201496626299
Namalwa,11404337,-2.5348333703062575
IMR-32,44137675,2.9562929137787712
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
UM-UC-3,54618771,3.8430059461326658
BT 147,11167602,1.7242539171723648
SNU-1077,49766530,-1.9738465664800544
NU-DUL-1,135659046,3.4749068685188176
BT-12,9903786,4.28961947380918
MDA-MB-231,10302451,3.1258043295368285
OV7,6918638,1.9769978883441133
NCI-H1734,124202324,0.8938869771507207
PE/CA-PJ34 (clone C12),9911463,3.905990041696765
BT 416,71729975,3.4448990537881876
KMS-18,654092,-1.4345580227089894
HuP-T3,24753719,4.122061219367772
KNS-60,148198,-2.9392498414813075
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
RVH-421,44137675,3.972961519882127
HeLa,JQ-1-UNC0638 (2-1 mol-mol),3.737781350527659
KE-39,753704,5.009174848734236
Karpas-422,10302451,2.97293319769233
HD-MY-Z,49766530,-2.787165933045758
OVCAR-4,11485656,2.719318989709532
NCI-H838,16013152,4.347206870092031
HEL,9911463,3.4775133545177774
CAL-33,2708,5.524002489250098
SNU-C1,54618771,0.8389876741679191
P3HR-1,2708,5.242129752027139
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
PaTu 8988s,54618771,-1.1165982816182902
Ki-JK,2708,3.7514152274399177
U-937,4259181,-0.871929709772469
KLE,4259181,-0.0203780302150134
NOMO-1,136227924,2.5449106490851263
KP-4,654092,-1.6065035678404882
KE-97,11167602,2.214438718590508
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
OVCAR-4,2708,5.591903055785372
HEY A8,9911463,4.0239951836348595
COV434,156414,1.5374263935363748
AML-193,327653,3.166198380644303
TM-31,tanespimycin-bortezomib (250-1 mol-mol),0.6359976993745172
CAL-54,9911463,4.0925396787823685
RPMI-8402,JQ-1-UNC0638 (2-1 mol-mol),0.1706999740110269
KNS-81,1716436,3.3558996512005597
YD-10B,151289,0.9889575147663882
LOX-IMVI,9911830,1.9996336712614449
CAL-29,11404337,-0.7991299862488138
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
HuH-6,151289,2.8743966361586843
YKG-1,327653,3.641218936705474
HCT 15,135984461,4.216464874302124
SNU-719,374536,0.7664524014772056
KYSE-510,49766530,3.99865541167158
OAW28,49766530,-0.5315014966120291
NCI-H810,151289,0.7202638201490781
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
NALM-6,124202324,0.7658229118703637
NCI-H146,46926350,-6.324766796143129
Peer,148198,-3.8508497827716264
L-428,327653,3.101823728208986
Kasumi-2,44137675,1.606596454570492
LOX-IMVI,11404337,-0.9085197853802874
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
NCI-H28,151289,-0.0078325604874549
LS123,tanespimycin-bortezomib (250-1 mol-mol),0.0311387625429896
NCI-H1703,44137675,2.011922348998249
BC-3C,2729026,3.0300305524792837
WM983B,156414,1.573204920480929
KCL-22,10385095,1.1871398170066128
NCI-H1693,11404337,-1.060288608943807
RL95-2,124202324,1.1410155197672471
A-375,100016,6.005492870785018
KP-N-YN,11404337,1.502474208515668
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
Panc 10.05,54618771,0.7242321681283157
SNU-449,374536,4.370390285639732
KYSE-140,11485656,2.138414918607982
KNS-62,148198,-1.7828109531829757
Calu-6,2708,5.644248497946965
UM-UC-3,9911830,3.528897912762674
KHM-1B,327653,2.4267430839124455
COLO 741,151289,1.000037692173218
RPMI-7951,124202324,2.0500814967899355
COR-L88,54618771,0.6942100062595253
SW1088,327653,3.9714894457937566
Hs 936.T,4259181,0.7907782963904789
DEL,753704,3.8281919602722017
SK-MEL-24,JQ-1-UNC0638 (2-1 mol-mol),2.688866554515844
G-292 clone A141B1,11404337,1.6382299378859118
CGTH-W-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.488146475296539
OCI-Ly3,24772860,-3.0235013678027656
Aska-SS,9843750,4.126997970153608
HuP-T3,11485656,3.0565489144797224
Mel JuSo,4259181,-1.462450394836602
Panc 02.03,11485656,5.602754460209725
DB,151289,-0.463432470682274
DU145,1716436,2.8760857102240034
Caki-2,10302451,2.957054551307016
TUHR14TKB,10302451,3.933491064202245
OE19,151289,3.718214698365438
HCC2279,4259181,0.9325870941028492
BV-173,16013152,3.5962038253142627
BT 422,9911830,3.891954985840177
RT-112,10385095,1.0115398078561386
MDA-MB-453,156414,0.9469838239648454
Calu-6,11485656,1.862079385018863
SNU-1077,124202324,3.0238569925896113
KP-N-SI9s,24772860,-3.278576675320743
OCI-AML-3,2708,2.1936523339198137
SYO-1,71729975,0.9472178067571876
RPMI-8402,9911463,3.009293370203492
AsPC-1,9911463,3.4970941612274693
KP-N-SI9s,11404337,-0.8140726577630073
HCC2108,54618771,2.799542688239582
SW1990,54618305,4.718025842071016
WSU-DLCL2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2228653391263355
Hs 934.T,156414,1.5290679569214394
JHH-1,136227924,2.990976056622349
HCC1438,10385095,0.8016310732930643
HDLM-2,54618771,0.2228052898730796
NCI-H647,100016,4.3873613110575045
SW1417,136227924,2.767989145735224
NUGC-3,11485656,2.456489968727232
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
HCC4006,2708,4.961548016713464
BT 359,sirolimus-bortezomib (250-1 mol-mol),0.4069320029327686
HCC4006,135984461,1.8301833848087097
HT-1376,3815108,3.792385903508108
KMS-20,6450551,1.8183077034001904
SNU-1079,135984461,-0.6651362104222878
NCI-H1869,44137675,3.883775403499402
NCI-H522,9911830,2.121034111225194
KMS-11,11404337,-0.8094185492018079
NCI-H1792,24772860,4.656315928277967
OCI-AML-2,10385095,1.002219409748186
SKM-1,9903786,0.91314187591027
PK-45H,136227924,2.93841309707887
SaOS-2,24772860,-2.2454069761524416
TE-1,374536,3.813410733407777
NCI-H446,4259181,-0.6278727967025163
KYM-1,71729975,-0.2990758103093402
KE-37,753704,3.1989748338155097
KMH-2,54618771,-0.6611868525273566
SNU-1077,54618305,5.347093142592056
SCaBER,11404337,0.8251582568604987
OPM-2,327653,2.4944005218311984
A-375,148198,-2.551882325467432
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
SK-MM-2,9911463,2.140550040440612
Raji,9868037,1.949547656703084
SNU-478,136227924,2.019778672481118
RPMI-8226,151289,0.2994151145922161
BT-474,9911463,4.372266907871184
JJN-3,11404337,-1.3886118473033382
TE-4,sirolimus-bortezomib (250-1 mol-mol),1.0624472113387091
HCC1438,selumetinib-BRD-A02303741 (4-1 mol-mol),5.505894193471892
SNU-C4,6918638,1.4968948752394289
KP-3,327653,2.831253990169757
NCI-H322,24753719,4.204705082811736
TCCSUP,3815108,3.0276070568390208
NCO2,24772860,-3.0039448567254095
HD-MY-Z,54618771,0.9859939173589182
BT 245,49766530,0.0902413739193597
EC-GI-10,44137675,3.4672278934446172
CCK-81,sirolimus-bortezomib (250-1 mol-mol),0.9757763076184672
T24,10302451,5.029855171051924
COLO 668,135659046,3.450093755240726
KYSE-510,374536,3.4543675814774795
ESS-1,100016,6.502595194480242
TCCSUP,10302451,3.6876382718765206
HGC-27,9911463,2.724483471079002
HCC2279,9911463,3.61509749059407
PE/CA-PJ34 (clone C12),135984461,4.299717419292052
OVTOKO,44137675,3.061815716534294
Hs 294T,10302451,3.786077352821612
HCC202,374536,2.4409895422267525
786-O,16013152,4.527361827035987
HEC-1-B,9903786,3.578370658582295
SF539,4259181,0.2869057369152892
KNS-81,10385095,2.623724927445881
KMS-11,100016,4.183673123455152
SET-2,148198,-7.743060156944655
SNU-8,49766530,-3.645853792041198
HEC-108,9911830,3.642303707567872
NCI-H889,11485656,2.9669952832356645
NCI-H1092,327653,2.585630282314354
TE-6,tanespimycin-bortezomib (250-1 mol-mol),-0.454134198851735
JL-1,9903786,5.3673726170242455
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966
KO52,46926350,-4.487744142578648
AMO1,753704,4.421237226454667
FTC-238,11404337,1.3350239521780074
FaDu,11404337,0.6518309370028597
SNU-5,374536,-0.4984434888744736
ES-2,136227924,4.099714373678264
TE-5,148198,-2.7916171681720567
SNU-1,11485656,1.6687756600657273
PaTu 8988t,11485656,1.82057121616084
SNU-899,6450551,5.649293032765806
NCI-H1573,100016,4.561614919470221
HCC1954,44493528,3.86549842878492
COLO 684,9911830,2.4510294564666513
Peer,100016,3.808596484759728
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
HEC-108,2729026,3.096957715125247
NCC-StC-K140,148198,-5.392485338723143
NCI-H2052,156414,5.289728467553055
NCI-H1385,6450551,1.787464543463894
ChaGo-K-1,136227924,2.8574479872364247
BT 286,54618771,0.8427122634128117
UM-UC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),1.535998782280574
KMM-1,9911830,2.7075788823009006
Ku812,11167602,0.0017995666708742
MHH-CALL-3,148198,-0.6982118974436664
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
Kelly,327653,2.684571007540684
T98G,1716436,3.6619972730594736
A2780,374536,0.6453837370733745
UO-31,753704,5.428977360742816
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
Caki-1,374536,-0.1159874512440625
SK-LMS-1,11485656,3.417878040932413
PSN1,sirolimus-bortezomib (250-1 mol-mol),0.321817101338521
LoVo,10302451,1.0215583424111876
SW1353,54618305,5.761463956285616
22Rv1,11404337,0.9568158231901654
HH [Human lymphoma],44137675,-0.0838201416248355
DU145,73707371,4.93745996630941
SCC-25,124202324,1.8365175038978816
DMS 114,327653,3.6475394486968025
MOTN-1,46926350,-5.325185076891933
NCI-H747,1716436,2.396158892908368
J82,2708,3.3767071851036894
UO-31,46926350,-3.585685539567035
U-118MG,11404337,-0.8562943449328914
GB-1,3815108,2.345620826339115
LOX-IMVI,10302451,1.9959018084394209
HD-MY-Z,9903786,3.5223384929798187
Kasumi-2,54618771,-0.6876381814105375
SNU-449,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2718140952083585
G-402,46926350,-4.4995580499854615
KMS-27,654092,-0.6433485810907916
OCI-Ly19,9911830,2.044000143992489
BT 228,2729026,1.8094400941179165
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
NCI-H1568,11404337,-0.63897934294681
HEC-6,2708,5.35983044372639
SNU-1033,46926350,-3.712986003015726
Hs 822.T,135659046,5.0235627389760715
MOLT-3,9911463,4.579256279183223
MHH-CALL-3,JQ-1-UNC0638 (2-1 mol-mol),2.307833561481707
A2780,2729026,1.9590477988732768
G-292 clone A141B1,2708,5.006276298158535
Rh41,135984461,3.8957403720163177
GB-1,11404337,-0.6005799825323985
MHH-CALL-4,3815108,2.38024137093579
COLO 201,2729026,2.2609501477858447
RPMI-8402,24753719,3.36311083579876
A-549,44137675,4.013710884820414
HCC1937,44137675,4.5720490779709655
OVCAR-5,11404337,-1.1267721710555685
SNU-8,100016,6.375529183181613
SNU-398,374536,4.04373737616728
EHEB,135984461,4.428627188495882
OV-90,10385095,1.3192036587024902
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
EB1,6918638,-0.9960989613224034
LXF 289,3815108,3.5075214319549683
A-204,11167602,-0.3115044738293965
NCI-H322,24772860,-2.7577425717853226
NALM-6,selumetinib-BRD-A02303741 (4-1 mol-mol),4.153720458864916
GSS,6450551,1.69313168732471
RD,753704,4.607452750531447
Hs 683,151289,0.7881286519354692
HDQ-P1,54618771,4.6079698372057605
SUP-HD1,24753719,1.8237157201858607
EBC-1,9911830,2.187384370509422
BT 248,327653,3.4402013175237394
BT 172,148198,-4.688822444710566
G-361,753704,4.860897165747179
BFTC-905,54618771,-0.6913922246342757
NCI-H747,46926350,-4.0436855286531905
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434
Ki-JK,1716436,2.2202595604384605
COLO 684,tanespimycin-bortezomib (250-1 mol-mol),-1.1171395210873645
MOLM-6,49766530,0.2890752826418397
NCI-H520,10302451,3.2587774106229146
COLO 680N,100016,6.604594090356929
Hs 852.T,tanespimycin-bortezomib (250-1 mol-mol),-1.155351108191556
CHP-126,9911463,3.8708790519739593
SNU-489,6450551,3.0388607258122686
NCI-H526,11404337,-0.7565430519554945
NCI-H1650,selumetinib-BRD-A02303741 (4-1 mol-mol),5.398822824470094
OPM-2,9911463,3.091122447781221
P31/FUJ,49766530,-2.577046245506879
PE/CA-PJ15,135659046,3.5653102065107176
BFTC-905,3815108,3.6909728381332263
SNU-685,9903786,5.039547940758868
BT 245,135659046,4.182181998244751
NCI-H1341,selumetinib-BRD-A02303741 (4-1 mol-mol),4.319283501161914
Kasumi-2,9911830,1.88551459110434
MFE-296,156414,1.6336035535804103
TE-5,136227924,2.0128832307516715
PC-14,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6810269495399257
WM88,2729026,3.0591005523609
Hs 746.T,148198,-2.6846160081126422
NCI-H211,327653,2.6447070202366776
HCC1428,753704,5.00802338215878
SK-LMS-1,2708,5.723768268048996
IGR-37,11167602,3.226073746517762
Ci-1,2708,3.391889073112906
COLO 680N,148198,-2.677671359011621
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
SK-N-DZ,JQ-1-UNC0638 (2-1 mol-mol),0.7973360514589402
LN-229,2729026,2.0995009654913215
KALS-1,JQ-1-UNC0638 (2-1 mol-mol),1.6679481171420965
697,4259181,-0.8537492099871785
NCI-H1563,49766530,0.5577612729828542
SUP-HD1,tanespimycin-bortezomib (250-1 mol-mol),-0.2470989811885863
CAL-62,11404337,0.5781549927115224
U266B1,9903786,3.1119057024478094
HOS,753704,4.420669365876278
SUP-HD1,753704,3.939355864617831
ZR-75-30,156414,-3.885096329656602
NCI-H1869,selumetinib-BRD-A02303741 (4-1 mol-mol),5.006102326506844
Hs 888.Lu,136227924,2.7652519196534304
JMSU-1,2708,4.260901707507232
NCI-H2110,11404337,1.6337523371229576
KE-37,44493528,4.221773830878064
WT2-iPS,6918638,1.254016270163871
HCC2935,374536,4.801991733129956
HEC-1-B,124202324,2.4746365064385487
GSS,327653,2.9951374094188172
KU-19-19,9911463,4.338553857034003
TE-10,54618771,1.2495537185307453
G-361,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.2016539567555065
T3M-10,148198,-1.9174912256431331
OV7,46926350,-3.9909622607709
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
SK-ES-1,9868037,1.8051819394038728
MOLT-16,54618771,-1.933148337810649
JMSU-1,374536,2.939714450170274
TE-10,11485656,2.3373155876615463
RERF-LC-Ad2,10302451,4.090867148457294
SK-LMS-1,10385095,1.8771783160907216
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485
RD,11404337,-1.7858539381850014
SUP-T11,327653,-0.0983618163081044
BT 271,10385095,1.1814538061663578
HCC1428,2708,5.59453346959129
EHEB,11404337,0.0364567319098325
U2OS,148198,-3.483181142521373
PE/CA-PJ15,9903786,2.2611792207171484
A101D,9903786,4.417171452040311
SNU-1033,2729026,2.996817399923943
HT-1376,148198,-2.6714995080003767
HCC1419,44493528,4.295803201146447
GMS-10,11404337,1.4547750638091848
TC-71,4259181,-1.3693696367229935
LNCaP clone FGC,44137675,-0.0914155631340202
MDA-MB-468,sirolimus-bortezomib (250-1 mol-mol),0.2787318869708576
NCI-H146,156414,1.153076826996135
DEL,9911463,3.5570893591949932
NCI-H660,4259181,0.4292897010686547
DV-90,9911463,2.614812777882286
COR-L47,2729026,3.013012085771584
NU-DHL-1,9911830,2.5877421671517578
DU4475,24753719,3.9456883650846266
CAL-33,10385095,1.604664266221027
JHUEM-2,3815108,1.92532326549014
SUP-T1,327653,1.5396768902081992
BT-12,4259181,0.5840557445964077
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123
G-402,135984461,1.930732604318706
KMS-34,11167602,1.5003618620555597
SNU-475,100016,7.606290519099935
UACC-62,JQ-1-UNC0638 (2-1 mol-mol),5.0885198746367015
PE/CA-PJ41 (clone D2),44493528,4.345645378925518
SNU-423,10302451,3.566969310878258
NCI-H2405,136227924,3.1304062683146747
BT 139,10302451,2.4564119741984785
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
SCC-25,24753719,4.468812461486699
HCT 15,10385095,0.6903357262692433
NCI-H929,4259181,0.6476848617762108
G-402,9911463,3.624660620930307
COLO 668,tanespimycin-bortezomib (250-1 mol-mol),-0.9107908194631724
MKN7,2708,5.222761420391291
LNCaP clone FGC,151289,1.132388420767888
OVSAHO,11485656,2.294193584233593
Kasumi-2,9868037,2.67651294484719
NCI-H1694,6918638,-0.6027220987996394
A-172,tanespimycin-bortezomib (250-1 mol-mol),0.1851985294738919
RERF-LC-MS,24772860,-2.3078196081029136
639V,124202324,4.223975455391191
SW1088,54618771,1.1113850453219438
NCI-H1435,10302451,1.1445716606648535
BT-12,24772860,-1.1744003605248672
KMRC-2,54618305,4.826508920504646
AsPC-1,2729026,3.0501658646319796
SaOS-2,6918638,1.2055090485954645
IMR-32,54618771,0.9755251255632068
CAL-51,156414,1.13799157004995
JMSU-1,135984461,4.473893168113172
IGR-1,46926350,-4.218458476982223
SNU-16,11167602,-0.1178640924914608
DND-41,6450551,2.188848043016208
BT 428,10385095,1.1753953127951546
A4/Fukuda,136227924,1.9204852137512072
769-P,10302451,1.402599220322161
TM-31,49766530,-2.5083427606022037
HuCC-T1,44137675,4.436543989352114
MIA PaCa-2,10385095,0.818601661096134
WM793,753704,5.060805642150714
KMS-27,9903786,2.0838522642379216
MKN7,24753719,4.312074399865491
HEC-59,9903786,2.2541518083702172
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
BT 145,tanespimycin-bortezomib (250-1 mol-mol),-2.391322475110553
HCC1833,2708,5.543444793516199
BT 416,44137675,3.067487252962228
U-118MG,1716436,3.638192915861602
C2BBe1,9903786,1.7742124050197758
SCaBER,753704,4.500232927297249
RPMI-8402,4259181,-1.5890412699882153
NCI-H1838,11404337,-0.072819025932654
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
769-P,100016,6.594067506922387
SF539,136227924,2.8154987155907905
YD-38,156414,-3.156839755481009
Malme-3M,9868037,3.7927874033279703
KNS-60,6450551,-0.5105591995690572
REC-1,11485656,4.187438515257482
OE21,2729026,3.0182002409216606
CAL-33,753704,5.049963421034316
769-P,1716436,3.040080653694363
Hs 822.T,11404337,0.2632617923039199
MOLM-6,2729026,1.7262110151060526
Hs 578T,1716436,2.638927503029608
HuH-6,JQ-1-UNC0638 (2-1 mol-mol),1.464271535928535
NCI-H838,44493528,4.484447335433128
BICR 22,374536,2.9550889228261386
BT 172,135659046,3.5133066038104355
ESS-1,JQ-1-UNC0638 (2-1 mol-mol),1.0012685328426527
SK-OV-3,54618771,2.5849230632376923
Yamato-SS,54618771,0.3737524907753581
SK-MEL-5,16013152,4.084760192264916
253J-BV,11404337,0.2786580160895149
HT115,9903786,1.6808315283009525
WM1799,4259181,0.910290049923774
HOP-92,11404337,-0.857854163470874
PK-59,124202324,2.744479074012848
SR,374536,2.647223306578982
NU-DHL-1,374536,0.7676256966435839
SK-MEL-31,54618771,1.4879835427229802
HCC1395,654092,-0.172853790722122
NCI-H2009,4259181,1.0344432117954978
SUP-M2,selumetinib-BRD-A02303741 (4-1 mol-mol),1.457732574001079
NUGC-4,54618305,4.338411628407715
Hs 729.T,JQ-1-UNC0638 (2-1 mol-mol),2.745133108352
MPP 89,6450551,2.039821858675848
MFE-319,10302451,3.878997082885385
SNU-489,3815108,3.619479374784647
EFE-184,10385095,1.4083515460753824
HEC-1-A,100016,7.347183870003149
SNU-201,11404337,0.8622736318146181
NCI-H446,10302451,3.623486069490957
VMRC-LCD,44137675,4.237977234713832
OC 314,tanespimycin-bortezomib (250-1 mol-mol),-1.1782334155710066
Hs 746.T,9911830,2.0393711728362742
SNU-620,10385095,2.2803267979745834
HSC-4,9911463,3.832706037448295
SNU-308,54618305,4.365090105355177
Hs 729.T,73707371,5.144241369935668
HPAF-II,10302451,3.631982907327204
HCC1428,9911830,2.8473630821079374
NCI-H23,135984461,4.675725917601218
KHM-1B,54618771,-0.6219515555388266
SNU-719,49766530,-1.9010790195453584
EM-2,4259181,-0.3573100934145777
CGTH-W-1,44493528,5.078721913165128
Mono-Mac-6,44137675,2.6440346912350545
KM12,sirolimus-bortezomib (250-1 mol-mol),1.529989038741449
HCC38,44493528,4.3442022500374815
NCI-H1623,44137675,2.921297693984664
GB-1,9911463,4.167195991638194
HEY A8,11404337,-0.225254822272347
G-401,2729026,2.5705443446476828
NCI-H1299,4259181,-0.5610817863206101
5637,24753719,4.154782017420858
Hs 729.T,9903786,3.958862053564968
RT-112,24772860,-3.135103297611737
Rh30,49766530,-2.324710777710102
DLD-1,1716436,3.214094982642395
DMS 53,9911830,2.2379705934233307
COLO 829,24753719,4.2760116652127484
YKG-1,24772860,-1.277942485629484
JVM-2,11404337,0.0691580331258648
KYSE-30,100016,6.190453384433256
SW1783,9903786,4.362374850125049
NCI-H1435,654092,1.2628556060917646
Jurkat,327653,3.0704554434178473
SW1116,4259181,0.852960615063059
COLO 699,327653,2.3345928950143597
LXF 289,4259181,0.8555931132792622
AsPC-1,24772860,0.3605797719579043
PE/CA-PJ49,1716436,3.7947980371388854
Hs 936.T,124202324,2.4413902131984537
BT 498,327653,3.5489603001727477
TE 617.T,2708,3.9220927277029505
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425
GSS,24772860,-2.5384701521759356
SUIT-2,654092,0.2357143964079242
GaMG,124202324,2.4131537922385813
Tm87-16,54618305,4.358739868911079
COV434,9911463,3.0126718428319905
UACC-62,sirolimus-bortezomib (250-1 mol-mol),1.7829668045842757
KYSE-450,46926350,-4.1870362089493804
M059K,9903786,3.785857349201863
HCC366,9868037,6.006558205006566
KYO-1,tanespimycin-bortezomib (250-1 mol-mol),0.6215111489817027
5637,2729026,2.987295948715679
KCL-22,24753719,3.821125268566526
TE-4,JQ-1-UNC0638 (2-1 mol-mol),1.351670583149183
NOMO-1,24753719,4.496099764979975
SW948,2708,5.7755473109613265
PC-3,156414,2.5844798005435696
Lu-65,151289,1.2132872341043388
D283 Med,54618771,1.215604089870786
MJ,24772860,-2.9241484283006565
WM115,9911830,1.4636751787761997
MCF-7,9903786,3.2865331154211743
U-BLC1,151289,1.013855043294461
COLO 320,327653,2.2113040618920596
A4/Fukuda,753704,3.7176461109746897
COV362,2708,5.62265357151256
HEL 92.1.7,44137675,4.01519513563731
NCI-H1155,10385095,-0.1024121821965068
NCI-H2286,327653,1.7676593790329698
HH [Human lymphoma],11404337,-1.3544677406632493
Kasumi-1,44493528,3.994031742837349
BT 232,54618305,4.404663674911541
ZR-75-30,11485656,1.735891499698879
SF268,2729026,2.3697727501253536
NCI-H1299,44137675,3.903392614600126
NCI-H810,9903786,3.328850282444774
BT 216,6450551,3.697064181575352
KP-2,6450551,4.203527500415555
LS513,10302451,3.84490458936503
MES-SA,135659046,3.2856375054871436
PE/CA-PJ49,44137675,2.9964477729791787
WSU-DLCL2,49766530,-5.110358860052542
OS-RC-2,4259181,0.8424139388103674
SU-DHL-1,2729026,1.1961155288156848
Ri-1,JQ-1-UNC0638 (2-1 mol-mol),-0.2670899012636173
BT-16,9911463,3.6213577746189514
HT,sirolimus-bortezomib (250-1 mol-mol),-1.783381881062306
BC-3C,374536,2.8246931045554473
NCI-H1838,9903786,2.204739159527363
GB-1,148198,-2.999255289786891
SU-DHL-8,24753719,2.049224728384907
HCC2279,sirolimus-bortezomib (250-1 mol-mol),1.5842839132976092
NCI-H226,654092,0.2112026793193106
A2058,JQ-1-UNC0638 (2-1 mol-mol),2.62837357751412
JL-1,9911463,4.108881360453434
Hep 3B2.1-7,753704,5.157243531098819
NCI-H1299,54618305,4.3112203505981554
LCLC-97TM1,24753719,4.6973214087473405
PE/CA-PJ49,54618305,4.991417436766986
SNU-213,9911830,2.5887674571936827
BT 159,2729026,2.4493802360298393
Hs 895.T,10302451,3.366157666522833
J82,4259181,0.7909526857706146
CAL-27,2708,6.67676136872839
SKM-1,11404337,-1.0204518416697923
IA-LM,9911463,2.6703246121465436
A-172,136227924,1.9508876589720905
DoHH2,9911830,0.7564656851720019
NCI-H838,136227924,3.210993191129446
JHUEM-1,374536,1.0610482819163725
EHEB,3815108,2.965320927013124
L-1236,54618771,1.349542879439561
LOX-IMVI,49766530,-3.939815107547984
CAL-51,156414,1.13799157004995
SNU-1033,10385095,1.019137651596638
RT-112,selumetinib-BRD-A02303741 (4-1 mol-mol),4.473543990793305
RS4;11,9911463,2.865814362111231
NCI-H1623,156414,-2.396664487331107
YD-15,2729026,2.7742552764731316
KMRC-3,135984461,3.851943021545312
Rh41,10385095,-0.194443175425209
OVCAR-5,6450551,6.029523164945035
CHP-212,44137675,1.82018000392081
HT-55,24772860,-3.359481250768097
Ci-1,374536,1.7269838049270425
IM95,9903786,2.260707421178731
Hs 944.T,10385095,1.1433247729283496
SW620,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.676288484350093
COLO 320,44137675,2.730042099939844
M-07e,44137675,3.272566804511678
IGR-37,135659046,4.488769216179786
EoL-1,54639665,4.29545945108559
HMCB,151289,0.8924062734288687
LAMA-84,10302451,-1.004459316754453
SaOS-2,9911830,2.995519789289086
Tm87-16,6918638,1.685877377601704
SF295,9911830,5.317347771430753
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529
KMRC-3,10385095,1.720120305356793
Hs 683,135659046,3.747937151940255
SK-MM-2,124202324,-0.4772828195179086
SNU-46,124202324,2.14210519585703
WM88,11485656,3.1313220477108996
IGROV-1,3815108,1.915722485757852
Mel Ho,44493528,4.666691199289373
NCI-H1105,sirolimus-bortezomib (250-1 mol-mol),0.3147728445720161
Granta-519,6450551,1.162651959279597
SNU-449,327653,3.836895463512291
CMK,46926350,-4.2413350827901155
RCH-ACV,124202324,0.425140274633714
EFO-27,2708,5.128228617584202
HGC-27,2729026,1.9408315260564617
SH-4,24753719,4.294817471843681
A-375,JQ-1-UNC0638 (2-1 mol-mol),2.8222057899480104
NCI-H1092,46926350,-4.274443636172462
M-07e,151289,0.7139069324508128
JK-1,753704,4.3191280222820225
SNU-620,6450551,0.9650119216949264
SET-2,54618305,3.97030944643435
CAL-12T,9903786,2.474655504914218
SK-ES-1,327653,3.091902548838085
NCI-H2087,11167602,0.4948017667702105
MEC-1,11404337,-2.8975071038846023
A-673,135659046,3.595490040408381
HEC-1-B,24753719,4.359915820911249
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
Kasumi-1,327653,2.8937710692107688
VCaP,135984461,3.022939486158339
LNCaP clone FGC,1716436,2.823622083342099
CAL-29,44493528,4.2702919799030035
NCI-H1838,44493528,4.677704143001884
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
TE-15,44137675,2.7760233846096845
KP-3,11485656,2.673409024797461
U-87MG ATCC,2708,6.264255469808134
NCI-H358,49766530,1.9873941918959552
HPB-ALL,24753719,3.680358106970135
LNCaP clone FGC,54618771,1.2210181091381391
OPM-2,6918638,-1.573449675489913
OPM-2,24772860,-2.8738620885527153
RMG-I,9911463,3.4639746242491545
OVCAR-5,44137675,4.8422422351039565
OCI-Ly19,156414,2.045097094802914
Capan-1,54618771,1.2966911040963736
JHUEM-2,4259181,-1.5019807031703976
AGS,9911830,2.854606152747599
SK-LU-1,9911463,4.212038568288349
HCC1428,9911463,4.299453342074575
HPB-ALL,1716436,2.4640191551840513
A-375,44137675,4.805163792846208
HEY A8,10302451,3.339170922140571
SW620,135984461,4.297796341732351
MOTN-1,753704,3.815298505943711
PaTu 8988s,44493528,4.319224054149941
NCI-H508,11485656,2.212922909681824
HEC-6,11485656,2.017714855695412
NCI-H23,374536,2.7090261266880105
NCI-H747,135984461,2.203794550549454
NCI-H747,327653,3.3601935070997264
SNU-668,9903786,2.616887117986772
MOLT-3,1716436,3.1276657570369464
A-375,44493528,5.0092859091998205
TUHR10TKB,11404337,0.4722597238806724
Mono-Mac-1,49766530,-2.16205133655403
DLD-1,54618771,1.295500773429104
HSC-4,148198,-2.795908666323494
JM-1,374536,-1.2279479926310035
LS513,9868037,2.665917193045876
SNU-761,654092,0.3721343866621542
TTC-709,9843750,4.363875911309475
HL-60,44493528,4.339853474381488
DMS 79,4259181,0.3860900214886335
HEC-151,6450551,3.129732127763604
SK-MES-1,4259181,0.518582282255732
BT 187,753704,5.028665791690541
NCI-H520,46926350,-5.841263127359055
TOV-21G,10302451,3.5434423725456092
MOLM-16,44137675,1.6139989276581546
SNU-738,54639665,4.332725290413926
BT 145,9911830,1.6824084137272743
COLO 741,327653,3.3444058509126076
SNG-M,10302451,2.428061040966125
BT-474,10385095,2.724644688135605
HD-MY-Z,11167602,1.6882998388727035
LOX-IMVI,selumetinib-BRD-A02303741 (4-1 mol-mol),2.511900136094648
SUP-M2,135984461,3.87048061577109
U2OS,151289,1.0324917956538018
RVH-421,selumetinib-BRD-A02303741 (4-1 mol-mol),1.2464292547035598
NCI-H2291,JQ-1-UNC0638 (2-1 mol-mol),-0.2565674584667012
SNU-C2A,JQ-1-UNC0638 (2-1 mol-mol),0.6359771027590772
KMS-20,49766530,-1.2962307066769267
SNU-1076,2708,4.46412794581006
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
MCF-7,3815108,3.233903494709178
JHOM-1,73707371,5.033603760550125
Aska-SS,100016,5.454856815374324
TUHR14TKB,1716436,2.281866473169947
RKO,10385095,1.2981289243482117
THP-1,44493528,4.188998476775423
Hs 888.T,4259181,0.9050777250600304
SNU-685,151289,1.853918183804949
OVCAR-4,selumetinib-BRD-A02303741 (4-1 mol-mol),6.112398696135899
LOX-IMVI,136227924,2.635687863612288
Hs 888.Lu,10385095,1.093902628388718
NCI-H647,9911830,1.9312757537429064
OUMS-23,1716436,3.1625147387162604
COLO 201,100016,6.515418099212221
SU-DHL-8,151289,1.5418831539611528
Karpas-422,4259181,-1.4276330915263615
SH-10-TC,6450551,4.176066692793308
ONS-76,49766530,-0.8397126534273769
HCT 8,9843750,4.475250854262149
BT-20,46926350,-4.100078845822285
COLO 792,2708,5.571037742492044
SW1088,10385095,1.7671822687646943
BT 271,135659046,3.5809922662045137
HT,9903786,3.804202680432086
OVCAR-5,11485656,2.327604850531282
LAMA-84,sirolimus-bortezomib (250-1 mol-mol),0.5037633346566652
LOX-IMVI,2729026,2.7048403427660204
Panc 02.03,11404337,1.528571500956484
PE/CA-PJ15,151289,0.6596724768960354
BV-173,1716436,2.353931002242621
8505C,24753719,4.418317774206583
AM-38,6450551,2.673108554893828
SK-MM-2,3815108,2.390454324892359
COLO 829,sirolimus-bortezomib (250-1 mol-mol),0.4169423726863133
A2780,9868037,1.6123332444026346
CW-2,11404337,-0.6368156397090832
DEL,2729026,2.357005408457736
Mel Ho,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.2438952767446845
Yamato-SS,136227924,3.1022512927874444
BT 145,49766530,-0.5681033515253969
COLO 680N,1716436,3.2892588679940373
SNU-16,46926350,-6.1724918394261
KP-4,11485656,2.2916969527324778
COR-L88,6450551,3.0191944660959016
HuT 78,156414,0.7736660521630903
SK-MEL-31,1716436,2.7734606643511652
Karpas-299,654092,-1.5063753832081268
U-87MG ATCC,10385095,0.087665858719859
HCC1395,54618305,4.96091768508178
RPMI-8226,11404337,-0.8965265864586413
EFE-184,sirolimus-bortezomib (250-1 mol-mol),0.9563190078492846
BT 482,24772860,-1.5429215445904447
EFO-27,374536,3.468329704237433
P12-Ichikawa,654092,-0.8973349387574588
JVM-3,136227924,1.9937281150641608
BT 179,11404337,-0.0288044782393938
PC-14,10302451,-1.9208505295158915
TT2609-C02,24753719,4.8060720980706195
BT 224,1716436,3.6566843228096215
LS513,24772860,-2.283970116847822
CAL-12T,327653,3.0974191705216794
253J-BV,9911830,3.5060206462431065
NCI-H322,46926350,-4.228168883590994
JHOS-2,9903786,4.753698085205414
GB-1,9868037,4.836422813626047
COV434,374536,2.275894982547334
LS123,4259181,0.5283924885744881
KMRC-2,148198,-2.5062257311600753
COLO 800,374536,1.934521252403809
LoVo,753704,4.37626239298451
Rh30,3815108,1.8421868623126207
SW1417,10385095,1.3111570658719054
GCT,1716436,3.2890427253575707
HD-MY-Z,9911463,3.453159994393753
HEC-108,10385095,1.228149017066595
BT 428,11167602,1.02406203093047
BT 224,tanespimycin-bortezomib (250-1 mol-mol),-3.111223300831193
NCI-H1155,73707371,2.6072725217800494
MDA-MB-157,9903786,1.458865596348786
SU-DHL-1,100016,4.0163007651424945
CAL-54,selumetinib-BRD-A02303741 (4-1 mol-mol),4.907118209597622
UACC-62,54618771,1.116169218616572
OAW28,44137675,4.561686598527574
CAL-85-1,24772860,-2.0792513850241905
SW1783,44493528,4.220460910824872
BT 330,2708,4.477643165741568
RPMI-8402,3815108,2.52829997476961
K029AX,54618771,0.9903222324801182
ZR-75-30,49766530,-1.248821284043819
HCC2279,44137675,4.096460023621017
MDA-MB-157,24772860,-2.2599749907314175
NCI-H358,156414,-1.317355730402675
PE/CA-PJ49,4259181,0.0577258955195342
VMRC-LCD,54618305,4.210523394539639
MeWo,54618771,2.702523015833562
LOU-NH91,327653,3.620861790086289
HCC15,3815108,3.1337581441750277
BT 286,9929138,6.547331402872382
BICR 31,24772860,-2.497965982707089
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517
CAL-51,9868037,3.5441777448678615
NB4,753704,4.547864898700116
BT 440,11404337,-1.269417175966202
Caki-2,49766530,0.634494181094052
EC-GI-10,JQ-1-UNC0638 (2-1 mol-mol),4.74361383743252
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
253J,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7573077735074305
SK-MEL-24,6918638,1.430971742186676
CHP-212,11485656,1.772260285582149
CADO-ES1,9911463,2.9400550809567454
MOLP-8,6450551,1.973885798572914
U-118MG,44137675,4.4626227482518255
HOS,44137675,4.060877623702009
5637,sirolimus-bortezomib (250-1 mol-mol),0.1813560942007127
Lu-65,11167602,5.906692389190635
M059K,9911463,4.34253595851811
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
IM95,24753719,4.235944018708707
HCC95,24753719,4.535760675090215
WM115,100016,7.477930972064711
OVCAR-8,4259181,0.2108264880727851
NB1,54618305,-4.477531236870953
KYSE-70,9911830,3.1951659700149886
MOLT-16,9929138,4.3035507183563615
SK-HEP-1,6450551,3.663777137244395
Ci-1,136227924,2.861978373437932
SF126,6450551,1.5600885886567424
KP-N-YN,24753719,5.28590811634551
TUHR10TKB,2708,5.206686842843534
MFE-296,46926350,-4.168398920966641
L-363,44137675,2.3171455213974705
U-CH1,753704,5.174443097184504
Calu-6,4259181,-2.1681015531295027
HCC366,135984461,4.314156466102652
JM-1,11404337,-2.1014875230304315
MPP 89,156414,1.6463851020768565
YD-8,3815108,3.012285181299406
NCI-H810,selumetinib-BRD-A02303741 (4-1 mol-mol),5.7319111741732565
A4/Fukuda,10385095,0.4549399411675465
BT 172,136227924,2.3975770198101545
BT 232,1716436,3.24358958747125
HCC2279,54618305,4.381528297963885
HEC-251,2708,5.604946066885222
NCI-H1869,10302451,1.963256574225826
NMC-G1,11404337,-0.1784694384642232
HuNS1,136227924,1.7771734051898846
VCaP,374536,3.346677987989801
ESS-1,136227924,3.049003867547222
BICR 31,4259181,2.3774772051226685
ONCO-DG-1,54618771,2.377307525963503
HSC-2,10302451,2.789258636905671
SW1116,135984461,2.388083333366143
HuP-T4,54618771,-0.0993332629416019
Panc 10.05,2729026,2.9367988519453716
HuT 78,4259181,-0.3142311669352864
NCI-H1341,sirolimus-bortezomib (250-1 mol-mol),-0.2391500871709352
LCLC-97TM1,3815108,3.2576294300862867
COLO 668,148198,-4.3418041773017135
U-251MG,11167602,1.923404426526953
EPLC-272H,44137675,1.4518508138465718
MDA-MB-361,136227924,3.324084435927791
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
BxPC-3,135984461,1.8776729747018608
GSS,753704,6.0092696995558645
T-47D,54618305,4.335856862288139
SW620,9911830,2.3998615697113403
KMS-34,6450551,1.2180226993153591
639V,136227924,2.8924456476929605
647V,1716436,4.877087047545325
NCI-H841,9903786,1.3953234404083057
COR-L51,148198,-5.724973954604913
SNU-119,654092,-3.073300249988697
BT 286,753704,4.971153206041931
OUMS-23,3815108,3.3235240359241227
RERF-LC-Ad2,11167602,5.947765325830758
MOLT-16,tanespimycin-bortezomib (250-1 mol-mol),0.076704677105394
KMH-2,JQ-1-UNC0638 (2-1 mol-mol),1.1907602496556098
NCI-H211,2729026,0.9148636412366948
HCC827,156414,3.2121505716961134
KMS-12-BM,11167602,1.7675298654448677
Panc 08.13,6450551,3.609722933908907
NCI-H1341,135984461,3.1611856157713607
SK-LMS-1,9911830,2.533802245803789
NALM-6,2729026,0.8972560492047826
SK-HEP-1,11485656,3.3898088020096324
NCI-H2228,156414,2.8304851039328565
BL-70,2729026,2.39228879135414
NCI-H322,2729026,2.9754544085555583
BT-549,100016,6.139281322747303
LS411N,124202324,2.3656166654970137
MOLP-8,9911830,1.992368688928045
TYK-nu,44137675,4.440530583797657
CMK,tanespimycin-bortezomib (250-1 mol-mol),0.1761627875965655
SNU-407,24772860,-1.4839208057036706
22Rv1,49766530,0.7330336721208812
TC-71,9911830,2.32382211110597
SCC-4,2729026,2.487594363780824
KYSE-180,10385095,1.0867111286980162
NCI-H196,9911830,5.051951455628038
SBC-5,374536,0.1871414147839566
HCC2935,24753719,4.859796375591352
ONCO-DG-1,374536,0.8752325159016582
HT-1376,100016,4.270787672820572
Hs 940.T,54618771,0.7106983337265675
A-375,24772860,0.9436662834694136
CL-11,6450551,1.4276131905793803
KYO-1,10302451,-1.541615937925273
TE 441.T,54618305,3.9313540825452775
NCI-H2122,136227924,3.797810316623325
NCI-H1650,1716436,1.5808418245432774
HCT 8,9911830,2.7561206776295712
SNU-601,tanespimycin-bortezomib (250-1 mol-mol),0.586889084570332
MV4-11,54618771,-0.7918947949340449
42-MG-BA,46926350,-3.9617440562978894
MDA-MB-415,4259181,1.0953651491998988
JHOC-5,11167602,4.441059570207515
SNG-M,54618771,1.0542976852091588
LC-1/sq-SF,4259181,1.283274293242228
SH-10-TC,4259181,1.4387365857426029
G-361,24753719,4.309851667537251
EFO-21,156414,3.642961879439636
Sq-1,124202324,2.6786409889142897
NCI-H226,24772860,3.592536904269388
TOV-21G,374536,2.7781959223740893
LUDLU-1,2708,5.508208292946171
JIMT-1,327653,3.612061547111272
TE-11,9911830,1.9048813646783824
LOX-IMVI,654092,-4.072489385896434
YH-13,6450551,2.0238267614967644
CCF-STTG1,2708,5.83554362826176
DU4475,9929138,2.965218723675565
MDA-MB-468,49766530,0.7158760984187301
BT 145,24753719,3.4612678536097814
BT 228,753704,4.364635443239377
SNU-16,selumetinib-BRD-A02303741 (4-1 mol-mol),4.244589882564095
MDA-MB-157,11485656,1.3019788320898549
SNU-C4,10385095,2.739530321811718
Jurkat,374536,2.5973919428258982
QGP-1,654092,1.0527171720799202
HD-MY-Z,46926350,-5.98174981199225
G-402,9911830,-1.8927081799919792
SU-DHL-10,44137675,1.8328439546997564
BT-474,JQ-1-UNC0638 (2-1 mol-mol),1.494130967754263
TE-9,10302451,6.106147723455812
NCI-H1395,1716436,2.423237318066945
639V,tanespimycin-bortezomib (250-1 mol-mol),0.3038823340698895
PC-14,136227924,3.162840410264972
A-673,6918638,-0.1443248090306654
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
BT 428,10302451,3.296855722335022
IMR-32,6450551,0.3087760037732445
OVCAR-8,9929138,6.802229697599492
OV-90,JQ-1-UNC0638 (2-1 mol-mol),1.522151134636872
HCC78,10302451,3.668800940704608
A-498,11404337,2.25955984981305
Hs 888.T,11167602,2.912486877165088
JHH-2,135659046,3.3681644336140284
HT-1197,156414,1.5339590025962693
Mono-Mac-6,11485656,1.0261248575156627
KYSE-70,2729026,2.877153539650856
BT 333,9911830,3.7396466566294126
Hs 746.T,JQ-1-UNC0638 (2-1 mol-mol),2.240140554615103
BICR 16,2729026,3.035256422338755
IPC-298,1716436,3.0061174888775257
Ri-1,753704,4.378804687168766
RPMI-6666,24753719,3.8145532012003938
SYO-1,JQ-1-UNC0638 (2-1 mol-mol),-0.9946882426942651
NB1,9929138,7.475182637248333
NCI-H889,9868037,2.7171029486851683
HCC78,54618771,0.9247891976251188
KMS-12-BM,9911830,2.539717819095299
MOLM-6,327653,2.4462105990382694
Kasumi-2,753704,4.42700120937948
LS411N,654092,0.6196619744838121
COLO 668,46926350,-4.43176870166758
KMS-11,tanespimycin-bortezomib (250-1 mol-mol),-4.691870791647551
TE-8,3815108,2.540451606533082
HSC-4,6450551,4.030000721690881
BT 224,6918638,1.2404651093328147
SNU-620,9929138,5.350432849489577
T98G,11485656,2.7510926894657977
BICR 31,9911830,2.2138272662609064
LCLC-97TM1,6450551,2.230680139016655
Hs 934.T,753704,5.03570838151056
MOLP-2,2729026,2.763081829481107
2004,11485656,0.272935055916473
GI-1,151289,1.1135513169740323
NUGC-3,3815108,3.6827946568557666
TCCSUP,2708,4.555473359535819
CCF-STTG1,24772860,-0.8765795135631896
SW1990,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2981500130451753
SCC-9,151289,2.789872420286255
TUHR10TKB,54618771,-1.4225066809641267
NCI-H2196,49766530,-0.5620796478121586
COLO 680N,sirolimus-bortezomib (250-1 mol-mol),1.5905576307574611
RPMI-8226,9911830,2.9345050444494696
BT-474,2729026,-1.442822039182543
ST486,4259181,0.03160083232378
SNU-685,2729026,3.063691381785551
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
DMS 273,54639665,4.46621146803559
ST486,9903786,1.7386739001111973
Hs 294T,sirolimus-bortezomib (250-1 mol-mol),0.1024720435012197
SNU-1033,135984461,1.7836640453843908
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
HCC1195,selumetinib-BRD-A02303741 (4-1 mol-mol),1.738983343571092
Hs 944.T,54618771,2.424765430874906
OS-RC-2,49766530,-2.9436814262452144
KO52,10385095,0.862604455305029
T3M-10,44137675,3.9014665271876146
SNU-245,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0609025549947777
SU-DHL-8,135984461,2.059848227553284
BT 328,selumetinib-BRD-A02303741 (4-1 mol-mol),6.07719627140778
HOS,24772860,-2.1119587370986865
JK-1,11485656,2.0269272789358332
8505C,654092,-2.5040445794956665
CHP-126,124202324,0.9087143597961738
ST486,JQ-1-UNC0638 (2-1 mol-mol),-1.007840059900225
SW1573,16013152,3.6979705228045354
MIA PaCa-2,6450551,2.264163954553481
JM-1,135984461,1.552881480804892
U266B1,10385095,0.7447923341287666
MM1.S,148198,-3.54523038003387
IGR-1,4259181,-0.2884937988554064
ONS-76,2708,5.792421817961339
JHH-2,100016,7.043022520962564
BT 232,9911830,3.5363082238879504
BT 231,44137675,2.8772495475471227
SNU-308,100016,6.582722131637771
HSC-3,11485656,2.2428743548360863
Hs 895.T,10385095,1.68656194127411
MeWo,73707371,4.543966825854081
PC-3,9911463,4.050651586625943
Hep 3B2.1-7,49766530,-1.5968741678942395
HL-60,11485656,2.725132337131944
HCC1143,135984461,4.873829103860087
DMS 273,6450551,2.589238729256945
HCC1438,6450551,3.2478956733899222
TC-71,11404337,-2.7316229346528145
SCC-4,327653,3.2036873464171003
HCC1588,136227924,2.6333776491111585
MOTN-1,11404337,-2.499451139937234
AsPC-1,10302451,4.160835682979353
HCT 116,tanespimycin-bortezomib (250-1 mol-mol),0.9696018979872172
SNU-840,148198,-2.353488885952442
HCC1500,136227924,2.675203690625814
KMS-18,44137675,2.6937954231394943
KMS-28BM,49766530,-3.0196417815888124
NCI-H522,6450551,3.1458433056927295
BV-173,327653,3.1495796349784477
SNU-899,11404337,-0.8978205339796733
HT-55,1716436,2.24792730196868
SW1990,6918638,1.2411625887645945
EFM-192A,54618305,4.273726836942187
SU-DHL-10,73707371,5.112543100858277
DU145,10385095,0.949692238641196
COLO 680N,44493528,4.52378169119992
HSC-3,24753719,4.387222706020441
CA46,6450551,1.1375422858810305
MHH-ES-1,100016,6.165620846351705
TTC-709,10385095,1.138092247834034
TUHR4TKB,9903786,3.6038306258320425
HSC-3,9911463,3.6821530137729983
KCL-22,3815108,1.9796793810881392
TE-9,11485656,2.3565091821731903
SNU-16,327653,2.968666215032176
Karpas-422,24772860,-2.5980734738396567
EPLC-272H,135984461,4.356023711246228
M059K,6450551,1.7552468395585827
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
Hs 578Bst,327653,2.576828219762845
BT 159,10385095,0.5382854517142396
SK-LMS-1,6918638,1.135857739605079
HLF,1716436,3.478254731253369
EoL-1,100016,3.3783759894754795
MDA-MB-231,9903786,4.774872525437021
SNU-738,124202324,2.8499266750011065
RPMI-6666,135659046,6.863233968439554
U-937,9911830,2.552949860232843
ST486,135984461,1.4882803556489697
CAS-1,54618771,0.3007933924780016
U-87MG ATCC,11485656,3.26618514793835
DU145,44137675,4.668364290879563
KMS-18,136227924,4.439422503928272
NCI-H1299,2729026,3.118725494880117
MFE-319,54618771,1.5027851162197383
NCI-H2286,49766530,-2.3239391037136654
ECC12,44137675,4.161039180912474
M-07e,54618771,0.3587170705521248
CMK,374536,0.9782417552205956
769-P,135984461,1.7373161428714323
IMR-32,11404337,-2.700681379951113
KE-39,753704,5.009174848734236
CML-T1,148198,-3.9003291277504526
BT 224,54618771,1.0609387834532893
CHP-126,654092,-0.1130236674232413
H-STS,374536,1.4789763498998243
HCC827,10385095,1.4458528410781517
F-36P,11485656,2.0495534401946647
PE/CA-PJ41 (clone D2),753704,5.093510117133769
NOMO-1,11404337,-0.1001889231988697
OC 314,24772860,-2.233738563369384
PaTu 8988s,374536,0.6964721820737422
CAL-27,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.4954599172382079
HEC-59,24772860,-2.0761129343585023
JM-1,100016,5.094244415703564
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
SK-ES-1,135984461,2.1821823459422
YD-10B,11404337,-1.441259923990304
HEL,151289,0.2321343459174182
KNS-42,sirolimus-bortezomib (250-1 mol-mol),0.2435231832120803
LS180,9911830,2.83226076921101
KYSE-410,16013152,4.977584509485277
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
L-363,24772860,-3.6962328717758544
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
KP-2,135984461,4.592059766741548
A3/Kawakami,151289,0.7664829074224649
NCI-H1703,10385095,0.811634941740761
SK-N-AS,10302451,3.6948168438870583
HSC-2,1716436,3.797741318136764
BT 482,9911463,4.164033493319952
Lu-99,9903786,2.034349953938994
BT 286,71729975,1.6702484611001218
NCI-H520,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5796629690366295
RERF-LC-MS,11485656,1.5190166417661397
U-BLC1,136227924,2.288895160726179
T84,46926350,-3.687733796852173
HCC1419,4259181,1.0183716467529351
GA-10,4259181,-0.2690364706183594
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615
MHH-NB-11,6450551,-0.0986199770393982
SNU-886,1716436,2.5748440651933766
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
SNU-81,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.6771468011681286
VMRC-RCZ,9911463,4.022790104530676
OAW28,49766530,-0.5315014966120291
HT115,44137675,3.77441658017914
BT 172,44137675,3.767326503342825
SNU-213,JQ-1-UNC0638 (2-1 mol-mol),3.293883125689118
NCI-H650,selumetinib-BRD-A02303741 (4-1 mol-mol),6.195762156115279
PE/CA-PJ34 (clone C12),2708,4.740071919144502
KE-39,9929138,5.605001473491643
KM12,374536,4.721790972098505
SNU-1066,136227924,3.4679855479635644
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
BT 112,1716436,2.062857445676959
JM-1,49766530,-3.0151701370453794
MDA-MB-468,JQ-1-UNC0638 (2-1 mol-mol),1.5308453367142645
BT 231,49766530,0.2532028472914431
AML-193,44137675,3.691829225340739
SK-N-AS,4259181,-0.3147022482615397
EPLC-272H,10385095,1.1702440891240469
BICR 6,10385095,1.2855816104984523
Fu97,10385095,1.9014860285103132
LC-1/sq-SF,9903786,4.361015168836896
SW579,9903786,2.7100621017301516
HCC1806,24772860,-2.5711014976732645
NCI-H841,135659046,3.31199371059189
OCI-AML-3,24772860,-3.7342569883538177
G-292 clone A141B1,24753719,4.492149342969766
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
OC 314,6918638,1.2645256695778866
WM983B,16013152,4.264752605068201
OCI-Ly10,9911830,3.818058704017732
Caki-2,4259181,2.3809189293534017
U-118MG,49766530,0.4314667015324968
NCI-H226,sirolimus-bortezomib (250-1 mol-mol),1.5737469522318486
SW1783,10302451,4.263014004956648
SNU-119,11167602,2.3286246928254335
SNU-601,24753719,4.305423273046676
P3HR-1,753704,4.966690212095988
PF-382,9903786,1.7632578420268197
SNU-601,9868037,3.788839029413147
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345
HSC-4,44137675,2.9134227764609735
A-549,753704,5.476427774826246
MG-63,9911830,1.9513563305490416
KYSE-410,124202324,2.809951119195219
PK-1,2729026,3.0900724274707763
BT-16,753704,6.150556812400125
NCI-H841,44137675,3.64508674528804
HOP-92,6450551,3.043201595005235
RL,100016,6.4335673885856135
KYSE-410,4259181,0.334687441755604
GB-1,54618305,4.728305083790762
IM95,10385095,1.0460048441425125
A2780,11167602,1.1290528312474395
Hs 611.T,44137675,1.8104045902610284
RVH-421,6918638,1.0964005679710755
MKN74,11404337,-0.8129110599609928
MCAS,654092,-1.435173669526354
DMS 114,9911463,4.412610597961803
SCC-9,9911463,4.4493328300482995
U-118MG,4259181,0.1154579425878505
A-673,10302451,3.0176041071951345
MFE-319,16013152,4.475491223269678
BT 504,JQ-1-UNC0638 (2-1 mol-mol),2.7294851811604786
A-498,1716436,3.6890609174990057
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788
GCT,100016,6.941224948418202
SK-N-MC,46926350,-4.4005283223676885
SNU-16,156414,1.3810749136744684
SW579,2708,5.317602022364756
COLO 741,124202324,4.505468853537659
Hs 822.T,24753719,4.3035414740623175
MHH-ES-1,3815108,3.2040420472757924
P3HR-1,4259181,1.18334464722064
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
TOV-112D,10302451,4.162111646950722
HT-55,24753719,4.165074033971129
BEN,10302451,4.117279782065388
Karpas-299,10302451,2.3096571602209655
RKN,4259181,0.9508926940780028
PE/CA-PJ49,10385095,0.7863644844399451
CMK,151289,0.290407119281786
SNU-1076,JQ-1-UNC0638 (2-1 mol-mol),2.431828167465315
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
SW1710,148198,-2.170250492388752
OUMS-23,9911463,3.126412201053572
FU-OV-1,9929138,5.415072941349914
Li-7,49766530,4.425008044849751
OCI-AML-3,54618771,-1.4994430738546511
KMS-18,135984461,4.3135759037232635
TE-8,selumetinib-BRD-A02303741 (4-1 mol-mol),4.446050724016617
DB,4259181,-1.103754913039793
RERF-LC-Ad1,374536,2.042610785182273
MOLP-2,753704,5.000687081119619
A3/Kawakami,100016,3.999978023882096
KMRC-2,4259181,1.2333196545111071
HuT 78,11167602,1.7844027861507523
KMRC-1,44137675,2.117874577310701
SUIT-2,54618771,1.0369427055295135
WM88,1716436,1.3012798597851012
A-673,148198,-7.755828732328633
HCC1395,49766530,0.1887726422432668
JHH-1,6450551,3.3773286854400877
LCLC-103H,753704,5.396939392004122
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436
CAL-148,2708,4.591624955723654
HuP-T4,11404337,-0.0710006834514767
HuH-6,9911830,2.45331857773806
COV434,9868037,3.5790100972586867
Becker,24772860,-1.986740443990647
697,100016,3.656696343596264
A-253,9911463,3.7937497344775815
786-O,100016,5.342252836782742
JHUEM-7,2708,5.089129361016784
Pfeiffer,54618771,-1.2193011849050512
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019
M059K,6918638,0.417143769995747
NCI-H23,11404337,-2.5552294487119664
NCI-H1869,49766530,-0.032716755694371
JHH-2,151289,1.6843462113490335
SNU-466,sirolimus-bortezomib (250-1 mol-mol),-0.4040247740859908
SW1271,54618771,-0.1319273231055389
GSS,9903786,1.9234294660474929
JL-1,1716436,5.375072224063116
SK-MES-1,11167602,2.859403378030726
JJN-3,10385095,0.9998368526729328
RD,tanespimycin-bortezomib (250-1 mol-mol),-1.016006094021389
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
KE-39,327653,3.149148027412197
DK-MG,100016,7.056187444773538
HeLa,9911830,3.0701846369034556
OCI-M1,9903786,1.4970236133945398
NCI-H1975,44137675,1.583246192745017
Lu-65,9903786,2.0553359532496875
KMS-34,4259181,-0.3254253333461033
T84,9868037,2.575833887310964
HCC2279,124202324,2.5487956742174527
BT 231,4259181,0.6722298764653775
SW1710,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9386363338844435
CAL-78,49766530,0.682857440978597
U-251MG,sirolimus-bortezomib (250-1 mol-mol),1.1740336487454477
KMS-27,54618771,0.0520641396166809
SH-4,9911463,2.562813688525255
KCL-22,327653,3.1814248646460603
NCI-H889,JQ-1-UNC0638 (2-1 mol-mol),2.7928695675417003
MHH-CALL-4,374536,-2.0256098249407795
HCC1438,46926350,-3.4630052948298617
JHOM-1,11404337,0.0884008871371316
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295
Karpas-299,9868037,2.0515454012978176
MDA-MB-231,1716436,3.293251407938337
CAL-62,11485656,2.1726256294721167
SK-OV-3,11404337,1.4011927232423718
TUHR10TKB,tanespimycin-bortezomib (250-1 mol-mol),1.8838456132179628
BT 422,JQ-1-UNC0638 (2-1 mol-mol),3.730590759995232
BICR 56,JQ-1-UNC0638 (2-1 mol-mol),0.1949658232324598
NCI-H2122,44137675,3.802561400221864
CAL-78,156414,2.419390315202125
BT 159,374536,3.3675327272250573
Fu97,4259181,-0.4565347445839081
HuH-6,selumetinib-BRD-A02303741 (4-1 mol-mol),5.214321512724216
IGROV-1,327653,3.667792542405671
SK-CO-1,124202324,2.795373404058925
PK-59,148198,-2.6043559024802763
F-36P,10302451,3.5545884157395604
SF539,9911830,1.1022803108352155
TT,sirolimus-bortezomib (250-1 mol-mol),1.7489880165366345
NCI-H2087,selumetinib-BRD-A02303741 (4-1 mol-mol),-3.5013411432634745
SK-ES-1,9911463,3.761079792155382
Hs 936.T,2708,6.739726031918015
HCC95,9903786,2.343121552943665
MCAS,9929138,6.918248380879042
BICR 31,2729026,2.966794528433677
HEL,100016,4.260371486080393
Peer,374536,2.3706070321908523
HPAF-II,11485656,2.414916440294545
L-363,3815108,3.017945389244147
Hs 688(A).T,2708,5.754933981842638
SKM-1,9911463,3.5328203832136276
U-251MG,71729975,2.3122388251276993
NCI-H1944,11485656,1.8149710014494984
NCI-H1975,JQ-1-UNC0638 (2-1 mol-mol),2.441914561129672
HOS,10302451,5.257386528026884
Hs 766T,2729026,3.054996218860806
EoL-1,44137675,0.8534374900316186
NCI-H1385,11404337,-0.5225028243847427
SNU-1,9911463,2.449424301931946
COLO 699,tanespimycin-bortezomib (250-1 mol-mol),0.6482920125737269
ESS-1,135984461,4.427051677708814
TE-5,2708,3.304014729599199
SW1783,9911830,2.094357885918856
SNU-719,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1990831379726958
HDLM-2,24772860,-1.7444844847021763
Panc 03.27,327653,3.706156295956661
RPMI-8226,54639665,6.381219990706471
KMS-26,44137675,1.7443136706864044
H-STS,49766530,-3.13255748664254
LS513,9911830,3.013228491628512
HT115,4259181,-1.337170717880476
NCI-H650,24772860,-2.0898020954298056
G-401,24772860,-1.622851891505981
SNU-1076,44137675,1.460651627196815
NCI-H2110,24772860,-1.5922871326648207
OUMS-23,11404337,-1.4377112711513047
NCI-H1650,654092,-1.669067546009256
HT,654092,-1.5540580704731608
TUHR4TKB,2708,5.214050445085476
ESS-1,44137675,3.2480943550658576
MKN7,16013152,3.726034430011717
D283 Med,11167602,1.7563320025634743
JHUEM-2,24753719,2.2917062172444203
DEL,6450551,1.178685314758963
VCaP,44493528,4.161690845377168
SF295,54618771,1.9072877365394525
NCI-H1184,327653,2.728641844903854
CML-T1,374536,2.401691970017444
EoL-1,10302451,-0.9784650240234488
L3.3,9911463,4.128757247123474
JVM-3,4259181,-1.842202711980964
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723
LS411N,3815108,3.549037613932863
PC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),5.433097430759296
NCI-H1339,JQ-1-UNC0638 (2-1 mol-mol),1.853432296866984
HCT 15,9903786,1.9585182501172609
JHUEM-1,2708,4.3274982573447245
5637,135984461,2.794564016216432
MKN7,49766530,-2.7589304585779493
Li-7,11167602,2.0459258123097968
Malme-3M,10385095,1.6346329465288842
SW1463,10302451,2.197754569420114
Hs 888.Lu,9911830,2.3425038490808645
BT 286,24772860,-2.7013383956612684
NCI-H23,4259181,0.0190895573933118
SW1271,49766530,-1.8216621121390524
SK-MEL-31,2708,4.827756721653885
NCO2,9911830,-2.256494513015068
Daudi,46926350,-6.041265180126537
TT2609-C02,374536,5.765115244542164
HeLa,54618771,0.9271666044907572
L-428,tanespimycin-bortezomib (250-1 mol-mol),0.8418435976707451
Capan-1,11485656,1.8375535341364733
TT,54618305,5.02275363611129
Pfeiffer,10385095,0.6381642015116235
JHUEM-2,10302451,3.19057171364304
SNU-449,1716436,3.0856052265463023
SK-N-FI,44137675,3.5647084172204107
WT2-iPS,10385095,0.7837031813281792
PSN1,6450551,3.1979363602298374
L-540,135659046,3.3513489819639837
HCC1954,tanespimycin-bortezomib (250-1 mol-mol),-2.182183839668862
BT 172,54618771,0.7743085294895093
WM266-4,9903786,4.44287748208762
MCF-7,24772860,0.1511503916945715
SUP-T11,9911830,2.1480309662360377
MeWo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.2339733019413142
SW620,54618305,4.6897742902806625
A-204,9911830,-3.308014491584552
F-36P,6918638,-0.9703997893287856
EN,44493528,3.9032470450473657
VCaP,sirolimus-bortezomib (250-1 mol-mol),0.185191058575781
DV-90,tanespimycin-bortezomib (250-1 mol-mol),-3.2159049827612356
JHH-1,9911463,5.178733241899389
RL,sirolimus-bortezomib (250-1 mol-mol),-0.1936565509728958
EBC-1,2708,5.086581665154692
SKM-1,2729026,2.7681439157014753
Caov-3,11485656,1.8981464424658587
SK-LU-1,124202324,4.662340386097748
NCI-H1568,148198,-4.9953315451672005
TC-71,135659046,3.771711324789507
NCI-H1355,6450551,3.4727476787688554
HeLa,11485656,1.8522393336584817
OC 314,2708,2.8406750246568193
SNU-175,10385095,-0.1957909072596834
DOV13,24753719,4.184041404375166
SK-ES-1,136227924,2.7143313352480143
Karpas-422,753704,4.670762479174696
MFE-296,11167602,2.816070749987398
KMS-21-BM,654092,-1.5504597637966335
NCI-H1184,2729026,2.2031194120356665
U2OS,24772860,-1.6680183114548612
HCC1143,10302451,1.8641137803790455
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
UACC-62,6918638,0.9187226840984998
ONCO-DG-1,124202324,2.5840835734854037
CHP-126,49766530,-2.0764650765443817
JHUEM-2,100016,5.904304927611702
Hs 611.T,9903786,0.3508528062947837
NCI-H526,3815108,1.6948045476716
SW1271,1716436,3.164329770032204
SNU-489,11485656,3.634321717493026
ONCO-DG-1,54618305,4.684283592340112
NCI-H322,148198,-4.812707384343781
TYK-nu,9911463,3.540996784535568
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
MM1.S,11404337,0.2422934532029092
SK-LU-1,10302451,0.6542414788556885
HCC1395,JQ-1-UNC0638 (2-1 mol-mol),1.3845299276438443
JURL-MK1,10302451,-2.0701843125790993
Mino,753704,3.5464865657469753
NCI-H661,24753719,3.905315348750775
RKO,54618771,2.3159310195777985
IGROV-1,10302451,0.4135234554742116
NCI-H1581,2708,3.146451836292259
Karpas-620,2729026,2.2844465226535253
HEC-265,654092,-0.3940751456383276
CCK-81,4259181,-0.0185863710788798
8305C,sirolimus-bortezomib (250-1 mol-mol),0.6983572372591207
RD,4259181,0.4253037663567937
Hs 683,JQ-1-UNC0638 (2-1 mol-mol),1.243801160638627
KP-3,9911463,3.5465517511972173
HEY A8,11485656,2.178163900753691
HCC-56,4259181,1.2024907271901706
NCI-H1838,sirolimus-bortezomib (250-1 mol-mol),2.042115006385595
KMS-18,54639665,4.4302920956465055
SNU-1076,sirolimus-bortezomib (250-1 mol-mol),0.4980535505825825
SNU-466,tanespimycin-bortezomib (250-1 mol-mol),-4.621211093162312
JHH-5,tanespimycin-bortezomib (250-1 mol-mol),-2.9889336169985454
CJM [Human melanoma],10385095,1.0314241373580202
SK-LMS-1,2729026,3.0741249685189564
BT 139,2729026,2.333147558824636
T-47D,9868037,4.066424821107803
22Rv1,JQ-1-UNC0638 (2-1 mol-mol),1.86243516389236
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
IGR-1,54618771,0.8622245008505476
HH [Human lymphoma],374536,1.6917771244139928
GCT,73707371,2.4625046392434475
WM266-4,9911463,4.039840859111318
Detroit 562,9903786,2.622976915424344
YD-10B,10302451,-1.3287756961511683
ChaGo-K-1,9911830,2.4299534095194084
MOLP-2,151289,0.4438270924997064
HCC2218,6450551,2.46170463884505
PK-45H,4259181,0.9843809610373756
CFPAC-1,54618771,0.7086931491389132
HT-55,9903786,2.6159451586769156
JHUEM-7,9911830,1.3841062029972715
HCC2108,2729026,3.184070590056279
5637,11485656,2.17002066337147
786-O,11485656,3.3310875403182423
DU4475,11404337,-2.480961012408467
HCC78,374536,3.7501085924887967
COV362,156414,3.3927888347468653
Hs 934.T,9868037,4.303687473486903
ECC10,9929138,5.792605196564901
BT 286,148198,-5.76188834046235
LC-1/sq-SF,sirolimus-bortezomib (250-1 mol-mol),0.7549261124626822
JL-1,10302451,3.780690005321544
WT2-iPS,11485656,-1.624206160773241
HSC-4,135659046,3.804399419736421
OCI-Ly10,selumetinib-BRD-A02303741 (4-1 mol-mol),4.187434832786027
UACC-62,46926350,-4.289527218278107
SYO-1,9903786,1.9235940661883033
COV644,9911463,4.1377396171756144
GMS-10,10385095,2.1230156170889756
NCI-H28,JQ-1-UNC0638 (2-1 mol-mol),0.395224631328478
NCI-H1651,2729026,3.109020303048401
Hep-G2,2729026,2.3048811631927344
KYSE-140,9911463,3.6059267318888817
KE-39,11485656,2.227722528153515
MES-SA,148198,-4.473330928142554
COV434,tanespimycin-bortezomib (250-1 mol-mol),-0.6221104075249205
AM-38,374536,-6.249248932389967
OAW28,148198,-3.8662210541116977
ACC-MESO-1,124202324,3.762951160491622
IM95,46926350,-4.671274944319378
NCI-H1092,11404337,-0.107357005094737
SNU-C1,46926350,-5.846049240358996
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
TOV-112D,10385095,0.7671064543335444
LXF 289,44493528,4.295099384269069
KE-39,9868037,3.621529869698051
VMRC-LCD,49766530,-0.8677922390975771
SK-MEL-28,2729026,2.910502254408236
GMS-10,148198,-3.621238851602685
Panc 05.04,9911463,4.206171655784268
NCI-H1792,54618771,0.988608164360901
BT 340,9868037,4.513244290019421
COLO 829,136227924,3.354215786550203
HCT 8,753704,5.094205507820999
GP2d,327653,2.337916149275068
NCI-H1694,selumetinib-BRD-A02303741 (4-1 mol-mol),7.25284865001485
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196
HEC-108,selumetinib-BRD-A02303741 (4-1 mol-mol),6.22303090572745
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
HuH-1,136227924,2.959438331398248
JJN-3,374536,2.1846698810790195
CA46,135659046,2.986085914123542
SJSA-1,6450551,3.1258645643789453
Caov-3,selumetinib-BRD-A02303741 (4-1 mol-mol),5.541773006188174
NCI-H1339,10385095,0.8150638105924319
LS411N,148198,-2.2204558676981576
ECC10,10385095,1.0735709305574426
OE21,148198,-3.484738735179186
KYSE-450,10302451,4.575458638647607
TE 441.T,4259181,0.3231515403820576
Hs 611.T,136227924,1.5120677878583844
EN,10302451,3.9663070096792303
HMCB,100016,6.123582467992384
MDA-MB-361,156414,-0.6405149363792559
RPMI-7951,JQ-1-UNC0638 (2-1 mol-mol),1.9085754129843169
BICR 22,46926350,-6.042960620867506
RERF-LC-A1,54618771,2.031168626063029
HT,54618771,1.085769963879092
CAL-62,10302451,3.3988758724895076
TUHR14TKB,44137675,5.398068129904822
MM1.S,2708,4.3305699285872095
SNU-478,11485656,1.921129079492399
PaTu 8902,9903786,4.041497343746548
SNU-398,selumetinib-BRD-A02303741 (4-1 mol-mol),4.667152105761822
SCC-25,148198,-2.3874045507068895
BICR 31,11167602,4.451308398956488
BT-474,148198,-3.4060318714272984
A4/Fukuda,9911463,2.417745886609146
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585
A3/Kawakami,327653,2.708987247942638
GA-10,135984461,1.4208058611129633
BICR 22,4259181,0.3497439952553443
A2058,9911463,4.395992822531059
NCI-H211,4259181,-0.6668256447017947
OE19,sirolimus-bortezomib (250-1 mol-mol),2.347707563651812
SK-LU-1,1716436,2.837995818679175
Panc 02.03,327653,3.634511095206161
EB1,148198,-5.218004052941106
KNS-81,9911830,4.481974457035793
Raji,654092,-1.8737175642963104
DK-MG,10385095,0.8287186184930233
EBC-1,1716436,1.9602928008384832
EHEB,11485656,2.717011543878295
ONS-76,44493528,4.396938069944904
SNU-1079,148198,-3.7175883561835295
B-CPAP,124202324,2.5126269670225994
Rh30,24772860,-2.9400063424346574
RMG-I,10385095,1.4066751823682933
NCI-H358,11404337,-0.2316736333548727
MHH-CALL-3,tanespimycin-bortezomib (250-1 mol-mol),0.530639980340651
8305C,11485656,2.5131422370464436
NCI-H838,selumetinib-BRD-A02303741 (4-1 mol-mol),6.805177680568063
JHOC-5,9903786,4.996792602991681
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
SNU-398,753704,4.82601128152336
PE/CA-PJ49,selumetinib-BRD-A02303741 (4-1 mol-mol),4.735000987700845
PC-14,10385095,2.2928310628241455
TUHR14TKB,136227924,3.4575547117836836
BICR 16,11167602,3.879250924421472
BT 179,9903786,4.337350994333445
SNU-81,148198,-1.0516438667772403
SU.86.86,10302451,2.9439020975191315
ALL-SIL,49766530,-2.347000417785464
BT 333,71729975,2.301066617533101
BT 147,sirolimus-bortezomib (250-1 mol-mol),0.9412516099169256
Hs 746.T,1716436,3.4161576933705833
TE-9,2729026,3.057259805842052
CAMA-1,9903786,5.004529624345284
TALL-1 [Human adult T-ALL],JQ-1-UNC0638 (2-1 mol-mol),0.0725502655258577
JHH-2,sirolimus-bortezomib (250-1 mol-mol),0.503615314024041
SNU-685,327653,3.6761409517937698
HCC-56,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.3829852689882363
OUMS-23,148198,-2.1659685214591664
TE-1,124202324,1.4332488226975717
LOX-IMVI,6450551,2.208346013373947
OVCAR-4,JQ-1-UNC0638 (2-1 mol-mol),1.5118508099017145
HEL 92.1.7,6450551,2.221162611596413
Mel Ho,9911463,3.195934345244136
TE-9,11404337,-0.8200746499862688
DK-MG,156414,1.729290001800195
IA-LM,44137675,5.685431340913792
Karpas-299,24772860,-3.182919271308408
NCI-H2087,3815108,2.498823187788804
BICR 18,JQ-1-UNC0638 (2-1 mol-mol),0.2707983631583921
SNU-201,3815108,3.3890609362793676
NCI-H1734,2708,3.718237100557233
HEC-50B,9903786,4.880358665703779
COLO 678,46926350,-4.000050573087121
BT 248,24753719,4.394714770526552
LN-229,3815108,1.9224525150898368
NB4,4259181,-1.8381008527339011
COR-L47,24772860,-1.8246527321403605
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
DEL,1716436,3.2303369332595344
JHH-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.3504347202254303
BT 504,71729975,0.9780893315836542
ZR-75-1,54618771,1.401899107302776
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
HCC1195,49766530,-2.234197173599504
ME-1 [Human leukemia],selumetinib-BRD-A02303741 (4-1 mol-mol),1.7955640107925823
CJM [Human melanoma],6450551,2.7502741967489306
SW948,135984461,4.375312800732864
NCI-H2106,JQ-1-UNC0638 (2-1 mol-mol),2.510824397870639
DND-41,156414,1.129076362273066
PE/CA-PJ49,11485656,1.6473553373420289
MKN7,753704,5.063733195911763
NCI-H520,753704,5.066347662071548
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
KYO-1,54618771,-0.1196374796023553
AGS,54618771,0.8602025015707093
BT 359,2708,5.7876006883282525
SNB-75,4259181,0.0553890152572084
NCI-H716,11404337,0.1274429986614186
ALL-SIL,9929138,4.286241964174987
SW1088,24753719,4.9947563556598285
JHUEM-1,135984461,4.231451308328731
KYSE-180,9911830,2.764203258021631
CJM [Human melanoma],tanespimycin-bortezomib (250-1 mol-mol),0.2668516284110745
Peer,124202324,0.0404350950751995
NCI-H1694,2708,2.503125295870866
Hs 888.T,6918638,2.9621316525739885
RERF-LC-A1,11485656,2.3794985324061217
SUP-B15,sirolimus-bortezomib (250-1 mol-mol),-0.2788872316489693
SNU-489,49766530,0.3539258431489716
EFO-27,49766530,-2.657964166176686
NCI-H1155,9911463,3.422756009393138
GA-10,753704,2.5889023664252107
CML-T1,3815108,1.7472513397157303
BT 216,10302451,3.7888700603694785
HSC-4,9911830,2.7717739782698563
Reh,6450551,0.8857967614439193
BT 286,46926350,-4.263889446024459
Malme-3M,9911830,2.489874332588209
SNU-1033,11404337,-1.419235655385228
JJN-3,10302451,3.2491275640758905
CGTH-W-1,sirolimus-bortezomib (250-1 mol-mol),1.647706898870075
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
Toledo,156414,2.776303134779206
HCC1195,11404337,1.6211275323325096
SIG-M5,9911463,2.49992979660486
HuG1-N,11485656,1.8957868376228804
HEL,9929138,6.278460484472286
SK-MEL-5,10302451,3.6618185056536574
NCI-H522,44493528,4.173254194812623
NCI-H841,54618305,4.564886723812773
NCI-H446,156414,1.4806898091900922
SK-N-AS,49766530,0.7065822517646133
OVSAHO,136227924,3.9451154225840783
HCC1171,10385095,1.858745136689112
Raji,44137675,4.0530836304331475
SW1783,11485656,3.310538702987134
RT-4,44137675,4.764559708105059
MHH-ES-1,753704,4.647380747429485
D283 Med,753704,2.8717556024543067
RERF-LC-Ad1,10302451,4.5263361411635366
A-204,9911463,3.1571313791441407
697,148198,-7.764222661633608
CAL-54,6918638,-0.089811229970637
BT 172,sirolimus-bortezomib (250-1 mol-mol),0.9880201722030184
HuNS1,46926350,-4.494097640967621
CAL-78,1716436,3.677273769849697
NCI-H2405,24753719,3.770423795130907
SNU-1196,11404337,0.8236083262137488
DOV13,3815108,3.242986221729535
HMCB,10385095,1.0131649772543003
Rh41,654092,-1.9663759438677284
L-428,100016,6.045371287660442
CAL-12T,44137675,3.180829967062084
L-363,4259181,0.187048408106301
SK-MEL-31,9911830,3.904454602522244
NCI-H810,24772860,0.920607491207528
CAL-148,9911463,3.7959797988422226
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
KNS-42,2729026,3.122282753564381
22Rv1,9903786,3.2246012387786536
HT-1376,24753719,2.891583671664211
Becker,24753719,4.281079864002637
NCI-H2342,46926350,-3.6810490506726294
MDA-MB-361,2729026,3.0293030616076093
P3HR-1,44493528,4.479492051657015
Jurkat,10302451,2.000902365022557
EC-GI-10,49766530,1.479780900637965
MDA-MB-435S,3815108,1.9449343798790784
BT 172,9868037,4.137588031447499
HuP-T3,46926350,-3.9956296104835447
Ri-1,156414,0.7366105303424468
J82,46926350,-3.9793069725268713
KYSE-450,6918638,1.5500469019976144
JHUEM-3,9903786,2.091612721233031
COLO 320,54618771,1.0088130808392026
L-540,4259181,-0.830522797129625
Hs 294T,46926350,-4.230367528422673
IGR-39,136227924,2.6355333557661167
SNU-1214,9911830,2.476886366604881
PF-382,54618771,-0.2642287573533248
KYSE-30,9868037,3.995382741587693
OE33,327653,3.4722328346839246
BFTC-905,4259181,-0.5196077824853107
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
U-CH1,44137675,2.4452601730062127
JHOC-5,100016,4.009706795291197
SUP-M2,6918638,-1.8081420223018785
HCC44,10385095,1.1962803833979956
SW1353,135984461,3.620259529955406
Caov-3,4259181,0.2335996818142696
EPLC-272H,9911463,4.277104632869788
TM-31,4259181,1.8515749843690743
SK-MM-2,9911830,2.774593612970169
JK-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.1426090393976551
Hs 746.T,44137675,2.823828860726613
BICR 56,100016,6.239283130221144
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
UACC-257,44137675,4.539950811075446
BC-3C,73707371,5.58385522692904
NCI-H1869,11404337,1.2362831155289085
NCI-H2291,sirolimus-bortezomib (250-1 mol-mol),1.1125015078342035
TE 617.T,135659046,3.676706194159886
BT 359,753704,4.895647485176585
8505C,9903786,3.4608112423981874
IGROV-1,11404337,-0.7659238947812715
HuH-28,11404337,0.2716572522655043
HEL 92.1.7,11485656,1.7969731884547977
Sq-1,374536,3.1526971013166536
LOU-NH91,654092,0.641619390442256
NCI-H1435,54618771,-0.0103086846499203
CCK-81,753704,4.7927542014476625
MM1.S,100016,6.180279624553647
KMBC-2,6918638,1.17976161020614
AN3-CA,148198,-4.708662281337999
IMR-32,148198,-7.685974048863974
OVCAR-5,327653,3.1617926735061737
BFTC-905,136227924,2.194418567728585
P12-Ichikawa,3815108,2.150069519100925
NB1,753704,4.717094887258093
MOLP-8,10302451,3.559537910744256
MDA-MB-453,71729975,-0.0804754192781109
SK-MEL-24,sirolimus-bortezomib (250-1 mol-mol),0.9554095387328968
NCI-H2029,9911463,2.565034474609612
GI-1,753704,4.409321165337755
HuCC-T1,9911463,3.575644452957985
NCI-H2029,2729026,2.9967184641692484
NCI-H650,tanespimycin-bortezomib (250-1 mol-mol),0.4769050892801147
VMRC-LCD,10385095,1.1989116175151169
Rh30,24753719,4.445119660878695
SW1088,16013152,4.698096042189786
KG-1-C,sirolimus-bortezomib (250-1 mol-mol),1.4643068357470623
BT-20,49766530,-3.0336116964226076
OCI-Ly3,374536,2.5418574168712644
PE/CA-PJ49,24772860,-2.410818078519462
TE-10,sirolimus-bortezomib (250-1 mol-mol),0.6005656385189257
LS1034,2729026,2.4065459889095253
HOP-62,6918638,0.8791129287698843
TE-5,54618305,4.248872316076633
KHM-1B,654092,-1.7753167598635085
P12-Ichikawa,24772860,-2.8370531861510653
2004,327653,3.3458019142742734
SU-DHL-8,sirolimus-bortezomib (250-1 mol-mol),-6.359979517729665
COR-L105,54618771,2.0419110046350135
Daoy,327653,2.9114644715771387
T98G,2708,5.5833460783973035
LS123,753704,4.967146676895974
JHH-4,11485656,1.6774790555680354
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996
SF268,11404337,-1.2777642443849726
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
PF-382,151289,0.3016891931318033
BV-173,136227924,2.1412277594985816
HPAC,9911463,2.695255349587433
P31/FUJ,54618771,-0.1557090961755644
ONS-76,9911463,3.87028315643254
NCI-H1915,16013152,3.87933138826976
Kelly,136227924,2.280835674454857
ECC10,54618771,0.89322852305294
L-363,9903786,1.2649504106242235
RS4;11,24753719,2.416843380239875
THP-1,11167602,1.2377873801120165
ONS-76,54618305,5.4771970245541866
NCI-H1869,9911463,4.397307517913515
OVSAHO,9903786,3.817356196338304
SNU-61,136227924,2.341371828887226
RVH-421,10385095,1.0938130776874428
EHEB,2729026,2.652912157322486
KM12,6450551,1.3140134858781036
DB,100016,4.066938426663746
F-36P,2729026,2.1465892266491915
HuH-6,49766530,0.8339176615571017
GCT,11485656,1.7878903123598318
JHH-1,49766530,-0.2614910303747365
SNU-685,100016,6.855109756647912
NCI-H2405,11404337,0.6998100573495162
SH-10-TC,16013152,4.599771500849873
NCI-H1734,54618771,0.2470181202194854
RERF-LC-MS,136227924,4.560045704487339
DK-MG,JQ-1-UNC0638 (2-1 mol-mol),1.4259464959240278
MDA-MB-435S,9903786,3.3965750050470356
YD-8,654092,-0.8686607010204063
Panc 08.13,11485656,2.1540849890217815
T24,2729026,3.070700850500058
EM-2,10302451,-1.381197320031158
BICR 56,2729026,3.57292224903503
KMS-21-BM,156414,1.1553403018808577
VMRC-RCZ,327653,3.628374275379161
AGS,tanespimycin-bortezomib (250-1 mol-mol),-1.1617791040203864
NCI-H1385,9868037,2.914000161841284
Ki-JK,54618305,4.056978478089845
JHH-1,4259181,0.0366010748409238
PK-45H,135984461,4.36472213501135
PLC/PRF/5,24772860,-2.245537876529176
KYSE-30,374536,1.9121137284030565
HCC4006,sirolimus-bortezomib (250-1 mol-mol),0.6132308595616923
BT 444,6918638,3.2929194636283023
BT 145,10385095,1.0797698804435325
NCI-H929,11404337,-0.6691193705825791
ChaGo-K-1,44493528,4.285653924871417
NCI-H2452,6450551,2.947106204512916
HCC44,9903786,0.5279756391305372
DB,JQ-1-UNC0638 (2-1 mol-mol),-1.175372796049797
NCI-H838,sirolimus-bortezomib (250-1 mol-mol),0.8112840650122598
TE-5,11167602,1.4006524913204792
T24,54618771,1.5069365622547568
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
EB1,9903786,1.1512361945239595
NCI-H2110,16013152,4.230924821724543
MDA-MB-468,100016,5.725845417349072
NCI-H841,327653,3.296188109973884
AGS,10302451,4.085579699676075
NH-6,10302451,3.668750555789657
NCI-H28,44494015,-5.3692657980463965
BT 359,6918638,2.662687063562674
T84,100016,6.649554415164183
RL,49766530,-2.7332300451243294
OVTOKO,sirolimus-bortezomib (250-1 mol-mol),1.6633585904908004
LOX-IMVI,10302451,1.9959018084394209
MSTO-211H,374536,3.2477584475462904
NCI-H23,49766530,-2.8295631960670735
A101D,148198,-1.280940502528239
TUHR4TKB,6450551,2.9031621704743085
GCT,16013152,4.1144354931734135
EFM-192A,54639665,5.165933724638737
ALL-SIL,100016,4.099229681419155
MOLM-6,54618771,-1.125250361131471
KE-39,135984461,4.3782777468955745
Tm87-16,148198,-4.741899128420961
NCI-H1944,24753719,5.3103553125067355
HMC-1-8,44137675,3.1358894441436105
MJ,6450551,1.4297502177824069
ChaGo-K-1,46926350,-4.424960815511268
BT 422,54618771,0.9695029183446764
Kasumi-2,6450551,0.5816635943537883
SR,11404337,-0.9358789780848294
RL95-2,151289,-0.0574545608094454
U266B1,54618771,0.5848544182666181
SK-HEP-1,2729026,3.094345392685322
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
TCC-Pan2,54618305,5.007378723744469
EBC-1,151289,1.5303957934942136
KALS-1,156414,2.413374739256189
HCC1806,3815108,3.603325621695257
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
NCI-H1915,148198,-3.0728174941376603
NCI-H1339,24772860,-1.8879714728988064
TE-6,44137675,2.649017770444666
HT-144,sirolimus-bortezomib (250-1 mol-mol),0.2937138425316054
DMS 114,4259181,0.0455858036720845
NCI-H1563,16013152,4.016655679694627
JHUEM-2,374536,0.0061662785812
SK-ES-1,100016,7.4795645853927475
SK-MEL-5,9903786,4.335376265950657
CHP-212,9911463,2.7015843726568005
SNU-475,136227924,3.0898415955820715
TCCSUP,44493528,4.420877523389051
NCI-N87,11404337,-0.8803091706648726
Mel JuSo,2708,6.750682167597677
CAL-120,11404337,0.6916203737378318
BT 359,9911463,3.139748899568744
U-BLC1,54618771,-0.2094086487307373
Pfeiffer,9929138,4.431024289942506
PC-14,100016,6.551425062945198
SW1271,654092,-0.6724961197062129
FTC-133,49766530,-1.1381086002707512
HL-60,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.592885464648152
HD-MY-Z,54618305,3.941215880627945
SNU-423,151289,1.2049619409118173
BT 416,6918638,-2.563404601621211e-06
COLO 699,11485656,2.4382594148828995
Hs 839.T,1716436,3.715132553019386
SCC-9,9911830,2.3699428367857145
SW1271,9911463,3.695583497273472
SNU-719,327653,3.2757208144159913
KMS-34,156414,0.8867581295421252
SUP-HD1,54618771,-0.1374288926012433
OVCAR-4,9911830,3.2323218486443013
SNU-466,3815108,3.1985417749763827
MOLP-2,44137675,4.907612042027901
SUP-M2,44137675,1.803652200431438
CL-11,10385095,1.583542969141602
Daudi,148198,-7.679285276133229
PaTu 8988s,148198,-4.140903608928441
Hs 578T,selumetinib-BRD-A02303741 (4-1 mol-mol),4.397028025338394
ACHN,11404337,1.842611884457436
KMS-12-BM,10302451,3.4855488172991924
MDA-MB-453,2729026,2.974469204821206
CCK-81,136227924,2.050553135971544
Kasumi-1,2708,4.80811988931615
NCI-H2122,10385095,1.3305975818263436
SW1088,49766530,2.123366462001536
SYO-1,327653,4.254978893518193
WSU-DLCL2,10385095,-0.5858040483296952
TE-9,10385095,1.1890447645443694
Hs 936.T,54618305,4.362446334432475
SEM,1716436,1.599764996763199
NU-DUL-1,9868037,0.9018542361543456
BT 504,selumetinib-BRD-A02303741 (4-1 mol-mol),4.78765966639542
SK-ES-1,2708,1.7201165974400532
LS123,JQ-1-UNC0638 (2-1 mol-mol),5.062664945927307
SNU-46,148198,-1.481074148002998
AU565,24772860,3.3222909323637455
JHOM-1,10302451,6.059670218544928
KP-N-YN,2708,5.375360692617648
HLF,374536,3.2815445500181983
LoVo,24753719,4.853832341629896
HCC78,10385095,1.2930087557549492
PL-21,44493528,4.151130838756699
A-375,11485656,2.720000014361131
COLO 668,11167602,1.730642767212305
HCC1833,54618305,4.412472871081104
COLO 684,148198,-5.116040428924247
SNU-1079,44137675,2.410585163354866
KE-39,135659046,4.845551344520264
JeKo-1,148198,-5.137467449260085
TOV-21G,11404337,1.0752571237200843
OCI-Ly10,46926350,-4.2452808474871855
Hs 766T,71729975,3.268467750635969
RL95-2,9911463,3.5456378999337077
HuG1-N,100016,5.877444193140431
CAL-27,374536,3.148755097754964
SK-MEL-24,11404337,-2.842069291243037
BT 164,44137675,3.3105200392419944
NCI-H2170,4259181,0.296825515381287
KP-2,selumetinib-BRD-A02303741 (4-1 mol-mol),3.11893499367889
NCI-H226,6450551,3.4108876045167116
MEC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.925263952790909
KYO-1,9911830,0.3076786264076178
Hs 839.T,46926350,1.6604966058442985
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
L-363,54618771,-0.4858237315579012
KE-39,9911463,3.415693188275342
DU145,JQ-1-UNC0638 (2-1 mol-mol),3.267881594409119
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128
DEL,10385095,0.3320635123477122
WM115,11167602,1.5239005360441813
TTC-709,327653,2.2719221156396223
NCI-H2009,136227924,2.9896301065010933
Rh18,24772860,-3.3210756663091874
COV362,16013152,4.136450576059214
MFE-296,11485656,2.443705584915375
2004,71729975,-0.0716383940300769
DoHH2,148198,-5.119936658223105
UO-31,374536,5.112711656348472
CCF-STTG1,1716436,2.5445739903865503
OE21,1716436,3.782733753033253
KYO-1,11404337,-0.4735869494306794
CCK-81,11485656,2.133914966176791
SW982,4259181,0.6436142208790868
RERF-LC-A1,156414,1.959545548959112
JJN-3,49766530,0.5555169127000841
SK-MEL-5,2708,5.160333011661181
ChaGo-K-1,148198,-4.908529159972166
JHH-6,9911463,4.586704502262201
KE-37,9911830,1.9882864572277257
JHOC-5,JQ-1-UNC0638 (2-1 mol-mol),2.200398836984841
8-MG-BA,44137675,4.464527222703918
TE-10,9903786,3.070607136357089
HCC1833,11404337,0.2409381121234374
SNU-C2A,3815108,3.3697032214045217
P-STS,2708,3.71480450183056
22Rv1,sirolimus-bortezomib (250-1 mol-mol),-5.664247196474798
697,44137675,1.44065038138075
NCI-H1666,6450551,4.23199327979035
JMSU-1,124202324,2.4700783805527218
BT 271,11404337,-1.9578148063056395
SUIT-2,124202324,4.338905517601424
A-549,24753719,4.621771717936227
Panc 04.03,54618771,1.7180394725494992
Panc 02.03,9911830,3.8856260346392903
RERF-LC-A1,148198,-3.1102576281385654
SNU-899,24753719,4.419339048792099
JHUEM-7,44493528,4.303413387370261
JHH-2,46926350,-4.086194029796017
PLC/PRF/5,100016,6.529147023700783
Hs 944.T,124202324,2.741284983645608
Lu-99,156414,1.6009276932034684
PL-21,327653,2.987235766281407
JHH-5,11167602,1.5103149068209596
JHUEM-2,11404337,-1.101426517745614
Yamato-SS,10302451,2.7279296260988284
Hs 578Bst,JQ-1-UNC0638 (2-1 mol-mol),2.8233607044447497
G-292 clone A141B1,151289,1.8634259914704696
SK-HEP-1,46926350,-4.110479335135347
8505C,tanespimycin-bortezomib (250-1 mol-mol),0.1990697698035682
HuH-6,9929138,4.876929493574036
NCI-H727,11485656,2.2939690780404423
YKG-1,156414,1.711503789054189
KMRC-3,sirolimus-bortezomib (250-1 mol-mol),0.4876779746525405
KMS-21-BM,44493528,3.35720206113814
K029AX,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7336624510738496
F-36P,9911463,3.056113876518826
KLE,9903786,3.130074514321622
HCC202,11404337,1.6013031156862827
SHP-77,100016,6.499498313563913
LAMA-84,100016,4.28644111913654
GI-1,10302451,3.8681627903392792
SNU-601,6450551,3.493201362731073
PE/CA-PJ15,54618771,-1.2856394778285385
NCI-H2171,73707371,5.940029655461802
Namalwa,JQ-1-UNC0638 (2-1 mol-mol),-1.843208201635932
SK-MM-2,9868037,2.838791027261754
NCI-H2170,46926350,-4.864744446907546
TCC-Pan2,JQ-1-UNC0638 (2-1 mol-mol),1.6741916670927068
U-BLC1,9868037,3.998089604427344
BT 359,9868037,4.109229289751441
NU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),1.320938208731918
THP-1,11404337,-1.5285516507486518
NCI-H1650,374536,0.3866180306349308
HuP-T4,JQ-1-UNC0638 (2-1 mol-mol),0.2844606125479142
Hs 852.T,54618771,3.3539274587451935
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
LNCaP clone FGC,9903786,4.486079979714403
WM266-4,2708,4.555862164926123
MHH-CALL-3,6450551,1.9762005640615192
NCI-H1155,1716436,2.341234021591016
DK-MG,54618771,1.0774373419981456
WM88,10385095,0.3545398644716653
KMS-21-BM,44137675,3.8703229661001153
MDA-MB-435S,11485656,2.972471846280711
NU-DHL-1,11485656,2.738678590842112
Panc 10.05,1716436,2.2680106591824245
YKG-1,9911463,4.439291278473792
OE21,11404337,-3.0833954848691234
ECC12,10385095,1.0249086857981329
Rh41,JQ-1-UNC0638 (2-1 mol-mol),-0.4802415115338747
KMBC-2,9868037,4.318288154925569
Hs 944.T,3815108,3.2288654112367925
HEY A8,49766530,-2.2509342663740566
KMS-28BM,9911830,2.6443818956107696
NCI-H1581,151289,0.6210243481787202
BT 159,2708,5.137712135818966
SNU-C4,71729975,3.0855281814774647
FaDu,10385095,0.7962717218730669
BT 359,136227924,4.313964424354799
Panc 05.04,54618771,3.033977458741074
SK-N-DZ,24772860,-1.9896472471035804
IMR-32,1716436,2.9168233069343272
LCLC-97TM1,54618771,0.7707104681824843
HCC1395,10385095,1.414977783873619
NCI-H2405,327653,4.67741902123664
LS180,10302451,1.4669812473297774
SK-HEP-1,24753719,4.401042857593667
UACC-257,sirolimus-bortezomib (250-1 mol-mol),1.215285215662541
OVCAR-4,327653,2.6970207290226136
253J-BV,124202324,2.540875845685371
IGR-37,71729975,0.7647548089190389
KCL-22,sirolimus-bortezomib (250-1 mol-mol),-0.943153613452708
KE-39,JQ-1-UNC0638 (2-1 mol-mol),1.0358339499253313
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167
MIA PaCa-2,148198,-3.7289909178632383
HEL,374536,0.3200488785786777
JHH-5,24772860,-2.991388468629526
CAL-148,4259181,-0.1870361959408835
TF-1,16013152,3.5009294199179823
BT 248,148198,-3.920391313180545
HCC1143,9903786,3.3387804215378885
SUP-HD1,135984461,4.187192866644665
LCLC-97TM1,148198,-1.8422045751990368
EB1,327653,2.3886030622482566
KMS-18,156414,1.6699936447003676
HT-1197,135659046,3.3219776451446923
8305C,148198,-1.8799510169056712
KNS-81,156414,2.524016739930243
CCF-STTG1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.572158178952437
PF-382,44137675,2.4985862116087283
TE-14,151289,1.2863290145875046
NCI-H2141,6918638,0.0318107940340185
MOLM-16,2708,4.3940216475756095
SUP-T1,2729026,1.937719337588338
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
ST486,54618305,3.679577166214843
Aska-SS,9868037,4.2121131114727435
NCI-H2081,6450551,1.1680905848909615
WSU-DLCL2,24772860,-3.237865503325646
OC 314,71729975,1.128969155872961
SNG-M,44137675,3.681065691525185
U2OS,327653,2.21685850175056
A-204,2708,3.44976824375403
NCI-H1341,1716436,2.002103914538858
KU-19-19,49766530,0.1366302187334878
SUP-M2,11167602,1.4540339199549586
NCC-StC-K140,10385095,0.7190988924751318
SK-MEL-3,44493528,4.418694031341945
COR-L95,6918638,0.5429028056483723
HEC-59,148198,-3.009683743491751
SW48,9868037,2.459515994210572
NCI-H929,24772860,-3.485705594224342
SK-MEL-1,24772860,-1.586354225256687
KYSE-70,1716436,3.404085131889099
OAW28,9911463,4.007690751229585
Sq-1,9929138,7.093151024107166
LS123,9903786,4.141854621966089
MOLP-2,24772860,-1.7496292717668738
BV-173,135984461,2.039918751992627
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
CCF-STTG1,46926350,-4.2806807633593325
TUHR4TKB,124202324,2.5254030775506844
G-402,9903786,2.6546356785146084
HMC-1-8,9868037,2.3858174570633848
KMBC-2,10302451,4.200978616748967
RKO,11485656,2.16906736756012
SUP-M2,327653,2.3610903124957336
OE33,135984461,4.2867065871619445
MG-63,753704,4.929441711190138
NCI-H1184,6450551,1.2392500168696166
LOX-IMVI,2729026,2.7048403427660204
OCI-AML-5,6918638,-0.9986415463571308
NCI-H841,151289,0.5912453892143986
MDA-MB-435S,1716436,0.9273081994285316
NCI-H2122,54618771,0.6219971058133998
Karpas-299,9903786,1.3697827730065784
Rh18,54618771,1.0178435523811953
Hs 578T,374536,2.5763562012085712
NCI-H2087,654092,-0.9197833232433122
SW1417,327653,3.3016307661200925
OCI-Ly19,100016,6.584850236816641
TE-8,151289,1.118560267015216
HCC1428,46926350,-4.173799840221115
BT 359,JQ-1-UNC0638 (2-1 mol-mol),3.738459416972128
CML-T1,10302451,-1.0288409878116755
HuT 78,9911830,2.253743254641726
SUP-HD1,11167602,5.788315638654396
SNU-1077,9911830,1.9332136731221603
22Rv1,2708,4.958508544767223
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
786-O,151289,1.2678264771333991
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642
TE-14,2708,5.504190603838346
P31/FUJ,148198,-3.664233852608881
NCI-H1395,10302451,4.201114377039751
KU-19-19,148198,-3.572091199224797
MKN74,10385095,1.1692289790304908
KALS-1,136227924,3.4972882997363257
OAW42,24753719,4.028981617914578
NCI-H69,124202324,1.0976330969749917
Capan-2,tanespimycin-bortezomib (250-1 mol-mol),-2.4756483134960385
MDST8,4259181,0.8851574645315519
MFE-319,6450551,3.344887453110109
Panc 03.27,9911830,2.184033870746351
PC-14,3815108,3.796609713170094
NCI-H1355,9911463,3.4182526352072458
UM-UC-1,135659046,3.598030387266929
SK-LMS-1,11404337,0.6927873506119244
FU-OV-1,11404337,-0.2130364442314083
OV-90,10302451,4.13641008716836
NCI-H526,148198,-3.313175192053609
HCC827,49766530,-2.1224128504974207
G-292 clone A141B1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.606867325018595
WM1799,1716436,1.2823726506149855
SET-2,135659046,3.4006834919950006
SNU-626,49766530,-0.2308457798178905
SET-2,4259181,0.1167213945949705
BT 422,148198,-4.041161285965411
Kasumi-2,151289,0.8385264971723331
NCI-H1581,49766530,-2.147039743069074
Hs 683,4259181,-0.0189213214010426
KYO-1,JQ-1-UNC0638 (2-1 mol-mol),1.3411207617103893
ZR-75-1,54618305,4.65018258042655
HCC1833,44137675,5.2142940282257015
SNU-1077,753704,5.47540794782016
IGR-37,JQ-1-UNC0638 (2-1 mol-mol),2.2226577881456167
COLO 678,4259181,1.135854109347033
TE-9,136227924,3.0742454984310825
SR,24772860,-3.549409781759578
RPMI-7951,10385095,1.3251666848544306
RPMI-6666,9911463,2.703428779423556
ES-2,148198,-2.2318104062196102
REC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.262800070062549
CAL-29,44137675,1.8963410533898948
697,9903786,0.9408007056276604
C2BBe1,135659046,3.558851122632108
LK-2,11485656,1.8402967364166432
RPMI-7951,9903786,2.3675771120862485
IGR-1,24753719,4.2023901433737425
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
CAS-1,sirolimus-bortezomib (250-1 mol-mol),2.076174664589587
SNU-1079,151289,1.232356175615026
SEM,9929138,6.8273209917060145
TF-1,100016,6.442708110888471
EKVX,tanespimycin-bortezomib (250-1 mol-mol),1.3495515941174134
NCI-H292,24753719,4.2962074219620225
COR-L51,6450551,1.8996774600524649
U266B1,11485656,1.9579580018826064
KE-39,100016,6.665188081944046
JVM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.7253415150610979
SIG-M5,11485656,1.8173379361731008
NCI-H1838,11485656,2.306632115850396
A3/Kawakami,374536,1.8044111522001824
SH-4,10302451,3.573247418595864
GP2d,24772860,-2.6636147322162427
GMS-10,4259181,-1.3122250193343967
BV-173,44137675,2.6270112873135045
SK-N-MC,374536,1.5956069670104858
LS513,9903786,1.9994254947829608
A-253,327653,3.6566862144122374
KMS-12-BM,24772860,-3.763334552284853
SEM,11485656,1.8495119352561953
NCI-H2126,selumetinib-BRD-A02303741 (4-1 mol-mol),5.979726323448733
NCI-N87,1716436,1.6921610156965474
Ki-JK,9868037,1.5525844066111418
NCI-H1573,151289,1.6038997142150275
T24,1716436,3.710009506981947
COLO 800,24753719,4.203367346938301
RL,156414,1.6345695399688598
NCI-H292,44137675,3.1459685562862707
KMS-11,753704,5.335959922282074
SF539,6918638,1.218816827551867
Panc 10.05,327653,3.574513043815001
KNS-60,1716436,2.4930056280716437
BT 164,sirolimus-bortezomib (250-1 mol-mol),-0.1632601406357518
BT 440,49766530,1.1711647007099082
NCI-H838,9911830,2.2761510361102495
SK-OV-3,124202324,3.0713957973247186
22Rv1,9911463,3.7822745291397646
NALM-6,135984461,1.4298238990327978
CCF-STTG1,4259181,1.4943010127790817
PK-1,9911463,3.7695460947373784
OVTOKO,124202324,3.859524609020987
KYSE-150,sirolimus-bortezomib (250-1 mol-mol),0.6836910361720296
SF539,46926350,-4.3784915774606175
A3/Kawakami,135984461,3.954538611976779
LK-2,44493528,4.239006121981403
TM-31,10385095,1.0519358784247812
MFE-296,tanespimycin-bortezomib (250-1 mol-mol),-0.069191081241384
CHP-212,151289,-0.2101258146299451
EFO-21,54618771,1.150184773372703
Hs 729.T,156414,1.628436706068538
TYK-nu,135984461,4.470061724636727
HDLM-2,11404337,-0.3778039113995139
BICR 18,11485656,2.3253115987118114
NCI-H322,11404337,0.5054322511135948
BT 328,11485656,2.729036955069127
OVTOKO,10302451,1.7851365810334463
CAS-1,1716436,3.2297808424349643
H-STS,10385095,1.1550393753572457
BT 320,11404337,0.6966185269279856
SNU-16,sirolimus-bortezomib (250-1 mol-mol),-0.2778167709338917
KYM-1,135659046,3.425924566474854
SW948,24753719,4.222068008445673
OCI-Ly19,136227924,2.004549918496879
BT 216,sirolimus-bortezomib (250-1 mol-mol),0.2946031494778452
KYSE-70,4259181,-4.187670573846372
NCI-N87,54618771,0.8863121899707505
JeKo-1,9911463,3.294378834813148
MKN7,46926350,-4.259779538476118
HCC44,136227924,2.988750330313465
Peer,24753719,1.725588631134334
BT-20,selumetinib-BRD-A02303741 (4-1 mol-mol),5.414807859072554
LCLC-103H,3815108,3.704858926741837
Hs 839.T,10302451,3.841231202168181
IM95,44137675,3.479093331751741
VCaP,54618771,1.0243470535164156
SNU-869,136227924,3.0372027283613505
NCI-H1792,11485656,2.6862672312545586
DOV13,24772860,-2.4740176137532424
COLO 684,10385095,-0.5620331148053794
SNU-1033,JQ-1-UNC0638 (2-1 mol-mol),0.3734309129675442
MOTN-1,44493528,4.082381508431214
LOU-NH91,9903786,3.184012464559237
BICR 22,9911830,2.5765146499323497
HEC-151,753704,4.907356002546064
LS180,54618771,0.643112685351952
NB4,136227924,2.0986844076590616
RVH-421,6450551,3.4794932843786066
BT 232,2708,5.603516637873742
KE-39,2729026,2.715568279593477
DK-MG,136227924,2.9692161266572707
NCI-H1651,2708,5.438526016919537
BT 482,71729975,1.5435488497194514
RT-112,1716436,3.588782151477224
EFE-184,135659046,5.053439307588332
Tm87-16,9843750,4.2180962824841375
BL-70,JQ-1-UNC0638 (2-1 mol-mol),0.2478853325669071
KMRC-3,136227924,3.033903598858876
AMO1,9903786,2.4699152046705253
COLO 699,9911463,3.7196306171977183
SU.86.86,2708,4.700193963447726
NCI-H1105,11485656,1.7078200129444954
JHH-5,2708,3.1250730584185886
NCI-N87,44486093,4.414725106733636
HCC1143,44493528,4.485488370266477
DMS 114,10302451,3.9352333210903625
MKN74,156414,1.3103031812830657
EC-GI-10,46926350,-4.3966401877845405
BT 428,71729975,0.8355335318792699
NCI-H526,49766530,-2.411772965733929
Malme-3M,16013152,4.033050887133735
NCI-H1623,46926350,-4.300601402935136
LXF 289,654092,-0.8888310934038361
HuG1-N,46926350,-4.127811587550289
NCI-H526,9929138,5.368953521226413
TUHR14TKB,6450551,2.4265156382984383
SNU-407,100016,6.489561303898527
KNS-60,16013152,3.8831991778182497
TYK-nu,16013152,3.157060358701267
HH [Human lymphoma],100016,3.957825935624259
HCT 116,54618771,0.4629468645075349
MCAS,49766530,-0.3094916991443784
NCI-H1395,JQ-1-UNC0638 (2-1 mol-mol),2.0863626902926065
OCUM-1,124202324,2.380179659585571
RD,327653,3.3022408948964306
NCI-H2170,10385095,1.0758750418417444
NCI-H1355,4259181,-0.3138430179747868
OVISE,9911830,4.830872688345326
HCC827,tanespimycin-bortezomib (250-1 mol-mol),-1.554763152633591
NCI-H2052,327653,2.777948843960099
HCC827,151289,0.7878145916755998
42-MG-BA,9903786,3.3707760791071184
NUGC-4,136227924,2.1432448607030308
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443
MEC-1,10385095,0.5052680490549927
WM793,10302451,3.996584762768067
COLO 699,124202324,2.230739996006032
NCI-H2170,135984461,4.266034929534041
KM12,11485656,1.3721990605630514
KALS-1,135984461,4.764345529991705
LAMA-84,3815108,2.0145606508362968
NCI-H23,9911830,1.4364857950022207
HSC-3,124202324,3.390137695130575
NCI-H358,54618771,2.9972263013300955
HOP-62,1716436,2.852163068438644
MOLM-13,24753719,4.086009941734247
OCI-AML-3,49766530,-3.0415372602627375
SK-N-SH,selumetinib-BRD-A02303741 (4-1 mol-mol),4.579985171887308
KLE,9911830,2.855789588066899
LNCaP clone FGC,156414,1.7669501564667316
JURL-MK1,136227924,2.4264924164691135
MIA PaCa-2,49766530,-2.3545367349028097
SNU-5,10302451,3.799734936594112
DK-MG,6918638,0.8133882736108148
BICR 22,24753719,4.1427183131543615
SUP-T11,49766530,-4.92791110390187
RPMI-8402,753704,3.186078195555112
SET-2,327653,2.598960189681515
TE-5,16013152,3.960753193882992
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
FTC-133,11485656,4.087051585535102
MEC-1,11167602,1.5646333943840791
BICR 18,9911830,1.5303849230242863
GB-1,654092,-1.462021293828314
SNU-668,9911463,3.9434734903909976
PSN1,46926350,-4.461271194457874
YD-10B,44137675,1.711438993741948
SUP-B15,11167602,3.88002295585875
SU-DHL-1,1716436,3.093009546519781
DU145,2708,5.064027511683006
SaOS-2,135659046,3.828911922642458
KYSE-140,136227924,3.3753020930843065
Mel Ho,11485656,2.770512917812994
SNU-738,9911830,2.353180115035864
Rh30,753704,4.636213241262484
KMS-21-BM,2729026,1.6254459939074395
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
DND-41,10302451,2.791919082066888
HT-1080,10385095,0.6979966425129256
OCI-AML-5,156414,1.749799487205322
A-375,44493528,5.0092859091998205
P3HR-1,2729026,2.5966857903671032
KCL-22,100016,3.971728515649248
NCI-H2286,44137675,3.699178646806645
MKN7,1716436,3.433593906359233
NCI-H1623,6918638,-0.0742651507067239
SNU-1076,654092,-0.0966873380298926
M-07e,11485656,1.7704573347594663
SNU-899,4259181,0.9668668372242236
BL-70,46926350,-5.521424806122161
GB-1,4259181,-1.4082863988824423
AMO1,2708,4.523485327159804
NCI-H838,148198,-3.726135487587838
SNU-61,327653,2.3439595497702985
NCI-H889,4259181,-0.8174872861875067
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143
Panc 05.04,44137675,2.5684604985714405
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
KYSE-520,54618771,1.6405254882986982
DND-41,46926350,-4.291463373781112
8-MG-BA,136227924,3.3968176736472446
BT-20,11485656,1.799713509383809
Ku812,9868037,1.2688072678140785
VM-CUB-1,9911463,3.9957694448680265
BICR 18,1716436,3.59350599821715
SUP-M2,54618305,3.727120428172907
NALM-6,24772860,-3.628106584076606
NCI-H1435,24753719,4.622788209855311
LoVo,2729026,2.166128688763036
Hs 944.T,135659046,3.5243934331701268
KYM-1,44137675,3.3639860702745765
HLF,135984461,4.657471192071366
SW1417,11404337,-1.4535869227082985
A101D,selumetinib-BRD-A02303741 (4-1 mol-mol),4.669849623886117
COLO 792,327653,2.8843710408539964
NCI-H1666,156414,-3.939657296511655
Ci-1,10385095,0.9596805208950844
Panc 08.13,10385095,1.049834622484976
HSC-3,10385095,1.3564065222448
MOLT-3,11404337,-3.211450754750083
SNU-869,100016,6.487538118719535
HDLM-2,124202324,1.2856563220279589
QGP-1,151289,0.666811284274705
HuH-1,6450551,4.76410370674851
Capan-2,1716436,2.3139473301111653
Pfeiffer,1716436,2.10823961753666
BFTC-905,11404337,-1.6179925215678757
UM-UC-1,10302451,3.891085801991747
Hs 852.T,44137675,2.7981577229729657
TOV-21G,9911830,2.632871994542491
NCI-H2228,54618771,2.218595953642778
SK-MEL-1,156414,2.027107668574744
NCI-H2052,sirolimus-bortezomib (250-1 mol-mol),3.0581569825638417
A-204,73707371,2.22344753384297
Peer,JQ-1-UNC0638 (2-1 mol-mol),0.1619928594826577
L-363,654092,0.7015054784190975
Reh,9911830,2.18019581180713
KYSE-30,2708,5.2345843532917335
JHH-2,6918638,0.332827130243307
K-562,1716436,3.607306146681396
MDA-MB-157,156414,1.5733069512528617
HT115,9929138,5.341285159279084
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
PL-21,136227924,2.3397761554923413
NCI-H1793,16013152,4.837836086227832
A2780,156414,1.0391092981452308
Jurkat,100016,5.920987823967134
MKN74,44137675,3.641659568739547
BT 232,24772860,-2.3015888793150645
EoL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1812661618005848
BL-70,327653,2.5776654277541216
NCI-H1703,9911830,-4.3228308305897825
YD-15,24753719,4.654665275696266
YD-10B,2708,5.221058205867933
SNU-1033,148198,-5.122632724392466
ONS-76,2729026,2.9392891978845626
NCI-H2087,54618771,-0.2190788311634532
TE-5,4259181,-0.2224269562564943
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
KMS-12-BM,753704,4.548989794941243
TTC-709,49766530,-2.0613056502019407
OCI-Ly3,44137675,3.54180594533019
HT-1080,46926350,-4.468739407423731
SNB-75,selumetinib-BRD-A02303741 (4-1 mol-mol),7.079242216096609
HCC1171,654092,0.5569611408138795
BT 440,100016,6.480442369798277
BT-474,11404337,1.3863676230346815
Reh,44493528,4.04802880439871
HCC827,124202324,2.5465852075125115
TF-1,2729026,3.1773207264569767
Ri-1,6450551,1.5942274465310526
NCI-H1623,selumetinib-BRD-A02303741 (4-1 mol-mol),6.385895152539582
U2OS,sirolimus-bortezomib (250-1 mol-mol),1.3880787640011472
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385
OV56,10302451,3.128852101084234
RPMI-7951,327653,2.8766150759858404
MPP 89,24772860,-1.928397636326886
COLO 320,24772860,-2.1607026353561487
CAL-85-1,2708,6.572440971975174
LP-1,24753719,3.6405716630369014
MEC-1,9911463,2.4578054116593555
HCC1588,10385095,1.6204955784292203
BT 239,24772860,-4.125311176298904
Calu-6,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0344239595307547
EJM,151289,0.6472385344760342
HSC-4,73707371,4.771220465805862
SCaBER,9911463,4.265148583814743
BT 286,6450551,1.4228047573938862
MCAS,100016,6.4909883414165135
JHUEM-1,44137675,2.2452983247336475
BT 286,9903786,1.725049982792706
Yamato-SS,327653,2.703551871712419
KNS-60,10385095,0.8805216107898952
SEM,2708,2.117173016792575
TE 617.T,24753719,3.744070928960869
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276
HCC1954,654092,-0.2275119782554979
Daudi,4259181,-0.0890599021012781
BT 239,54618771,0.6858691475419959
SYO-1,6918638,0.2602930891489552
SR,6450551,2.718004271142833
HCC78,9911463,4.271642559456931
8-MG-BA,24772860,-1.655272534049236
TE-10,9911463,4.005414561442447
P3HR-1,tanespimycin-bortezomib (250-1 mol-mol),1.2081674914796665
ST486,9911463,2.5005951178615775
LMSU,2729026,3.1039498249859183
SU.86.86,54618771,0.7552640390383902
Karpas-422,135984461,4.3057747311374746
Calu-1,1716436,1.9874335474801637
Rh30,148198,-2.9975267063849507
T3M-10,24753719,4.5173650451398375
HuT 78,6450551,0.5524678941583652
CW-2,4259181,0.7022652209474797
CAL-78,753704,7.020016814720299
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
SNU-478,24772860,-3.130076044509982
RMG-I,327653,2.533792218134815
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
CAL-120,135984461,5.818041384121715
NCI-H1299,100016,6.953805951258825
KE-39,9911830,2.572250482212608
NCI-H1869,136227924,3.4575085361719955
Karpas-620,16013152,3.603853995799779
Ki-JK,11485656,1.8508993883264373
BICR 18,46926350,-3.3944656426419098
NUGC-4,24772860,-1.20224776097102
SNU-1105,148198,-2.088080435846721
WM266-4,10302451,4.017909136506136
WT2-iPS,9903786,4.00311264543886
COLO 668,9903786,3.4728233461843745
JVM-3,148198,-2.4779915493019646
PK-59,44137675,3.067468574429604
ALL-SIL,54618305,4.365324809283883
MDA-MB-453,9929138,5.862527790185705
TALL-1 [Human adult T-ALL],selumetinib-BRD-A02303741 (4-1 mol-mol),5.754543795197586
23132/87,11485656,1.6570697759405837
NCI-H1666,54639665,4.462050745406922
HLF,44493528,4.4251404257348295
HSC-2,6450551,2.750950274554251
KYM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),7.404231883132065
KE-97,1716436,3.092375705574746
MHH-CALL-3,100016,3.61949081353442
TE-6,11404337,-2.253854386513332
Kelly,654092,-0.5239878481095741
RPMI-7951,4259181,-0.293226545536714
DAN-G,10385095,2.273453653362206
SNU-685,9911463,4.245246526228465
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181
LK-2,6918638,-0.400750886877545
THP-1,124202324,0.927769552160574
SK-HEP-1,16013152,4.2454363352103925
KYM-1,24772860,-1.8761160262409973
CHP-212,100016,6.525746829388361
GDM-1,49766530,-5.08643578606908
NCI-H2141,374536,3.0901566665241003
EM-2,11404337,-1.9269330473502917
Kasumi-1,24753719,3.975004241105681
KPL-1,44494015,4.459934814858864
SH-10-TC,10385095,3.3084843138225715
NCI-H1869,4259181,0.9705477170328122
MOLT-16,2708,1.5889366928788633
DMS 454,71729975,3.3513340466309853
SK-UT-1,6918638,1.3984076220807655
KYSE-510,9911830,3.344308722430599
Hs 611.T,11404337,-3.0246332650270777
BT 286,156414,1.5712991446224744
NCI-H2052,4259181,-0.2621110612765442
BT 112,4259181,0.804943209632055
LCLC-97TM1,10302451,3.3699574981481217
EKVX,44137675,4.017040042041308
CAL-27,tanespimycin-bortezomib (250-1 mol-mol),-0.409380186496711
Panc 08.13,135984461,4.38718124814828
AGS,sirolimus-bortezomib (250-1 mol-mol),0.9913550717108452
U-BLC1,4259181,-0.0351960911080245
MPP 89,10302451,3.6853052068561816
Hs 822.T,49766530,-2.239699786404697
T98G,24753719,3.9354730231291186
KMRC-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.480458444032737
SCC-25,10302451,1.3739474591398615
BICR 6,135984461,4.397394430442058
SNU-899,54618771,0.9144402364445118
OPM-2,9929138,4.40255967212205
HeLa,148198,-3.5416719655217976
U-937,148198,-3.074403033711411
OV56,16013152,4.414923881242918
OCI-Ly10,151289,1.3520724655977314
NCI-H2452,11485656,2.991875358712002
GI-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.4497114483204845
KE-97,151289,-1.1407202077225715
TE-9,3815108,3.738855732248574
NCI-H2110,2708,5.257811785679327
HPAC,54618771,1.6074763393424083
NCI-H1355,54618771,0.7096344074223282
RMG-I,753704,4.958958971413961
HCC78,tanespimycin-bortezomib (250-1 mol-mol),1.9748974265856916
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
NCI-H716,1716436,2.4874306466030607
BT-20,151289,1.4218910334497323
SNU-626,54618771,3.903853524129119
RMG-I,54618305,4.556986541858906
EJM,9929138,6.263891211273599
B-CPAP,11404337,-1.1633647036433346
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
WM1799,3815108,3.1837230031746406
BT 131,753704,4.603702332813639
SW620,9929138,6.470174413186685
G-402,11485656,-0.4595745654780468
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
UACC-257,46926350,-4.421098771033138
CAL-62,tanespimycin-bortezomib (250-1 mol-mol),1.0619884321927937
EKVX,9868037,3.7956253257863217
UACC-62,24753719,4.34536967174679
SaOS-2,2729026,3.0079080963172573
NCI-H2085,6450551,3.065761078803679
BT 504,54618305,4.42433904701444
Fu97,124202324,0.8550876859272485
P31/FUJ,374536,-2.654779926412406
A2780,9911830,1.8386970616579583
YD-10B,44493528,3.7407231951864497
HCC1143,11404337,-0.7051632820466462
SU.86.86,16013152,5.600026055777677
TTC-709,11485656,2.1468859036039327
RVH-421,tanespimycin-bortezomib (250-1 mol-mol),-0.2539281679768233
RCH-ACV,151289,0.3520860299882317
MHH-NB-11,151289,-0.2740077529879822
JHH-1,JQ-1-UNC0638 (2-1 mol-mol),2.3593718191705197
OAW28,374536,3.018534312402979
LS411N,9911463,4.267700407985282
Panc 10.05,49766530,2.44365810580744
Caov-3,6450551,1.4513187965866765
YD-8,9911830,1.9962756690281929
HDQ-P1,124202324,3.0071911341260416
MG-63,100016,6.791496028485962
IGR-39,753704,5.13496523619658
NCI-H520,9911463,3.6961325383043007
BT 340,6450551,3.0702004499892115
UM-UC-1,6918638,0.4127396353013411
NCI-H2172,10302451,4.417347550930714
NCI-H2286,9911463,4.284933717494527
NCI-H526,9903786,2.628275304590264
JM-1,2708,2.6994993672471774
EFO-21,100016,8.032262329904976
DMS 454,327653,3.1848583000561215
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
DU4475,151289,0.5444837346380128
KMS-12-BM,44493528,3.477782404349953
NCI-H2141,46926350,-5.833766963931078
CHP-126,9868037,2.7962624557740385
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
JIMT-1,654092,-1.4010722347381654
SCaBER,156414,3.639722880324369
Granta-519,136227924,1.3333863896282263
MDA-MB-468,753704,3.87058940631134
P12-Ichikawa,2729026,2.256257371865758
NCI-H1581,44493528,4.36885070157506
COLO 678,24753719,4.6560213294731865
Tm87-16,9911463,3.8938855092804454
MOLP-2,9903786,4.729359936369518
BT 145,9903786,2.2676133006053965
NB4,327653,2.4394737339105452
SK-N-FI,136227924,2.3066593011882084
KM12,327653,3.395524528646188
OVCAR-5,selumetinib-BRD-A02303741 (4-1 mol-mol),1.606286324913611
MCAS,10385095,0.5712472701663329
RL,2729026,2.8576336464808016
OCI-Ly3,1716436,3.3637178625732655
NCI-H838,10385095,1.1161561983941106
Karpas-299,1716436,2.1391570109110263
KP-N-SI9s,135984461,3.392026045664003
SU-DHL-10,654092,-1.3953334004437012
SNU-899,tanespimycin-bortezomib (250-1 mol-mol),0.5360677802944718
A-549,11404337,-0.2898707579606809
SK-N-MC,4259181,-0.9619910881284685
TM-31,selumetinib-BRD-A02303741 (4-1 mol-mol),7.2882191692184835
SK-MEL-5,654092,0.5475945767149036
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667
BT 422,4259181,1.564610339660692
AsPC-1,54618771,1.0442216511349782
PC-3,54618771,1.1708182294918184
SNU-308,24772860,-1.8975415647068492
HuP-T3,6450551,3.7588607556856006
EoL-1,135984461,1.5166332685892363
BT 482,136227924,3.374884803280594
PL-21,24772860,-3.4194775314954717
42-MG-BA,2729026,3.115786625114021
CAMA-1,374536,3.668398043090317
Hs 822.T,9911463,4.380200456677196
REC-1,6450551,3.361583238713797
KMS-27,11485656,2.096815262793708
IM95,135984461,1.6793347325377754
IGROV-1,11404337,-0.7659238947812715
NCI-H446,753704,4.587237605322713
SNU-16,54618305,3.809629362468688
Karpas-422,9903786,1.5566107707645094
HEC-6,10385095,1.086644508305165
HMCB,6918638,0.939566819440244
Karpas-422,2708,4.388605602289197
CAL-12T,100016,6.470654025405006
NCO2,9911463,2.9393398457743163
SCaBER,4259181,0.8939054398138756
LP-1,148198,-3.8284047012705846
AsPC-1,10385095,2.76496705920137
697,156414,0.8194955479278566
NCI-H650,2708,6.082601936065024
WM88,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.9395395427840283
GP2d,4259181,0.2488799202775051
SNU-407,24753719,4.181962435947778
MOR/CPR,9911463,3.708088966162912
CW-2,753704,4.86883641771595
KMS-18,100016,3.3973864073508864
HT115,156414,-1.6734320997584922
TT2609-C02,6918638,0.9374667365701628
SNU-16,148198,-5.297053925095674
NCI-N87,156414,-4.435299577962505
CA46,151289,0.6780663351050565
HuG1-N,sirolimus-bortezomib (250-1 mol-mol),-0.2161746161621927
HuH-28,3815108,2.835726431789329
L-363,44493528,5.083298031137833
253J-BV,6450551,3.415835349095032
BT 112,JQ-1-UNC0638 (2-1 mol-mol),2.705069065658094
Hs 852.T,124202324,1.866206280249401
TCCSUP,54618305,5.536232511374765
Ci-1,10302451,3.7319108360157944
BT 333,148198,-2.763261808909799
OVSAHO,10385095,1.067864313486602
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
MG-63,10302451,3.049772862204908
BT 482,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4708607129031228
Jurkat,9911463,3.146935995662798
NCI-H889,2729026,2.303266982520877
NCI-H1395,327653,3.4863341416729847
CML-T1,135984461,1.8956927240773784
BT 340,tanespimycin-bortezomib (250-1 mol-mol),0.797080968963508
JJN-3,753704,4.7063094006872355
HCC38,753704,4.841240703007911
SW1783,54618771,3.657201070811366
SNU-16,11404337,-2.6898366893784997
SNU-878,24772860,-2.168779205640107
BT-12,327653,3.045855605227353
EBC-1,11485656,1.836879581205612
SNU-213,151289,2.6508507215309556
SNU-503,4259181,2.077412365798562
SW1783,11404337,0.7381457579106708
HuT 78,54618305,4.369358935790669
ALL-SIL,9903786,1.532435199339551
NCI-H1734,10385095,0.2874995552525176
CAL-78,4259181,0.9156565377024688
WM115,135984461,4.094268409164816
253J-BV,24772860,-1.1925305671608937
RL,44137675,2.607640086896043
GOS-3,44137675,4.312209162350938
RCH-ACV,374536,-4.30360935865895
LC-1F,11167602,-1.348931537750626
TALL-1 [Human adult T-ALL],374536,1.4478467431301354
HT-144,11167602,1.9204372739091764
SK-MEL-24,10302451,3.694685850061357
RCC10RGB,2729026,3.187414345119047
MOLT-13,sirolimus-bortezomib (250-1 mol-mol),-0.8755495405790606
AsPC-1,11485656,3.206693439346989
KNS-81,654092,0.1101873344117448
THP-1,100016,3.892329450898836
MHH-CALL-4,44493528,4.165612428769394
MOLT-16,151289,-0.0002766935082625
RMG-I,JQ-1-UNC0638 (2-1 mol-mol),2.397636937092221
P12-Ichikawa,JQ-1-UNC0638 (2-1 mol-mol),0.2690790345954399
TE-6,24772860,-3.153812007564067
RCC10RGB,11485656,3.364959979667133
ALL-SIL,1716436,3.0252724323132374
NCI-H2452,24772860,-2.067021978185303
JHH-4,11404337,-2.717621679177181
BL-70,24772860,-2.823895341725822
Granta-519,374536,-1.3755413186728007
BICR 6,11404337,-0.1935615710602951
P31/FUJ,3815108,3.712799909664185
SNU-C1,100016,6.347812039507436
COLO 800,46926350,-4.25291658455006
SUP-HD1,JQ-1-UNC0638 (2-1 mol-mol),0.7919694880655943
SNU-466,11485656,2.57362986775831
SK-MM-2,16013152,-0.9058098931176974
A-549,10302451,3.5203591354698016
IGROV-1,156414,1.4212019235656712
NCI-H1838,selumetinib-BRD-A02303741 (4-1 mol-mol),5.845108178923666
LN-229,1716436,1.7366517430336743
YD-15,156414,-0.6443248940127515
HCT 8,10302451,3.901700462546551
NCI-H1155,11485656,2.0166410350389885
Kasumi-2,327653,2.4977161394914953
PL-21,9911463,3.159423653145491
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904
COLO 800,54618305,4.447513462605581
B-CPAP,136227924,3.258845757188781
SNU-C1,10302451,3.924518569101239
Kasumi-1,11485656,-2.0824070606449534
MOLT-13,2729026,2.0450637836071093
HCC15,24753719,5.171121417544096
SNU-449,6450551,3.816508101047544
Peer,selumetinib-BRD-A02303741 (4-1 mol-mol),5.089819543315443
Becker,16013152,6.289892146912785
MSTO-211H,156414,0.8242215144670997
SNU-423,44137675,3.771329187315914
MOLM-6,374536,-0.6168142996132108
HEL,4259181,-1.3539346499127438
Sq-1,sirolimus-bortezomib (250-1 mol-mol),0.8750306611034651
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
JJN-3,71729975,0.730727064911539
Toledo,49766530,2.126888986810566
Hs 611.T,148198,-3.7604102025742345
CCF-STTG1,49766530,2.4939305222304955
HCC1500,10302451,3.7658874637842135
RCC10RGB,9911463,4.415558893727306
SK-LU-1,4259181,0.0552405649133211
SNG-M,2729026,3.1113178955347696
BT 428,156414,0.1234393926344954
PLC/PRF/5,selumetinib-BRD-A02303741 (4-1 mol-mol),6.433067058708403
MOLT-16,10385095,0.8199182110324024
Daudi,753704,2.787779434331829
Panc 02.03,10385095,1.3097039910351371
MFE-319,6918638,0.7924367103155517
LK-2,16013152,4.1054828420829494
JM-1,4259181,-0.0762731042787348
SNU-213,10385095,2.7554812107877065
Hs 888.T,327653,3.5406754693481153
CAL-51,9929138,6.421072450841616
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
BICR 18,73707371,5.023393077953448
Daoy,9911463,4.106155174248402
HSC-2,11404337,-1.7488575927200145
SNU-1066,24772860,-2.3123014880492354
LXF 289,11404337,0.1273620702572638
U-87MG ATCC,9911830,4.425829488387339
NCI-H1341,753704,2.748136017323882
YD-38,10385095,1.2654205909097365
Calu-3,10302451,0.1750089967931517
HSC-4,3815108,3.178044313970192
RT-112,3815108,3.2598333962418446
Hs 578Bst,9868037,5.270219324127126
WSU-DLCL2,54618305,4.290605558681752
AsPC-1,49766530,-1.5554439905221051
SK-MM-2,11485656,1.7777783316384888
PC-14,44137675,3.2204053533427284
Hs 888.T,2729026,0.6447913251012506
BT 145,JQ-1-UNC0638 (2-1 mol-mol),3.470265004108929
SNU-503,11485656,3.1307090285748953
CAL-62,6450551,3.3399846755903395
PaTu 8988s,16013152,4.180001717808194
GaMG,135659046,4.983259743883316
BT 147,2729026,1.1879144552162328
TUHR4TKB,24772860,-1.3419055363296075
697,151289,-0.097171059902199
U-CH1,54618771,1.7714870299819865
SNU-1214,54618305,4.749041864711717
NCI-H841,136227924,2.950651455010232
CAL-51,148198,-3.728190383000159
HCC2935,327653,3.691870307618831
HCC38,2708,5.0858320495730975
A101D,4259181,-1.780447840165833
NCI-H1341,156414,0.9119467847999114
ONCO-DG-1,44137675,3.103389645768138
BICR 31,9903786,2.10396775229317
U-937,tanespimycin-bortezomib (250-1 mol-mol),-0.8253884714136634
P12-Ichikawa,9903786,1.487769039842012
Calu-6,327653,3.0403330128886306
KMRC-1,16013152,4.7431155582488325
NCI-H508,156414,-1.5494173849361004
BT 245,2708,6.067628010390521
IPC-298,9911830,3.243562235650486
MOTN-1,11485656,1.953778379439836
SNU-1105,9903786,3.6171667561714056
SW1116,9911830,1.7664188791377746
OPM-2,11404337,-1.9830798838769188
KYSE-150,4259181,1.17340557634434
KMS-12-BM,10385095,1.107401404691538
DU145,54618771,3.337458824494602
L-428,JQ-1-UNC0638 (2-1 mol-mol),-0.0618171801686899
K029AX,2708,6.005635851131997
Jurkat,24753719,2.875512939853453
SCC-9,24772860,-2.0717241396099473
SW620,374536,2.946693939855593
SNU-8,11404337,-0.4750422228003279
NCI-H2291,selumetinib-BRD-A02303741 (4-1 mol-mol),1.678182736648448
DoHH2,124202324,-1.646664696465438
SCC-9,54639665,4.512228528266098
769-P,11485656,3.1520053079529955
WSU-DLCL2,6450551,2.449295462746393
HCC1954,9911830,3.1305041112898286
LOX-IMVI,100016,4.319089113839007
KMS-18,374536,1.6822213286952032
Hs 888.T,16013152,4.486881621131485
MKN7,11167602,1.88082569725068
OE21,9911463,3.2233291636106727
253J,9868037,1.5770762651025676
COLO 201,9903786,2.3732534001710426
AML-193,24753719,3.879406334074648
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821
RKO,11404337,-0.3534280477619294
SF295,10385095,1.9844654960624617
HT-144,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1549232336540735
SNU-C1,6918638,-0.1919705082946097
OAW28,124202324,1.9264961190623875
DMS 53,46926350,-3.5276361479911564
U-87MG ATCC,49766530,-0.4723901829194296
SF295,11485656,3.5430104374180806
OE19,11404337,2.1559744659791975
NB1,136227924,2.7984479768491335
CAL-78,selumetinib-BRD-A02303741 (4-1 mol-mol),4.4625372271319454
CL-11,100016,6.945803371228119
NH-6,136227924,2.082013315983653
SK-MEL-5,54618771,0.7093345512366925
OV-90,148198,-2.8305147037841425
UM-UC-1,2708,4.287457363701231
TALL-1 [Human adult T-ALL],11404337,-1.3736940548636651
CW-2,10302451,1.0482757335808135
NCI-H2126,44493528,4.793880451858377
SNU-478,654092,-0.116957989667139
SET-2,136227924,2.6175155289445646
TT,4259181,-1.5685992068812522
A-549,49766530,0.1688758689952186
VMRC-RCZ,11404337,1.035796097984766
BICR 22,10385095,0.7738978245677988
MDA-MB-157,9868037,3.2071579521245823
Hs 688(A).T,156414,1.563615855647258
KG-1-C,49766530,-1.9927650239452297
NCI-H2342,44493528,4.387491480960399
WM793,124202324,3.2510114503738894
SK-MEL-28,6450551,3.516250339851913
SH-4,16013152,4.20501302703953
HT-144,11485656,1.9072618769680565
Ishikawa (Heraklio) 02 ER-,9911463,4.4894975893783435
TE-14,6918638,0.7581256744070354
SCC-9,1716436,3.7585685406918783
SK-HEP-1,6918638,1.490993863020431
NCI-H1105,9903786,2.2828684981562013
CAL-51,9929138,6.421072450841616
Karpas-620,4259181,1.426015705799775
NCI-H524,11404337,-1.0230582740337757
Toledo,16013152,3.767227847127025
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
HOP-92,135659046,3.870872238104053
PE/CA-PJ49,148198,-3.4268639622300516
HuH-6,44493528,4.083061527046497
SNU-16,100016,4.136425652163891
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
HCC1143,54618771,1.714955024233068
SHP-77,654092,-1.2372906137431694
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
EM-2,44137675,2.7795518520340754
CAL-27,sirolimus-bortezomib (250-1 mol-mol),0.4239769214934303
SNU-489,54618771,1.3505446494743896
EoL-1,54618771,-1.3490437314976569
BCP-1,54618771,1.535577379039456
GDM-1,6450551,0.6399661557529115
NCI-H1703,6918638,1.6559021523664152
SJSA-1,156414,2.20247372262641
HOP-62,10385095,0.93787190415745
COLO 205,sirolimus-bortezomib (250-1 mol-mol),2.1268339041997457
COLO 205,124202324,2.729149160829362
M059K,54618771,3.2179449616328775
IA-LM,10385095,1.8174613436578264
NCI-H838,44137675,4.054803017699142
OPM-2,44137675,3.238695939616315
Hs 940.T,10385095,3.184897938078862
SNU-475,4259181,0.9455014217250642
NCI-H1105,44493528,4.252977962816797
QGP-1,sirolimus-bortezomib (250-1 mol-mol),1.0320237802548329
SK-HEP-1,2708,5.260013220141412
BT 330,JQ-1-UNC0638 (2-1 mol-mol),3.496932096076456
HEC-6,124202324,0.7427868764494542
ECC10,24753719,4.390592261959423
SNG-M,6450551,3.4142676602011286
PaTu 8902,136227924,3.2072125986231117
NCI-H1703,9903786,2.5255687748265903
BT-549,9903786,2.513972936103366
JHH-4,148198,-4.065659017093723
COLO 800,10385095,0.8108166811299345
HT-1197,73707371,6.232305901693353
NCI-H1155,156414,1.1883560015419388
NCI-H526,374536,2.493328822521131
OCI-Ly19,753704,4.08925581469373
DMS 114,49766530,0.1100604585503799
OCI-AML-3,11404337,-2.717957747989526
KP-3,4259181,-0.2815852402422203
TE-14,11404337,-0.8774681002045693
OC 314,9911463,3.7977277680710393
647V,11485656,1.780919145003727
NCI-H660,9911463,3.200978092874424
KMH-2,11404337,-1.9075326301634037
NCI-H23,9911463,3.868491646866135
HPAF-II,9911830,3.274305955299227
ACC-MESO-1,1716436,3.110385863355361
JVM-2,374536,2.1354489760476376
KYO-1,49766530,-0.7028254429711305
HT,374536,2.645486499954188
OCI-Ly19,2708,1.904120725881428
MM1.S,24753719,4.473744821146246
GDM-1,2729026,2.245856819358974
CCF-STTG1,148198,-4.129311374884182
23132/87,54618771,0.9253043807120772
KHM-1B,156414,1.0383008800592366
Pfeiffer,selumetinib-BRD-A02303741 (4-1 mol-mol),3.431620963382137
NCI-H1975,9911830,1.490717109847118
HCC1500,135659046,2.9858139057826905
HCC1438,156414,1.65905389006548
SNU-503,54618771,1.215393479173298
PE/CA-PJ41 (clone D2),9911830,2.474692527897134
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
BHT-101,11485656,2.812775629456312
IGR-1,151289,1.0217855859417022
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
BT 112,24772860,-3.2237648858189742
WSU-DLCL2,148198,-3.6374417896025513
A-375,49766530,-0.2051662663719206
HCC1395,136227924,3.3223803208690135
LAMA-84,151289,-0.2630120461935693
SNU-1196,24753719,5.368207599086299
U-118MG,JQ-1-UNC0638 (2-1 mol-mol),2.422856809819278
BICR 56,44137675,2.25614267890379
HCT 15,11485656,1.8077127542489733
KMRC-1,100016,6.458679548763862
LNCaP clone FGC,148198,-3.4579469990265124
SNU-601,JQ-1-UNC0638 (2-1 mol-mol),0.0638503324693459
KMRC-1,136227924,2.9529226708788734
Raji,9911463,2.729188500459454
TCC-Pan2,2729026,2.831360973921185
SNU-216,136227924,2.452598137182288
JVM-3,sirolimus-bortezomib (250-1 mol-mol),-5.712232327729444
KYSE-140,24772860,-1.7161918630451445
Panc 08.13,4259181,0.6585404981574742
PF-382,6450551,1.027271835386555
Hs 852.T,4259181,0.4038883720534522
HCC1419,24772860,-2.3880053593630195
SiMa,11404337,-1.9067460076304843
NCI-H1339,11404337,0.2277853658172252
WM266-4,JQ-1-UNC0638 (2-1 mol-mol),3.009211007095854
L-428,9868037,2.0739066262106265
SK-N-MC,JQ-1-UNC0638 (2-1 mol-mol),0.1438339567229112
BT 440,11485656,2.455280972559295
NCI-H1299,11485656,2.4848432250614843
MOR/CPR,9911830,2.8520547891794945
EC-GI-10,11404337,-0.7610557200028516
P12-Ichikawa,49766530,-2.0130843351151437
COR-L88,9929138,3.603535907252336
HPB-ALL,24772860,-3.437204457699974
CL-11,148198,-1.969557000481989
SUP-T1,2708,3.159296683549462
LMSU,9911830,1.6369573582733428
Aska-SS,6918638,1.1582390446838242
TE-8,135659046,3.4515439367981435
OE33,9903786,4.225835285233996
LXF 289,753704,4.962227230589067
CW-2,sirolimus-bortezomib (250-1 mol-mol),1.6646573064439074
WM266-4,49766530,-0.4074764037641682
SK-N-SH,6918638,-0.7450895378891518
NCI-H522,156414,0.937566519659893
A3/Kawakami,JQ-1-UNC0638 (2-1 mol-mol),-2.039254200709544
WM88,6918638,-0.228247400007117
HT-29,11485656,2.2620864353624786
GSU,9903786,4.148563338701872
NCI-H1568,151289,0.8908355813530987
BT 428,46926350,-4.319561662968833
DU145,24753719,4.348475848084312
HOS,4259181,0.2461191052601901
CAL-54,135984461,1.524237172079529
SIG-M5,374536,0.939365748644882
LS180,374536,-1.6764778169414856
M059K,JQ-1-UNC0638 (2-1 mol-mol),0.7975878894225275
BT 504,6918638,2.3418262484979593
A2780,2708,1.6817262399506028
OV7,4259181,0.7460960676293698
DOV13,2729026,2.999632789830007
NCI-H841,11404337,-0.1615181645680822
NCI-H2141,156414,1.72197296337886
SET-2,9911463,3.8788092570896184
BT 147,9911463,2.928240500663929
HCC1569,4259181,0.6490126665134603
JJN-3,136227924,1.2624051766932831
KYSE-410,2729026,2.3808934175081378
HCC1419,6918638,0.6452864183541364
CAL-54,374536,1.0765433188852287
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
NCI-H1355,10385095,1.6952620298374113
HCT 8,sirolimus-bortezomib (250-1 mol-mol),1.4500182233315906
HCC1806,2729026,2.714850020668062
SW1417,374536,3.1494868779862504
SU-DHL-10,11404337,-3.1168849698273404
HD-MY-Z,selumetinib-BRD-A02303741 (4-1 mol-mol),2.20501426712932
NCI-H1435,753704,4.9976257651958305
SNU-878,sirolimus-bortezomib (250-1 mol-mol),1.804977895321967
YH-13,135984461,4.0881390777757245
NCI-H1568,9911463,2.564901149372131
CHP-212,selumetinib-BRD-A02303741 (4-1 mol-mol),-4.549038820936692
JJN-3,46926350,-4.3976142043739985
TT2609-C02,11404337,0.8244882242749442
KMRC-1,11485656,3.5314695534539045
NCI-H2444,sirolimus-bortezomib (250-1 mol-mol),0.8470480091874228
OVCAR-5,JQ-1-UNC0638 (2-1 mol-mol),1.402375120603818
MKN7,156414,1.3312403404244495
8305C,6450551,2.7455346307914414
NCI-H1573,11485656,1.6192247576925332
KMRC-20,10302451,3.571501385736242
NCI-H2085,9911830,1.4316472600892705
Daudi,135984461,3.9990978127252728
YD-38,9911463,4.143159410614896
JM-1,156414,0.9517000986854224
CGTH-W-1,9903786,1.99445591465905
SK-N-AS,6918638,-0.3067046964839828
REC-1,4259181,2.258839706285654
RCH-ACV,24753719,3.8377277120048863
IGROV-1,374536,0.7022324251593053
KP-3,49766530,-2.4187443119050904
SW1990,6450551,3.4368390730521203
Capan-2,71729975,1.516081526821681
SEM,753704,2.726890937341564
SU-DHL-10,JQ-1-UNC0638 (2-1 mol-mol),0.072730308476368
JHH-5,327653,3.1748835184568907
NCI-H23,327653,2.841152187489534
SK-BR-3,24772860,-2.10781871600694
HCC2108,136227924,3.562843531024723
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
Reh,9911463,2.887324979980584
MHH-NB-11,124202324,0.9375251824200628
Karpas-299,151289,0.0119125528996565
NB1,10302451,3.721240237409207
BT 179,9911463,3.927482199479875
PK-45H,selumetinib-BRD-A02303741 (4-1 mol-mol),1.0831431111712064
TE-1,654092,-0.3139587132391279
Hs 944.T,4259181,0.8815824268316962
PaTu 8902,654092,0.4014878659730266
OPM-2,46926350,-5.934740852723627
COLO 320,100016,4.196375737127383
HCC95,9911463,3.4166261837623098
D283 Med,11404337,-0.900512184015852
RCH-ACV,156414,0.8173746965984037
KCL-22,6450551,-0.449920944383749
OCI-M1,374536,1.352754792423625
CAL-54,151289,1.3517966217225088
L-363,1716436,2.8241847008079413
LCLC-97TM1,9903786,1.8016114643921617
IGROV-1,44137675,1.8406125640672395
OCI-Ly19,tanespimycin-bortezomib (250-1 mol-mol),0.3425077317029711
Hs 746.T,4259181,1.0284627919078262
DMS 273,135659046,3.477426326571923
HuP-T3,10385095,0.7178899916931367
K-562,9911463,2.5078915917546336
NU-DUL-1,654092,-1.5917414201369582
CJM [Human melanoma],46926350,-4.165563174240511
BICR 56,10385095,1.0617029264490752
SCC-25,24772860,-2.6570530223857496
CHP-126,24753719,3.177202687001685
L-428,2708,3.4929095959760836
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
KCL-22,44137675,3.827369948528343
U-937,156414,1.3451910574911532
SNU-899,2708,6.58682746071086
JVM-3,24772860,-3.2984134326682915
MOLT-16,3815108,1.694733962906003
NCI-H2085,49766530,1.4049840507927902
EFM-192A,54618771,1.407035681084211
BICR 6,9911830,2.371136443682152
HCC44,54618771,-0.1525308444748626
SNU-182,2729026,0.8235809809481912
GSS,9929138,2.058801232137709
BICR 16,10302451,3.722394392304981
HLF,327653,3.1143570229746653
HeLa,3815108,2.701103625010151
DU4475,2708,2.499388566879049
DoHH2,654092,-4.744655207398057
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699
IA-LM,148198,-11.384967135346804
DMS 454,JQ-1-UNC0638 (2-1 mol-mol),1.3127299291522974
EFO-27,73707371,4.965139584704115
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
SNU-738,tanespimycin-bortezomib (250-1 mol-mol),1.4501924886201147
Hs 746.T,selumetinib-BRD-A02303741 (4-1 mol-mol),2.681106816195763
PSN1,24753719,4.290295429710992
KMS-11,374536,1.926866690661452
NCI-H841,9868037,4.373708012827469
RERF-LC-MS,374536,3.716253113618047
Hs 852.T,11404337,0.7011610270367453
TUHR10TKB,9903786,1.579233705567475
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
NCI-H28,44493528,4.782322739725782
DB,11404337,-1.658875879170345
SNU-410,11485656,3.512018724098686
SNU-840,3815108,3.808702697837115
AU565,135659046,3.967998335471068
KMRC-1,11167602,5.704956856257104
PE/CA-PJ41 (clone D2),136227924,3.7691635351021855
HDQ-P1,9911830,3.444043244952707
NCI-H2170,6918638,0.3062237011393727
EBC-1,654092,0.4740057055050578
NCI-H146,6918638,-1.4860665745363582
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414
OE33,JQ-1-UNC0638 (2-1 mol-mol),1.6826826815341247
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
D283 Med,135984461,1.545115225409391
8505C,11167602,1.7953198802479176
NCI-H520,1716436,3.682324003372517
NCI-H508,148198,-2.3107893902367116
A-172,1716436,3.774753027660324
BT 248,753704,4.567621051188063
NCI-H23,sirolimus-bortezomib (250-1 mol-mol),0.1265190636772679
CAL-54,54618771,-0.0146618789918735
MOLT-16,654092,-0.1015617895709401
SR,124202324,1.806428647366455
SU-DHL-10,49766530,-0.2943285235939838
SNU-81,10302451,3.60256279960024
SU.86.86,136227924,3.0459574781144014
SNU-738,11485656,2.5933785348749243
SF268,4259181,0.1615840122785245
Mono-Mac-1,9929138,7.711944602530317
SNU-216,148198,-4.857755213358989
EB1,11167602,1.3482748147027377
RPMI-7951,BRD-K13185470,4.283548482725321
OVTOKO,tanespimycin-bortezomib (250-1 mol-mol),0.5504148489500027
HT-144,9903786,5.3539912005761705
LOX-IMVI,9911830,1.9996336712614449
NCI-H661,49766530,1.1318827683023138
HCC95,10385095,0.8007390261026306
KO52,4259181,-1.031664922111082
SCaBER,374536,4.133146596539564
OCI-M1,1716436,2.642109277761982
B-CPAP,10302451,2.5954421947302344
SW1088,148198,-1.1652739532057856
OCI-M1,4259181,0.123787677516806
HEL 92.1.7,10302451,3.8368515417641142
OVCAR-5,136227924,3.2070295394145782
KE-97,9903786,1.2492215046339803
LS123,10385095,1.1165638509540754
VMRC-LCD,9911830,2.082442328496714
SNU-410,1716436,0.8857926852405207
EM-2,374536,2.060592408193078
MDA-MB-435S,374536,3.202875139655675
KYSE-450,11404337,-0.7664225185438103
CCF-STTG1,9911463,4.668972921835481
NCI-H520,11485656,2.0255953186148674
BT 248,6450551,3.394353011187604
BT 359,9911830,3.790221030687113
GA-10,9903786,1.0626395044563215
LP-1,11404337,-1.552804364872206
Ku812,654092,-1.4885664585268723
HCC2279,654092,-1.184200223284283
HDLM-2,9903786,0.9941602221273084
MDA-MB-453,16013152,4.031304285322853
SNU-601,136227924,3.114119824082727
Hs 746.T,156414,1.629229892534377
BT 159,156414,2.2120697636728353
Li-7,11485656,1.4880931297803832
IGROV-1,6450551,2.579641476451469
NCI-H1944,11404337,1.0777396024830528
COR-L95,374536,2.031472802797221
G-402,16013152,4.526478814824651
A2058,6918638,1.2547310541014554
VM-CUB-1,148198,-2.29434239766537
RT-112,4259181,-0.3287525972412779
VMRC-RCZ,sirolimus-bortezomib (250-1 mol-mol),0.0993693702457471
WSU-DLCL2,327653,2.070157362085428
IST-Mes1,11404337,-0.5180157624887997
Karpas-422,54618771,1.0964695949683176
TE-8,10385095,0.7440006584278842
SKM-1,9929138,6.747336348801134
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
42-MG-BA,44137675,3.7319971704009336
LS1034,10385095,2.0322534617013623
HCC1419,374536,0.8618556045812632
HCC1171,selumetinib-BRD-A02303741 (4-1 mol-mol),2.396082610942698
SU-DHL-1,9929138,3.6810672504095385
JM-1,327653,2.4402793258430786
KU-19-19,124202324,2.2262797687523266
SNU-1,73707371,6.410049634463487
KMS-27,54618305,4.755877459713762
EFE-184,3815108,3.502963660952743
SNU-466,4259181,0.976739173619952
SNG-M,151289,0.9561756312708068
NCC-StC-K140,24772860,-2.8025445944996115
KE-37,11167602,1.8775363642517875
KMS-26,148198,-4.824995568216466
OUMS-23,654092,0.1592963135716326
COR-L95,9911830,2.1813921058815553
PE/CA-PJ49,46926350,-4.40046738056835
NCI-H1155,2729026,2.3719618105146014
ACC-MESO-1,11404337,0.4174226395883805
DB,156414,1.1616934223159214
SK-N-SH,54618771,1.3194145394853296
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928
T98G,6918638,1.4380012949673455
TE-11,11485656,1.7659776894381034
NCI-H1838,100016,6.459213557236613
BT 482,9911830,3.0772009625144325
GSS,9868037,1.8794585438915803
HuH-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.146685464704295
SNU-489,2729026,3.1816038825634556
HT,9911830,3.0639968978476513
IGROV-1,54618771,1.2456991772210466
NU-DHL-1,10302451,2.2542174061675055
HCC15,44137675,4.493981948720765
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
TE-9,sirolimus-bortezomib (250-1 mol-mol),1.65156532299436
SW1116,374536,0.6726467432117932
SF126,11404337,-0.0225096476236154
NCC-StC-K140,16013152,4.289231404195202
EHEB,10385095,1.253390881214325
NCI-H1355,654092,-1.388358713746556
HT-144,9911463,4.304760863766968
NCI-H28,11485656,1.9192630984441017
KLE,54618771,1.0287660425791825
PC-14,1716436,3.681033549628276
JHUEM-3,136227924,3.0400208358424243
639V,54639665,5.761167112647425
EHEB,374536,2.309110674045564
SK-N-BE(2),11167602,1.930499183272272
TALL-1 [Human adult T-ALL],tanespimycin-bortezomib (250-1 mol-mol),0.1356817268288457
MOLT-16,327653,2.613678241642498
LN-18,49766530,0.2968190625783926
OVTOKO,11404337,0.3114289672372418
NCI-H2009,151289,0.8401149520435854
Rh41,1716436,2.550389977428493
SNU-620,sirolimus-bortezomib (250-1 mol-mol),0.2829661483143316
EC-GI-10,156414,-0.2987346529077731
SW948,374536,1.478775672326772
COLO 668,44493528,4.28656407628961
KYSE-140,2729026,3.0470002368671034
DU145,374536,1.9068384141255408
BT-20,135659046,3.529178166961368
HuH-28,9911830,1.7583822057953695
PL-21,135984461,4.312224560924431
KP-2,11404337,1.570112378340211
NCI-H460,2708,4.613368759945332
PSN1,73707371,6.463890165569429
BT 428,2708,3.3990260220989983
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
SNU-1,1716436,2.9920949292736303
SNU-761,10302451,2.865362622311559
UM-UC-3,sirolimus-bortezomib (250-1 mol-mol),1.1405696257506746
KMS-12-BM,11485656,1.287590694324435
AU565,136227924,2.2371309282915184
QGP-1,3815108,3.2418749594170024
EN,1716436,3.5257740478668245
HCC1806,124202324,3.4747112790589605
NCI-H226,1716436,3.0158842951905895
KNS-60,2708,3.780409135839423
G-401,135984461,4.271777659576195
Raji,2708,4.369088535017227
SNU-1066,151289,1.985718364175832
B-CPAP,24753719,4.549431908166172
SK-UT-1,4259181,0.5247904304596981
KYSE-510,54618771,0.5023256188939713
MHH-ES-1,9868037,2.631225103410452
NCI-H1694,10385095,-0.2584704723374293
OE33,100016,6.493432597771833
PE/CA-PJ34 (clone C12),6450551,2.8483436332661873
CCK-81,9929138,5.48307425077135
LK-2,2729026,3.077265406630673
NCI-H292,3815108,3.432884993584308
YD-8,JQ-1-UNC0638 (2-1 mol-mol),2.771778742465765
SNU-738,3815108,3.7163957137796393
BT 231,6450551,2.336132555682411
SK-MEL-3,4259181,0.967538636263607
HCT 116,10385095,2.270155964027336
SW1783,1716436,2.7857036486954567
RCH-ACV,135659046,3.4161353826802783
NCI-H661,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5299727991020555
KATO III,JQ-1-UNC0638 (2-1 mol-mol),1.6625628681299218
HSC-4,2729026,2.4603123985812276
HT-1080,44137675,3.6125340618181943
SNU-1,6918638,0.043682815737195
Calu-3,2708,3.6888578294378833
BT 286,44137675,3.839918217335364
T-47D,10385095,1.8124181388020704
CAL-27,9911463,3.9808339840731537
NALM-6,11485656,1.650692330200231
Mel Ho,3815108,3.2507135979038986
PE/CA-PJ15,327653,3.705959138945344
NCI-H460,9911463,4.421747687015995
SNU-1214,156414,-3.2304362437665812
SK-UT-1,10302451,4.065117068717504
HSC-2,46926350,-6.01394572804466
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
SYO-1,1716436,2.6896985636247304
BT 147,753704,4.913095995514445
DEL,10302451,2.7814314514381775
OV7,11485656,2.0479156787278257
KP-N-YN,136227924,3.0572578369433376
A-375,3815108,3.2255108045963694
HuH-28,148198,-2.021570879292896
BT 359,2729026,1.9196343643175828
OC 314,148198,-4.2730667463972285
JHUEM-3,374536,-2.6551227521179115
KMS-34,tanespimycin-bortezomib (250-1 mol-mol),0.6300462572492305
BT 147,tanespimycin-bortezomib (250-1 mol-mol),-3.7345384366794665
NCI-H1341,148198,-4.8101463840826595
SNU-761,11167602,1.5600382089395972
MeWo,135659046,3.600051172308168
8505C,24772860,-2.3057592145548313
C2BBe1,11485656,1.765877240742798
NCI-H322,selumetinib-BRD-A02303741 (4-1 mol-mol),2.523890471890109
Capan-1,JQ-1-UNC0638 (2-1 mol-mol),1.5938386873588442
HT-1197,24772860,0.6353489056825131
Mel JuSo,11404337,-0.8493423015678001
WM266-4,73707371,4.070032209092997
HCC2935,10302451,0.5371939191045066
NH-6,151289,0.4654918501582688
Kasumi-1,54618771,-0.5933473150200181
CAL-29,156414,1.0955099591770534
NCI-H1703,54618305,4.148207764421203
HuH-1,46926350,-4.1564644316345
NALM-6,44493528,3.763100774394441
BT 333,46926350,-3.419738257733303
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
YD-15,151289,0.734915486816281
SNU-1,6450551,2.137841405075532
NCI-H508,9911830,2.7644631186921003
TOV-112D,49766530,0.7305238585252054
HCC2935,11404337,1.520718137800647
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699
KE-97,654092,-1.6868341613842803
U-87MG ATCC,3815108,3.90048987056903
NCI-H2141,9911463,2.830365569007881
BT 224,100016,6.546386559669457
B-CPAP,135984461,1.7006873444468935
SNU-626,44137675,4.561831342632874
WM88,136227924,2.639448330236639
P3HR-1,4259181,1.18334464722064
HCC-56,2708,5.060984105225448
BT-549,10385095,1.777553004720717
786-O,135984461,4.712417821590371
CJM [Human melanoma],2729026,3.101917091332913
GOS-3,374536,2.2437065899634843
DU145,6918638,0.5820093502251232
U266B1,24753719,4.293400712044674
NCI-H1385,1716436,1.447341557412423
OAW28,9911463,4.007690751229585
KMS-26,327653,1.2405471954530771
HCC1438,136227924,3.0530124683265725
SW1271,3815108,3.2377532103389832
EN,327653,3.831719900381987
HT,148198,-3.46019179150445
EPLC-272H,654092,0.4131403866992423
AsPC-1,4259181,1.083384461798112
ECC12,9903786,2.9866335342643953
OCI-AML-5,148198,-5.018972426044919
SK-MEL-28,2708,5.4002065413787275
RERF-LC-Ad2,1716436,3.755030175494451
LOX-IMVI,44137675,3.173066580571396
MOTN-1,2729026,1.916855381733085
HCC1428,135984461,5.872132902333047
NCI-H1734,9929138,5.157080013193966
BT-549,49766530,-1.005486623843658
Ki-JK,2729026,1.0556663329191818
HEC-1-A,10302451,3.536868477856568
TYK-nu,11404337,-1.0316748871481556
KMH-2,54618305,4.158753389755641
KP-3,10302451,2.012637643935689
BxPC-3,44137675,2.990010873447489
HCC44,selumetinib-BRD-A02303741 (4-1 mol-mol),2.575395153999874
HEC-151,9911463,4.0043305736729105
EFO-27,148198,-4.612142049540045
SiMa,151289,-1.4076805448156686
MHH-CALL-3,9911830,3.1939579003268133
MDA-MB-453,10302451,3.3014196832790628
OE19,9911463,4.190839758314233
A-375,JQ-1-UNC0638 (2-1 mol-mol),2.8222057899480104
HuH-28,156414,2.1488017743760586
ACHN,374536,4.742071917979416
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296
SUP-M2,151289,-0.4453974379831692
VMRC-RCW,135984461,3.0066717091132182
CAL-85-1,9911830,1.7649505016171554
SU-DHL-10,10385095,0.7045701508639168
T98G,374536,-0.154456492909018
Hs 822.T,2729026,2.8110663894327925
T84,6450551,3.0234528631913795
TOV-112D,6918638,-0.2708686651634265
MDA-MB-468,6918638,1.4750739327280944
GSS,2729026,0.973159646767844
GDM-1,11404337,-0.1697685825330185
LC-1/sq-SF,2729026,3.0809509595475326
NCI-H2122,24772860,-2.6241487308525526
NCI-H2110,148198,-2.105563861688736
NCI-H1092,16013152,3.726585488555384
JIMT-1,374536,3.743694733757177
TM-31,2708,5.311283534464269
647V,9911463,4.409219514766685
CAL-85-1,11404337,-0.674659950000608
NCI-H28,44137675,3.632433117722122
COLO 668,6450551,2.7112914528794296
Calu-3,10385095,1.1090887882860962
MHH-CALL-4,148198,-4.435182205055272
A-375,135984461,4.563596493696721
SW1990,148198,-3.981392088661051
JeKo-1,135659046,3.5634335603711995
Kelly,10385095,0.4242417641374412
THP-1,tanespimycin-bortezomib (250-1 mol-mol),-1.1093068334471472
SU-DHL-1,24753719,3.670729792524347
PaTu 8902,1716436,3.3992265902353425
LNCaP clone FGC,11404337,0.2192821981043099
JHOM-1,6450551,3.008552398429558
HuH-6,44137675,4.634555742771081
TE-15,2729026,3.117170834129398
IGROV-1,753704,6.461140333581179
OS-RC-2,327653,3.437190963071175
CAL-78,11485656,3.0303268993035233
HEC-6,24753719,4.021686089972085
HuT 78,2708,0.286348811973392
EFO-27,135659046,3.7618075322397297
KMS-18,6450551,1.6153042731997436
SNU-489,151289,-0.2429646261911837
NCI-H1915,11404337,-0.6754401964347063
COR-L88,tanespimycin-bortezomib (250-1 mol-mol),-0.4696067896304535
Calu-3,11485656,1.9769247449011944
T84,11485656,2.016527723529138
A2058,24753719,4.097483540961699
BT 416,49766530,0.2372877169340128
COR-L279,54618771,0.9541573251908244
SW1353,selumetinib-BRD-A02303741 (4-1 mol-mol),4.684826068868717
KYSE-150,JQ-1-UNC0638 (2-1 mol-mol),4.418807330876471
MOLT-13,6450551,1.2147467523148994
RT-4,10385095,2.2650869360881742
HCC2279,9911830,2.3540320094713456
NCI-H1339,2729026,3.0533386554011295
MDA-MB-231,3815108,4.227938717893777
U-CH1,4259181,1.3998648787040493
KMRC-2,9911830,1.0904583461694266
CJM [Human melanoma],54618771,1.1195989916695683
Kelly,9903786,1.651293069080272
G-292 clone A141B1,JQ-1-UNC0638 (2-1 mol-mol),0.3104316826241478
OVISE,24772860,-1.0102375693918164
BT 428,374536,-2.5752106252331113
MKN1,11485656,3.044092336546056
FaDu,135659046,3.4851599686971544
8305C,9911463,3.96844449411402
LC-1/sq-SF,24753719,4.740792040152904
ZR-75-30,44493528,5.463168492919208
JHH-4,6450551,2.912808322892344
EN,46926350,-4.44692434431431
CML-T1,9868037,1.2045012402986977
NCI-H1734,148198,-1.222978862296857
DLD-1,654092,0.6329502057139799
CCK-81,11404337,-0.4332164579586651
WM266-4,2729026,3.028668532515177
HCT 15,753704,5.136626971567783
Sq-1,11167602,2.104600718889136
MDA-MB-435S,sirolimus-bortezomib (250-1 mol-mol),0.878398861878788
BT-549,46926350,-4.493585638609818
HT-1376,44493528,4.459541638540956
YD-10B,11485656,0.9298228362843758
DMS 454,9868037,2.022820925899878
SK-MEL-30,3815108,3.8079083579854327
Detroit 562,3815108,3.1504935200254875
KM12,10385095,1.303034363246703
KP-4,9868037,2.659555107849518
TUHR14TKB,9911463,3.7384474172031976
Hs 294T,156414,1.7651646794166465
P12-Ichikawa,124202324,0.9274399847646314
OS-RC-2,135984461,1.5869411346906208
AU565,49766530,1.448288738772077
Hs 940.T,9911463,3.592326868154122
COLO 201,4259181,-1.4500669762010117
BICR 22,151289,1.1052603945032196
BT 428,11485656,2.0550266467475407
CCK-81,151289,0.680153202722249
IM95,10302451,2.0980422588361143
COLO 741,374536,-2.3969712900341777
Hs 683,11167602,3.3707679458067195
KP-4,100016,6.84348879863886
NCI-H1155,3815108,1.8322593722147364
JHOC-5,2708,4.89023042953599
NCI-H322,4259181,-0.0410950856069719
SNU-C2A,156414,1.9531845574719549
MOLP-8,327653,2.384727852533787
U-937,2729026,2.264989067844502
JHUEM-2,135984461,4.241514174817559
Peer,753704,2.887096711530073
SUIT-2,2729026,2.930269762051551
LAMA-84,374536,0.9712251099089576
HCC202,2729026,3.1896930903050253
EBC-1,54618305,4.408004821032484
RERF-LC-Ad1,124202324,3.7772146428282385
EKVX,1716436,3.55992404886312
SUP-HD1,44493528,3.885514545819132
SNU-626,11404337,1.6916289336018857
HGC-27,54618771,0.7122849148463839
SW1271,44493528,4.286060334293371
MV4-11,2708,1.4535030563668654
L-363,135984461,2.740673882414865
MEC-1,2729026,2.8205668841399345
U-937,3815108,3.877956887657112
TE 617.T,10302451,0.2926739718102283
HT-1376,11485656,2.207084161817658
NCI-H2405,9911463,3.94220055080447
ONCO-DG-1,148198,-3.7879992500612407
NUGC-4,10302451,-0.3779920067585693
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
WSU-DLCL2,24753719,3.632100272535821
G-402,sirolimus-bortezomib (250-1 mol-mol),0.1655413434951251
YH-13,151289,0.8746416780528874
BT 328,24772860,-1.739359818332389
RT-4,3815108,3.2555557052481
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
HCT 15,JQ-1-UNC0638 (2-1 mol-mol),-0.339185420576323
Kelly,24753719,3.0223005039038213
HCC1806,148198,-2.202923064459824
NCI-H2009,2729026,1.97459320968498
CAL-51,9903786,2.1849161121493847
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055
BT 330,selumetinib-BRD-A02303741 (4-1 mol-mol),4.602699425351198
SNU-869,9911830,2.5314086207825635
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633
BxPC-3,11404337,-0.6361724208993981
Ki-JK,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7086623304849953
COR-L88,1716436,0.973250839640326
KP-2,46926350,-3.379764102532408
RERF-LC-MS,54618771,0.9955970244631366
HGC-27,753704,4.827154806176179
MPP 89,44137675,4.05066146798406
VCaP,10385095,1.1570117666550257
BT 145,44137675,2.6693333273764583
HCC1500,6450551,2.2317386689521816
DMS 79,2729026,0.9986201447968104
SU-DHL-1,24772860,-2.736237819232434
WM1799,136227924,5.317137472440357
SNU-626,JQ-1-UNC0638 (2-1 mol-mol),0.7363220478838004
NCI-H1915,10302451,3.466946799076096
NCI-H1666,11404337,-2.6853606173229125
OVTOKO,9911830,2.7891133715732983
RT-4,124202324,3.016060322906711
NCI-H647,9903786,3.1378024767973827
Kelly,148198,-5.169099507303906
CA46,9911463,2.565133854881976
J82,6918638,1.767532826285683
JMSU-1,151289,0.7235627590340927
HCC2279,9868037,3.3429801008899833
SF539,9903786,2.8297220739955993
BICR 22,11485656,1.7887481250962165
KNS-42,tanespimycin-bortezomib (250-1 mol-mol),0.1852378636050138
HD-MY-Z,10302451,3.8671846767021663
SK-HEP-1,10385095,2.0924930980552148
RD,2708,6.677826134844926
U-251MG,2729026,3.0466684975026217
Yamato-SS,71729975,0.8758786032859185
M059K,2708,6.32402728082049
G-401,selumetinib-BRD-A02303741 (4-1 mol-mol),3.259716171612134
ZR-75-30,327653,3.117084253257466
BICR 16,24772860,-3.089006752561269
KG-1-C,1716436,3.803136900311973
P3HR-1,10302451,3.345429510731406
LS180,124202324,2.088899784140079
BT-12,10302451,3.882054819598992
NCI-H522,73707371,4.918377506073214
VCaP,4259181,0.5963848512304438
HT115,100016,5.804685245268015
COLO 668,44137675,3.761856572132536
KMS-28BM,9868037,2.7524179653938172
HCC366,148198,-3.0667828762214344
G-401,11485656,1.708547873036538
HEC-1-B,54618771,2.2656883390933342
MCF-7,2708,7.262313848688556
SK-MEL-1,44137675,5.602923992598762
KP-N-SI9s,10302451,3.2446889985836265
HPAF-II,tanespimycin-bortezomib (250-1 mol-mol),0.3261912422307886
HEL 92.1.7,148198,-5.4580431363429645
KM12,156414,3.95208807087735
MDA-MB-468,135984461,4.286487577540472
SU-DHL-1,54618305,4.34503505735179
TE-5,46926350,-5.182290706303911
Tm87-16,54618771,0.1838114986679219
NUGC-4,4259181,-0.8315529215214057
LP-1,49766530,0.7133399832547254
SNU-C5,753704,4.981011072301579
BT 422,10385095,2.26397401850802
HEC-151,JQ-1-UNC0638 (2-1 mol-mol),1.268930454659871
MKN45,136227924,3.646033724215572
KHM-1B,11167602,5.170482443949449
MKN7,9903786,5.918197098229428
TUHR14TKB,71729975,4.790194478245681
CCF-STTG1,136227924,3.7108552267199504
Hs 611.T,4259181,0.1161520407552913
NCI-H460,54618771,1.6853262233131374
LS180,4259181,0.5796574720850999
SNU-685,148198,-4.368451814809559
EB1,9911463,2.50745807911791
NCI-H2405,654092,-0.1732372662129063
HEC-251,374536,0.5261416636531915
NCI-H1105,44137675,5.382298355846886
SHP-77,49766530,-2.4195879391735216
HCC1500,327653,2.623652361439541
Hs 611.T,54618771,-1.6189149218844685
NCI-H929,136227924,1.899057841083653
SUIT-2,9911830,3.581224696062468
KHM-1B,44493528,1.720576936641076
HCC1588,9911830,2.990297763031185
KE-97,4259181,-2.1334519305493647
Pfeiffer,327653,2.2333046287861
COV362,10302451,3.875331140880436
TE-1,44493528,5.0979019635900364
KYSE-150,2729026,3.191041359897472
CHP-126,135984461,6.03528386391008
COLO 741,11404337,-0.2468832755936964
UM-UC-1,10385095,0.7230126678224916
HDQ-P1,136227924,3.063540067223108
CAL-85-1,151289,0.7512187388654272
AML-193,753704,6.989426434419144
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
KO52,JQ-1-UNC0638 (2-1 mol-mol),0.0630474759486333
HCC1438,10302451,4.112625269368406
KALS-1,1716436,3.6309348474737946
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
Hs 940.T,9903786,1.9949918440372123
SNU-1033,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.3301681028325698
SW1417,9903786,3.296338786408906
RVH-421,4259181,1.1736255747855893
SNU-685,753704,5.257056432017604
LNCaP clone FGC,4259181,1.1537445787746927
KYSE-150,10385095,2.102532274232982
NCI-H1373,10385095,1.3516674750323112
OAW28,327653,3.155680016062074
MHH-CALL-3,135984461,3.2485861141409975
SNU-899,24772860,-1.9138128751185317
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
NCI-H146,49766530,4.81095512251176
TUHR14TKB,374536,-1.8469624017710204
CML-T1,9911463,2.5893115421622737
Caov-3,44137675,4.575679752584547
SNG-M,9911463,4.222801467969213
MOLM-13,374536,0.9670025892080272
MOLM-13,156414,-0.1970532812518614
CHP-212,JQ-1-UNC0638 (2-1 mol-mol),-1.8633116536094043
KYSE-30,49766530,-1.4671789919373923
TC-71,2729026,3.173974249036213
NCI-H69,2708,5.385283745121711
NCI-H2171,11485656,1.3701169509015756
CCF-STTG1,10302451,5.711005870244634
Li-7,124202324,2.575827777416187
MKN1,11404337,1.138047347798436
RERF-LC-Ad2,44137675,3.5131029762271564
Panc 03.27,10385095,1.0322111934041436
OVK18,sirolimus-bortezomib (250-1 mol-mol),-3.215952535759779
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616
HCC1438,2729026,3.104085235831951
BT 444,11404337,0.6214326786633448
NCI-H2196,374536,1.665092888364934
SW982,136227924,1.7454954285641082
Fu97,selumetinib-BRD-A02303741 (4-1 mol-mol),4.864095839608479
U-87MG ATCC,11404337,1.6069036214157395
OUMS-23,44493528,4.557464457918189
HPAF-II,654092,0.744566644457016
A-549,24772860,-0.5810344959117316
BT 224,2729026,3.0363630729116955
ONCO-DG-1,JQ-1-UNC0638 (2-1 mol-mol),2.0371663677199945
JL-1,9911830,2.651716959952657
TALL-1 [Human adult T-ALL],124202324,0.2469812105534063
NCI-H1395,44137675,3.7508448726513737
NCI-H1355,3815108,2.870464538546434
TT,44493528,4.253407146513618
TUHR10TKB,2729026,2.339713696777875
OVK18,1716436,2.807518751362668
MOLP-2,4259181,0.166016027920661
BICR 18,24753719,3.9463687451027254
PC-3,6918638,2.0608196100088336
OCI-Ly10,327653,2.9834360685132073
UACC-62,10302451,4.162006257380555
NCI-H1915,136227924,2.449863082820113
HuCC-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.370448841464423
FTC-238,1716436,3.0820291404203615
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
JIMT-1,11485656,3.0502841230880327
NCI-H2052,374536,3.7135394016128025
SR,54618771,1.0757630585056626
Kasumi-1,135984461,1.8896899929854232
TF-1,753704,3.808840991855387
GMS-10,49766530,-2.0823399026837888
SNU-840,327653,3.6160038244402495
BT-16,10302451,2.960014135095809
COV434,sirolimus-bortezomib (250-1 mol-mol),-0.3799222121291876
NCI-H1573,124202324,1.7667546780830077
Hs 746.T,24753719,4.48003826242694
VMRC-RCZ,135659046,3.396736562465423
BT 164,156414,0.5587758047388703
NH-6,JQ-1-UNC0638 (2-1 mol-mol),0.8264152491605086
KYSE-510,135659046,4.68799289750423
HSC-2,100016,6.282703144403752
MSTO-211H,24772860,-3.3585393605141824
HEC-151,24753719,4.229390718265724
CJM [Human melanoma],151289,0.7631215435645524
VM-CUB-1,100016,6.234028822794693
BT 131,6918638,1.6036373067765148
JURL-MK1,24772860,-3.090916700049897
COV644,54618771,0.8361295238713768
SK-N-DZ,46926350,-4.308121635388687
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
ALL-SIL,11404337,-1.8413362349398936
A-549,1716436,2.5951939484521724
MOLT-3,11485656,1.5036964754289828
HD-MY-Z,44137675,4.197912651663419
BT 444,selumetinib-BRD-A02303741 (4-1 mol-mol),5.0022216220502935
OCI-AML-2,2729026,2.1826544164615576
LS180,2708,3.937371430907984
PaTu 8988s,24772860,-3.347769561665238
A-673,135984461,3.9402009784769745
UACC-257,9911830,3.1260296610953513
SCC-9,136227924,3.721677265331546
DEL,sirolimus-bortezomib (250-1 mol-mol),-0.5963284229759003
CAL-51,9903786,2.1849161121493847
Hep-G2,24772860,-3.6408811512611137
KG-1-C,9911463,4.124800665042544
RERF-LC-A1,2729026,3.044350513676348
HCC1395,11404337,-0.1331965245654414
HuP-T3,54618771,0.8132197250487964
GA-10,151289,0.2012811235538998
NCI-H1703,11404337,0.332581718456744
DLD-1,151289,1.2067862264788165
G-402,JQ-1-UNC0638 (2-1 mol-mol),0.0069899032911466
TUHR14TKB,selumetinib-BRD-A02303741 (4-1 mol-mol),4.314671334917714
NCI-H2286,9903786,1.3981147995547691
253J-BV,11485656,2.0873911665192555
UM-UC-1,24753719,4.148551390379188
GB-1,54618771,2.0040836599793077
Detroit 562,753704,5.056788340203794
CL-11,11167602,1.668699813232642
SUP-B15,156414,1.1180314683979184
TE-5,24753719,4.174035669818234
A-549,24772860,-0.5810344959117316
SNU-878,327653,3.747079580265773
CAL-27,24753719,4.134679985346333
SK-LMS-1,46926350,-3.8599934013437434
HCC1195,9911830,3.5554387852718654
SNU-1196,148198,-2.167238950864192
C2BBe1,11404337,-0.9784657174077572
MEC-1,327653,2.805783862154475
BT-12,2729026,2.545868438749934
NCI-H1869,44137675,3.883775403499402
KG-1-C,148198,-3.394740607582078
BFTC-909,11404337,0.4468911705694049
Hs 683,148198,-3.2312790086257057
MOLP-8,136227924,1.5113872866650588
F-36P,136227924,2.476842028434826
MSTO-211H,6450551,1.5186693992042568
NOMO-1,100016,4.546215242968586
NCI-H2009,3815108,3.061482559784255
RMG-I,135984461,4.206545511526054
T84,71729975,0.6789587118033428
OVK18,100016,6.632788488948234
MOR/CPR,4259181,0.2734993531272701
BT-549,1716436,2.964006130486385
CAL-51,2729026,2.5757432896171517
HCC38,11485656,1.880745325077396
SNU-1041,3815108,3.860091892451264
OVCAR-5,4259181,0.5065591256292203
SNU-878,9868037,3.069026942604855
HeLa,100016,5.8653655502295
LCLC-97TM1,10385095,1.2595894653665305
SNU-1,151289,0.3962956023353094
OVCAR-8,100016,5.760214455598188
B-CPAP,4259181,0.2789779013360439
KE-39,2729026,2.715568279593477
LN-229,135984461,0.9798021343059176
KMRC-3,6450551,4.391846840701613
Hep 3B2.1-7,136227924,5.40641673036814
MOLP-2,3815108,3.0168942279913664
SF539,327653,3.3770394007544953
Kasumi-1,10302451,0.677780573615616
KE-97,327653,2.8684214732318094
CA46,327653,2.398308016277815
SW48,6450551,-0.0066484474606689
DMS 114,24772860,-2.222426128689729
BT-549,2708,5.415828272287544
VMRC-RCZ,JQ-1-UNC0638 (2-1 mol-mol),2.5074711750643996
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021
NCI-H1155,sirolimus-bortezomib (250-1 mol-mol),0.0856236991825952
HCC2279,11404337,1.1407968347244497
AU565,6918638,0.3564513775218086
NCI-H2052,54639665,-0.9573654652535992
HCC1806,9911830,3.548402491023982
KNS-60,11404337,-0.460790888098764
SNU-423,11167602,4.222331627049854
SK-MES-1,54618771,-0.0773843626642112
SNU-761,9868037,3.0815059044101822
KMS-12-BM,6450551,2.204544668217096
NCI-H1869,54618771,2.934235316942264
NMC-G1,3815108,5.45575599507398
KALS-1,54618771,1.5195853448840246
HuG1-N,156414,1.680497486867769
OE19,10302451,2.815743510977312
A2780,9911463,2.7303797257759235
SH-4,100016,6.480724052638794
WSU-DLCL2,9911830,1.368165043083695
COLO 680N,44137675,4.710639938196788
NCI-H1568,4259181,0.5766231269303183
MC116,44137675,3.996036994442279
Hs 936.T,11404337,0.4334403969580954
MOLT-13,9911463,3.0690071291401626
EFM-192A,1716436,1.4336657550769754
SK-MEL-24,9911463,3.297368561955771
NCI-H2110,73707371,5.04412555046355
Hep 3B2.1-7,selumetinib-BRD-A02303741 (4-1 mol-mol),2.249491244384491
MOLP-2,44493528,4.982078328127478
TE-6,136227924,2.9118612520968803
OCI-Ly3,327653,2.887990377015542
C2BBe1,6918638,0.4020582532011564
SW1353,11404337,0.8555790619059997
GSU,11485656,2.5421521977711135
Hs 688(A).T,327653,3.599815702688107
NCI-H322,9911830,3.326024724200298
MDST8,3815108,3.655140825789689
G-402,136227924,2.8538202085088185
BT 444,10302451,3.953897921649189
SK-UT-1,100016,6.311695779547894
OCI-AML-2,1716436,2.423029082405581
BT 416,151289,0.4993724992596378
MKN74,2729026,2.361059527438538
GI-1,4259181,0.0748069509367487
ME-1 [Human leukemia],100016,5.540349228215307
TE-5,10302451,1.837949927472816
OV7,135659046,3.534077236182633
JHH-5,49766530,-2.9566039137212137
SK-UT-1,9911830,2.8726761747893756
Hs 936.T,2729026,2.722667895416921
EFO-27,44137675,3.925812188621705
8305C,2729026,2.358496041408276
NCI-H1793,2729026,3.214392837640452
BT 145,9911463,3.096023169309247
G-401,54618305,4.431468655886698
KATO III,11167602,2.032256481829287
KYSE-30,6918638,1.557418868446986
SF295,4259181,0.2902320947492574
OVCAR-5,148198,-5.433409896244414
SNU-466,6450551,4.838358269077631
BT 440,46926350,-3.727097166710165
CAL-85-1,100016,6.683113656599713
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
ESS-1,9911830,2.1910771619648077
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908
SW982,135984461,2.5678712779652364
FTC-133,6918638,0.7173410835371117
SNU-886,2708,4.666368688758876
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
SU-DHL-8,124202324,0.904632550757724
CAL-27,49766530,0.710892933347092
BHT-101,24753719,4.428246432741456
HCC2218,327653,1.357600314803345
SH-10-TC,JQ-1-UNC0638 (2-1 mol-mol),1.5414740224774004
647V,148198,-4.071650146213555
OV56,sirolimus-bortezomib (250-1 mol-mol),0.4454120384496641
CW-2,1716436,2.5096377912600483
LCLC-97TM1,2708,5.63991197078878
NCI-H1792,9929138,7.3864021797267485
OV-90,100016,6.511633470460193
NCI-H747,10385095,0.9147538624065388
GI-1,9911463,4.305477844403804
RL95-2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.0151953631206852
RPMI-6666,24772860,-3.0440721419588503
YD-38,10302451,0.2221462011029107
SNU-1066,3815108,3.9112122029181178
NU-DUL-1,44493528,4.021728675000071
C2BBe1,46926350,-5.143212008080528
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
COLO 680N,10385095,1.9656390133911903
IMR-32,136227924,2.2103917598606326
COLO 678,2708,5.7182634190678945
BT 139,156414,0.911612783306993
OAW28,54618771,1.1011370240470315
BT 416,selumetinib-BRD-A02303741 (4-1 mol-mol),3.586228621763195
BICR 31,9911463,4.617619725588035
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
KNS-62,4259181,0.7585731297182399
DU4475,156414,1.2292286945344073
KP-N-SI9s,3815108,2.102427176142962
JHH-5,10385095,1.1597118706977676
JMSU-1,3815108,2.87906314369876
LMSU,9911463,4.298553287365515
BT-12,1716436,3.0981467033154133
MDA-MB-157,2708,2.34132544783096
HuP-T4,9911463,3.108892921619022
EKVX,135659046,3.5210765242905304
MG-63,9903786,3.648237948966595
ZR-75-1,327653,3.194009791572073
KMS-20,54618771,0.3177440488164709
IM95,sirolimus-bortezomib (250-1 mol-mol),0.6284965219885708
KMS-12-BM,374536,-3.694674622373437
BT 145,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6596943929584358
HCC15,151289,0.5818248951012718
Hs 611.T,2708,2.861727852355751
SIG-M5,46926350,-5.121747869995948
SNU-407,1716436,3.1802113520750948
EHEB,44137675,1.9983784239702664
SNU-8,136227924,2.992589463119238
SNU-449,4259181,0.6587440570439733
NCI-H1573,374536,-0.074649586673384
COLO 320,71729975,-0.2929489612015474
KNS-62,16013152,4.307930450821523
MeWo,4259181,-1.000732445958145
SW620,124202324,2.7132591918658604
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
JeKo-1,44493528,3.836571201329888
MDA-MB-157,49766530,-2.405889714389838
NCI-H522,54618771,1.252244709003548
HCC1419,10302451,2.8904756214047556
TE-11,100016,3.880053912311749
NCO2,11485656,2.116269191877006
JM-1,24772860,-4.004711239665373
TT2609-C02,2708,6.09185992649996
SKM-1,374536,2.026505336627946
Ci-1,44493528,4.267807025719403
GI-1,sirolimus-bortezomib (250-1 mol-mol),0.2030703478127671
BT 228,24753719,4.472096298736932
DB,tanespimycin-bortezomib (250-1 mol-mol),-0.1936867614029041
KMH-2,49766530,-1.67617119568669
SU-DHL-8,11404337,-3.4588929056554245
SF539,24753719,4.7612365798691405
TE-4,6450551,3.7476048921403535
SK-MEL-2,1716436,3.9824529155827655
NCI-H2170,sirolimus-bortezomib (250-1 mol-mol),0.3634507455744757
OCI-AML-5,2729026,3.1376692394463506
KO52,54618771,1.4631554759036511
BT 172,4259181,1.1172021573082116
DMS 79,654092,-0.4776212181346619
CAL-148,24772860,-2.1539314451622293
REC-1,1716436,3.388391652618184
COV434,selumetinib-BRD-A02303741 (4-1 mol-mol),5.688002190974135
MOLT-16,156414,0.7801911907074802
BT 504,9868037,3.967723190943412
SNU-478,156414,-1.265366418020168
COV644,selumetinib-BRD-A02303741 (4-1 mol-mol),5.082549137245942
WM793,2708,5.5820491292106516
KYSE-150,11167602,1.7294148916205108
COLO 684,9903786,4.137443964220156
Hs 888.Lu,24772860,-0.892128055207547
Mono-Mac-1,9903786,0.9536797288397608
D283 Med,151289,0.5549046196657793
COV644,10385095,1.9854494861644112
HuP-T4,10385095,2.091530291453941
CGTH-W-1,9911830,-1.7904254886383355
Hs 895.T,2708,6.6899784667145425
SNU-216,71729975,0.1345091184633045
Hs 934.T,49766530,-2.9625051950902455
CCK-81,9911463,3.2040299523214304
PE/CA-PJ34 (clone C12),327653,3.4791017722352815
COR-L95,10302451,3.773437494355592
SNU-761,148198,-3.4808535079888494
SF268,1716436,2.9406464665980807
SNU-410,9911463,3.9048002645235536
SK-CO-1,9903786,1.8148473241522671
MKN1,2708,5.004720090270962
SNU-719,11404337,-0.3522965671167558
MHH-CALL-4,9911463,4.039768304149654
VMRC-LCD,54618771,1.8324078419915515
PC-14,9868037,2.5861209247826644
SF268,JQ-1-UNC0638 (2-1 mol-mol),1.939243995240552
KMS-18,49766530,-2.077336380213563
SNU-1272,10385095,3.7094210277095274
PSN1,6918638,0.0567405704969879
HCC44,135984461,3.9649295662301585
BHY,JQ-1-UNC0638 (2-1 mol-mol),2.015646653404413
NUGC-3,135984461,5.20039455882723
Hs 611.T,9911830,0.7898774616432335
HCT 8,1716436,3.629695031244335
SNU-1041,11404337,0.704382749568953
UACC-257,135659046,3.626518059791559
KMBC-2,24753719,5.4446471977662245
JK-1,24753719,4.0136408647796165
OVCAR-8,44137675,4.51086639147155
Yamato-SS,4259181,1.112549648652854
TE-6,54618771,1.015505758549108
SNU-840,sirolimus-bortezomib (250-1 mol-mol),-1.042474975863496
SNU-C1,156414,1.7952824452797074
OC 314,11485656,2.060949002481836
MG-63,9911463,4.367195765244299
SNU-899,136227924,3.189426259363562
COLO 800,11404337,0.0903366557424785
HCC366,374536,4.64952890343297
SW1783,10385095,3.137926014779676
KE-39,10385095,1.3052459079941114
MIA PaCa-2,151289,1.9491714685560824
SNU-61,4259181,0.2985440005718957
SUP-T1,148198,-4.331447588752824
SNU-1196,9911463,4.32461924704032
KMRC-3,71729975,3.941586436761713
SW1353,24753719,5.958124958528096
HEC-251,9903786,4.825179909690824
MDA-MB-453,JQ-1-UNC0638 (2-1 mol-mol),-0.1830175507337199
NCI-H1581,654092,-1.7004928974698583
HCC1954,44137675,1.6159684859278507
BT 271,6450551,1.6352124935163377
Hs 940.T,11404337,-0.6222132136822929
BT 164,49766530,-0.4702645034832948
KE-39,54618305,4.948156947347383
BT 440,44137675,4.39574012550054
SNU-1,JQ-1-UNC0638 (2-1 mol-mol),-1.829484697646575
IGROV-1,9929138,6.483056540257463
UACC-257,10385095,1.15357102602932
Ki-JK,4259181,-0.8442803156053552
KMH-2,135984461,4.570908568849745
JVM-3,124202324,0.2402486619450604
BT 239,54618305,4.325444578852527
SH-4,374536,3.183860727333143
COV644,148198,-3.8315909355374607
Hep 3B2.1-7,9911830,1.7769280634909912
JK-1,3815108,1.7179061967701652
JHH-4,16013152,3.499271621402533
SNU-216,10302451,1.428515381214255
HGC-27,24753719,4.105970639778359
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
SNU-119,44137675,3.0443625578269096
HCC1438,11167602,2.937384581285184
Peer,sirolimus-bortezomib (250-1 mol-mol),-1.139363807048106
MKN74,4259181,1.058479464010789
OV7,44137675,4.254589887249724
CAMA-1,4259181,0.5315390076391365
NCI-H2172,148198,-0.2534137859754289
BT-20,10385095,0.9284855433615824
MHH-ES-1,9911463,3.923380979166965
HCC366,9903786,2.568010100247165
J82,16013152,4.170472178441978
Karpas-299,2729026,1.9323343788967708
CW-2,54639665,-0.4017445704850298
BV-173,753704,4.61610004338707
HCC827,44486093,3.738878114347266
Panc 04.03,44493528,4.362737332857046
NCI-H441,753704,5.010328780748505
SUP-T11,11167602,2.323687506743599
L-540,9911463,3.3305533835855528
MIA PaCa-2,44137675,3.4223653989045593
BT 179,6450551,3.606676662555525
NCI-H661,11485656,2.0326011859644075
SK-LMS-1,24772860,-1.5940075969157808
HCT 8,136227924,3.7452024891634785
RPMI-8226,24772860,-2.374641587089694
P31/FUJ,2708,3.1798246734444535
HCC2935,156414,-3.3183452375606572
NCI-H23,11485656,1.2913107211319887
TT,148198,-1.9923096051392415
SHP-77,1716436,3.0930679846039255
NCI-H1693,JQ-1-UNC0638 (2-1 mol-mol),0.5080161771188252
JIMT-1,54618771,0.8201229283888136
LS1034,54618305,4.642113072115868
BICR 6,2729026,3.2093317811431596
JK-1,2729026,1.3400985124655287
Panc 02.03,100016,6.582809568040202
Mono-Mac-6,100016,3.84240036835353
NU-DHL-1,71729975,0.4748567113914174
MOLP-2,11167602,3.580459987371732
YH-13,9911463,4.412003433189975
HCC95,654092,0.3489345732282578
MOLT-16,49766530,-2.0330031999498255
LS123,2708,4.499616305203706
Rh41,44493528,3.718016939158044
SW1710,11404337,0.2062189220113439
CJM [Human melanoma],JQ-1-UNC0638 (2-1 mol-mol),3.6691048943133753
TM-31,44137675,4.97447265179521
SF295,100016,6.949657377166824
SH-4,2729026,1.1866323340425942
Reh,654092,-1.5841586618701164
COV434,9929138,5.510182738323978
SNU-1077,4259181,2.3802371330202137
MKN74,24753719,4.72692215200023
MKN1,10385095,1.5634257957183793
Hs 839.T,11404337,1.04111897538683
Caki-2,374536,0.5977767618523634
SNU-81,44137675,1.234825635215107
UM-UC-3,10385095,1.4265186510957917
OCI-AML-5,46926350,-4.42221750780303
SNU-C2A,9911830,2.9981708324913727
SF539,11404337,-0.0923032150573938
A-375,148198,-2.551882325467432
WM115,148198,-2.543343591950365
A-549,136227924,3.1395144761786486
BT 498,136227924,4.389685115045935
Hs 766T,tanespimycin-bortezomib (250-1 mol-mol),-1.398950675536224
GA-10,selumetinib-BRD-A02303741 (4-1 mol-mol),4.834591707871012
DMS 79,9911463,3.344915999400502
BT 482,6918638,6.285533973123243
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
Kuramochi,54618771,2.421317406339968
COLO 684,11404337,-0.4632176529743375
Ku812,JQ-1-UNC0638 (2-1 mol-mol),-1.3299079938073646
SUP-T11,9903786,1.3476542683573176
IGR-1,tanespimycin-bortezomib (250-1 mol-mol),1.1267581666470343
MDA-MB-157,selumetinib-BRD-A02303741 (4-1 mol-mol),5.186273377251054
NCI-H2009,9903786,1.8298580590992315
SW1990,327653,3.573318417462307
TF-1,54618771,1.249031073864191
YD-8,6450551,2.2155909562952685
YH-13,327653,3.132127686900927
TE-14,10302451,1.496270675992236
WM793,10385095,0.6081370186912695
JHH-4,49766530,0.9310698609536
BT-16,100016,4.275534033025709
SaOS-2,135984461,4.8186429168984475
ESS-1,11485656,1.966597488234831
JeKo-1,49766530,-3.0518255026052454
OVK18,327653,2.633798721468076
UO-31,11485656,2.1661292847689944
Karpas-299,11485656,1.6568638130307944
SK-UT-1,24772860,-2.1685737338015505
M-07e,753704,4.196177956584847
NCI-H2286,24753719,4.826815158403235
NCI-H810,374536,2.4049279563777466
DEL,11485656,1.7732311398144052
VMRC-LCD,136227924,2.9641387298533868
JIMT-1,1716436,3.8024353465464182
OCI-AML-2,135984461,3.686177545558833
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
VCaP,24753719,3.942596689247525
SNU-C5,9911830,2.8374821007130206
SHP-77,sirolimus-bortezomib (250-1 mol-mol),1.6844110283136058
A-673,24753719,3.397650756866718
MDST8,54618771,1.2096098448968695
HCC1806,327653,3.4854765950585453
SK-UT-1,9911463,4.1504947350424315
NCI-H2087,10302451,3.0804347644462813
TCCSUP,9903786,3.558837088709428
G-292 clone A141B1,6450551,1.0157917708716409
CFPAC-1,1716436,3.681270165505168
U-937,327653,2.9204709055129365
NCI-H929,654092,-1.4076135504033414
Kelly,6450551,1.0860311548486437
SCC-25,54618771,-1.4085770807185976
COV362,selumetinib-BRD-A02303741 (4-1 mol-mol),5.87089539271988
NCI-H2291,10385095,3.0052020950396803
HCC366,11485656,2.823123661586525
SK-MEL-31,9911463,4.28610993232139
LS123,10302451,3.382571500430193
SK-LU-1,11485656,3.4042769893477023
KMS-26,11167602,0.2768125005658594
KMBC-2,156414,2.2596369338990976
OCI-Ly19,148198,-5.638964397793588
NCI-H1581,54618771,2.0706230217486468
HT-1197,46926350,-4.036388663695743
BT 228,136227924,3.2498510190278314
SK-MEL-31,6450551,3.479891770288908
AsPC-1,54618771,1.0442216511349782
HCC4006,selumetinib-BRD-A02303741 (4-1 mol-mol),2.5062410084067963
Karpas-422,11404337,-0.752603119365503
HCT 15,10302451,3.496013643332504
RT-112,327653,3.237746861222672
NCI-H1581,136227924,2.9082899651974734
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
OE21,10385095,0.8074841582682157
786-O,sirolimus-bortezomib (250-1 mol-mol),0.3515124224328601
RCH-ACV,54618771,-1.6129004186602771
PLC/PRF/5,9903786,4.947267974127204
WM1799,11404337,0.7575845894663391
FTC-238,11485656,1.7631950190895933
BT 444,54618305,4.416023109657525
DLD-1,4259181,0.6000897890539907
EC-GI-10,374536,3.468474079387167
Mono-Mac-6,3815108,3.983768441649259
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
SNU-410,11404337,1.1102019570699369
PK-1,24753719,4.344966881263849
SNU-C5,16013152,3.394707599905423
NCI-H1666,9911463,2.79017781981442
HCC827,44137675,2.5780557889574243
TE-5,24772860,-2.883651410476049
CAL-33,374536,2.9494572117238267
SIG-M5,6450551,1.6469806326118368
BT 147,11404337,-1.2546311246387
DEL,3815108,2.594930616733353
NCI-H661,9911463,3.595935737335879
WM115,49766530,-0.6421157759153451
RVH-421,46926350,-4.31065860615447
YD-8,9911463,3.690343271752708
Hs 895.T,1716436,4.277680465466805
NCI-H1105,JQ-1-UNC0638 (2-1 mol-mol),1.470468058571248
PC-3,100016,6.704789318152335
MOTN-1,6450551,1.2240373074242206
ESS-1,1716436,3.7627823141372874
PE/CA-PJ49,135984461,4.387949775407799
NCI-H508,49766530,-1.9711369921584831
OVISE,9911463,4.4041109725525525
CMK,148198,-5.18058405335292
JVM-2,9911830,1.797667981617692
KLE,54618305,4.289261640342655
SK-HEP-1,54618771,0.9570801540222316
NCI-H446,24753719,4.670302039262769
IGROV-1,9911830,1.9130562323799436
Daoy,sirolimus-bortezomib (250-1 mol-mol),0.3965851996199208
SW620,2708,4.469291535270044
KMS-12-BM,44137675,1.9058431411693373
SW1417,2729026,3.060757931679598
G-401,JQ-1-UNC0638 (2-1 mol-mol),-0.8221581174940659
IGROV-1,24772860,-3.2892316801587835
SUP-T1,9911463,3.1631435618556827
Tm87-16,11485656,2.0934920623366784
NCI-H23,151289,0.3341891950706012
786-O,selumetinib-BRD-A02303741 (4-1 mol-mol),5.83933819933193
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338
HCC15,49766530,0.5190445493569186
GP2d,24753719,3.999563090079058
SK-LMS-1,49766530,-1.7559370930712266
SNU-719,10302451,3.933124965880032
OV7,6450551,3.849262863871108
769-P,9911463,4.323897233798415
SNU-387,46926350,-4.010709181080464
YH-13,6918638,0.7209706519949683
SU.86.86,3815108,2.866570308421752
U-BLC1,11485656,2.1961180988259086
DMS 79,374536,3.368378711916207
SNU-1077,654092,-1.0014927314306907
BT-20,9911463,4.1322446502045285
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
COLO 205,327653,3.1447698331614857
KMS-34,2708,1.8358920731610084
SK-OV-3,2708,5.531711784720637
Hs 578T,136227924,2.600789152961688
PC-3,374536,3.6883052139313466
MKN74,4259181,1.058479464010789
NCI-H1975,4259181,-0.1828008143345393
IGR-39,4259181,1.0118736726180315
BL-70,9903786,1.6201088809137068
HCC1588,151289,0.8100916228309721
BT 147,4259181,1.073603835274746
TUHR10TKB,654092,0.3065005245454
BxPC-3,10385095,1.8732992891777025
RPMI-8402,9911830,1.9895553724691295
KNS-62,selumetinib-BRD-A02303741 (4-1 mol-mol),5.476760012277778
VMRC-RCW,selumetinib-BRD-A02303741 (4-1 mol-mol),6.553882063425284
TE-9,151289,0.7868867600433281
COR-L88,11404337,0.6108297700178786
MCAS,9903786,3.9207216019302007
SNU-1,2708,4.569753124109182
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
Daoy,2708,3.137038810969335
WM1799,654092,0.4230178760711833
HGC-27,10385095,0.038631327360896
JHH-5,6918638,1.17562922333198
U-BLC1,9911463,3.7218159913620887
MCAS,4259181,0.6276233805104566
OCI-AML-2,11404337,-1.0891062211328033
HCC15,9911463,3.642862209488471
KM12,10302451,1.390637807064829
SF539,1716436,2.913378639025297
SK-BR-3,46926350,-4.173892984913858
HCC1569,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7064531864566663
OAW42,46926350,-3.851405236672868
SJSA-1,10385095,1.3301881302452143
SNU-1079,1716436,2.5518661326018424
ONCO-DG-1,11404337,-0.4359581165609131
OE33,9911463,4.318006925608157
HMCB,136227924,3.0347930044007643
8-MG-BA,11404337,1.0898140469965
BT-20,9911830,2.435320622289844
SW620,44493528,4.454828902160922
MKN45,11485656,2.493574157806649
SNU-466,2708,4.491320224459201
SNU-761,tanespimycin-bortezomib (250-1 mol-mol),1.2423836146793283
NCI-H1703,selumetinib-BRD-A02303741 (4-1 mol-mol),5.219181395802378
IGR-1,327653,3.4717478303608655
T3M-10,2708,5.521175878151888
A-204,10385095,-0.0930629845983446
KMH-2,9911463,2.975818602931934
TCCSUP,44137675,4.277803621948158
Aska-SS,44137675,1.3416422792711555
F-36P,374536,0.4233765448194311
SNU-738,selumetinib-BRD-A02303741 (4-1 mol-mol),5.503954140833103
DB,11167602,0.5461148982527376
CAL-27,54618771,1.1214145254285035
HCC202,1716436,2.2396847854267428
JeKo-1,JQ-1-UNC0638 (2-1 mol-mol),2.321221810993542
NCI-H1395,11404337,2.1973197619817832
GSU,JQ-1-UNC0638 (2-1 mol-mol),2.2004135551382937
CAL-120,6450551,3.671444365946916
Capan-2,24772860,-2.1755418841577536
SNU-1033,6450551,4.4287775672397345
LP-1,136227924,2.2350423658008416
JeKo-1,54618771,0.9651230591785864
NCI-H1568,16013152,3.794215458313736
MIA PaCa-2,11404337,-1.8965485173920145
BT 187,2708,6.2752152756823305
KG-1-C,136227924,2.6958486075351944
ESS-1,54618771,1.2318880484657342
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
MKN7,10302451,4.64665224424522
SNU-601,10385095,1.2470698415779116
22Rv1,3815108,3.2771072510196113
CAL-29,2729026,0.1456472552270464
BT 482,6450551,1.7363773424224498
SK-ES-1,11404337,-1.5843384891531491
HEL,9903786,1.206049982415758
SNU-869,1716436,3.667359638054621
YD-8,44493528,4.2998537557563346
Sq-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1287409673737927
Hep 3B2.1-7,11404337,0.0289427466491547
NCI-H520,6918638,-0.4821268163650811
HT-1376,10385095,2.277565827704352
NCI-H1341,16013152,3.604313983587226
LS513,11485656,2.48053451645545
NCI-H2085,2708,5.04631768282038
SNU-245,JQ-1-UNC0638 (2-1 mol-mol),1.4173219227984324
HEC-1-B,4259181,-1.3712023171307914
YD-15,136227924,2.6934840054154834
AML-193,73707371,2.164482229688541
Hs 766T,24772860,-2.2597982369774443
MHH-ES-1,54618305,4.636026356107167
SUP-T11,54618771,1.250827086156436
KNS-60,11167602,0.3409321951638689
Kelly,24772860,-3.330150496467353
SW1463,44137675,3.7114847318755806
KMRC-20,10385095,2.891783125869015
SW620,10385095,-0.3354769525576651
SNU-1272,9903786,4.921324329124853
CAL-12T,4259181,-1.3475002263625786
HEC-1-B,3815108,3.715386751808956
CAL-78,135984461,4.031920307936069
G-292 clone A141B1,136227924,3.074698527992838
EJM,135659046,3.4058346184663693
ALL-SIL,327653,2.0915878780614623
YAPC,9929138,5.651296587688524
SNU-119,2708,4.611503362669174
SK-OV-3,9903786,2.611217845094376
KP-N-SI9s,11485656,2.178887968945585
SNU-878,10302451,3.582077732565662
OE19,135984461,5.542264217224972
CAL-51,9868037,3.5441777448678615
CAL-120,54618771,-0.541329282057163
Hs 578T,9911463,4.370366906905746
NCI-H196,9868037,4.869553170308075
LXF 289,54618771,-0.5375230222620658
SK-ES-1,1716436,2.386826444328191
HPAF-II,54618771,2.4967516753926216
HCC4006,10385095,0.8428128861435789
KNS-81,sirolimus-bortezomib (250-1 mol-mol),0.8491294280424774
EC-GI-10,6918638,0.7617636190742709
OE21,10302451,0.4947890408637831
LN-18,9911830,2.2683333599151254
MHH-CALL-3,2708,1.4799736431076884
IGR-37,374536,0.9176034794816106
COLO 201,3815108,4.060915637280979
CJM [Human melanoma],753704,5.890756897872801
HT-144,tanespimycin-bortezomib (250-1 mol-mol),-0.8683575179427937
JHUEM-2,2708,2.6131077375000196
SK-MEL-30,654092,-0.0800301670696543
A-375,374536,3.591388157416232
LS180,11404337,-0.0678179476465551
Hs 895.T,24753719,4.81444426124174
RL,44493528,4.146088733572883
KYSE-140,6450551,2.874882665468633
BT 245,9911463,3.0517796790400173
HEL,136227924,2.725456875957553
BT 245,11404337,-1.7449999203479594
MOLT-13,2708,3.5326953930382317
BT 159,1716436,2.884763066062879
MOLM-13,136227924,1.704251401840426
SNU-1079,54618771,-1.146333378136814
A-204,JQ-1-UNC0638 (2-1 mol-mol),0.2876726857387106
BT 231,6918638,3.0604187031451437
YD-15,124202324,2.1174247302685547
JHUEM-2,11485656,1.361181565006939
OPM-2,2729026,2.502425703285658
Daudi,44137675,1.0044684727898117
786-O,327653,3.776777557893351
NCI-H522,136227924,2.2034936459857506
SNU-761,9929138,6.284127493402678
SNU-1214,135984461,4.331180195663339
JHUEM-7,selumetinib-BRD-A02303741 (4-1 mol-mol),4.810620689703725
Detroit 562,2729026,2.2829602834368083
SK-UT-1,136227924,4.460190875137593
MHH-CALL-3,4259181,0.8022730547571968
KP-N-SI9s,9911463,3.657189132130691
SK-MES-1,148198,-4.042000221520934
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364
697,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1934944710354247
SR,3815108,2.201442264211337
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678
253J,4259181,-1.4081977312183471
697,11167602,1.3401738421970035
VM-CUB-1,151289,0.7616501822086222
SUP-HD1,9903786,1.2830576514216323
JHH-2,24753719,4.644854006308001
Toledo,54618305,4.370635560016167
NCI-H522,44137675,3.8599044567005434
LS180,148198,-2.644013472885731
JVM-3,151289,-0.9747262555724112
JJN-3,4259181,-0.711865550445762
Ri-1,374536,1.215254129911067
BT 228,44137675,3.298381522244784
T3M-10,16013152,4.099960029982373
BT 444,10385095,2.291363159248322
LCLC-103H,9911830,2.9324210354523195
Peer,2708,4.012156718816145
NU-DUL-1,11485656,1.905169788673151
SU.86.86,10385095,1.2045752824309466
IGR-37,9929138,7.412799255181445
A-549,753704,5.476427774826246
MFE-319,1716436,3.800957721302237
JVM-2,10385095,0.5822709341989288
NCI-H524,148198,-1.189369331000223
P3HR-1,44137675,3.063811429234895
SK-N-SH,4259181,0.0308340137854706
NCC-StC-K140,sirolimus-bortezomib (250-1 mol-mol),-1.963369351991784
HeLa,4259181,0.2156486881613415
HeLa,374536,4.0035832763140995
Capan-2,753704,5.654268419584611
NCI-H1568,1716436,2.664872339798973
ES-2,11485656,2.323063224970118
Hs 944.T,2729026,2.3326012397538363
T84,9911830,2.4807327035496662
Calu-1,10302451,5.51693152602978
CCK-81,54618771,1.3252136057849369
HCC4006,1716436,1.2388496207361142
CL-11,4259181,0.4150214368956425
Hs 766T,148198,-4.268636450980236
LK-2,1716436,3.9938263786664754
KMS-27,44137675,3.9560542315733738
COR-L51,9929138,5.641097380037884
A-549,73707371,7.165992114804081
SW1417,46926350,-3.704831362174934
OVCAR-5,10385095,1.4205658100211482
NCI-H1792,9911463,4.29249161845891
HuP-T4,374536,3.606528297857486
MHH-NB-11,156414,0.3603526018764347
BT 139,9911463,2.810742843963801
MDA-MB-468,selumetinib-BRD-A02303741 (4-1 mol-mol),4.702969188204742
JK-1,9868037,1.2248431410806535
NMC-G1,10302451,5.170100461056351
WM266-4,156414,1.6191743084759036
TT2609-C02,54618771,3.852922772730834
253J,54618305,3.985513491818871
EJM,2708,5.071772468532641
BT 228,151289,4.971547661447798
OVK18,654092,-1.3788724854849757
NCI-H146,327653,2.704686127708374
NCI-H1915,46926350,-4.0727115485524115
SUP-HD1,156414,1.2814810366686893
NCI-H1563,11485656,2.498309340246036
VMRC-LCD,374536,-2.6397150595741925
Panc 04.03,2708,5.3340089352485816
TE-8,9903786,2.2578315560817432
HCC827,9903786,1.5312362888468285
LN-18,4259181,-1.3558758274682057
NCI-H1339,151289,1.086653425019276
HT115,11404337,-1.1807464120641065
NCI-H2170,9911463,3.949150680542003
NCI-H1184,11404337,-0.3594338062101045
SNU-182,753704,4.046626955799094
NCI-H838,4259181,1.813760126667212
Pfeiffer,11485656,1.3826588653804326
SW1990,44493528,4.327134813333531
SF126,9911830,2.2004202096383194
Tm87-16,2729026,2.3685623753879854
KYM-1,11404337,-1.4539042664575286
SNU-685,44137675,3.9020710232153872
SET-2,46926350,-5.829442769281559
UM-UC-3,3815108,2.83034724692265
FTC-238,6450551,1.9617960169768265
DMS 454,6918638,-0.5364847082053857
AGS,136227924,3.766909782373439
FTC-133,9911463,4.36756965003986
Hs 746.T,10302451,3.5755968540448704
KMS-27,24772860,-3.008057341051857
SK-LMS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.250412004550364
DMS 114,9903786,5.060139909585821
COLO 205,4259181,0.4383947336306227
U-937,151289,-0.3856664700147835
NU-DUL-1,156414,0.3562766461235795
CAL-12T,10302451,-0.1514723125226502
42-MG-BA,9868037,4.648919905548912
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
NCI-H1155,10302451,3.872107344192631
MOLT-3,44137675,1.5912985564235815
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
SW1417,24753719,4.352651557823784
EHEB,124202324,1.636771857102227
SK-N-AS,54618771,1.0154959522530718
NCI-H1184,135984461,3.671317509665682
HuG1-N,374536,0.8897544472578539
SNU-423,selumetinib-BRD-A02303741 (4-1 mol-mol),4.623650435815717
RVH-421,73707371,5.110888301475437
GMS-10,10302451,3.793654439719216
HEC-251,2729026,3.106653341801665
GDM-1,54618771,1.3683939355818997
BT 172,2708,5.987541897401016
TE-11,10302451,1.4712971313049523
639V,49766530,3.725635459384192
C2BBe1,753704,4.927205972880587
KALS-1,2729026,3.0214039787916573
BxPC-3,24772860,-3.1359973170310993
CJM [Human melanoma],374536,4.565656968819476
LXF 289,10385095,0.5776298837700374
BT 232,6450551,3.5199211045957695
MIA PaCa-2,73707371,5.326975910300329
Lu-65,6918638,0.8216407628444748
NCI-H520,11167602,5.235788711953261
P3HR-1,753704,4.966690212095988
SNU-46,9903786,2.745048797484884
SNU-626,9903786,4.459436811322819
HCC1806,44137675,4.0083957529302925
DMS 114,9929138,6.976557704238316
SW1353,9903786,3.629285684044714
KHM-1B,2729026,0.9110795955585352
NCI-H929,135984461,1.9075332391524664
BT 504,1716436,2.231722818879149
LN-18,54618771,-0.903169975136804
LS411N,136227924,3.1900427132689724
RKO,6450551,2.9764230599456782
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
OE21,JQ-1-UNC0638 (2-1 mol-mol),0.7092763534327602
TALL-1 [Human adult T-ALL],11485656,1.8418453381137807
JHUEM-2,54618305,4.313629109650022
JHUEM-1,11167602,1.7927694326745718
COLO 320,10385095,0.1624567480450137
L-428,6450551,2.3471618079471215
Panc 08.13,136227924,2.4171431229910265
HCT 116,11404337,-1.072028422937356
MOR/CPR,tanespimycin-bortezomib (250-1 mol-mol),-0.9000697563150304
SNU-1,9903786,3.1259833622650315
C2BBe1,73707371,5.146456600066712
A4/Fukuda,1716436,2.785785051354721
HCC44,6450551,1.225842629386928
SH-10-TC,9911830,2.2874215720180464
NCI-H2081,10302451,3.961972444166296
LNCaP clone FGC,2708,4.692892865043915
NCI-H1703,11167602,-0.8464886698666326
SNU-478,2729026,2.6785001815472596
BT 320,JQ-1-UNC0638 (2-1 mol-mol),3.976442415564575
OVCAR-8,24772860,-2.851650832769237
UACC-257,11404337,0.2193965048118893
A3/Kawakami,156414,1.7639181798832415
SNU-5,151289,0.437785523718984
ESS-1,327653,3.2040700098938837
RMG-I,49766530,-2.064948903327457
Hs 611.T,49766530,-2.7427307114148545
GDM-1,136227924,3.363011715884638
NU-DUL-1,374536,1.2465866792233622
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
Toledo,sirolimus-bortezomib (250-1 mol-mol),2.5454023047541985
NCI-H810,JQ-1-UNC0638 (2-1 mol-mol),-0.4550575810344969
SUP-HD1,73707371,4.837514907738729
MOR/CPR,sirolimus-bortezomib (250-1 mol-mol),1.9515018462114049
NCI-H1666,44493528,4.3408217178767545
IGR-37,6450551,3.538187993545274
HT115,327653,3.079050830894509
TE-14,1716436,4.07265498806864
MDST8,9903786,2.958137426904596
KYSE-410,2708,5.464005595955719
PC-3,24753719,4.295930498728442
SNU-1077,9868037,3.077547755538649
JHH-6,11485656,3.907926018805903
HLF,24772860,-1.9699880886697656
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034
SNU-16,135984461,3.245976227672491
JHH-5,24753719,3.9547152551319567
HCC1143,24753719,5.247680835091332
OCI-Ly19,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6757944621359593
EoL-1,9903786,-0.1437472034571408
HuG1-N,327653,3.6334081946843506
M059K,44137675,3.7919642207639295
RVH-421,24753719,4.348289476497124
RD,54618771,0.0144347314731342
Panc 03.27,selumetinib-BRD-A02303741 (4-1 mol-mol),4.349236763215798
KO52,136227924,2.4006650771153923
NCI-H520,2708,5.51683926365148
Hs 766T,10302451,2.1536955794158668
GSU,sirolimus-bortezomib (250-1 mol-mol),1.8357391099692455
T3M-10,135659046,3.5498820327325875
T3M-10,11404337,0.3404159052495322
Karpas-299,100016,4.52969889794102
MDA-MB-361,tanespimycin-bortezomib (250-1 mol-mol),-3.253650081939563
LS123,100016,6.571994849278421
HCC1937,24772860,3.2370606761059713
TYK-nu,10302451,3.5311892845206123
NCI-H2106,148198,-2.940594124176384
KYSE-30,54618771,0.4265256767943792
BT 428,100016,4.306836909333982
CHP-212,148198,-4.905957419463446
SNU-398,9903786,4.103035354116066
YD-15,2708,4.333267456599628
HCC366,1716436,3.5658734937189087
NCI-H1666,100016,7.086863626956854
SNU-601,11485656,1.403357522956854
P12-Ichikawa,11485656,2.301138805430704
NUGC-4,9911463,3.797597719438973
U266B1,100016,6.458228016262307
EC-GI-10,327653,3.618269807161223
GA-10,54618305,3.7110732839259257
KMS-28BM,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7991300529966185
SNU-46,2708,5.968392341524591
KMS-27,24753719,3.911687472760716
NCI-H226,136227924,3.4351319272724585
WM793,54618771,0.892561932009902
IPC-298,148198,-2.1157958847718237
IST-Mes1,54618771,0.8929247318821524
253J,11167602,1.8529047716124176
G-402,151289,1.0899385610450962
SNU-5,124202324,2.278076041636707
SNU-245,JQ-1-UNC0638 (2-1 mol-mol),1.4173219227984324
SNU-1041,11485656,2.4138197522707383
SK-N-DZ,6450551,1.3880329544315455
NCI-H1395,49766530,-2.8850236043305792
HCC1806,136227924,2.6306602850580387
TOV-21G,tanespimycin-bortezomib (250-1 mol-mol),-2.720450448840342
COR-L105,136227924,2.729950058152846
YAPC,148198,-3.117185181322903
SW948,24772860,-2.2115718578693495
NCI-H1651,46926350,-3.451069216323595
RPMI-8402,148198,-4.480624262249758
T3M-10,54618771,0.7014662357085544
TTC-709,54618771,0.1325833030612315
HCC2218,11485656,1.6045404853234653
CAS-1,11404337,-0.7290961346307245
SNU-626,2729026,3.046244986768741
BV-173,151289,0.2570750794728873
NCI-H1092,10385095,0.6716651912361483
NCI-H1155,24772860,-2.585367236786541
Malme-3M,46926350,-3.658433778884547
NCI-H2228,9903786,2.418550241736446
IA-LM,49766530,-3.412847117105243
LN-229,11404337,0.1730765836405472
NCI-H2444,9868037,3.8466322726518256
DB,1716436,3.4915043236590497
HCT 8,10385095,2.576875256318049
EJM,136227924,2.8681258655198367
SNU-668,11485656,2.3773285837214444
NCI-H1395,6918638,1.485308761584704
TE-1,3815108,3.698135135790559
DMS 273,49766530,-1.3487399530522592
A101D,44137675,4.301974893045519
BICR 18,sirolimus-bortezomib (250-1 mol-mol),2.192378588292802
REC-1,2708,6.648601387442783
YD-8,10385095,1.4410870728115226
CL-11,9911463,4.035953193106903
U-251MG,54618771,1.0937916825211575
NCI-H1703,1716436,1.8466504543414697
LS180,327653,3.1909584751660973
Rh30,10385095,1.4974792753109163
Rh18,753704,5.034277326233849
IST-Mes1,327653,2.848745693869025
CAL-54,54618305,4.3484536151131135
KE-97,124202324,0.5572542384516758
NCI-H69,9868037,3.2675827879881556
NCI-H524,sirolimus-bortezomib (250-1 mol-mol),0.5181816489165546
DMS 53,9903786,1.7776029378286846
VMRC-RCZ,135984461,4.612343951091238
8305C,11404337,-0.9530165105805044
RERF-LC-A1,151289,0.7053307673930717
Ishikawa (Heraklio) 02 ER-,4259181,-1.51348893728215
BT 416,24772860,-2.3054453114917073
SW48,374536,2.9137455711630365
OAW28,753704,4.708152366597851
CMK,9903786,0.6507335736439642
G-361,54618771,0.3816147000987149
Fu97,54618771,-4.808914794700833
Hs 578T,6918638,0.545294838071351
A-549,100016,7.181380121169662
NCI-H292,54618305,4.4370648491662195
RERF-LC-A1,9911830,2.8330661508640542
NCI-H747,9911463,3.270591530161213
NCI-H2106,49766530,-2.15877326131524
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264
NCI-H1915,4259181,1.4857184154845886
NCI-H441,327653,3.4037680370042276
BICR 56,9911463,4.962922659402967
KMS-12-BM,4259181,-0.5634255522920182
PaTu 8988t,4259181,-1.3402011211504403
NCI-H1184,2708,2.9862822870174375
SIG-M5,135659046,3.608194247499591
MKN74,10302451,4.165847653983995
LOX-IMVI,374536,3.2599798177927823
KP-2,44493528,4.335007894737588
IGR-37,10385095,1.6634682367301483
PE/CA-PJ41 (clone D2),9911463,4.289796480511007
JJN-3,135984461,3.369618368566917
TE-4,124202324,2.9499612153231514
A-549,100016,7.181380121169662
UO-31,71729975,2.2837717347808173
Mino,136227924,1.7493984310197022
JHOS-2,6918638,1.6953141096129207
HuP-T4,156414,-2.045710295199573
SK-N-MC,2708,2.69792354614516
HEC-108,3815108,3.3299414273071273
SW48,44493528,3.8128145383765992
KYSE-510,151289,1.5856860037874574
2004,2729026,1.976205608765296
HCC1395,1716436,5.630836115528551
HEC-6,327653,3.024082416501414
Calu-1,9911463,4.35367590047306
HCC1419,156414,-1.6616800850124382
JVM-3,10302451,2.965184799004603
DK-MG,9911463,4.35158589399959
NCI-H508,1716436,3.4077003770271053
NUGC-4,156414,-3.830513888497556
JHH-4,4259181,-0.2871438619353636
KYSE-520,753704,5.023965350017259
NCI-H647,6918638,1.1619683266292729
KYSE-450,11485656,2.990129749938368
LXF 289,135984461,4.539632657840611
CML-T1,11404337,-1.4571467715346416
SNU-1105,44137675,3.063897567756704
GCT,753704,4.799800998787055
HCC202,11485656,2.3105434374490734
CW-2,44137675,3.861913917357568
KYSE-510,11404337,0.4094464488051804
NCI-H446,148198,-3.559974715415813
BL-70,11404337,-3.370287818653298
KU-19-19,9903786,4.470072542277405
CAL-51,24753719,3.9981702522006257
KYO-1,135984461,2.714539808295769
COLO 678,156414,-0.6332509558751841
Daoy,9903786,4.877795508066272
KNS-42,10302451,3.728146529938257
Hs 294T,54618771,1.144454520663973
OC 314,151289,0.625068375256002
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
COLO 699,136227924,2.9902058739506385
VMRC-RCW,100016,5.733604538717687
SUP-B15,44493528,3.997635669118944
DB,54618305,3.8621754509529262
KMS-21-BM,4259181,-1.425243005712458
A-253,10385095,0.7860799600541231
HCC44,54618305,5.3306637356323705
Mino,selumetinib-BRD-A02303741 (4-1 mol-mol),4.878986734293034
OCI-Ly3,JQ-1-UNC0638 (2-1 mol-mol),-0.6391350353766526
G-361,11404337,-0.7972280561087973
SF126,9903786,3.79320485000813
SNU-407,54618305,4.292854914169787
SK-MES-1,6450551,2.793295367167699
Li-7,156414,1.35161341660602
RKN,135984461,0.6080422026652917
HCC2108,4259181,0.1536721114746798
Pfeiffer,100016,6.236222400968574
SW948,136227924,2.9576701343794145
KE-39,10302451,3.0941257531868858
NB1,151289,0.437012704460796
SUP-T11,9868037,1.5602991106462112
VM-CUB-1,1716436,3.1478377397395425
JHOC-5,4259181,0.5152500246672413
SK-BR-3,49766530,-0.361082625264213
G-361,3815108,2.3973506494376777
NCI-H1793,selumetinib-BRD-A02303741 (4-1 mol-mol),4.680916311899612
CCK-81,327653,2.928466613082437
BT 139,44137675,3.208547495705803
SK-N-AS,327653,3.714692783839888
A-172,selumetinib-BRD-A02303741 (4-1 mol-mol),4.448022869219221
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
A-549,11404337,-0.2898707579606809
JVM-3,44137675,3.840505667116036
SW48,9903786,0.6824641791663469
SNB-75,54618771,2.061985596678881
Ku812,374536,1.5029739319713498
NCI-H2228,11404337,1.3876441913514168
SK-N-MC,6918638,-1.6031189268800108
IST-Mes1,JQ-1-UNC0638 (2-1 mol-mol),0.9628638270224468
KMS-27,selumetinib-BRD-A02303741 (4-1 mol-mol),1.1339783497693052
NCO2,4259181,-1.6856701146210389
KM12,3815108,2.9605401437437577
GSU,44137675,4.338315237110527
OE33,54618305,4.272506927413016
MDST8,54618305,4.422279328619345
SF539,148198,-6.422680321892083
ME-1 [Human leukemia],3815108,1.7940596279143997
RCH-ACV,11485656,1.6994895445887253
BT 416,24753719,4.37847280119279
JMSU-1,2729026,2.830966683546884
THP-1,1716436,1.164527947241687
HDQ-P1,tanespimycin-bortezomib (250-1 mol-mol),3.130731084653335
JURL-MK1,6450551,-1.803496613334559
EBC-1,10385095,0.7726573405677492
SK-MEL-24,1716436,3.6415447925726703
CAL-27,136227924,2.2169431722835324
BT 139,1716436,2.2745354204675667
MOLP-2,327653,2.910106907615282
Yamato-SS,1716436,2.453744831331092
CAMA-1,2708,6.975944656785998
TT2609-C02,1716436,3.70935198391604
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
L-540,100016,3.9234848652304097
KNS-62,2729026,3.2182517099633303
LS411N,4259181,-1.386635238211632
M059K,11404337,1.3426444842625342
HEC-6,4259181,0.4272977056155777
BT 440,6918638,3.62148033116424
2004,11404337,-1.336940767900643
KMRC-20,100016,7.210629640241846
ST486,327653,2.3248651822642734
PK-59,10385095,1.2934299374128844
BT-474,374536,3.467524619875936
KMBC-2,9903786,2.1846129600819353
GCT,4259181,0.217188934537872
JK-1,49766530,-2.0838340114086047
SW48,2729026,2.3283979545053155
HCC95,2729026,2.954013738372899
HT-55,10385095,1.4002254501907747
NCI-H2087,9903786,2.3520196427400717
KYSE-30,10302451,4.500697624442922
TE-1,sirolimus-bortezomib (250-1 mol-mol),1.4536947416119834
NCI-H520,151289,0.039040478566736
YD-15,4259181,-0.9565744428001864
SK-CO-1,327653,3.1822308576162692
NCO2,100016,5.1199760357582385
RKO,24753719,3.882573791668401
T3M-10,9911830,2.185392352919696
DLD-1,2708,5.116725923480377
MES-SA,10302451,4.142527408006535
CFPAC-1,24772860,-1.883570704311996
JHOM-1,11485656,1.6870772577759805
SNU-182,54618771,-1.075104843594332
YD-10B,9903786,0.9692609848682356
Hs 940.T,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354962123324142
CA46,49766530,-5.499020578204802
MV4-11,selumetinib-BRD-A02303741 (4-1 mol-mol),1.7152942113380312
Panc 03.27,54618771,0.0634128871766815
Rh18,6450551,2.2158692102216446
U2OS,3815108,3.122394452327091
KNS-62,135659046,4.2739779007754
DMS 114,156414,1.696613759181163
HMC-1-8,100016,5.583587343649554
KG-1-C,10302451,1.8404484115585815
KMS-20,11485656,2.050412836201762
NCI-H810,11404337,-1.324114158027616
BT-474,46926350,-3.6678762288963234
GDM-1,753704,4.569652523873731
NCI-H2141,11404337,-1.2716473405568056
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849
SU-DHL-8,9868037,2.223027391830787
ST486,2729026,1.857732795675916
SKM-1,136227924,2.5339244468963407
FU-OV-1,136227924,3.2834953568281597
HCC1428,6450551,3.591786442053999
NCI-H1650,124202324,3.4098480888997935
NCI-H1944,44137675,2.987105223017835
CFPAC-1,100016,6.545938487461667
HDLM-2,2729026,2.382728805197318
Hep-G2,11485656,-0.7210069253709863
JL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.114783834243625
BICR 6,151289,1.022239921705652
Sq-1,11485656,3.136931266066648
Mino,148198,-4.997781998015961
HL-60,753704,4.7748455509749395
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891
769-P,JQ-1-UNC0638 (2-1 mol-mol),2.0060153651533073
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
Panc 10.05,tanespimycin-bortezomib (250-1 mol-mol),-0.5396853932122618
Ki-JK,24772860,-3.522303414554251
SW579,10302451,1.116201799162962
DMS 454,2708,5.704980864081999
SW1088,3815108,3.443730447981211
NALM-6,1716436,3.0915962709257583
G-292 clone A141B1,156414,2.3907012362809623
NCI-H2052,44137675,3.93914542007801
SNU-C4,sirolimus-bortezomib (250-1 mol-mol),0.5711150121168962
NCI-H2023,9903786,4.254062749563359
HT-29,4259181,1.101372694592505
CGTH-W-1,2729026,3.0012182046739055
H-STS,11404337,-0.7903033287308603
639V,148198,-2.584767342306116
KP-N-YN,4259181,2.3669451828988612
PaTu 8988s,156414,1.7268071269453409
U-251MG,2708,4.467085015103141
COLO 684,JQ-1-UNC0638 (2-1 mol-mol),1.0146996616599124
LOU-NH91,10302451,4.426232341068122
Hs 936.T,10385095,1.5324384752571614
EJM,6918638,-1.326291213724497
BT-16,JQ-1-UNC0638 (2-1 mol-mol),1.980056798911896
SNG-M,156414,2.487976389206047
HuP-T4,100016,6.7159168289197915
SK-MEL-2,46926350,-3.526858160660795
MDA-MB-157,9911830,0.0801478348660684
NUGC-4,9903786,1.3800210436357438
MCF-7,753704,5.135051458428832
HCC1438,11485656,3.297814060039802
Hs 936.T,11485656,2.4154558200874803
OC 314,11167602,2.889183254159994
SNU-182,9911463,2.9412810978967867
SK-OV-3,9911463,4.2249846626647125
Karpas-422,10385095,1.106745644266175
SK-N-BE(2),44137675,2.9941039857009444
LS1034,1716436,2.473843546229987
P12-Ichikawa,151289,0.2265245024857755
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
ECC12,tanespimycin-bortezomib (250-1 mol-mol),-0.7458523006445992
NCI-H211,6450551,0.6391965821364272
CAL-12T,2729026,2.5589266634239554
KYSE-140,654092,-0.1825739700951138
CGTH-W-1,54618305,6.0196010994102815
UACC-257,9911463,4.265034719630062
YD-10B,6450551,2.718885996478702
SK-BR-3,44137675,1.2217485868546172
RS4;11,100016,4.815282587104974
SNU-C1,JQ-1-UNC0638 (2-1 mol-mol),-0.1489339940717722
WM793,136227924,4.7819042035619255
PE/CA-PJ15,16013152,4.170385211383189
HT-144,16013152,4.0214822090235645
Hs 746.T,327653,2.7924805493418567
KPL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.27324309908227
NCI-H661,24772860,-4.399665014096174
KNS-62,374536,3.629460605866128
AsPC-1,24753719,4.618559637878285
MKN45,10385095,2.790688226275196
MV4-11,654092,-0.6811324758012701
COLO 320,2729026,2.495755427511187
SUP-T1,24753719,2.6929520515821515
NCI-H1105,6450551,1.5310510452467678
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
EBC-1,9929138,6.205761956690981
ACHN,54618771,1.0716775131315517
SCC-9,4259181,1.940043087837339
Daudi,136227924,1.3476403322374937
NCI-H841,10302451,4.064570970847571
BT 147,54618771,0.8857496125783197
SNU-119,54618305,4.480526935824261
SNU-1272,4259181,2.0481969958420683
CAMA-1,11167602,4.874000698373902
FTC-238,49766530,-0.9457086114172378
JHUEM-1,73707371,3.865871672975358
KYO-1,327653,3.22619937571039
NCI-H1734,10302451,1.8692313112057235
CAMA-1,44493528,5.154958060978957
PLC/PRF/5,24753719,3.8725658441506368
HeLa,124202324,3.0083342437629708
HuP-T4,49766530,-2.034879085363831
BT 422,327653,3.2329647078391046
DMS 53,tanespimycin-bortezomib (250-1 mol-mol),0.0429262611809588
FTC-133,9911830,2.8814152307979946
MOLT-3,9903786,0.9925932748260368
MES-SA,10385095,1.0508846247548498
P31/FUJ,44137675,3.225768708166513
L-540,54618771,-0.836764308956379
CCK-81,1716436,2.7324061500197137
DU4475,1716436,1.5365844533545316
HuP-T4,24772860,-3.081981839686685
Karpas-620,11167602,2.9384748402816947
Rh18,2729026,2.145416249469362
MOLM-6,11404337,-1.8876803787246543
JVM-3,54618771,-1.0453450586020971
JHUEM-1,9911463,4.030543660927087
23132/87,2729026,2.918454228644193
BHT-101,9911463,4.450414123842211
THP-1,10302451,3.9077455908783856
RVH-421,1716436,3.7681726813822354
RVH-421,11404337,-0.9304733374413466
MOLM-6,151289,-0.191594110755076
GI-1,11404337,-1.291312367049636
KYSE-150,6918638,1.3155627931216132
GDM-1,54618305,-2.5154618566340323
HEC-251,135984461,5.040099547557525
NCI-H2009,100016,6.24887408197215
NCI-H1563,6450551,2.667054599227582
GB-1,49766530,-2.426410648312405
RL95-2,135984461,4.241681706125587
HT-1376,4259181,-0.3817300080320475
NCI-H2081,6918638,-1.1409095287475362
ECC10,136227924,2.5549710603978366
PE/CA-PJ15,6918638,0.9363103788474072
CCF-STTG1,100016,6.985278157575169
NCI-H2228,54639665,4.4666627207641065
T-47D,49766530,-0.4213805978343772
Panc 08.13,6918638,1.0573629526558566
GaMG,9911830,2.2746668067781486
SKM-1,44137675,2.6593794287267127
Lu-65,54618771,-0.448084270947246
EFO-27,2729026,3.178460421270277
NCI-H1435,9911830,2.666269312606889
KMS-20,135984461,4.215331371407202
YD-38,148198,-2.2054243046269044
NCI-H1373,1716436,2.724550382500996
Lu-65,9911463,3.1807959522129905
NCI-H358,10385095,1.945629004610518
YKG-1,1716436,3.7130114389790982
NCI-H2029,44137675,5.826872871908305
BT 216,49766530,0.8435993289862541
ME-1 [Human leukemia],54618771,1.2979456738996673
DBTRG-05MG,sirolimus-bortezomib (250-1 mol-mol),2.2547470483609637
PK-45H,54639665,4.450076753179179
NCI-H1944,sirolimus-bortezomib (250-1 mol-mol),1.314144105484395
RMG-I,1716436,3.2843382680644058
KP-N-YN,54618771,4.352699986589353
QGP-1,10302451,4.783649693632775
EBC-1,11404337,-0.1600536834306797
SK-BR-3,JQ-1-UNC0638 (2-1 mol-mol),1.372522523247758
MOLP-2,11485656,2.290738081221924
A-172,49766530,0.1361021615856843
Ci-1,2729026,2.8303844888034493
GB-1,327653,3.144088026604962
HCC4006,tanespimycin-bortezomib (250-1 mol-mol),1.0336276508061957
KMS-21-BM,6450551,0.5858214957382045
K029AX,4259181,-1.2018440065990823
SK-MES-1,136227924,2.193847007439744
COLO 320,4259181,0.6482581902948412
MDA-MB-453,24753719,4.38597739181452
HCC1833,selumetinib-BRD-A02303741 (4-1 mol-mol),6.847446627412621
T3M-10,49766530,1.7153212560254725
RD,135984461,3.5201159395246293
THP-1,24772860,-3.4400039947470913
DU145,148198,-3.066698935751989
OVCAR-4,10385095,1.0528960580780835
SJSA-1,9911830,3.7897570327927994
GOS-3,753704,4.989890215550621
NCI-H1915,6450551,3.564397055606924
SF539,73707371,2.192047905744571
SNU-620,49766530,-0.1917979569590051
SNU-1076,124202324,2.856927091883119
L-363,tanespimycin-bortezomib (250-1 mol-mol),-2.487698550401284
TYK-nu,327653,3.2225765861053506
SK-CO-1,9911830,2.5560928673864676
LS123,654092,-3.224807692198304
DEL,JQ-1-UNC0638 (2-1 mol-mol),2.165388290167217
WT2-iPS,tanespimycin-bortezomib (250-1 mol-mol),-2.960139188693383
NCI-H810,156414,1.380169056406662
LP-1,44493528,4.0079037689618815
NCI-N87,327653,3.392428289503534
HT-55,selumetinib-BRD-A02303741 (4-1 mol-mol),1.950695137388723
SK-MM-2,6450551,2.738969069423452
HSC-2,44493528,4.3031885175258475
NCI-H522,1716436,2.601362471636894
SU.86.86,654092,-0.0261985546095291
OC 314,sirolimus-bortezomib (250-1 mol-mol),0.336828605445857
OCI-M1,9911463,3.27082780782835
ChaGo-K-1,6918638,0.8510727110172542
NCI-H2087,6450551,3.476307552225245
HEL,2708,3.2519957529556716
MV4-11,24772860,-4.510581373197828
RMG-I,2729026,2.3154049767466836
SNU-407,selumetinib-BRD-A02303741 (4-1 mol-mol),1.534759509298901
SK-LMS-1,4259181,1.6246211060463709
TE-8,124202324,1.3296758496691568
OVK18,24772860,-2.175327924166279
EPLC-272H,9903786,1.2271384419186997
NCI-H1693,10302451,0.2338111119921639
HCC1954,11485656,2.196220765169822
BT 440,11167602,1.2625640094474482
ONCO-DG-1,136227924,3.186548860778023
Lu-99,2708,2.8412311363237905
TE-14,selumetinib-BRD-A02303741 (4-1 mol-mol),3.442750300003047
HCC1428,44493528,4.080046839622648
A-172,10385095,2.860957773873438
SNU-1033,374536,2.1253296894333595
NOMO-1,6450551,1.2307950565416117
SU-DHL-1,44137675,2.905771721153928
OV56,24772860,0.6577652773836704
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
HPAF-II,4259181,1.9900492431716317
HCC202,JQ-1-UNC0638 (2-1 mol-mol),1.977852516639051
NCI-H1563,136227924,3.549094897051017
A-204,24753719,4.486389218856005
DV-90,sirolimus-bortezomib (250-1 mol-mol),0.1354476911070701
TE 441.T,135659046,3.3291028889346066
MOLP-2,124202324,1.314568413024939
BT 145,11404337,-1.106330552835472
SUP-B15,11485656,1.8615959467984833
MDA-MB-453,10385095,0.8735195901829151
NCI-H358,136227924,2.8821870791202873
BT 416,JQ-1-UNC0638 (2-1 mol-mol),-0.1426012267621706
NCI-H2087,151289,1.6053570877631234
OCI-Ly3,135659046,3.630790427153339
769-P,148198,-2.315494485063685
NCI-H2110,136227924,4.625762146403413
SW48,49766530,3.606492941369466
EoL-1,136227924,1.175653355009707
ZR-75-1,10385095,1.3245901682852046
SNU-503,2729026,3.213184295503936
KMS-21-BM,124202324,0.388476458705525
FTC-133,135984461,4.350998124633342
NCI-H2342,9903786,5.089610325302681
SJSA-1,654092,0.4244759534691126
NCI-H446,124202324,1.4896524552370616
WM983B,136227924,4.383113443662036
BICR 22,54618305,4.315554591509874
NCI-H2286,10302451,3.84942208037586
MDA-MB-453,46926350,-4.337117227146235
NCI-H1573,9911830,2.169886437603078
NCI-H889,3815108,2.455955232467125
42-MG-BA,753704,5.518840310846055
A-204,9903786,2.6800363782821517
LN-18,135984461,4.397956692211827
NCO2,135984461,1.9525292456009808
BHT-101,4259181,0.1634706521315197
HCC827,374536,2.845596431232398
NCI-H1666,16013152,2.4131399000778635
MDST8,1716436,1.1500764778734351
COV434,327653,2.7172148793284094
COLO 792,9911463,3.3724671090253793
KP-N-YN,9911463,4.355119869591486
SNU-1,10302451,3.250909305490784
OCI-Ly3,148198,-4.419938902375586
TE-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.774357774762747
Panc 02.03,753704,5.09544361232119
G-401,374536,1.448879337840406
U2OS,9911830,1.6488004545095722
SaOS-2,151289,0.9278405880660672
CAL-27,9911830,3.339248730221888
RKO,9911463,3.963116579454927
SUP-B15,100016,6.907261874504965
MKN1,73707371,3.8420133696618266
Hs 746.T,11485656,1.8868493516636309
HCC1395,135984461,4.308264403922993
TALL-1 [Human adult T-ALL],9868037,2.0698659893863884
NCI-H1694,sirolimus-bortezomib (250-1 mol-mol),0.6427280207840891
HMCB,9911463,4.262652850494811
ALL-SIL,10302451,-1.1728976190372558
HCC-56,9911463,4.275331241701339
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
DBTRG-05MG,49766530,0.0162384250619963
ESS-1,10385095,0.0154495368261296
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
RPMI-8402,124202324,0.7809027378037724
TF-1,148198,-5.222866140328133
SNU-1079,11485656,2.444580254592115
Panc 04.03,135659046,3.760242578723066
F-36P,9903786,0.2788806994422486
TE-10,11404337,-0.3956055748669924
BT 131,135659046,3.687491752801227
CAL-54,6450551,3.595739128468546
JURL-MK1,JQ-1-UNC0638 (2-1 mol-mol),0.7154427520276402
RPMI-8402,327653,2.524650226639341
U-937,11167602,1.9406749416671407
PSN1,327653,3.415730458851978
JHH-6,11404337,1.87275396496971
Hs 766T,10385095,2.0923812413059992
NCI-H1581,4259181,0.5053402023869984
NOMO-1,44137675,1.7607667559168472
NH-6,1716436,2.990586639050882
NCI-H1755,tanespimycin-bortezomib (250-1 mol-mol),-0.7433958922894784
NCI-H23,24772860,-3.217864764201672
SU-DHL-4,11485656,1.626108094127111
HCC1438,JQ-1-UNC0638 (2-1 mol-mol),2.228151579031515
A-375,9911463,4.039687099931349
HCC1833,11485656,2.071891952669738
NCI-H1693,49766530,-2.9408096951220384
KMS-12-BM,654092,-2.2721779873504224
EoL-1,24772860,-4.421397988751503
LP-1,2708,5.18278855176843
GCT,9911830,2.6925449491003755
C2BBe1,9911463,3.464782033118563
Panc 04.03,44137675,4.02019355498934
COLO 201,9929138,6.828783569682717
TCC-Pan2,654092,-0.7930560777321752
Hs 852.T,selumetinib-BRD-A02303741 (4-1 mol-mol),2.607109640073044
HEY A8,54618771,0.8975201265586629
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
NCI-H841,selumetinib-BRD-A02303741 (4-1 mol-mol),6.616690293035314
KP-2,10302451,4.044083771623064
KMS-26,24772860,-3.367525017190178
SF126,327653,3.680322233248929
Panc 04.03,9911830,2.4999304852863404
Hs 746.T,46926350,-4.647433614544131
ECC12,151289,0.5348690467555489
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
Panc 05.04,10302451,2.631724593174731
KNS-42,16013152,4.230775269462075
JM-1,9911830,1.0886367976495992
KE-39,156414,4.025830312298652
LC-1F,4259181,-1.2761645262124546
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
Hs 822.T,selumetinib-BRD-A02303741 (4-1 mol-mol),5.899949637825784
SIG-M5,135984461,4.131261553814095
786-O,10385095,1.074274496181899
MFE-296,16013152,6.27008265447619
JeKo-1,10302451,3.7878208830718862
LS123,124202324,1.9046622509614484
LK-2,156414,1.7745779166627789
JMSU-1,148198,-4.3097725771524225
MDST8,327653,3.1544218347658375
HCC1195,9903786,3.7437324544379487
NCI-H292,9911830,2.887423578139022
SNU-245,11404337,1.1841340979823434
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
MOLM-6,100016,5.4880920806856865
TTC-709,374536,2.464209943291182
BT 228,156414,1.710173414440736
DMS 53,JQ-1-UNC0638 (2-1 mol-mol),-0.4153391039905905
Daudi,9929138,3.458684768924583
KYSE-520,6918638,1.4732887931926149
HCC1954,10302451,1.381919447819224
HT-29,2729026,3.016933977850852
NCI-H1435,3815108,3.6120925730427462
BV-173,654092,0.4979263179669975
Hs 578T,JQ-1-UNC0638 (2-1 mol-mol),0.8827750270624418
BT 333,2708,5.822864274343857
Detroit 562,135984461,4.371525738638509
ME-1 [Human leukemia],1716436,2.2185370595077045
SNU-C4,11485656,2.7013405303612408
SNU-216,327653,3.2539044842694183
VM-CUB-1,374536,5.006947250013233
OVISE,148198,-3.4121309130102055
NCI-H1693,11485656,1.8796712280136327
8305C,124202324,1.8072898216465532
DAN-G,9911830,2.362643332226753
GSS,10385095,0.9297454334410128
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
OCI-Ly19,46926350,-4.671862996277618
L-540,3815108,2.4971814381506245
KMRC-20,3815108,3.353399483495532
MCF-7,327653,2.921277434210666
BT 504,2708,4.541496394952082
SNU-423,10385095,0.9709432237153084
KMH-2,327653,2.6435192789338724
Panc 04.03,49766530,1.2448845141630578
RERF-LC-MS,9903786,2.6182355767545213
HCC1806,9903786,3.5202039340354636
EJM,46926350,-5.52167397488298
JHH-6,2729026,3.2014894182468163
T84,1716436,1.840058680235384
Calu-1,16013152,4.996425837572467
SW620,327653,3.021193441393605
WM266-4,tanespimycin-bortezomib (250-1 mol-mol),-3.087265381880702
COLO 699,73707371,5.214303267456427
5637,54618305,4.243965384291741
SNU-685,11404337,-1.4693578983295623
BT-474,9868037,4.006182036110513
TC-71,148198,-5.123045083168725
T-47D,sirolimus-bortezomib (250-1 mol-mol),1.0675161294174855
KE-97,148198,-2.582378915330286
DND-41,327653,2.6177902685494834
HOP-92,148198,-3.4956728974738756
EKVX,11167602,3.3348952564527865
MM1.S,4259181,0.3083006728289762
TE-1,tanespimycin-bortezomib (250-1 mol-mol),-1.7455027047349927
HCC44,44137675,1.3674106990549282
Tm87-16,11404337,-0.2481919010875855
NCI-H1693,6450551,3.6020757972052246
EC-GI-10,10385095,2.518396307471165
COLO 829,6918638,1.0233016863586175
ZR-75-30,9903786,5.791062866548605
ECC12,136227924,3.114580380384796
KYSE-510,100016,5.186546688011686
NCI-H1155,54618771,1.281458310238897
CCF-STTG1,2708,5.83554362826176
RERF-LC-MS,2729026,3.1361811776879644
A-498,selumetinib-BRD-A02303741 (4-1 mol-mol),2.466660305447313
TYK-nu,654092,-1.5610145919703686
RD,11485656,1.6123587927279353
COLO 205,6450551,1.151866696376116
EFM-192A,4259181,0.6735686495327354
NCI-H747,11167602,2.3003371875721323
IMR-32,135984461,1.157056096731398
Daudi,2708,2.1654486353587266
LNCaP clone FGC,100016,6.505127339133147
SNU-1077,11404337,-0.4720370259421129
CW-2,10385095,1.8686327254160755
Malme-3M,6918638,1.0970595783496475
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388
HCC1438,9868037,4.0008009235248005
SHP-77,11485656,2.0449362643576854
22Rv1,10302451,3.5915895791665746
TC-71,54618771,1.220599365734416
KMS-27,10302451,3.849053848839269
NCI-H1373,135659046,5.766842578733638
HEY A8,24772860,-3.017962937595702
EFO-21,10302451,4.310388254749294
BICR 16,11485656,3.0485171549819476
BHY,136227924,2.366046867351899
BICR 56,6450551,4.508583910064371
ECC10,654092,0.359825476731589
COR-L51,11404337,-0.9884929367070868
BT 444,156414,1.6442847888531638
WM88,24772860,-2.263338691376954
KE-37,4259181,-0.5515633382074134
NCI-H2023,9911463,3.271912940774434
HCC4006,11485656,1.7497368979267094
NCI-H2110,54618771,2.4596551535175504
AMO1,44137675,4.2621345465158225
TE-9,24753719,4.526239655009243
SUP-B15,10302451,1.4777499767205602
DBTRG-05MG,44137675,2.129839393707218
HuNS1,151289,0.4174144499948718
CAS-1,124202324,2.104068105448661
HCC1569,sirolimus-bortezomib (250-1 mol-mol),0.3856699137888855
OC 314,374536,1.2810674669459376
BL-70,selumetinib-BRD-A02303741 (4-1 mol-mol),5.080029485351211
RERF-LC-Ad1,4259181,1.1969151495318886
NCI-H727,9903786,3.725485605999375
TC-71,49766530,1.0136455106007916
AGS,124202324,2.848661039624227
CML-T1,11485656,1.9899616795432975
HCC2108,374536,3.656255875705604
NCI-H929,24753719,4.216810454357832
HCC1500,11485656,2.6610961572019103
TM-31,24772860,-1.7005816443712594
Kuramochi,11485656,3.4177082965516328
NCI-H660,71729975,0.2920848846281965
NB1,2708,3.5039715268157843
NCI-H2228,49766530,-0.2388260531706088
A-549,9911830,2.245916242551202
RS4;11,3815108,0.9283167947954354
P-STS,1716436,1.7955091943125692
NCI-H2085,4259181,0.4906519027073793
42-MG-BA,49766530,-1.7138070922942703
MOLP-8,2729026,2.779201693602774
MFE-296,1716436,3.628559981444792
HCC1833,1716436,1.3578944478620694
TE-10,148198,-2.165511242505793
WM115,6918638,1.2765614986990457
MFE-319,46926350,-4.138900404614356
RVH-421,2708,5.1791480989766985
BT 245,24772860,-2.1859286876708035
RVH-421,11485656,3.351347691760053
EJM,9903786,2.5710642236856818
BT 504,49766530,1.1284892746391262
U-937,24753719,4.219333200465045
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428
Pfeiffer,44137675,-0.2611834055085357
NCI-H23,156414,1.2888959311526778
BT-16,54618771,-1.2134331946377312
SK-MEL-1,1716436,3.820132210959846
SNU-878,151289,-0.700326747674137
HEL 92.1.7,136227924,2.7818707499809188
HuT 78,24753719,4.53725590635391
DU145,11404337,1.4411442495527176
CAL-33,148198,-4.199943057412928
NCI-H1915,11485656,1.946470366394693
Mino,100016,3.8828597807205023
BT 248,selumetinib-BRD-A02303741 (4-1 mol-mol),5.279106159978606
HCC15,11485656,2.480533785053976
SK-LU-1,3815108,3.2616265579045702
MHH-CALL-3,10385095,1.4473660892521885
RL95-2,11485656,2.119003838335733
MDST8,11404337,0.5498361952050128
BT 422,6450551,3.6759349472172818
TM-31,6450551,1.6042843524977906
Panc 10.05,2708,5.635954642409902
CAL-85-1,753704,5.0895025339233095
DU4475,9903786,2.594571624962549
DMS 454,11404337,1.0460109741609804
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
NCI-H661,9868037,2.6835007144938032
SaOS-2,71729975,2.29546286795302
JHOM-1,374536,-0.4379800773805031
NCI-H2081,753704,4.35902455138568
YD-38,124202324,1.7206527447558553
HT-55,44137675,3.1216842958952227
LNCaP clone FGC,9911830,1.9985262700964304
SK-OV-3,11485656,3.3782074628341894
FTC-133,46926350,-4.117104249862265
Hs 578Bst,9911463,4.212238001895026
HLF,tanespimycin-bortezomib (250-1 mol-mol),-1.3704475916887384
KP-4,327653,3.0161374219123727
RERF-LC-A1,9868037,1.4970424039127654
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
TT2609-C02,44137675,4.376712200187487
Karpas-620,135984461,2.8856459263707213
CAL-51,11404337,-1.4033364127444676
COLO 829,44137675,4.4799238893526585
BT 422,6918638,3.528900316043955
A-549,100016,7.181380121169662
SK-BR-3,11485656,1.9391537366026357
GB-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.7476578532230755
GCT,135659046,3.4332962928318893
MHH-ES-1,124202324,1.5748338770735049
SNU-1079,136227924,2.5648904820695693
VMRC-RCW,2708,5.811082677392248
697,2729026,2.1872626935322734
Hs 940.T,6450551,2.230188218028444
SET-2,753704,4.217890366544489
QGP-1,10385095,1.9081018172996016
OAW28,10302451,2.68651474445359
SET-2,156414,0.9354500438685124
LNCaP clone FGC,11167602,1.6735547882241617
LMSU,148198,-4.18626130759339
SW1116,54618771,-0.9904180488449444
TE-5,10385095,1.0844383451266395
FTC-238,4259181,-0.2851243695387588
VCaP,156414,1.5741450298899773
COLO 829,374536,4.862629225957209
BT 333,10385095,1.869788440737833
SNU-1196,10302451,1.5502793512476396
SW982,46926350,-3.7964983245202943
MOLT-3,374536,-0.4172774640629056
NCI-H520,9911830,1.0152339024945511
MHH-CALL-4,11404337,-1.4992681274735582
NCI-H1734,9903786,1.4575898804478404
HCC2218,1716436,1.618358710169954
Hs 888.Lu,tanespimycin-bortezomib (250-1 mol-mol),0.5097438432490347
BT 333,9868037,4.601052403948759
Yamato-SS,24772860,-1.852471968632109
Hs 578Bst,10302451,3.7780341903913848
Tm87-16,24753719,4.184606573495666
CML-T1,124202324,0.7419542279604492
253J,3815108,3.079497668712548
CAL-148,11404337,0.0721234409222233
SYO-1,10302451,3.63681748537988
SK-UT-1,16013152,4.42318413525966
HCC1438,327653,3.873621877618888
HEC-108,54618771,2.78064765565191
SNU-C2A,9911463,4.1542386249666094
HT-144,2729026,2.5979909006316464
JIMT-1,124202324,3.4672374850401284
AsPC-1,2708,5.587707055847425
NCI-H1869,6918638,1.090174259453097
Yamato-SS,374536,3.5103420056647896
HOS,6450551,3.4072631331277448
LUDLU-1,9911463,2.6555573112592494
NCI-H727,3815108,3.498449156165097
COLO 205,tanespimycin-bortezomib (250-1 mol-mol),-2.2778936602109483
COLO 800,1716436,2.4390064930558175
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883
NCI-H1694,156414,1.085717982075386
HPB-ALL,3815108,3.2937153926668556
SUP-HD1,24772860,-2.9198827607626554
COLO 201,sirolimus-bortezomib (250-1 mol-mol),2.3709690887392516
IM95,151289,0.6481053364206861
NCI-H69,136227924,3.1937315471147443
SNU-503,6450551,4.924629844786596
NCI-H1838,654092,1.1796616715849724
EoL-1,9911463,2.487921562669019
HEC-1-B,136227924,3.6469104939920154
BT 245,selumetinib-BRD-A02303741 (4-1 mol-mol),6.290408046736785
YD-15,3815108,3.18725300888999
PE/CA-PJ15,44137675,2.851716707756922
HMC-1-8,2708,5.787450779615794
BT 320,11485656,3.3413754154715796
SK-MES-1,11485656,2.7243488930071607
KMS-12-BM,148198,-2.3401169496211778
SW579,sirolimus-bortezomib (250-1 mol-mol),0.6765835324099176
Ri-1,11485656,1.6570467994982818
NCI-H661,654092,0.3537062860674825
OVCAR-5,9911463,3.385912841679363
8-MG-BA,6450551,2.0103310344891168
Capan-2,10385095,1.6516866773102918
Kasumi-1,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9385486820489295
HCC1500,11404337,-1.1638452247583002
SNU-410,9868037,3.710526937668442
Lu-99,11167602,1.8840831812456384
LK-2,54618305,-5.911740174807013
BFTC-905,JQ-1-UNC0638 (2-1 mol-mol),2.295529954383562
KMS-34,44137675,0.9623307498851286
SNU-626,3815108,3.197702009634793
HCC1428,16013152,4.110702409037189
NCI-H322,100016,6.362238943247445
NH-6,327653,2.9210802264449445
KMS-21-BM,9911463,2.539829104515626
COR-L88,46926350,-4.354504637592192
NCI-H2228,9868037,2.633347793828571
Raji,136227924,2.5188827267380116
MCAS,2729026,3.0980354631151883
BHY,1716436,3.0278541650554325
T-47D,24772860,-0.711798060710614
Hep 3B2.1-7,3815108,3.427138188438471
TTC-709,9903786,2.3304378522453866
DND-41,6918638,-0.9223144661019224
HCC827,11485656,1.9566672010968855
L-540,24772860,-3.777979453517287
TTC-709,9929138,5.828368594409336
JURL-MK1,44137675,3.749328397288097
SNU-16,151289,-0.441493000955797
SNU-182,selumetinib-BRD-A02303741 (4-1 mol-mol),4.335054083163596
COLO 201,327653,3.050776662774606
KMS-26,135984461,1.0857498172669495
CML-T1,JQ-1-UNC0638 (2-1 mol-mol),0.1970824478028413
22Rv1,11485656,2.087552873694697
HCC1954,9903786,3.647576872659031
SNU-1272,11404337,1.107901220459772
NCI-H2342,1716436,2.639018004569244
A-204,6450551,-2.3720057497468203
MOTN-1,374536,1.4798177744273358
KMRC-1,2729026,3.101959850286169
SW1417,10302451,3.631964421069336
KMH-2,151289,-0.4757556797265575
NB4,100016,6.294523599868374
SNU-16,11485656,1.507998082337787
EBC-1,148198,-1.529856681948531
GI-1,24753719,4.3958442293343305
IST-Mes1,11485656,3.5408910362273835
LS513,135984461,3.023375368580486
KYSE-30,9903786,5.462463083669851
D283 Med,6450551,2.1323753590226686
MV4-11,1716436,1.5774561262341125
WM266-4,135659046,3.439590672760098
SCC-25,16013152,4.26893227216868
UM-UC-3,2708,3.324211247745314
OC 314,2729026,2.998132040191627
SIG-M5,11167602,1.4551156840002482
COV362,54618771,1.3077362978490088
NCO2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.4968282558437219
OVCAR-8,49766530,-0.1649030183556315
KALS-1,9911463,4.316842396735623
KMRC-1,24753719,4.192591897270876
SNU-5,2729026,2.922096407456526
SNU-475,11404337,1.9630553602139893
NCI-H2085,2729026,2.314553062345401
HT115,54618771,0.5275869701844733
MOLT-13,148198,-2.9272995134597157
COLO 668,sirolimus-bortezomib (250-1 mol-mol),1.0327595793559854
BT 286,1716436,2.8152439824486244
NCI-H1869,148198,-2.251684124095355
COLO 829,9911463,4.4284990844241126
JVM-3,374536,1.6916593951658374
CAS-1,4259181,1.2102737727072803
MFE-319,10385095,0.9790688990862756
8305C,tanespimycin-bortezomib (250-1 mol-mol),1.1491228196694627
SKM-1,9868037,0.7505046314280106
NCO2,9903786,1.4505958737560818
SCC-25,9911830,2.7876324164703736
KP-N-SI9s,2729026,2.2828187796625183
Panc 03.27,10302451,2.8157600725630285
SaOS-2,753704,5.53840358060444
NCI-H2444,49766530,-1.881288849348997
GMS-10,2708,5.42375963792899
JL-1,10385095,3.307622791524891
JHUEM-3,24753719,4.082083068058561
Hs 895.T,54618305,6.468585963277805
KYSE-70,327653,3.7336437717951103
JHUEM-3,327653,4.2565613639882525
SNU-C5,151289,1.8725177522862948
IGR-1,1716436,3.053946554252675
NCI-H747,135659046,3.644022415013725
NCI-H1105,10385095,0.6230711413041305
MCF-7,10302451,6.463530538408448
RKN,1716436,3.648262431092988
KYSE-520,10302451,2.683760674034906
SNU-899,11485656,2.609975330684587
SET-2,1716436,3.333075721211582
A2058,148198,-2.943445139558103
MEC-1,6918638,-1.2393643982661684
OCI-M1,753704,2.7515273583684583
TUHR4TKB,sirolimus-bortezomib (250-1 mol-mol),1.666673224601644
MPP 89,sirolimus-bortezomib (250-1 mol-mol),1.5945655725799224
CAL-12T,3815108,2.722464637008455
BT-16,44137675,4.682801497227278
NB1,9911830,2.845476067890297
NU-DUL-1,11167602,1.4420689285823494
GDM-1,327653,1.6980121732900797
NCI-H2286,2708,4.165652476104929
TE-10,10302451,1.870187527499395
FaDu,16013152,3.952634972633592
MEC-1,44137675,1.429862143500774
BT 231,151289,0.783350278693398
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316
Hs 729.T,tanespimycin-bortezomib (250-1 mol-mol),1.0644356767516514
LK-2,sirolimus-bortezomib (250-1 mol-mol),0.5771573831788563
COR-L51,24753719,4.364015816260333
HuT 78,44137675,1.3553085189057965
JJN-3,9903786,1.1978093816271655
Ci-1,11167602,4.192862947655439
HLF,136227924,2.390310427445978
YD-10B,54618771,-0.547775158029887
PC-3,6450551,3.858841073378308
C2BBe1,11167602,1.733240679037377
HEL 92.1.7,374536,-0.8650910380411433
CMK,JQ-1-UNC0638 (2-1 mol-mol),-0.8671204026506125
JHUEM-3,9911463,3.690046931710037
JMSU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9678894652146584
WM88,24753719,4.471197406675096
NCI-H727,11404337,0.8145711342672778
BT-12,tanespimycin-bortezomib (250-1 mol-mol),0.4298883528890555
HOP-92,135984461,4.9526709086531415
TT,54618771,0.4529536382950971
KU-19-19,54618771,0.4920305765445359
HT-29,selumetinib-BRD-A02303741 (4-1 mol-mol),5.022972417954181
Hs 746.T,6450551,4.310918640042312
697,374536,-2.9220475563213095
MHH-CALL-3,44137675,1.60816084217575
SNU-C4,54618771,0.9535591955957128
SNU-201,selumetinib-BRD-A02303741 (4-1 mol-mol),5.519563970872631
WM1799,2708,5.353855840321326
IST-Mes1,24753719,4.106786270688489
OVTOKO,4259181,0.8127160476513252
JHH-5,4259181,0.4721409889584527
CHP-126,11404337,-0.8425306912863763
RMG-I,11404337,0.6551142499064945
COLO 680N,4259181,0.0202986259192109
D283 Med,100016,3.728925578699804
CAL-27,4259181,0.0205363318924195
Hs 683,24753719,4.249788601430605
CAL-27,10302451,1.505930195385636
Hs 936.T,10302451,3.751378963953563
L-428,11404337,-1.5944494988953837
RERF-LC-Ad2,327653,2.6151456371110404
BT 231,24772860,-2.67844720532028
KE-97,10302451,3.3442916828036675
SU-DHL-4,753704,4.351430526327723
KATO III,148198,-3.9142793385091186
SW48,156414,-3.5613148313114293
SW1990,11404337,0.292005149466272
SKM-1,4259181,-0.1122232838107409
CAL-54,148198,-3.3099024859791286
VMRC-RCW,10385095,2.320143164196655
OE21,6450551,3.896590607543263
KMS-20,136227924,2.296093636743899
IGR-37,44137675,4.5147656758908745
KHM-1B,JQ-1-UNC0638 (2-1 mol-mol),-0.1764853483992549
Fu97,tanespimycin-bortezomib (250-1 mol-mol),-2.3506071651033733
JHUEM-7,11404337,0.6000529311141187
OCI-Ly19,44137675,2.3679558923660333
MSTO-211H,3815108,2.5678993468563913
HCC1438,71729975,1.8405594359264488
A4/Fukuda,11485656,1.5130746228374388
HSC-4,24753719,5.996217074466553
KMH-2,10385095,1.3020469045256973
BT 416,11404337,-1.6662073764284366
JURL-MK1,100016,3.373338788856286
TCCSUP,54618771,0.6448534643306117
SUP-HD1,6450551,1.4924530542960874
Kasumi-1,sirolimus-bortezomib (250-1 mol-mol),0.3681691235754297
MDA-MB-468,10385095,1.6609124988223734
KMS-12-BM,49766530,-2.33896572420352
JURL-MK1,sirolimus-bortezomib (250-1 mol-mol),0.9558536767512098
P31/FUJ,9911830,2.020541196825024
HMCB,JQ-1-UNC0638 (2-1 mol-mol),1.877058831391371
MOTN-1,24753719,3.563807007676044
Panc 03.27,4259181,0.909110974092044
OC 314,49766530,-1.543055424188454
MKN45,2729026,3.206261332446347
KG-1-C,71729975,4.747785431252355
SK-MEL-3,2708,5.344714114373152
BT 216,11167602,3.059440616592098
NCI-H524,24772860,-1.3087275004492671
CAS-1,11485656,3.26266946526555
SNU-407,654092,0.3697475734908541
BT 482,11485656,2.703365491527676
SUP-B15,6918638,-0.8049733622393979
Panc 03.27,44493528,4.213944098974542
Hs 895.T,6450551,3.001050751256472
HCC1428,sirolimus-bortezomib (250-1 mol-mol),2.58650359596758
SU-DHL-4,2708,3.4053245033521713
BT 172,1716436,2.1771388217095993
Caov-3,24772860,-3.025566484938214
CAL-29,11167602,3.3383566807946288
JHOC-5,135984461,1.694493037424127
KE-97,54618305,4.294665496814293
CAL-27,24772860,-2.8278764601248274
KP-4,73707371,2.537312209041087
SW948,11167602,-0.1815305116238505
NCI-H1703,148198,-3.5169860092327587
MHH-CALL-4,135984461,1.796074414413381
BL-70,73707371,5.067539770481929
Panc 05.04,24772860,-2.9601078904369578
FU-OV-1,6450551,4.626381712180732
NCI-H2172,4259181,0.413697798920579
JHUEM-7,4259181,0.2879228284005847
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068
Kelly,sirolimus-bortezomib (250-1 mol-mol),0.1077150919065075
HCC38,10385095,1.2215690544753306
A-549,9929138,6.139762216307962
SUIT-2,9911463,4.378510442631056
RL,753704,3.896552588967951
SNU-1033,10302451,2.931783952664607
DEL,4259181,-1.3760879211511634
F-36P,24772860,-2.6351824640153763
SNU-182,2708,5.059685933759318
Ku812,24753719,3.51384685300995
TE 441.T,24772860,-4.205282472336712
OV56,100016,6.603582199202106
A-172,46926350,-4.396406733680627
SU-DHL-8,753704,4.36356218442609
SJSA-1,10302451,4.357577903208362
MOLM-13,11404337,-1.791363376051536
A2780,124202324,1.685811695923782
HLF,753704,4.633571663294208
CW-2,151289,0.2181536124759329
NCI-H2081,11167602,4.408206719858069
L-428,49766530,-2.874438748279996
GDM-1,44137675,2.7570773503896713
PE/CA-PJ15,9911830,3.3068944538526672
KMRC-2,11485656,3.489579667056433
Rh41,100016,7.167579216403683
Detroit 562,10302451,2.263442382574537
LOX-IMVI,24772860,-2.5240469828526804
GI-1,24772860,-2.3533285455497657
8505C,753704,4.5823361843887485
KYSE-70,11485656,2.2230455690794404
CA46,10385095,0.6992054873225039
KP-3,24772860,-1.376396591458844
Mel JuSo,9929138,7.586814417068839
TOV-112D,73707371,5.00249336642374
HCC4006,100016,6.421907923076987
Panc 04.03,4259181,1.0934261994249337
T98G,9911830,1.7364710964395085
EJM,156414,1.801807158025587
Becker,49766530,0.5239013848654858
NCI-H661,16013152,4.678017706607999
PK-45H,1716436,3.7988626900403526
NCI-H522,16013152,4.870026952980287
P12-Ichikawa,tanespimycin-bortezomib (250-1 mol-mol),0.3962036190597272
M-07e,100016,5.065678373530031
AMO1,11485656,2.1088209303297853
Rh18,10385095,0.8210854840293843
KU-19-19,10385095,1.1563887024661463
F-36P,2708,4.819851744198275
SW579,9911463,4.038751545861884
SUP-HD1,1716436,2.7716731084323016
SNU-398,1716436,1.836783199484958
SNU-398,24753719,4.047798166557335
T-47D,71729975,2.1492138438934
DU145,16013152,4.600431994901221
DBTRG-05MG,11404337,1.1943390639472689
CML-T1,654092,-1.9909155078044125
CAL-78,2708,4.711360500170474
L-363,sirolimus-bortezomib (250-1 mol-mol),-5.312309266116436
SNU-886,9868037,2.869419012431549
Tm87-16,46926350,-4.44804316966816
42-MG-BA,6450551,0.8751814188005194
P3HR-1,11404337,-1.4937921094684845
WM88,49766530,-2.7931642846980336
TE-14,156414,0.150817369290719
COLO 668,11485656,1.801054934064134
CCF-STTG1,49766530,2.4939305222304955
HCC95,44137675,3.41438877812816
VM-CUB-1,24772860,-2.0696156142982423
Kasumi-2,9911463,3.4999156831259524
NU-DHL-1,136227924,1.2519389073848997
Panc 10.05,71729975,2.7302095930183676
Panc 08.13,148198,-3.0939761234000867
A4/Fukuda,46926350,-6.021657358635238
DU4475,10302451,3.9480605085423934
COR-L95,135659046,3.614564650544248
TE-8,24772860,-2.4753695450245843
253J,10385095,0.938050191732742
SK-LU-1,654092,-1.297052349889113
HEC-151,1716436,2.3472897882552934
NCI-H2106,24772860,-1.9055903633608384
Peer,11485656,-0.7259490318952384
DB,327653,2.4976994881662176
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
SNU-81,11404337,-1.7380856142345846
MOTN-1,49766530,-1.5651845787849432
IMR-32,2708,-0.4057818743536672
Namalwa,135659046,3.012855120581617
IM95,4259181,0.4193994056923691
SH-10-TC,11485656,3.549629960388959
NCI-H2171,136227924,2.167829841056951
KE-37,11485656,2.1580092270767195
SNU-738,sirolimus-bortezomib (250-1 mol-mol),1.9846643128257275
JHH-1,11485656,1.826654230939741
SNB-75,44137675,2.606291063080676
MOLM-6,136227924,2.6719988051227386
Mel JuSo,54618771,-0.9101150768043303
SUP-T1,151289,-0.1549685683143522
GCT,9911463,3.61026772748382
LOX-IMVI,1716436,2.742191548992314
NCI-H522,selumetinib-BRD-A02303741 (4-1 mol-mol),6.687730464329683
LS123,44137675,2.6196340300963823
NCI-H358,654092,-0.1898986712275995
COR-L51,JQ-1-UNC0638 (2-1 mol-mol),0.9333834310105288
RERF-LC-Ad2,24753719,4.674751178496499
JHH-1,tanespimycin-bortezomib (250-1 mol-mol),1.1160802698150678
SW1710,327653,3.020796751011318
DU145,54618305,4.450294310090801
NCI-H196,44137675,5.149945093178445
BICR 16,4259181,0.912961687518015
MKN7,sirolimus-bortezomib (250-1 mol-mol),1.1357480366001242
CAL-54,16013152,4.245347288600714
Hs 895.T,44137675,5.596751403992499
SK-CO-1,9911463,3.850014047184169
Hs 936.T,selumetinib-BRD-A02303741 (4-1 mol-mol),1.0598371629693188
JK-1,156414,0.0859453244387242
MOLT-16,135984461,1.926751672348732
HCC1171,1716436,1.7315968522075582
KP-3,2729026,1.3395123265794755
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
MOLP-8,151289,0.9447515089929442
KMS-21-BM,11485656,0.7331254638608181
SUP-T1,11485656,1.1772627696716973
VMRC-RCZ,tanespimycin-bortezomib (250-1 mol-mol),0.3038563935305308
F-36P,49766530,-1.869404688444432
C2BBe1,tanespimycin-bortezomib (250-1 mol-mol),0.2943844142837441
LoVo,44137675,-1.419079349485425
WM983B,54618771,1.7213296960323683
Lu-65,2708,5.479352175899552
TE-9,148198,-2.1853005512510273
PK-1,10385095,1.3878392375696291
LN-18,11404337,-1.073662299758218
SUP-T1,9911830,2.159346176314347
TF-1,11167602,1.5429843870165718
JM-1,10302451,3.097435274235228
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
KMRC-20,44493528,4.509843443263092
Kuramochi,2708,6.131312428318119
JJN-3,tanespimycin-bortezomib (250-1 mol-mol),-0.8037062174146113
IM95,54618771,0.6089600215622465
COLO 684,54618771,1.417005870587021
MDA-MB-361,6450551,3.384125096029797
IGR-37,10302451,3.8582187124778256
TCC-Pan2,24772860,-2.893365435945881
JHUEM-3,JQ-1-UNC0638 (2-1 mol-mol),-0.2276777929693784
Mino,54618771,0.6228570132231963
Hs 729.T,136227924,2.3598946894515014
EFM-192A,9911830,2.136951075803696
Rh18,9911463,3.04547091228865
HCC1806,11404337,0.4604274664094434
NCI-H838,2708,5.593660299890968
NCI-H1563,9868037,3.932153442928962
KMS-26,9868037,2.2608372373619035
NCI-H1650,10302451,0.6144197701725324
NCI-H1105,4259181,0.6146385538816125
DK-MG,9903786,4.148261806293546
Tm87-16,327653,5.240333301807643
T84,24772860,-2.2321870957335044
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
NCI-H1666,654092,-1.445610835865283
SUP-B15,2729026,2.692343978657963
BICR 56,136227924,3.153782585129781
HCC2935,6918638,1.4896193076974535
OC 314,327653,2.3635468308659884
KMRC-3,156414,2.3420261536798663
KM12,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5028366223098897
A-549,11404337,-0.2898707579606809
A-549,73707371,7.165992114804081
SW1990,54618771,1.819696432191247
KE-97,JQ-1-UNC0638 (2-1 mol-mol),-0.6270436261512444
PK-1,44493528,4.319827010327948
COLO 678,54618771,1.45327687843265
MOTN-1,10385095,0.7679120233788934
SCC-9,44137675,3.491154886377157
KMRC-3,46926350,-3.688095057910011
B-CPAP,JQ-1-UNC0638 (2-1 mol-mol),3.2358489904077974
UM-UC-1,9903786,1.5514700820318568
MOLT-13,100016,6.122983577816604
HMCB,10302451,4.070081150685941
BT 147,327653,3.2470694295501925
HEC-108,136227924,3.134071919213167
NCI-H520,2729026,2.308184531900117
SW579,151289,0.9431909293310275
MKN7,135984461,4.326296832547204
LAMA-84,6450551,-1.6156867594557935
SW579,2729026,2.212246109373124
OAW28,11404337,-1.5682838378564492
JHH-2,9911830,1.7687500662887066
NCI-H520,151289,0.039040478566736
P3HR-1,44493528,4.479492051657015
BT 179,54618771,0.9924128093703488
SK-MEL-31,11404337,-0.7650509670659701
BT-16,6918638,2.124835074302428
MDA-MB-415,9911830,3.5900525948825943
SNU-1105,11167602,4.397999517431836
Jurkat,148198,-2.758721203845009
UACC-62,44137675,4.219765185876073
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
SNU-1077,9903786,3.350516769184116
BT 147,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2804682208262355
RCH-ACV,2729026,1.7385305215865103
JMSU-1,sirolimus-bortezomib (250-1 mol-mol),0.8204079064012788
RS4;11,2708,1.600681854906589
KYSE-180,24753719,4.5603328664886815
HCC1500,4259181,0.9827468065480526
HPAF-II,44137675,4.264045865375576
TOV-21G,11485656,3.507052738885456
Ri-1,44137675,-1.093711141379852
BT 216,1716436,2.8982950278539437
HPAF-II,2708,6.325129443475367
SNU-1,44137675,2.385620066916014
NCI-H1184,44493528,4.250778003560126
SU.86.86,44137675,3.841169845767472
SNU-626,10385095,1.227927473052019
SNU-478,24753719,4.1429991016755245
NCI-H650,753704,4.877646476379343
TT2609-C02,sirolimus-bortezomib (250-1 mol-mol),1.6449110161663607
SW1353,3815108,2.6898468007627714
Kelly,54618771,0.9246671147478912
NCI-H1581,73707371,3.4076225972881065
769-P,11404337,1.353529745525745
TALL-1 [Human adult T-ALL],11167602,2.991652645826846
A4/Fukuda,4259181,-0.5702867723998835
CAL-78,327653,3.706712543295155
CAL-33,71729975,1.8021369908286369
RKO,151289,1.190219151105647
NCI-H460,4259181,-0.2054535095090753
NCI-H810,24753719,4.056303258094418
Kasumi-2,11404337,-1.9658161518336
HCC1195,54618771,3.4499455256162475
KMBC-2,46926350,-3.492426009474656
HCC827,4259181,1.5760084140568134
BT-549,6918638,1.3825585614023566
JHOC-5,9911830,3.201289712563667
Namalwa,10385095,0.4710651537039255
MSTO-211H,9903786,1.212702371904443
HCC1806,44493528,4.3111329846285456
BT 179,10385095,1.0109187966932571
NCI-H716,136227924,3.096712149885638
NCI-H1650,44137675,2.783386782394636
IPC-298,10302451,3.9740679982268583
THP-1,49766530,-1.885819657206308
A-549,124202324,3.059134662451402
SNU-423,4259181,1.1208846332757925
SNB-75,9911463,3.761177145867038
SW1088,tanespimycin-bortezomib (250-1 mol-mol),0.2648421366318154
HEC-108,11404337,0.7883165010808656
HL-60,9911463,4.3879479306105535
MHH-ES-1,2729026,2.110594567233672
KMS-27,135984461,4.260058247162953
SUIT-2,2708,5.853191341721484
BICR 31,24753719,4.233476426959058
OCI-Ly3,2708,2.3361844090683954
HEC-1-A,136227924,3.4085098693584603
NCI-H647,135659046,3.6743271693589854
UACC-257,tanespimycin-bortezomib (250-1 mol-mol),0.2764764402822645
KCL-22,selumetinib-BRD-A02303741 (4-1 mol-mol),4.022431947674124
BICR 22,6918638,0.0558003797401064
KE-39,24753719,4.8851025960405074
NCI-H2030,JQ-1-UNC0638 (2-1 mol-mol),1.861719916285668
LS513,124202324,2.511077432388408
EBC-1,2729026,2.018219663942541
SNU-478,10302451,0.1456730012173813
JHUEM-2,10385095,1.0298503293450711
MeWo,1716436,3.795811577007405
OCI-Ly3,9903786,0.6513092256101434
SW620,44137675,3.8457015455646646
HuG1-N,10385095,1.5611722738302254
Kasumi-2,135984461,1.6284116850001094
SNU-1066,148198,-2.6456216345814636
LMSU,374536,2.9263574161338046
HEC-6,9929138,7.579418638994079
Caki-2,2729026,2.9887282671303645
Mono-Mac-1,11485656,2.9972427080576836
Hs 683,46926350,-4.250334489293196
DMS 454,4259181,-0.0206188051189722
TM-31,148198,-3.484551999538721
SNU-466,11404337,-0.8937710860512643
NU-DHL-1,10385095,-0.0540424655836512
SNU-878,374536,-1.6762250123080131
HCC78,654092,0.5520512448578595
HCC827,24772860,-3.827013750759483
5637,1716436,3.3242913974609505
HCC202,10302451,3.435018280200959
PC-14,151289,1.4486982071000016
Peer,24772860,-2.8212788231800396
GaMG,654092,0.3145137986177059
JHUEM-3,2708,5.357001425929142
PK-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.3428687974510214
OCI-Ly10,24753719,4.462719317862582
COLO 699,654092,-0.0714299922843553
MKN74,156414,1.3103031812830657
LK-2,4259181,-0.1712437938177803
CCF-STTG1,JQ-1-UNC0638 (2-1 mol-mol),3.4637042850719095
MHH-ES-1,4259181,-2.005736185062781
JURL-MK1,10385095,1.017024501660633
PF-382,135984461,1.6582229573318208
NCI-H1155,124202324,2.474753814913204
OV7,selumetinib-BRD-A02303741 (4-1 mol-mol),4.639093854306231
CAL-148,9929138,4.85675773122561
NCI-H1299,10385095,1.4970328026397637
TOV-21G,148198,-4.474336423229386
Peer,3815108,1.5156656137434028
SK-N-AS,100016,6.379811774246359
LS513,6450551,2.077374330010029
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
KYM-1,100016,6.934049900113359
GA-10,374536,0.5877741453587988
KMS-20,11167602,1.9500667412435135
HD-MY-Z,100016,6.5820470291511555
NCI-H1299,11404337,0.8410914432786373
NU-DHL-1,49766530,-4.7275009055236445
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356
YH-13,2708,5.143963890139275
HCT 116,3815108,3.4290107179159617
CAL-85-1,9903786,2.154153676778314
TALL-1 [Human adult T-ALL],136227924,2.458144705929413
EFM-192A,135659046,3.6859856473219175
T-47D,6450551,2.553066965945153
HuCC-T1,2708,5.065665330708941
NCI-H1734,24753719,3.5136564159683092
Fu97,54639665,-0.9928942554758008
SW982,9911463,4.45911198153204
EM-2,9903786,1.526711348749508
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
BDCM,44137675,-0.3389667125505894
SW1116,124202324,1.63903378008797
HOS,148198,-4.398135238674327
GSU,100016,6.3262103117900805
NALM-6,753704,2.6234635799418786
UM-UC-3,11485656,2.116231508741626
Granta-519,151289,0.2062194994497177
RS4;11,sirolimus-bortezomib (250-1 mol-mol),0.1711857782285224
KYSE-30,10385095,1.4963223193065267
KYSE-450,9911830,2.46681001783931
HCT 15,44137675,2.1168770528875953
MCF-7,9911830,3.315374840346173
HuH-28,9903786,2.984330186348554
MIA PaCa-2,9911830,2.066034374401692
Mel JuSo,selumetinib-BRD-A02303741 (4-1 mol-mol),4.153695307613076
Mel Ho,327653,3.195481244425943
MM1.S,10302451,3.7035556434363808
Hs 578T,11485656,1.5061337844813831
UM-UC-3,9911463,4.051295962185813
Mino,11167602,5.227056331573394
YD-38,11404337,-1.21391516825444
MSTO-211H,2729026,1.9618514095460544
OS-RC-2,54618771,2.9628716823736334
BT 440,JQ-1-UNC0638 (2-1 mol-mol),2.869213983756096
BICR 16,9903786,3.9167102075651785
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
P31/FUJ,1716436,3.053886593694114
EJM,54618771,0.5366367501744294
